{\rtf1\adeflang1025\ansi\ansicpg10000\uc1\adeff0\deff0\stshfdbch0\stshfloch0\stshfhich0\stshfbi0\deflang1033\deflangfe1033\themelang1033\themelangfe0\themelangcs0{\fonttbl{\f0\fbidi \fnil\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\f1\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604020202020204}Arial;}{\f2\fbidi \fnil\fcharset0\fprq2{\*\panose 02070309020205020404}Courier New;}{\f3\fbidi \fnil\fcharset2\fprq2{\*\panose 00000000000000000000}Symbol;}{\f4\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Times;}{\f5\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}Helvetica;}{\f6\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Courier;}{\f7\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503030404040204}Geneva;}{\f8\fbidi \froman\fcharset77\fprq2{\*\panose 00000000000000000000}Tms Rmn;}{\f9\fbidi \fswiss\fcharset77\fprq2{\*\panose 00000000000000000000}Helv;}{\f10\fbidi \froman\fcharset77\fprq2{\*\panose 00000000000000000000}MS Serif;}{\f11\fbidi \fswiss\fcharset77\fprq2{\*\panose 00000000000000000000}MS Sans Serif;}{\f12\fbidi \froman\fcharset77\fprq2{\*\panose 00000000000000000000}New York;}{\f13\fbidi \fswiss\fcharset77\fprq2{\*\panose 00000000000000000000}System;}{\f14\fbidi \fnil\fcharset2\fprq2{\*\panose 05000000000000000000}Wingdings;}{\f15\fbidi \fnil\fcharset78\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9;}{\f16\fbidi \fnil\fcharset79\fprq2 \'b9\'d9\'c5\'c1;}{\f17\fbidi \fnil\fcharset80\fprq2 \'cb\'ce\'cc\'e5;}{\f18\fbidi \fnil\fcharset81\fprq2 \'b7\'73\'b2\'d3\'a9\'fa\'c5\'e9;}{\f19\fbidi \fnil\fcharset78\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e;}{\f20\fbidi \fnil\fcharset0\fprq2{\*\panose 02040604050505020304}Century;}{\f21\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604030504040204}Verdana;}{\f22\fbidi \froman\fcharset222\fprq2{\*\panose 00000000000000000000}Angsana New;}{\f23\fbidi \froman\fcharset222\fprq2{\*\panose 00000000000000000000}Cordia New;}{\f24\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Mangal;}{\f25\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Latha;}{\f26\fbidi \froman\fcharset77\fprq2{\*\panose 00000000000000000000}Sylfaen;}{\f27\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Vrinda;}{\f28\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Raavi;}{\f29\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Shruti;}{\f30\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Sendnya;}{\f31\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Gautami;}{\f32\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Tunga;}{\f33\fbidi \froman\fcharset1\fprq2{\*\panose 00000000000000000000}Estrangelo Edessa;}{\f34\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050406030204}Cambria Math;}{\f35\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0502020204030204}Calibri;}{\f36\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050406030204}Cambria;}{\f37\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0a06030101010103}Abadi MT Condensed Extra Bold;}{\f38\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0306030101010103}Abadi MT Condensed Light;}{\f39\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Academy Engraved LET;}{\f40\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050201020203}Adobe Arabic;}{\f41\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703060201020203}Adobe Arabic Bold;}{\f42\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703060201090203}Adobe Arabic Bold Italic;}{\f43\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050201090203}Adobe Arabic Italic;}{\f44\fbidi \fnil\fcharset0\fprq2{\*\panose 0205050205050a020403}Adobe Caslon Pro;}{\f45\fbidi \fnil\fcharset0\fprq2{\*\panose 0205070206050a020403}Adobe Caslon Pro Bold;}{\f46\fbidi \fnil\fcharset0\fprq2{\*\panose 0205070206050b090a03}Adobe Caslon Pro Bold Italic;}{\f47\fbidi \fnil\fcharset0\fprq2{\*\panose 0205050205050b090a03}Adobe Caslon Pro Italic;}{\f48\fbidi \fnil\fcharset0\fprq2{\*\panose 0205060205050a020403}Adobe Caslon Pro SmBd;}{\f49\fbidi \fnil\fcharset0\fprq2{\*\panose 0205060205050b090a03}Adobe Caslon Pro SmBd Italic;}{\f50\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050201020203}Adobe Devanagari;}{\f51\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703060201020203}Adobe Devanagari Bold;}{\f52\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703060201090203}Adobe Devanagari Bold Italic;}{\f53\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050201090203}Adobe Devanagari Italic;}{\f54\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502060506020403}Adobe Garamond Pro;}{\f55\fbidi \fnil\fcharset0\fprq2{\*\panose 02020702060506020403}Adobe Garamond Pro Bold;}{\f56\fbidi \fnil\fcharset0\fprq2{\*\panose 02020702060506090403}Adobe Garamond Pro Bold Italic;}{\f57\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502050506090403}Adobe Garamond Pro Italic;}{\f58\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050201020203}Adobe Hebrew;}{\f59\fbidi \fnil\fcharset0\fprq2{\*\panose 02040603060201020203}Adobe Hebrew Bold;}{\f60\fbidi \fnil\fcharset0\fprq2{\*\panose 02040603060201090203}Adobe Hebrew Bold Italic;}{\f61\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050201090203}Adobe Hebrew Italic;}{\f62\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Adobe Naskh Medium;}{\f63\fbidi \fnil\fcharset0\fprq2{\*\panose 02090604020004020304}American Typewriter;}{\f64\fbidi \fnil\fcharset0\fprq2{\*\panose 02090606020004020304}American Typewriter Condensed;}{\f65\fbidi \fnil\fcharset0\fprq2{\*\panose 02090304020004020304}American Typewriter Light;}{\f66\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0509000000000004}Andale Mono;}{\f67\fbidi \fnil\fcharset0\fprq2{\*\panose 03020702040506060504}Apple Chancery;}{\f68\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Apple Symbols;}{\f69\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0a04020102020204}Arial Black;}{\f70\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0704020202020204}Arial Bold;}{\f71\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0704020202090204}Arial Bold Italic;}{\f72\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604020202090204}Arial Italic;}{\f73\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506020202030204}Arial Narrow;}{\f74\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0706020202030204}Arial Narrow Bold;}{\f75\fbidi \fnil\fcharset0\fprq2{\*\panose 020b07060202020a0204}Arial Narrow Bold Italic;}{\f76\fbidi \fnil\fcharset0\fprq2{\*\panose 020b06060202020a0204}Arial Narrow Italic;}{\f77\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0704030504030204}Arial Rounded MT Bold;}{\f78\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604020202020204}Arial Unicode MS;}{\f79\fbidi \fnil\fcharset0\fprq2{\*\panose 02000803070000020003}Athelas Bold;}{\f80\fbidi \fnil\fcharset0\fprq2{\*\panose 02000803000000090003}Athelas Bold Italic;}{\f81\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503000000090003}Athelas Italic;}{\f82\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503000000020003}Athelas Regular;}{\f83\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803020203020204}Avenir Black;}{\f84\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803020203090204}Avenir Black Oblique;}{\f85\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503020000020003}Avenir Book;}{\f86\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503020000020003}Avenir Book Oblique;}{\f87\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020203020204}Avenir Heavy;}{\f88\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020203090204}Avenir Heavy Oblique;}{\f89\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0402020203020204}Avenir Light;}{\f90\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0402020203090204}Avenir Light Oblique;}{\f91\fbidi \fnil\fcharset0\fprq2{\*\panose 02000603020000020003}Avenir Medium;}{\f92\fbidi \fnil\fcharset0\fprq2{\*\panose 02000603020000020003}Avenir Medium Oblique;}{\f93\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803020202020204}Avenir Next Bold;}{\f94\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803020202090204}Avenir Next Bold Italic;}{\f95\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0806020202020204}Avenir Next Condensed Bold;}{\f96\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0706020202020204}Avenir Next Condensed Demi Bold;}{\f97\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0906020202020204}Avenir Next Condensed Heavy;}{\f98\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506020202090204}Avenir Next Condensed Italic;}{\f99\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0606020202020204}Avenir Next Condensed Medium;}{\f100\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506020202020204}Avenir Next Condensed Regular;}{\f101\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020202020204}Avenir Next Demi Bold;}{\f102\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020202090204}Avenir Next Demi Bold Italic;}{\f103\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0903020202020204}Avenir Next Heavy;}{\f104\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0903020202090204}Avenir Next Heavy Italic;}{\f105\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020202090204}Avenir Next Italic;}{\f106\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603020202020204}Avenir Next Medium;}{\f107\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603020202090204}Avenir Next Medium Italic;}{\f108\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020202020204}Avenir Next Regular;}{\f109\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0203020202020204}Avenir Next Ultra Light;}{\f110\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0203020202090204}Avenir Next Ultra Light Italic;}{\f111\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020203090204}Avenir Oblique;}{\f112\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020203020204}Avenir Roman;}{\f113\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Ayuthaya;}{\f114\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500020000000000}Bangla MN;}{\f115\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500020000000000}Bangla MN Bold;}{\f116\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Bangla Sangam MN;}{\f117\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Bangla Sangam MN Bold;}{\f118\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Bank Gothic;}{\f119\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Baoli SC Regular;}{\f120\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502070401020303}Baskerville;}{\f121\fbidi \fnil\fcharset0\fprq2{\*\panose 02020802070401020303}Baskerville Bold;}{\f122\fbidi \fnil\fcharset0\fprq2{\*\panose 02020802070401090303}Baskerville Bold Italic;}{\f123\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502070401020303}Baskerville Italic;}{\f124\fbidi \fnil\fcharset0\fprq2{\*\panose 02020602080505020303}Baskerville Old Face;}{\f125\fbidi \fnil\fcharset0\fprq2{\*\panose 02020802070401020303}Baskerville SemiBold;}{\f126\fbidi \fnil\fcharset0\fprq2{\*\panose 02020702070400090203}Baskerville SemiBold Italic;}{\f127\fbidi \fnil\fcharset0\fprq2{\*\panose 04030905020b02020c02}Bauhaus 93;}{\f128\fbidi \fnil\fcharset0\fprq2{\*\panose 00000600000000000000}Beirut;}{\f129\fbidi \fnil\fcharset0\fprq2{\*\panose 02020503060305020303}Bell MT;}{\f130\fbidi \fnil\fcharset0\fprq2{\*\panose 02050806060905020404}Bernard MT Condensed;}{\f131\fbidi \fnil\fcharset0\fprq2{\*\panose 02000603090000020003}Big Caslon;}{\f132\fbidi \fnil\fcharset0\fprq2{\*\panose 03060502040705060204}Birch Std;}{\f133\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Blackmoor LET;}{\f134\fbidi \fnil\fcharset0\fprq2{\*\panose 04050907060602020202}Blackoak Std;}{\f135\fbidi \fnil\fcharset0\fprq2{\*\panose 00000500000000000000}BlairMdITC TT-Medium;}{\f136\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Bodoni Ornaments ITC TT;}{\f137\fbidi \fnil\fcharset0\fprq2{\*\panose 00000700000000000000}Bodoni SvtyTwo ITC TT-Bold;}{\f138\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Bodoni SvtyTwo ITC TT-Book;}{\f139\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Bodoni SvtyTwo ITC TT-BookIta;}{\f140\fbidi \fnil\fcharset0\fprq2{\*\panose 00000700000000000000}Bodoni SvtyTwo OS ITC TT-Bold;}{\f141\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Bodoni SvtyTwo OS ITC TT-Book;}{\f142\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Bodoni SvtyTwo OS ITC TT-BookIt;}{\f143\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Bodoni SvtyTwo SC ITC TT-Book;}{\f144\fbidi \fnil\fcharset0\fprq2{\*\panose 02040602050305030304}Book Antiqua;}{\f145\fbidi \fnil\fcharset0\fprq2{\*\panose 02050604050505020204}Bookman Old Style;}{\f146\fbidi \fnil\fcharset0\fprq2{\*\panose 05010101010101010101}Bookshelf Symbol 7;}{\f147\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Bordeaux Roman Bold LET;}{\f148\fbidi \fnil\fcharset0\fprq2{\*\panose 00000700000000000000}Bradley Hand ITC TT-Bold;}{\f149\fbidi \fnil\fcharset0\fprq2{\*\panose 04030b070d0b02020403}Braggadocio;}{\f150\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0903060703020204}Britannic Bold;}{\f151\fbidi \fnil\fcharset0\fprq2{\*\panose 03060802040406070304}Brush Script MT Italic;}{\f152\fbidi \fnil\fcharset0\fprq2{\*\panose 03060802040607070404}Brush Script Std;}{\f153\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0702030404030204}Calibri Bold;}{\f154\fbidi \fnil\fcharset0\fprq2{\*\panose 020f07020304040a0204}Calibri Bold Italic;}{\f155\fbidi \fnil\fcharset0\fprq2{\*\panose 020f05020202040a0204}Calibri Italic;}{\f156\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0302020204030204}Calibri Light;}{\f157\fbidi \fnil\fcharset0\fprq2{\*\panose 02040603050505030304}Calisto MT;}{\f158\fbidi \fnil\fcharset0\fprq2{\*\panose 02040803050406030204}Cambria Bold;}{\f159\fbidi \fnil\fcharset0\fprq2{\*\panose 020408030504060a0204}Cambria Bold Italic;}{\f160\fbidi \fnil\fcharset0\fprq2{\*\panose 020405030504060a0204}Cambria Italic;}{\f161\fbidi \fnil\fcharset0\fprq2{\*\panose 020e0502030303020204}Candara;}{\f162\fbidi \fnil\fcharset0\fprq2{\*\panose 020e0702030303020204}Candara Bold;}{\f163\fbidi \fnil\fcharset0\fprq2{\*\panose 020e0702030303090204}Candara Bold Italic;}{\f164\fbidi \fnil\fcharset0\fprq2{\*\panose 020e0502030303090204}Candara Italic;}{\f165\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Capitals;}{\f166\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0502020202020204}Century Gothic;}{\f167\fbidi \fnil\fcharset0\fprq2{\*\panose 02040604050505020304}Century Schoolbook;}{\f168\fbidi \fnil\fcharset0\fprq2{\*\panose 03050602040202020205}Chalkboard;}{\f169\fbidi \fnil\fcharset0\fprq2{\*\panose 03050602040202020205}Chalkboard Bold;}{\f170\fbidi \fnil\fcharset0\fprq2{\*\panose 03050602040202020205}Chalkboard SE Bold;}{\f171\fbidi \fnil\fcharset0\fprq2{\*\panose 03050602040202020205}Chalkboard SE Light;}{\f172\fbidi \fnil\fcharset0\fprq2{\*\panose 03050602040202020205}Chalkboard SE Regular;}{\f173\fbidi \fnil\fcharset0\fprq2{\*\panose 03050602040202020205}Chalkduster;}{\f174\fbidi \fnil\fcharset0\fprq2{\*\panose 02060503040505020203}Chaparral Pro;}{\f175\fbidi \fnil\fcharset0\fprq2{\*\panose 02060503040505020203}Chaparral Pro Bold;}{\f176\fbidi \fnil\fcharset0\fprq2{\*\panose 02060803050505090203}Chaparral Pro Bold Ital;}{\f177\fbidi \fnil\fcharset0\fprq2{\*\panose 02060503040505090203}Chaparral Pro Ital;}{\f178\fbidi \fnil\fcharset0\fprq2{\*\panose 02060403030505090203}Chaparral Pro Light Ital;}{\f179\fbidi \fnil\fcharset0\fprq2{\*\panose 04020705060702020204}Charlemagne Std Bold;}{\f180\fbidi \fnil\fcharset0\fprq2{\*\panose 02040803050506020203}Charter Black;}{\f181\fbidi \fnil\fcharset0\fprq2{\*\panose 02040803050506090203}Charter Black Italic;}{\f182\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703050506020203}Charter Bold;}{\f183\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703050506090203}Charter Bold Italic;}{\f184\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050506090203}Charter Italic;}{\f185\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050506020203}Charter Roman;}{\f186\fbidi \fnil\fcharset0\fprq2{\*\panose 02000603020000020003}Cochin;}{\f187\fbidi \fnil\fcharset0\fprq2{\*\panose 04020805060202030203}Colonna MT;}{\f188\fbidi \fnil\fcharset0\fprq2{\*\panose 030f0702030302020204}Comic Sans MS;}{\f189\fbidi \fnil\fcharset0\fprq2{\*\panose 030f0902030302020204}Comic Sans MS Bold;}{\f190\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0609020204030204}Consolas;}{\f191\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0709020204030204}Consolas Bold;}{\f192\fbidi \fnil\fcharset0\fprq2{\*\panose 020b07090202040a0204}Consolas Bold Italic;}{\f193\fbidi \fnil\fcharset0\fprq2{\*\panose 020b06090202040a0204}Consolas Italic;}{\f194\fbidi \fnil\fcharset0\fprq2{\*\panose 02030602050306030303}Constantia;}{\f195\fbidi \fnil\fcharset0\fprq2{\*\panose 02030702060306030303}Constantia Bold;}{\f196\fbidi \fnil\fcharset0\fprq2{\*\panose 020307020603060a0303}Constantia Bold Italic;}{\f197\fbidi \fnil\fcharset0\fprq2{\*\panose 020306020503060a0303}Constantia Italic;}{\f198\fbidi \fnil\fcharset0\fprq2{\*\panose 0208090404030b020404}Cooper Black;}{\f199\fbidi \fnil\fcharset0\fprq2{\*\panose 0208090305030b090404}Cooper Black Std Italic;}{\f200\fbidi \fnil\fcharset0\fprq2{\*\panose 0208090304030b020404}Cooper Std Black;}{\f201\fbidi \fnil\fcharset0\fprq2{\*\panose 02000504000000020004}Copperplate;}{\f202\fbidi \fnil\fcharset0\fprq2{\*\panose 02000904050000020004}Copperplate Bold;}{\f203\fbidi \fnil\fcharset0\fprq2{\*\panose 020e0705020206020404}Copperplate Gothic Bold;}{\f204\fbidi \fnil\fcharset0\fprq2{\*\panose 020e0507020206020404}Copperplate Gothic Light;}{\f205\fbidi \fnil\fcharset0\fprq2{\*\panose 02000604030000020004}Copperplate Light;}{\f206\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020204020204}Corbel;}{\f207\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020204020204}Corbel Bold;}{\f208\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020204090204}Corbel Bold Italic;}{\f209\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020204090204}Corbel Italic;}{\f210\fbidi \fnil\fcharset0\fprq2{\*\panose 02070609020205020404}Courier New Bold;}{\f211\fbidi \fnil\fcharset0\fprq2{\*\panose 02070609020205090404}Courier New Bold Italic;}{\f212\fbidi \fnil\fcharset0\fprq2{\*\panose 02070409020205090404}Courier New Italic;}{\f213\fbidi \fnil\fcharset0\fprq2{\*\panose 04040404050702020202}Curlz MT;}{\f214\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Damascus;}{\f215\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Damascus Bold;}{\f216\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}Damascus Medium;}{\f217\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}Damascus Semi Bold;}{\f218\fbidi \fnil\fcharset0\fprq2{\*\panose 04020505020e03040504}Desdemona;}{\f219\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Devanagari Sangam MN;}{\f220\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Devanagari Sangam MN Bold;}{\f221\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0500000000000000}DIN Alternate Bold;}{\f222\fbidi \fnil\fcharset0\fprq2{\*\panose 00000500000000000000}DIN Condensed Bold;}{\f223\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503000000020003}Didot;}{\f224\fbidi \fnil\fcharset0\fprq2{\*\panose 030303020407070d0804}Edwardian Script ITC;}{\f225\fbidi \fnil\fcharset0\fprq2{\*\panose 02090707080505020304}Engravers MT;}{\f226\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503040102020104}Euphemia UCAS;}{\f227\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803040102020104}Euphemia UCAS Bold;}{\f228\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503040102020104}Euphemia UCAS Italic;}{\f229\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0504020202050204}Eurostile;}{\f230\fbidi \fnil\fcharset0\fprq2{\*\panose 0204060206030a020304}Footlight MT Light;}{\f231\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020102020204}Franklin Gothic Book;}{\f232\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020102090204}Franklin Gothic Book Italic;}{\f233\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603020102020204}Franklin Gothic Medium;}{\f234\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603020102090204}Franklin Gothic Medium Italic;}{\f235\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0602020204020303}Futura;}{\f236\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506020204030204}Futura Condensed;}{\f237\fbidi \fnil\fcharset0\fprq2{\*\panose 04040605051002020d02}Gabriola;}{\f238\fbidi \fnil\fcharset0\fprq2{\*\panose 02020404030301010803}Garamond;}{\f239\fbidi \fnil\fcharset0\fprq2{\*\panose 02040502050405020303}Georgia;}{\f240\fbidi \fnil\fcharset0\fprq2{\*\panose 02040802050405020203}Georgia Bold;}{\f241\fbidi \fnil\fcharset0\fprq2{\*\panose 02040802050405090203}Georgia Bold Italic;}{\f242\fbidi \fnil\fcharset0\fprq2{\*\panose 02040502050405090303}Georgia Italic;}{\f243\fbidi \fnil\fcharset0\fprq2{\*\panose 03050402040302040404}Giddyup Std;}{\f244\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0502020104020203}Gill Sans;}{\f245\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0302020104020203}Gill Sans Light;}{\f246\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0502020104020203}Gill Sans MT;}{\f247\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0802020104020203}Gill Sans MT Bold;}{\f248\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0802020104090203}Gill Sans MT Bold Italic;}{\f249\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0502020104090203}Gill Sans MT Italic;}{\f250\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0702020104020203}Gill Sans SemiBold;}{\f251\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0702020104090203}Gill Sans SemiBold Italic;}{\f252\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0b04020104020203}Gill Sans UltraBold;}{\f253\fbidi \fnil\fcharset0\fprq2{\*\panose 02030808020601010101}Gloucester MT Extra Condensed;}{\f254\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502050305020303}Goudy Old Style;}{\f255\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Gujarati Sangam MN;}{\f256\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Gujarati Sangam MN Bold;}{\f257\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Gurmukhi MN;}{\f258\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Gurmukhi MN Bold;}{\f259\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Gurmukhi Sangam MN;}{\f260\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Gurmukhi Sangam MN Bold;}{\f261\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0706040902060204}Haettenschweiler;}{\f262\fbidi \fnil\fcharset0\fprq2{\*\panose 04040505050a02020702}Harrington;}{\f263\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0403020202020204}Helvetica Light;}{\f264\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503000000020004}Helvetica Neue;}{\f265\fbidi \fnil\fcharset0\fprq2{\*\panose 02000a06000000020004}Helvetica Neue Black Condensed;}{\f266\fbidi \fnil\fcharset0\fprq2{\*\panose 02000806000000020004}Helvetica Neue Bold Condensed;}{\f267\fbidi \fnil\fcharset0\fprq2{\*\panose 02000403000000020004}Helvetica Neue Light;}{\f268\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604020202020204}Helvetica Neue Medium;}{\f269\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0403020202020204}Helvetica Neue Thin;}{\f270\fbidi \fnil\fcharset0\fprq2{\*\panose 02000206000000020004}Helvetica Neue UltraLight;}{\f271\fbidi \fnil\fcharset0\fprq2{\*\panose 02000505000000020004}Herculanum;}{\f272\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803040709020204}Hobo Std;}{\f273\fbidi \fnil\fcharset0\fprq2{\*\panose 02030602050506020203}Hoefler Text;}{\f274\fbidi \fnil\fcharset2\fprq2{\*\panose 00000000000000000000}Hoefler Text Ornaments;}{\f275\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0806030902050204}Impact;}{\f276\fbidi \fnil\fcharset0\fprq2{\*\panose 04020605060303030202}Imprint MT Shadow;}{\f277\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}InaiMathi;}{\f278\fbidi \fnil\fcharset0\fprq2{\*\panose 02040805050506020204}Iowan Old Style Black;}{\f279\fbidi \fnil\fcharset0\fprq2{\*\panose 02040805050506090204}Iowan Old Style Black Italic;}{\f280\fbidi \fnil\fcharset0\fprq2{\*\panose 02040702050506020204}Iowan Old Style Bold;}{\f281\fbidi \fnil\fcharset0\fprq2{\*\panose 02040702050506090204}Iowan Old Style Bold Italic;}{\f282\fbidi \fnil\fcharset0\fprq2{\*\panose 02040602040506090204}Iowan Old Style Italic;}{\f283\fbidi \fnil\fcharset0\fprq2{\*\panose 02040602040506020204}Iowan Old Style Roman;}{\f284\fbidi \fnil\fcharset0\fprq2{\*\panose 02040602040506020204}Iowan Old Style Titling;}{\f285\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Jazz LET;}{\f286\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Kaiti SC Black;}{\f287\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Kannada MN;}{\f288\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Kannada MN Bold;}{\f289\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Kannada Sangam MN;}{\f290\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Kannada Sangam MN Bold;}{\f291\fbidi \fnil\fcharset0\fprq2{\*\panose 02000506000000020004}Kefa;}{\f292\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Khmer MN;}{\f293\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Khmer MN Bold;}{\f294\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Khmer Sangam MN;}{\f295\fbidi \fnil\fcharset0\fprq2{\*\panose 040307050d0c02020703}Kino MT;}{\f296\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Krungthep;}{\f297\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}KufiStandardGK;}{\f298\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Lantinghei SC Demibold;}{\f299\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Lantinghei SC Extralight;}{\f300\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Lantinghei SC Heavy;}{\f301\fbidi \fnil\fcharset0\fprq2{\*\panose 03000509000000000000}Lantinghei TC Demibold;}{\f302\fbidi \fnil\fcharset0\fprq2{\*\panose 03000509000000000000}Lantinghei TC Extralight;}{\f303\fbidi \fnil\fcharset0\fprq2{\*\panose 03000509000000000000}Lantinghei TC Heavy;}{\f304\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Lao MN;}{\f305\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Lao MN Bold;}{\f306\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Lao Sangam MN;}{\f307\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0409020202030304}Letter Gothic Std;}{\f308\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0509020202030304}Letter Gothic Std Bold;}{\f309\fbidi \fnil\fcharset0\fprq2{\*\panose 020b05090202020a0304}Letter Gothic Std Bold Slanted;}{\f310\fbidi \fnil\fcharset0\fprq2{\*\panose 020b04090202020a0304}Letter Gothic Std Slanted;}{\f311\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Libian SC Regular;}{\f312\fbidi \fnil\fcharset0\fprq2{\*\panose 04020905040e02020a04}Lithos Pro Black;}{\f313\fbidi \fnil\fcharset0\fprq2{\*\panose 04020505030e02020a04}Lithos Pro Regular;}{\f314\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}Lucida Blackletter;}{\f315\fbidi \fnil\fcharset0\fprq2{\*\panose 02040602050505020304}Lucida Bright;}{\f316\fbidi \fnil\fcharset0\fprq2{\*\panose 03010101010101010101}Lucida Calligraphy;}{\f317\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0609040504020204}Lucida Console;}{\f318\fbidi \fnil\fcharset0\fprq2{\*\panose 02060602050505020204}Lucida Fax;}{\f319\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0600040502020204}Lucida Grande;}{\f320\fbidi \fnil\fcharset0\fprq2{\*\panose 03010101010101010101}Lucida Handwriting;}{\f321\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0602030504020204}Lucida Sans;}{\f322\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0509030504030204}Lucida Sans Typewriter;}{\f323\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0602030504020204}Lucida Sans Unicode;}{\f324\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Malayalam MN;}{\f325\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Malayalam MN Bold;}{\f326\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Malayalam Sangam MN;}{\f327\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Malayalam Sangam MN Bold;}{\f328\fbidi \fnil\fcharset0\fprq2{\*\panose 02020802060400020003}Marion Bold;}{\f329\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502060400020003}Marion Italic;}{\f330\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502060400020003}Marion Regular;}{\f331\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Marker Felt;}{\f332\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}Marlett;}{\f333\fbidi \fnil\fcharset0\fprq2{\*\panose 03020802060602070202}Matura MT Script Capitals;}{\f334\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0709030604020204}Menlo Bold;}{\f335\fbidi \fnil\fcharset0\fprq2{\*\panose 020b07090303040b0204}Menlo Bold Italic;}{\f336\fbidi \fnil\fcharset0\fprq2{\*\panose 020b06090303040b0204}Menlo Italic;}{\f337\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0609030804020204}Menlo Regular;}{\f338\fbidi \fnil\fcharset0\fprq2{\*\panose 04090703060e02020a04}Mesquite Std;}{\f339\fbidi \fnil\fcharset0\fprq2{\*\panose 01010100010101010101}Microsoft Himalaya;}{\f340\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604020202020204}Microsoft Sans Serif;}{\f341\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0502040204020203}Microsoft Tai Le;}{\f342\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0802040204020203}Microsoft Tai Le Bold;}{\f343\fbidi \fnil\fcharset0\fprq2{\*\panose 03000500000000000000}Microsoft Yi Baiti;}{\f344\fbidi \fnil\fcharset81\fprq2{\*\panose 02020500000000000000}MingLiU-ExtB;}{\f345\fbidi \fnil\fcharset81\fprq2{\*\panose 02020500000000000000}@MingLiU-ExtB;}{\f346\fbidi \fnil\fcharset81\fprq2{\*\panose 02020500000000000000}MingLiU_HKSCS-ExtB;}{\f347\fbidi \fnil\fcharset81\fprq2{\*\panose 02020500000000000000}@MingLiU_HKSCS-ExtB;}{\f348\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050306020203}Minion Pro;}{\f349\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703060306020203}Minion Pro Bold;}{\f350\fbidi \fnil\fcharset0\fprq2{\*\panose 02040706060306020203}Minion Pro Bold Cond;}{\f351\fbidi \fnil\fcharset0\fprq2{\*\panose 02040706060306090203}Minion Pro Bold Cond Ital;}{\f352\fbidi \fnil\fcharset0\fprq2{\*\panose 02040703060306090203}Minion Pro Bold Ital;}{\f353\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050306090203}Minion Pro Ital;}{\f354\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050306020203}Minion Pro Med;}{\f355\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050306090203}Minion Pro Med Ital;}{\f356\fbidi \fnil\fcharset0\fprq2{\*\panose 02040603060306020203}Minion Pro SmBd;}{\f357\fbidi \fnil\fcharset0\fprq2{\*\panose 02040603060306090203}Minion Pro SmBd Ital;}{\f358\fbidi \fnil\fcharset0\fprq2{\*\panose 03090702030407020403}Mistral;}{\f359\fbidi \fnil\fcharset0\fprq2{\*\panose 02070704070505020303}Modern No. 20;}{\f360\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Mona Lisa Solid ITC TT;}{\f361\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Monaco;}{\f362\fbidi \fnil\fcharset0\fprq2{\*\panose 03000500000000000000}Mongolian Baiti;}{\f363\fbidi \fnil\fcharset0\fprq2{\*\panose 03010101010201010101}Monotype Corsiva;}{\f364\fbidi \fnil\fcharset2\fprq2{\*\panose 01010601010101010101}Monotype Sorts;}{\f365\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604030504040204}MS Reference Sans Serif;}{\f366\fbidi \fnil\fcharset0\fprq2{\*\panose 05000500000000000000}MS Reference Specialty;}{\f367\fbidi \fnil\fcharset2\fprq2{\*\panose 05050102010205020202}MT Extra;}{\f368\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Myanmar MN;}{\f369\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Myanmar MN Bold;}{\f370\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Myanmar Sangam MN;}{\f371\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Arabic;}{\f372\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Arabic Bold;}{\f373\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Arabic Bold Italic;}{\f374\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Arabic Italic;}{\f375\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Hebrew Bold;}{\f376\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Hebrew Bold Italic;}{\f377\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Hebrew Italic;}{\f378\fbidi \fnil\fcharset0\fprq2{\*\panose 01010101010101010101}Myriad Hebrew Regular;}{\f379\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503030403020204}Myriad Pro;}{\f380\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703030403020204}Myriad Pro Bold;}{\f381\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0706030403020204}Myriad Pro Bold Cond;}{\f382\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0706030403090204}Myriad Pro Bold Cond It;}{\f383\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703030403090204}Myriad Pro Bold It;}{\f384\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506030403020204}Myriad Pro Cond;}{\f385\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506030403090204}Myriad Pro Cond It;}{\f386\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503030403090204}Myriad Pro It;}{\f387\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603030403020204}Myriad Pro Semibold;}{\f388\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603030403090204}Myriad Pro Semibold It;}{\f389\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0504020203020204}News Gothic MT;}{\f390\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Noteworthy Bold;}{\f391\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Noteworthy Light;}{\f392\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803070504020203}Nueva Std Bold;}{\f393\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0806070504020203}Nueva Std Bold Cond;}{\f394\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0806070504090203}Nueva Std Bold Cond Italic;}{\f395\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506070504020203}Nueva Std Cond;}{\f396\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506070504090203}Nueva Std Cond Italic;}{\f397\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503070504090203}Nueva Std Italic;}{\f398\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0609000104060307}OCR A Std;}{\f399\fbidi \fnil\fcharset0\fprq2{\*\panose 04050602080702020203}Onyx;}{\f400\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503060000020004}Optima;}{\f401\fbidi \fnil\fcharset0\fprq2{\*\panose 02000b03000000020004}Optima ExtraBlack;}{\f402\fbidi \fnil\fcharset0\fprq2{\*\panose 020d0509020203030204}Orator Std;}{\f403\fbidi \fnil\fcharset0\fprq2{\*\panose 020d05090202030a0204}Orator Std Slanted;}{\f404\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Oriya MN;}{\f405\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Oriya MN Bold;}{\f406\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Oriya Sangam MN;}{\f407\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Oriya Sangam MN Bold;}{\f408\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Palatino;}{\f409\fbidi \fnil\fcharset0\fprq2{\*\panose 02000800000000000000}Palatino Bold;}{\f410\fbidi \fnil\fcharset0\fprq2{\*\panose 02000800000000000000}Palatino Bold Italic;}{\f411\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Palatino Italic;}{\f412\fbidi \fnil\fcharset0\fprq2{\*\panose 02040502050505030304}Palatino Linotype;}{\f413\fbidi \fnil\fcharset0\fprq2{\*\panose 020407020603050a0204}Palatino Linotype Bold;}{\f414\fbidi \fnil\fcharset0\fprq2{\*\panose 020407020603050a0204}Palatino Linotype Bold Italic;}{\f415\fbidi \fnil\fcharset0\fprq2{\*\panose 020405020503050a0304}Palatino Linotype Italic;}{\f416\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0602040200020303}Papyrus;}{\f417\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0602040200020303}Papyrus Condensed;}{\f418\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Party LET;}{\f419\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502060401020303}Perpetua;}{\f420\fbidi \fnil\fcharset0\fprq2{\*\panose 02020802060401020303}Perpetua Bold;}{\f421\fbidi \fnil\fcharset0\fprq2{\*\panose 02020802060401090303}Perpetua Bold Italic;}{\f422\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502060401090303}Perpetua Italic;}{\f423\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502060505020804}Perpetua Titling MT;}{\f424\fbidi \fnil\fcharset0\fprq2{\*\panose 02020000000000000000}Plantagenet Cherokee;}{\f425\fbidi \fnil\fcharset0\fprq2{\*\panose 040506030a0602020202}Playbill;}{\f426\fbidi \fnil\fcharset81\fprq2{\*\panose 02020500000000000000}PMingLiU-ExtB;}{\f427\fbidi \fnil\fcharset81\fprq2{\*\panose 02020500000000000000}@PMingLiU-ExtB;}{\f428\fbidi \fnil\fcharset0\fprq2{\*\panose 04020903030b02020202}Poplar Std;}{\f429\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}PortagoITC TT;}{\f430\fbidi \fnil\fcharset0\fprq2{\*\panose 02060509020206020304}Prestige Elite Std Bold;}{\f431\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Princetown LET;}{\f432\fbidi \fnil\fcharset0\fprq2{\*\panose 02060509020205020204}PT Mono;}{\f433\fbidi \fnil\fcharset0\fprq2{\*\panose 02060709020205020204}PT Mono Bold;}{\f434\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020203020204}PT Sans;}{\f435\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020203020204}PT Sans Bold;}{\f436\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020203090204}PT Sans Bold Italic;}{\f437\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603020203020204}PT Sans Caption;}{\f438\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020203020204}PT Sans Caption Bold;}{\f439\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503020203090204}PT Sans Italic;}{\f440\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0506020203020204}PT Sans Narrow;}{\f441\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0706020203020204}PT Sans Narrow Bold;}{\f442\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0603040505020204}PT Serif;}{\f443\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0703040505020204}PT Serif Bold;}{\f444\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0703040505090204}PT Serif Bold Italic;}{\f445\fbidi \fnil\fcharset0\fprq2{\*\panose 02060603050505020204}PT Serif Caption;}{\f446\fbidi \fnil\fcharset0\fprq2{\*\panose 02060603050505090204}PT Serif Caption Italic;}{\f447\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0603040505090204}PT Serif Italic;}{\f448\fbidi \fnil\fcharset0\fprq2{\*\panose 02060603020205020403}Rockwell;}{\f449\fbidi \fnil\fcharset0\fprq2{\*\panose 02060903040505020403}Rockwell Extra Bold;}{\f450\fbidi \fnil\fcharset0\fprq2{\*\panose 04090804040204020202}Rosewood Std Regular;}{\f451\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0802070306020202}Sabon Next LT Pro Bold;}{\f452\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0802070306090202}Sabon Next LT Pro Bold Italic;}{\f453\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0702070306020202}Sabon Next LT Pro Demi;}{\f454\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0702070306090202}Sabon Next LT Pro Demi Italic;}{\f455\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0902070306020202}Sabon Next LT Pro Extra Bold;}{\f456\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0902070306090202}Sabon Next LT Pro Extra Bold It;}{\f457\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0502070306090202}Sabon Next LT Pro Italic;}{\f458\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0502070306020202}Sabon Next LT Pro Regular;}{\f459\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}Santa Fe LET;}{\f460\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Sathu;}{\f461\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Savoye LET;}{\f462\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}Savoye LET Plain CC.:1.0;}{\f463\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}SchoolHouse Cursive B;}{\f464\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}SchoolHouse Printed A;}{\f465\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503040000020004}Seravek;}{\f466\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803050000020004}Seravek Bold;}{\f467\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0803050000090004}Seravek Bold Italic;}{\f468\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503040000020004}Seravek ExtraLight;}{\f469\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503040000090004}Seravek ExtraLight Italic;}{\f470\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503050000090004}Seravek Italic;}{\f471\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503040000020004}Seravek Light;}{\f472\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0503040000090004}Seravek Light Italic;}{\f473\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703050000020004}Seravek Medium;}{\f474\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703050000090004}Seravek Medium Italic;}{\f475\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Silom;}{\f476\fbidi \fnil\fcharset81\fprq2{\*\panose 02010609060101010101}SimSun-ExtB;}{\f477\fbidi \fnil\fcharset81\fprq2{\*\panose 02010609060101010101}@SimSun-ExtB;}{\f478\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503080000020003}Sinhala MN;}{\f479\fbidi \fnil\fcharset0\fprq2{\*\panose 02000503080000020003}Sinhala MN Bold;}{\f480\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Sinhala Sangam MN;}{\f481\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Sinhala Sangam MN Bold;}{\f482\fbidi \fnil\fcharset0\fprq2{\*\panose 020d0502020204020204}Skia;}{\f483\fbidi \fnil\fcharset0\fprq2{\*\panose 02000603080000090004}Snell Roundhand;}{\f484\fbidi \fnil\fcharset0\fprq2{\*\panose 02000a04090000090004}Snell Roundhand Black;}{\f485\fbidi \fnil\fcharset0\fprq2{\*\panose 02000803090000090004}Snell Roundhand Bold;}{\f486\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Songti SC Black;}{\f487\fbidi \fnil\fcharset0\fprq2{\*\panose 00000800000000000000}STIXGeneral-Bold;}{\f488\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXGeneral-BoldItalic;}{\f489\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXGeneral-Italic;}{\f490\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXGeneral-Regular;}{\f491\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsD-Bold;}{\f492\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsD-Regular;}{\f493\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsSm-Bold;}{\f494\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsSm-Regular;}{\f495\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsUp-Bold;}{\f496\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsUp-Regular;}{\f497\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsUpD-Bold;}{\f498\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsUpD-Regular;}{\f499\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsUpSm-Bold;}{\f500\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXIntegralsUpSm-Regular;}{\f501\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXNonUnicode-Bold;}{\f502\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXNonUnicode-BoldItalic;}{\f503\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXNonUnicode-Italic;}{\f504\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXNonUnicode-Regular;}{\f505\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeFiveSym-Regular;}{\f506\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeFourSym-Bold;}{\f507\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeFourSym-Regular;}{\f508\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeOneSym-Bold;}{\f509\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeOneSym-Regular;}{\f510\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeThreeSym-Bold;}{\f511\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeThreeSym-Regular;}{\f512\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeTwoSym-Bold;}{\f513\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXSizeTwoSym-Regular;}{\f514\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXVariants-Bold;}{\f515\fbidi \fnil\fcharset0\fprq2{\*\panose 00000000000000000000}STIXVariants-Regular;}{\f516\fbidi \fnil\fcharset0\fprq2{\*\panose 040409050d0802020404}Stencil;}{\f517\fbidi \fnil\fcharset0\fprq2{\*\panose 04020904080802020404}Stencil Std;}{\f518\fbidi \fnil\fcharset0\fprq2{\*\panose 00000700000000000000}Stone Sans ITC TT-Bold;}{\f519\fbidi \fnil\fcharset0\fprq2{\*\panose 00000600000000000000}Stone Sans ITC TT-Semi;}{\f520\fbidi \fnil\fcharset0\fprq2{\*\panose 00000600000000000000}Stone Sans ITC TT-SemiIta;}{\f521\fbidi \fnil\fcharset0\fprq2{\*\panose 02060a05060000020003}Superclarendon Black;}{\f522\fbidi \fnil\fcharset0\fprq2{\*\panose 02060a05060000020003}Superclarendon Black Italic;}{\f523\fbidi \fnil\fcharset0\fprq2{\*\panose 02060805060000020003}Superclarendon Bold;}{\f524\fbidi \fnil\fcharset0\fprq2{\*\panose 02060805060000020003}Superclarendon Bold Italic;}{\f525\fbidi \fnil\fcharset0\fprq2{\*\panose 02060605060000020003}Superclarendon Italic;}{\f526\fbidi \fnil\fcharset0\fprq2{\*\panose 02060305060000020003}Superclarendon Light;}{\f527\fbidi \fnil\fcharset0\fprq2{\*\panose 02060305060000020003}Superclarendon Light Italic;}{\f528\fbidi \fnil\fcharset0\fprq2{\*\panose 02060605060000020003}Superclarendon Regular;}{\f529\fbidi \fnil\fcharset0\fprq2{\*\panose 00000400000000000000}Synchro LET;}{\f530\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604030504040204}Tahoma;}{\f531\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0804030504040204}Tahoma Bold;}{\f532\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Tamil MN;}{\f533\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Tamil MN Bold;}{\f534\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Tamil Sangam MN;}{\f535\fbidi \fnil\fcharset0\fprq2{\*\panose 02000400000000000000}Tamil Sangam MN Bold;}{\f536\fbidi \fnil\fcharset0\fprq2{\*\panose 050b0102010101010101}TeamViewer8;}{\f537\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0603020208020904}Tekton Pro Bold;}{\f538\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0606020208020904}Tekton Pro BoldCond;}{\f539\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0605020208020904}Tekton Pro BoldExt;}{\f540\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0603020208090904}Tekton Pro BoldObl;}{\f541\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Telugu MN;}{\f542\fbidi \fnil\fcharset0\fprq2{\*\panose 02020600050405020304}Telugu MN Bold;}{\f543\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Telugu Sangam MN;}{\f544\fbidi \fnil\fcharset0\fprq2{\*\panose 02000000000000000000}Telugu Sangam MN Bold;}{\f545\fbidi \fnil\fcharset0\fprq2{\*\panose 00000300000000000000}Thonburi Light;}{\f546\fbidi \fnil\fcharset0\fprq2{\*\panose 02020803070505020304}Times New Roman Bold;}{\f547\fbidi \fnil\fcharset0\fprq2{\*\panose 02020703060505090304}Times New Roman Bold Italic;}{\f548\fbidi \fnil\fcharset0\fprq2{\*\panose 02020503050405090304}Times New Roman Italic;}{\f549\fbidi \fnil\fcharset0\fprq2{\*\panose 02020502050506020301}Trajan Pro;}{\f550\fbidi \fnil\fcharset0\fprq2{\*\panose 02020802050506020301}Trajan Pro Bold;}{\f551\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603020202020204}Trebuchet MS;}{\f552\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020202020204}Trebuchet MS Bold;}{\f553\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0703020202090204}Trebuchet MS Bold Italic;}{\f554\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0603020202090204}Trebuchet MS Italic;}{\f555\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0602020104020603}Tw Cen MT;}{\f556\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0802020104020603}Tw Cen MT Bold;}{\f557\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0802020104090603}Tw Cen MT Bold Italic;}{\f558\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0602020104090603}Tw Cen MT Italic;}{\f559\fbidi \fnil\fcharset0\fprq2{\*\panose 02000500000000000000}Type Embellishments One LET;}{\f560\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0804030504040204}Verdana Bold;}{\f561\fbidi \fnil\fcharset0\fprq2{\*\panose 020b08040305040b0204}Verdana Bold Italic;}{\f562\fbidi \fnil\fcharset0\fprq2{\*\panose 020b06040305040b0204}Verdana Italic;}{\f563\fbidi \fnil\fcharset0\fprq2{\*\panose 040b0500000000000000}Wawati SC Regular;}{\f564\fbidi \fnil\fcharset0\fprq2{\*\panose 040b0500000000000000}Wawati TC Regular;}{\f565\fbidi \fnil\fcharset2\fprq2{\*\panose 05030102010509060703}Webdings;}{\f566\fbidi \fnil\fcharset0\fprq2{\*\panose 020a0a07050505020404}Wide Latin;}{\f567\fbidi \fnil\fcharset2\fprq2{\*\panose 05020102010507070707}Wingdings 2;}{\f568\fbidi \fnil\fcharset2\fprq2{\*\panose 05040102010807070707}Wingdings 3;}{\f569\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Xingkai SC Bold;}{\f570\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Xingkai SC Light;}{\f571\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Yuanti SC Bold;}{\f572\fbidi \fnil\fcharset0\fprq2{\*\panose 02010800040101010101}Yuanti SC Regular;}{\f573\fbidi \fnil\fcharset2\fprq2{\*\panose 05020102010704020609}Zapf Dingbats;}{\f574\fbidi \fnil\fcharset0\fprq2{\*\panose 03030300040707070c03}Zapfino;}{\f575\fbidi \fnil\fcharset88\fprq2{\*\panose 020b0600040502020204}Lucida Grande CE;}{\f576\fbidi \fnil\fcharset89\fprq2{\*\panose 00000400000000000000}Charcoal CY;}{\f577\fbidi \fnil\fcharset89\fprq2{\*\panose 00000400000000000000}Geneva CY;}{\f578\fbidi \fnil\fcharset89\fprq2{\*\panose 00000400000000000000}Helvetica CY;}{\f579\fbidi \fnil\fcharset89\fprq2{\*\panose 020b0600040502020204}Lucida Grande CY;}{\f580\fbidi \fnil\fcharset89\fprq2{\*\panose 00000400000000000000}Thonburi;}{\f581\fbidi \fnil\fcharset89\fprq2{\*\panose 00000400000000000000}Thonburi Bold;}{\f582\fbidi \fnil\fcharset81\fprq2 Adobe \'a9\'fa\'c5\'e9 Std L;}{\f583\fbidi \fnil\fcharset81\fprq2 @Adobe \'a9\'fa\'c5\'e9 Std L;}{\f584\fbidi \fnil\fcharset81\fprq2 Adobe \'c1\'63\'b6\'c2\'c5\'e9 Std B;}{\f585\fbidi \fnil\fcharset81\fprq2 @Adobe \'c1\'63\'b6\'c2\'c5\'e9 Std B;}{\f586\fbidi \fnil\fcharset81\fprq2{\*\panose 02000500000000000000}Apple LiGothic Medium;}{\f587\fbidi \fnil\fcharset81\fprq2{\*\panose 02000500000000000000}@Apple LiGothic Medium;}{\f588\fbidi \fnil\fcharset81\fprq2{\*\panose 02000500000000000000}Apple LiSung Light;}{\f589\fbidi \fnil\fcharset81\fprq2{\*\panose 02000500000000000000}@Apple LiSung Light;}{\f590\fbidi \fnil\fcharset81\fprq2{\*\panose 02000500000000000000}BiauKai;}{\f591\fbidi \fnil\fcharset81\fprq2{\*\panose 02000500000000000000}@BiauKai;}{\f592\fbidi \fnil\fcharset81\fprq2{\*\panose 03000700000000000000}Hannotate TC Bold;}{\f593\fbidi \fnil\fcharset81\fprq2{\*\panose 03000700000000000000}@Hannotate TC Bold;}{\f594\fbidi \fnil\fcharset81\fprq2{\*\panose 03000500000000000000}Hannotate TC Regular;}{\f595\fbidi \fnil\fcharset81\fprq2{\*\panose 03000500000000000000}@Hannotate TC Regular;}{\f596\fbidi \fnil\fcharset81\fprq2{\*\panose 03000500000000000000}HanziPen TC Bold;}{\f597\fbidi \fnil\fcharset81\fprq2{\*\panose 03000500000000000000}@HanziPen TC Bold;}{\f598\fbidi \fnil\fcharset81\fprq2{\*\panose 03000300000000000000}HanziPen TC Regular;}{\f599\fbidi \fnil\fcharset81\fprq2{\*\panose 03000300000000000000}@HanziPen TC Regular;}{\f600\fbidi \fnil\fcharset81\fprq2{\*\panose 02000000000000000000}Heiti TC Light;}{\f601\fbidi \fnil\fcharset81\fprq2{\*\panose 02000000000000000000}@Heiti TC Light;}{\f602\fbidi \fnil\fcharset81\fprq2{\*\panose 00000000000000000000}Heiti TC Medium;}{\f603\fbidi \fnil\fcharset81\fprq2{\*\panose 00000000000000000000}@Heiti TC Medium;}{\f604\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}Kaiti TC Bold;}{\f605\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}@Kaiti TC Bold;}{\f606\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}Kaiti TC Regular;}{\f607\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}@Kaiti TC Regular;}{\f608\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}Songti TC Bold;}{\f609\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}@Songti TC Bold;}{\f610\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}Songti TC Light;}{\f611\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}@Songti TC Light;}{\f612\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}Songti TC Regular;}{\f613\fbidi \fnil\fcharset81\fprq2{\*\panose 02010600040101010101}@Songti TC Regular;}{\f614\fbidi \fnil\fcharset81\fprq2{\*\panose 03000800000000000000}Weibei TC Bold;}{\f615\fbidi \fnil\fcharset81\fprq2{\*\panose 03000800000000000000}@Weibei TC Bold;}{\f616\fbidi \fnil\fcharset81\fprq2{\*\panose 00000600000000000000}Yuppy TC Regular;}{\f617\fbidi \fnil\fcharset81\fprq2{\*\panose 00000600000000000000}@Yuppy TC Regular;}{\f618\fbidi \fnil\fcharset81\fprq2 \'b2\'d3\'a9\'fa\'c5\'e9;}{\f619\fbidi \fnil\fcharset81\fprq2 @\'b2\'d3\'a9\'fa\'c5\'e9;}{\f620\fbidi \fnil\fcharset81\fprq2 \'b2\'d3\'a9\'fa\'c5\'e9_HKSCS;}{\f621\fbidi \fnil\fcharset81\fprq2 @\'b2\'d3\'a9\'fa\'c5\'e9_HKSCS;}{\f622\fbidi \fnil\fcharset81\fprq2 @\'b7\'73\'b2\'d3\'a9\'fa\'c5\'e9;}{\f623\fbidi \fnil\fcharset81\fprq2 \'c4\'d7\'a7\'ba Pro;}{\f624\fbidi \fnil\fcharset81\fprq2 @\'c4\'d7\'a7\'ba Pro;}{\f625\fbidi \fnil\fcharset81\fprq2 \'c4\'d7\'b6\'c2 Pro;}{\f626\fbidi \fnil\fcharset81\fprq2 @\'c4\'d7\'b6\'c2 Pro;}{\f627\fbidi \fnil\fcharset80\fprq2 Adobe \'b7\'c2\'cb\'ce Std R;}{\f628\fbidi \fnil\fcharset80\fprq2 @Adobe \'b7\'c2\'cb\'ce Std R;}{\f629\fbidi \fnil\fcharset80\fprq2 Adobe \'ba\'da\'cc\'e5 Std R;}{\f630\fbidi \fnil\fcharset80\fprq2 @Adobe \'ba\'da\'cc\'e5 Std R;}{\f631\fbidi \fnil\fcharset80\fprq2 Adobe \'bf\'ac\'cc\'e5 Std R;}{\f632\fbidi \fnil\fcharset80\fprq2 @Adobe \'bf\'ac\'cc\'e5 Std R;}{\f633\fbidi \fnil\fcharset80\fprq2 Adobe \'cb\'ce\'cc\'e5 Std L;}{\f634\fbidi \fnil\fcharset80\fprq2 @Adobe \'cb\'ce\'cc\'e5 Std L;}{\f635\fbidi \fnil\fcharset80\fprq2 GB18030 Bitmap;}{\f636\fbidi \fnil\fcharset80\fprq2 @GB18030 Bitmap;}{\f637\fbidi \fnil\fcharset80\fprq2{\*\panose 03000700000000000000}Hannotate SC Bold;}{\f638\fbidi \fnil\fcharset80\fprq2{\*\panose 03000700000000000000}@Hannotate SC Bold;}{\f639\fbidi \fnil\fcharset80\fprq2{\*\panose 03000500000000000000}Hannotate SC Regular;}{\f640\fbidi \fnil\fcharset80\fprq2{\*\panose 03000500000000000000}@Hannotate SC Regular;}{\f641\fbidi \fnil\fcharset80\fprq2{\*\panose 03000500000000000000}HanziPen SC Bold;}{\f642\fbidi \fnil\fcharset80\fprq2{\*\panose 03000500000000000000}@HanziPen SC Bold;}{\f643\fbidi \fnil\fcharset80\fprq2{\*\panose 03000300000000000000}HanziPen SC Regular;}{\f644\fbidi \fnil\fcharset80\fprq2{\*\panose 03000300000000000000}@HanziPen SC Regular;}{\f645\fbidi \fnil\fcharset80\fprq2{\*\panose 02000500000000000000}Hei;}{\f646\fbidi \fnil\fcharset80\fprq2{\*\panose 02000500000000000000}@Hei;}{\f647\fbidi \fnil\fcharset80\fprq2{\*\panose 02000000000000000000}Heiti SC Light;}{\f648\fbidi \fnil\fcharset80\fprq2{\*\panose 02000000000000000000}@Heiti SC Light;}{\f649\fbidi \fnil\fcharset80\fprq2{\*\panose 00000000000000000000}Heiti SC Medium;}{\f650\fbidi \fnil\fcharset80\fprq2{\*\panose 00000000000000000000}@Heiti SC Medium;}{\f651\fbidi \fnil\fcharset80\fprq2{\*\panose 020b0300000000000000}Hiragino Sans GB W3;}{\f652\fbidi \fnil\fcharset80\fprq2{\*\panose 020b0300000000000000}@Hiragino Sans GB W3;}{\f653\fbidi \fnil\fcharset80\fprq2{\*\panose 020b0600000000000000}Hiragino Sans GB W6;}{\f654\fbidi \fnil\fcharset80\fprq2{\*\panose 020b0600000000000000}@Hiragino Sans GB W6;}{\f655\fbidi \fnil\fcharset80\fprq2{\*\panose 02000500000000000000}Kai;}{\f656\fbidi \fnil\fcharset80\fprq2{\*\panose 02000500000000000000}@Kai;}{\f657\fbidi \fnil\fcharset80\fprq2{\*\panose 02010800040101010101}Kaiti SC Bold;}{\f658\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}@Kaiti SC Bold;}{\f659\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}Kaiti SC Regular;}{\f660\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}@Kaiti SC Regular;}{\f661\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}Songti SC Bold;}{\f662\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}@Songti SC Bold;}{\f663\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}Songti SC Light;}{\f664\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}@Songti SC Light;}{\f665\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}Songti SC Regular;}{\f666\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}@Songti SC Regular;}{\f667\fbidi \fnil\fcharset80\fprq2{\*\panose 03000800000000000000}Weibei SC Bold;}{\f668\fbidi \fnil\fcharset80\fprq2{\*\panose 03000800000000000000}@Weibei SC Bold;}{\f669\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}Yuanti SC Light;}{\f670\fbidi \fnil\fcharset80\fprq2{\*\panose 02010600040101010101}@Yuanti SC Light;}{\f671\fbidi \fnil\fcharset80\fprq2{\*\panose 00000500000000000000}Yuppy SC Regular;}{\f672\fbidi \fnil\fcharset80\fprq2{\*\panose 00000500000000000000}@Yuppy SC Regular;}{\f673\fbidi \fnil\fcharset80\fprq2 \'ba\'da\'cc\'e5;}{\f674\fbidi \fnil\fcharset80\fprq2 @\'ba\'da\'cc\'e5;}{\f675\fbidi \fnil\fcharset80\fprq2 \'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce;}{\f676\fbidi \fnil\fcharset80\fprq2 @\'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce;}{\f677\fbidi \fnil\fcharset80\fprq2 \'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5;}{\f678\fbidi \fnil\fcharset80\fprq2 @\'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5;}{\f679\fbidi \fnil\fcharset80\fprq2 \'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5;}{\f680\fbidi \fnil\fcharset80\fprq2 @\'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5;}{\f681\fbidi \fnil\fcharset80\fprq2 \'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5;}{\f682\fbidi \fnil\fcharset80\fprq2 @\'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5;}{\f683\fbidi \fnil\fcharset80\fprq2 \'bb\'aa\'ce\'c4\'cf\'b8\'ba\'da;}{\f684\fbidi \fnil\fcharset80\fprq2 @\'bb\'aa\'ce\'c4\'cf\'b8\'ba\'da;}{\f685\fbidi \fnil\fcharset80\fprq2 @\'cb\'ce\'cc\'e5;}{\f686\fbidi \fnil\fcharset78\fprq2 \'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e;}{\f687\fbidi \fnil\fcharset78\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e;}{\f688\fbidi \fnil\fcharset78\fprq2 \'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9;}{\f689\fbidi \fnil\fcharset78\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9;}{\f690\fbidi \fnil\fcharset78\fprq2 @\'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e;}{\f691\fbidi \fnil\fcharset78\fprq2 @\'82\'6c\'82\'72 \'96\'be\'92\'a9;}{\f692\fbidi \fnil\fcharset78\fprq2{\*\panose 020b0600000000000000}Osaka;}{\f693\fbidi \fnil\fcharset78\fprq2{\*\panose 020b0600000000000000}@Osaka;}{\f694\fbidi \fnil\fcharset78\fprq2 Osaka\'81\'7c\'93\'99\'95\'9d;}{\f695\fbidi \fnil\fcharset78\fprq2 @Osaka\'81\'7c\'93\'99\'95\'9d;}{\f696\fbidi \fnil\fcharset78\fprq2{\*\panose 020b0700000000000000}YuGothic Bold;}{\f697\fbidi \fnil\fcharset78\fprq2{\*\panose 020b0700000000000000}@YuGothic Bold;}{\f698\fbidi \fnil\fcharset78\fprq2{\*\panose 020b0500000000000000}YuGothic Medium;}{\f699\fbidi \fnil\fcharset78\fprq2{\*\panose 020b0500000000000000}@YuGothic Medium;}{\f700\fbidi \fnil\fcharset78\fprq2{\*\panose 02020600000000000000}YuMincho Demibold;}{\f701\fbidi \fnil\fcharset78\fprq2{\*\panose 02020600000000000000}@YuMincho Demibold;}{\f702\fbidi \fnil\fcharset78\fprq2{\*\panose 02020500000000000000}YuMincho Medium;}{\f703\fbidi \fnil\fcharset78\fprq2{\*\panose 02020500000000000000}@YuMincho Medium;}{\f704\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3;}{\f705\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3;}{\f706\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6;}{\f707\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6;}{\f708\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3;}{\f709\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3;}{\f710\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6;}{\f711\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6;}{\f712\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8;}{\f713\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8;}{\f714\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8;}{\f715\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8;}{\f716\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4;}{\f717\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4;}{\f718\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4;}{\f719\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4;}{\f720\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3;}{\f721\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3;}{\f722\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6;}{\f723\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6;}{\f724\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3;}{\f725\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3;}{\f726\fbidi \fnil\fcharset78\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6;}{\f727\fbidi \fnil\fcharset78\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6;}{\f728\fbidi \fnil\fcharset78\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49;}{\f729\fbidi \fnil\fcharset78\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49;}{\f730\fbidi \fnil\fcharset78\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e;}{\f731\fbidi \fnil\fcharset78\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e;}{\f732\fbidi \fnil\fcharset78\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68;}{\f733\fbidi \fnil\fcharset78\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68;}{\f734\fbidi \fnil\fcharset78\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e;}{\f735\fbidi \fnil\fcharset78\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e;}{\f736\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B;}{\f737\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B;}{\f738\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL;}{\f739\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL;}{\f740\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H;}{\f741\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H;}{\f742\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L;}{\f743\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L;}{\f744\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M;}{\f745\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M;}{\f746\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R;}{\f747\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R;}{\f748\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro B;}{\f749\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro B;}{\f750\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro EL;}{\f751\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro EL;}{\f752\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro H;}{\f753\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro H;}{\f754\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro L;}{\f755\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro L;}{\f756\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro M;}{\f757\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro M;}{\f758\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro R;}{\f759\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro R;}{\f760\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B;}{\f761\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B;}{\f762\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL;}{\f763\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL;}{\f764\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H;}{\f765\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H;}{\f766\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L;}{\f767\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L;}{\f768\fbidi \fnil\fcharset0\fprq2 \'e8\'a8\'ed\'c0\'f1\'e6\'ed\'a9 Pr6N M;}{\f769\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R;}{\f770\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R;}{\f771\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro B;}{\f772\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro B;}{\f773\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro EL;}{\f774\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro EL;}{\f775\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro H;}{\f776\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro H;}{\f777\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro L;}{\f778\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro L;}{\f779\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro M;}{\f780\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro M;}{\f781\fbidi \fnil\fcharset78\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro R;}{\f782\fbidi \fnil\fcharset78\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro R;}{\f783\fbidi \fnil\fcharset79\fprq2 Adobe \'b0\'ed\'b5\'f1 Std B;}{\f784\fbidi \fnil\fcharset79\fprq2 @Adobe \'b0\'ed\'b5\'f1 Std B;}{\f785\fbidi \fnil\fcharset79\fprq2 Adobe \'b8\'ed\'c1\'b6 Std M;}{\f786\fbidi \fnil\fcharset79\fprq2 @Adobe \'b8\'ed\'c1\'b6 Std M;}{\f787\fbidi \fnil\fcharset79\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'b9\'ab\'b0\'c5\'bf\'ee;}{\f788\fbidi \fnil\fcharset79\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'b9\'ab\'b0\'c5\'bf\'ee;}{\f789\fbidi \fnil\fcharset79\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'ba\'bc\'b5\'e5\'c3\'bc;}{\f790\fbidi \fnil\fcharset79\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'ba\'bc\'b5\'e5\'c3\'bc;}{\f791\fbidi \fnil\fcharset79\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'be\'e3\'c0\'ba\'c3\'bc;}{\f792\fbidi \fnil\fcharset79\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'be\'e3\'c0\'ba\'c3\'bc;}{\f793\fbidi \fnil\fcharset79\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'bf\'b6\'c0\'ba\'c3\'bc;}{\f794\fbidi \fnil\fcharset79\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'bf\'b6\'c0\'ba\'c3\'bc;}{\f795\fbidi \fnil\fcharset79\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c0\'cf\'b9\'dd\'c3\'bc;}{\f796\fbidi \fnil\fcharset79\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c0\'cf\'b9\'dd\'c3\'bc;}{\f797\fbidi \fnil\fcharset79\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c1\'df\'b0\'a3\'c3\'bc;}{\f798\fbidi \fnil\fcharset79\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c1\'df\'b0\'a3\'c3\'bc;}{\f799\fbidi \fnil\fcharset79\fprq2{\*\panose 02000500000000000000}AppleGothic;}{\f800\fbidi \fnil\fcharset79\fprq2{\*\panose 02000500000000000000}@AppleGothic;}{\f801\fbidi \fnil\fcharset79\fprq2{\*\panose 02000500000000000000}AppleMyungjo;}{\f802\fbidi \fnil\fcharset79\fprq2{\*\panose 02000500000000000000}@AppleMyungjo;}{\f803\fbidi \fnil\fcharset79\fprq2 PC\'b8\'ed\'c1\'b6;}{\f804\fbidi \fnil\fcharset79\fprq2 @PC\'b8\'ed\'c1\'b6;}{\f805\fbidi \fnil\fcharset79\fprq2 \'b1\'bc\'b8\'b2;}{\f806\fbidi \fnil\fcharset79\fprq2 @\'b1\'bc\'b8\'b2;}{\f807\fbidi \fnil\fcharset79\fprq2 \'b1\'c3\'bc\'ad\'c3\'bc;}{\f808\fbidi \fnil\fcharset79\fprq2 @\'b1\'c3\'bc\'ad\'c3\'bc;}{\f809\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1;}{\f810\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1;}{\f811\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 Bold;}{\f812\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 Bold;}{\f813\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 ExtraBold;}{\f814\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 ExtraBold;}{\f815\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6;}{\f816\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6;}{\f817\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 Bold;}{\f818\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 Bold;}{\f819\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 ExtraBold;}{\f820\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 ExtraBold;}{\f821\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'ba\'d7;}{\f822\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'ba\'d7;}{\f823\fbidi \fnil\fcharset79\fprq2 \'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'c6\'e6;}{\f824\fbidi \fnil\fcharset79\fprq2 @\'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'c6\'e6;}{\f825\fbidi \fnil\fcharset79\fprq2 @\'b9\'d9\'c5\'c1;}{\f826\fbidi \fnil\fcharset79\fprq2 \'c7\'ca\'b1\'e2\'c3\'bc;}{\f827\fbidi \fnil\fcharset79\fprq2 @\'c7\'ca\'b1\'e2\'c3\'bc;}{\f828\fbidi \fnil\fcharset79\fprq2 \'c7\'ec\'b5\'e5\'b6\'f3\'c0\'ceA;}{\f829\fbidi \fnil\fcharset79\fprq2 @\'c7\'ec\'b5\'e5\'b6\'f3\'c0\'ceA;}{\f830\fbidi \froman\fcharset77\fprq0{\*\panose 00000000000000000000}Ming(for ISO10646) {\*\falt &#39636,MingLiU_HKSCS};}{\flomajor\f31500\fbidi \fnil\fcharset0\fprq2{\*\panose 020b0604020202020204}Arial;}{\fdbmajor\f31501\fbidi \fnil\fcharset78\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e;}{\fhimajor\f31502\fbidi \fnil\fcharset0\fprq2{\*\panose 020f0502020204030204}Calibri;}{\fbimajor\f31503\fbidi \fnil\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\flominor\f31504\fbidi \fnil\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\fdbminor\f31505\fbidi \fnil\fcharset78\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9;}{\fhiminor\f31506\fbidi \fnil\fcharset0\fprq2{\*\panose 02040503050406030204}Cambria;}{\fbiminor\f31507\fbidi \fnil\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\f831\fbidi \fnil\fcharset238\fprq2 Times New Roman CE;}{\f832\fbidi \fnil\fcharset204\fprq2 Times New Roman Cyr;}{\f834\fbidi \fnil\fcharset161\fprq2 Times New Roman Greek;}{\f835\fbidi \fnil\fcharset162\fprq2 Times New Roman Tur;}{\f836\fbidi \fnil\fcharset177\fprq2 Times New Roman (Hebrew);}{\f837\fbidi \fnil\fcharset178\fprq2 Times New Roman (Arabid);}{\f838\fbidi \fnil\fcharset186\fprq2 Times New Roman Baltic;}{\f839\fbidi \fnil\fcharset163\fprq2 Times New Roman (Vietnamese);}{\f841\fbidi \fnil\fcharset238\fprq2 Arial CE;}{\f842\fbidi \fnil\fcharset204\fprq2 Arial Cyr;}{\f844\fbidi \fnil\fcharset161\fprq2 Arial Greek;}{\f845\fbidi \fnil\fcharset162\fprq2 Arial Tur;}{\f846\fbidi \fnil\fcharset177\fprq2 Arial (Hebrew);}{\f847\fbidi \fnil\fcharset178\fprq2 Arial (Arabid);}{\f848\fbidi \fnil\fcharset186\fprq2 Arial Baltic;}{\f849\fbidi \fnil\fcharset163\fprq2 Arial (Vietnamese);}{\f851\fbidi \fnil\fcharset238\fprq2 Courier New CE;}{\f852\fbidi \fnil\fcharset204\fprq2 Courier New Cyr;}{\f854\fbidi \fnil\fcharset161\fprq2 Courier New Greek;}{\f855\fbidi \fnil\fcharset162\fprq2 Courier New Tur;}{\f856\fbidi \fnil\fcharset177\fprq2 Courier New (Hebrew);}{\f857\fbidi \fnil\fcharset178\fprq2 Courier New (Arabid);}{\f858\fbidi \fnil\fcharset186\fprq2 Courier New Baltic;}{\f859\fbidi \fnil\fcharset163\fprq2 Courier New (Vietnamese);}{\f881\fbidi \fnil\fcharset238\fprq2 Helvetica CE;}{\f882\fbidi \fnil\fcharset204\fprq2 Helvetica Cyr;}{\f884\fbidi \fnil\fcharset161\fprq2 Helvetica Greek;}{\f885\fbidi \fnil\fcharset162\fprq2 Helvetica Tur;}{\f888\fbidi \fnil\fcharset186\fprq2 Helvetica Baltic;}{\f889\fbidi \fnil\fcharset163\fprq2 Helvetica (Vietnamese);}{\f901\fbidi \fnil\fcharset238\fprq2 Geneva CE;}{\f905\fbidi \fnil\fcharset162\fprq2 Geneva Tur;}{\f908\fbidi \fnil\fcharset186\fprq2 Geneva Baltic;}{\f983\fbidi \fnil\fcharset0\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Western;}{\f981\fbidi \fnil\fcharset238\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 CE;}{\f982\fbidi \fnil\fcharset204\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Cyr;}{\f984\fbidi \fnil\fcharset161\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Greek;}{\f985\fbidi \fnil\fcharset162\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Tur;}{\f988\fbidi \fnil\fcharset186\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Baltic;}{\f993\fbidi \fnil\fcharset0\fprq2 \'b9\'d9\'c5\'c1 Western;}{\f991\fbidi \fnil\fcharset238\fprq2 \'b9\'d9\'c5\'c1 CE;}{\f992\fbidi \fnil\fcharset204\fprq2 \'b9\'d9\'c5\'c1 Cyr;}{\f994\fbidi \fnil\fcharset161\fprq2 \'b9\'d9\'c5\'c1 Greek;}{\f995\fbidi \fnil\fcharset162\fprq2 \'b9\'d9\'c5\'c1 Tur;}{\f998\fbidi \fnil\fcharset186\fprq2 \'b9\'d9\'c5\'c1 Baltic;}{\f1003\fbidi \fnil\fcharset0\fprq2 \'cb\'ce\'cc\'e5 Western;}{\f1013\fbidi \fnil\fcharset0\fprq2 \'b7\'73\'b2\'d3\'a9\'fa\'c5\'e9 Western;}{\f1023\fbidi \fnil\fcharset0\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Western;}{\f1021\fbidi \fnil\fcharset238\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e CE;}{\f1022\fbidi \fnil\fcharset204\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Cyr;}{\f1024\fbidi \fnil\fcharset161\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Greek;}{\f1025\fbidi \fnil\fcharset162\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Tur;}{\f1028\fbidi \fnil\fcharset186\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Baltic;}{\f1031\fbidi \fnil\fcharset238\fprq2 Century CE;}{\f1032\fbidi \fnil\fcharset204\fprq2 Century Cyr;}{\f1034\fbidi \fnil\fcharset161\fprq2 Century Greek;}{\f1035\fbidi \fnil\fcharset162\fprq2 Century Tur;}{\f1038\fbidi \fnil\fcharset186\fprq2 Century Baltic;}{\f1041\fbidi \fnil\fcharset238\fprq2 Verdana CE;}{\f1042\fbidi \fnil\fcharset204\fprq2 Verdana Cyr;}{\f1044\fbidi \fnil\fcharset161\fprq2 Verdana Greek;}{\f1045\fbidi \fnil\fcharset162\fprq2 Verdana Tur;}{\f1048\fbidi \fnil\fcharset186\fprq2 Verdana Baltic;}{\f1049\fbidi \fnil\fcharset163\fprq2 Verdana (Vietnamese);}{\f1092\fbidi \froman\fcharset204\fprq2 Sylfaen Cyr;}{\f1094\fbidi \froman\fcharset161\fprq2 Sylfaen Greek;}{\f1171\fbidi \fnil\fcharset238\fprq2 Cambria Math CE;}{\f1172\fbidi \fnil\fcharset204\fprq2 Cambria Math Cyr;}{\f1174\fbidi \fnil\fcharset161\fprq2 Cambria Math Greek;}{\f1175\fbidi \fnil\fcharset162\fprq2 Cambria Math Tur;}{\f1178\fbidi \fnil\fcharset186\fprq2 Cambria Math Baltic;}{\f1179\fbidi \fnil\fcharset163\fprq2 Cambria Math (Vietnamese);}{\f1181\fbidi \fnil\fcharset238\fprq2 Calibri CE;}{\f1182\fbidi \fnil\fcharset204\fprq2 Calibri Cyr;}{\f1184\fbidi \fnil\fcharset161\fprq2 Calibri Greek;}{\f1185\fbidi \fnil\fcharset162\fprq2 Calibri Tur;}{\f1188\fbidi \fnil\fcharset186\fprq2 Calibri Baltic;}{\f1189\fbidi \fnil\fcharset163\fprq2 Calibri (Vietnamese);}{\f1191\fbidi \fnil\fcharset238\fprq2 Cambria CE;}{\f1192\fbidi \fnil\fcharset204\fprq2 Cambria Cyr;}{\f1194\fbidi \fnil\fcharset161\fprq2 Cambria Greek;}{\f1195\fbidi \fnil\fcharset162\fprq2 Cambria Tur;}{\f1198\fbidi \fnil\fcharset186\fprq2 Cambria Baltic;}{\f1199\fbidi \fnil\fcharset163\fprq2 Cambria (Vietnamese);}{\f1237\fbidi \fnil\fcharset178\fprq2 Adobe Arabic (Arabid);}{\f1247\fbidi \fnil\fcharset178\fprq2 Adobe Arabic Bold (Arabid);}{\f1257\fbidi \fnil\fcharset178\fprq2 Adobe Arabic Bold Italic (Arabid);}{\f1267\fbidi \fnil\fcharset178\fprq2 Adobe Arabic Italic (Arabid);}{\f1271\fbidi \fnil\fcharset238\fprq2 Adobe Caslon Pro CE;}{\f1275\fbidi \fnil\fcharset162\fprq2 Adobe Caslon Pro Tur;}{\f1278\fbidi \fnil\fcharset186\fprq2 Adobe Caslon Pro Baltic;}{\f1281\fbidi \fnil\fcharset238\fprq2 Adobe Caslon Pro Bold CE;}{\f1285\fbidi \fnil\fcharset162\fprq2 Adobe Caslon Pro Bold Tur;}{\f1288\fbidi \fnil\fcharset186\fprq2 Adobe Caslon Pro Bold Baltic;}{\f1291\fbidi \fnil\fcharset238\fprq2 Adobe Caslon Pro Bold Italic CE;}{\f1295\fbidi \fnil\fcharset162\fprq2 Adobe Caslon Pro Bold Italic Tur;}{\f1298\fbidi \fnil\fcharset186\fprq2 Adobe Caslon Pro Bold Italic Baltic;}{\f1301\fbidi \fnil\fcharset238\fprq2 Adobe Caslon Pro Italic CE;}{\f1305\fbidi \fnil\fcharset162\fprq2 Adobe Caslon Pro Italic Tur;}{\f1308\fbidi \fnil\fcharset186\fprq2 Adobe Caslon Pro Italic Baltic;}{\f1311\fbidi \fnil\fcharset238\fprq2 Adobe Caslon Pro SmBd CE;}{\f1315\fbidi \fnil\fcharset162\fprq2 Adobe Caslon Pro SmBd Tur;}{\f1318\fbidi \fnil\fcharset186\fprq2 Adobe Caslon Pro SmBd Baltic;}{\f1321\fbidi \fnil\fcharset238\fprq2 Adobe Caslon Pro SmBd Italic CE;}{\f1325\fbidi \fnil\fcharset162\fprq2 Adobe Caslon Pro SmBd Italic Tur;}{\f1328\fbidi \fnil\fcharset186\fprq2 Adobe Caslon Pro SmBd Italic Baltic;}{\f1371\fbidi \fnil\fcharset238\fprq2 Adobe Garamond Pro CE;}{\f1375\fbidi \fnil\fcharset162\fprq2 Adobe Garamond Pro Tur;}{\f1378\fbidi \fnil\fcharset186\fprq2 Adobe Garamond Pro Baltic;}{\f1381\fbidi \fnil\fcharset238\fprq2 Adobe Garamond Pro Bold CE;}{\f1385\fbidi \fnil\fcharset162\fprq2 Adobe Garamond Pro Bold Tur;}{\f1388\fbidi \fnil\fcharset186\fprq2 Adobe Garamond Pro Bold Baltic;}{\f1391\fbidi \fnil\fcharset238\fprq2 Adobe Garamond Pro Bold Italic CE;}{\f1395\fbidi \fnil\fcharset162\fprq2 Adobe Garamond Pro Bold Italic Tur;}{\f1398\fbidi \fnil\fcharset186\fprq2 Adobe Garamond Pro Bold Italic Baltic;}{\f1401\fbidi \fnil\fcharset238\fprq2 Adobe Garamond Pro Italic CE;}{\f1405\fbidi \fnil\fcharset162\fprq2 Adobe Garamond Pro Italic Tur;}{\f1408\fbidi \fnil\fcharset186\fprq2 Adobe Garamond Pro Italic Baltic;}{\f1416\fbidi \fnil\fcharset177\fprq2 Adobe Hebrew (Hebrew);}{\f1426\fbidi \fnil\fcharset177\fprq2 Adobe Hebrew Bold (Hebrew);}{\f1436\fbidi \fnil\fcharset177\fprq2 Adobe Hebrew Bold Italic (Hebrew);}{\f1446\fbidi \fnil\fcharset177\fprq2 Adobe Hebrew Italic (Hebrew);}{\f1457\fbidi \fnil\fcharset178\fprq2 Adobe Naskh Medium (Arabid);}{\f1465\fbidi \fnil\fcharset162\fprq2 American Typewriter Tur;}{\f1469\fbidi \fnil\fcharset163\fprq2 American Typewriter (Vietnamese);}{\f1475\fbidi \fnil\fcharset162\fprq2 American Typewriter Condensed Tur;}{\f1479\fbidi \fnil\fcharset163\fprq2 American Typewriter Condensed (Vietnamese);}{\f1485\fbidi \fnil\fcharset162\fprq2 American Typewriter Light Tur;}{\f1489\fbidi \fnil\fcharset163\fprq2 American Typewriter Light (Vietnamese);}{\f1491\fbidi \fnil\fcharset238\fprq2 Andale Mono CE;}{\f1492\fbidi \fnil\fcharset204\fprq2 Andale Mono Cyr;}{\f1494\fbidi \fnil\fcharset161\fprq2 Andale Mono Greek;}{\f1495\fbidi \fnil\fcharset162\fprq2 Andale Mono Tur;}{\f1498\fbidi \fnil\fcharset186\fprq2 Andale Mono Baltic;}{\f1501\fbidi \fnil\fcharset238\fprq2 Apple Chancery CE;}{\f1505\fbidi \fnil\fcharset162\fprq2 Apple Chancery Tur;}{\f1506\fbidi \fnil\fcharset177\fprq2 Apple Chancery (Hebrew);}{\f1507\fbidi \fnil\fcharset178\fprq2 Apple Chancery (Arabid);}{\f1508\fbidi \fnil\fcharset186\fprq2 Apple Chancery Baltic;}{\f1509\fbidi \fnil\fcharset163\fprq2 Apple Chancery (Vietnamese);}{\f1511\fbidi \fnil\fcharset238\fprq2 Apple Symbols CE;}{\f1514\fbidi \fnil\fcharset161\fprq2 Apple Symbols Greek;}{\f1515\fbidi \fnil\fcharset162\fprq2 Apple Symbols Tur;}{\f1516\fbidi \fnil\fcharset177\fprq2 Apple Symbols (Hebrew);}{\f1517\fbidi \fnil\fcharset178\fprq2 Apple Symbols (Arabid);}{\f1518\fbidi \fnil\fcharset186\fprq2 Apple Symbols Baltic;}{\f1519\fbidi \fnil\fcharset163\fprq2 Apple Symbols (Vietnamese);}{\f1521\fbidi \fnil\fcharset238\fprq2 Arial Black CE;}{\f1522\fbidi \fnil\fcharset204\fprq2 Arial Black Cyr;}{\f1524\fbidi \fnil\fcharset161\fprq2 Arial Black Greek;}{\f1525\fbidi \fnil\fcharset162\fprq2 Arial Black Tur;}{\f1528\fbidi \fnil\fcharset186\fprq2 Arial Black Baltic;}{\f1531\fbidi \fnil\fcharset238\fprq2 Arial Bold CE;}{\f1532\fbidi \fnil\fcharset204\fprq2 Arial Bold Cyr;}{\f1534\fbidi \fnil\fcharset161\fprq2 Arial Bold Greek;}{\f1535\fbidi \fnil\fcharset162\fprq2 Arial Bold Tur;}{\f1536\fbidi \fnil\fcharset177\fprq2 Arial Bold (Hebrew);}{\f1537\fbidi \fnil\fcharset178\fprq2 Arial Bold (Arabid);}{\f1538\fbidi \fnil\fcharset186\fprq2 Arial Bold Baltic;}{\f1539\fbidi \fnil\fcharset163\fprq2 Arial Bold (Vietnamese);}{\f1541\fbidi \fnil\fcharset238\fprq2 Arial Bold Italic CE;}{\f1542\fbidi \fnil\fcharset204\fprq2 Arial Bold Italic Cyr;}{\f1544\fbidi \fnil\fcharset161\fprq2 Arial Bold Italic Greek;}{\f1545\fbidi \fnil\fcharset162\fprq2 Arial Bold Italic Tur;}{\f1546\fbidi \fnil\fcharset177\fprq2 Arial Bold Italic (Hebrew);}{\f1548\fbidi \fnil\fcharset186\fprq2 Arial Bold Italic Baltic;}{\f1549\fbidi \fnil\fcharset163\fprq2 Arial Bold Italic (Vietnamese);}{\f1551\fbidi \fnil\fcharset238\fprq2 Arial Italic CE;}{\f1552\fbidi \fnil\fcharset204\fprq2 Arial Italic Cyr;}{\f1554\fbidi \fnil\fcharset161\fprq2 Arial Italic Greek;}{\f1555\fbidi \fnil\fcharset162\fprq2 Arial Italic Tur;}{\f1556\fbidi \fnil\fcharset177\fprq2 Arial Italic (Hebrew);}{\f1558\fbidi \fnil\fcharset186\fprq2 Arial Italic Baltic;}{\f1559\fbidi \fnil\fcharset163\fprq2 Arial Italic (Vietnamese);}{\f1561\fbidi \fnil\fcharset238\fprq2 Arial Narrow CE;}{\f1562\fbidi \fnil\fcharset204\fprq2 Arial Narrow Cyr;}{\f1564\fbidi \fnil\fcharset161\fprq2 Arial Narrow Greek;}{\f1565\fbidi \fnil\fcharset162\fprq2 Arial Narrow Tur;}{\f1568\fbidi \fnil\fcharset186\fprq2 Arial Narrow Baltic;}{\f1571\fbidi \fnil\fcharset238\fprq2 Arial Narrow Bold CE;}{\f1572\fbidi \fnil\fcharset204\fprq2 Arial Narrow Bold Cyr;}{\f1574\fbidi \fnil\fcharset161\fprq2 Arial Narrow Bold Greek;}{\f1575\fbidi \fnil\fcharset162\fprq2 Arial Narrow Bold Tur;}{\f1578\fbidi \fnil\fcharset186\fprq2 Arial Narrow Bold Baltic;}{\f1581\fbidi \fnil\fcharset238\fprq2 Arial Narrow Bold Italic CE;}{\f1582\fbidi \fnil\fcharset204\fprq2 Arial Narrow Bold Italic Cyr;}{\f1584\fbidi \fnil\fcharset161\fprq2 Arial Narrow Bold Italic Greek;}{\f1585\fbidi \fnil\fcharset162\fprq2 Arial Narrow Bold Italic Tur;}{\f1588\fbidi \fnil\fcharset186\fprq2 Arial Narrow Bold Italic Baltic;}{\f1591\fbidi \fnil\fcharset238\fprq2 Arial Narrow Italic CE;}{\f1592\fbidi \fnil\fcharset204\fprq2 Arial Narrow Italic Cyr;}{\f1594\fbidi \fnil\fcharset161\fprq2 Arial Narrow Italic Greek;}{\f1595\fbidi \fnil\fcharset162\fprq2 Arial Narrow Italic Tur;}{\f1598\fbidi \fnil\fcharset186\fprq2 Arial Narrow Italic Baltic;}{\f1611\fbidi \fnil\fcharset238\fprq2 Arial Unicode MS CE;}{\f1612\fbidi \fnil\fcharset204\fprq2 Arial Unicode MS Cyr;}{\f1614\fbidi \fnil\fcharset161\fprq2 Arial Unicode MS Greek;}{\f1615\fbidi \fnil\fcharset162\fprq2 Arial Unicode MS Tur;}{\f1616\fbidi \fnil\fcharset177\fprq2 Arial Unicode MS (Hebrew);}{\f1617\fbidi \fnil\fcharset178\fprq2 Arial Unicode MS (Arabid);}{\f1618\fbidi \fnil\fcharset186\fprq2 Arial Unicode MS Baltic;}{\f1619\fbidi \fnil\fcharset163\fprq2 Arial Unicode MS (Vietnamese);}{\f1620\fbidi \fnil\fcharset222\fprq2 Arial Unicode MS (That);}{\f1621\fbidi \fnil\fcharset238\fprq2 Athelas Bold CE;}{\f1625\fbidi \fnil\fcharset162\fprq2 Athelas Bold Tur;}{\f1628\fbidi \fnil\fcharset186\fprq2 Athelas Bold Baltic;}{\f1631\fbidi \fnil\fcharset238\fprq2 Athelas Bold Italic CE;}{\f1634\fbidi \fnil\fcharset161\fprq2 Athelas Bold Italic Greek;}{\f1635\fbidi \fnil\fcharset162\fprq2 Athelas Bold Italic Tur;}{\f1638\fbidi \fnil\fcharset186\fprq2 Athelas Bold Italic Baltic;}{\f1641\fbidi \fnil\fcharset238\fprq2 Athelas Italic CE;}{\f1644\fbidi \fnil\fcharset161\fprq2 Athelas Italic Greek;}{\f1645\fbidi \fnil\fcharset162\fprq2 Athelas Italic Tur;}{\f1648\fbidi \fnil\fcharset186\fprq2 Athelas Italic Baltic;}{\f1651\fbidi \fnil\fcharset238\fprq2 Athelas Regular CE;}{\f1654\fbidi \fnil\fcharset161\fprq2 Athelas Regular Greek;}{\f1655\fbidi \fnil\fcharset162\fprq2 Athelas Regular Tur;}{\f1658\fbidi \fnil\fcharset186\fprq2 Athelas Regular Baltic;}{\f1661\fbidi \fnil\fcharset238\fprq2 Avenir Black CE;}{\f1664\fbidi \fnil\fcharset161\fprq2 Avenir Black Greek;}{\f1665\fbidi \fnil\fcharset162\fprq2 Avenir Black Tur;}{\f1668\fbidi \fnil\fcharset186\fprq2 Avenir Black Baltic;}{\f1671\fbidi \fnil\fcharset238\fprq2 Avenir Black Oblique CE;}{\f1674\fbidi \fnil\fcharset161\fprq2 Avenir Black Oblique Greek;}{\f1675\fbidi \fnil\fcharset162\fprq2 Avenir Black Oblique Tur;}{\f1678\fbidi \fnil\fcharset186\fprq2 Avenir Black Oblique Baltic;}{\f1681\fbidi \fnil\fcharset238\fprq2 Avenir Book CE;}{\f1684\fbidi \fnil\fcharset161\fprq2 Avenir Book Greek;}{\f1685\fbidi \fnil\fcharset162\fprq2 Avenir Book Tur;}{\f1688\fbidi \fnil\fcharset186\fprq2 Avenir Book Baltic;}{\f1691\fbidi \fnil\fcharset238\fprq2 Avenir Book Oblique CE;}{\f1694\fbidi \fnil\fcharset161\fprq2 Avenir Book Oblique Greek;}{\f1695\fbidi \fnil\fcharset162\fprq2 Avenir Book Oblique Tur;}{\f1698\fbidi \fnil\fcharset186\fprq2 Avenir Book Oblique Baltic;}{\f1701\fbidi \fnil\fcharset238\fprq2 Avenir Heavy CE;}{\f1704\fbidi \fnil\fcharset161\fprq2 Avenir Heavy Greek;}{\f1705\fbidi \fnil\fcharset162\fprq2 Avenir Heavy Tur;}{\f1708\fbidi \fnil\fcharset186\fprq2 Avenir Heavy Baltic;}{\f1711\fbidi \fnil\fcharset238\fprq2 Avenir Heavy Oblique CE;}{\f1714\fbidi \fnil\fcharset161\fprq2 Avenir Heavy Oblique Greek;}{\f1715\fbidi \fnil\fcharset162\fprq2 Avenir Heavy Oblique Tur;}{\f1718\fbidi \fnil\fcharset186\fprq2 Avenir Heavy Oblique Baltic;}{\f1721\fbidi \fnil\fcharset238\fprq2 Avenir Light CE;}{\f1724\fbidi \fnil\fcharset161\fprq2 Avenir Light Greek;}{\f1725\fbidi \fnil\fcharset162\fprq2 Avenir Light Tur;}{\f1728\fbidi \fnil\fcharset186\fprq2 Avenir Light Baltic;}{\f1731\fbidi \fnil\fcharset238\fprq2 Avenir Light Oblique CE;}{\f1734\fbidi \fnil\fcharset161\fprq2 Avenir Light Oblique Greek;}{\f1735\fbidi \fnil\fcharset162\fprq2 Avenir Light Oblique Tur;}{\f1738\fbidi \fnil\fcharset186\fprq2 Avenir Light Oblique Baltic;}{\f1741\fbidi \fnil\fcharset238\fprq2 Avenir Medium CE;}{\f1744\fbidi \fnil\fcharset161\fprq2 Avenir Medium Greek;}{\f1745\fbidi \fnil\fcharset162\fprq2 Avenir Medium Tur;}{\f1748\fbidi \fnil\fcharset186\fprq2 Avenir Medium Baltic;}{\f1751\fbidi \fnil\fcharset238\fprq2 Avenir Medium Oblique CE;}{\f1754\fbidi \fnil\fcharset161\fprq2 Avenir Medium Oblique Greek;}{\f1755\fbidi \fnil\fcharset162\fprq2 Avenir Medium Oblique Tur;}{\f1758\fbidi \fnil\fcharset186\fprq2 Avenir Medium Oblique Baltic;}{\f1761\fbidi \fnil\fcharset238\fprq2 Avenir Next Bold CE;}{\f1764\fbidi \fnil\fcharset161\fprq2 Avenir Next Bold Greek;}{\f1765\fbidi \fnil\fcharset162\fprq2 Avenir Next Bold Tur;}{\f1768\fbidi \fnil\fcharset186\fprq2 Avenir Next Bold Baltic;}{\f1771\fbidi \fnil\fcharset238\fprq2 Avenir Next Bold Italic CE;}{\f1774\fbidi \fnil\fcharset161\fprq2 Avenir Next Bold Italic Greek;}{\f1775\fbidi \fnil\fcharset162\fprq2 Avenir Next Bold Italic Tur;}{\f1778\fbidi \fnil\fcharset186\fprq2 Avenir Next Bold Italic Baltic;}{\f1781\fbidi \fnil\fcharset238\fprq2 Avenir Next Condensed Bold CE;}{\f1784\fbidi \fnil\fcharset161\fprq2 Avenir Next Condensed Bold Greek;}{\f1785\fbidi \fnil\fcharset162\fprq2 Avenir Next Condensed Bold Tur;}{\f1788\fbidi \fnil\fcharset186\fprq2 Avenir Next Condensed Bold Baltic;}{\f1791\fbidi \fnil\fcharset238\fprq2 Avenir Next Condensed Demi Bold CE;}{\f1794\fbidi \fnil\fcharset161\fprq2 Avenir Next Condensed Demi Bold Greek;}{\f1795\fbidi \fnil\fcharset162\fprq2 Avenir Next Condensed Demi Bold Tur;}{\f1798\fbidi \fnil\fcharset186\fprq2 Avenir Next Condensed Demi Bold Baltic;}{\f1801\fbidi \fnil\fcharset238\fprq2 Avenir Next Condensed Heavy CE;}{\f1804\fbidi \fnil\fcharset161\fprq2 Avenir Next Condensed Heavy Greek;}{\f1805\fbidi \fnil\fcharset162\fprq2 Avenir Next Condensed Heavy Tur;}{\f1808\fbidi \fnil\fcharset186\fprq2 Avenir Next Condensed Heavy Baltic;}{\f1811\fbidi \fnil\fcharset238\fprq2 Avenir Next Condensed Italic CE;}{\f1814\fbidi \fnil\fcharset161\fprq2 Avenir Next Condensed Italic Greek;}{\f1815\fbidi \fnil\fcharset162\fprq2 Avenir Next Condensed Italic Tur;}{\f1818\fbidi \fnil\fcharset186\fprq2 Avenir Next Condensed Italic Baltic;}{\f1821\fbidi \fnil\fcharset238\fprq2 Avenir Next Condensed Medium CE;}{\f1824\fbidi \fnil\fcharset161\fprq2 Avenir Next Condensed Medium Greek;}{\f1825\fbidi \fnil\fcharset162\fprq2 Avenir Next Condensed Medium Tur;}{\f1828\fbidi \fnil\fcharset186\fprq2 Avenir Next Condensed Medium Baltic;}{\f1831\fbidi \fnil\fcharset238\fprq2 Avenir Next Condensed Regular CE;}{\f1834\fbidi \fnil\fcharset161\fprq2 Avenir Next Condensed Regular Greek;}{\f1835\fbidi \fnil\fcharset162\fprq2 Avenir Next Condensed Regular Tur;}{\f1838\fbidi \fnil\fcharset186\fprq2 Avenir Next Condensed Regular Baltic;}{\f1841\fbidi \fnil\fcharset238\fprq2 Avenir Next Demi Bold CE;}{\f1844\fbidi \fnil\fcharset161\fprq2 Avenir Next Demi Bold Greek;}{\f1845\fbidi \fnil\fcharset162\fprq2 Avenir Next Demi Bold Tur;}{\f1848\fbidi \fnil\fcharset186\fprq2 Avenir Next Demi Bold Baltic;}{\f1851\fbidi \fnil\fcharset238\fprq2 Avenir Next Demi Bold Italic CE;}{\f1854\fbidi \fnil\fcharset161\fprq2 Avenir Next Demi Bold Italic Greek;}{\f1855\fbidi \fnil\fcharset162\fprq2 Avenir Next Demi Bold Italic Tur;}{\f1858\fbidi \fnil\fcharset186\fprq2 Avenir Next Demi Bold Italic Baltic;}{\f1861\fbidi \fnil\fcharset238\fprq2 Avenir Next Heavy CE;}{\f1864\fbidi \fnil\fcharset161\fprq2 Avenir Next Heavy Greek;}{\f1865\fbidi \fnil\fcharset162\fprq2 Avenir Next Heavy Tur;}{\f1868\fbidi \fnil\fcharset186\fprq2 Avenir Next Heavy Baltic;}{\f1871\fbidi \fnil\fcharset238\fprq2 Avenir Next Heavy Italic CE;}{\f1874\fbidi \fnil\fcharset161\fprq2 Avenir Next Heavy Italic Greek;}{\f1875\fbidi \fnil\fcharset162\fprq2 Avenir Next Heavy Italic Tur;}{\f1878\fbidi \fnil\fcharset186\fprq2 Avenir Next Heavy Italic Baltic;}{\f1881\fbidi \fnil\fcharset238\fprq2 Avenir Next Italic CE;}{\f1884\fbidi \fnil\fcharset161\fprq2 Avenir Next Italic Greek;}{\f1885\fbidi \fnil\fcharset162\fprq2 Avenir Next Italic Tur;}{\f1888\fbidi \fnil\fcharset186\fprq2 Avenir Next Italic Baltic;}{\f1891\fbidi \fnil\fcharset238\fprq2 Avenir Next Medium CE;}{\f1894\fbidi \fnil\fcharset161\fprq2 Avenir Next Medium Greek;}{\f1895\fbidi \fnil\fcharset162\fprq2 Avenir Next Medium Tur;}{\f1898\fbidi \fnil\fcharset186\fprq2 Avenir Next Medium Baltic;}{\f1901\fbidi \fnil\fcharset238\fprq2 Avenir Next Medium Italic CE;}{\f1904\fbidi \fnil\fcharset161\fprq2 Avenir Next Medium Italic Greek;}{\f1905\fbidi \fnil\fcharset162\fprq2 Avenir Next Medium Italic Tur;}{\f1908\fbidi \fnil\fcharset186\fprq2 Avenir Next Medium Italic Baltic;}{\f1911\fbidi \fnil\fcharset238\fprq2 Avenir Next Regular CE;}{\f1914\fbidi \fnil\fcharset161\fprq2 Avenir Next Regular Greek;}{\f1915\fbidi \fnil\fcharset162\fprq2 Avenir Next Regular Tur;}{\f1918\fbidi \fnil\fcharset186\fprq2 Avenir Next Regular Baltic;}{\f1921\fbidi \fnil\fcharset238\fprq2 Avenir Next Ultra Light CE;}{\f1924\fbidi \fnil\fcharset161\fprq2 Avenir Next Ultra Light Greek;}{\f1925\fbidi \fnil\fcharset162\fprq2 Avenir Next Ultra Light Tur;}{\f1928\fbidi \fnil\fcharset186\fprq2 Avenir Next Ultra Light Baltic;}{\f1931\fbidi \fnil\fcharset238\fprq2 Avenir Next Ultra Light Italic CE;}{\f1934\fbidi \fnil\fcharset161\fprq2 Avenir Next Ultra Light Italic Greek;}{\f1935\fbidi \fnil\fcharset162\fprq2 Avenir Next Ultra Light Italic Tur;}{\f1938\fbidi \fnil\fcharset186\fprq2 Avenir Next Ultra Light Italic Baltic;}{\f1941\fbidi \fnil\fcharset238\fprq2 Avenir Oblique CE;}{\f1944\fbidi \fnil\fcharset161\fprq2 Avenir Oblique Greek;}{\f1945\fbidi \fnil\fcharset162\fprq2 Avenir Oblique Tur;}{\f1948\fbidi \fnil\fcharset186\fprq2 Avenir Oblique Baltic;}{\f1951\fbidi \fnil\fcharset238\fprq2 Avenir Roman CE;}{\f1954\fbidi \fnil\fcharset161\fprq2 Avenir Roman Greek;}{\f1955\fbidi \fnil\fcharset162\fprq2 Avenir Roman Tur;}{\f1958\fbidi \fnil\fcharset186\fprq2 Avenir Roman Baltic;}{\f1961\fbidi \fnil\fcharset238\fprq2 Ayuthaya CE;}{\f1962\fbidi \fnil\fcharset204\fprq2 Ayuthaya Cyr;}{\f1964\fbidi \fnil\fcharset161\fprq2 Ayuthaya Greek;}{\f1965\fbidi \fnil\fcharset162\fprq2 Ayuthaya Tur;}{\f1966\fbidi \fnil\fcharset177\fprq2 Ayuthaya (Hebrew);}{\f1967\fbidi \fnil\fcharset178\fprq2 Ayuthaya (Arabid);}{\f1968\fbidi \fnil\fcharset186\fprq2 Ayuthaya Baltic;}{\f1969\fbidi \fnil\fcharset163\fprq2 Ayuthaya (Vietnamese);}{\f1970\fbidi \fnil\fcharset222\fprq2 Ayuthaya (That);}{\f2011\fbidi \fnil\fcharset238\fprq2 Bank Gothic CE;}{\f2015\fbidi \fnil\fcharset162\fprq2 Bank Gothic Tur;}{\f2018\fbidi \fnil\fcharset186\fprq2 Bank Gothic Baltic;}{\f2019\fbidi \fnil\fcharset163\fprq2 Bank Gothic (Vietnamese);}{\f2031\fbidi \fnil\fcharset238\fprq2 Baskerville CE;}{\f2032\fbidi \fnil\fcharset204\fprq2 Baskerville Cyr;}{\f2034\fbidi \fnil\fcharset161\fprq2 Baskerville Greek;}{\f2035\fbidi \fnil\fcharset162\fprq2 Baskerville Tur;}{\f2038\fbidi \fnil\fcharset186\fprq2 Baskerville Baltic;}{\f2039\fbidi \fnil\fcharset163\fprq2 Baskerville (Vietnamese);}{\f2041\fbidi \fnil\fcharset238\fprq2 Baskerville Bold CE;}{\f2042\fbidi \fnil\fcharset204\fprq2 Baskerville Bold Cyr;}{\f2044\fbidi \fnil\fcharset161\fprq2 Baskerville Bold Greek;}{\f2045\fbidi \fnil\fcharset162\fprq2 Baskerville Bold Tur;}{\f2048\fbidi \fnil\fcharset186\fprq2 Baskerville Bold Baltic;}{\f2049\fbidi \fnil\fcharset163\fprq2 Baskerville Bold (Vietnamese);}{\f2051\fbidi \fnil\fcharset238\fprq2 Baskerville Bold Italic CE;}{\f2052\fbidi \fnil\fcharset204\fprq2 Baskerville Bold Italic Cyr;}{\f2054\fbidi \fnil\fcharset161\fprq2 Baskerville Bold Italic Greek;}{\f2055\fbidi \fnil\fcharset162\fprq2 Baskerville Bold Italic Tur;}{\f2058\fbidi \fnil\fcharset186\fprq2 Baskerville Bold Italic Baltic;}{\f2059\fbidi \fnil\fcharset163\fprq2 Baskerville Bold Italic (Vietnamese);}{\f2061\fbidi \fnil\fcharset238\fprq2 Baskerville Italic CE;}{\f2062\fbidi \fnil\fcharset204\fprq2 Baskerville Italic Cyr;}{\f2064\fbidi \fnil\fcharset161\fprq2 Baskerville Italic Greek;}{\f2065\fbidi \fnil\fcharset162\fprq2 Baskerville Italic Tur;}{\f2068\fbidi \fnil\fcharset186\fprq2 Baskerville Italic Baltic;}{\f2069\fbidi \fnil\fcharset163\fprq2 Baskerville Italic (Vietnamese);}{\f2081\fbidi \fnil\fcharset238\fprq2 Baskerville SemiBold CE;}{\f2082\fbidi \fnil\fcharset204\fprq2 Baskerville SemiBold Cyr;}{\f2084\fbidi \fnil\fcharset161\fprq2 Baskerville SemiBold Greek;}{\f2085\fbidi \fnil\fcharset162\fprq2 Baskerville SemiBold Tur;}{\f2088\fbidi \fnil\fcharset186\fprq2 Baskerville SemiBold Baltic;}{\f2089\fbidi \fnil\fcharset163\fprq2 Baskerville SemiBold (Vietnamese);}{\f2091\fbidi \fnil\fcharset238\fprq2 Baskerville SemiBold Italic CE;}{\f2092\fbidi \fnil\fcharset204\fprq2 Baskerville SemiBold Italic Cyr;}{\f2094\fbidi \fnil\fcharset161\fprq2 Baskerville SemiBold Italic Greek;}{\f2095\fbidi \fnil\fcharset162\fprq2 Baskerville SemiBold Italic Tur;}{\f2098\fbidi \fnil\fcharset186\fprq2 Baskerville SemiBold Italic Baltic;}{\f2099\fbidi \fnil\fcharset163\fprq2 Baskerville SemiBold Italic (Vietnamese);}{\f2141\fbidi \fnil\fcharset238\fprq2 Big Caslon CE;}{\f2144\fbidi \fnil\fcharset161\fprq2 Big Caslon Greek;}{\f2145\fbidi \fnil\fcharset162\fprq2 Big Caslon Tur;}{\f2146\fbidi \fnil\fcharset177\fprq2 Big Caslon (Hebrew);}{\f2147\fbidi \fnil\fcharset178\fprq2 Big Caslon (Arabid);}{\f2148\fbidi \fnil\fcharset186\fprq2 Big Caslon Baltic;}{\f2149\fbidi \fnil\fcharset163\fprq2 Big Caslon (Vietnamese);}{\f2315\fbidi \fnil\fcharset162\fprq2 Bradley Hand ITC TT-Bold Tur;}{\f2319\fbidi \fnil\fcharset163\fprq2 Bradley Hand ITC TT-Bold (Vietnamese);}{\f2341\fbidi \fnil\fcharset238\fprq2 Brush Script MT Italic CE;}{\f2344\fbidi \fnil\fcharset161\fprq2 Brush Script MT Italic Greek;}{\f2345\fbidi \fnil\fcharset162\fprq2 Brush Script MT Italic Tur;}{\f2346\fbidi \fnil\fcharset177\fprq2 Brush Script MT Italic (Hebrew);}{\f2350\fbidi \fnil\fcharset222\fprq2 Brush Script MT Italic (That);}{\f2361\fbidi \fnil\fcharset238\fprq2 Calibri Bold CE;}{\f2362\fbidi \fnil\fcharset204\fprq2 Calibri Bold Cyr;}{\f2364\fbidi \fnil\fcharset161\fprq2 Calibri Bold Greek;}{\f2365\fbidi \fnil\fcharset162\fprq2 Calibri Bold Tur;}{\f2368\fbidi \fnil\fcharset186\fprq2 Calibri Bold Baltic;}{\f2369\fbidi \fnil\fcharset163\fprq2 Calibri Bold (Vietnamese);}{\f2371\fbidi \fnil\fcharset238\fprq2 Calibri Bold Italic CE;}{\f2372\fbidi \fnil\fcharset204\fprq2 Calibri Bold Italic Cyr;}{\f2374\fbidi \fnil\fcharset161\fprq2 Calibri Bold Italic Greek;}{\f2375\fbidi \fnil\fcharset162\fprq2 Calibri Bold Italic Tur;}{\f2378\fbidi \fnil\fcharset186\fprq2 Calibri Bold Italic Baltic;}{\f2379\fbidi \fnil\fcharset163\fprq2 Calibri Bold Italic (Vietnamese);}{\f2381\fbidi \fnil\fcharset238\fprq2 Calibri Italic CE;}{\f2382\fbidi \fnil\fcharset204\fprq2 Calibri Italic Cyr;}{\f2384\fbidi \fnil\fcharset161\fprq2 Calibri Italic Greek;}{\f2385\fbidi \fnil\fcharset162\fprq2 Calibri Italic Tur;}{\f2388\fbidi \fnil\fcharset186\fprq2 Calibri Italic Baltic;}{\f2389\fbidi \fnil\fcharset163\fprq2 Calibri Italic (Vietnamese);}{\f2391\fbidi \fnil\fcharset238\fprq2 Calibri Light CE;}{\f2392\fbidi \fnil\fcharset204\fprq2 Calibri Light Cyr;}{\f2394\fbidi \fnil\fcharset161\fprq2 Calibri Light Greek;}{\f2395\fbidi \fnil\fcharset162\fprq2 Calibri Light Tur;}{\f2398\fbidi \fnil\fcharset186\fprq2 Calibri Light Baltic;}{\f2411\fbidi \fnil\fcharset238\fprq2 Cambria Bold CE;}{\f2412\fbidi \fnil\fcharset204\fprq2 Cambria Bold Cyr;}{\f2414\fbidi \fnil\fcharset161\fprq2 Cambria Bold Greek;}{\f2415\fbidi \fnil\fcharset162\fprq2 Cambria Bold Tur;}{\f2418\fbidi \fnil\fcharset186\fprq2 Cambria Bold Baltic;}{\f2419\fbidi \fnil\fcharset163\fprq2 Cambria Bold (Vietnamese);}{\f2421\fbidi \fnil\fcharset238\fprq2 Cambria Bold Italic CE;}{\f2422\fbidi \fnil\fcharset204\fprq2 Cambria Bold Italic Cyr;}{\f2424\fbidi \fnil\fcharset161\fprq2 Cambria Bold Italic Greek;}{\f2425\fbidi \fnil\fcharset162\fprq2 Cambria Bold Italic Tur;}{\f2428\fbidi \fnil\fcharset186\fprq2 Cambria Bold Italic Baltic;}{\f2429\fbidi \fnil\fcharset163\fprq2 Cambria Bold Italic (Vietnamese);}{\f2431\fbidi \fnil\fcharset238\fprq2 Cambria Italic CE;}{\f2432\fbidi \fnil\fcharset204\fprq2 Cambria Italic Cyr;}{\f2434\fbidi \fnil\fcharset161\fprq2 Cambria Italic Greek;}{\f2435\fbidi \fnil\fcharset162\fprq2 Cambria Italic Tur;}{\f2438\fbidi \fnil\fcharset186\fprq2 Cambria Italic Baltic;}{\f2439\fbidi \fnil\fcharset163\fprq2 Cambria Italic (Vietnamese);}{\f2441\fbidi \fnil\fcharset238\fprq2 Candara CE;}{\f2442\fbidi \fnil\fcharset204\fprq2 Candara Cyr;}{\f2444\fbidi \fnil\fcharset161\fprq2 Candara Greek;}{\f2445\fbidi \fnil\fcharset162\fprq2 Candara Tur;}{\f2448\fbidi \fnil\fcharset186\fprq2 Candara Baltic;}{\f2449\fbidi \fnil\fcharset163\fprq2 Candara (Vietnamese);}{\f2451\fbidi \fnil\fcharset238\fprq2 Candara Bold CE;}{\f2452\fbidi \fnil\fcharset204\fprq2 Candara Bold Cyr;}{\f2454\fbidi \fnil\fcharset161\fprq2 Candara Bold Greek;}{\f2455\fbidi \fnil\fcharset162\fprq2 Candara Bold Tur;}{\f2458\fbidi \fnil\fcharset186\fprq2 Candara Bold Baltic;}{\f2459\fbidi \fnil\fcharset163\fprq2 Candara Bold (Vietnamese);}{\f2461\fbidi \fnil\fcharset238\fprq2 Candara Bold Italic CE;}{\f2462\fbidi \fnil\fcharset204\fprq2 Candara Bold Italic Cyr;}{\f2464\fbidi \fnil\fcharset161\fprq2 Candara Bold Italic Greek;}{\f2465\fbidi \fnil\fcharset162\fprq2 Candara Bold Italic Tur;}{\f2468\fbidi \fnil\fcharset186\fprq2 Candara Bold Italic Baltic;}{\f2469\fbidi \fnil\fcharset163\fprq2 Candara Bold Italic (Vietnamese);}{\f2471\fbidi \fnil\fcharset238\fprq2 Candara Italic CE;}{\f2472\fbidi \fnil\fcharset204\fprq2 Candara Italic Cyr;}{\f2474\fbidi \fnil\fcharset161\fprq2 Candara Italic Greek;}{\f2475\fbidi \fnil\fcharset162\fprq2 Candara Italic Tur;}{\f2478\fbidi \fnil\fcharset186\fprq2 Candara Italic Baltic;}{\f2479\fbidi \fnil\fcharset163\fprq2 Candara Italic (Vietnamese);}{\f2571\fbidi \fnil\fcharset238\fprq2 Chaparral Pro CE;}{\f2575\fbidi \fnil\fcharset162\fprq2 Chaparral Pro Tur;}{\f2578\fbidi \fnil\fcharset186\fprq2 Chaparral Pro Baltic;}{\f2581\fbidi \fnil\fcharset238\fprq2 Chaparral Pro Bold CE;}{\f2585\fbidi \fnil\fcharset162\fprq2 Chaparral Pro Bold Tur;}{\f2588\fbidi \fnil\fcharset186\fprq2 Chaparral Pro Bold Baltic;}{\f2591\fbidi \fnil\fcharset238\fprq2 Chaparral Pro Bold Ital CE;}{\f2595\fbidi \fnil\fcharset162\fprq2 Chaparral Pro Bold Ital Tur;}{\f2598\fbidi \fnil\fcharset186\fprq2 Chaparral Pro Bold Ital Baltic;}{\f2601\fbidi \fnil\fcharset238\fprq2 Chaparral Pro Ital CE;}{\f2605\fbidi \fnil\fcharset162\fprq2 Chaparral Pro Ital Tur;}{\f2608\fbidi \fnil\fcharset186\fprq2 Chaparral Pro Ital Baltic;}{\f2611\fbidi \fnil\fcharset238\fprq2 Chaparral Pro Light Ital CE;}{\f2615\fbidi \fnil\fcharset162\fprq2 Chaparral Pro Light Ital Tur;}{\f2618\fbidi \fnil\fcharset186\fprq2 Chaparral Pro Light Ital Baltic;}{\f2635\fbidi \fnil\fcharset162\fprq2 Charter Black Tur;}{\f2645\fbidi \fnil\fcharset162\fprq2 Charter Black Italic Tur;}{\f2655\fbidi \fnil\fcharset162\fprq2 Charter Bold Tur;}{\f2665\fbidi \fnil\fcharset162\fprq2 Charter Bold Italic Tur;}{\f2675\fbidi \fnil\fcharset162\fprq2 Charter Italic Tur;}{\f2685\fbidi \fnil\fcharset162\fprq2 Charter Roman Tur;}{\f2691\fbidi \fnil\fcharset238\fprq2 Cochin CE;}{\f2692\fbidi \fnil\fcharset204\fprq2 Cochin Cyr;}{\f2711\fbidi \fnil\fcharset238\fprq2 Comic Sans MS CE;}{\f2712\fbidi \fnil\fcharset204\fprq2 Comic Sans MS Cyr;}{\f2714\fbidi \fnil\fcharset161\fprq2 Comic Sans MS Greek;}{\f2715\fbidi \fnil\fcharset162\fprq2 Comic Sans MS Tur;}{\f2718\fbidi \fnil\fcharset186\fprq2 Comic Sans MS Baltic;}{\f2721\fbidi \fnil\fcharset238\fprq2 Comic Sans MS Bold CE;}{\f2722\fbidi \fnil\fcharset204\fprq2 Comic Sans MS Bold Cyr;}{\f2724\fbidi \fnil\fcharset161\fprq2 Comic Sans MS Bold Greek;}{\f2725\fbidi \fnil\fcharset162\fprq2 Comic Sans MS Bold Tur;}{\f2728\fbidi \fnil\fcharset186\fprq2 Comic Sans MS Bold Baltic;}{\f2731\fbidi \fnil\fcharset238\fprq2 Consolas CE;}{\f2732\fbidi \fnil\fcharset204\fprq2 Consolas Cyr;}{\f2734\fbidi \fnil\fcharset161\fprq2 Consolas Greek;}{\f2735\fbidi \fnil\fcharset162\fprq2 Consolas Tur;}{\f2738\fbidi \fnil\fcharset186\fprq2 Consolas Baltic;}{\f2739\fbidi \fnil\fcharset163\fprq2 Consolas (Vietnamese);}{\f2741\fbidi \fnil\fcharset238\fprq2 Consolas Bold CE;}{\f2742\fbidi \fnil\fcharset204\fprq2 Consolas Bold Cyr;}{\f2744\fbidi \fnil\fcharset161\fprq2 Consolas Bold Greek;}{\f2745\fbidi \fnil\fcharset162\fprq2 Consolas Bold Tur;}{\f2748\fbidi \fnil\fcharset186\fprq2 Consolas Bold Baltic;}{\f2749\fbidi \fnil\fcharset163\fprq2 Consolas Bold (Vietnamese);}{\f2751\fbidi \fnil\fcharset238\fprq2 Consolas Bold Italic CE;}{\f2752\fbidi \fnil\fcharset204\fprq2 Consolas Bold Italic Cyr;}{\f2754\fbidi \fnil\fcharset161\fprq2 Consolas Bold Italic Greek;}{\f2755\fbidi \fnil\fcharset162\fprq2 Consolas Bold Italic Tur;}{\f2758\fbidi \fnil\fcharset186\fprq2 Consolas Bold Italic Baltic;}{\f2759\fbidi \fnil\fcharset163\fprq2 Consolas Bold Italic (Vietnamese);}{\f2761\fbidi \fnil\fcharset238\fprq2 Consolas Italic CE;}{\f2762\fbidi \fnil\fcharset204\fprq2 Consolas Italic Cyr;}{\f2764\fbidi \fnil\fcharset161\fprq2 Consolas Italic Greek;}{\f2765\fbidi \fnil\fcharset162\fprq2 Consolas Italic Tur;}{\f2768\fbidi \fnil\fcharset186\fprq2 Consolas Italic Baltic;}{\f2769\fbidi \fnil\fcharset163\fprq2 Consolas Italic (Vietnamese);}{\f2771\fbidi \fnil\fcharset238\fprq2 Constantia CE;}{\f2772\fbidi \fnil\fcharset204\fprq2 Constantia Cyr;}{\f2774\fbidi \fnil\fcharset161\fprq2 Constantia Greek;}{\f2775\fbidi \fnil\fcharset162\fprq2 Constantia Tur;}{\f2778\fbidi \fnil\fcharset186\fprq2 Constantia Baltic;}{\f2779\fbidi \fnil\fcharset163\fprq2 Constantia (Vietnamese);}{\f2781\fbidi \fnil\fcharset238\fprq2 Constantia Bold CE;}{\f2782\fbidi \fnil\fcharset204\fprq2 Constantia Bold Cyr;}{\f2784\fbidi \fnil\fcharset161\fprq2 Constantia Bold Greek;}{\f2785\fbidi \fnil\fcharset162\fprq2 Constantia Bold Tur;}{\f2788\fbidi \fnil\fcharset186\fprq2 Constantia Bold Baltic;}{\f2789\fbidi \fnil\fcharset163\fprq2 Constantia Bold (Vietnamese);}{\f2791\fbidi \fnil\fcharset238\fprq2 Constantia Bold Italic CE;}{\f2792\fbidi \fnil\fcharset204\fprq2 Constantia Bold Italic Cyr;}{\f2794\fbidi \fnil\fcharset161\fprq2 Constantia Bold Italic Greek;}{\f2795\fbidi \fnil\fcharset162\fprq2 Constantia Bold Italic Tur;}{\f2798\fbidi \fnil\fcharset186\fprq2 Constantia Bold Italic Baltic;}{\f2799\fbidi \fnil\fcharset163\fprq2 Constantia Bold Italic (Vietnamese);}{\f2801\fbidi \fnil\fcharset238\fprq2 Constantia Italic CE;}{\f2802\fbidi \fnil\fcharset204\fprq2 Constantia Italic Cyr;}{\f2804\fbidi \fnil\fcharset161\fprq2 Constantia Italic Greek;}{\f2805\fbidi \fnil\fcharset162\fprq2 Constantia Italic Tur;}{\f2808\fbidi \fnil\fcharset186\fprq2 Constantia Italic Baltic;}{\f2809\fbidi \fnil\fcharset163\fprq2 Constantia Italic (Vietnamese);}{\f2845\fbidi \fnil\fcharset162\fprq2 Copperplate Tur;}{\f2849\fbidi \fnil\fcharset163\fprq2 Copperplate (Vietnamese);}{\f2855\fbidi \fnil\fcharset162\fprq2 Copperplate Bold Tur;}{\f2859\fbidi \fnil\fcharset163\fprq2 Copperplate Bold (Vietnamese);}{\f2885\fbidi \fnil\fcharset162\fprq2 Copperplate Light Tur;}{\f2889\fbidi \fnil\fcharset163\fprq2 Copperplate Light (Vietnamese);}{\f2891\fbidi \fnil\fcharset238\fprq2 Corbel CE;}{\f2892\fbidi \fnil\fcharset204\fprq2 Corbel Cyr;}{\f2894\fbidi \fnil\fcharset161\fprq2 Corbel Greek;}{\f2895\fbidi \fnil\fcharset162\fprq2 Corbel Tur;}{\f2898\fbidi \fnil\fcharset186\fprq2 Corbel Baltic;}{\f2899\fbidi \fnil\fcharset163\fprq2 Corbel (Vietnamese);}{\f2901\fbidi \fnil\fcharset238\fprq2 Corbel Bold CE;}{\f2902\fbidi \fnil\fcharset204\fprq2 Corbel Bold Cyr;}{\f2904\fbidi \fnil\fcharset161\fprq2 Corbel Bold Greek;}{\f2905\fbidi \fnil\fcharset162\fprq2 Corbel Bold Tur;}{\f2908\fbidi \fnil\fcharset186\fprq2 Corbel Bold Baltic;}{\f2909\fbidi \fnil\fcharset163\fprq2 Corbel Bold (Vietnamese);}{\f2911\fbidi \fnil\fcharset238\fprq2 Corbel Bold Italic CE;}{\f2912\fbidi \fnil\fcharset204\fprq2 Corbel Bold Italic Cyr;}{\f2914\fbidi \fnil\fcharset161\fprq2 Corbel Bold Italic Greek;}{\f2915\fbidi \fnil\fcharset162\fprq2 Corbel Bold Italic Tur;}{\f2918\fbidi \fnil\fcharset186\fprq2 Corbel Bold Italic Baltic;}{\f2919\fbidi \fnil\fcharset163\fprq2 Corbel Bold Italic (Vietnamese);}{\f2921\fbidi \fnil\fcharset238\fprq2 Corbel Italic CE;}{\f2922\fbidi \fnil\fcharset204\fprq2 Corbel Italic Cyr;}{\f2924\fbidi \fnil\fcharset161\fprq2 Corbel Italic Greek;}{\f2925\fbidi \fnil\fcharset162\fprq2 Corbel Italic Tur;}{\f2928\fbidi \fnil\fcharset186\fprq2 Corbel Italic Baltic;}{\f2929\fbidi \fnil\fcharset163\fprq2 Corbel Italic (Vietnamese);}{\f2931\fbidi \fnil\fcharset238\fprq2 Courier New Bold CE;}{\f2932\fbidi \fnil\fcharset204\fprq2 Courier New Bold Cyr;}{\f2934\fbidi \fnil\fcharset161\fprq2 Courier New Bold Greek;}{\f2935\fbidi \fnil\fcharset162\fprq2 Courier New Bold Tur;}{\f2936\fbidi \fnil\fcharset177\fprq2 Courier New Bold (Hebrew);}{\f2937\fbidi \fnil\fcharset178\fprq2 Courier New Bold (Arabid);}{\f2938\fbidi \fnil\fcharset186\fprq2 Courier New Bold Baltic;}{\f2939\fbidi \fnil\fcharset163\fprq2 Courier New Bold (Vietnamese);}{\f2941\fbidi \fnil\fcharset238\fprq2 Courier New Bold Italic CE;}{\f2942\fbidi \fnil\fcharset204\fprq2 Courier New Bold Italic Cyr;}{\f2944\fbidi \fnil\fcharset161\fprq2 Courier New Bold Italic Greek;}{\f2945\fbidi \fnil\fcharset162\fprq2 Courier New Bold Italic Tur;}{\f2946\fbidi \fnil\fcharset177\fprq2 Courier New Bold Italic (Hebrew);}{\f2948\fbidi \fnil\fcharset186\fprq2 Courier New Bold Italic Baltic;}{\f2949\fbidi \fnil\fcharset163\fprq2 Courier New Bold Italic (Vietnamese);}{\f2951\fbidi \fnil\fcharset238\fprq2 Courier New Italic CE;}{\f2952\fbidi \fnil\fcharset204\fprq2 Courier New Italic Cyr;}{\f2954\fbidi \fnil\fcharset161\fprq2 Courier New Italic Greek;}{\f2955\fbidi \fnil\fcharset162\fprq2 Courier New Italic Tur;}{\f2956\fbidi \fnil\fcharset177\fprq2 Courier New Italic (Hebrew);}{\f2958\fbidi \fnil\fcharset186\fprq2 Courier New Italic Baltic;}{\f2959\fbidi \fnil\fcharset163\fprq2 Courier New Italic (Vietnamese);}{\f2987\fbidi \fnil\fcharset178\fprq2 Damascus Bold (Arabid);}{\f3045\fbidi \fnil\fcharset162\fprq2 DIN Alternate Bold Tur;}{\f3049\fbidi \fnil\fcharset163\fprq2 DIN Alternate Bold (Vietnamese);}{\f3061\fbidi \fnil\fcharset238\fprq2 Didot CE;}{\f3064\fbidi \fnil\fcharset161\fprq2 Didot Greek;}{\f3065\fbidi \fnil\fcharset162\fprq2 Didot Tur;}{\f3066\fbidi \fnil\fcharset177\fprq2 Didot (Hebrew);}{\f3067\fbidi \fnil\fcharset178\fprq2 Didot (Arabid);}{\f3068\fbidi \fnil\fcharset186\fprq2 Didot Baltic;}{\f3069\fbidi \fnil\fcharset163\fprq2 Didot (Vietnamese);}{\f3091\fbidi \fnil\fcharset238\fprq2 Euphemia UCAS CE;}{\f3095\fbidi \fnil\fcharset162\fprq2 Euphemia UCAS Tur;}{\f3096\fbidi \fnil\fcharset177\fprq2 Euphemia UCAS (Hebrew);}{\f3097\fbidi \fnil\fcharset178\fprq2 Euphemia UCAS (Arabid);}{\f3098\fbidi \fnil\fcharset186\fprq2 Euphemia UCAS Baltic;}{\f3099\fbidi \fnil\fcharset163\fprq2 Euphemia UCAS (Vietnamese);}{\f3101\fbidi \fnil\fcharset238\fprq2 Euphemia UCAS Bold CE;}{\f3105\fbidi \fnil\fcharset162\fprq2 Euphemia UCAS Bold Tur;}{\f3106\fbidi \fnil\fcharset177\fprq2 Euphemia UCAS Bold (Hebrew);}{\f3107\fbidi \fnil\fcharset178\fprq2 Euphemia UCAS Bold (Arabid);}{\f3108\fbidi \fnil\fcharset186\fprq2 Euphemia UCAS Bold Baltic;}{\f3109\fbidi \fnil\fcharset163\fprq2 Euphemia UCAS Bold (Vietnamese);}{\f3111\fbidi \fnil\fcharset238\fprq2 Euphemia UCAS Italic CE;}{\f3115\fbidi \fnil\fcharset162\fprq2 Euphemia UCAS Italic Tur;}{\f3116\fbidi \fnil\fcharset177\fprq2 Euphemia UCAS Italic (Hebrew);}{\f3117\fbidi \fnil\fcharset178\fprq2 Euphemia UCAS Italic (Arabid);}{\f3118\fbidi \fnil\fcharset186\fprq2 Euphemia UCAS Italic Baltic;}{\f3119\fbidi \fnil\fcharset163\fprq2 Euphemia UCAS Italic (Vietnamese);}{\f3141\fbidi \fnil\fcharset238\fprq2 Franklin Gothic Book CE;}{\f3142\fbidi \fnil\fcharset204\fprq2 Franklin Gothic Book Cyr;}{\f3144\fbidi \fnil\fcharset161\fprq2 Franklin Gothic Book Greek;}{\f3145\fbidi \fnil\fcharset162\fprq2 Franklin Gothic Book Tur;}{\f3148\fbidi \fnil\fcharset186\fprq2 Franklin Gothic Book Baltic;}{\f3151\fbidi \fnil\fcharset238\fprq2 Franklin Gothic Book Italic CE;}{\f3152\fbidi \fnil\fcharset204\fprq2 Franklin Gothic Book Italic Cyr;}{\f3154\fbidi \fnil\fcharset161\fprq2 Franklin Gothic Book Italic Greek;}{\f3155\fbidi \fnil\fcharset162\fprq2 Franklin Gothic Book Italic Tur;}{\f3158\fbidi \fnil\fcharset186\fprq2 Franklin Gothic Book Italic Baltic;}{\f3161\fbidi \fnil\fcharset238\fprq2 Franklin Gothic Medium CE;}{\f3162\fbidi \fnil\fcharset204\fprq2 Franklin Gothic Medium Cyr;}{\f3164\fbidi \fnil\fcharset161\fprq2 Franklin Gothic Medium Greek;}{\f3165\fbidi \fnil\fcharset162\fprq2 Franklin Gothic Medium Tur;}{\f3168\fbidi \fnil\fcharset186\fprq2 Franklin Gothic Medium Baltic;}{\f3171\fbidi \fnil\fcharset238\fprq2 Franklin Gothic Medium Italic CE;}{\f3172\fbidi \fnil\fcharset204\fprq2 Franklin Gothic Medium Italic Cyr;}{\f3174\fbidi \fnil\fcharset161\fprq2 Franklin Gothic Medium Italic Greek;}{\f3175\fbidi \fnil\fcharset162\fprq2 Franklin Gothic Medium Italic Tur;}{\f3178\fbidi \fnil\fcharset186\fprq2 Franklin Gothic Medium Italic Baltic;}{\f3181\fbidi \fnil\fcharset238\fprq2 Futura CE;}{\f3184\fbidi \fnil\fcharset161\fprq2 Futura Greek;}{\f3185\fbidi \fnil\fcharset162\fprq2 Futura Tur;}{\f3186\fbidi \fnil\fcharset177\fprq2 Futura (Hebrew);}{\f3187\fbidi \fnil\fcharset178\fprq2 Futura (Arabid);}{\f3188\fbidi \fnil\fcharset186\fprq2 Futura Baltic;}{\f3189\fbidi \fnil\fcharset163\fprq2 Futura (Vietnamese);}{\f3191\fbidi \fnil\fcharset238\fprq2 Futura Condensed CE;}{\f3194\fbidi \fnil\fcharset161\fprq2 Futura Condensed Greek;}{\f3195\fbidi \fnil\fcharset162\fprq2 Futura Condensed Tur;}{\f3196\fbidi \fnil\fcharset177\fprq2 Futura Condensed (Hebrew);}{\f3197\fbidi \fnil\fcharset178\fprq2 Futura Condensed (Arabid);}{\f3198\fbidi \fnil\fcharset186\fprq2 Futura Condensed Baltic;}{\f3199\fbidi \fnil\fcharset163\fprq2 Futura Condensed (Vietnamese);}{\f3201\fbidi \fnil\fcharset238\fprq2 Gabriola CE;}{\f3202\fbidi \fnil\fcharset204\fprq2 Gabriola Cyr;}{\f3204\fbidi \fnil\fcharset161\fprq2 Gabriola Greek;}{\f3205\fbidi \fnil\fcharset162\fprq2 Gabriola Tur;}{\f3208\fbidi \fnil\fcharset186\fprq2 Gabriola Baltic;}{\f3221\fbidi \fnil\fcharset238\fprq2 Georgia CE;}{\f3222\fbidi \fnil\fcharset204\fprq2 Georgia Cyr;}{\f3224\fbidi \fnil\fcharset161\fprq2 Georgia Greek;}{\f3225\fbidi \fnil\fcharset162\fprq2 Georgia Tur;}{\f3228\fbidi \fnil\fcharset186\fprq2 Georgia Baltic;}{\f3231\fbidi \fnil\fcharset238\fprq2 Georgia Bold CE;}{\f3232\fbidi \fnil\fcharset204\fprq2 Georgia Bold Cyr;}{\f3234\fbidi \fnil\fcharset161\fprq2 Georgia Bold Greek;}{\f3235\fbidi \fnil\fcharset162\fprq2 Georgia Bold Tur;}{\f3238\fbidi \fnil\fcharset186\fprq2 Georgia Bold Baltic;}{\f3241\fbidi \fnil\fcharset238\fprq2 Georgia Bold Italic CE;}{\f3242\fbidi \fnil\fcharset204\fprq2 Georgia Bold Italic Cyr;}{\f3244\fbidi \fnil\fcharset161\fprq2 Georgia Bold Italic Greek;}{\f3245\fbidi \fnil\fcharset162\fprq2 Georgia Bold Italic Tur;}{\f3248\fbidi \fnil\fcharset186\fprq2 Georgia Bold Italic Baltic;}{\f3251\fbidi \fnil\fcharset238\fprq2 Georgia Italic CE;}{\f3252\fbidi \fnil\fcharset204\fprq2 Georgia Italic Cyr;}{\f3254\fbidi \fnil\fcharset161\fprq2 Georgia Italic Greek;}{\f3255\fbidi \fnil\fcharset162\fprq2 Georgia Italic Tur;}{\f3258\fbidi \fnil\fcharset186\fprq2 Georgia Italic Baltic;}{\f3271\fbidi \fnil\fcharset238\fprq2 Gill Sans CE;}{\f3272\fbidi \fnil\fcharset204\fprq2 Gill Sans Cyr;}{\f3275\fbidi \fnil\fcharset162\fprq2 Gill Sans Tur;}{\f3276\fbidi \fnil\fcharset177\fprq2 Gill Sans (Hebrew);}{\f3277\fbidi \fnil\fcharset178\fprq2 Gill Sans (Arabid);}{\f3278\fbidi \fnil\fcharset186\fprq2 Gill Sans Baltic;}{\f3279\fbidi \fnil\fcharset163\fprq2 Gill Sans (Vietnamese);}{\f3281\fbidi \fnil\fcharset238\fprq2 Gill Sans Light CE;}{\f3282\fbidi \fnil\fcharset204\fprq2 Gill Sans Light Cyr;}{\f3285\fbidi \fnil\fcharset162\fprq2 Gill Sans Light Tur;}{\f3286\fbidi \fnil\fcharset177\fprq2 Gill Sans Light (Hebrew);}{\f3287\fbidi \fnil\fcharset178\fprq2 Gill Sans Light (Arabid);}{\f3288\fbidi \fnil\fcharset186\fprq2 Gill Sans Light Baltic;}{\f3289\fbidi \fnil\fcharset163\fprq2 Gill Sans Light (Vietnamese);}{\f3291\fbidi \fnil\fcharset238\fprq2 Gill Sans MT CE;}{\f3301\fbidi \fnil\fcharset238\fprq2 Gill Sans MT Bold CE;}{\f3311\fbidi \fnil\fcharset238\fprq2 Gill Sans MT Bold Italic CE;}{\f3321\fbidi \fnil\fcharset238\fprq2 Gill Sans MT Italic CE;}{\f3332\fbidi \fnil\fcharset204\fprq2 Gill Sans SemiBold Cyr;}{\f3342\fbidi \fnil\fcharset204\fprq2 Gill Sans SemiBold Italic Cyr;}{\f3351\fbidi \fnil\fcharset238\fprq2 Gill Sans UltraBold CE;}{\f3352\fbidi \fnil\fcharset204\fprq2 Gill Sans UltraBold Cyr;}{\f3354\fbidi \fnil\fcharset161\fprq2 Gill Sans UltraBold Greek;}{\f3355\fbidi \fnil\fcharset162\fprq2 Gill Sans UltraBold Tur;}{\f3358\fbidi \fnil\fcharset186\fprq2 Gill Sans UltraBold Baltic;}{\f3359\fbidi \fnil\fcharset163\fprq2 Gill Sans UltraBold (Vietnamese);}{\f3501\fbidi \fnil\fcharset238\fprq2 Helvetica Neue Light CE;}{\f3502\fbidi \fnil\fcharset204\fprq2 Helvetica Neue Light Cyr;}{\f3511\fbidi \fnil\fcharset238\fprq2 Helvetica Neue Medium CE;}{\f3514\fbidi \fnil\fcharset161\fprq2 Helvetica Neue Medium Greek;}{\f3515\fbidi \fnil\fcharset162\fprq2 Helvetica Neue Medium Tur;}{\f3518\fbidi \fnil\fcharset186\fprq2 Helvetica Neue Medium Baltic;}{\f3521\fbidi \fnil\fcharset238\fprq2 Helvetica Neue Thin CE;}{\f3522\fbidi \fnil\fcharset204\fprq2 Helvetica Neue Thin Cyr;}{\f3524\fbidi \fnil\fcharset161\fprq2 Helvetica Neue Thin Greek;}{\f3525\fbidi \fnil\fcharset162\fprq2 Helvetica Neue Thin Tur;}{\f3528\fbidi \fnil\fcharset186\fprq2 Helvetica Neue Thin Baltic;}{\f3561\fbidi \fnil\fcharset238\fprq2 Hoefler Text CE;}{\f3562\fbidi \fnil\fcharset204\fprq2 Hoefler Text Cyr;}{\f3565\fbidi \fnil\fcharset162\fprq2 Hoefler Text Tur;}{\f3568\fbidi \fnil\fcharset186\fprq2 Hoefler Text Baltic;}{\f3569\fbidi \fnil\fcharset163\fprq2 Hoefler Text (Vietnamese);}{\f3573\fbidi \fnil\fcharset0\fprq2 Hoefler Text Ornaments;}{\f3576\fbidi \fnil\fcharset177\fprq2 Hoefler Text Ornaments (Hebrew);}{\f3577\fbidi \fnil\fcharset178\fprq2 Hoefler Text Ornaments (Arabid);}{\f3580\fbidi \fnil\fcharset222\fprq2 Hoefler Text Ornaments (That);}{\f3581\fbidi \fnil\fcharset238\fprq2 Impact CE;}{\f3582\fbidi \fnil\fcharset204\fprq2 Impact Cyr;}{\f3584\fbidi \fnil\fcharset161\fprq2 Impact Greek;}{\f3585\fbidi \fnil\fcharset162\fprq2 Impact Tur;}{\f3588\fbidi \fnil\fcharset186\fprq2 Impact Baltic;}{\f3611\fbidi \fnil\fcharset238\fprq2 Iowan Old Style Black CE;}{\f3615\fbidi \fnil\fcharset162\fprq2 Iowan Old Style Black Tur;}{\f3618\fbidi \fnil\fcharset186\fprq2 Iowan Old Style Black Baltic;}{\f3621\fbidi \fnil\fcharset238\fprq2 Iowan Old Style Black Italic CE;}{\f3625\fbidi \fnil\fcharset162\fprq2 Iowan Old Style Black Italic Tur;}{\f3628\fbidi \fnil\fcharset186\fprq2 Iowan Old Style Black Italic Baltic;}{\f3631\fbidi \fnil\fcharset238\fprq2 Iowan Old Style Bold CE;}{\f3635\fbidi \fnil\fcharset162\fprq2 Iowan Old Style Bold Tur;}{\f3638\fbidi \fnil\fcharset186\fprq2 Iowan Old Style Bold Baltic;}{\f3641\fbidi \fnil\fcharset238\fprq2 Iowan Old Style Bold Italic CE;}{\f3645\fbidi \fnil\fcharset162\fprq2 Iowan Old Style Bold Italic Tur;}{\f3648\fbidi \fnil\fcharset186\fprq2 Iowan Old Style Bold Italic Baltic;}{\f3651\fbidi \fnil\fcharset238\fprq2 Iowan Old Style Italic CE;}{\f3655\fbidi \fnil\fcharset162\fprq2 Iowan Old Style Italic Tur;}{\f3658\fbidi \fnil\fcharset186\fprq2 Iowan Old Style Italic Baltic;}{\f3661\fbidi \fnil\fcharset238\fprq2 Iowan Old Style Roman CE;}{\f3665\fbidi \fnil\fcharset162\fprq2 Iowan Old Style Roman Tur;}{\f3668\fbidi \fnil\fcharset186\fprq2 Iowan Old Style Roman Baltic;}{\f3671\fbidi \fnil\fcharset238\fprq2 Iowan Old Style Titling CE;}{\f3675\fbidi \fnil\fcharset162\fprq2 Iowan Old Style Titling Tur;}{\f3678\fbidi \fnil\fcharset186\fprq2 Iowan Old Style Titling Baltic;}{\f3791\fbidi \fnil\fcharset238\fprq2 Krungthep CE;}{\f3795\fbidi \fnil\fcharset162\fprq2 Krungthep Tur;}{\f3798\fbidi \fnil\fcharset186\fprq2 Krungthep Baltic;}{\f3799\fbidi \fnil\fcharset163\fprq2 Krungthep (Vietnamese);}{\f3951\fbidi \fnil\fcharset238\fprq2 Lithos Pro Black CE;}{\f3954\fbidi \fnil\fcharset161\fprq2 Lithos Pro Black Greek;}{\f3955\fbidi \fnil\fcharset162\fprq2 Lithos Pro Black Tur;}{\f3958\fbidi \fnil\fcharset186\fprq2 Lithos Pro Black Baltic;}{\f3961\fbidi \fnil\fcharset238\fprq2 Lithos Pro Regular CE;}{\f3964\fbidi \fnil\fcharset161\fprq2 Lithos Pro Regular Greek;}{\f3965\fbidi \fnil\fcharset162\fprq2 Lithos Pro Regular Tur;}{\f3968\fbidi \fnil\fcharset186\fprq2 Lithos Pro Regular Baltic;}{\f4001\fbidi \fnil\fcharset238\fprq2 Lucida Console CE;}{\f4002\fbidi \fnil\fcharset204\fprq2 Lucida Console Cyr;}{\f4004\fbidi \fnil\fcharset161\fprq2 Lucida Console Greek;}{\f4005\fbidi \fnil\fcharset162\fprq2 Lucida Console Tur;}{\f4021\fbidi \fnil\fcharset238\fprq2 Lucida Grande CE;}{\f4022\fbidi \fnil\fcharset204\fprq2 Lucida Grande Cyr;}{\f4024\fbidi \fnil\fcharset161\fprq2 Lucida Grande Greek;}{\f4025\fbidi \fnil\fcharset162\fprq2 Lucida Grande Tur;}{\f4026\fbidi \fnil\fcharset177\fprq2 Lucida Grande (Hebrew);}{\f4028\fbidi \fnil\fcharset186\fprq2 Lucida Grande Baltic;}{\f4029\fbidi \fnil\fcharset163\fprq2 Lucida Grande (Vietnamese);}{\f4061\fbidi \fnil\fcharset238\fprq2 Lucida Sans Unicode CE;}{\f4062\fbidi \fnil\fcharset204\fprq2 Lucida Sans Unicode Cyr;}{\f4064\fbidi \fnil\fcharset161\fprq2 Lucida Sans Unicode Greek;}{\f4065\fbidi \fnil\fcharset162\fprq2 Lucida Sans Unicode Tur;}{\f4066\fbidi \fnil\fcharset177\fprq2 Lucida Sans Unicode (Hebrew);}{\f4068\fbidi \fnil\fcharset186\fprq2 Lucida Sans Unicode Baltic;}{\f4111\fbidi \fnil\fcharset238\fprq2 Marion Bold CE;}{\f4118\fbidi \fnil\fcharset186\fprq2 Marion Bold Baltic;}{\f4119\fbidi \fnil\fcharset163\fprq2 Marion Bold (Vietnamese);}{\f4121\fbidi \fnil\fcharset238\fprq2 Marion Italic CE;}{\f4128\fbidi \fnil\fcharset186\fprq2 Marion Italic Baltic;}{\f4129\fbidi \fnil\fcharset163\fprq2 Marion Italic (Vietnamese);}{\f4131\fbidi \fnil\fcharset238\fprq2 Marion Regular CE;}{\f4138\fbidi \fnil\fcharset186\fprq2 Marion Regular Baltic;}{\f4139\fbidi \fnil\fcharset163\fprq2 Marion Regular (Vietnamese);}{\f4145\fbidi \fnil\fcharset162\fprq2 Marker Felt Tur;}{\f4149\fbidi \fnil\fcharset163\fprq2 Marker Felt (Vietnamese);}{\f4171\fbidi \fnil\fcharset238\fprq2 Menlo Bold CE;}{\f4172\fbidi \fnil\fcharset204\fprq2 Menlo Bold Cyr;}{\f4174\fbidi \fnil\fcharset161\fprq2 Menlo Bold Greek;}{\f4175\fbidi \fnil\fcharset162\fprq2 Menlo Bold Tur;}{\f4177\fbidi \fnil\fcharset178\fprq2 Menlo Bold (Arabid);}{\f4178\fbidi \fnil\fcharset186\fprq2 Menlo Bold Baltic;}{\f4179\fbidi \fnil\fcharset163\fprq2 Menlo Bold (Vietnamese);}{\f4181\fbidi \fnil\fcharset238\fprq2 Menlo Bold Italic CE;}{\f4182\fbidi \fnil\fcharset204\fprq2 Menlo Bold Italic Cyr;}{\f4184\fbidi \fnil\fcharset161\fprq2 Menlo Bold Italic Greek;}{\f4185\fbidi \fnil\fcharset162\fprq2 Menlo Bold Italic Tur;}{\f4188\fbidi \fnil\fcharset186\fprq2 Menlo Bold Italic Baltic;}{\f4189\fbidi \fnil\fcharset163\fprq2 Menlo Bold Italic (Vietnamese);}{\f4191\fbidi \fnil\fcharset238\fprq2 Menlo Italic CE;}{\f4192\fbidi \fnil\fcharset204\fprq2 Menlo Italic Cyr;}{\f4194\fbidi \fnil\fcharset161\fprq2 Menlo Italic Greek;}{\f4195\fbidi \fnil\fcharset162\fprq2 Menlo Italic Tur;}{\f4198\fbidi \fnil\fcharset186\fprq2 Menlo Italic Baltic;}{\f4199\fbidi \fnil\fcharset163\fprq2 Menlo Italic (Vietnamese);}{\f4201\fbidi \fnil\fcharset238\fprq2 Menlo Regular CE;}{\f4202\fbidi \fnil\fcharset204\fprq2 Menlo Regular Cyr;}{\f4204\fbidi \fnil\fcharset161\fprq2 Menlo Regular Greek;}{\f4205\fbidi \fnil\fcharset162\fprq2 Menlo Regular Tur;}{\f4207\fbidi \fnil\fcharset178\fprq2 Menlo Regular (Arabid);}{\f4208\fbidi \fnil\fcharset186\fprq2 Menlo Regular Baltic;}{\f4209\fbidi \fnil\fcharset163\fprq2 Menlo Regular (Vietnamese);}{\f4231\fbidi \fnil\fcharset238\fprq2 Microsoft Sans Serif CE;}{\f4232\fbidi \fnil\fcharset204\fprq2 Microsoft Sans Serif Cyr;}{\f4234\fbidi \fnil\fcharset161\fprq2 Microsoft Sans Serif Greek;}{\f4235\fbidi \fnil\fcharset162\fprq2 Microsoft Sans Serif Tur;}{\f4236\fbidi \fnil\fcharset177\fprq2 Microsoft Sans Serif (Hebrew);}{\f4237\fbidi \fnil\fcharset178\fprq2 Microsoft Sans Serif (Arabid);}{\f4238\fbidi \fnil\fcharset186\fprq2 Microsoft Sans Serif Baltic;}{\f4239\fbidi \fnil\fcharset163\fprq2 Microsoft Sans Serif (Vietnamese);}{\f4240\fbidi \fnil\fcharset222\fprq2 Microsoft Sans Serif (That);}{\f4273\fbidi \fnil\fcharset0\fprq2 MingLiU-ExtB Western;}{\f4283\fbidi \fnil\fcharset0\fprq2 @MingLiU-ExtB Western;}{\f4293\fbidi \fnil\fcharset0\fprq2 MingLiU_HKSCS-ExtB Western;}{\f4303\fbidi \fnil\fcharset0\fprq2 @MingLiU_HKSCS-ExtB Western;}{\f4311\fbidi \fnil\fcharset238\fprq2 Minion Pro CE;}{\f4312\fbidi \fnil\fcharset204\fprq2 Minion Pro Cyr;}{\f4314\fbidi \fnil\fcharset161\fprq2 Minion Pro Greek;}{\f4315\fbidi \fnil\fcharset162\fprq2 Minion Pro Tur;}{\f4318\fbidi \fnil\fcharset186\fprq2 Minion Pro Baltic;}{\f4319\fbidi \fnil\fcharset163\fprq2 Minion Pro (Vietnamese);}{\f4321\fbidi \fnil\fcharset238\fprq2 Minion Pro Bold CE;}{\f4322\fbidi \fnil\fcharset204\fprq2 Minion Pro Bold Cyr;}{\f4324\fbidi \fnil\fcharset161\fprq2 Minion Pro Bold Greek;}{\f4325\fbidi \fnil\fcharset162\fprq2 Minion Pro Bold Tur;}{\f4328\fbidi \fnil\fcharset186\fprq2 Minion Pro Bold Baltic;}{\f4329\fbidi \fnil\fcharset163\fprq2 Minion Pro Bold (Vietnamese);}{\f4331\fbidi \fnil\fcharset238\fprq2 Minion Pro Bold Cond CE;}{\f4332\fbidi \fnil\fcharset204\fprq2 Minion Pro Bold Cond Cyr;}{\f4334\fbidi \fnil\fcharset161\fprq2 Minion Pro Bold Cond Greek;}{\f4335\fbidi \fnil\fcharset162\fprq2 Minion Pro Bold Cond Tur;}{\f4338\fbidi \fnil\fcharset186\fprq2 Minion Pro Bold Cond Baltic;}{\f4339\fbidi \fnil\fcharset163\fprq2 Minion Pro Bold Cond (Vietnamese);}{\f4341\fbidi \fnil\fcharset238\fprq2 Minion Pro Bold Cond Ital CE;}{\f4342\fbidi \fnil\fcharset204\fprq2 Minion Pro Bold Cond Ital Cyr;}{\f4344\fbidi \fnil\fcharset161\fprq2 Minion Pro Bold Cond Ital Greek;}{\f4345\fbidi \fnil\fcharset162\fprq2 Minion Pro Bold Cond Ital Tur;}{\f4348\fbidi \fnil\fcharset186\fprq2 Minion Pro Bold Cond Ital Baltic;}{\f4349\fbidi \fnil\fcharset163\fprq2 Minion Pro Bold Cond Ital (Vietnamese);}{\f4351\fbidi \fnil\fcharset238\fprq2 Minion Pro Bold Ital CE;}{\f4352\fbidi \fnil\fcharset204\fprq2 Minion Pro Bold Ital Cyr;}{\f4354\fbidi \fnil\fcharset161\fprq2 Minion Pro Bold Ital Greek;}{\f4355\fbidi \fnil\fcharset162\fprq2 Minion Pro Bold Ital Tur;}{\f4358\fbidi \fnil\fcharset186\fprq2 Minion Pro Bold Ital Baltic;}{\f4359\fbidi \fnil\fcharset163\fprq2 Minion Pro Bold Ital (Vietnamese);}{\f4361\fbidi \fnil\fcharset238\fprq2 Minion Pro Ital CE;}{\f4362\fbidi \fnil\fcharset204\fprq2 Minion Pro Ital Cyr;}{\f4364\fbidi \fnil\fcharset161\fprq2 Minion Pro Ital Greek;}{\f4365\fbidi \fnil\fcharset162\fprq2 Minion Pro Ital Tur;}{\f4368\fbidi \fnil\fcharset186\fprq2 Minion Pro Ital Baltic;}{\f4369\fbidi \fnil\fcharset163\fprq2 Minion Pro Ital (Vietnamese);}{\f4371\fbidi \fnil\fcharset238\fprq2 Minion Pro Med CE;}{\f4372\fbidi \fnil\fcharset204\fprq2 Minion Pro Med Cyr;}{\f4374\fbidi \fnil\fcharset161\fprq2 Minion Pro Med Greek;}{\f4375\fbidi \fnil\fcharset162\fprq2 Minion Pro Med Tur;}{\f4378\fbidi \fnil\fcharset186\fprq2 Minion Pro Med Baltic;}{\f4379\fbidi \fnil\fcharset163\fprq2 Minion Pro Med (Vietnamese);}{\f4381\fbidi \fnil\fcharset238\fprq2 Minion Pro Med Ital CE;}{\f4382\fbidi \fnil\fcharset204\fprq2 Minion Pro Med Ital Cyr;}{\f4384\fbidi \fnil\fcharset161\fprq2 Minion Pro Med Ital Greek;}{\f4385\fbidi \fnil\fcharset162\fprq2 Minion Pro Med Ital Tur;}{\f4388\fbidi \fnil\fcharset186\fprq2 Minion Pro Med Ital Baltic;}{\f4389\fbidi \fnil\fcharset163\fprq2 Minion Pro Med Ital (Vietnamese);}{\f4391\fbidi \fnil\fcharset238\fprq2 Minion Pro SmBd CE;}{\f4392\fbidi \fnil\fcharset204\fprq2 Minion Pro SmBd Cyr;}{\f4394\fbidi \fnil\fcharset161\fprq2 Minion Pro SmBd Greek;}{\f4395\fbidi \fnil\fcharset162\fprq2 Minion Pro SmBd Tur;}{\f4398\fbidi \fnil\fcharset186\fprq2 Minion Pro SmBd Baltic;}{\f4399\fbidi \fnil\fcharset163\fprq2 Minion Pro SmBd (Vietnamese);}{\f4401\fbidi \fnil\fcharset238\fprq2 Minion Pro SmBd Ital CE;}{\f4402\fbidi \fnil\fcharset204\fprq2 Minion Pro SmBd Ital Cyr;}{\f4404\fbidi \fnil\fcharset161\fprq2 Minion Pro SmBd Ital Greek;}{\f4405\fbidi \fnil\fcharset162\fprq2 Minion Pro SmBd Ital Tur;}{\f4408\fbidi \fnil\fcharset186\fprq2 Minion Pro SmBd Ital Baltic;}{\f4409\fbidi \fnil\fcharset163\fprq2 Minion Pro SmBd Ital (Vietnamese);}{\f4435\fbidi \fnil\fcharset162\fprq2 Mona Lisa Solid ITC TT Tur;}{\f4439\fbidi \fnil\fcharset163\fprq2 Mona Lisa Solid ITC TT (Vietnamese);}{\f4481\fbidi \fnil\fcharset238\fprq2 MS Reference Sans Serif CE;}{\f4482\fbidi \fnil\fcharset204\fprq2 MS Reference Sans Serif Cyr;}{\f4484\fbidi \fnil\fcharset161\fprq2 MS Reference Sans Serif Greek;}{\f4485\fbidi \fnil\fcharset162\fprq2 MS Reference Sans Serif Tur;}{\f4488\fbidi \fnil\fcharset186\fprq2 MS Reference Sans Serif Baltic;}{\f4489\fbidi \fnil\fcharset163\fprq2 MS Reference Sans Serif (Vietnamese);}{\f4503\fbidi \fnil\fcharset0\fprq2 MT Extra;}{\f4541\fbidi \fnil\fcharset238\fprq2 Myriad Arabic CE;}{\f4547\fbidi \fnil\fcharset178\fprq2 Myriad Arabic (Arabid);}{\f4551\fbidi \fnil\fcharset238\fprq2 Myriad Arabic Bold CE;}{\f4557\fbidi \fnil\fcharset178\fprq2 Myriad Arabic Bold (Arabid);}{\f4561\fbidi \fnil\fcharset238\fprq2 Myriad Arabic Bold Italic CE;}{\f4567\fbidi \fnil\fcharset178\fprq2 Myriad Arabic Bold Italic (Arabid);}{\f4571\fbidi \fnil\fcharset238\fprq2 Myriad Arabic Italic CE;}{\f4577\fbidi \fnil\fcharset178\fprq2 Myriad Arabic Italic (Arabid);}{\f4581\fbidi \fnil\fcharset238\fprq2 Myriad Hebrew Bold CE;}{\f4586\fbidi \fnil\fcharset177\fprq2 Myriad Hebrew Bold (Hebrew);}{\f4591\fbidi \fnil\fcharset238\fprq2 Myriad Hebrew Bold Italic CE;}{\f4596\fbidi \fnil\fcharset177\fprq2 Myriad Hebrew Bold Italic (Hebrew);}{\f4601\fbidi \fnil\fcharset238\fprq2 Myriad Hebrew Italic CE;}{\f4606\fbidi \fnil\fcharset177\fprq2 Myriad Hebrew Italic (Hebrew);}{\f4611\fbidi \fnil\fcharset238\fprq2 Myriad Hebrew Regular CE;}{\f4616\fbidi \fnil\fcharset177\fprq2 Myriad Hebrew Regular (Hebrew);}{\f4621\fbidi \fnil\fcharset238\fprq2 Myriad Pro CE;}{\f4622\fbidi \fnil\fcharset204\fprq2 Myriad Pro Cyr;}{\f4624\fbidi \fnil\fcharset161\fprq2 Myriad Pro Greek;}{\f4625\fbidi \fnil\fcharset162\fprq2 Myriad Pro Tur;}{\f4628\fbidi \fnil\fcharset186\fprq2 Myriad Pro Baltic;}{\f4629\fbidi \fnil\fcharset163\fprq2 Myriad Pro (Vietnamese);}{\f4631\fbidi \fnil\fcharset238\fprq2 Myriad Pro Bold CE;}{\f4632\fbidi \fnil\fcharset204\fprq2 Myriad Pro Bold Cyr;}{\f4634\fbidi \fnil\fcharset161\fprq2 Myriad Pro Bold Greek;}{\f4635\fbidi \fnil\fcharset162\fprq2 Myriad Pro Bold Tur;}{\f4638\fbidi \fnil\fcharset186\fprq2 Myriad Pro Bold Baltic;}{\f4639\fbidi \fnil\fcharset163\fprq2 Myriad Pro Bold (Vietnamese);}{\f4641\fbidi \fnil\fcharset238\fprq2 Myriad Pro Bold Cond CE;}{\f4642\fbidi \fnil\fcharset204\fprq2 Myriad Pro Bold Cond Cyr;}{\f4644\fbidi \fnil\fcharset161\fprq2 Myriad Pro Bold Cond Greek;}{\f4645\fbidi \fnil\fcharset162\fprq2 Myriad Pro Bold Cond Tur;}{\f4648\fbidi \fnil\fcharset186\fprq2 Myriad Pro Bold Cond Baltic;}{\f4649\fbidi \fnil\fcharset163\fprq2 Myriad Pro Bold Cond (Vietnamese);}{\f4651\fbidi \fnil\fcharset238\fprq2 Myriad Pro Bold Cond It CE;}{\f4652\fbidi \fnil\fcharset204\fprq2 Myriad Pro Bold Cond It Cyr;}{\f4654\fbidi \fnil\fcharset161\fprq2 Myriad Pro Bold Cond It Greek;}{\f4655\fbidi \fnil\fcharset162\fprq2 Myriad Pro Bold Cond It Tur;}{\f4658\fbidi \fnil\fcharset186\fprq2 Myriad Pro Bold Cond It Baltic;}{\f4659\fbidi \fnil\fcharset163\fprq2 Myriad Pro Bold Cond It (Vietnamese);}{\f4661\fbidi \fnil\fcharset238\fprq2 Myriad Pro Bold It CE;}{\f4662\fbidi \fnil\fcharset204\fprq2 Myriad Pro Bold It Cyr;}{\f4664\fbidi \fnil\fcharset161\fprq2 Myriad Pro Bold It Greek;}{\f4665\fbidi \fnil\fcharset162\fprq2 Myriad Pro Bold It Tur;}{\f4668\fbidi \fnil\fcharset186\fprq2 Myriad Pro Bold It Baltic;}{\f4669\fbidi \fnil\fcharset163\fprq2 Myriad Pro Bold It (Vietnamese);}{\f4671\fbidi \fnil\fcharset238\fprq2 Myriad Pro Cond CE;}{\f4672\fbidi \fnil\fcharset204\fprq2 Myriad Pro Cond Cyr;}{\f4674\fbidi \fnil\fcharset161\fprq2 Myriad Pro Cond Greek;}{\f4675\fbidi \fnil\fcharset162\fprq2 Myriad Pro Cond Tur;}{\f4678\fbidi \fnil\fcharset186\fprq2 Myriad Pro Cond Baltic;}{\f4679\fbidi \fnil\fcharset163\fprq2 Myriad Pro Cond (Vietnamese);}{\f4681\fbidi \fnil\fcharset238\fprq2 Myriad Pro Cond It CE;}{\f4682\fbidi \fnil\fcharset204\fprq2 Myriad Pro Cond It Cyr;}{\f4684\fbidi \fnil\fcharset161\fprq2 Myriad Pro Cond It Greek;}{\f4685\fbidi \fnil\fcharset162\fprq2 Myriad Pro Cond It Tur;}{\f4688\fbidi \fnil\fcharset186\fprq2 Myriad Pro Cond It Baltic;}{\f4689\fbidi \fnil\fcharset163\fprq2 Myriad Pro Cond It (Vietnamese);}{\f4691\fbidi \fnil\fcharset238\fprq2 Myriad Pro It CE;}{\f4692\fbidi \fnil\fcharset204\fprq2 Myriad Pro It Cyr;}{\f4694\fbidi \fnil\fcharset161\fprq2 Myriad Pro It Greek;}{\f4695\fbidi \fnil\fcharset162\fprq2 Myriad Pro It Tur;}{\f4698\fbidi \fnil\fcharset186\fprq2 Myriad Pro It Baltic;}{\f4699\fbidi \fnil\fcharset163\fprq2 Myriad Pro It (Vietnamese);}{\f4701\fbidi \fnil\fcharset238\fprq2 Myriad Pro Semibold CE;}{\f4702\fbidi \fnil\fcharset204\fprq2 Myriad Pro Semibold Cyr;}{\f4704\fbidi \fnil\fcharset161\fprq2 Myriad Pro Semibold Greek;}{\f4705\fbidi \fnil\fcharset162\fprq2 Myriad Pro Semibold Tur;}{\f4708\fbidi \fnil\fcharset186\fprq2 Myriad Pro Semibold Baltic;}{\f4709\fbidi \fnil\fcharset163\fprq2 Myriad Pro Semibold (Vietnamese);}{\f4711\fbidi \fnil\fcharset238\fprq2 Myriad Pro Semibold It CE;}{\f4712\fbidi \fnil\fcharset204\fprq2 Myriad Pro Semibold It Cyr;}{\f4714\fbidi \fnil\fcharset161\fprq2 Myriad Pro Semibold It Greek;}{\f4715\fbidi \fnil\fcharset162\fprq2 Myriad Pro Semibold It Tur;}{\f4718\fbidi \fnil\fcharset186\fprq2 Myriad Pro Semibold It Baltic;}{\f4719\fbidi \fnil\fcharset163\fprq2 Myriad Pro Semibold It (Vietnamese);}{\f4735\fbidi \fnil\fcharset162\fprq2 Noteworthy Bold Tur;}{\f4739\fbidi \fnil\fcharset163\fprq2 Noteworthy Bold (Vietnamese);}{\f4745\fbidi \fnil\fcharset162\fprq2 Noteworthy Light Tur;}{\f4749\fbidi \fnil\fcharset163\fprq2 Noteworthy Light (Vietnamese);}{\f4846\fbidi \fnil\fcharset177\fprq2 Optima ExtraBlack (Hebrew);}{\f4847\fbidi \fnil\fcharset178\fprq2 Optima ExtraBlack (Arabid);}{\f4850\fbidi \fnil\fcharset222\fprq2 Optima ExtraBlack (That);}{\f4911\fbidi \fnil\fcharset238\fprq2 Palatino CE;}{\f4915\fbidi \fnil\fcharset162\fprq2 Palatino Tur;}{\f4918\fbidi \fnil\fcharset186\fprq2 Palatino Baltic;}{\f4919\fbidi \fnil\fcharset163\fprq2 Palatino (Vietnamese);}{\f4921\fbidi \fnil\fcharset238\fprq2 Palatino Bold CE;}{\f4925\fbidi \fnil\fcharset162\fprq2 Palatino Bold Tur;}{\f4928\fbidi \fnil\fcharset186\fprq2 Palatino Bold Baltic;}{\f4929\fbidi \fnil\fcharset163\fprq2 Palatino Bold (Vietnamese);}{\f4931\fbidi \fnil\fcharset238\fprq2 Palatino Bold Italic CE;}{\f4935\fbidi \fnil\fcharset162\fprq2 Palatino Bold Italic Tur;}{\f4938\fbidi \fnil\fcharset186\fprq2 Palatino Bold Italic Baltic;}{\f4939\fbidi \fnil\fcharset163\fprq2 Palatino Bold Italic (Vietnamese);}{\f4941\fbidi \fnil\fcharset238\fprq2 Palatino Italic CE;}{\f4945\fbidi \fnil\fcharset162\fprq2 Palatino Italic Tur;}{\f4948\fbidi \fnil\fcharset186\fprq2 Palatino Italic Baltic;}{\f4949\fbidi \fnil\fcharset163\fprq2 Palatino Italic (Vietnamese);}{\f4951\fbidi \fnil\fcharset238\fprq2 Palatino Linotype CE;}{\f4952\fbidi \fnil\fcharset204\fprq2 Palatino Linotype Cyr;}{\f4954\fbidi \fnil\fcharset161\fprq2 Palatino Linotype Greek;}{\f4955\fbidi \fnil\fcharset162\fprq2 Palatino Linotype Tur;}{\f4958\fbidi \fnil\fcharset186\fprq2 Palatino Linotype Baltic;}{\f4959\fbidi \fnil\fcharset163\fprq2 Palatino Linotype (Vietnamese);}{\f4961\fbidi \fnil\fcharset238\fprq2 Palatino Linotype Bold CE;}{\f4962\fbidi \fnil\fcharset204\fprq2 Palatino Linotype Bold Cyr;}{\f4964\fbidi \fnil\fcharset161\fprq2 Palatino Linotype Bold Greek;}{\f4965\fbidi \fnil\fcharset162\fprq2 Palatino Linotype Bold Tur;}{\f4968\fbidi \fnil\fcharset186\fprq2 Palatino Linotype Bold Baltic;}{\f4969\fbidi \fnil\fcharset163\fprq2 Palatino Linotype Bold (Vietnamese);}{\f4971\fbidi \fnil\fcharset238\fprq2 Palatino Linotype Bold Italic CE;}{\f4972\fbidi \fnil\fcharset204\fprq2 Palatino Linotype Bold Italic Cyr;}{\f4974\fbidi \fnil\fcharset161\fprq2 Palatino Linotype Bold Italic Greek;}{\f4975\fbidi \fnil\fcharset162\fprq2 Palatino Linotype Bold Italic Tur;}{\f4978\fbidi \fnil\fcharset186\fprq2 Palatino Linotype Bold Italic Baltic;}{\f4979\fbidi \fnil\fcharset163\fprq2 Palatino Linotype Bold Italic (Vietnamese);}{\f4981\fbidi \fnil\fcharset238\fprq2 Palatino Linotype Italic CE;}{\f4982\fbidi \fnil\fcharset204\fprq2 Palatino Linotype Italic Cyr;}{\f4984\fbidi \fnil\fcharset161\fprq2 Palatino Linotype Italic Greek;}{\f4985\fbidi \fnil\fcharset162\fprq2 Palatino Linotype Italic Tur;}{\f4988\fbidi \fnil\fcharset186\fprq2 Palatino Linotype Italic Baltic;}{\f4989\fbidi \fnil\fcharset163\fprq2 Palatino Linotype Italic (Vietnamese);}{\f4996\fbidi \fnil\fcharset177\fprq2 Papyrus (Hebrew);}{\f4997\fbidi \fnil\fcharset178\fprq2 Papyrus (Arabid);}{\f5006\fbidi \fnil\fcharset177\fprq2 Papyrus Condensed (Hebrew);}{\f5007\fbidi \fnil\fcharset178\fprq2 Papyrus Condensed (Arabid);}{\f5071\fbidi \fnil\fcharset238\fprq2 Plantagenet Cherokee CE;}{\f5075\fbidi \fnil\fcharset162\fprq2 Plantagenet Cherokee Tur;}{\f5076\fbidi \fnil\fcharset177\fprq2 Plantagenet Cherokee (Hebrew);}{\f5077\fbidi \fnil\fcharset178\fprq2 Plantagenet Cherokee (Arabid);}{\f5078\fbidi \fnil\fcharset186\fprq2 Plantagenet Cherokee Baltic;}{\f5079\fbidi \fnil\fcharset163\fprq2 Plantagenet Cherokee (Vietnamese);}{\f5093\fbidi \fnil\fcharset0\fprq2 PMingLiU-ExtB Western;}{\f5103\fbidi \fnil\fcharset0\fprq2 @PMingLiU-ExtB Western;}{\f5151\fbidi \fnil\fcharset238\fprq2 PT Mono CE;}{\f5152\fbidi \fnil\fcharset204\fprq2 PT Mono Cyr;}{\f5155\fbidi \fnil\fcharset162\fprq2 PT Mono Tur;}{\f5158\fbidi \fnil\fcharset186\fprq2 PT Mono Baltic;}{\f5161\fbidi \fnil\fcharset238\fprq2 PT Mono Bold CE;}{\f5162\fbidi \fnil\fcharset204\fprq2 PT Mono Bold Cyr;}{\f5165\fbidi \fnil\fcharset162\fprq2 PT Mono Bold Tur;}{\f5168\fbidi \fnil\fcharset186\fprq2 PT Mono Bold Baltic;}{\f5171\fbidi \fnil\fcharset238\fprq2 PT Sans CE;}{\f5172\fbidi \fnil\fcharset204\fprq2 PT Sans Cyr;}{\f5175\fbidi \fnil\fcharset162\fprq2 PT Sans Tur;}{\f5178\fbidi \fnil\fcharset186\fprq2 PT Sans Baltic;}{\f5181\fbidi \fnil\fcharset238\fprq2 PT Sans Bold CE;}{\f5182\fbidi \fnil\fcharset204\fprq2 PT Sans Bold Cyr;}{\f5185\fbidi \fnil\fcharset162\fprq2 PT Sans Bold Tur;}{\f5188\fbidi \fnil\fcharset186\fprq2 PT Sans Bold Baltic;}{\f5191\fbidi \fnil\fcharset238\fprq2 PT Sans Bold Italic CE;}{\f5192\fbidi \fnil\fcharset204\fprq2 PT Sans Bold Italic Cyr;}{\f5195\fbidi \fnil\fcharset162\fprq2 PT Sans Bold Italic Tur;}{\f5198\fbidi \fnil\fcharset186\fprq2 PT Sans Bold Italic Baltic;}{\f5201\fbidi \fnil\fcharset238\fprq2 PT Sans Caption CE;}{\f5202\fbidi \fnil\fcharset204\fprq2 PT Sans Caption Cyr;}{\f5205\fbidi \fnil\fcharset162\fprq2 PT Sans Caption Tur;}{\f5208\fbidi \fnil\fcharset186\fprq2 PT Sans Caption Baltic;}{\f5211\fbidi \fnil\fcharset238\fprq2 PT Sans Caption Bold CE;}{\f5212\fbidi \fnil\fcharset204\fprq2 PT Sans Caption Bold Cyr;}{\f5215\fbidi \fnil\fcharset162\fprq2 PT Sans Caption Bold Tur;}{\f5218\fbidi \fnil\fcharset186\fprq2 PT Sans Caption Bold Baltic;}{\f5221\fbidi \fnil\fcharset238\fprq2 PT Sans Italic CE;}{\f5222\fbidi \fnil\fcharset204\fprq2 PT Sans Italic Cyr;}{\f5225\fbidi \fnil\fcharset162\fprq2 PT Sans Italic Tur;}{\f5228\fbidi \fnil\fcharset186\fprq2 PT Sans Italic Baltic;}{\f5231\fbidi \fnil\fcharset238\fprq2 PT Sans Narrow CE;}{\f5232\fbidi \fnil\fcharset204\fprq2 PT Sans Narrow Cyr;}{\f5235\fbidi \fnil\fcharset162\fprq2 PT Sans Narrow Tur;}{\f5238\fbidi \fnil\fcharset186\fprq2 PT Sans Narrow Baltic;}{\f5241\fbidi \fnil\fcharset238\fprq2 PT Sans Narrow Bold CE;}{\f5242\fbidi \fnil\fcharset204\fprq2 PT Sans Narrow Bold Cyr;}{\f5245\fbidi \fnil\fcharset162\fprq2 PT Sans Narrow Bold Tur;}{\f5248\fbidi \fnil\fcharset186\fprq2 PT Sans Narrow Bold Baltic;}{\f5251\fbidi \fnil\fcharset238\fprq2 PT Serif CE;}{\f5252\fbidi \fnil\fcharset204\fprq2 PT Serif Cyr;}{\f5255\fbidi \fnil\fcharset162\fprq2 PT Serif Tur;}{\f5258\fbidi \fnil\fcharset186\fprq2 PT Serif Baltic;}{\f5261\fbidi \fnil\fcharset238\fprq2 PT Serif Bold CE;}{\f5262\fbidi \fnil\fcharset204\fprq2 PT Serif Bold Cyr;}{\f5265\fbidi \fnil\fcharset162\fprq2 PT Serif Bold Tur;}{\f5268\fbidi \fnil\fcharset186\fprq2 PT Serif Bold Baltic;}{\f5271\fbidi \fnil\fcharset238\fprq2 PT Serif Bold Italic CE;}{\f5272\fbidi \fnil\fcharset204\fprq2 PT Serif Bold Italic Cyr;}{\f5275\fbidi \fnil\fcharset162\fprq2 PT Serif Bold Italic Tur;}{\f5278\fbidi \fnil\fcharset186\fprq2 PT Serif Bold Italic Baltic;}{\f5281\fbidi \fnil\fcharset238\fprq2 PT Serif Caption CE;}{\f5282\fbidi \fnil\fcharset204\fprq2 PT Serif Caption Cyr;}{\f5285\fbidi \fnil\fcharset162\fprq2 PT Serif Caption Tur;}{\f5288\fbidi \fnil\fcharset186\fprq2 PT Serif Caption Baltic;}{\f5291\fbidi \fnil\fcharset238\fprq2 PT Serif Caption Italic CE;}{\f5292\fbidi \fnil\fcharset204\fprq2 PT Serif Caption Italic Cyr;}{\f5295\fbidi \fnil\fcharset162\fprq2 PT Serif Caption Italic Tur;}{\f5298\fbidi \fnil\fcharset186\fprq2 PT Serif Caption Italic Baltic;}{\f5301\fbidi \fnil\fcharset238\fprq2 PT Serif Italic CE;}{\f5302\fbidi \fnil\fcharset204\fprq2 PT Serif Italic Cyr;}{\f5305\fbidi \fnil\fcharset162\fprq2 PT Serif Italic Tur;}{\f5308\fbidi \fnil\fcharset186\fprq2 PT Serif Italic Baltic;}{\f5341\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Bold CE;}{\f5344\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Bold Greek;}{\f5345\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Bold Tur;}{\f5348\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Bold Baltic;}{\f5351\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Bold Italic CE;}{\f5354\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Bold Italic Greek;}{\f5355\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Bold Italic Tur;}{\f5358\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Bold Italic Baltic;}{\f5361\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Demi CE;}{\f5364\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Demi Greek;}{\f5365\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Demi Tur;}{\f5368\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Demi Baltic;}{\f5371\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Demi Italic CE;}{\f5374\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Demi Italic Greek;}{\f5375\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Demi Italic Tur;}{\f5378\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Demi Italic Baltic;}{\f5381\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Extra Bold CE;}{\f5384\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Extra Bold Greek;}{\f5385\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Extra Bold Tur;}{\f5388\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Extra Bold Baltic;}{\f5391\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Extra Bold It CE;}{\f5394\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Extra Bold It Greek;}{\f5395\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Extra Bold It Tur;}{\f5398\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Extra Bold It Baltic;}{\f5401\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Italic CE;}{\f5404\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Italic Greek;}{\f5405\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Italic Tur;}{\f5408\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Italic Baltic;}{\f5411\fbidi \fnil\fcharset238\fprq2 Sabon Next LT Pro Regular CE;}{\f5414\fbidi \fnil\fcharset161\fprq2 Sabon Next LT Pro Regular Greek;}{\f5415\fbidi \fnil\fcharset162\fprq2 Sabon Next LT Pro Regular Tur;}{\f5418\fbidi \fnil\fcharset186\fprq2 Sabon Next LT Pro Regular Baltic;}{\f5431\fbidi \fnil\fcharset238\fprq2 Sathu CE;}{\f5432\fbidi \fnil\fcharset204\fprq2 Sathu Cyr;}{\f5435\fbidi \fnil\fcharset162\fprq2 Sathu Tur;}{\f5438\fbidi \fnil\fcharset186\fprq2 Sathu Baltic;}{\f5439\fbidi \fnil\fcharset163\fprq2 Sathu (Vietnamese);}{\f5451\fbidi \fnil\fcharset238\fprq2 Savoye LET Plain CC.:1.0 CE;}{\f5452\fbidi \fnil\fcharset204\fprq2 Savoye LET Plain CC.:1.0 Cyr;}{\f5454\fbidi \fnil\fcharset161\fprq2 Savoye LET Plain CC.:1.0 Greek;}{\f5455\fbidi \fnil\fcharset162\fprq2 Savoye LET Plain CC.:1.0 Tur;}{\f5458\fbidi \fnil\fcharset186\fprq2 Savoye LET Plain CC.:1.0 Baltic;}{\f5459\fbidi \fnil\fcharset163\fprq2 Savoye LET Plain CC.:1.0 (Vietnamese);}{\f5481\fbidi \fnil\fcharset238\fprq2 Seravek CE;}{\f5482\fbidi \fnil\fcharset204\fprq2 Seravek Cyr;}{\f5484\fbidi \fnil\fcharset161\fprq2 Seravek Greek;}{\f5485\fbidi \fnil\fcharset162\fprq2 Seravek Tur;}{\f5488\fbidi \fnil\fcharset186\fprq2 Seravek Baltic;}{\f5491\fbidi \fnil\fcharset238\fprq2 Seravek Bold CE;}{\f5492\fbidi \fnil\fcharset204\fprq2 Seravek Bold Cyr;}{\f5494\fbidi \fnil\fcharset161\fprq2 Seravek Bold Greek;}{\f5495\fbidi \fnil\fcharset162\fprq2 Seravek Bold Tur;}{\f5498\fbidi \fnil\fcharset186\fprq2 Seravek Bold Baltic;}{\f5501\fbidi \fnil\fcharset238\fprq2 Seravek Bold Italic CE;}{\f5502\fbidi \fnil\fcharset204\fprq2 Seravek Bold Italic Cyr;}{\f5504\fbidi \fnil\fcharset161\fprq2 Seravek Bold Italic Greek;}{\f5505\fbidi \fnil\fcharset162\fprq2 Seravek Bold Italic Tur;}{\f5508\fbidi \fnil\fcharset186\fprq2 Seravek Bold Italic Baltic;}{\f5511\fbidi \fnil\fcharset238\fprq2 Seravek ExtraLight CE;}{\f5512\fbidi \fnil\fcharset204\fprq2 Seravek ExtraLight Cyr;}{\f5514\fbidi \fnil\fcharset161\fprq2 Seravek ExtraLight Greek;}{\f5515\fbidi \fnil\fcharset162\fprq2 Seravek ExtraLight Tur;}{\f5518\fbidi \fnil\fcharset186\fprq2 Seravek ExtraLight Baltic;}{\f5521\fbidi \fnil\fcharset238\fprq2 Seravek ExtraLight Italic CE;}{\f5522\fbidi \fnil\fcharset204\fprq2 Seravek ExtraLight Italic Cyr;}{\f5524\fbidi \fnil\fcharset161\fprq2 Seravek ExtraLight Italic Greek;}{\f5525\fbidi \fnil\fcharset162\fprq2 Seravek ExtraLight Italic Tur;}{\f5528\fbidi \fnil\fcharset186\fprq2 Seravek ExtraLight Italic Baltic;}{\f5531\fbidi \fnil\fcharset238\fprq2 Seravek Italic CE;}{\f5532\fbidi \fnil\fcharset204\fprq2 Seravek Italic Cyr;}{\f5534\fbidi \fnil\fcharset161\fprq2 Seravek Italic Greek;}{\f5535\fbidi \fnil\fcharset162\fprq2 Seravek Italic Tur;}{\f5538\fbidi \fnil\fcharset186\fprq2 Seravek Italic Baltic;}{\f5541\fbidi \fnil\fcharset238\fprq2 Seravek Light CE;}{\f5542\fbidi \fnil\fcharset204\fprq2 Seravek Light Cyr;}{\f5544\fbidi \fnil\fcharset161\fprq2 Seravek Light Greek;}{\f5545\fbidi \fnil\fcharset162\fprq2 Seravek Light Tur;}{\f5548\fbidi \fnil\fcharset186\fprq2 Seravek Light Baltic;}{\f5551\fbidi \fnil\fcharset238\fprq2 Seravek Light Italic CE;}{\f5552\fbidi \fnil\fcharset204\fprq2 Seravek Light Italic Cyr;}{\f5554\fbidi \fnil\fcharset161\fprq2 Seravek Light Italic Greek;}{\f5555\fbidi \fnil\fcharset162\fprq2 Seravek Light Italic Tur;}{\f5558\fbidi \fnil\fcharset186\fprq2 Seravek Light Italic Baltic;}{\f5561\fbidi \fnil\fcharset238\fprq2 Seravek Medium CE;}{\f5562\fbidi \fnil\fcharset204\fprq2 Seravek Medium Cyr;}{\f5564\fbidi \fnil\fcharset161\fprq2 Seravek Medium Greek;}{\f5565\fbidi \fnil\fcharset162\fprq2 Seravek Medium Tur;}{\f5568\fbidi \fnil\fcharset186\fprq2 Seravek Medium Baltic;}{\f5571\fbidi \fnil\fcharset238\fprq2 Seravek Medium Italic CE;}{\f5572\fbidi \fnil\fcharset204\fprq2 Seravek Medium Italic Cyr;}{\f5574\fbidi \fnil\fcharset161\fprq2 Seravek Medium Italic Greek;}{\f5575\fbidi \fnil\fcharset162\fprq2 Seravek Medium Italic Tur;}{\f5578\fbidi \fnil\fcharset186\fprq2 Seravek Medium Italic Baltic;}{\f5581\fbidi \fnil\fcharset238\fprq2 Silom CE;}{\f5585\fbidi \fnil\fcharset162\fprq2 Silom Tur;}{\f5588\fbidi \fnil\fcharset186\fprq2 Silom Baltic;}{\f5589\fbidi \fnil\fcharset163\fprq2 Silom (Vietnamese);}{\f5593\fbidi \fnil\fcharset0\fprq2 SimSun-ExtB Western;}{\f5603\fbidi \fnil\fcharset0\fprq2 @SimSun-ExtB Western;}{\f5665\fbidi \fnil\fcharset162\fprq2 Snell Roundhand Tur;}{\f5669\fbidi \fnil\fcharset163\fprq2 Snell Roundhand (Vietnamese);}{\f5675\fbidi \fnil\fcharset162\fprq2 Snell Roundhand Black Tur;}{\f5679\fbidi \fnil\fcharset163\fprq2 Snell Roundhand Black (Vietnamese);}{\f5685\fbidi \fnil\fcharset162\fprq2 Snell Roundhand Bold Tur;}{\f5689\fbidi \fnil\fcharset163\fprq2 Snell Roundhand Bold (Vietnamese);}{\f5701\fbidi \fnil\fcharset238\fprq2 STIXGeneral-Bold CE;}{\f5702\fbidi \fnil\fcharset204\fprq2 STIXGeneral-Bold Cyr;}{\f5704\fbidi \fnil\fcharset161\fprq2 STIXGeneral-Bold Greek;}{\f5705\fbidi \fnil\fcharset162\fprq2 STIXGeneral-Bold Tur;}{\f5706\fbidi \fnil\fcharset177\fprq2 STIXGeneral-Bold (Hebrew);}{\f5707\fbidi \fnil\fcharset178\fprq2 STIXGeneral-Bold (Arabid);}{\f5708\fbidi \fnil\fcharset186\fprq2 STIXGeneral-Bold Baltic;}{\f5709\fbidi \fnil\fcharset163\fprq2 STIXGeneral-Bold (Vietnamese);}{\f5711\fbidi \fnil\fcharset238\fprq2 STIXGeneral-BoldItalic CE;}{\f5712\fbidi \fnil\fcharset204\fprq2 STIXGeneral-BoldItalic Cyr;}{\f5714\fbidi \fnil\fcharset161\fprq2 STIXGeneral-BoldItalic Greek;}{\f5715\fbidi \fnil\fcharset162\fprq2 STIXGeneral-BoldItalic Tur;}{\f5716\fbidi \fnil\fcharset177\fprq2 STIXGeneral-BoldItalic (Hebrew);}{\f5717\fbidi \fnil\fcharset178\fprq2 STIXGeneral-BoldItalic (Arabid);}{\f5718\fbidi \fnil\fcharset186\fprq2 STIXGeneral-BoldItalic Baltic;}{\f5719\fbidi \fnil\fcharset163\fprq2 STIXGeneral-BoldItalic (Vietnamese);}{\f5721\fbidi \fnil\fcharset238\fprq2 STIXGeneral-Italic CE;}{\f5722\fbidi \fnil\fcharset204\fprq2 STIXGeneral-Italic Cyr;}{\f5724\fbidi \fnil\fcharset161\fprq2 STIXGeneral-Italic Greek;}{\f5725\fbidi \fnil\fcharset162\fprq2 STIXGeneral-Italic Tur;}{\f5726\fbidi \fnil\fcharset177\fprq2 STIXGeneral-Italic (Hebrew);}{\f5727\fbidi \fnil\fcharset178\fprq2 STIXGeneral-Italic (Arabid);}{\f5728\fbidi \fnil\fcharset186\fprq2 STIXGeneral-Italic Baltic;}{\f5729\fbidi \fnil\fcharset163\fprq2 STIXGeneral-Italic (Vietnamese);}{\f5731\fbidi \fnil\fcharset238\fprq2 STIXGeneral-Regular CE;}{\f5732\fbidi \fnil\fcharset204\fprq2 STIXGeneral-Regular Cyr;}{\f5734\fbidi \fnil\fcharset161\fprq2 STIXGeneral-Regular Greek;}{\f5735\fbidi \fnil\fcharset162\fprq2 STIXGeneral-Regular Tur;}{\f5736\fbidi \fnil\fcharset177\fprq2 STIXGeneral-Regular (Hebrew);}{\f5737\fbidi \fnil\fcharset178\fprq2 STIXGeneral-Regular (Arabid);}{\f5738\fbidi \fnil\fcharset186\fprq2 STIXGeneral-Regular Baltic;}{\f5739\fbidi \fnil\fcharset163\fprq2 STIXGeneral-Regular (Vietnamese);}{\f5889\fbidi \fnil\fcharset163\fprq2 STIXSizeFiveSym-Regular (Vietnamese);}{\f5909\fbidi \fnil\fcharset163\fprq2 STIXSizeFourSym-Regular (Vietnamese);}{\f5929\fbidi \fnil\fcharset163\fprq2 STIXSizeOneSym-Regular (Vietnamese);}{\f5949\fbidi \fnil\fcharset163\fprq2 STIXSizeThreeSym-Regular (Vietnamese);}{\f5969\fbidi \fnil\fcharset163\fprq2 STIXSizeTwoSym-Regular (Vietnamese);}{\f6041\fbidi \fnil\fcharset238\fprq2 Superclarendon Black CE;}{\f6048\fbidi \fnil\fcharset186\fprq2 Superclarendon Black Baltic;}{\f6049\fbidi \fnil\fcharset163\fprq2 Superclarendon Black (Vietnamese);}{\f6051\fbidi \fnil\fcharset238\fprq2 Superclarendon Black Italic CE;}{\f6058\fbidi \fnil\fcharset186\fprq2 Superclarendon Black Italic Baltic;}{\f6059\fbidi \fnil\fcharset163\fprq2 Superclarendon Black Italic (Vietnamese);}{\f6061\fbidi \fnil\fcharset238\fprq2 Superclarendon Bold CE;}{\f6068\fbidi \fnil\fcharset186\fprq2 Superclarendon Bold Baltic;}{\f6069\fbidi \fnil\fcharset163\fprq2 Superclarendon Bold (Vietnamese);}{\f6071\fbidi \fnil\fcharset238\fprq2 Superclarendon Bold Italic CE;}{\f6078\fbidi \fnil\fcharset186\fprq2 Superclarendon Bold Italic Baltic;}{\f6079\fbidi \fnil\fcharset163\fprq2 Superclarendon Bold Italic (Vietnamese);}{\f6081\fbidi \fnil\fcharset238\fprq2 Superclarendon Italic CE;}{\f6088\fbidi \fnil\fcharset186\fprq2 Superclarendon Italic Baltic;}{\f6089\fbidi \fnil\fcharset163\fprq2 Superclarendon Italic (Vietnamese);}{\f6091\fbidi \fnil\fcharset238\fprq2 Superclarendon Light CE;}{\f6098\fbidi \fnil\fcharset186\fprq2 Superclarendon Light Baltic;}{\f6099\fbidi \fnil\fcharset163\fprq2 Superclarendon Light (Vietnamese);}{\f6101\fbidi \fnil\fcharset238\fprq2 Superclarendon Light Italic CE;}{\f6108\fbidi \fnil\fcharset186\fprq2 Superclarendon Light Italic Baltic;}{\f6109\fbidi \fnil\fcharset163\fprq2 Superclarendon Light Italic (Vietnamese);}{\f6111\fbidi \fnil\fcharset238\fprq2 Superclarendon Regular CE;}{\f6118\fbidi \fnil\fcharset186\fprq2 Superclarendon Regular Baltic;}{\f6119\fbidi \fnil\fcharset163\fprq2 Superclarendon Regular (Vietnamese);}{\f6131\fbidi \fnil\fcharset238\fprq2 Tahoma CE;}{\f6132\fbidi \fnil\fcharset204\fprq2 Tahoma Cyr;}{\f6134\fbidi \fnil\fcharset161\fprq2 Tahoma Greek;}{\f6135\fbidi \fnil\fcharset162\fprq2 Tahoma Tur;}{\f6136\fbidi \fnil\fcharset177\fprq2 Tahoma (Hebrew);}{\f6137\fbidi \fnil\fcharset178\fprq2 Tahoma (Arabid);}{\f6138\fbidi \fnil\fcharset186\fprq2 Tahoma Baltic;}{\f6139\fbidi \fnil\fcharset163\fprq2 Tahoma (Vietnamese);}{\f6140\fbidi \fnil\fcharset222\fprq2 Tahoma (That);}{\f6141\fbidi \fnil\fcharset238\fprq2 Tahoma Bold CE;}{\f6142\fbidi \fnil\fcharset204\fprq2 Tahoma Bold Cyr;}{\f6144\fbidi \fnil\fcharset161\fprq2 Tahoma Bold Greek;}{\f6145\fbidi \fnil\fcharset162\fprq2 Tahoma Bold Tur;}{\f6146\fbidi \fnil\fcharset177\fprq2 Tahoma Bold (Hebrew);}{\f6147\fbidi \fnil\fcharset178\fprq2 Tahoma Bold (Arabid);}{\f6148\fbidi \fnil\fcharset186\fprq2 Tahoma Bold Baltic;}{\f6149\fbidi \fnil\fcharset163\fprq2 Tahoma Bold (Vietnamese);}{\f6150\fbidi \fnil\fcharset222\fprq2 Tahoma Bold (That);}{\f6201\fbidi \fnil\fcharset238\fprq2 Tekton Pro Bold CE;}{\f6205\fbidi \fnil\fcharset162\fprq2 Tekton Pro Bold Tur;}{\f6208\fbidi \fnil\fcharset186\fprq2 Tekton Pro Bold Baltic;}{\f6211\fbidi \fnil\fcharset238\fprq2 Tekton Pro BoldCond CE;}{\f6215\fbidi \fnil\fcharset162\fprq2 Tekton Pro BoldCond Tur;}{\f6218\fbidi \fnil\fcharset186\fprq2 Tekton Pro BoldCond Baltic;}{\f6221\fbidi \fnil\fcharset238\fprq2 Tekton Pro BoldExt CE;}{\f6225\fbidi \fnil\fcharset162\fprq2 Tekton Pro BoldExt Tur;}{\f6228\fbidi \fnil\fcharset186\fprq2 Tekton Pro BoldExt Baltic;}{\f6231\fbidi \fnil\fcharset238\fprq2 Tekton Pro BoldObl CE;}{\f6235\fbidi \fnil\fcharset162\fprq2 Tekton Pro BoldObl Tur;}{\f6238\fbidi \fnil\fcharset186\fprq2 Tekton Pro BoldObl Baltic;}{\f6281\fbidi \fnil\fcharset238\fprq2 Thonburi Light CE;}{\f6285\fbidi \fnil\fcharset162\fprq2 Thonburi Light Tur;}{\f6288\fbidi \fnil\fcharset186\fprq2 Thonburi Light Baltic;}{\f6289\fbidi \fnil\fcharset163\fprq2 Thonburi Light (Vietnamese);}{\f6291\fbidi \fnil\fcharset238\fprq2 Times New Roman Bold CE;}{\f6292\fbidi \fnil\fcharset204\fprq2 Times New Roman Bold Cyr;}{\f6294\fbidi \fnil\fcharset161\fprq2 Times New Roman Bold Greek;}{\f6295\fbidi \fnil\fcharset162\fprq2 Times New Roman Bold Tur;}{\f6296\fbidi \fnil\fcharset177\fprq2 Times New Roman Bold (Hebrew);}{\f6297\fbidi \fnil\fcharset178\fprq2 Times New Roman Bold (Arabid);}{\f6298\fbidi \fnil\fcharset186\fprq2 Times New Roman Bold Baltic;}{\f6299\fbidi \fnil\fcharset163\fprq2 Times New Roman Bold (Vietnamese);}{\f6301\fbidi \fnil\fcharset238\fprq2 Times New Roman Bold Italic CE;}{\f6302\fbidi \fnil\fcharset204\fprq2 Times New Roman Bold Italic Cyr;}{\f6304\fbidi \fnil\fcharset161\fprq2 Times New Roman Bold Italic Greek;}{\f6305\fbidi \fnil\fcharset162\fprq2 Times New Roman Bold Italic Tur;}{\f6306\fbidi \fnil\fcharset177\fprq2 Times New Roman Bold Italic (Hebrew);}{\f6308\fbidi \fnil\fcharset186\fprq2 Times New Roman Bold Italic Baltic;}{\f6309\fbidi \fnil\fcharset163\fprq2 Times New Roman Bold Italic (Vietnamese);}{\f6311\fbidi \fnil\fcharset238\fprq2 Times New Roman Italic CE;}{\f6312\fbidi \fnil\fcharset204\fprq2 Times New Roman Italic Cyr;}{\f6314\fbidi \fnil\fcharset161\fprq2 Times New Roman Italic Greek;}{\f6315\fbidi \fnil\fcharset162\fprq2 Times New Roman Italic Tur;}{\f6316\fbidi \fnil\fcharset177\fprq2 Times New Roman Italic (Hebrew);}{\f6318\fbidi \fnil\fcharset186\fprq2 Times New Roman Italic Baltic;}{\f6319\fbidi \fnil\fcharset163\fprq2 Times New Roman Italic (Vietnamese);}{\f6321\fbidi \fnil\fcharset238\fprq2 Trajan Pro CE;}{\f6325\fbidi \fnil\fcharset162\fprq2 Trajan Pro Tur;}{\f6328\fbidi \fnil\fcharset186\fprq2 Trajan Pro Baltic;}{\f6331\fbidi \fnil\fcharset238\fprq2 Trajan Pro Bold CE;}{\f6335\fbidi \fnil\fcharset162\fprq2 Trajan Pro Bold Tur;}{\f6338\fbidi \fnil\fcharset186\fprq2 Trajan Pro Bold Baltic;}{\f6341\fbidi \fnil\fcharset238\fprq2 Trebuchet MS CE;}{\f6342\fbidi \fnil\fcharset204\fprq2 Trebuchet MS Cyr;}{\f6344\fbidi \fnil\fcharset161\fprq2 Trebuchet MS Greek;}{\f6345\fbidi \fnil\fcharset162\fprq2 Trebuchet MS Tur;}{\f6348\fbidi \fnil\fcharset186\fprq2 Trebuchet MS Baltic;}{\f6351\fbidi \fnil\fcharset238\fprq2 Trebuchet MS Bold CE;}{\f6352\fbidi \fnil\fcharset204\fprq2 Trebuchet MS Bold Cyr;}{\f6354\fbidi \fnil\fcharset161\fprq2 Trebuchet MS Bold Greek;}{\f6355\fbidi \fnil\fcharset162\fprq2 Trebuchet MS Bold Tur;}{\f6358\fbidi \fnil\fcharset186\fprq2 Trebuchet MS Bold Baltic;}{\f6361\fbidi \fnil\fcharset238\fprq2 Trebuchet MS Bold Italic CE;}{\f6362\fbidi \fnil\fcharset204\fprq2 Trebuchet MS Bold Italic Cyr;}{\f6364\fbidi \fnil\fcharset161\fprq2 Trebuchet MS Bold Italic Greek;}{\f6365\fbidi \fnil\fcharset162\fprq2 Trebuchet MS Bold Italic Tur;}{\f6368\fbidi \fnil\fcharset186\fprq2 Trebuchet MS Bold Italic Baltic;}{\f6371\fbidi \fnil\fcharset238\fprq2 Trebuchet MS Italic CE;}{\f6372\fbidi \fnil\fcharset204\fprq2 Trebuchet MS Italic Cyr;}{\f6374\fbidi \fnil\fcharset161\fprq2 Trebuchet MS Italic Greek;}{\f6375\fbidi \fnil\fcharset162\fprq2 Trebuchet MS Italic Tur;}{\f6378\fbidi \fnil\fcharset186\fprq2 Trebuchet MS Italic Baltic;}{\f6381\fbidi \fnil\fcharset238\fprq2 Tw Cen MT CE;}{\f6391\fbidi \fnil\fcharset238\fprq2 Tw Cen MT Bold CE;}{\f6401\fbidi \fnil\fcharset238\fprq2 Tw Cen MT Bold Italic CE;}{\f6411\fbidi \fnil\fcharset238\fprq2 Tw Cen MT Italic CE;}{\f6431\fbidi \fnil\fcharset238\fprq2 Verdana Bold CE;}{\f6432\fbidi \fnil\fcharset204\fprq2 Verdana Bold Cyr;}{\f6434\fbidi \fnil\fcharset161\fprq2 Verdana Bold Greek;}{\f6435\fbidi \fnil\fcharset162\fprq2 Verdana Bold Tur;}{\f6438\fbidi \fnil\fcharset186\fprq2 Verdana Bold Baltic;}{\f6439\fbidi \fnil\fcharset163\fprq2 Verdana Bold (Vietnamese);}{\f6441\fbidi \fnil\fcharset238\fprq2 Verdana Bold Italic CE;}{\f6442\fbidi \fnil\fcharset204\fprq2 Verdana Bold Italic Cyr;}{\f6444\fbidi \fnil\fcharset161\fprq2 Verdana Bold Italic Greek;}{\f6445\fbidi \fnil\fcharset162\fprq2 Verdana Bold Italic Tur;}{\f6448\fbidi \fnil\fcharset186\fprq2 Verdana Bold Italic Baltic;}{\f6449\fbidi \fnil\fcharset163\fprq2 Verdana Bold Italic (Vietnamese);}{\f6451\fbidi \fnil\fcharset238\fprq2 Verdana Italic CE;}{\f6452\fbidi \fnil\fcharset204\fprq2 Verdana Italic Cyr;}{\f6454\fbidi \fnil\fcharset161\fprq2 Verdana Italic Greek;}{\f6455\fbidi \fnil\fcharset162\fprq2 Verdana Italic Tur;}{\f6458\fbidi \fnil\fcharset186\fprq2 Verdana Italic Baltic;}{\f6459\fbidi \fnil\fcharset163\fprq2 Verdana Italic (Vietnamese);}{\f6461\fbidi \fnil\fcharset238\fprq2 Wawati SC Regular CE;}{\f6471\fbidi \fnil\fcharset238\fprq2 Wawati TC Regular CE;}{\f6571\fbidi \fnil\fcharset238\fprq2 Zapfino CE;}{\f6575\fbidi \fnil\fcharset162\fprq2 Zapfino Tur;}{\f6578\fbidi \fnil\fcharset186\fprq2 Zapfino Baltic;}{\f6583\fbidi \fnil\fcharset0\fprq2 Lucida Grande CE;}{\f6582\fbidi \fnil\fcharset204\fprq2 Lucida Grande CE Cyr;}{\f6584\fbidi \fnil\fcharset161\fprq2 Lucida Grande CE Greek;}{\f6585\fbidi \fnil\fcharset162\fprq2 Lucida Grande CE Tur;}{\f6586\fbidi \fnil\fcharset177\fprq2 Lucida Grande CE (Hebrew);}{\f6588\fbidi \fnil\fcharset186\fprq2 Lucida Grande CE Baltic;}{\f6589\fbidi \fnil\fcharset163\fprq2 Lucida Grande CE (Vietnamese);}{\f6591\fbidi \fnil\fcharset238\fprq2 Charcoal CY CE;}{\f6597\fbidi \fnil\fcharset178\fprq2 Charcoal CY (Arabid);}{\f6598\fbidi \fnil\fcharset186\fprq2 Charcoal CY Baltic;}{\f6599\fbidi \fnil\fcharset163\fprq2 Charcoal CY (Vietnamese);}{\f6601\fbidi \fnil\fcharset238\fprq2 Geneva CY CE;}{\f6607\fbidi \fnil\fcharset178\fprq2 Geneva CY (Arabid);}{\f6608\fbidi \fnil\fcharset186\fprq2 Geneva CY Baltic;}{\f6609\fbidi \fnil\fcharset163\fprq2 Geneva CY (Vietnamese);}{\f6611\fbidi \fnil\fcharset238\fprq2 Helvetica CY CE;}{\f6617\fbidi \fnil\fcharset178\fprq2 Helvetica CY (Arabid);}{\f6618\fbidi \fnil\fcharset186\fprq2 Helvetica CY Baltic;}{\f6619\fbidi \fnil\fcharset163\fprq2 Helvetica CY (Vietnamese);}{\f6623\fbidi \fnil\fcharset0\fprq2 Lucida Grande CY;}{\f6621\fbidi \fnil\fcharset238\fprq2 Lucida Grande CY CE;}{\f6624\fbidi \fnil\fcharset161\fprq2 Lucida Grande CY Greek;}{\f6625\fbidi \fnil\fcharset162\fprq2 Lucida Grande CY Tur;}{\f6626\fbidi \fnil\fcharset177\fprq2 Lucida Grande CY (Hebrew);}{\f6628\fbidi \fnil\fcharset186\fprq2 Lucida Grande CY Baltic;}{\f6629\fbidi \fnil\fcharset163\fprq2 Lucida Grande CY (Vietnamese);}{\f6633\fbidi \fnil\fcharset0\fprq2 Thonburi;}{\f6631\fbidi \fnil\fcharset238\fprq2 Thonburi CE;}{\f6635\fbidi \fnil\fcharset162\fprq2 Thonburi Tur;}{\f6638\fbidi \fnil\fcharset186\fprq2 Thonburi Baltic;}{\f6639\fbidi \fnil\fcharset163\fprq2 Thonburi (Vietnamese);}{\f6643\fbidi \fnil\fcharset0\fprq2 Thonburi Bold;}{\f6641\fbidi \fnil\fcharset238\fprq2 Thonburi Bold CE;}{\f6645\fbidi \fnil\fcharset162\fprq2 Thonburi Bold Tur;}{\f6648\fbidi \fnil\fcharset186\fprq2 Thonburi Bold Baltic;}{\f6649\fbidi \fnil\fcharset163\fprq2 Thonburi Bold (Vietnamese);}{\f6653\fbidi \fnil\fcharset0\fprq2 Adobe \'a9\'fa\'c5\'e9 Std L Western;}{\f6652\fbidi \fnil\fcharset204\fprq2 Adobe \'a9\'fa\'c5\'e9 Std L Cyr;}{\f6663\fbidi \fnil\fcharset0\fprq2 @Adobe \'a9\'fa\'c5\'e9 Std L Western;}{\f6662\fbidi \fnil\fcharset204\fprq2 @Adobe \'a9\'fa\'c5\'e9 Std L Cyr;}{\f6673\fbidi \fnil\fcharset0\fprq2 Adobe \'c1\'63\'b6\'c2\'c5\'e9 Std B Western;}{\f6672\fbidi \fnil\fcharset204\fprq2 Adobe \'c1\'63\'b6\'c2\'c5\'e9 Std B Cyr;}{\f6683\fbidi \fnil\fcharset0\fprq2 @Adobe \'c1\'63\'b6\'c2\'c5\'e9 Std B Western;}{\f6682\fbidi \fnil\fcharset204\fprq2 @Adobe \'c1\'63\'b6\'c2\'c5\'e9 Std B Cyr;}{\f6753\fbidi \fnil\fcharset0\fprq2 Hannotate TC Bold Western;}{\f6763\fbidi \fnil\fcharset0\fprq2 @Hannotate TC Bold Western;}{\f6773\fbidi \fnil\fcharset0\fprq2 Hannotate TC Regular Western;}{\f6783\fbidi \fnil\fcharset0\fprq2 @Hannotate TC Regular Western;}{\f6793\fbidi \fnil\fcharset0\fprq2 HanziPen TC Bold Western;}{\f6803\fbidi \fnil\fcharset0\fprq2 @HanziPen TC Bold Western;}{\f6813\fbidi \fnil\fcharset0\fprq2 HanziPen TC Regular Western;}{\f6823\fbidi \fnil\fcharset0\fprq2 @HanziPen TC Regular Western;}{\f6873\fbidi \fnil\fcharset0\fprq2 Kaiti TC Bold Western;}{\f6871\fbidi \fnil\fcharset238\fprq2 Kaiti TC Bold CE;}{\f6872\fbidi \fnil\fcharset204\fprq2 Kaiti TC Bold Cyr;}{\f6874\fbidi \fnil\fcharset161\fprq2 Kaiti TC Bold Greek;}{\f6875\fbidi \fnil\fcharset162\fprq2 Kaiti TC Bold Tur;}{\f6883\fbidi \fnil\fcharset0\fprq2 @Kaiti TC Bold Western;}{\f6881\fbidi \fnil\fcharset238\fprq2 @Kaiti TC Bold CE;}{\f6882\fbidi \fnil\fcharset204\fprq2 @Kaiti TC Bold Cyr;}{\f6884\fbidi \fnil\fcharset161\fprq2 @Kaiti TC Bold Greek;}{\f6885\fbidi \fnil\fcharset162\fprq2 @Kaiti TC Bold Tur;}{\f6893\fbidi \fnil\fcharset0\fprq2 Kaiti TC Regular Western;}{\f6891\fbidi \fnil\fcharset238\fprq2 Kaiti TC Regular CE;}{\f6892\fbidi \fnil\fcharset204\fprq2 Kaiti TC Regular Cyr;}{\f6894\fbidi \fnil\fcharset161\fprq2 Kaiti TC Regular Greek;}{\f6895\fbidi \fnil\fcharset162\fprq2 Kaiti TC Regular Tur;}{\f6903\fbidi \fnil\fcharset0\fprq2 @Kaiti TC Regular Western;}{\f6901\fbidi \fnil\fcharset238\fprq2 @Kaiti TC Regular CE;}{\f6902\fbidi \fnil\fcharset204\fprq2 @Kaiti TC Regular Cyr;}{\f6904\fbidi \fnil\fcharset161\fprq2 @Kaiti TC Regular Greek;}{\f6905\fbidi \fnil\fcharset162\fprq2 @Kaiti TC Regular Tur;}{\f6913\fbidi \fnil\fcharset0\fprq2 Songti TC Bold Western;}{\f6911\fbidi \fnil\fcharset238\fprq2 Songti TC Bold CE;}{\f6912\fbidi \fnil\fcharset204\fprq2 Songti TC Bold Cyr;}{\f6914\fbidi \fnil\fcharset161\fprq2 Songti TC Bold Greek;}{\f6915\fbidi \fnil\fcharset162\fprq2 Songti TC Bold Tur;}{\f6918\fbidi \fnil\fcharset186\fprq2 Songti TC Bold Baltic;}{\f6923\fbidi \fnil\fcharset0\fprq2 @Songti TC Bold Western;}{\f6921\fbidi \fnil\fcharset238\fprq2 @Songti TC Bold CE;}{\f6922\fbidi \fnil\fcharset204\fprq2 @Songti TC Bold Cyr;}{\f6924\fbidi \fnil\fcharset161\fprq2 @Songti TC Bold Greek;}{\f6925\fbidi \fnil\fcharset162\fprq2 @Songti TC Bold Tur;}{\f6928\fbidi \fnil\fcharset186\fprq2 @Songti TC Bold Baltic;}{\f6933\fbidi \fnil\fcharset0\fprq2 Songti TC Light Western;}{\f6931\fbidi \fnil\fcharset238\fprq2 Songti TC Light CE;}{\f6932\fbidi \fnil\fcharset204\fprq2 Songti TC Light Cyr;}{\f6934\fbidi \fnil\fcharset161\fprq2 Songti TC Light Greek;}{\f6935\fbidi \fnil\fcharset162\fprq2 Songti TC Light Tur;}{\f6943\fbidi \fnil\fcharset0\fprq2 @Songti TC Light Western;}{\f6941\fbidi \fnil\fcharset238\fprq2 @Songti TC Light CE;}{\f6942\fbidi \fnil\fcharset204\fprq2 @Songti TC Light Cyr;}{\f6944\fbidi \fnil\fcharset161\fprq2 @Songti TC Light Greek;}{\f6945\fbidi \fnil\fcharset162\fprq2 @Songti TC Light Tur;}{\f6953\fbidi \fnil\fcharset0\fprq2 Songti TC Regular Western;}{\f6951\fbidi \fnil\fcharset238\fprq2 Songti TC Regular CE;}{\f6952\fbidi \fnil\fcharset204\fprq2 Songti TC Regular Cyr;}{\f6954\fbidi \fnil\fcharset161\fprq2 Songti TC Regular Greek;}{\f6955\fbidi \fnil\fcharset162\fprq2 Songti TC Regular Tur;}{\f6958\fbidi \fnil\fcharset186\fprq2 Songti TC Regular Baltic;}{\f6963\fbidi \fnil\fcharset0\fprq2 @Songti TC Regular Western;}{\f6961\fbidi \fnil\fcharset238\fprq2 @Songti TC Regular CE;}{\f6962\fbidi \fnil\fcharset204\fprq2 @Songti TC Regular Cyr;}{\f6964\fbidi \fnil\fcharset161\fprq2 @Songti TC Regular Greek;}{\f6965\fbidi \fnil\fcharset162\fprq2 @Songti TC Regular Tur;}{\f6968\fbidi \fnil\fcharset186\fprq2 @Songti TC Regular Baltic;}{\f6973\fbidi \fnil\fcharset0\fprq2 Weibei TC Bold Western;}{\f6971\fbidi \fnil\fcharset238\fprq2 Weibei TC Bold CE;}{\f6972\fbidi \fnil\fcharset204\fprq2 Weibei TC Bold Cyr;}{\f6978\fbidi \fnil\fcharset186\fprq2 Weibei TC Bold Baltic;}{\f6979\fbidi \fnil\fcharset163\fprq2 Weibei TC Bold (Vietnamese);}{\f6983\fbidi \fnil\fcharset0\fprq2 @Weibei TC Bold Western;}{\f6981\fbidi \fnil\fcharset238\fprq2 @Weibei TC Bold CE;}{\f6982\fbidi \fnil\fcharset204\fprq2 @Weibei TC Bold Cyr;}{\f6988\fbidi \fnil\fcharset186\fprq2 @Weibei TC Bold Baltic;}{\f6989\fbidi \fnil\fcharset163\fprq2 @Weibei TC Bold (Vietnamese);}{\f6993\fbidi \fnil\fcharset0\fprq2 Yuppy TC Regular Western;}{\f6992\fbidi \fnil\fcharset204\fprq2 Yuppy TC Regular Cyr;}{\f7003\fbidi \fnil\fcharset0\fprq2 @Yuppy TC Regular Western;}{\f7002\fbidi \fnil\fcharset204\fprq2 @Yuppy TC Regular Cyr;}{\f7013\fbidi \fnil\fcharset0\fprq2 \'b2\'d3\'a9\'fa\'c5\'e9 Western;}{\f7023\fbidi \fnil\fcharset0\fprq2 @\'b2\'d3\'a9\'fa\'c5\'e9 Western;}{\f7033\fbidi \fnil\fcharset0\fprq2 \'b2\'d3\'a9\'fa\'c5\'e9_HKSCS Western;}{\f7043\fbidi \fnil\fcharset0\fprq2 @\'b2\'d3\'a9\'fa\'c5\'e9_HKSCS Western;}{\f7053\fbidi \fnil\fcharset0\fprq2 @\'b7\'73\'b2\'d3\'a9\'fa\'c5\'e9 Western;}{\f7103\fbidi \fnil\fcharset0\fprq2 Adobe \'b7\'c2\'cb\'ce Std R Western;}{\f7101\fbidi \fnil\fcharset238\fprq2 Adobe \'b7\'c2\'cb\'ce Std R CE;}{\f7102\fbidi \fnil\fcharset204\fprq2 Adobe \'b7\'c2\'cb\'ce Std R Cyr;}{\f7113\fbidi \fnil\fcharset0\fprq2 @Adobe \'b7\'c2\'cb\'ce Std R Western;}{\f7111\fbidi \fnil\fcharset238\fprq2 @Adobe \'b7\'c2\'cb\'ce Std R CE;}{\f7112\fbidi \fnil\fcharset204\fprq2 @Adobe \'b7\'c2\'cb\'ce Std R Cyr;}{\f7123\fbidi \fnil\fcharset0\fprq2 Adobe \'ba\'da\'cc\'e5 Std R Western;}{\f7121\fbidi \fnil\fcharset238\fprq2 Adobe \'ba\'da\'cc\'e5 Std R CE;}{\f7122\fbidi \fnil\fcharset204\fprq2 Adobe \'ba\'da\'cc\'e5 Std R Cyr;}{\f7133\fbidi \fnil\fcharset0\fprq2 @Adobe \'ba\'da\'cc\'e5 Std R Western;}{\f7131\fbidi \fnil\fcharset238\fprq2 @Adobe \'ba\'da\'cc\'e5 Std R CE;}{\f7132\fbidi \fnil\fcharset204\fprq2 @Adobe \'ba\'da\'cc\'e5 Std R Cyr;}{\f7143\fbidi \fnil\fcharset0\fprq2 Adobe \'bf\'ac\'cc\'e5 Std R Western;}{\f7141\fbidi \fnil\fcharset238\fprq2 Adobe \'bf\'ac\'cc\'e5 Std R CE;}{\f7142\fbidi \fnil\fcharset204\fprq2 Adobe \'bf\'ac\'cc\'e5 Std R Cyr;}{\f7153\fbidi \fnil\fcharset0\fprq2 @Adobe \'bf\'ac\'cc\'e5 Std R Western;}{\f7151\fbidi \fnil\fcharset238\fprq2 @Adobe \'bf\'ac\'cc\'e5 Std R CE;}{\f7152\fbidi \fnil\fcharset204\fprq2 @Adobe \'bf\'ac\'cc\'e5 Std R Cyr;}{\f7163\fbidi \fnil\fcharset0\fprq2 Adobe \'cb\'ce\'cc\'e5 Std L Western;}{\f7161\fbidi \fnil\fcharset238\fprq2 Adobe \'cb\'ce\'cc\'e5 Std L CE;}{\f7162\fbidi \fnil\fcharset204\fprq2 Adobe \'cb\'ce\'cc\'e5 Std L Cyr;}{\f7173\fbidi \fnil\fcharset0\fprq2 @Adobe \'cb\'ce\'cc\'e5 Std L Western;}{\f7171\fbidi \fnil\fcharset238\fprq2 @Adobe \'cb\'ce\'cc\'e5 Std L CE;}{\f7172\fbidi \fnil\fcharset204\fprq2 @Adobe \'cb\'ce\'cc\'e5 Std L Cyr;}{\f7183\fbidi \fnil\fcharset0\fprq2 GB18030 Bitmap Western;}{\f7181\fbidi \fnil\fcharset238\fprq2 GB18030 Bitmap CE;}{\f7182\fbidi \fnil\fcharset204\fprq2 GB18030 Bitmap Cyr;}{\f7184\fbidi \fnil\fcharset161\fprq2 GB18030 Bitmap Greek;}{\f7185\fbidi \fnil\fcharset162\fprq2 GB18030 Bitmap Tur;}{\f7188\fbidi \fnil\fcharset186\fprq2 GB18030 Bitmap Baltic;}{\f7193\fbidi \fnil\fcharset0\fprq2 @GB18030 Bitmap Western;}{\f7191\fbidi \fnil\fcharset238\fprq2 @GB18030 Bitmap CE;}{\f7192\fbidi \fnil\fcharset204\fprq2 @GB18030 Bitmap Cyr;}{\f7194\fbidi \fnil\fcharset161\fprq2 @GB18030 Bitmap Greek;}{\f7195\fbidi \fnil\fcharset162\fprq2 @GB18030 Bitmap Tur;}{\f7198\fbidi \fnil\fcharset186\fprq2 @GB18030 Bitmap Baltic;}{\f7203\fbidi \fnil\fcharset0\fprq2 Hannotate SC Bold Western;}{\f7213\fbidi \fnil\fcharset0\fprq2 @Hannotate SC Bold Western;}{\f7223\fbidi \fnil\fcharset0\fprq2 Hannotate SC Regular Western;}{\f7233\fbidi \fnil\fcharset0\fprq2 @Hannotate SC Regular Western;}{\f7243\fbidi \fnil\fcharset0\fprq2 HanziPen SC Bold Western;}{\f7253\fbidi \fnil\fcharset0\fprq2 @HanziPen SC Bold Western;}{\f7263\fbidi \fnil\fcharset0\fprq2 HanziPen SC Regular Western;}{\f7273\fbidi \fnil\fcharset0\fprq2 @HanziPen SC Regular Western;}{\f7343\fbidi \fnil\fcharset0\fprq2 Hiragino Sans GB W3 Western;}{\f7341\fbidi \fnil\fcharset238\fprq2 Hiragino Sans GB W3 CE;}{\f7342\fbidi \fnil\fcharset204\fprq2 Hiragino Sans GB W3 Cyr;}{\f7353\fbidi \fnil\fcharset0\fprq2 @Hiragino Sans GB W3 Western;}{\f7351\fbidi \fnil\fcharset238\fprq2 @Hiragino Sans GB W3 CE;}{\f7352\fbidi \fnil\fcharset204\fprq2 @Hiragino Sans GB W3 Cyr;}{\f7363\fbidi \fnil\fcharset0\fprq2 Hiragino Sans GB W6 Western;}{\f7361\fbidi \fnil\fcharset238\fprq2 Hiragino Sans GB W6 CE;}{\f7362\fbidi \fnil\fcharset204\fprq2 Hiragino Sans GB W6 Cyr;}{\f7373\fbidi \fnil\fcharset0\fprq2 @Hiragino Sans GB W6 Western;}{\f7371\fbidi \fnil\fcharset238\fprq2 @Hiragino Sans GB W6 CE;}{\f7372\fbidi \fnil\fcharset204\fprq2 @Hiragino Sans GB W6 Cyr;}{\f7403\fbidi \fnil\fcharset0\fprq2 Kaiti SC Bold Western;}{\f7401\fbidi \fnil\fcharset238\fprq2 Kaiti SC Bold CE;}{\f7402\fbidi \fnil\fcharset204\fprq2 Kaiti SC Bold Cyr;}{\f7404\fbidi \fnil\fcharset161\fprq2 Kaiti SC Bold Greek;}{\f7405\fbidi \fnil\fcharset162\fprq2 Kaiti SC Bold Tur;}{\f7413\fbidi \fnil\fcharset0\fprq2 @Kaiti SC Bold Western;}{\f7411\fbidi \fnil\fcharset238\fprq2 @Kaiti SC Bold CE;}{\f7412\fbidi \fnil\fcharset204\fprq2 @Kaiti SC Bold Cyr;}{\f7414\fbidi \fnil\fcharset161\fprq2 @Kaiti SC Bold Greek;}{\f7415\fbidi \fnil\fcharset162\fprq2 @Kaiti SC Bold Tur;}{\f7423\fbidi \fnil\fcharset0\fprq2 Kaiti SC Regular Western;}{\f7421\fbidi \fnil\fcharset238\fprq2 Kaiti SC Regular CE;}{\f7422\fbidi \fnil\fcharset204\fprq2 Kaiti SC Regular Cyr;}{\f7424\fbidi \fnil\fcharset161\fprq2 Kaiti SC Regular Greek;}{\f7425\fbidi \fnil\fcharset162\fprq2 Kaiti SC Regular Tur;}{\f7433\fbidi \fnil\fcharset0\fprq2 @Kaiti SC Regular Western;}{\f7431\fbidi \fnil\fcharset238\fprq2 @Kaiti SC Regular CE;}{\f7432\fbidi \fnil\fcharset204\fprq2 @Kaiti SC Regular Cyr;}{\f7434\fbidi \fnil\fcharset161\fprq2 @Kaiti SC Regular Greek;}{\f7435\fbidi \fnil\fcharset162\fprq2 @Kaiti SC Regular Tur;}{\f7443\fbidi \fnil\fcharset0\fprq2 Songti SC Bold Western;}{\f7441\fbidi \fnil\fcharset238\fprq2 Songti SC Bold CE;}{\f7442\fbidi \fnil\fcharset204\fprq2 Songti SC Bold Cyr;}{\f7444\fbidi \fnil\fcharset161\fprq2 Songti SC Bold Greek;}{\f7445\fbidi \fnil\fcharset162\fprq2 Songti SC Bold Tur;}{\f7448\fbidi \fnil\fcharset186\fprq2 Songti SC Bold Baltic;}{\f7453\fbidi \fnil\fcharset0\fprq2 @Songti SC Bold Western;}{\f7451\fbidi \fnil\fcharset238\fprq2 @Songti SC Bold CE;}{\f7452\fbidi \fnil\fcharset204\fprq2 @Songti SC Bold Cyr;}{\f7454\fbidi \fnil\fcharset161\fprq2 @Songti SC Bold Greek;}{\f7455\fbidi \fnil\fcharset162\fprq2 @Songti SC Bold Tur;}{\f7458\fbidi \fnil\fcharset186\fprq2 @Songti SC Bold Baltic;}{\f7463\fbidi \fnil\fcharset0\fprq2 Songti SC Light Western;}{\f7461\fbidi \fnil\fcharset238\fprq2 Songti SC Light CE;}{\f7462\fbidi \fnil\fcharset204\fprq2 Songti SC Light Cyr;}{\f7464\fbidi \fnil\fcharset161\fprq2 Songti SC Light Greek;}{\f7465\fbidi \fnil\fcharset162\fprq2 Songti SC Light Tur;}{\f7473\fbidi \fnil\fcharset0\fprq2 @Songti SC Light Western;}{\f7471\fbidi \fnil\fcharset238\fprq2 @Songti SC Light CE;}{\f7472\fbidi \fnil\fcharset204\fprq2 @Songti SC Light Cyr;}{\f7474\fbidi \fnil\fcharset161\fprq2 @Songti SC Light Greek;}{\f7475\fbidi \fnil\fcharset162\fprq2 @Songti SC Light Tur;}{\f7483\fbidi \fnil\fcharset0\fprq2 Songti SC Regular Western;}{\f7481\fbidi \fnil\fcharset238\fprq2 Songti SC Regular CE;}{\f7482\fbidi \fnil\fcharset204\fprq2 Songti SC Regular Cyr;}{\f7484\fbidi \fnil\fcharset161\fprq2 Songti SC Regular Greek;}{\f7485\fbidi \fnil\fcharset162\fprq2 Songti SC Regular Tur;}{\f7488\fbidi \fnil\fcharset186\fprq2 Songti SC Regular Baltic;}{\f7493\fbidi \fnil\fcharset0\fprq2 @Songti SC Regular Western;}{\f7491\fbidi \fnil\fcharset238\fprq2 @Songti SC Regular CE;}{\f7492\fbidi \fnil\fcharset204\fprq2 @Songti SC Regular Cyr;}{\f7494\fbidi \fnil\fcharset161\fprq2 @Songti SC Regular Greek;}{\f7495\fbidi \fnil\fcharset162\fprq2 @Songti SC Regular Tur;}{\f7498\fbidi \fnil\fcharset186\fprq2 @Songti SC Regular Baltic;}{\f7503\fbidi \fnil\fcharset0\fprq2 Weibei SC Bold Western;}{\f7501\fbidi \fnil\fcharset238\fprq2 Weibei SC Bold CE;}{\f7502\fbidi \fnil\fcharset204\fprq2 Weibei SC Bold Cyr;}{\f7508\fbidi \fnil\fcharset186\fprq2 Weibei SC Bold Baltic;}{\f7509\fbidi \fnil\fcharset163\fprq2 Weibei SC Bold (Vietnamese);}{\f7513\fbidi \fnil\fcharset0\fprq2 @Weibei SC Bold Western;}{\f7511\fbidi \fnil\fcharset238\fprq2 @Weibei SC Bold CE;}{\f7512\fbidi \fnil\fcharset204\fprq2 @Weibei SC Bold Cyr;}{\f7518\fbidi \fnil\fcharset186\fprq2 @Weibei SC Bold Baltic;}{\f7519\fbidi \fnil\fcharset163\fprq2 @Weibei SC Bold (Vietnamese);}{\f7523\fbidi \fnil\fcharset0\fprq2 Yuanti SC Light Western;}{\f7521\fbidi \fnil\fcharset238\fprq2 Yuanti SC Light CE;}{\f7522\fbidi \fnil\fcharset204\fprq2 Yuanti SC Light Cyr;}{\f7524\fbidi \fnil\fcharset161\fprq2 Yuanti SC Light Greek;}{\f7525\fbidi \fnil\fcharset162\fprq2 Yuanti SC Light Tur;}{\f7528\fbidi \fnil\fcharset186\fprq2 Yuanti SC Light Baltic;}{\f7533\fbidi \fnil\fcharset0\fprq2 @Yuanti SC Light Western;}{\f7531\fbidi \fnil\fcharset238\fprq2 @Yuanti SC Light CE;}{\f7532\fbidi \fnil\fcharset204\fprq2 @Yuanti SC Light Cyr;}{\f7534\fbidi \fnil\fcharset161\fprq2 @Yuanti SC Light Greek;}{\f7535\fbidi \fnil\fcharset162\fprq2 @Yuanti SC Light Tur;}{\f7538\fbidi \fnil\fcharset186\fprq2 @Yuanti SC Light Baltic;}{\f7543\fbidi \fnil\fcharset0\fprq2 Yuppy SC Regular Western;}{\f7541\fbidi \fnil\fcharset238\fprq2 Yuppy SC Regular CE;}{\f7542\fbidi \fnil\fcharset204\fprq2 Yuppy SC Regular Cyr;}{\f7553\fbidi \fnil\fcharset0\fprq2 @Yuppy SC Regular Western;}{\f7551\fbidi \fnil\fcharset238\fprq2 @Yuppy SC Regular CE;}{\f7552\fbidi \fnil\fcharset204\fprq2 @Yuppy SC Regular Cyr;}{\f7563\fbidi \fnil\fcharset0\fprq2 \'ba\'da\'cc\'e5 Western;}{\f7573\fbidi \fnil\fcharset0\fprq2 @\'ba\'da\'cc\'e5 Western;}{\f7583\fbidi \fnil\fcharset0\fprq2 \'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Western;}{\f7581\fbidi \fnil\fcharset238\fprq2 \'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce CE;}{\f7582\fbidi \fnil\fcharset204\fprq2 \'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Cyr;}{\f7584\fbidi \fnil\fcharset161\fprq2 \'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Greek;}{\f7585\fbidi \fnil\fcharset162\fprq2 \'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Tur;}{\f7588\fbidi \fnil\fcharset186\fprq2 \'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Baltic;}{\f7593\fbidi \fnil\fcharset0\fprq2 @\'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Western;}{\f7591\fbidi \fnil\fcharset238\fprq2 @\'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce CE;}{\f7592\fbidi \fnil\fcharset204\fprq2 @\'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Cyr;}{\f7594\fbidi \fnil\fcharset161\fprq2 @\'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Greek;}{\f7595\fbidi \fnil\fcharset162\fprq2 @\'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Tur;}{\f7598\fbidi \fnil\fcharset186\fprq2 @\'bb\'aa\'ce\'c4\'b7\'c2\'cb\'ce Baltic;}{\f7603\fbidi \fnil\fcharset0\fprq2 \'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Western;}{\f7601\fbidi \fnil\fcharset238\fprq2 \'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 CE;}{\f7602\fbidi \fnil\fcharset204\fprq2 \'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Cyr;}{\f7604\fbidi \fnil\fcharset161\fprq2 \'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Greek;}{\f7605\fbidi \fnil\fcharset162\fprq2 \'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Tur;}{\f7608\fbidi \fnil\fcharset186\fprq2 \'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Baltic;}{\f7613\fbidi \fnil\fcharset0\fprq2 @\'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Western;}{\f7611\fbidi \fnil\fcharset238\fprq2 @\'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 CE;}{\f7612\fbidi \fnil\fcharset204\fprq2 @\'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Cyr;}{\f7614\fbidi \fnil\fcharset161\fprq2 @\'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Greek;}{\f7615\fbidi \fnil\fcharset162\fprq2 @\'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Tur;}{\f7618\fbidi \fnil\fcharset186\fprq2 @\'bb\'aa\'ce\'c4\'ba\'da\'cc\'e5 Baltic;}{\f7623\fbidi \fnil\fcharset0\fprq2 \'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Western;}{\f7621\fbidi \fnil\fcharset238\fprq2 \'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 CE;}{\f7622\fbidi \fnil\fcharset204\fprq2 \'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Cyr;}{\f7624\fbidi \fnil\fcharset161\fprq2 \'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Greek;}{\f7625\fbidi \fnil\fcharset162\fprq2 \'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Tur;}{\f7633\fbidi \fnil\fcharset0\fprq2 @\'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Western;}{\f7631\fbidi \fnil\fcharset238\fprq2 @\'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 CE;}{\f7632\fbidi \fnil\fcharset204\fprq2 @\'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Cyr;}{\f7634\fbidi \fnil\fcharset161\fprq2 @\'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Greek;}{\f7635\fbidi \fnil\fcharset162\fprq2 @\'bb\'aa\'ce\'c4\'bf\'ac\'cc\'e5 Tur;}{\f7643\fbidi \fnil\fcharset0\fprq2 \'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Western;}{\f7641\fbidi \fnil\fcharset238\fprq2 \'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 CE;}{\f7642\fbidi \fnil\fcharset204\fprq2 \'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Cyr;}{\f7644\fbidi \fnil\fcharset161\fprq2 \'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Greek;}{\f7645\fbidi \fnil\fcharset162\fprq2 \'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Tur;}{\f7653\fbidi \fnil\fcharset0\fprq2 @\'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Western;}{\f7651\fbidi \fnil\fcharset238\fprq2 @\'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 CE;}{\f7652\fbidi \fnil\fcharset204\fprq2 @\'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Cyr;}{\f7654\fbidi \fnil\fcharset161\fprq2 @\'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Greek;}{\f7655\fbidi \fnil\fcharset162\fprq2 @\'bb\'aa\'ce\'c4\'cb\'ce\'cc\'e5 Tur;}{\f7663\fbidi \fnil\fcharset0\fprq2 \'bb\'aa\'ce\'c4\'cf\'b8\'ba\'da Western;}{\f7673\fbidi \fnil\fcharset0\fprq2 @\'bb\'aa\'ce\'c4\'cf\'b8\'ba\'da Western;}{\f7683\fbidi \fnil\fcharset0\fprq2 @\'cb\'ce\'cc\'e5 Western;}{\f7693\fbidi \fnil\fcharset0\fprq2 \'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Western;}{\f7691\fbidi \fnil\fcharset238\fprq2 \'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e CE;}{\f7692\fbidi \fnil\fcharset204\fprq2 \'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Cyr;}{\f7694\fbidi \fnil\fcharset161\fprq2 \'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Greek;}{\f7695\fbidi \fnil\fcharset162\fprq2 \'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Tur;}{\f7698\fbidi \fnil\fcharset186\fprq2 \'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Baltic;}{\f7703\fbidi \fnil\fcharset0\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Western;}{\f7701\fbidi \fnil\fcharset238\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e CE;}{\f7702\fbidi \fnil\fcharset204\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Cyr;}{\f7704\fbidi \fnil\fcharset161\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Greek;}{\f7705\fbidi \fnil\fcharset162\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Tur;}{\f7708\fbidi \fnil\fcharset186\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'83\'53\'83\'56\'83\'62\'83\'4e Baltic;}{\f7713\fbidi \fnil\fcharset0\fprq2 \'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Western;}{\f7711\fbidi \fnil\fcharset238\fprq2 \'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 CE;}{\f7712\fbidi \fnil\fcharset204\fprq2 \'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Cyr;}{\f7714\fbidi \fnil\fcharset161\fprq2 \'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Greek;}{\f7715\fbidi \fnil\fcharset162\fprq2 \'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Tur;}{\f7718\fbidi \fnil\fcharset186\fprq2 \'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Baltic;}{\f7723\fbidi \fnil\fcharset0\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Western;}{\f7721\fbidi \fnil\fcharset238\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 CE;}{\f7722\fbidi \fnil\fcharset204\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Cyr;}{\f7724\fbidi \fnil\fcharset161\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Greek;}{\f7725\fbidi \fnil\fcharset162\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Tur;}{\f7728\fbidi \fnil\fcharset186\fprq2 @\'82\'6c\'82\'72 \'82\'6f\'96\'be\'92\'a9 Baltic;}{\f7733\fbidi \fnil\fcharset0\fprq2 @\'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Western;}{\f7731\fbidi \fnil\fcharset238\fprq2 @\'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e CE;}{\f7732\fbidi \fnil\fcharset204\fprq2 @\'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Cyr;}{\f7734\fbidi \fnil\fcharset161\fprq2 @\'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Greek;}{\f7735\fbidi \fnil\fcharset162\fprq2 @\'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Tur;}{\f7738\fbidi \fnil\fcharset186\fprq2 @\'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Baltic;}{\f7743\fbidi \fnil\fcharset0\fprq2 @\'82\'6c\'82\'72 \'96\'be\'92\'a9 Western;}{\f7741\fbidi \fnil\fcharset238\fprq2 @\'82\'6c\'82\'72 \'96\'be\'92\'a9 CE;}{\f7742\fbidi \fnil\fcharset204\fprq2 @\'82\'6c\'82\'72 \'96\'be\'92\'a9 Cyr;}{\f7744\fbidi \fnil\fcharset161\fprq2 @\'82\'6c\'82\'72 \'96\'be\'92\'a9 Greek;}{\f7745\fbidi \fnil\fcharset162\fprq2 @\'82\'6c\'82\'72 \'96\'be\'92\'a9 Tur;}{\f7748\fbidi \fnil\fcharset186\fprq2 @\'82\'6c\'82\'72 \'96\'be\'92\'a9 Baltic;}{\f7753\fbidi \fnil\fcharset0\fprq2 Osaka Western;}{\f7751\fbidi \fnil\fcharset238\fprq2 Osaka CE;}{\f7755\fbidi \fnil\fcharset162\fprq2 Osaka Tur;}{\f7758\fbidi \fnil\fcharset186\fprq2 Osaka Baltic;}{\f7763\fbidi \fnil\fcharset0\fprq2 @Osaka Western;}{\f7761\fbidi \fnil\fcharset238\fprq2 @Osaka CE;}{\f7765\fbidi \fnil\fcharset162\fprq2 @Osaka Tur;}{\f7768\fbidi \fnil\fcharset186\fprq2 @Osaka Baltic;}{\f7773\fbidi \fnil\fcharset0\fprq2 Osaka\'81\'7c\'93\'99\'95\'9d Western;}{\f7771\fbidi \fnil\fcharset238\fprq2 Osaka\'81\'7c\'93\'99\'95\'9d CE;}{\f7775\fbidi \fnil\fcharset162\fprq2 Osaka\'81\'7c\'93\'99\'95\'9d Tur;}{\f7778\fbidi \fnil\fcharset186\fprq2 Osaka\'81\'7c\'93\'99\'95\'9d Baltic;}{\f7783\fbidi \fnil\fcharset0\fprq2 @Osaka\'81\'7c\'93\'99\'95\'9d Western;}{\f7781\fbidi \fnil\fcharset238\fprq2 @Osaka\'81\'7c\'93\'99\'95\'9d CE;}{\f7785\fbidi \fnil\fcharset162\fprq2 @Osaka\'81\'7c\'93\'99\'95\'9d Tur;}{\f7788\fbidi \fnil\fcharset186\fprq2 @Osaka\'81\'7c\'93\'99\'95\'9d Baltic;}{\f7793\fbidi \fnil\fcharset0\fprq2 YuGothic Bold Western;}{\f7791\fbidi \fnil\fcharset238\fprq2 YuGothic Bold CE;}{\f7792\fbidi \fnil\fcharset204\fprq2 YuGothic Bold Cyr;}{\f7794\fbidi \fnil\fcharset161\fprq2 YuGothic Bold Greek;}{\f7795\fbidi \fnil\fcharset162\fprq2 YuGothic Bold Tur;}{\f7798\fbidi \fnil\fcharset186\fprq2 YuGothic Bold Baltic;}{\f7803\fbidi \fnil\fcharset0\fprq2 @YuGothic Bold Western;}{\f7801\fbidi \fnil\fcharset238\fprq2 @YuGothic Bold CE;}{\f7802\fbidi \fnil\fcharset204\fprq2 @YuGothic Bold Cyr;}{\f7804\fbidi \fnil\fcharset161\fprq2 @YuGothic Bold Greek;}{\f7805\fbidi \fnil\fcharset162\fprq2 @YuGothic Bold Tur;}{\f7808\fbidi \fnil\fcharset186\fprq2 @YuGothic Bold Baltic;}{\f7813\fbidi \fnil\fcharset0\fprq2 YuGothic Medium Western;}{\f7811\fbidi \fnil\fcharset238\fprq2 YuGothic Medium CE;}{\f7812\fbidi \fnil\fcharset204\fprq2 YuGothic Medium Cyr;}{\f7814\fbidi \fnil\fcharset161\fprq2 YuGothic Medium Greek;}{\f7815\fbidi \fnil\fcharset162\fprq2 YuGothic Medium Tur;}{\f7818\fbidi \fnil\fcharset186\fprq2 YuGothic Medium Baltic;}{\f7823\fbidi \fnil\fcharset0\fprq2 @YuGothic Medium Western;}{\f7821\fbidi \fnil\fcharset238\fprq2 @YuGothic Medium CE;}{\f7822\fbidi \fnil\fcharset204\fprq2 @YuGothic Medium Cyr;}{\f7824\fbidi \fnil\fcharset161\fprq2 @YuGothic Medium Greek;}{\f7825\fbidi \fnil\fcharset162\fprq2 @YuGothic Medium Tur;}{\f7828\fbidi \fnil\fcharset186\fprq2 @YuGothic Medium Baltic;}{\f7833\fbidi \fnil\fcharset0\fprq2 YuMincho Demibold Western;}{\f7831\fbidi \fnil\fcharset238\fprq2 YuMincho Demibold CE;}{\f7832\fbidi \fnil\fcharset204\fprq2 YuMincho Demibold Cyr;}{\f7834\fbidi \fnil\fcharset161\fprq2 YuMincho Demibold Greek;}{\f7835\fbidi \fnil\fcharset162\fprq2 YuMincho Demibold Tur;}{\f7838\fbidi \fnil\fcharset186\fprq2 YuMincho Demibold Baltic;}{\f7843\fbidi \fnil\fcharset0\fprq2 @YuMincho Demibold Western;}{\f7841\fbidi \fnil\fcharset238\fprq2 @YuMincho Demibold CE;}{\f7842\fbidi \fnil\fcharset204\fprq2 @YuMincho Demibold Cyr;}{\f7844\fbidi \fnil\fcharset161\fprq2 @YuMincho Demibold Greek;}{\f7845\fbidi \fnil\fcharset162\fprq2 @YuMincho Demibold Tur;}{\f7848\fbidi \fnil\fcharset186\fprq2 @YuMincho Demibold Baltic;}{\f7853\fbidi \fnil\fcharset0\fprq2 YuMincho Medium Western;}{\f7851\fbidi \fnil\fcharset238\fprq2 YuMincho Medium CE;}{\f7852\fbidi \fnil\fcharset204\fprq2 YuMincho Medium Cyr;}{\f7854\fbidi \fnil\fcharset161\fprq2 YuMincho Medium Greek;}{\f7855\fbidi \fnil\fcharset162\fprq2 YuMincho Medium Tur;}{\f7858\fbidi \fnil\fcharset186\fprq2 YuMincho Medium Baltic;}{\f7863\fbidi \fnil\fcharset0\fprq2 @YuMincho Medium Western;}{\f7861\fbidi \fnil\fcharset238\fprq2 @YuMincho Medium CE;}{\f7862\fbidi \fnil\fcharset204\fprq2 @YuMincho Medium Cyr;}{\f7864\fbidi \fnil\fcharset161\fprq2 @YuMincho Medium Greek;}{\f7865\fbidi \fnil\fcharset162\fprq2 @YuMincho Medium Tur;}{\f7868\fbidi \fnil\fcharset186\fprq2 @YuMincho Medium Baltic;}{\f7873\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3 Western;}{\f7872\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3 Cyr;}{\f7874\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3 Greek;}{\f7883\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3 Western;}{\f7882\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3 Cyr;}{\f7884\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W3 Greek;}{\f7893\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6 Western;}{\f7892\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6 Cyr;}{\f7894\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6 Greek;}{\f7903\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6 Western;}{\f7902\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6 Cyr;}{\f7904\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Pro W6 Greek;}{\f7913\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3 Western;}{\f7912\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3 Cyr;}{\f7914\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3 Greek;}{\f7923\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3 Western;}{\f7922\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3 Cyr;}{\f7924\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W3 Greek;}{\f7933\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6 Western;}{\f7932\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6 Cyr;}{\f7934\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6 Greek;}{\f7943\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6 Western;}{\f7942\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6 Cyr;}{\f7944\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 ProN W6 Greek;}{\f7953\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8 Western;}{\f7952\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8 Cyr;}{\f7954\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8 Greek;}{\f7963\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8 Western;}{\f7962\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8 Cyr;}{\f7964\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 Std W8 Greek;}{\f7973\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8 Western;}{\f7972\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8 Cyr;}{\f7974\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8 Greek;}{\f7983\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8 Western;}{\f7982\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8 Cyr;}{\f7984\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'70\'83\'53 StdN W8 Greek;}{\f7993\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4 Western;}{\f7992\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4 Cyr;}{\f7994\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4 Greek;}{\f8003\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4 Western;}{\f8002\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4 Cyr;}{\f8004\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 Pro W4 Greek;}{\f8013\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4 Western;}{\f8012\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4 Cyr;}{\f8014\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4 Greek;}{\f8023\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4 Western;}{\f8022\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4 Cyr;}{\f8024\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'8a\'db\'83\'53 ProN W4 Greek;}{\f8033\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3 Western;}{\f8032\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3 Cyr;}{\f8034\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3 Greek;}{\f8043\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3 Western;}{\f8042\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3 Cyr;}{\f8044\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W3 Greek;}{\f8053\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6 Western;}{\f8052\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6 Cyr;}{\f8054\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6 Greek;}{\f8063\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6 Western;}{\f8062\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6 Cyr;}{\f8064\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 Pro W6 Greek;}{\f8073\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3 Western;}{\f8072\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3 Cyr;}{\f8074\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3 Greek;}{\f8083\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3 Western;}{\f8082\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3 Cyr;}{\f8084\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W3 Greek;}{\f8093\fbidi \fnil\fcharset0\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6 Western;}{\f8092\fbidi \fnil\fcharset204\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6 Cyr;}{\f8094\fbidi \fnil\fcharset161\fprq2 \'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6 Greek;}{\f8103\fbidi \fnil\fcharset0\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6 Western;}{\f8102\fbidi \fnil\fcharset204\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6 Cyr;}{\f8104\fbidi \fnil\fcharset161\fprq2 @\'83\'71\'83\'89\'83\'4d\'83\'6d\'96\'be\'92\'a9 ProN W6 Greek;}{\f8113\fbidi \fnil\fcharset0\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 Western;}{\f8111\fbidi \fnil\fcharset238\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 CE;}{\f8112\fbidi \fnil\fcharset204\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 Cyr;}{\f8114\fbidi \fnil\fcharset161\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 Greek;}{\f8115\fbidi \fnil\fcharset162\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 Tur;}{\f8118\fbidi \fnil\fcharset186\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 Baltic;}{\f8123\fbidi \fnil\fcharset0\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 Western;}{\f8121\fbidi \fnil\fcharset238\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 CE;}{\f8122\fbidi \fnil\fcharset204\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 Cyr;}{\f8124\fbidi \fnil\fcharset161\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 Greek;}{\f8125\fbidi \fnil\fcharset162\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 Tur;}{\f8128\fbidi \fnil\fcharset186\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 Baltic;}{\f8133\fbidi \fnil\fcharset0\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Western;}{\f8131\fbidi \fnil\fcharset238\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e CE;}{\f8132\fbidi \fnil\fcharset204\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Cyr;}{\f8134\fbidi \fnil\fcharset161\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Greek;}{\f8135\fbidi \fnil\fcharset162\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Tur;}{\f8138\fbidi \fnil\fcharset186\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Baltic;}{\f8143\fbidi \fnil\fcharset0\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Western;}{\f8141\fbidi \fnil\fcharset238\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e CE;}{\f8142\fbidi \fnil\fcharset204\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Cyr;}{\f8144\fbidi \fnil\fcharset161\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Greek;}{\f8145\fbidi \fnil\fcharset162\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Tur;}{\f8148\fbidi \fnil\fcharset186\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Baltic;}{\f8153\fbidi \fnil\fcharset0\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Western;}{\f8151\fbidi \fnil\fcharset238\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 CE;}{\f8152\fbidi \fnil\fcharset204\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Cyr;}{\f8154\fbidi \fnil\fcharset161\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Greek;}{\f8155\fbidi \fnil\fcharset162\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Tur;}{\f8158\fbidi \fnil\fcharset186\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Baltic;}{\f8163\fbidi \fnil\fcharset0\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Western;}{\f8161\fbidi \fnil\fcharset238\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 CE;}{\f8162\fbidi \fnil\fcharset204\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Cyr;}{\f8164\fbidi \fnil\fcharset161\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Greek;}{\f8165\fbidi \fnil\fcharset162\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Tur;}{\f8168\fbidi \fnil\fcharset186\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 Baltic;}{\f8173\fbidi \fnil\fcharset0\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Western;}{\f8171\fbidi \fnil\fcharset238\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e CE;}{\f8172\fbidi \fnil\fcharset204\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Cyr;}{\f8174\fbidi \fnil\fcharset161\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Greek;}{\f8175\fbidi \fnil\fcharset162\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Tur;}{\f8178\fbidi \fnil\fcharset186\fprq2 \'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Baltic;}{\f8183\fbidi \fnil\fcharset0\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Western;}{\f8181\fbidi \fnil\fcharset238\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e CE;}{\f8182\fbidi \fnil\fcharset204\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Cyr;}{\f8184\fbidi \fnil\fcharset161\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Greek;}{\f8185\fbidi \fnil\fcharset162\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Tur;}{\f8188\fbidi \fnil\fcharset186\fprq2 @\'83\'81\'83\'43\'83\'8a\'83\'49 \'83\'7b\'81\'5b\'83\'8b\'83\'68 \'83\'43\'83\'5e\'83\'8a\'83\'62\'83\'4e Baltic;}{\f8193\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Western;}{\f8191\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B CE;}{\f8192\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Cyr;}{\f8194\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Greek;}{\f8195\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Tur;}{\f8198\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Baltic;}{\f8203\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Western;}{\f8201\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B CE;}{\f8202\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Cyr;}{\f8204\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Greek;}{\f8205\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Tur;}{\f8208\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N B Baltic;}{\f8213\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Western;}{\f8211\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL CE;}{\f8212\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Cyr;}{\f8214\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Greek;}{\f8215\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Tur;}{\f8218\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Baltic;}{\f8223\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Western;}{\f8221\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL CE;}{\f8222\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Cyr;}{\f8224\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Greek;}{\f8225\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Tur;}{\f8228\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N EL Baltic;}{\f8233\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Western;}{\f8231\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H CE;}{\f8232\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Cyr;}{\f8234\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Greek;}{\f8235\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Tur;}{\f8238\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Baltic;}{\f8243\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Western;}{\f8241\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H CE;}{\f8242\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Cyr;}{\f8244\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Greek;}{\f8245\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Tur;}{\f8248\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N H Baltic;}{\f8253\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Western;}{\f8251\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L CE;}{\f8252\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Cyr;}{\f8254\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Greek;}{\f8255\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Tur;}{\f8258\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Baltic;}{\f8263\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Western;}{\f8261\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L CE;}{\f8262\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Cyr;}{\f8264\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Greek;}{\f8265\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Tur;}{\f8268\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N L Baltic;}{\f8273\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Western;}{\f8271\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M CE;}{\f8272\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Cyr;}{\f8274\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Greek;}{\f8275\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Tur;}{\f8278\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Baltic;}{\f8283\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Western;}{\f8281\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M CE;}{\f8282\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Cyr;}{\f8284\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Greek;}{\f8285\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Tur;}{\f8288\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N M Baltic;}{\f8293\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Western;}{\f8291\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R CE;}{\f8292\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Cyr;}{\f8294\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Greek;}{\f8295\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Tur;}{\f8298\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Baltic;}{\f8303\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Western;}{\f8301\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R CE;}{\f8302\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Cyr;}{\f8304\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Greek;}{\f8305\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Tur;}{\f8308\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pr6N R Baltic;}{\f8313\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro B Western;}{\f8312\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro B Cyr;}{\f8323\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro B Western;}{\f8322\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro B Cyr;}{\f8333\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro EL Western;}{\f8332\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro EL Cyr;}{\f8343\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro EL Western;}{\f8342\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro EL Cyr;}{\f8353\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro H Western;}{\f8352\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro H Cyr;}{\f8363\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro H Western;}{\f8362\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro H Cyr;}{\f8373\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro L Western;}{\f8372\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro L Cyr;}{\f8383\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro L Western;}{\f8382\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro L Cyr;}{\f8393\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro M Western;}{\f8392\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro M Cyr;}{\f8403\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro M Western;}{\f8402\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro M Cyr;}{\f8413\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro R Western;}{\f8412\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro R Cyr;}{\f8423\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro R Western;}{\f8422\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'83\'53\'83\'56\'83\'62\'83\'4e Pro R Cyr;}{\f8433\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Western;}{\f8431\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B CE;}{\f8432\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Cyr;}{\f8434\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Greek;}{\f8435\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Tur;}{\f8438\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Baltic;}{\f8443\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Western;}{\f8441\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B CE;}{\f8442\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Cyr;}{\f8444\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Greek;}{\f8445\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Tur;}{\f8448\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N B Baltic;}{\f8453\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Western;}{\f8451\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL CE;}{\f8452\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Cyr;}{\f8454\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Greek;}{\f8455\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Tur;}{\f8458\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Baltic;}{\f8463\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Western;}{\f8461\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL CE;}{\f8462\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Cyr;}{\f8464\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Greek;}{\f8465\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Tur;}{\f8468\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N EL Baltic;}{\f8473\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Western;}{\f8471\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H CE;}{\f8472\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Cyr;}{\f8474\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Greek;}{\f8475\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Tur;}{\f8478\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Baltic;}{\f8483\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Western;}{\f8481\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H CE;}{\f8482\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Cyr;}{\f8484\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Greek;}{\f8485\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Tur;}{\f8488\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N H Baltic;}{\f8493\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Western;}{\f8491\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L CE;}{\f8492\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Cyr;}{\f8494\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Greek;}{\f8495\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Tur;}{\f8498\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Baltic;}{\f8503\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Western;}{\f8501\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L CE;}{\f8502\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Cyr;}{\f8504\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Greek;}{\f8505\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Tur;}{\f8508\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N L Baltic;}{\f8511\fbidi \fnil\fcharset238\fprq2 \'e8\'a8\'ed\'c0\'f1\'e6\'ed\'a9 Pr6N M CE;}{\f8512\fbidi \fnil\fcharset204\fprq2 \'e8\'a8\'ed\'c0\'f1\'e6\'ed\'a9 Pr6N M Cyr;}{\f8514\fbidi \fnil\fcharset161\fprq2 \'e8\'a8\'ed\'c0\'f1\'e6\'ed\'a9 Pr6N M Greek;}{\f8515\fbidi \fnil\fcharset162\fprq2 \'e8\'a8\'ed\'c0\'f1\'e6\'ed\'a9 Pr6N M Tur;}{\f8518\fbidi \fnil\fcharset186\fprq2 \'e8\'a8\'ed\'c0\'f1\'e6\'ed\'a9 Pr6N M Baltic;}{\f8523\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Western;}{\f8521\fbidi \fnil\fcharset238\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R CE;}{\f8522\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Cyr;}{\f8524\fbidi \fnil\fcharset161\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Greek;}{\f8525\fbidi \fnil\fcharset162\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Tur;}{\f8528\fbidi \fnil\fcharset186\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Baltic;}{\f8533\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Western;}{\f8531\fbidi \fnil\fcharset238\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R CE;}{\f8532\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Cyr;}{\f8534\fbidi \fnil\fcharset161\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Greek;}{\f8535\fbidi \fnil\fcharset162\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Tur;}{\f8538\fbidi \fnil\fcharset186\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pr6N R Baltic;}{\f8543\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro B Western;}{\f8542\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro B Cyr;}{\f8553\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro B Western;}{\f8552\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro B Cyr;}{\f8563\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro EL Western;}{\f8562\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro EL Cyr;}{\f8573\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro EL Western;}{\f8572\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro EL Cyr;}{\f8583\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro H Western;}{\f8582\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro H Cyr;}{\f8593\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro H Western;}{\f8592\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro H Cyr;}{\f8603\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro L Western;}{\f8602\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro L Cyr;}{\f8613\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro L Western;}{\f8612\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro L Cyr;}{\f8623\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro M Western;}{\f8622\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro M Cyr;}{\f8633\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro M Western;}{\f8632\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro M Cyr;}{\f8643\fbidi \fnil\fcharset0\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro R Western;}{\f8642\fbidi \fnil\fcharset204\fprq2 \'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro R Cyr;}{\f8653\fbidi \fnil\fcharset0\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro R Western;}{\f8652\fbidi \fnil\fcharset204\fprq2 @\'8f\'ac\'92\'cb\'96\'be\'92\'a9 Pro R Cyr;}{\f8663\fbidi \fnil\fcharset0\fprq2 Adobe \'b0\'ed\'b5\'f1 Std B Western;}{\f8662\fbidi \fnil\fcharset204\fprq2 Adobe \'b0\'ed\'b5\'f1 Std B Cyr;}{\f8673\fbidi \fnil\fcharset0\fprq2 @Adobe \'b0\'ed\'b5\'f1 Std B Western;}{\f8672\fbidi \fnil\fcharset204\fprq2 @Adobe \'b0\'ed\'b5\'f1 Std B Cyr;}{\f8683\fbidi \fnil\fcharset0\fprq2 Adobe \'b8\'ed\'c1\'b6 Std M Western;}{\f8682\fbidi \fnil\fcharset204\fprq2 Adobe \'b8\'ed\'c1\'b6 Std M Cyr;}{\f8693\fbidi \fnil\fcharset0\fprq2 @Adobe \'b8\'ed\'c1\'b6 Std M Western;}{\f8692\fbidi \fnil\fcharset204\fprq2 @Adobe \'b8\'ed\'c1\'b6 Std M Cyr;}{\f8703\fbidi \fnil\fcharset0\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'b9\'ab\'b0\'c5\'bf\'ee Western;}{\f8702\fbidi \fnil\fcharset204\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'b9\'ab\'b0\'c5\'bf\'ee Cyr;}{\f8713\fbidi \fnil\fcharset0\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'b9\'ab\'b0\'c5\'bf\'ee Western;}{\f8712\fbidi \fnil\fcharset204\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'b9\'ab\'b0\'c5\'bf\'ee Cyr;}{\f8723\fbidi \fnil\fcharset0\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'ba\'bc\'b5\'e5\'c3\'bc Western;}{\f8722\fbidi \fnil\fcharset204\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'ba\'bc\'b5\'e5\'c3\'bc Cyr;}{\f8733\fbidi \fnil\fcharset0\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'ba\'bc\'b5\'e5\'c3\'bc Western;}{\f8732\fbidi \fnil\fcharset204\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'ba\'bc\'b5\'e5\'c3\'bc Cyr;}{\f8743\fbidi \fnil\fcharset0\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'be\'e3\'c0\'ba\'c3\'bc Western;}{\f8742\fbidi \fnil\fcharset204\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'be\'e3\'c0\'ba\'c3\'bc Cyr;}{\f8753\fbidi \fnil\fcharset0\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'be\'e3\'c0\'ba\'c3\'bc Western;}{\f8752\fbidi \fnil\fcharset204\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'be\'e3\'c0\'ba\'c3\'bc Cyr;}{\f8763\fbidi \fnil\fcharset0\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'bf\'b6\'c0\'ba\'c3\'bc Western;}{\f8762\fbidi \fnil\fcharset204\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'bf\'b6\'c0\'ba\'c3\'bc Cyr;}{\f8773\fbidi \fnil\fcharset0\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'bf\'b6\'c0\'ba\'c3\'bc Western;}{\f8772\fbidi \fnil\fcharset204\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'bf\'b6\'c0\'ba\'c3\'bc Cyr;}{\f8783\fbidi \fnil\fcharset0\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c0\'cf\'b9\'dd\'c3\'bc Western;}{\f8782\fbidi \fnil\fcharset204\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c0\'cf\'b9\'dd\'c3\'bc Cyr;}{\f8793\fbidi \fnil\fcharset0\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c0\'cf\'b9\'dd\'c3\'bc Western;}{\f8792\fbidi \fnil\fcharset204\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c0\'cf\'b9\'dd\'c3\'bc Cyr;}{\f8803\fbidi \fnil\fcharset0\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c1\'df\'b0\'a3\'c3\'bc Western;}{\f8802\fbidi \fnil\fcharset204\fprq2 Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c1\'df\'b0\'a3\'c3\'bc Cyr;}{\f8813\fbidi \fnil\fcharset0\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c1\'df\'b0\'a3\'c3\'bc Western;}{\f8812\fbidi \fnil\fcharset204\fprq2 @Apple SD \'bb\'ea\'b5\'b9\'b0\'ed\'b5\'f1 Neo \'c1\'df\'b0\'a3\'c3\'bc Cyr;}{\f8883\fbidi \fnil\fcharset0\fprq2 \'b1\'bc\'b8\'b2 Western;}{\f8881\fbidi \fnil\fcharset238\fprq2 \'b1\'bc\'b8\'b2 CE;}{\f8882\fbidi \fnil\fcharset204\fprq2 \'b1\'bc\'b8\'b2 Cyr;}{\f8884\fbidi \fnil\fcharset161\fprq2 \'b1\'bc\'b8\'b2 Greek;}{\f8885\fbidi \fnil\fcharset162\fprq2 \'b1\'bc\'b8\'b2 Tur;}{\f8888\fbidi \fnil\fcharset186\fprq2 \'b1\'bc\'b8\'b2 Baltic;}{\f8893\fbidi \fnil\fcharset0\fprq2 @\'b1\'bc\'b8\'b2 Western;}{\f8891\fbidi \fnil\fcharset238\fprq2 @\'b1\'bc\'b8\'b2 CE;}{\f8892\fbidi \fnil\fcharset204\fprq2 @\'b1\'bc\'b8\'b2 Cyr;}{\f8894\fbidi \fnil\fcharset161\fprq2 @\'b1\'bc\'b8\'b2 Greek;}{\f8895\fbidi \fnil\fcharset162\fprq2 @\'b1\'bc\'b8\'b2 Tur;}{\f8898\fbidi \fnil\fcharset186\fprq2 @\'b1\'bc\'b8\'b2 Baltic;}{\f8923\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 Western;}{\f8933\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 Western;}{\f8943\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 Bold Western;}{\f8953\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 Bold Western;}{\f8963\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 ExtraBold Western;}{\f8973\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'b0\'ed\'b5\'f1 ExtraBold Western;}{\f8983\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 Western;}{\f8993\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 Western;}{\f9003\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 Bold Western;}{\f9013\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 Bold Western;}{\f9023\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 ExtraBold Western;}{\f9033\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'b8\'ed\'c1\'b6 ExtraBold Western;}{\f9043\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'ba\'d7 Western;}{\f9053\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'ba\'d7 Western;}{\f9063\fbidi \fnil\fcharset0\fprq2 \'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'c6\'e6 Western;}{\f9073\fbidi \fnil\fcharset0\fprq2 @\'b3\'aa\'b4\'ae\'bc\'d5\'b1\'db\'be\'be \'c6\'e6 Western;}{\f9083\fbidi \fnil\fcharset0\fprq2 @\'b9\'d9\'c5\'c1 Western;}{\f9081\fbidi \fnil\fcharset238\fprq2 @\'b9\'d9\'c5\'c1 CE;}{\f9082\fbidi \fnil\fcharset204\fprq2 @\'b9\'d9\'c5\'c1 Cyr;}{\f9084\fbidi \fnil\fcharset161\fprq2 @\'b9\'d9\'c5\'c1 Greek;}{\f9085\fbidi \fnil\fcharset162\fprq2 @\'b9\'d9\'c5\'c1 Tur;}{\f9088\fbidi \fnil\fcharset186\fprq2 @\'b9\'d9\'c5\'c1 Baltic;}{\flomajor\f31508\fbidi \fnil\fcharset238\fprq2 Arial CE;}{\flomajor\f31509\fbidi \fnil\fcharset204\fprq2 Arial Cyr;}{\flomajor\f31511\fbidi \fnil\fcharset161\fprq2 Arial Greek;}{\flomajor\f31512\fbidi \fnil\fcharset162\fprq2 Arial Tur;}{\flomajor\f31513\fbidi \fnil\fcharset177\fprq2 Arial (Hebrew);}{\flomajor\f31514\fbidi \fnil\fcharset178\fprq2 Arial (Arabid);}{\flomajor\f31515\fbidi \fnil\fcharset186\fprq2 Arial Baltic;}{\flomajor\f31516\fbidi \fnil\fcharset163\fprq2 Arial (Vietnamese);}{\fdbmajor\f31520\fbidi \fnil\fcharset0\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Western;}{\fdbmajor\f31518\fbidi \fnil\fcharset238\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e CE;}{\fdbmajor\f31519\fbidi \fnil\fcharset204\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Cyr;}{\fdbmajor\f31521\fbidi \fnil\fcharset161\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Greek;}{\fdbmajor\f31522\fbidi \fnil\fcharset162\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Tur;}{\fdbmajor\f31525\fbidi \fnil\fcharset186\fprq2 \'82\'6c\'82\'72 \'83\'53\'83\'56\'83\'62\'83\'4e Baltic;}{\fhimajor\f31528\fbidi \fnil\fcharset238\fprq2 Calibri CE;}{\fhimajor\f31529\fbidi \fnil\fcharset204\fprq2 Calibri Cyr;}{\fhimajor\f31531\fbidi \fnil\fcharset161\fprq2 Calibri Greek;}{\fhimajor\f31532\fbidi \fnil\fcharset162\fprq2 Calibri Tur;}{\fhimajor\f31535\fbidi \fnil\fcharset186\fprq2 Calibri Baltic;}{\fhimajor\f31536\fbidi \fnil\fcharset163\fprq2 Calibri (Vietnamese);}{\fbimajor\f31538\fbidi \fnil\fcharset238\fprq2 Times New Roman CE;}{\fbimajor\f31539\fbidi \fnil\fcharset204\fprq2 Times New Roman Cyr;}{\fbimajor\f31541\fbidi \fnil\fcharset161\fprq2 Times New Roman Greek;}{\fbimajor\f31542\fbidi \fnil\fcharset162\fprq2 Times New Roman Tur;}{\fbimajor\f31543\fbidi \fnil\fcharset177\fprq2 Times New Roman (Hebrew);}{\fbimajor\f31544\fbidi \fnil\fcharset178\fprq2 Times New Roman (Arabid);}{\fbimajor\f31545\fbidi \fnil\fcharset186\fprq2 Times New Roman Baltic;}{\fbimajor\f31546\fbidi \fnil\fcharset163\fprq2 Times New Roman (Vietnamese);}{\flominor\f31548\fbidi \fnil\fcharset238\fprq2 Times New Roman CE;}{\flominor\f31549\fbidi \fnil\fcharset204\fprq2 Times New Roman Cyr;}{\flominor\f31551\fbidi \fnil\fcharset161\fprq2 Times New Roman Greek;}{\flominor\f31552\fbidi \fnil\fcharset162\fprq2 Times New Roman Tur;}{\flominor\f31553\fbidi \fnil\fcharset177\fprq2 Times New Roman (Hebrew);}{\flominor\f31554\fbidi \fnil\fcharset178\fprq2 Times New Roman (Arabid);}{\flominor\f31555\fbidi \fnil\fcharset186\fprq2 Times New Roman Baltic;}{\flominor\f31556\fbidi \fnil\fcharset163\fprq2 Times New Roman (Vietnamese);}{\fdbminor\f31560\fbidi \fnil\fcharset0\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Western;}{\fdbminor\f31558\fbidi \fnil\fcharset238\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 CE;}{\fdbminor\f31559\fbidi \fnil\fcharset204\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Cyr;}{\fdbminor\f31561\fbidi \fnil\fcharset161\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Greek;}{\fdbminor\f31562\fbidi \fnil\fcharset162\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Tur;}{\fdbminor\f31565\fbidi \fnil\fcharset186\fprq2 \'82\'6c\'82\'72 \'96\'be\'92\'a9 Baltic;}{\fhiminor\f31568\fbidi \fnil\fcharset238\fprq2 Cambria CE;}{\fhiminor\f31569\fbidi \fnil\fcharset204\fprq2 Cambria Cyr;}{\fhiminor\f31571\fbidi \fnil\fcharset161\fprq2 Cambria Greek;}{\fhiminor\f31572\fbidi \fnil\fcharset162\fprq2 Cambria Tur;}{\fhiminor\f31575\fbidi \fnil\fcharset186\fprq2 Cambria Baltic;}{\fhiminor\f31576\fbidi \fnil\fcharset163\fprq2 Cambria (Vietnamese);}{\fbiminor\f31578\fbidi \fnil\fcharset238\fprq2 Times New Roman CE;}{\fbiminor\f31579\fbidi \fnil\fcharset204\fprq2 Times New Roman Cyr;}{\fbiminor\f31581\fbidi \fnil\fcharset161\fprq2 Times New Roman Greek;}{\fbiminor\f31582\fbidi \fnil\fcharset162\fprq2 Times New Roman Tur;}{\fbiminor\f31583\fbidi \fnil\fcharset177\fprq2 Times New Roman (Hebrew);}{\fbiminor\f31584\fbidi \fnil\fcharset178\fprq2 Times New Roman (Arabid);}{\fbiminor\f31585\fbidi \fnil\fcharset186\fprq2 Times New Roman Baltic;}{\fbiminor\f31586\fbidi \fnil\fcharset163\fprq2 Times New Roman (Vietnamese);}}{\colortbl;\red0\green0\blue0;\red0\green0\blue255;\red0\green255\blue255;\red0\green255\blue0;\red255\green0\blue255;\red255\green0\blue0;\red255\green255\blue0;\red255\green255\blue255;\red0\green0\blue128;\red0\green128\blue128;\red0\green128\blue0;\red128\green0\blue128;\red128\green0\blue0;\red128\green128\blue0;\red128\green128\blue128;\red192\green192\blue192;\red235\green235\blue216;\red204\green0\blue51;}{\*\defchp }{\*\defpap \ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 }\noqfpromote {\stylesheet{\ql \li0\ri0\nowidctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 \snext0 \sqformat \spriority0 Normal;}{\*\cs10 \additive \ssemihidden \sunhideused \spriority1 Default Paragraph Font;}{\*\ts11\tsrowd\trftsWidthB3\trpaddl108\trpaddr108\trpaddfl3\trpaddft3\trpaddfb3\trpaddfr3\tblind0\tblindtype3\tsvertalt\tsbrdrt\tsbrdrl\tsbrdrb\tsbrdrr\tsbrdrdgl\tsbrdrdgr\tsbrdrh\tsbrdrv \ql \li0\ri0\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 \snext11 \ssemihidden \sunhideused Normal Table;}}{\*\revtbl {Unknown;}}{\*\rsidtbl \rsid4002276\rsid10175759\rsid15420928}{\mmathPr\mmathFont34\mbrkBin0\mbrkBinSub0\msmallFrac0\mdispDef1\mlMargin0\mrMargin0\mdefJc1\mwrapIndent1440\mintLim0\mnaryLim1}{\info{\operator Duco Wiertsema}{\creatim\yr2013\mo11\dy26\hr10\min34}{\revtim\yr2013\mo11\dy26\hr11\min57}{\version3}{\edmins40}{\nofpages145}{\nofwords64679}{\nofchars368671}{\nofcharsws432486}{\vern49555}{\*\saveprevpict}}{\*\xmlnstbl {\xmlns1 http://schemas.microsoft.com/office/word/2003/wordml}}\paperw12240\paperh15840\margl1296\margr1296\margt1728\margb1296\gutter0\ltrsect \ftnbj\aenddoc\trackmoves0\trackformatting1\donotembedsysfont0\relyonvml0\donotembedlingdata1\grfdocevents0\validatexml0\showplaceholdtext0\ignoremixedcontent0\saveinvalidxml0\showxmlerrors0\hyphauto1\horzdoc\dghspace120\dgvspace120\dghorigin1701\dgvorigin1984\dghshow0\dgvshow3\jcompress\viewkind1\viewscale140\rsidroot4002276\outdisponlyhtml \fet0{\*\wgrffmtfilter 2450}\ilfomacatclnup0{\*\ftnsep \ltrpar \pard\plain \ltrpar\ql \li0\ri0\nowidctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af0 \ltrch\fcs0 \insrsid10175759 \chftnsep \par }}{\*\ftnsepc \ltrpar \pard\plain \ltrpar\ql \li0\ri0\nowidctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af0 \ltrch\fcs0 \insrsid10175759 \chftnsepc \par }}{\*\aftnsep \ltrpar \pard\plain \ltrpar\ql \li0\ri0\nowidctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af0 \ltrch\fcs0 \insrsid10175759 \chftnsep \par }}{\*\aftnsepc \ltrpar \pard\plain \ltrpar\ql \li0\ri0\nowidctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af0 \ltrch\fcs0 \insrsid10175759 \chftnsepc \par }}\ltrpar \sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}{\*\pnseclvl1\pnucrm\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl2\pnucltr\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl3\pndec\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl4\pnlcltr\pnstart1\pnindent720\pnhang {\pntxta )}}{\*\pnseclvl5\pndec\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl6\pnlcltr\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl7\pnlcrm\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl8\pnlcltr\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl9\pnlcrm\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}\ltrrow\trowd \irow0\irowband0\ltrrow\ts11\trgaph60\trleft-60\trhdr\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \clcfpat17\clcbpat17\clshdng10000\cltxlrtb\clftsWidth3\clwWidth540\clcbpatraw17\clcfpatraw17\clshdngraw10000 \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \clcfpat17\clcbpat17\clshdng10000\cltxlrtb\clftsWidth3\clwWidth9180\clcbpatraw17\clcfpatraw17\clshdngraw10000 \cellx9660\pard\plain \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_1_0}{\*\bkmkstart cite_id_1}{\*\bkmkend DOC_ID_1_0}{\*\bkmkend cite_id_1} \cell Results\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\ltrrow\ts11\trgaph60\trleft-60\trhdr\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \clcfpat17\clcbpat17\clshdng10000\cltxlrtb\clftsWidth3\clwWidth540\clcbpatraw17\clcfpatraw17\clshdngraw10000 \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \clcfpat17\clcbpat17\clshdng10000\cltxlrtb\clftsWidth3\clwWidth9180\clcbpatraw17\clcfpatraw17\clshdngraw10000 \cellx9660\row \ltrrow}\trowd \irow1\irowband1\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 1.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_1"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0031000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Indian pharma firms go shopping abroad;  They are acquiring Western companies to overcome the restrictions of a new patent regime}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   The Business Times Singapore, May 25, 2006 Thursday, VIEWS AND OPINIONS; BT Comment Others, 1125  words, Yogi Aggarwal\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow1\irowband1\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_2_0}{\*\bkmkstart cite_id_2}{\*\bkmkend DOC_ID_2_0}{\*\bkmkend cite_id_2}2.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_2"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0032000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 U.S. pushes to limit generic drug rights;  Agreements seek to extend monopolies in exchange for improvements in trade}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   The International Herald Tribune, April 19, 2006 Wednesday, NEWS; Pg. 1, 1610 words, Anand Giridharadas\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_3_0}{\*\bkmkstart cite_id_3}{\*\bkmkend DOC_ID_3_0}{\*\bkmkend cite_id_3}3.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_3"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0033000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 U.S. pushes to limit generic-drug rights in trade pacts}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   The International Herald Tribune, April 19, 2006 Wednesday, FINANCE; Pg. 13, 1381 words, Anand Giridharadas\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_4_0}{\*\bkmkstart cite_id_4}{\*\bkmkend DOC_ID_4_0}{\*\bkmkend cite_id_4}4.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_4"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0034000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 HIV-Aids and STDs; Global Aids Treatment Drive Takes Off}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  Africa News, April 28, 2005 Thursday, 3207 words, Africa Renewal\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_5_0}{\*\bkmkstart cite_id_5}{\*\bkmkend DOC_ID_5_0}{\*\bkmkend cite_id_5}5.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_5"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0035000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Is it the end of cheap drugs from India?; Medicine prices may soar in a few years as the country can no longer make generic drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  The Business Times Singapore, April 12, 2005 Tuesday, VIEWS AND OPINIONS; BT Comment Others, 1347 words, Yogi Aggarwal\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_6_0}{\*\bkmkstart cite_id_6}{\*\bkmkend DOC_ID_6_0}{\*\bkmkend cite_id_6}6.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_6"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0036000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 PanAfrica; New Law in India Drives Up Africa's Cost of Halting Aids}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  Africa News, March 29, 2005 Tuesday, 752 words, Business Day\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_7_0}{\*\bkmkstart cite_id_7}{\*\bkmkend DOC_ID_7_0}{\*\bkmkend cite_id_7}7.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_7"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0037000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Zambia; India's Cheap Medicines}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  Africa News, March 29, 2005 Tuesday, 776 words, The Post\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_8_0}{\*\bkmkstart cite_id_8}{\*\bkmkend DOC_ID_8_0}{\*\bkmkend cite_id_8}8.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_8"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0038000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 PanAfrica; Goodbye to Cheap Indian Aids Drugs?}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  Africa News, November 26, 2004 Friday, 1225 words, Inter Press Service\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_9_0}{\*\bkmkstart cite_id_9}{\*\bkmkend DOC_ID_9_0}{\*\bkmkend cite_id_9}9.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_9"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000900000064006f0063005f00690064005f0039000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 PanAfrica; Daily HIV/Aids Report}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  Africa News, July 13, 2004 Tuesday, 11362 words, Kaisernetwork.org\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_10_0}{\*\bkmkstart cite_id_10}{\*\bkmkend DOC_ID_10_0}{\*\bkmkend cite_id_10}10.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_10"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310030000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 AIDS; Daily HIV/Aids Report}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  Africa News, July 7, 2004 Wednesday, 4531 words, Kaisernetwork.org\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_11_0}{\*\bkmkstart cite_id_11}{\*\bkmkend DOC_ID_11_0}{\*\bkmkend cite_id_11}11.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_11"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310031000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Indian drug firms stand to gain much from WTO talks; Potential to carve out slice of US$15b US generics market}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  The Business Times Singapore, June 7, 2004 Monday, THE NEWS; South Asia, 632 words, Yogi Aggarwal in Bombay\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_12_0}{\*\bkmkstart cite_id_12}{\*\bkmkend DOC_ID_12_0}{\*\bkmkend cite_id_12}12.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_12"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310032000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 WTO drug deal to spark competition}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  The Business Times Singapore, September 2, 2003 Tuesday, THE NEWS; World, 610 words, By RAVI KANTH IN GENEVA\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_13_0}{\*\bkmkstart cite_id_13}{\*\bkmkend DOC_ID_13_0}{\*\bkmkend cite_id_13}13.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_13"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310033000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Cheap drug plan founders}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   The Globe and Mail (Canada), August 30, 2003 Saturday, REPORT ON BUSINESS: INTERNATIONAL; Pg. B6, 544 words, WARREN GILES, Bloomberg News\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_14_0}{\*\bkmkstart cite_id_14}{\*\bkmkend DOC_ID_14_0}{\*\bkmkend cite_id_14}14.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_14"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310034000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Proposed WTO deal set to bring hope to poorer nations; It calls for relaxing patent provisions, issuing of licences to producers in poorer nations}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  The Business Times Singapore, August 29, 2003 Friday, THE NEWS; World, 416 words, Ravi Kanth\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_15_0}{\*\bkmkstart cite_id_15}{\*\bkmkend DOC_ID_15_0}{\*\bkmkend cite_id_15}15.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_15"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310035000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Last-minute deal on cheap drugs: Late deal on cheap drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  The Guardian (London), August 28, 2003, Guardian Home Pages, Pg. 1, 757 words, Charlotte Denny and Sarah Boseley\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_16_0}{\*\bkmkstart cite_id_16}{\*\bkmkend DOC_ID_16_0}{\*\bkmkend cite_id_16}16.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_16"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310036000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Americans seeking pledges on drug rules}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  The Toronto Star, August 26, 2003 Tuesday, 238 words, Warren Giles, Bloomberg News\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_17_0}{\*\bkmkstart cite_id_17}{\*\bkmkend DOC_ID_17_0}{\*\bkmkend cite_id_17}17.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_17"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310037000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Uganda; 3 Firms to Supply Cheap Aids Drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  Africa News, May 8, 2003 Thursday, 363 words, The Monitor\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_18_0}{\*\bkmkstart cite_id_18}{\*\bkmkend DOC_ID_18_0}{\*\bkmkend cite_id_18}18.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_18"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310038000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 PanAfrica; Aids: Even With Discounts from Drug Firms, Generics Remain Far Cheaper}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  Africa News, May 5, 2003 Monday, 1233 words, The East African\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_19_0}{\*\bkmkstart cite_id_19}{\*\bkmkend DOC_ID_19_0}{\*\bkmkend cite_id_19}19.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_19"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00310039000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Saving grace: Yusuf Hamied Generic drugs boss: He says he could save millions from death if the western giants would waive their patent rights and more governments would buy his drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  The Guardian (London), February 18, 2003, Guardian Special Supplement, Pg. 8, 1353 words\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_20_0}{\*\bkmkstart cite_id_20}{\*\bkmkend DOC_ID_20_0}{\*\bkmkend cite_id_20}20.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_20"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320030000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Nigeria; Problems Dog Abuja's ARV Programme}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  Africa News, April 5, 2002 Friday, 1856 words, Access Alert\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_21_0}{\*\bkmkstart cite_id_21}{\*\bkmkend DOC_ID_21_0}{\*\bkmkend cite_id_21}21.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_21"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320031000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 PanAfrica; U.S. Post-Doha Conditions Can Kill}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  Africa News, March 4, 2002 Monday, 3501 words, Health Gap\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_22_0}{\*\bkmkstart cite_id_22}{\*\bkmkend DOC_ID_22_0}{\*\bkmkend cite_id_22}22.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_22"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320032000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 South Africa; US Gives Licence to Ignore Patents}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  Africa News, November 5, 2001 Monday, 539 words, Business Day\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_23_0}{\*\bkmkstart cite_id_23}{\*\bkmkend DOC_ID_23_0}{\*\bkmkend cite_id_23}23.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_23"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320033000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Co-operation, not coercion, to improve drug access}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  National Post (Canada), July 09, 2001 Monday, 886 words, Owen Lippert;Owen Lippert is a senior fellow of The Fraser Institute and lives in Santiago, Chile.\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_24_0}{\*\bkmkstart cite_id_24}{\*\bkmkend DOC_ID_24_0}{\*\bkmkend cite_id_24}24.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_24"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320034000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Kenya; Country to Feature in WTO Talks}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   Africa News, June 19, 2001, NEWS, DOCUMENTS & COMMENTARY, 881 words, The Nation\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_25_0}{\*\bkmkstart cite_id_25}{\*\bkmkend DOC_ID_25_0}{\*\bkmkend cite_id_25}25.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_25"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320035000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Dying for drugs: Battle over cheap drugs goes to WTO: Since the Guardian's award-winning series began, prices have been slashed, but the fight goes on}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  The Guardian (London), June 16, 2001, Guardian Foreign Pages, Pg. 14, 1064 words, Sarah Boseley and James Astill\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_26_0}{\*\bkmkstart cite_id_26}{\*\bkmkend DOC_ID_26_0}{\*\bkmkend cite_id_26}26.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_26"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320036000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Kenya; New Move to Bring Down Prices of HIV/AIDS Drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   Africa News, May 28, 2001, NEWS, DOCUMENTS & COMMENTARY, 729 words, African Church Information Service\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_27_0}{\*\bkmkstart cite_id_27}{\*\bkmkend DOC_ID_27_0}{\*\bkmkend cite_id_27}27.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_27"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320037000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Paying for AIDS}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  Newsweek, March 19, 2001,, EUROPE; Pg. 16, 1738 words, By Carla Power; With Tom Masland, Esther Pan and Lara Santoro in Africa, Ron Moreau in Thailand and Mac Margolis in Rio\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_28_0}{\*\bkmkstart cite_id_28}{\*\bkmkend DOC_ID_28_0}{\*\bkmkend cite_id_28}28.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_28"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320038000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928  What price a life?}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  The Times (London), March 19, 2001, Monday, Features, 1408 words, Anjana Ahuja\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_29_0}{\*\bkmkstart cite_id_29}{\*\bkmkend DOC_ID_29_0}{\*\bkmkend cite_id_29}29.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_29"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00320039000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Global groups seek AIDS drugs for poor patients; Drug firms back off from patents}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  The Washington Times, March 19, 2001, Monday, Final Edition, PART A; WORLD; AFRICA; Pg. A13, 795 words, Ben Barber; THE WASHINGTON TIMES\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_30_0}{\*\bkmkstart cite_id_30}{\*\bkmkend DOC_ID_30_0}{\*\bkmkend cite_id_30}30.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_30"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330030000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Profits versus patients in South Africa}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  The Business Times Singapore, March 15, 2001, Thursday, Editorial & Opinion, Pg. 10, The Bottom Line, 738 words, G Panicker\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_31_0}{\*\bkmkstart cite_id_31}{\*\bkmkend DOC_ID_31_0}{\*\bkmkend cite_id_31}31.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_31"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330031000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 South Africa Resists Call For AIDS 'Emergency'}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   The Washington Post, March 15, 2001 Thursday, A SECTION; Pg. A01, 1063 words, Jon Jeter, Washington Post Foreign Service\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_32_0}{\*\bkmkstart cite_id_32}{\*\bkmkend DOC_ID_32_0}{\*\bkmkend cite_id_32}32.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_32"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330032000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 South Africa; Cipla Request Will Test Patent Act Ability To Allow Cheap Aids Drugs In}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   Africa News, March 9, 2001, NEWS, DOCUMENTS & COMMENTARY, 597 words, WOZA Internet\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_33_0}{\*\bkmkstart cite_id_33}{\*\bkmkend DOC_ID_33_0}{\*\bkmkend cite_id_33}33.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_33"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330033000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 South Africa; Indian Generic AIDS Drug Offer Puts EU in Dilemma}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   Africa News, March 9, 2001, NEWS, DOCUMENTS & COMMENTARY, 374 words, SouthScan\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_34_0}{\*\bkmkstart cite_id_34}{\*\bkmkend DOC_ID_34_0}{\*\bkmkend cite_id_34}34.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_34"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330034000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Poverty, Prejudice Hinder India's AIDS Fight;  Drug Maker Fears 'Another Africa'}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   The Washington Post, March 7, 2001 Wednesday, A SECTION; Pg. A01, 1839 words, Pamela Constable, Washington Post Foreign Service\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_35_0}{\*\bkmkstart cite_id_35}{\*\bkmkend DOC_ID_35_0}{\*\bkmkend cite_id_35}35.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_35"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330035000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Kenya; Why Not Take Up Offer Of Cheaper Aids Drugs?}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   Africa News, February 24, 2001, NEWS, DOCUMENTS & COMMENTARY, 983 words, The Daily Nation\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_36_0}{\*\bkmkstart cite_id_36}{\*\bkmkend DOC_ID_36_0}{\*\bkmkend cite_id_36}36.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_36"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330036000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Kenya; Aids: Drug Firms Making A Killing}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   Africa News, February 23, 2001, NEWS, DOCUMENTS & COMMENTARY, 402 words, The Daily Nation\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_37_0}{\*\bkmkstart cite_id_37}{\*\bkmkend DOC_ID_37_0}{\*\bkmkend cite_id_37}37.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_37"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330037000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Kenyan Orphanage Takes Initiative on AIDS Drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   The Washington Post, February 22, 2001 Thursday, A SECTION; Pg. A12, 1295 words, Karl Vick, Washington Post Foreign Service\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_38_0}{\*\bkmkstart cite_id_38}{\*\bkmkend DOC_ID_38_0}{\*\bkmkend cite_id_38}38.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_38"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330038000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Kenyan Orphanage Takes Initiative on AIDS Drugs}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   The Washington Post, February 22, 2001 Thursday, A SECTION; Pg. A12, 1295 words, Karl Vick, Washington Post Foreign Service\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_39_0}{\*\bkmkstart cite_id_39}{\*\bkmkend DOC_ID_39_0}{\*\bkmkend cite_id_39}39.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_39"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00330039000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Prognosis: grim;  FEATURES}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   Australian Financial Review, February 20, 2001 Tuesday, NEWS; Pg. 47, 1689 words, Julie Macken\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_40_0}{\*\bkmkstart cite_id_40}{\*\bkmkend DOC_ID_40_0}{\*\bkmkend cite_id_40}40.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_40"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00340030000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 An AIDS Drug-Price War}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  Newsweek, February 19, 2001,, SCIENCE TECHNOLOGY; Public Health; Pg. 53, 627 words, By Fred Guterl; With Mac Margolis in Rio, Sudip Mazumdar in New Delhi, Tom Masland in Cape Town and Shehnaz Suterwalla in London\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_41_0}{\*\bkmkstart cite_id_41}{\*\bkmkend DOC_ID_41_0}{\*\bkmkend cite_id_41}41.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_41"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00340031000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 Cipla launches AIDS drugs price battle}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   Australian Financial Review, February 13, 2001 Tuesday, NEWS; International News; Pg. 10, 388 words, Julie Macken\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_42_0}{\*\bkmkstart cite_id_42}{\*\bkmkend DOC_ID_42_0}{\*\bkmkend cite_id_42}42.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_42"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00340032000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 At the mercy of drug giants: Millions struggle with disease as pharmaceutical firms go to court to protect profits}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928  The Guardian (London), February 12, 2001, Guardian Home Pages, Pg. 1, 2245 words, Sarah Boseley in Johannesburg\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par \ltrrow}\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\hyphpar0\faauto\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 {\*\bkmkstart DOC_ID_43_0}{\*\bkmkstart cite_id_43}{\*\bkmkend DOC_ID_43_0}{\*\bkmkend cite_id_43}43.\cell }{\field{\*\fldinst {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 HYPERLINK \\l"doc_id_43"}{\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000064006f0063005f00690064005f00340033000000}}}{\fldrslt {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\ul\cf2\insrsid15420928 South Africa; MSF Challenges Pharmaceutical Industry To Match Generic AIDS Drug Cuts}}}\sectd \ltrsect\pgnrestart\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928   Africa News, February 9, 2001, NEWS, DOCUMENTS & COMMENTARY, 654 words, WOZA Internet\cell }\pard \ltrpar\ql \li0\ri0\widctlpar\intbl\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0 {\rtlch\fcs1 \af1\afs18 \ltrch\fcs0 \f1\fs18\insrsid15420928 \trowd \irow0\irowband0\lastrow \ltrrow\ts11\trgaph60\trleft-60\trftsWidth1\trpaddl60\trpaddr60\trpaddfl3\trpaddfr3\tblind0\tblindtype3 \clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth540\clshdrawnil \cellx480\clvertalt\clbrdrt\brdrs\brdrw15 \clbrdrl\brdrs\brdrw15 \clbrdrb\brdrs\brdrw15 \clbrdrr\brdrs\brdrw15 \cltxlrtb\clftsWidth3\clwWidth9180\clshdrawnil \cellx9660\row }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Indian pharma firms go shopping abroad; They are acquiring Western companies to overcome the restrictions of a new patent regime The Business Times Singapore May 25, 2006 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_44}{\*\bkmkstart DOC_ID_44_0}{\*\bkmkstart doc_id_1}{\*\bkmkend DOC_ID_44}{\*\bkmkend DOC_ID_44_0}{\*\bkmkend doc_id_1}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_1"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0031000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 May}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  25, 2006 Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Indian pharma firms go shopping abroad; \par They are acquiring Western companies to overcome the restrictions of a new patent regime}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Yogi Aggarwal\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 VIEWS AND OPINIONS; BT Comment Others\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1125  words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WHEN the patents regime was changed at the end of 2004 as part of India's }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  commitments, there were many fears that Indian companies, used to reverse engineering of patented medicines, would not be able to survive in the new environment. This has not happened.\par The new patent regime has accelerated the pace of globalisation of Indian industry, which has responded to the new situation by developing strategies that have taken them to the heart of the developed markets. \par A central part of the new strategy is to buy out existing manufacturers of generic medicines in Europe and the US. 'Indian companies had started thinking of ways to meet the patent challenge some time before the new patent rules began to apply,' says Timmie Kandhari, executive director at the Indian office of Price W}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 terhouseCoopers (PWC), the international consultancy.\par Takeovers of international pharmas by Indian firms increased from $139US million in 2004 to $341US million last year. During the first four months of 2006, takeovers skyrocketed further to $904US million. Takeovers of companies serve to expand the market for Indian companies.\par Other strategies include contract manufacturing or outsourcing the manufacture of pharmaceuticals for fo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 eign companies by Indian partners, joint ventures to develop and produce drugs, in-licensing deals where the foreign firms market drugs made by Indian firms under license, and R&D work that includes clinical trials done by Indian companies for their foreign partners.\par While such deals have expanded options for Indian companies after 2004, it is the takeover of foreign co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 panies that is the major step. Until last year the deals were generally small ones, varying from $5US million to $59US million. The biggest deal in 2005 was the $263US million buyout of the Belgian company Docpharma by Matrix labs.\par In the first three months of 2006, two major deals have been struck - the buyout for $572US million of the German generic manufacturer Betapharma by Dr Reddy's from India, and the takeover of the Romanian g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nerics drug company Terapia for $324US million by Ranbaxy, India's largest pharma. Besides these deals, Ranbaxy has bought out Allen SpA of Italy and Ethimed of Belgium for undisclosed sums. And this is just the beginning. Indian pharmas are planning to raise over $2US.5 billion in the international market through co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 vertible bonds.\par Ranbaxy has already raised $400US million and is planning on raising another $1US.1 billion, Wockhardt has got shareholder approval to raise $800US million. Other companies such as }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Sun Pharma, Nicolas Piramal and Torrent are also sitting on tidy piles of cash, waiting for the right acquisition opportunity.\par One reason for the aggressive buying is the lack of substantial success and high cost in legally opposing big pharma's extension of their patents on drugs going off-patent. 'Big pharma will fight you every inch of the way,' says Mr Kandhari. So while companies like Ranbaxy also pursue this strategy, it is no longer enough.\par The route of filing abbreviated new drug applications (Anda) is cumbersome and expensive. It takes two to three years to file Anda in the US and Europe and each application could cost a couple of million dollars. D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 spite this, Ranbaxy has over 70 products registered in the US while Dr Raddy's has over a dozen, says D G Shah, secretary general of the Indian Pharmaceutical Alliance (IPA), which represents big pharma comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nies.\par Foreign acquisitions were another route. They mean that the Indian company takes over an established E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ropean company which already has approval to sell several generic drug brands and an established custo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 er base. They also allow the drug to be made at lower cost in India and packaged and sold in the European market.\par Bigger sales base\par 'Whether this translates to a sales increase by a factor of two, three or four is subject to the company cap}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 bilities,' maintains Jayashri Kulkarni, director of healthcare practise at Frost & Sullivan India in an emailed response to questions.\par 'With three of the top five markets in Europe, it is imperative for a company in the pharmaceutical industry to focus on strategies that help it evolve in the region. Acquisitions are a quick boost to Indian companies by providing ready access to a new and growing market.\par 'Secondly, directly selling in the country will allow for growth of the bottom line as well given our cost a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 vantage,' maintains Ms Kulkarni.\par Another reason why European generic companies are preferred is that they are generally smaller than US companies and more affordable. Of course, the deals can really be big as in the $7US.4 billion acquisition last July by the Israeli generics company Teva of Ivax Corporation in Europe.\par An acquisition of a European pharma company also means that it is easier to sell in the other countries of the EU. The total pharma market for the top seven countries in EU is estimated at $162US billion. Of the five biggest pharma markets, three (Germany, France and the UK) are in Europe. While generics only form around one-tenth of the total pharma market in Europe, in these countries it's between 20 per cent and 25 per cent.\par And the generics market is growing more rapidly than any other. Estimates put together by PWC show that the European generics market is growing at a 22 per cent CAGR. It was at $29US.8 billion in 2003, estima}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ed at $54US.2 billion in 2006 and at $80US.7 billion in 2009.\par 'By 2010 we can get 20 per cent of the world generics market,' maintains Mr Shah of IPA. 'Now that India is trying to grow into a global pharma giant,' says Mr Kandhari, 'it makes sense to concentrate on Europe since we are buying into a safe space.' For the Mumbai-based Wockhardt, with 2005 sales of 14.1 billion rupees ($488S million), Europe is already the biggest market, larger than even the domestic Indian market. It has made three acquisitions in Europe so far, Wallis Laboratory and CP Pharmaceuticals in UK, and Esparma GmbH in Germany.\par They are now scouting for acquisitions in the US. 'We look for a strong front-end organisation that will give us market access, we also look for technical capabilities that will compliment ours,' says Habil Khorakiwala, chairman of Wockhardt. 'We should be able to drive faster growth of the acquired asset through our ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 agement.' Mr Khorakiwala is also quite relaxed about the changes in the industry after the new patent r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gime. \par 'Many people were led to believe that Indian companies would be at a disadvantage with the introduction of product patents. But now outsourcing into India has gathered momentum and Indian companies are adapting themselves to integrate their businesses into the global economy. Companies are discovering their strengths and weaknesses with the rest of the world.'\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PATENTS (90%); EDITORIALS & OPINIONS (91%); PHARMACEUTICALS INDUSTRY (91%); TAKEOVERS (90%); PHARMACEUTICALS PATENTS (90%); GENERIC DRUGS (90%); RESEARCH & DEVELOPMENT (90%); GENERIC PRODUCTS (89%); ALLIANCES & PARTNERSHIPS (90%); INTERN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TIONAL TRADE (78%); GLOBALIZATION (78%); OUTSOURCING (78%); PATENT LAW (78%); DRUG DESIGN & DISCOVERY (77%); PHARMACEUTICAL PREPARATION MFG (77%); ENTERPRISE GLOBA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 IZATION (73%); LICENSING AGREEMENTS (73%); PHARMACEUTICALS PRODUCT DEVELOPMENT (71%); MANUFACTURING OUTPUT (70%); SHAREHOLDERS (68%); JOINT VENTURES (66%); BONDS (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PRICEWATERHOUSECOOPERS (70%); RANBAXY LABORATORIES LTD (52%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  LTD (58%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (58%); RANBAXY (NSE) (52%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS541211 OFFICES OF CERTIFIED PUBLIC ACCOUNTANTS (70%); SIC8721 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 C}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 COUNTING, AUDITING, & BOOKKEEPING SERVICES (70%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 JOSEPH C PAPA (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 INDIA (94%); UNITED STATES (79%); GERMANY (77%); BELGIUM (72%); EUROPE (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 May 24, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2006 Singapore Press Holdings Limited\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 U.S. pushes to limit generic drug rights; Agreements seek to extend monopolies in exchange for improvements in trade The International Herald Tribune April 19, 2006 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_45}{\*\bkmkstart DOC_ID_45_0}{\*\bkmkstart doc_id_2}{\*\bkmkend DOC_ID_45}{\*\bkmkend DOC_ID_45_0}{\*\bkmkend doc_id_2}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_2"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0032000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 2 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The International Herald Tribune\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  19, 2006 Wednesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 U.S. pushes to limit generic drug rights; \par Agreements seek to extend monopolies in exchange for improvements in trade}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Anand Giridharadas\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NEWS; Pg. 1\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1610 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NEW DELHI \par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Brian Knowlton in Washington contributed reporting to this article.\par *\par Under global trading rules, the inventors of medicines ordinarily enjoy the right to a 20-year monopoly on their inventions. But five years ago, the United States joined 141 other countries to sign the Doha Declar}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion, confirming the right of poor countries to break drug patents and produce cheap generic drugs in the event of contagions like HIV.\par At the time, Thailand was heartened. It had been trying everything in its fight against AIDS. It coined a jingle to promote safe sex. It placed condoms in massage parlors. Most important, it curbed deaths among the poor by giving them generic versions of medicines invented by multinational drug makers. \par So it came as a jolt in January when the United States asked Thailand to sign a free trade agreement that would, on paper, dilute its right to break patents and use generics.\par Washington said the agreement would save lives by spurring innovation and by making multinationals more confident in selling drugs in the country. But Thai officials saw the proposal as a morbid bargain: either r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 fuse the U.S. offer, and thereby scuttle a trade deal with the United States worth billions of dollars, or accept it and lift the price of AIDS drugs beyond the reach of the poor.\par ''Those who require the essential drugs but cannot afford it, they will have to die,'' said Dr. Suwit Wibu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 polprasert, the Thai official who is coordinating the Public Health Ministry's response to the U.S. proposal.\par Thailand is not alone. It is merely the latest target of a quiet worldwide campaign by the administration of President George W. Bush to coax developing nations to barter away their patent-breaking rights in e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 change for lucrative trade benefits, according to public-health experts and government officials from Thailand to Brazil.\par Specifically, Washington is pushing bilateral and regional trade agreements in which countries enact ''supe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 patents'' that prolong U.S. drug makers' monopolies and limit the conditions under which their patents can be broken. These new rules, once they are adopted by developing countries, roll back the patent-breaking rights that were confirmed by the 2001 declaration at World Trade Organization talks in Doha, Qatar.\par In effect, Washington is stitching together its own parallel global patents system. The trade deals, negotiated in secret, attract little notice. But they have already been signed with developing countries battling AIDS, i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cluding six in Central America. And negotiations are beginning with several nations pivotal to the fight against the virus, from Thailand to five southern African countries, including South Africa and Botswana.\par Because of these agreements, India's generics industry, the world's largest, is reining in plans to supply poor countries and refocusing on richer ones, said Dilip Shah, head of the Indian Pharmaceutical Alliance, which represents generic makers.\par "For the Indian pharma industry," he said, "it's not doomed; it will find a way out. But for the patients in the third world, it's bad."\par Public health officials warn of catastrophic consequences if the bilateral deals are applied to AIDS drugs.\par ''If you prevent countries from using generic drugs,'' said Pedro Chequer, the head of Brazil's national AIDS program, ''you are creating a concrete obstacle to providing access to drugs. You are promoting genocide, because you're killing people.''\par First-generation AIDS drugs reached the world's poorest people only when the use of generics cut their cost to $140 a year from more than $10,000. As new drugs emerge to treat patients resistant to first-line med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cines, the trade agreements make a similar drop ''extremely difficult to ensure,'' according to Medecins Sans Frontieres, or Doctors Without Borders.\par Washington maintains that the trade deals are directed toward diseases other than AIDS.\par And Richard Feachem, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, based in Geneva, acknowledged that it was too early to tell whether the bilateral agreements would be used to block access to AIDS drugs.\par ''If we do see this in practice,'' he said, ''we should condemn it. But it really is in the interpretation of these agreements in very particular circumstances.''\par Yet, in defending the bilateral agreements, Bush administration officials often cite the AIDS example to make their case. Stronger patents save lives, the argument goes, by keeping companies confident enough in profit to keep discovering new drugs.\par Dr. Mark Dybul, the second-ranking official in the White House program to fight AIDS, said that because AIDS patients constantly grow resistant to medicines, it is disastrous to widen access today and have no drugs tomorrow.\par ''As an individual physician sitting in front of an individual patient, you will do whatever you need to for that patient now,'' said Dybul, a physician by training. ''When you're a public-health physician, you're not a phys}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cian for one person but for millions of people. And you need to be thinking about whether the action in that single setting, repeated hundreds of thousands of times, will cause a problem for the millions.''\par Spreading the new patents system are U.S. trade negotiators, who some experts believe are assuming the influence that public health experts once had over the Bush administration's AIDS policy.\par Victoria Espinel, an assistant U.S. trade representative, strongly defended the use of trade agreements to promote patents that ''have more in place'' than the patents agreed upon at the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  talks in Doha, which she described as merely ''harmonizing minimum standards.''\par ''It is crucial to public health,'' she said, ''to promote the innovation of drugs and to make sure that research and development of drugs continues.''\par As for exempting AIDS drugs from the new accords on patent-breaking, she said, ''I want to emphasize that there is enough flexibility in our free-trade agreements to allow our partners to do what they need to do.''\par An explicit promise to exempt AIDS drugs, however, is not in the agreements, said Wibulpolprasert, the Thai official. And that, experts say, is at the heart of the problem: Nations must take Washington's word for it.\par An examination by the International Herald Tribune of several free-trade accords reveals provisions that a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 pear, on paper, to limit the freedom to use generics.\par Several agreements, for example, prolong a patent monopoly beyond 20 years if the developing country's regulators show ''unreasonable delays'' in approving a patent. This provision, absent from World Trade O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ganization rules, sustains higher prices.\par Many agreements also serve to prolong patents by requiring generics to be retested as if they were new i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ventions. Retesting a drug biologically equivalent to one already approved takes time and may be unethical, since infected patients must be given placebos. The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  rejected this five-year ban on the use by generic makers of the safety data submitted for the original branded drug.\par And while the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  lets countries decide when to break patents, the new U.S. agreements limit this action to special cases to enforce antitrust law, for example, or during emergencies. Experts say the most important use of generics is excluded: to reduce costs by making branded products compete with generics.\par The generics question has also opened a rift in the United States, between Bush and former President Bill Clinton. On a recent visit to New Delhi, Clinton said he had confronted Bush about generics while flying to Rome for the papal funeral last April.\par ''The American position is untenable,'' Clinton recalled saying.\par In an interview, Clinton said Washington was succumbing to the influence of the drug lobby in undermining the Agreement on Trade-Related Aspects of Intellectual Property Rights, or TRIPS, the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  framework on which the Doha Declaration built.\par ''The TRIPS system essentially said there was an exception for life-saving medicine,'' Clinton said. ''And b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sically, the American drug companies and the American government really put the hammer on the bill not to use the TRIPS system.''\par Referring to generic producers, he added: ''If a company develops a new advance in AIDS, TB, malaria, you need large numbers right away and all the people who need it are in poor places. If you don't have }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Ranbaxy, Hetero, Aspen in South Africa and other people to step into the breach, how are we going to do that?''\par Last year, when Brazil was faced with upgrading tens of thousands from $140-a-year generics to Kaletra, a patented drug costing more than $3,000 a year, it threatened to break the patent unless given a discount by the U.S. company Abbott Laboratories, Kaletra's inventor. Members of Congress in the United States threa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ened import tariffs in retaliation. Although the Bush administration says it was not involved, Espinel, the a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sistant U.S. trade representative, hinted at how Washington's tacit desires can be enough to make countries fall into line.\par ''Do I think that that would be the best way for a country to go about promoting itself as an innovation player and a destination for foreign investment?'' Espinel said. ''Probably not.''\par Clinton came to Brazil's rescue. His foundation tapped overseas contacts to find a generic drug for about $900 a year a price Brazil used to negotiate with Abbott, which spent $1.8 billion on research in 2005 and reported a profit of $3.4 billion\par Finally, Brazil backed down from its threat to break the patent, and Abbott gave it a discount of about 50 pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cent.\par Abbott is ''gratified to get support'' from ''people in and outside of government,'' said a company spokesman, Brian Kyhos.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GENERIC DRUGS (91%); TRADE TREATIES & AGREEMENTS (90%); AIDS & HIV (90%); TREATIES & AGREEMENTS (90%); PHARMACEUTICALS INDUSTRY (90%); GENERIC PRODUCTS (90%); INTERNATIONAL TRADE LAW (89%); TRADE DEVELOPMENT (89%); PHARMACEUTICAL PREPARATION MFG (89%); PATENTS (89%); INTERNATIONAL TRADE (89%); DEVELOPING COU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TRIES (89%); PHARMACEUTICALS PATENTS (78%); AGENCY RULEMAKING (78%); AIDS & HIV TREATMENT (78%); ANTIVIRALS (78%); HEALTH DEPARTMENTS (78%); MULTINATIONAL CORPOR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TIONS (78%); EMERGING MARKETS (78%); INTERGOVERNMENTAL TALKS (77%); FREE TRADE TREATIES & AGREEMENTS (77%); DRUG PRICES (73%); US PRESIDENTS (72%); PUBLIC HEALTH ADMINISTRATION (66%); MASSAGE SERVICES (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GEORGE W BUSH (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NEW DELHI, INDIA (79%) UNITED STATES (99%); THAILAND (93%); INDIA (92%); Q}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TAR (92%); BOTSWANA (79%); AFRICA (79%); CENTRAL AMERICA (79%); SOUTHERN AFRICA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 April 19, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2006 International Herald Tribune\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 U.S. pushes to limit generic-drug rights in trade pacts The International Herald Tribune April 19, 2006 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_46}{\*\bkmkstart DOC_ID_46_0}{\*\bkmkstart doc_id_3}{\*\bkmkend DOC_ID_46}{\*\bkmkend DOC_ID_46_0}{\*\bkmkend doc_id_3}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_3"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0033000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 3 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The International Herald Tribune\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  19, 2006 Wednesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 U.S. pushes to limit generic-drug rights in trade pacts}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Anand Giridharadas\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 FINANCE; Pg. 13\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1381 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NEW DELHI \par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Brian Knowlton in Washington contributed reporting to this article.\par *\par Under global trading rules, the inventors of medicines ordinarily have the right to a 20-year monopoly on their inventions. But five years ago, the United States joined 141 other countries in signing the Doha Declaration, confirming the right of poor countries to break drug patents and produce cheap generic drugs in the event of contagions like HIV.\par At the time, Thailand was heartened. It had been trying everything in its fight against AIDS. It coined a jingle to promote safe sex. It placed condoms in massage parlors. Most important, it curbed deaths among the poor by giving them generic versions of medicines invented by multinational drug makers. \par So it came as a jolt in January when the United States asked Thailand to sign a free trade agreement that would, on paper, dilute its right to break patents and use generics.\par Washington said the agreement would save lives by spurring innovation and by making multinationals more confident to sell drugs in the country. But Thai officials saw the proposal as a morbid bargain: either refuse the U.S. offer and scuttle a trade deal with the United States worth billions of dollars, or accept it and lift the price of AIDS drugs beyond the reach of the poor.\par ''Those who require the essential drugs but cannot afford it, they will have to die,'' said Dr. Suwit Wibu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 polprasert, the Thai official who is coordinating the Public Health Ministry's response to the U.S. proposal.\par Thailand is not alone. It is merely the latest target of a quiet worldwide campaign by the administration of President George W. Bush to coax developing nations to barter away their patent-breaking rights in e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 change for lucrative trade benefits, according to public health experts and government officials from Thailand to Brazil.\par Specifically, Washington is pushing bilateral and regional trade agreements in which countries enact ''supe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 patents'' that prolong U.S. drug makers' monopolies and limit the conditions under which their patents can be broken.\par These new rules, once they are adopted by developing countries, roll back the patent-breaking rights that were confirmed by the 2001 declaration at World Trade Organization talks in Doha, Qatar.\par In effect, Washington is stitching together a parallel global patents system.\par The trade deals, negotiated in secret, attract little notice. But they have already been signed with developing countries battling AIDS, including six in Central America. And negotiations are beginning with several nations pivotal to the fight against the virus, from Thailand to five southern African countries, including South Africa and Botswana.\par Because of these agreements, India's generics industry, the world's largest, is reining in plans to supply poor countries and refocusing on richer ones, said Dilip Shah, head of the Indian Pharmaceutical Alliance, which represents generic makers.\par ''For the Indian pharma industry,'' he said, ''it's not doomed; it will find a way out. But for the patients in the Third World, it's bad.''\par Public health officials warn of catastrophic consequences if the bilateral deals are applied to AIDS drugs.\par ''If you prevent countries from using generic drugs,'' said Pedro Chequer, the head of Brazil's national AIDS program, ''you are creating a concrete obstacle to providing access to drugs. You are promoting genocide, because you're killing people.''\par First-generation AIDS drugs reached the world's poorest people only when the use of generics cut their cost to $140 a year from more than $10,000. As new drugs emerge to treat patients resistant to first-line med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cines, the trade agreements make a similar drop ''extremely difficult to ensure,'' according to Medecins Sans Frontieres, or Doctors Without Borders.\par Washington maintains that the trade deals are directed toward diseases other than AIDS.\par And Richard Feachem, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, based in Geneva, acknowledged that it was too early to tell whether the bilateral agreements would be used to block access to AIDS drugs.\par ''If we do see this in practice,'' he said, ''we should condemn it. But it really is in the interpretation of these agreements in very particular circumstances.''\par Yet, in defending the bilateral agreements, Bush administration officials often cite the AIDS example to make their case. Stronger patents save lives, the argument goes, by keeping companies confident enough in profit to keep discovering new drugs.\par Dr. Mark Dybul, the second-ranking official in the White House program to fight AIDS, said that because AIDS patients constantly grow resistant to medicines, it is disastrous to widen access today and have no drugs tomorrow.\par ''As an individual physician sitting in front of an individual patient, you will do whatever you need to for that patient now,'' said Dybul, a physician. ''When you're a public health physician, you're not a physician for one person but for millions of people. And you need to be thinking about whether the action in that single setting, repeated hundreds of thousands of times, will cause a problem for the millions.''\par Spreading the new patents system are U.S. trade negotiators, who some experts believe are assuming the influence that public health experts once had over the Bush administration's AIDS policy.\par Victoria Espinel, an assistant U.S. trade representative, strongly defended the use of trade agreements to promote patents that ''have more in place'' than the patents agreed upon at the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  talks in Doha, a step she described as merely ''harmonizing minimum standards.''\par ''It is crucial to public health,'' she said, ''to promote the innovation of drugs and to make sure that research and development of drugs continues.''\par As for exempting AIDS drugs from the new accords on patent-breaking, she said, ''I want to emphasize that there is enough flexibility in our free trade agreements to allow our partners to do what they need to do.''\par An explicit promise to exempt AIDS drugs, however, is not in the agreements, said Wibulpolprasert, the Thai official. And that, experts say, is at the heart of the problem: Nations must take Washington's word for it.\par An examination by the International Herald Tribune of several free trade agreements reveals provisions that appear, on paper, to limit the freedom to use generics.\par Several agreements, for example, prolong a patent monopoly beyond 20 years if the developing country's regulators show ''unreasonable delays'' in approving a patent. This provision, absent from }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  rules, su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tains higher prices.\par Many agreements also serve to prolong patents by requiring generics to be retested as if they were new i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ventions. Retesting a drug biologically equivalent to one already approved takes time and may be unethical, since infected patients must be given placebos.\par The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  rejected this requirement, a five-year ban on the use by generics makers of the safety data submi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ted for the original branded drug.\par And while the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  lets countries decide when to break patents, the new U.S. agreements limit this action to special cases to enforce antitrust law, for example, or during emergencies.\par Experts say the most important use of generics is excluded: to reduce costs by making branded products compete with generics.\par The generics question has also opened a rift in the United States, between Bush and former President Bill Clinton. On a recent visit to New Delhi, Clinton said he had confronted Bush about generics while flying to Rome for the papal funeral last April.\par ''The American position is untenable,'' Clinton recalled saying.\par In an interview, Clinton said Washington was succumbing to the influence of the drug lobby in undermining the Agreement on Trade-Related Aspects of Intellectual Property Rights, or Trips, the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  framework on which the Doha declaration built.\par ''If a company develops a new advance in AIDS, TB, malaria, you need large numbers right away and all the people who need it are in poor places,'' Clinton said, referring to generics producers.\par ''If you don't have }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Ranbaxy, Hetero, Aspen in South Africa and other people to step into the breach, how are we going to do that? I don't understand the apparent obsession with some of the big pharma inte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ests in trying to block them off.''\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GENERIC DRUGS (91%); TRADE TREATIES & AGREEMENTS (90%); AIDS & HIV (90%); TREATIES & AGREEMENTS (90%); PHARMACEUTICALS INDUSTRY (90%); GENERIC PRODUCTS (90%); INTERNATIONAL TRADE LAW (89%); TRADE DEVELOPMENT (89%); PHARMACEUTICAL PREPARATION MFG (89%); PATENTS (89%); INTERNATIONAL TRADE (89%); DEVELOPING COU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TRIES (89%); PHARMACEUTICALS PATENTS (78%); AGENCY RULEMAKING (78%); AIDS & HIV TREATMENT (78%); ANTIVIRALS (78%); HEALTH DEPARTMENTS (78%); MULTINATIONAL CORPOR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TIONS (78%); EMERGING MARKETS (78%); INTERGOVERNMENTAL TALKS (77%); FREE TRADE TREATIES & AGREEMENTS (77%); DRUG PRICES (73%); US PRESIDENTS (72%); PUBLIC HEALTH ADMINISTRATION (66%); MASSAGE SERVICES (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GEORGE W BUSH (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NEW DELHI, INDIA (79%) UNITED STATES (99%); THAILAND (93%); INDIA (92%); Q}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TAR (92%); BOTSWANA (79%); AFRICA (79%); CENTRAL AMERICA (79%); SOUTHERN AFRICA (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 April 19, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2006 International Herald Tribune\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HIV-Aids and STDs;Global Aids Treatment Drive Takes Off Africa News April 28, 2005 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_47}{\*\bkmkstart DOC_ID_47_0}{\*\bkmkstart doc_id_4}{\*\bkmkend DOC_ID_47}{\*\bkmkend DOC_ID_47_0}{\*\bkmkend doc_id_4}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_4"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0034000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 4 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  28, 2005 Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 HIV-Aids and STDs;\par Global Aids Treatment Drive Takes Off}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Africa Renewal\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 3207 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Rapid increase in number of people receiving ARV medicines\par When a reporter first met seven-year-old Bongani in a hardscrabble shantytown near Johannesburg in 2003, it was evident the child was dying. He was too weak for school, stunted and racked by diarrhoea. There was little question that he, like his deceased parents, was infected with the human immunodeficiency virus that causes AIDS. It seemed equally certain that he would soon lie in a tiny grave next to theirs -- joining the 370,000 South Africans who died from the disease that year.\par But when the journalist, Mr. Martin Plaut of the BBC, returned a year later, he found a healthy, laughing Bo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gani poring over his lesson book. "The transformation," Mr. Plaut wrote last December, "was remarkable." \par That transformation -- and the difference between life and death for Bongani and a growing number of pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ple living with HIV and AIDS in Africa -- has resulted from access to anti-retroviral drugs (ARVs) that attack the virus and can dramatically reduce AIDS deaths. For years high costs severely limited their use in Africa. The Joint UN Programme on HIV/AIDS (UNAIDS) estimated that only about 50,000 of the 4 million Africans in urgent need of the drugs were able to obtain them in 2002. But with prices dropping in the face of d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 mands for treatment access and competition from generic copies of the patented medications, the politics and economics of AIDS treatment have finally begun to shift.\par In December 2003, the World Health Organization (WHO) announced an unprecedented drive to put 3 mi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lion people living with HIV/AIDS in developing countries on ARV treatment by the end of 2005, the "3x5" campaign. Two months later, the US launched an ambitious programme of its own, the President's Eme}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gency Plan for AIDS Relief (PEPFAR) -- a 5-year, $15 bn initiative to provide ARV therapy to 2 million people and prevent 7 million new infections by 2008 in 15 countries, including 12 in Africa.\par 'Irresponsible' goal now in sight\par The early results are encouraging. In January 2005, WHO, joined by representatives of the US government, UNAIDS and the multilateral Global Fund to Fight AIDS, Tuberculosis and Malaria, announced that the nu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ber of people receiving ARV treatment in developing countries had increased by 75 per cent during 2004 to over 700,000 -- including an estimated 325,000 in sub-Saharan Africa. In the view of many public health e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 perts, the rapid increase vindicates what some critics derided as WHO's "irresponsible" and unrealistic 3x5 pledge.\par The results also seem to belie predictions that the mix of multilateral and bilateral funding and treatment pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 grammes would prove impossible to coordinate and only further burden overstretched health systems in the worst-affected countries. South Africa, Nigeria and India account for over 40 per cent of the total number of people still in need of ARV treatment, and experts say that a focus in those three countries could produce major gains for treatment access in a short time.\par Speaking at a press conference at the World Economic Forum in Davos on 26 January, WHO Director-General Dr. Lee Jong-wook singled out developing countries for much of the credit. "We salute the countries that have now shown us that treatment is possible and can be scaled up even in the poorest settings," he said. "AIDS treatment access is expanding every day thanks to the dedicated work of doctors, nurses, health workers and people living with HIV and AIDS, who are often working under difficult circumstances to turn the dream of universal treatment into a reality." WHO officials assert that at current rates the world is on track to reach the 3x5 goal.\par This upbeat assessment is tempered, however, by an estimated $2 bn shortfall to reach the 3 million mark by the end of this year. That amount is part of the $6 bn in additional resources UNAIDS says is needed in 2005 for the full range of HIV/AIDS programmes in developing regions. The treatment drive in many countries is hampered by severe shortages of trained medical personnel and facilities and by continuing controversies over drug prices and patents. "Unless these and other pressing issues are addressed urgently," declared the non-governmental organization Medecins sans Frontieres (MSF), "many of those living with HIV/AIDS in d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 veloping countries will never get access to life-saving treatment or may not be able to survive once on trea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment over the long term."\par MSF and other advocacy groups point out that the 700,000 people in ARV treatment represent only about 12 per cent of the nearly 6 million people in developing countries who need it. With the disease taking 8,000 lives daily, and new infections topping 5 million last year alone, MSF declared that "the global picture is bleak... WHO ... and other institutions should be sounding the alarm."\par 'A tremendous determination'\par Whether one views the pill bottle as half empty or half full, the increased availability of anti-AIDS medicines in Africa is very good news. Although the percentage of Africans currently receiving the life-prolonging drugs remains a low 8 per cent of those requiring it -- ARVs are prescribed only for those in the final stages of the disease -- the continental average masks significant advances in some countries.\par In Botswana, the country with the second-highest HIV-infection rate in the world, an estimated 50 per cent of those in need currently receive ARV drugs. This is due in large part to the government's pioneering decision in 2002 to provide the medications free of charge through the public health system.\par Uganda, whose AIDS prevention campaign is already considered a model for effective programmes, now provides ARV treatment to 40 per cent of the 114,000 people who require it. In Cameroon, reports WHO, strong political leadership combined with increased funding assistance and a sharp drop in drug prices has allowed some 12,000 people to begin ARV therapy. Cameroonian authorities say they will triple that number by the end of 2005.\par Overall, notes WHO in its December 2004 3x5 Campaign Report, anti-retroviral medications are now avail}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ble at more than 700 sites across the region. The study also found that African ARV patients are equally or more likely than patients in developed countries to maintain the drugs' strict daily treatment schedule. This finding has confounded critics who argued that poor adherence rates would accelerate the emergence of drug-resistant strains of the virus.\par WHO also reported that men and women have roughly equal access to ARVs in Africa under the new trea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment programmes. This means that women, who make up 57 per cent of Africans living with the virus, are underrepresented in some countries; but the numbers have allayed, at least for now, fears that women would be excluded from national treatment strategies.\par In Botswana, the country with the second-highest HIV-infection rate in the world, an estimated 50 per cent of those in need currently receive ARV drugs.\par The early success of the treatment drive, says UN Special Envoy for HIV/AIDS in Africa Stephen Lewis, r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 flects the coming together of new resources from the Global Fund and the US government, the technical support and momentum of WHO's 3x5 campaign and a new sense of urgency among African governments and civil society. Mr. Lewis, a former Canadian diplomat known for his criticism of responses to the pandemic by both donors and African governments, told Africa Renewal that in recent months "there has been a huge change for the better" among African political leaders and health officials. "It's like night and day. There is tremendous determination to meet those 3x5 targets."\par The reason for the sudden change, he notes, is that in the hardest-hit countries, HIV/AIDS can no longer be ignored. For some leaders "it was the fear that the country was falling apart, the sense that every indicator was being turned back, from life expectancy to levels of poverty to infant and maternal mortality. It made the political leadership say, 'Oh my God, we've got to turn this around.'" In the worst affected regions, "the pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 vasiveness of death is almost unbelievable. They're in a life-and-death battle, and now everybody sees it that way."\par Building capacity\par Despite the progress, obstacles to treatment access remain stubbornly in place. Chief among them is the absence of the public health capacity -- hospitals and clinics, diagnostic and laboratory facilities, trained medical personnel -- to maintain millions of people on the powerful anti-retroviral medications. Although Mr. Lewis estimates that Africa already has the capacity to maintain double the current number of people now on treatment, "the need to increase capacity is huge, and there's a kind of grim, gritted-teeth determination to get it built."\par Part of the problem, notes a recent study by WHO and other international health organizations, is the "fatal flow" of African health professionals to better-paying jobs overseas. The study notes that there are more M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lawian doctors practicing in the UK city of Manchester than in Malawi itself, while Zambia, with one of the highest HIV-infection rates in the world, has lost to foreign employers 550 of the 600 doctors it has trained since independence.\par Malawi and its development partners have responded to the desperate staffing shortage with a programme to improve salaries and working conditions for health professionals and to train a new cadre of health wor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ers able to dispense ARVs and provide basic medical services.\par Rebuilding Africa's threadbare public health systems will take time, however, and for millions of people in the last stages of AIDS, time is running out. "Almost everyone would agree that the largest challenge resides around capacity," says Dr. Mark Dybul, the assistant US global AIDS coordinator and chief medical officer for the PEPFAR programme. The US, the Global Fund and WHO programmes therefore focus on "supporting new people on therapy, but simultaneously building new capacity. I don't think it's correct to say that all [the recent increases] have been done using existing capacity."\par One small PEPFAR-supported clinic in Namibia, he notes, had the resources to treat several hundred pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ple. "Now they have the capacity to treat a couple of thousand people. They're taking people off the waiting list and putting them on the rolls, because they built new capacity at the same time they began treatment."\par Funding support, technical assistance and drugs and equipment could come from outside, Dr. Dybul told A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 rica Renewal. But for the programme to expand, there also needs to be capacity within the country. "And that's got to begin with the national strategy commitment" of the governments and civil societies of affected countries. "What we do is support them... We [all] need to do more, and we're not there yet... but capacity has been expanded over the past year with tremendous success."\par The US programme alone added 155,000 people to the treatment rolls in just eight months in its 15 target countries: Botswana, Cote d'Ivoire, Ethiopia, Kenya, Mozambique, Namibia, Nigeria, Rwanda, Tanzania, Uganda, Zambia, Haiti, Guyana and Vietnam. Dr. Dybul says it is on track to reach the 500,000 mark by June 2006.\par "I think there are a lot of misconceptions about [ARV] drugs," Dr. Dybul adds. "The cost of anti-retroviral therapy is not drugs... The major costs are supporting and training personnel, laboratory capacity and su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 porting those laboratories."\par Dr. Dybul puts the annual cost of ARV treatment in Africa at $1,500- $2,500 per person, with drugs accoun}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing for just $300-$600 of the total. "Arguments about the cost of the drugs are for us a red herring," he e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 plains. "That's not the problem right now."\par Patent, pricing controversies\par But controversies over the safety, supply and cost of anti-AIDS drugs have continued. In contrast to Dr. D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 bul's assessment, WHO reported last December that "the high cost of ARV drugs remains a barrier to scaling up HIV treatment and care." Prices for the next generation of anti-AIDS drugs, which will be needed as the virus develops resistance to current medications, "remain prohibitively expensive throughout much of the world," the organization noted. It warned that action is needed now to control future costs.\par For more than a decade after the development of the first anti-retrovirals in the late 1980s, their high cost and the complexity of using them kept the life-prolonging medications out of the hands of all but a few very wealthy or very fortunate people in poor countries. At $10,000-$15,000 per year, ARV treatment was simply unaffordable. Efforts by UNAIDS to negotiate discounted prices for developing countries enjoyed only limited success, and the major Northern pharmaceutical companies generally resisted calls to licence inexpensive generic versions of their patented products.\par In 2001, however, an Indian pharmaceutical firm, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  introduced an innovative generic medication that combined three of the most effective anti-retroviral drugs into a single pill, known as the triple fixed dose combination tablet (FDC). Not only was the drug easier to administer than its patented competitors -- two pills a day compared with six or more of some of the patented formulations -- it was available initially for the unheard-of price of $350 per year. After a two-year investigation by WHO's drug prequalification programme, the triple FDC was certified safe and medically equivalent to the patented originals, and went into wide use. With prices now as low as $140 a year, the triple FDC has emerged as the pharmaceutical backbone of the 3x5 campaign and is credited with making it possible to expand ARV treatment.\par But PEPFAR requires its grantees to use only drugs certified by the US Food and Drug Administration (FDA), a policy that, in practice, has meant the programme buys only patented products, mainly from US suppliers. PEPFAR officials say the policy is necessary to ensure the safety and quality of drugs and note that a number of generic ARVs have been removed from the WHO pre-approval list after problems were di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 covered in the certification documents. They also note that foreign generics producers are welcome to su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 mit their products for FDA approval under a special "fast track" procedure.\par To date, however, none of the triple FDC drugs favoured in international treatment programmes has secured FDA approval. The result, reported the US government General Accounting Office, is that PEPFAR currently pays about twice as much for anti-retroviral medications as treatment schemes using generics. The agency estimates that the costs could potentially run into hundreds of millions of dollars over the five-year span of the PEPFAR initiative, reducing the number of people who can be treated for the same money.\par In late January, the FDA approved its first generic ARV product, a two-pill package taken twice daily, and applications for other generic products, including triple FDCs, are under review. Treatment advocates we}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 come the development but charge that the failure of the US to adopt the preferred triple FDC tablet is forcing participating countries to manage different supply chains and treatment regimes -- complicating the drive to expand treatment.\par Trade rules threaten affordability\par The extension of 20-year patent protections to all but the least developed countries on 1 January 2005, u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 der the World Trade Organization's agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), has also set off alarm bells among advocates and health officials. The agreement makes it more difficult for India and other major exporters of generic drugs to continue to supply developing countries with low-cost ARVs and other vital medicines.\par The current generation of frontline anti-AIDS drugs are exempt from the new patent rules, says Mr. Brook Baker, a professor at Northeastern University in the US and a member of the treatment advocacy group Health Gap. "The problem will be with the next generation of ARVs in the pipeline. TRIPS will prevent the kind of generic competition that has driven prices down in the past."\par In August 2003, the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  TRIPS Council, under pressure particularly from African countries to create a public-health exemption to the new rules, reached an agreement to permit the export of generic drugs for public health emergencies. But the exemption is limited and procedurally complex. To date, no country has attempted to use it.\par Mr. Baker also notes that US negotiators are seeking patent protections in excess of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  requirements in regional and bilateral trade talks. These so-called "TRIPS plus" agreements, Global AIDS Fund head Richard Feacham said last year, have the effect of "either pushing [drug] prices up or preventing their fall," further limiting the availability of affordable medications.\par Canada recently amended its patent laws to permit the pharmaceutical industry to use the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  exemption, but according to Mr. Richard Elliot, the director of legal research and policy at the Canadian HIV/AIDS Legal Network and a member of the government's Ministerial Council on AIDS, its provisions too are complex and restrictive. So far, he told Africa Renewal, no Canadian company has sought an export license under the new law.\par Short on resources, long on needs\par The rapid expansion of AIDS treatment programmes has brought with it equally dramatic demands for new resources. And while the 3x5 campaign and the US programme have short-term targets, they are creating long-term obligations to the millions of people entering treatment, since ARV therapy must continue for life. When UNAIDS was launched in 1996, the organization noted recently, global spending on the full range of HIV/AIDS initiatives in low- and moderate-income countries was $300 mn. Last year, reports the Washin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ton-based Kaiser Family Foundation, spending topped $6 bn.\par But even that impressive figure, notes the UN's Mr. Lewis, is just half the $12 bn UNAIDS estimates is nee}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ed this year to continue expanding treatment programmes and meet education, prevention, counselling and research needs. The Global Fund needs $1 bn this year to cover its commitments, he says. "WHO is short $60 mn for the final vital push on 3x5 and they still don't have it. I don't understand this grudging incrementa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ism by Western countries. We're losing incredible numbers of lives every day."\par UNAIDS estimates that by 2007 $20 bn will be needed for the fight against AIDS, and Mr. Lewis calls on wealthy governments to make major new commitments at the upcoming meeting of the Group of Eight indu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 trialized countries. "We have more money now, but in a few years we'll be fighting desperately for dollars again. Prices for the next generation of drugs are very, very high. They will have to be negotiated down and ways found to make generics."\par "Everywhere we turn we have impediments," he acknowledges. "But we also have a momentum that is u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 stoppable. I see the focus everywhere in Africa. Now the commitment is tremendous."\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV (99%); AIDS & HIV TREATMENT (91%); SEXUALLY TRANSMITTED DISEASE (90%); PUBLIC HEALTH ADMINISTRATION (89%); HEALTH CARE ACCESS (78%); GENERIC DRUGS (78%); ANTIVIRALS (78%); DISEASES & DISORDERS (78%); AIDS POLICY (76%); VIRUSES (76%); M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 LARIA (76%); PHARMACEUTICALS PATENTS (73%); HEALTH DEPARTMENTS (73%); DEVELOPING COUNTRIES (72%); UNITED NATIONS INSTITUTIONS (71%); TUBERCULOSIS (71%); INTERNATIONAL ASSISTANCE (67%); GENERIC PRODUCTS (65%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MARTIN PLAUT (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (82%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AFRICA (94%); SOUTH AFRICA (92%); UNITED STATES (92%); SUB SAHARAN AFRICA (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 JOHANNESBURG, SOUTH AFRICA (92%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (81%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 May 2, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2005 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Business Times Singapore April 12, 2005 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_48}{\*\bkmkstart DOC_ID_48_0}{\*\bkmkstart doc_id_5}{\*\bkmkend DOC_ID_48}{\*\bkmkend DOC_ID_48_0}{\*\bkmkend doc_id_5}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_5"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0035000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 5 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Is it the end of cheap drugs from India?;\par Medicine prices may soar in a few years as the country can no longer make generic drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  12, 2005 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par Yogi Aggarwal\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 THE Indian pharmaceutical industry is at a cusp. Prices of medicines could start rising sharply in three to five years and Indian companies, which had prospered under the Indian Patent Act of 1970, could see their fo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tunes declining as those of the multinationals rise.\par 'What is at stake is the health of the Indian people and even their lives,' says Yusuf Hameid, the Cambridge-educated organic chemist who heads }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 , one of India's largest pharmaceutical companies.\par The earlier legislation only recognised 'process' patents and allowed Indian companies to reverse engineer drugs to manufacture them by another route. It led to India having the cheapest medicine prices in the world, typically less than a tenth of those prevailing in neighbouring Pakistan, which largely imported them. \par While trade minister Kamal Nath assured the Indian Parliament when the Patent Amendment Bill was intr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 duced on March 22 that 'strong safeguards and comprehensive provisions' would check any price increases and availability of medicines, the industry, health workers and many parliamentarians were far from co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 vinced.\par But if the public protest in India was muted, it was more vocal in African countries which heavily rely on Ind}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 an anti-Aids drugs in their public health programmes. A few days before the Bill was to be voted in Parli}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment, there were demonstrations in Nairobi and Kampala. Many international health NGOs, including the Geneva based Doctors Without Borders (Medecin Sans Frontiers - MSF) came to India to campaign against the bill.\par Michael Angaga, African Regional Co-ordinator of Network of African People Infected with HIV/Aids, said in a telephone conversation: 'Generic drugs from India are used in public hospitals in Nairobi. People cannot a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ford patented drugs manufactured by MNCs in Kenya or other African countries. We appeal to the Indian Parliament to see this as a humanitarian issue since otherwise millions of people will die in Africa as the pu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lic health system will collapse. Patented medicines cost as much as US$100, which is a family's monthly i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 come.'\par This feeling was echoed by the MSF, whose spokeswoman, Ellen Thoen, told The Business Times: 'It is very sad and a matter of great concern that India should no longer have process patents which made medicines so affordable. But we realise that India has obligations under the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  and within that we understand the government could not do otherwise. India has modified the earlier ordinance and we take that as a positive signal.'\par While the amended bill as passed is a vast improvement on the ordinance passed by the government in D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cember 2004 (it was formulated by the earlier BJP-led government in 2003) to meet the January 2005 dea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 line under }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 , it has not used the full flexibility allowed under the trade-related aspects of intellectual pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 erty rights (Trips) negotiations.\par Concern\par Many of the provisions also make the domestic pharmaceutical industry uneasy. Some of the amended se}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tions are worded such that 'they could have been drafted in a multinational company's office' says one o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 server.\par There are several areas of concern. One is whether patents can be extended beyond the stipulated 20 years by some small change. Another relates to whether patented medicines will compulsorily have to be licensed to Indian manufacturers or if the patent holder can retain a monopoly over their supply.\par The backdating of patents from 1995 instead of 2005 has also been criticised, and it is feared that the amb}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 guity in the royalty payable could lead to time consuming and expensive litigation. And while Indian comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nies will be allowed to export some vital drugs to countries which do not have a manufacturing base, they will not be allowed to sell them in India.\par One paradoxical fact is that while less than 25 new molecules have been discovered in the 10 years from 1995 to 2004, there are some seven to eight thousand applications for patents pending or in the 'mailbox' in the Indian patent office. This is because most of them are frivolous and even if 90 per cent are rejected by the office, this still leaves several hundred dubious applications which would have to be opposed, opening a Pandora's box of litigation.\par Spokesmen for drug industry associations concede that while many of their objections to the earlier ord}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nance were met, some were not. Says Dara Patel, secretary general of the Indian Drug Manufacturers Ass}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ciation (IDMA): 'Most of our recommendations were accepted but our suggestions on compulsory license procedure and more powers for the government did not get through.'\par 'We are not against patents, we are against monopoly,' explains Dr Hameid of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 . 'There is an intimate link between monopoly and prices, greater monopoly leading to higher prices'. He poses a vital and painful question: 'Does the globalisation of healthcare imply that we have the means to treat the sick and needy but are at a liberty to make the terrible choice between profits and lives?'\par To answer that, we have to look at how the first world chose to respond to the Aids epidemic. Before }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  started making retroviral drugs for treating Aids, the annual cost of treatment was US$ 2,000, several times the family income of those afflicted by Aids in Africa and Asia. In 2000, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  came out with a formulation which it offered to the international community for US$800 a year and within a year was able to offer an Aids treatment for under US$300 a year.\par There was an international uproar against the looting by big pharma. 'Everyone suddenly knew that effective, affordable anti-Aids drugs were available from Indian generic manufacturers. The monopoly leading to high prices of drugs the patent regime had created stood clearly exposed. Thy were forced to drop prices to US $800. This still allowed a huge profit as the cost was around US$100,' says Dr Hameid.\par Monopoly, and the advantage of controlling knowledge for profit lie at the heart of linking intellectual property rights under Trips to trade negotiations under the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 . India had opposed the new IPR first proposed at the Gatt trade negotiations in the early 1990s, but like many other countries, was browbeaten into submission.\par The target of attack is the 1970 Indian Patents Act, which has allowed the Indian pharmaceutical industry to become a force to reckon with. In 1971, drug prices in India were as high as in Pakistan and 33 of the top 50 pharmaceutical companies were multinationals who had a 70 per cent market share of the total industry sales of Rs 3.6 billion. (S$126 million).\par By 1996, the industry sale had grown to 109 billion rupees with multinationals having a market share of 34 per cent. By 2004, the industry had further grown to 354 billion rupees and 37 of the top 50 companies were Indian, while the market share of Indian companies had grown to 78 per cent.\par Exports of drugs from India in 2003-04 touched US$3.18 billion while imports were just US$687 million. The wide use of affordable Indian medicines in Africa and Asia also meant that potentially lucrative markets were being lost to US and European drug companies. This had to change.\par Changes\par The powerful multinational drug companies pushed for the changes evident in the December 2004 Ord}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nance. Though they have had to yield a little ground in the bill as passed recently, the Indian industry is now on the defensive. As new patented molecules start coming into the market from 2008, their prices will be much higher.\par Indian companies will lose ground and market share. The people of India will find themselves paying much more for medicines. Many will not be able to afford them. 'In another 20 years,' muses Dr Hameid, 'we'll be back to where we started in 1970 and a large part of Indian industry will have been acquired by the multin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tionals.'\par Unless, that is, further amendments are made in the bill to ensure that affordable medicines continue to reach the Indian people without hindrance.\par The writer is a Mumbai-based journalist who contributes regularly to BT\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par  DRUG PRICES (92%); EDITORIALS & OPINIONS (91%); PHARMACEUTICALS INDUSTRY (90%); P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TENTS (90%); LEGISLATION (90%); PATENT LAW (90%); LEGISLATIVE BODIES (90%); GENERIC DRUGS (90%); PHARMACEUTICALS PATENTS (89%); PHARMACEUTICAL PREPARATION MFG (89%); MULTINATIONAL CORPORATIONS (89%); INTELLECTUAL PROPERTY LAW (89%); AIDS & HIV TREATMENT (78%); PRICE INCREASES (78%); AIDS & HIV (78%); MEDICAL CHARITIES (78%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 LECTUAL PROPERTY (78%); NONGOVERNMENTAL ORGANIZATIONS (77%); COMMERCE DEPAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MENTS (73%); REVERSE ENGINEERING (72%); PROTESTS & DEMONSTRATIONS (72%); PHYSICIANS & SURGEONS (70%); RELIEF ORGANIZATIONS (70%); HOSPITALS (65%); INTERNATIONAL ASSI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TANCE (65%); \par \par  CIPLA LTD (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 VIEWS AND OPINIONS; BT Comment Others\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1347 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 April 11, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2005 Singapore Press Holdings Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PanAfrica;New Law in India Drives Up Africa's Cost of Halting Aids Africa News March 29, 2005 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_49}{\*\bkmkstart DOC_ID_49_0}{\*\bkmkstart doc_id_6}{\*\bkmkend DOC_ID_49}{\*\bkmkend DOC_ID_49_0}{\*\bkmkend doc_id_6}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_6"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0036000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 6 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 March}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  29, 2005 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 PanAfrica;\par New Law in India Drives Up Africa's Cost of Halting Aids}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Business Day\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 752 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 THE Indian government's recent moves to curtail the copying of patented medicines have received a mixed response in SA. Critics warn this threatens the future supply of cheap drugs, but manufacturers hope that India's new patent laws will boost their prospects.\par Last week India amended its 1970 Patent Act to bring it in line with its World Trade Organisation (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ) obl}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gations. The amendments extend the scope of patentable inventions to include products; previously the law only allowed "process patents", which enabled drug makers to copy other firms' products by making small changes in manufacturing. \par "The 1970 law let the Indians reverse engineer, which is what they became very good at," says Jonathan Berger, a researcher at the AIDS Law Project at the University of the Witwatersrand.\par India's generic AIDS drug industry flourished in the absence of patents, and today it supplies drugs to about half of the 700000 people receiving HIV treatment in developing countries, says Marta Darder, the South A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 rican advocacy co-ordinator for Medicines Sans Frontieres, which provides treatment to 2500 patients in SA.\par }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\highlight7\insrsid15420928\charrsid15420928 Cheap, high-quality Indian generics such as those made}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  by }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  and Ranbaxy have boosted competition, says Berger, driving the price of generic AIDS drugs down to affordable levels for people in the developing world.\par A month's supply of generic antiretroviral medicines typically costs about $30, or 5% of the price paid in d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 veloped countries.\par Because of a last-minute concession to activists, India's new patent laws do not threaten the supply of gene}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ic drugs already on the market, but critics are worried about the supply of drugs in the pipeline.\par Indian generic firms will have to wait three years before they can apply for licences to produce copies of p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tented drugs. If their application is opposed, litigation in courts could hold up the launch of generic versions for years, says Berger.\par The new laws also say that generic companies must pay "reasonable royalties" to a patent holder which grants them manufacturing licences, but doesn't set a limit.\par Critics fear this will drive up the price of generics, making them too expensive for many patients.\par "It's disappointing to see that India didn't follow recent international trends and set a royalty limit of 4%-5%," says Tenu Avafia, a researcher at the Trade Law Centre for Southern Africa.\par Europe's biggest drug maker, GlaxoSmithKline, tried to charge royalties of 45% for a licence to make copies of its AIDS drugs in SA before it reached a settlement with activists and the Competition Commission, which set royalties at 5%.\par India's new patent laws include provisions for the issuing of "compulsory licences" in a public emergency, effectively cancelling a drug maker's patent rights and allowing India to export drugs to countries unable to manufacture them.\par But its ambiguous provisions mean that litigation concerning compulsory licenses could be lengthy and co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 plicated, says Avafia. So far no developing country lacking the capacity to manufacture essential medicines has made use of a special }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  mechanism designed to assist them issue compulsory licenses to import such drugs.\par Afavia suggests that South African consumers are in a slightly more fortunate position than many of their African counterparts, as there is a strong local generics industry. Aspen Pharmacare is Africa's largest g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 neric drug maker and will supply a large number of the AIDS drugs provided in government clinics. But wit}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 out competition from other generic companies, prices may eventually rise, he says.\par The National Association of Pharmaceutical Manufacturers, which represents South African generic drug makers, is optimistic.\par The new patent laws will level the playing field between Indian and local firms, and increase competition, says association chairman Muhammad Bodhania.\par He says the nature of the Indian generics industry is set to change significantly, with firms likely to shift their attention to medicines that are no longer protected by 20-year patents. This is the market segment South African firms such as Aspen and Adcock Ingram focus on, because SA has strong patent laws.\par Bodhania says local firms that import raw materials from Indian drug makers already comply with South Afr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 can patent laws, and so their supplies should not be affected by last week's developments. But he concedes that in the long term there might be problems if the Indian raw materials industry dwindles.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PATENTS (93%); GENERIC DRUGS (92%); ANTIVIRALS (91%); AIDS & HIV TREATMENT (91%); AIDS & HIV (91%); GENERIC PRODUCTS (90%); PHARMACEUTICALS PATENTS (90%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 LECTUAL PROPERTY LAW (90%); PHARMACEUTICALS INDUSTRY (90%); PATENT LAW (90%); PHARMACEUTICAL PREPARATION MFG (89%); ROYALTIES (89%); DRUG PRICES (89%); LEGISL}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TION (89%); DRUG DESIGN & DISCOVERY (78%); INTERNATIONAL TRADE LAW (77%); EMERGING MARKETS (77%); DEVELOPING COUNTRIES (77%); TRADE DEVELOPMENT (76%); INTERNATIONAL TRADE (76%); EXPORT TRADE (76%); PHARMACEUTICALS PRODUCT DEVELOPMENT (75%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TERNATIONAL ECONOMIC ORGANIZATIONS (73%); EXPORT CONTROLS (72%); LICENSES & PE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MITS (68%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (90%); GSK (NYSE) (84%); GSK (LSE) (84%); RANBAXY (NSE) (55%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (90%); SIC2834 PHARMACEUTICAL PREPARATIONS (90%); SIC2834 PHARMACEUTICAL PREPARATIONS  (84%); N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ICS325411 MEDICINAL & BOTANICAL MANUFACTURING (55%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (55%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 JONATHAN BERGER (62%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION  (83%); WORLD TRADE ORGANIZATION (83%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 INDIA (98%); AFRICA (93%); EUROPE (79%); SOUTHERN AFRICA (79%); SOUTH AFRICA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION (83%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 March 29, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2005 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Zambia;India's Cheap Medicines Africa News March 29, 2005 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_50}{\*\bkmkstart DOC_ID_50_0}{\*\bkmkstart doc_id_7}{\*\bkmkend DOC_ID_50}{\*\bkmkend DOC_ID_50_0}{\*\bkmkend doc_id_7}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_7"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0037000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 7 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 March}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  29, 2005 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Zambia;\par India's Cheap Medicines}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Post\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 776 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 INDIA'S enactment of a law making it illegal for their pharmaceutical companies to make generic copies of patented drugs will certainly deprive millions of people across the world of inexpensive life-saving medicines.\par This law was enacted in compliance with India's commitment to the World Trade Organisation's Agreement on Trade-related Aspects of Intellectual Property Rights, or TRIPS.\par This law is very difficult to accept for us who believe that the highest level of political and economic thought was reached when some people became aware that no people and no human being had the right to exploit others, and that the fruits of the efforts and intelligence of each human being should reach all others; that man really had no need to be a wolf, but could be a brother to man.\par And although the Indian Congress Party government has pledged to its leftist allies and other opposition lawmakers that the new law won't push up the medicine prices in the country, we don't see how this will be guaranteed, especially for the export market. \par India's pharmaceutical market has thrived in the last three decades because the country's law had allowed patented drugs to be copied, as long as a different manufacturing process is used to make them. The co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 panies were legally producing generic versions of medicines that were under patent elsewhere, including the much in demand low-cost AIDS drugs for 50 per cent of nearly one million HIV patients taking antiretroviral medicines in developing countries.\par Some of the AIDS drugs made by reputable Indian companies cost about 5 per cent of the price of similar drugs sold by United States and European Union pharmaceutical companies.\par We know that the news of the new Indian law is honey to the ears of international pharmaceutical companies but this law will spell doom for the access to medicine in poor and developing countries by sky-rocketing the drug prices, making them unaffordable.\par Indian pharmaceutical majors like }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  and Ranbaxy were spearheading making AIDS drugs and exporting them to African nations at a very low cost as compared to multinational pharmaceutical majors. All this seems to be changing now.\par This new law spells long-term disaster for India and other Third World countries in health. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  had virtually become a household name in African countries, as its generic or chemically similar AIDS drugs took on mu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tinational companies selling in the market.\par In Africa, exports by Indian companies, helped nose-dive the annual price of antiretroviral treatment down from US $14,000 a decade ago to about $200. They also simplified the therapy by making pills containing three AIDS drugs.\par Generics made up about 15 per cent of India's $10 billion pharmaceutical industry that has 300 large and moderate-sized firms, plus 10,000 small companies, making 8 per cent of the world's drugs. According to pharmaceutical industry statistics, nearly 70 per cent of production is by the top 100 companies and about a third of that is exports, which were rising by 25 per cent a year. Indian companies will no longer be able to make copies of over-priced western drugs, which will affect poor countries around the world.\par But the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  obligation does not require India to grant patents on new uses of known drugs, or combinations of known drugs. However, Indian lawmakers have included double-usage patents in their law. A drug like AZT, which was used against cancer in the mid '70s and now used for HIV, can be patented simply on the grounds of new usage.\par And five cancer drugs such as Gefitinib, Temozolomide, Zoledronic acid, Letrozole and Ganciclovir are set to see a multi-fold increase in prices, as a result of this new law. Prices on these drugs will increase between two and 12 times.\par And simply because India is one of the world's biggest producers of generic drugs, this law will have a s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 vere ripple effect on many developing countries which depend on imported generic drugs from India.\par Under the agreement on intellectual property at the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 , India had to introduce amendments to its existing patent Act by January 1, 2005. Unfortunately, the Indian government waited until the very last minute and then rushed it through the parliament, leaving no space for democratic debate and consideration of wider public health implications.\par We are deeply disturbed and concerned that the Congress Party government has failed to listen to the voi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 es of so many people who have entrusted them with their welfare. And it is difficult to accept the Indian go}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ernment's assurance that it has enough safeguards to protect the interests of the poor. How?\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PHARMACEUTICALS INDUSTRY (91%); PHARMACEUTICAL PREPARATION MFG (90%); GENERIC PRODUCTS (90%); PHARMACEUTICALS & BIOTECHNOLOGY REGULATORY COMPLIANCE (90%); PHARMACEUTICALS PATENTS (90%); AIDS & HIV TREATMENT (90%); INTELLECTUAL PRO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ERTY LAW (90%); GENERIC DRUGS (90%); AIDS & HIV (90%); ANTIVIRALS (89%); DRUG PRICES (89%); INTERNATIONAL TRADE (89%); EXPORT TRADE (89%); LEGISLATION (89%); DEVELOPING COUNTRIES (89%); LEGISLATORS (78%); PATENT LAW (78%); MULTINATIONAL CORPORATIONS (77%); EXPORT PRICES (72%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (58%); RANBAXY (NSE) (52%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (58%); SIC2834 PHARMACEUTICAL PREPARATIONS (58%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ING (52%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (52%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION  (58%); WORLD TRADE ORGANIZATION (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 INDIA (95%); AFRICA (93%); ZAMBIA (92%); UNITED STATES (79%); EUROPEAN UNION MEMBER STATES (53%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION (60%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 March 29, 2005\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2005 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PanAfrica;Goodbye to Cheap Indian Aids Drugs? Africa News November 26, 2004 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_51}{\*\bkmkstart DOC_ID_51_0}{\*\bkmkstart doc_id_8}{\*\bkmkend DOC_ID_51}{\*\bkmkend DOC_ID_51_0}{\*\bkmkend doc_id_8}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_8"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0038000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 8 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  26, 2004 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 PanAfrica;\par Goodbye to Cheap Indian Aids Drugs?}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Inter Press Service\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1225 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 As India moves to meet a New Year's Day deadline to comply with the Trade Related Aspects of Intellectual Property Rights (TRIPS) regime of the World Trade Organisation (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ) the cheap, generic anti-AIDS drugs that this country is famed for could be a thing of the past.\par On Nov.19, the World Health Organisation (WHO) announced that the Hyderabad-based pharmaceutical Hetero Drugs Limited, had voluntarily withdrawn all six of its generic antiretroviral (ARV) drugs from the world body's list of approved drugs following concerns about their laboratory tests.\par ARVs are substances used to kill or inhibit the multiplication of retroviruses such as HIV.\par It was the third time since June that an Indian company has removed anti-AIDS drugs following WHO inspe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tions which claimed that bioequivalence tests -- meant to show the drugs have the same effect as the original patented brands - were faulty. And this has deeply upset those involved in fighting the global HIV/AIDS ep}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 demic. \par Earlier this month Indian pharmaceutical giant Ranbaxy pulled its AIDS drugs off the WHO's list after the global body also claimed there were discrepancies in the equivalency tests. It followed the removal by India's }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  of two HIV/AIDS drugs in June for similar problems..\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  is the Indian company credited with introducing the 'dollar-a-day' treatment that dramatically tran}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 formed drug access for HIV-infected people around the world.\par But the fact of the matter remains.\par Both Ranbaxy and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  were able to prove to WHO, before the voluntary pull-off, that their ARVs met the global body's bioequivalence standards -- though not before their world business had taken a knock that benefited the manufacturers of costlier patented drugs.\par That initially led to charges from non-governmental organisations (NGOs) that the world health body was acting at the behest of western pharmaceutical giants.\par However, things, now, have become more complicated.\par Why did the two Indian pharmaceutical companies pull their ARVs from the market, if they had insisted all along that their drugs met WHO pre-qualification standards?\par "We are concerned over the withdrawals. Earlier it was WHO which dropped the drugs. This time the co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 panies are doing it own their own. We may ask the Drugs Controller of India (DCGI) to look into the issue," a senior health official told IPS.\par WHO's pre-qualification list was created to guide procurement by aid agencies and donors interested in fighting the global HIV/AIDS epidemic and includes more than 60 ARVs made by both patented and generic drug manufacturers.\par According to the internationally-known drug policy expert, Mira Shiva, the actual culprit in the whole debacle involving Hetero, Ranbaxy and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  was actually the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  and not WHO.\par Shiva who is attached to the Voluntary Health Association of India (VHAI), a leading health NGO, said Indian pharmaceutical companies that specialise in cheap generics drugs could face legal action, initiated by the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 , if they continued to manufacture and sell them after Jan. 1, 2005.\par "The TRIPS regime (in the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  structure) has been identified as one of the worst international trade r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gimes and resistance to it in developing countries has come from farmers, public interest and human rights minded social action groups, as well as drug and health activists," Shiva told IPS.\par TRIPS agreement, introduced in the late 1990s, defines how products can be protected from piracy. A major criticism has been that in its current form, intellectual property rights regimes (IPR) -- like TRIPS -- serve to stifle competition. For poor nations it makes developing their own industries independently more costly, if at all possible.\par "Excessively high levels of intellectual property protection required by TRIPS have shifted the balance away from the public interest, towards the monopolistic privileges of IPR holders," said Martin Khor of the Mala}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sia-based Third World Network. "This undermines sustainable development objectives, including eradicating poverty, meeting public health needs, conserving biodiversity, protecting the environment and the realisation of economic, social and cultural rights."\par Shiva pointed out that a TRIPS review was due in 2000 but was never carried out although the WHO was both aware and concerned about the effect the regime would cause to drug prices and access especially in the developing countries.\par So far, India's pharmaceutical business has followed the fiercely nationalistic India Patents Act of 1970 that fostered the phenomenal growth of the industry that came to be hailed by the United Nations Council for Trade and Development (UNCTAD) as a model for developing countries.\par According to a World Bank study in the mid-1990's prices for four typical drugs were ten times more expe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sive in neighbouring Pakistan, 17 times more expensive in Britain and 37 times more expensive in the United States than in India.\par The Indian law has safeguards for both inventors as well as users but recognizes process patents as against the product patents regime required by TRIPS/}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 .\par An amendment to the Act, designed to meet the WHO deadline is slated to be tabled by the government du}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing the winter session of the Indian Parliament next month. If the government fails to get a consensus, it is expected to resort to an ordinance.\par India signed the relevant }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  agreement on the issue in 1995 as part of its economic liberalisation under a Congress government but the party lost the elections in the following year because of widespread public pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ception that globalisation had benefited only a small elite.\par The Congress party had to wait eight years before it could return to power in May on a promise to pursue liberalisation "with a human face." But Kamal Nath its current minister for commerce and industry said the country could not avoid taking at least "credible steps" to fulfill its multi-lateral obligations.\par Political opposition to the bill that would amend the Indian Patents Act has come from the major communist parties united as the Left Front, which provides critical support to the Congress-led coalition government.\par "The Jan. 1 deadline should not be used as a plea to rush through legislation for which the country may have to pay a heavy price later," said D. Raja, National Secretary of the Communist Party of India (CPI).\par In the meanwhile Poornima Mane, director for social mobilisation and communication at UNAIDS, the U.N. body charged with fighting HIV/AIDS said patients should continue using Ranbaxy and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  drugs that are available in the market.\par "We want to clarify this so that patients do not panic. This (the voluntary withdrawals) does not mean that the drugs are not good. The worst thing will be if people stop using these drugs and develop resistance," she said.\par But Mane said both UNAIDS and WHO were monitoring the situation in India "since this country will have to follow the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  restrictions coming up next year and also because it is the biggest producer of generic drugs."\par India itself has 5.1 million people afflicted with HIV according to the 'AIDS Epidemic Update', an annual r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 port prepared by UNAIDS and WHO and released here this week. Globally, the number of the HIV-afflicted people has reached 39.4 million up from the 36.6 million estimated in 2002.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV TREATMENT (94%); AIDS & HIV (94%); ANTIVIRALS (92%); INTERNATIONAL ECONOMIC ORGANIZATIONS (90%); INTERNATIONAL TRADE (90%); PHARMACEUTICAL PREPAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TION MFG (89%); EPIDEMICS (89%); NONGOVERNMENTAL ORGANIZATIONS (89%); INTELLECTUAL PROPERTY LAW (89%); PHARMACEUTICALS INDUSTRY (89%); GENERIC DRUGS (89%); PUBLIC HEALTH ADMINISTRATION (89%); DISEASES & DISORDERS (89%); RELIEF ORGANIZATIONS (89%); PUBLIC POLICY (78%); PHARMACEUTICALS & BIOTECHNOLOGY REGULATORY COMPLIANCE (78%); PHARMACEUTICALS PATENTS (77%); PRESCRIPTION FORMULARIES (77%); HEALTH DEPAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MENTS (77%); VIRUSES (75%); GENERIC PRODUCTS (72%); DRUG POLICY (72%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (92%); RANBAXY (NSE) (55%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (92%); SIC2834 PHARMACEUTICAL PREPARATIONS (92%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ING (72%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (72%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MIRA SHIVA (74%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION  (91%); WORLD TRADE ORGANIZATION (91%); WORLD HEALTH ORGANIZATION  (90%); WORLD HEALTH ORGANIZATION (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 INDIA (94%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 STATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ANDHRA PRADESH, INDIA (73%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYDERABAD, INDIA (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HETERO DRUGS LTD (66%);  WORLD TRADE ORGANISATION (84%);  HETERO DRUGS LTD (72%); RANBAXY LABORATORIES LTD (55%);  WORLD TRADE ORGANIZATION  (91%); WORLD HEALTH ORGANIZATION  (90%); WORLD HEALTH ORGANIZATION (90%); WORLD TRADE ORGAN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ZATION (84%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 November 29, 2004\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2004 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PanAfrica;Daily HIV/Aids Report Africa News July 13, 2004 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_52}{\*\bkmkstart DOC_ID_52_0}{\*\bkmkstart doc_id_9}{\*\bkmkend DOC_ID_52}{\*\bkmkend DOC_ID_52_0}{\*\bkmkend doc_id_9}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_9"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000a00000063006900740065005f00690064005f0039000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 9 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 July}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  13, 2004 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 PanAfrica;\par Daily HIV/Aids Report}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Kaisernetwork.org\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 11362 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Bangkok Daily Update\par Discussion at XV International AIDS Conference Focuses on How To Provide Antiretroviral Drugs to Deve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 oping World\par [Jul 13, 2004]\par Delegates and speakers at the XV International AIDS Conference in Bangkok, Thailand, on Tuesday called for broader accessibility to antiretroviral treatment, as access to HIV/AIDS medications continues to elude millions around the world. Jim Kim, who heads the World Health Organization project tasked with scaling up treatment -- the <a ="http://www.who.int/3by5/about/en/">3 by 5 Initiative</a> -- expressed shame over the six million people who have died of AIDS since the conference last met two years ago. "By these measures of human life, the ones that really matter, we have failed and we have failed miserably to do enough in the precious time that has passed since Barcelona," he said.\par Protestors agreed, arguing that the availability of cheap generic drugs would remove the largest barrier to access. But first, advocates said that brand-name pharmaceutical companies must forgo their patents for certain drugs in developing countries. Hank McKinnell, CEO of <a ="http://www.pfizer.com/">Pfizer</a>, a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gued that forgoing patents will dry-up innovation. "People living with HIV are going to need a steady stream of new therapies as this virus mutates and currently available treatments fail patients. If 'Access for All' is all that we do in the first sense, access for those needing medicines today, then the theme of future IAS confe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ences will surely be 'Why are treatments failing patients?'" \par However, maintaining research and development should not keep needed medications from people who cannot afford them, according to Walden Bello from the University of the Philippines. "R&D for HIV drugs and other essential medicines is no longer efficient within a corporate context. Big pharma is more interested in protecting its 20% margin, provided by monopolistic pricing based on patents, than in providing drugs to people with little purchasing power."\par Neither side denies there is a need to provide these medications; they just disagree on the best way to get them to the millions of people who need them (Jill Braden, Kaiser Daily HIV/AIDS Report, 7/13).\par Video highlights of the day's events are available <a ="http://www.kaisernetwork.org/health_cast/hcast_index.cfm?display=detail&hc=1178">online</a>.\par Bangkok Notebook\par Kaiser Family Foundation Senior Visiting Fellow Jackie Judd Discusses XV IAC Events With Science R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 porter Jon Cohen\par [Jul 13, 2004]\par Kaiser Family Foundation Senior Visiting Fellow Jackie Judd each day during the <a ="http://www.aids2004.org/">XV International AIDS Conference</a> is interviewing Science magazine corr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 spondent Jon Cohen about news coming out of the conference. On Monday, Jon discussed an opening ce}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 emony that did not go as planned, and on Tuesday he talked about the bold admission by World Health O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ganization HIV/AIDS Program Director Jim Kim, who said that the world has "failed miserably" to provide treatment to HIV-positive people worldwide. The interviews are available <a ="http://www.kaisernetwork.org/health_cast/hcast_index.cfm?display=detail&hc=1181">online</a> from ka}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sernetwork.org (Kaiser Daily HIV/AIDS Report, 7/13).\par Global Challenges\par Costs for Antiretroviral Drug Treatment, HIV Prevention, AIDS Orphan Care in Developing Countries Will Be $12B by 2005, UNAIDS Report Says\par [Jul 13, 2004]\par The cost of providing antiretroviral drug treatment, care for AIDS orphans and HIV prevention in services in developing countries is expected to reach $12 billion by 2005 and could reach $20 billion by 2007, according to a report released Monday by UNAIDS, the <a ="http://sfgate.com/cgi-bin/article.cgi?f=/c/a/2004/07/13/MNG2B7KGJQ1.DTL">San Francisco Chronicle reports. The bulk of the increase reflects the cost of expanding treatment from fewer than 500,000 people to six million HIV-positive people by 2007, as well as the provision of essential services, according to the report (Russell, San Franci}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 co Chronicle, 7/13). According to the report, titled "Financing the Expanded Response to AIDS," funding for next year is still anticipated to fall short by $6 billion in 2005, even though total global spending to combat HIV/AIDS increased from $1.2 billion in 2000 to $6 billion in 2004. UNAIDS researchers used new data from 78 countries on "actual costs" for prevention, care, treatment, orphan support, policy, advocacy and admini}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 trative programs to complete the report. Bilateral support for the efforts to combat the HIV/AIDS pandemic has increased 64% among leading donor countries between 2000 and 2002. UNAIDS predicts that bilateral spending will reach $1.3 billion by the end of 2004, according to a UNAIDS <a ="http://www.unaids.org/NetTools/Misc/DocInfo.aspx?LANG=en&=http%3a%2f%2fgva-doc-owl%2fWEBcontent%2fDocuments%2fpub%2fMedia%2fPress-Releases02%2fPR_Funding-BKK_12Jul04_en%26%2346%3bpdf">release</a>.\par U.S. Spending\par According to the report, the United States is the leading bilateral donor "in terms of absolute dollars," the r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lease said (UNAIDS release, 7/12). The House Appropriations Committee on Friday approved by voice vote a $19.4 billion foreign aid spending bill for fiscal year 2005, <a ="http://www.reuters.com/newsArticle.jhtml?type=topNews&storyID=5633849">Reuters</a> reports. The foreign aid bill provides $2.2 billion for HIV/AIDS, tuberculosis and malaria initiatives. Some critics have called the amount "inadequate" compared with the funding provided for the war on terror and post-war Iraq, Reuters reports (Willard, Reuters, 7/9). Although the approved funding -- most of which will go to AIDS pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 grams -- meets President Bush's request for FY 2005, an appropriations subcommittee allocated a larger portion of the money to the <a ="http://www.theglobalfund.org/en/">Global Fund to Fight AIDS, Tuberculosis and Malaria than Bush had requested. Bush's proposed FY 2005 budget, which is $1.9 billion more than the total amount the subcommittee approved, includes $2.8 billion for international HIV/AIDS, TB and malaria programs. That amount includes $1.45 billion for the <a ="http://www.state.gov/">State Department</a> <a ="http://www.state.gov/s/gac/">Office of the Global AIDS Coordinator, which will administer the <a ="http://www.state.gov/s/gac/rl/or/c11652.htm">President's Emergency Plan for AIDS Relief, and $200 mi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lion for the Global Fund. Because the draft spending bill would double the requested Global Fund contrib}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion to $400 million, less money would go to PEPFAR. The $2.2 billion approved by the House subcommittee combined with an anticipated $600 million in funding from the Labor-HHS-Education appropriations bill would bring overall global AIDS, TB and malaria spending to $2.8 billion for FY 2005 (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=24395">Kaiser Daily HIV/AIDS Report, 6/24).\par Funding Gap Getting Worse?\par UNAIDS Director of Evaluation Dr. Paul De Lay said, "Unless more resources are directed toward the global response, the gap between the need and available resources will grow significantly in coming years" (U}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS release, 7/12). The situation could be worsened by a lack of inexpensive second-line treatments for HIV-positive people who develop resistance to first-line drugs, according to the Chronicle. Because about 10% to 20% of people living with HIV/AIDS who take antiretroviral drugs develop resistance, some adv}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cates predict the costs for providing second-line treatments to cause a "sort of balloon payment down the road," the Chronicle reports.\par Global Fund\par Advocates are "step[ping] up their campaign" for wealthy countries to increase their donations to the Global Fund. Richard Feachem, executive director of the fund, said that it would not be possible to reach the fund's 2005 $3.5 billion goal if wealthy countries do not increase contributions, according to the Chronicle (San Francisco Chronicle, 7/13). U.N. Special Envoy for HIV/AIDS in Africa Stephen Lewis said that funding co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cerns have put efforts to combat HIV/AIDS "on the knife's edge of the chasm," adding, "Either we continue the flow of funds and continue to increase treatment and make people feel there's hope, or we suffer a dreadful setback in responding to the pandemic." Ambassador Randall Tobias, head of the State Department Office of the Global AIDS Coordinator, said that the United States is "certainly going to continue to contribute to the Global Fund," but he added, "We need to put more emphasis on getting [the money already contribu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ed to the fund] put to work." <a ="http://www.globalaidsalliance.org/">Global AIDS Alliance</a> President Paul Zeitz said that the funding situation amounts to a "battle between a U.S. go-it-alone approach and mult}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lateralism" (Nakashima, Washington Post, 7/13).\par Abstinence Best Way To Prevent HIV/AIDS, Ugandan President Museveni Says\par  [Jul 13, 2004]\par Abstinence is the best way to curb the spread of HIV/AIDS, Ugandan President Yoweri Museveni said during a plenary session on the first full day of the XV International AIDS Conference in Bangkok, Thailand, <a ="http://www.reuters.co.uk/newsPackageArticle.jhtml?type=topNews&storyID=545616A\u223\'a7ion=news">Reuters</a> reports (Schuettler, Reuters, 7/12). Museveni has said that the country's HIV prevention slogan, "ABC" -- Abstinence, Be faithful, use Condoms -- could be used elsewhere in Africa to stem the spread of HIV. M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 seveni said that the "C" is meant to be a "fallback position," a "means of last resort" if a person "cannot ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 age A and B." Museveni also has said that the country has the funding, supplies and infrastructure in place to begin treating the 60,000 HIV-positive people in the country who need antiretroviral drugs (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=24461">Kaiser Daily HIV/AIDS Report, 6/29). Museveni said, "I look at condoms as an improvisation, not a solution," adding that he favors "optimal relationships based on love and trust instead of institutional mistrust which is what the condom is all about" (Reuters, 7/12). Museveni said that in some societies, sexual intercourse "is so elaborate that co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 doms are a hindrance" (<a ="http://www.ajc.com/news/content/news/0704/12aids.html">AP/Atlanta Journal-Constitution, 7/12). "Let the condom be used by people who cannot abstain, cannot be faithful, or are e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tranged," he added (BBC News, 7/12). Museveni's comments contradict the opinion of some health experts who support condom use as a first-line defense against HIV infection, according to Reuters (Reuters, 7/12).\par Reaction\par International AIDS Society President and conference Co-Chair Joep Lange said, "Condoms are effective, but you have to look at different cultures in each country." Dr. Tim Brown, director of the UNAIDS Collaborating Center at the <a ="http://www.eastwestcenter.org/">East-West Center</a> in Hawaii, said that condoms, in addition to abstinence, are an "essential component" of HIV/AIDS prevention campaigns, Reuters reports. Brown said, "We need to move our prevention programs back to prevention science, and the one thing that is very clear for young people is that the best programs are those that provide full information," including info}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 mation on abstinence, sexually transmitted diseases and condoms (Reuters, 7/12). <a ="http://www.ippf.org/">International Planned Parenthood Federation</a> Director-General Steven Sinding said, "The religious-focused or oriented groups denigrate condoms, and believe that serious efforts to control [HIV] can be successful without recourse to condoms, and we don't believe that" (BBC News, 7/12). Rep. Barbara Lee (D) -- the only member of Congress to attend the conference -- said that the Bush administr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion uses "ideology, not science, to dictate policy," according to Reuters (Reuters, 7/12). "In an age where five million people are newly infected each year and women and girls too often do not have the choice to a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 stain, an abstinence until marriage program is not only irresponsible, it's really inhumane," Lee said (Joshi, <a ="http://www.washingtontimes.com/world/20040712-094622-5261r.htm">AP/Washington Times, 7/13). She added, "Abstaining from sex is oftentimes not a choice, and therefore their only hope in preventing HIV infection is the use of condoms" (Reuters, 7/12).\par BBC's "<a ="http://www.bbc.co.uk/worldservice/programmes/worldupdate/">World Update" on Monday r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ported on abstinence as a method of preventing HIV/AIDS. The segment includes comments from Sinding (Hogg, "World Update," BBC, 7/12). The complete segment is available <a ="http://www.bbc.co.uk/worldservice/ondemand/rams/wup28014__2004.ram">online</a> in RealPlayer.\par Fight Against HIV/AIDS Hindered by Duplicated Efforts, XV International AIDS Conference Participants Say\par [Jul 13, 2004]\par The duplication of efforts by donors in the fight against AIDS is leading to waste and inefficiency and slowing the fight against the disease, a panel of experts at the XV International AIDS Conference said on Monday, the <a ="http://www.nytimes.com/2004/07/13/international/asia/13aids.html">New York Times reports. In a session titled "Funding the Response to HIV/AIDS: Why Are Donors Not Working Together?" moderator Hank McKinnell, CEO of Pfizer, said that the donor community is "pledging, moving and disbursing funds and materials at unprecedented rates." However, an overall "lack of agreement on approaches and key issues among the donors themselves has ... led to delays or problems in program implementation and coordin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion," Dr. Biziwick Mwale, executive director of the National AIDS Commission in Malawi, said. The partic}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 pants agreed that standardized measures to monitor the costs and effectiveness of prevention efforts as well as the adoption of U.N. recommendations on using resources efficiently are needed to improve coordination among donors and developing countries. However, participants offered no formal proposals, saying that it would "take more time to resolve the complexities involved in the relationships between donors and recipient countries," according to the Times (Altman, New York Times, 7/13).\par A kaisernetwork.org webcast of the session is available <a ="http://www.kaisernetwork.org/health_cast/hcast_index.cfm?display=detail&hc=1193">online</a>.\par Chinese Premier Wen Jiabao Appeals to Government, Public for Help in Fighting HIV/AIDS\par [Jul 13, 2004]\par Chinese Premier Wen Jiabao on Saturday ahead of the <a ="http://www.aids2004.org/">XV International AIDS Conference</a> in Bangkok, Thailand, released a public appeal for "all levels of government and the entire society [to] attach great importance to preventing and controlling AIDS," London's <a ="http://www.guardian.co.uk/aids/story/0,7369,1259101,00.html">Guardian</a> reports (Boseley, Guardian, 7/12). The Chinese government estimates that there are 840,000 HIV-positive people in the country and that 80,000 people have AIDS; however, some experts believe that those figures are an underestimate. The United Nations estimates that there are at least one million HIV-positive people in China (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=24484">Kaiser Daily HIV/AIDS Report, 6/30). Wen said that the rural areas where most of the population lives presented the greatest cha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lenge because of "backward hygiene and medical conditions" and because people in rural areas "are not well educated about legal and health issues" (Agence France-Presse, 7/9). Wen's statement, which was pu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lished on the front page of Chinese newspapers, called on Chinese scientists to "work hard to develop new drugs and optimize therapies" and said that prevention would be a "long-term, arduous task." In addition, Wen said that the country would invest more in the fight against the disease (Guardian, 7/12). Wen also called for expanded HIV testing -- 90% of HIV-positive people in the country are unaware of their status, a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cording to government figures (Agence France-Presse, 7/9). UNAIDS Executive Director Peter Piot on Mo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 day at a session on nongovernmental AIDS organizations in China said that Wen's statement showed that "China means business when it comes to AIDS." However, he said that the country must address AIDS-related stigma and other social issues, such as injection drug use, commercial sex workers and their clients and men who have sex with men (Associated Press, 7/12).\par Medical Students\par China plans to send 1,300 medical students to rural areas to help with HIV/AIDS prevention programs during their summer break, <a ="http://story.news.yahoo.com/news?tmpl=story&cid=571&ncid=751&e=5&u=/nm/20040710/hl_nm/aids_china_dc">Reuters</a> reports (Reuters, 7/12). The program is part of the country's AIDS education campaign that 12 government departments, ministries and organizations launched on Saturday. In addition, the go}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ernment will distribute millions of posters on AIDS prevention to rural villages, urban communities, univers}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ties and schools throughout the country. The education campaign also will include "face-to-face" AIDS ed}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cation for women ages 15 to 49 in 51 counties. Khalid Malik, U.N. resident coordinator in China, said that the program is one of the biggest HIV prevention initiatives in the world (Xinhua News Agency, 7/10).\par ABCNews' "<a ="http://abcnews.go.com/Sections/Nightline/">Nightline</a>" on Monday focused on HIV/AIDS in Russia and China, two countries where HIV prevalence rates are "exploding." The segment on China examines the unsafe blood collection practices that facilitated HIV transmission in the country and the stigma HIV/AIDS patients experience. The segment includes comments from UNAIDS Executive Director Peter Piot (Wright, "Nightline," ABCNews, 7/12). The segment on Russia examines the lack of needle-exchange programs in cities with high rates of injection drug use and profiles an orphanage serving HIV-positive children. According to "Nightline," Russian President Vladimir Putin has spoken exactly one se}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tence about HIV/AIDS (Litke, "Nightline," ABCNews, 7/12). A video excerpt of the segment on China is avai}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 able online in RealPlayer.\par Most Global Fund Grant Programs Performing as Expected, Some Underperforming, Fund Report Says\par [Jul 13, 2004]\par Twelve of the first 25 programs that received funding from the <a ="http://www.theglobalfund.org/en/">Global Fund to Fight AIDS, Tuberculosis and Malaria more than one year ago are either on schedule or ahead of schedule for meeting their goals, according to a report released on Monday at the XV International AIDS Conference, <a ="http://www.guardian.co.uk/international/story/0,3604,1258976,00.html">London's Guardian reports (Boseley, Guardian, 7/12). The report analyzed the first 25 grants for HIV, TB and malaria programs in operation for one year between May 1, 2003, and April 30, 2004 (Global Fund <a ="http://www.theglobalfund.org/en/media_center/press/pr_040711b.asp">release</a>, 7/11). The report, t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tled "A Force for Change: The Global Fund at 30 Months," also says that eight programs that received grants from the Global Fund are below target and five programs are underperforming. Of the five programs consi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ered to be underperforming, two are in Sri Lanka, two are in Senegal and one is in Tanzania, according to the report (Guardian, 7/12). Other countries -- such as Honduras, which placed nearly twice as many people on antiretroviral treatment as planned -- are "substantial overachievers," according to the release. The 25 programs have provided interventions such as testing, treatment and care to 2.3 million people and trained 340,000 people to administer antiretroviral drugs, according to the report. Sixty percent of Global Fund grants go to AIDS programs, through which about 12,000 people have received antiretroviral drugs, the r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 port says, according to the Guardian. Global Fund Executive Director Richard Feachem said that in five years, more than 1.6 million people are expected to be receiving antiretroviral treatment through programs receiving fund money (Guardian, 7/12). He added, "We hope this report is an indication that the innovative ways in which the Global Fund works are beginning to make the impact envisioned at its creation 30 months ago. The systems work and the Global Fund is ready to dramatically expand funding to countries fighting the three pandemics" (Global Fund release, 7/12).\par More Funding Needed\par Any delay in funding from major donors to the Global Fund will affect the group's efforts to fight the three di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 eases, especially HIV/AIDS, Feachem said, Thailand's Nation reports. The Global Fund needs $1.65 billion to fund projects through this year and an additional $3.56 billion in funds next year, according to Feachem (Arthit, Nation, 7/12). The Global Fund has approved grants to nearly 300 programs in 130 countries thus far; 25 of them have been running for more than one year, according to the Guardian (Guardian, 7/12). The group is planning to launch the fifth round of grants in November and the sixth round in the middle of 2005, but it will not be able to proceed without the necessary funds, according to the Nation. Donations to the Global Fund are expected to peak at $3 billion per year by 2008, with more than half of the total dedicated to AIDS programs (Nation, 7/12).\par Kaisernetwork.org on Tuesday webcasted a Global Fund <a ="http://www.kaisernetwork.org/health_cast/hcast_index.cfm?display=detail&hc=1222">session</a> and a <a ="http://www.kaisernetwork.org/health_cast/hcast_index.cfm?display=detail&hc=1193">session</a> on cooperation among donors in the fight against AIDS. The webcasts and other coverage are available <a ="http://www.kaisernetwork.org/aids2004/kffsyndication.asp?show=portal.html">online</a>.\par More Than 35 M Working-Age Adults Living with HIV/AIDS, International Labor Organization Report Says\par [Jul 13, 2004]\par About 36.5 million adults of working age are HIV-positive and about 28 million working-age adults have died from AIDS-related causes since the beginning of the epidemic, according to a report released on Sunday by the International Labor Organization at the <a ="http://www.aids2004.org/">XV International AIDS Confe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ence</a> in Bangkok, Thailand, <a ="http://www.voanews.com/article.cfm?objectID=A5A874E1-ED77-47DA-8B61D9FAC9FF1190&title=ILO%20Says%20HIV%2DAIDS%20Takes%20Heavy%20Toll%20%20at%20%20Workplace&catOID=45C9C786-88AD-11D4-A57200A0CC5EE46C&categoryname=Health%20%26%20Medicine">VOA News reports. ILO surveyed workers between the ages of 15 and 64 in 50 countries and found that HIV/AIDS is "one of the biggest cau}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 es of mortality in the working world," according to VOA News. The report, titled "<a ="http://www.ilo.org/public/english/protection/trav/aids/publ/global_est/index.htm">HIV/AIDS and Work: Global Estimates, Impact and Response," shows that if access to antiretroviral drug treatment is not i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 creased, the number of workers who die from AIDS-related causes will increase to 48 million by 2010 and 74 million by 2015, according to the report. In addition, about two million people by 2005 and four million by 2015 will be too ill to work and will have "dropped out of the labor force," Odile Frank, the report's author, said. The loss of workers at their most productive stage in life costs the world approximately $25 billion a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nually, according to the report (Schlein, VOA News, 7/1). In addition, young women -- who are usually r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sponsible for caring for family members with HIV and other family members in addition to often being r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sponsible for subsistence farming -- account for the largest increases in HIV-prevalence rates worldwide, the report says, according to <a ="http://news.xinhuanet.com/english/2004-07/12/content_1591227.htm">Xinhuanet</a>. The combination of these factors "jeopardizes their capacity" to provide food for the household and care for family members, Xinhuanet reports (Xinhuanet, 7/11). ILO D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 rector-General Juan Somavia said, "HIV/AIDS is not only a human crisis, it is a threat to sustainable global, social and economic development," adding that the loss of life from AIDS-related causes and the "debilitating effects of the illness will lead not only to a reduced capacity to sustain production and employment, reduce poverty and promote development, but will be a burden borne by all societies -- rich and poor alike" (Xinhua News Agency, 7/11).\par 'Brain Drain' of African Health Workers Slowing Fight Against AIDS, Physicians for Human Rights Report Says\par [Jul 13, 2004]\par A "brain drain" of health care workers from Africa is "further crippling ... already fragile" health care infrastru}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tures throughout the continent, as it "struggl[es]" to provide HIV/AIDS drugs and treatment to hundreds of thousands of people, according to a <a ="http://www.phrusa.org/">Physicians for Human Rights</a> report to be released Thursday, the <a ="http://www.nytimes.com/2004/07/13/international/africa/13afri.html?pagewanted=all">New York Times r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ports. The report, titled "An Action Plan to Prevent Brain Drain," proposes specific measures to slow the m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gration of African health care workers to wealthier nations and increase staff in African health care facilities. Recommendations include calling upon developed nations to:\par Reimburse African countries for the loss of African-educated health professionals;\par Combat their own health care worker shortages by training more people domestically rather than recruiting workers from developing countries; and\par Work with international organizations to directly support higher salaries or other forms of reimbursement for underpaid African health professionals.\par The report advocates limiting recruitment of African health professionals by developed countries and private organizations, saying, "The balance will be best achieved when policies that make it more difficult for health professionals to emigrate, such as restrictions on recruitment, are implemented in the context of improving working conditions, fairer salaries and other advances in health professionals' ability to enjoy their rights." However, the report recognizes the difficulty in accomodating both the rights of African health care workers to seek better living conditions and the rights of African patients to receive adequate health care, according to the Times. "Everyone says it's not sustainable to pay salaries. But we're facing the worst health crisis in human history. Let's do things outside the box," Holly Burkhalter, PHR's U.S. policy director, said (Dugger, New York Times, 7/13).\par France Criticizes United States for 'Pressuring' Developing Countries To Give Up Producing Generic Drugs, Including Antiretrovirals\par [Jul 13, 2004]\par French President Jacques Chirac in a written statement to the <a ="http://www.aids2004.org/">XV Intern}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tional AIDS Conference</a> said on Tuesday that the United States is "pressuring" developing countries to give up the right to make generic drugs -- including antiretroviral drugs -- in exchange for free trade agre}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ments, the <a ="http://www.kansascity.com/mld/kansascity/news/world/9142736.htm">AP/Kansas City Star reports. Chirac said that U.S. methods concerning generic drugs in free trade negotiations have been "ta}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tamount to blackmail." Mireille Guigaz, France's global ambassador on AIDS, said, "The United States wants to put pressure on developing countries who try to stand up for their own industries." A U.S. official, speaking on condition of anonymity, called Chirac's allegations "nonsense," and said that trade agreements entered into by the United States would be consistent with <a ="http://www.}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 wto.}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 org/">World Trade Organization</a> rules that allow developing countries to produce generic drugs (Joshi, AP/Kansas City Star, 7/13).\par Australia Pledges To More Than Double Funding To Fight AIDS in Asia-Pacific Region\par [Jul 13, 2004]\par Australian Foreign Minister Alexander Downer announced on Sunday at the Second Asia-Pacific Ministerial Meeting on HIV/AIDS in Bangkok that Australia would more than double to $437 million its funding to fight HIV/AIDS in the Asia-Pacific region, the <a ="http://smh.com.au/articles/2004/07/11/1089484229581.html?oneclick=true">Sydney Morning Herald r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ports (Pollard, Sydney Morning Herald, 7/12). Downer did not specify whether the funding would go toward the <a ="http://www.theglobalfund.org/en/">Global Fund to Fight AIDS, Tuberculosis and Malaria or ind}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 pendent programs, saying only that the money "will mostly be spent" in the Asia-Pacific region, the Associa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ed Press reports (Associated Press, 7/11). Australia also will provide $2.2 million to the <a ="http://www.ausaid.gov.au/hottopics/hivaids/aplsf.cfm">Asia-Pacific Leadership Forum on HIV/AIDS, Dow}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 er said (Sydney Morning Herald, 7/12). Downer also announced the appointment of Annmaree O'Keeffe, a senior official with Australia's Agency for International Development, as the country's first special represent}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tive on HIV/AIDS, the Sydney Daily Telegraph reports (Sydney Daily Telegraph, 7/12). "[HIV/AIDS] is not just a health issue; it is a human security issue, it is an issue that can tear apart the fabric of societies and cause deep economic damage," Downer said (Sydney Morning Herald, 7/12). He added that Australia's main co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cern was for Papua New Guinea and Cambodia. Downer said, "We do have strong HIV/AIDS programs that we are running in Papua New Guinea. But I think the growth in the problem there is serious" (Associated Press, 7/12).\par Several U.S. and international broadcast programs reported on strategies for fighting HIV/AIDS in Thailand and the South Pacific:\par Australian Broadcasting Corporation's "<a ="http://www.abc.net.au/ra/asiapac/default.htm">Asia Pacific</a>": The segment includes comments from World Health Organizations's Dr. Jack Chow; <a ="http://www.unaids.org/en/default.asp">UNAIDS</a> Executive Director Peter Piot; and Relaki Ngawu, an HIV-positive AIDS advocate from Nigeria (Lloyd, "Asia Pacific," ABC, 7/13). The complete segment is avail}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ble <a ="http://www.abc.net.au/ra/asiapac/programs/m914586.asx">online</a> in Windows Media.\par NPR's "Talk of the Nation": The segment will examine how to maintain political will in fighting HIV/AIDS (Neary, "Talk of the Nation," NPR, 7/13). The complete segment will be available <a ="http://www.npr.org/programs/totn/">online</a> in RealPlayer and Windows Media after the broadcast. E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 panded NPR coverage is available <a ="http://www.npr.org/healthscience/aids2004/">online</a>.\par Xtra Broadband News: The segment includes comments from Dr. Kathleen Cravero, deputy executive dire}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tor of UNAIDS; Helen Leslie, a New Zealand government official; and Rachael Le Mesurier of the <a ="http://www.nzaf.org.nz/">New Zealand AIDS Foundation</a> (Glennie, Xtra Broadband News, 7/13). The complete segment is available online in Windows Media.\par Vietnam Population Policy Should Highlight Reproductive Health, HIV/AIDS Initiatives, Official Says\par [Jul 13, 2004]\par Le Thi Thu, minister of Vietnam's <a ="http://www.danang.gov.vn/home/view.asp?id=79&id_theloai=392&id_tin=3288">Committee for Population, Family and Children, on Friday at a meeting marking World Population Day called for the nation to work t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gether to implement a population policy, including HIV/AIDS initiatives and reproductive health care for ad}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lescents and pregnant women, BBC News reports. The government should focus on developing reproductive health and HIV/AIDS policies, in addition to raising awareness about contraception and providing medical services in inaccessible areas. Le said that population growth in Vietnam could impede the plan's impleme}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tation, according to BBC News. The number of women who reach reproductive age each year is three times higher than the number of women who are outside of that age range (BBC News, 7/11).\par USA Today Profile\par <a ="http://www.usatoday.com/news/health/2004-07-11-vietnam-aids_x.htm">USA Today on Monday pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 filed HIV/AIDS initiatives in Vietnam, which is the only country outside of Africa and the Caribbean eligible for funds under the five-year, $15 billion <a ="http://www.state.gov/s/gac/rl/or/c11652.htm">President's Eme}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gency Plan for AIDS Relief (Sternberg, USA Today, 7/12). Although there are currently about 200,000 HIV-positive people in Vietnam, some analysts predict that number could increase eightfold to one million people by 2010. Senior Bush administration officials said that the administration "considers that Vietnam is a place where the American people's money can really make a tremendous impact because it is on the brink of a very explosive epidemic" (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=24636">Kaiser Daily HIV/AIDS Report, 7/9). According to Ambassador Randall Tobias, head of the State Department's <a ="http://www.state.gov/s/gac/">Office of the Global AIDS Coordinator, the HIV/AIDS epidemic in Vietnam is concentrated among high-risk groups such as injection drug users and commercial sex workers. Currently, fewer than 300 of the approximately 130,000 HIV/AIDS patients in Vietnam receive treatment, and there is only one doctor for every 11,250 HIV/AIDS patients in the country. With the additional $10 million in funding from PEPFAR, Vietnam plans to provide HIV/AIDS treatment to more patients nationwide; establish preve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion, treatment and care programs in walled rehabilitation camps where tens of thousands of commercial sex workers and drug addicts -- half of whom are HIV-positive -- are "warehoused"; and enlist several faith-based organizations to become active in HIV/AIDS initiatives, according to USA Today. Tobias said that the United States will not finance needle-exchange programs in Vietnam. Tim Brown, senior fellow at the <a ="http://www.eastwestcenter.org/">East-West Center</a>, in Bangkok on Sunday criticized the administr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion's restriction on needle exchange programs as well as its reluctance to promote condom use (USA T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 day, 7/12).\par XV International AIDS Conference\par Protestors Demanding Increased Antiretroviral Drug Access 'Disrupt' Events During XV International AIDS Conference\par [Jul 13, 2004]\par Protestors demanding increased antiretroviral drug access on Tuesday "disrupted" several events during the XV International AIDS Conference in Bangkok, Thailand, Agence France-Presse reports. Approximately 30 AIDS advocates "stormed" the main debating arena at the conference while Pfizer CEO Hank McKinnell was preparing to speak, according to Agence France-Presse. The demonstrators carried banners saying, "Patient rights, not patent rights" and chanted "Free the people, break the patents." Some AIDS advocates have crit}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cized developed countries for not giving sufficient funding to fighting HIV/AIDS and have blamed some pharmaceutical companies for the high price of antiretrovirals, according to Agence France-Presse. Me}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 bers of the French AIDS advocacy group <a ="http://www.actupparis.org/">ACT UP-Paris</a> on Tuesday "jeered" French Minister for Development and Cooperation Xavier Darcos as he was preparing to deliver a speech on behalf of French President Jacques Chirac, according to Agence France-Presse. The protestors chanted, "10,000 deaths [from AIDS-related causes] per day, Darcos wants more." In his speech on behalf of Chirac, Darcos said that France would like to see $3 billion annually from Europe, the United States and ot}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 er donors to the <a ="http://www.theglobalfund.org/en/">Global Fund To Fight AIDS, Tuberculosis and Mala}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ia, according to Agence France-Presse (Agence France-Presse, 7/13). Some AIDS advocates also said that the conference's Global Village community, an area set aside for community gatherings and activities, was an "insincer[e ]" effort by conference organizers to recognize HIV-positive people because it was "completely ignored" by the world leaders and celebrities attending the conference, according to Thailand's Nation. Pa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 son Suwannawong, chair of the Thai Treatment Action Group, said, "How could the organizers say we come here to learn from one another when those big names didn't even bother to show up where we are," adding, "Didn't they say they want to learn from people really living with the disease?" Princess Zulu, an AIDS adv}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cate from Zambia, said, "You just invited us to be tokens to make your conference look good," adding, "If you want to fight AIDS, you have to listen to us because the virus is in our veins" (Nantiya, Nation, 7/13).\par Five Pharmaceutical Companies Close Booths During Protest\par Five pharmaceutical companies -- <a ="http://www.gsk.com/index.htm">GlaxoSmithKline</a>, <a ="http://www.bms.com/landing/data/index.html">Bristol-Myers Squibb</a>, Merck, <a ="http://www.abbott.com/">Abbott Laboratories</a> and <a ="http://www.roche.com/">Roche</a> -- closed their booths on the conference's exhibition floor when a group of protestors arrived to ask the companies to sign a "Treatment Access Pledge" that would commit the companies to "stand down" from patent enforc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment in developing countries, according to an AIDS Healthcare Foundation release. Two pharmaceutical companies -- <a ="http://www.gilead.com/wt/home">Gilead</a> and <a ="http://www.boehringer-ingelheim.com/corporate/home/home.asp">Boehringer Ingelheim -- kept their booths open and addressed the protestors, according to the release. The protestors who presented the pledge included AIDS advocates from South Africa, the United States, Thailand and Uganda. Michael Weinstein, AHF president, said, "We want to acknowledge and thank both Boehringer Ingelheim and Gilead for being willing to hear our concerns and engage in discussion," adding, "Some are in agreement with our position on patent enforcement in the developing world, particularly a company like Gilead, which doesn't even register drug patents in many r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 source-poor countries" (AHF release, 7/13).\par The <a ="http://www.abc.net.au/news/newsitems/200407/s1153170.htm">Australian Broadcasting Corpor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion on Tuesday reported on the protests about drug prices and the lack of HIV/AIDS funding. The audio r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 port includes an interview with McKinnell (Lloyd, ABC, 7/13). The complete segment is available <a ="http://www.abc.net.au/reslib/200407/r25247_62453.ram">online</a> in RealPlayer and <a ="http://www.abc.net.au/reslib/200407/r25247_62454.asx">online</a> in Windows Media.\par Drug Access\par Brazil, Seven Other Countries To Form Alliance To Share Antiretroviral Drug Manufacturing, Technology I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 formation\par [Jul 13, 2004]\par Brazil and seven other countries plan to establish an alliance aimed at improving the manufacture of drugs -- including antiretroviral drugs -- by sharing information on technologies, the Associated Press reports. Brazil, Russia, China, India, South Africa, Ukraine, Thailand and Nigeria are set to formally announce the partne}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ship during the <a ="http://www.aids2004.org/">XV International AIDS Conference</a> in Bangkok, Thailand, through July 16, according to the Brazilian <a ="http://portal.saude.gov.br/saude/">Ministry of Health</a>. In a statement, the health ministry said that the alliance will focus on two issues: "investments for the produ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion of new drugs, and the improvement of the capacity of local production of generics." In addition, the all}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ance will help bolster negotiations for low-cost antiretrovirals and "speed up the dissemination of new tec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nologies," according to the Associated Press (Radowitz, Associated Press, 7/10). Brazil's <a ="http://www.aids.gov.br/indexpingl.htm">National STD/AIDS Programme, which is considered to be one of the most progressive in the world, manufactures and distributes generic versions of antiretrovirals to HIV-positive people. Although the health ministry has recorded 310,310 AIDS cases, experts estimate that there are 600,000 HIV-positive people in the country (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=23957">Kaiser Daily HIV/AIDS Report, 5/28). The country also managed to negotiate discounts with pharmaceutical companies "simply by threatening to break the rules if treatments became too costly" when it entered the World Trade Organization -- which mandates compliance with trademark rules, according to the <a ="http://www.billingsgazette.com/index.php?id=1&display=rednews/2004/07/06/build/health/35-aids-drug.inc">AP/Milwaukee Journal Sentinel. Brazil's drug program has cut the number of AIDS-related deaths in half in four years and has kept approximately 100,000 HIV/AIDS patients alive, the AP/Journal Sentinel reports. The country spends $175 million a year -- or 1.5% of its health budget -- on antiretrovirals alone (A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tor, AP/Milwaukee Journal Sentinel, 7/12). Jarbas Barbosa, secretary of sanitary vigilance for the Ministry of Health, said, "If India or China have a product that isn't protected by patents, we will use the agreement to transfer technology and vice versa." Brazilian officials also plan to meet with British health officials at the co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ference to discuss the HIV/AIDS epidemic in Bolivia, according to the Ministry of Health statement, the Ass}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ciated Press reports (Associated Press, 7/10).\par Lack of Doctors, Health Workers in Developing Countries Hinders Fight Against AIDS, TREAT Asia Report Says\par [Jul 13, 2004]\par Shortages of doctors, nurses and health care workers in developing countries are hindering efforts to distri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ute antiretroviral drugs to people living with HIV/AIDS in the most-affected areas, according to a <a ="http://www.amfar.org/cgi-bin/iowa/asia/about/index.html?record=15">report</a> released by the American Foundation for AIDS Research and the <a ="http://www.amfar.org/cgi-bin/iowa/asia/index.html">Therapeutics Research, Education and AIDS Training in Asia at this week's <a ="http://www.aids2004.org/">XV International AIDS Conference</a>, in Bangkok, Thailand, the Asian Wall Street Journal reports (Chase/Efrati, Asian Wall Street Journal, 7/13). The report includes a table that co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 pares the number of trained doctors to HIV-positive people in 13 Asian countries. Researchers found that Japan had the best ratio with one doctor for every 24 HIV-positive people, followed by Taiwan, Hong Kong, Singapore and the Philippines. Vietnam had the worst ratio with one doctor for every 11,250 HIV-positive people, followed by Thailand with one doctor for every 6,700 HIV-positive people, Indonesia with one doctor for every 4,630 HIV-positive people and China with one doctor for every 4,200 HIV-positive people, the r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 port says. There are fewer than 200 doctors in China who are trained to administer antiretroviral treatment, the report says (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=24617">Kaiser Daily HIV/AIDS Report, 7/8).\par Deep Roots\par This shortage of health care workers in developing countries has "deep roots," including illiteracy, lack of e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ucation, poverty and famine, according to the Wall Street Journal (Chase/Efrati, Wall Street Journal, 7/13). "The race is to scale up the infrastructure," Kevin Frost, TREAT Asia director, said, adding, "Hand in hand with the availability of treatment is the need to provide it safely." Dr. Patrick Li, principal investigator for TREAT Asia in Hong Kong, said that it is important for HIV-positive people to receive counseling and instru}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tions on when and how to take antiretroviral treatments because "[i]f the complicated regimen is not adhered to, the patients may become resistant to the drugs and it will be even harder to treat them later." (Mitchell, <a ="http://www.reuters.co.uk/newsArticle.jhtml?type=healthNews&storyID=5647425A\u223\'a7ion=news">Reuters</a>, 7/12). Without counseling and instruction, "desperate" patients are self-treating, taking incorrect doses, sharing medications with HIV-positive family members or "just dropping out of treatment," the Journal reports (Wall Street Journal, 7/13). Physicians, nurses and "a range" of other health care professionals and comm}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nity volunteers should be recruited and trained in affected countries, Helene Gayle, director of <a ="http://www.gatesfoundation.org/GlobalHealth/HIVAIDSTB/">HIV/AIDS and TB and <a ="http://www.gatesfoundation.org/GlobalHealth/ReproductiveChildHealth/">Reproductive and Child Health at the Bill & Melinda Gates Foundation, said, the Asian Wall Street Journal reports. UNAIDS Executive Director Peter Piot said that some young U.S. and European doctors are also "filling some gaps," according to the Asian Wall Street Journal (Asian Wall Street Journal, 7/13).\par Politics and Policy\par Kerry Calls for Doubling of U.S. Funding for Global HIV/AIDS Efforts, Ending Ban on Immigrants With HIV\par [Jul 13, 2004]\par Presumptive Democratic presidential nominee Sen. <a ="http://www.johnkerry.com/front/splash.html">John Kerry</a> (Mass.) on Saturday said that if elected he would double U.S. funding for global HIV/AIDS pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 grams and would seek to lift a U.S. ban on HIV-positive immigrants, Agence France-Presse reports. In a statement released to coincide with the opening of the XV International AIDS Conference, which is being held in Bangkok, Thailand, Kerry said, "I will turn up the diplomatic pressure to seek similar increases from our partners. I will provide rapid distribution of quality medicines, including generic affordable, safe and effe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tive drugs" (Agence France-Presse, 7/10). "We cannot fight AIDS without adequate weapons to prevent new infections and without providing treatment for the millions already living with HIV and AIDS. "The Bush a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ministration has hampered U.S. efforts with policies created to appease its political constituencies, putting ideology before science," Kerry said in the statement(Kerry campaign <a ="http://www.johnkerry.com/pressroom/releases/pr_2004_0710.html">release</a>, 7/10). President Bush last year annouced his five-year, $15 billion <a ="http://www.state.gov/s/gac/rl/or/c11652.htm">President's Emergency Plan for AIDS Relief, which some AIDS advocates have criticized for its slow response and e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 phasis on abstinence-only education (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=24409">Kaiser Daily HIV/AIDS Report, 6/25). Kerry said he also would "work with Congress to lift the immigration ban on HIV-positive pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ple that has prohibited the United States from hosting" the International AIDS conference. The United States tests all new immigrants for HIV, and if an immigrant tests positive for the disease, he or she generally is d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nied admission, according to Agence France-Presse (Agence France-Presse, 7/10). "As president, I will work side by side with our international partners, faith-based, nongovernmental, affected communities and private sector groups in order to strengthen the capacity for sustained response by those on the front lines," Kerry said, adding, "A 'go it alone' approach to the war on AIDS is not how we will succeed; only in partnership can we have a chance of defeating this deadly disease" (Kerry campaign release, 7/10).\par Science & Medicine\par USA Today Examines Efforts To Develop AIDS Vaccine\par [Jul 13, 2004]\par USA Today on Tuesday examined efforts to develop an HIV/AIDS vaccine, which researchers at the XV I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ternational AIDS Conference in Bangkok, Thailand, on Monday said is "all but starting over" after two de}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ades of work (Sternberg, USA Today, 7/13). According to a report by the International AIDS Vaccine Initiative released Monday, the effort needs almost a doubling of funds, and researchers might have to start over if the current approach fails. More than 30 vaccines are in clinical trials, compared with a handful two years ago, according to the IAVI report. However, of the 30 vaccine candidates being researched in 19 countries, only one has reached the final testing phase, according to the IAVI report. IAVI has called for $1.3 billion in fun}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing for vaccine development. IAVI President and CEO Seth Berkley said that annual spending on vaccine research is about $650 million -- less than 1% of the total spending on all HIV/AIDS product development (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=24674">Kaiser Daily HIV/AIDS Report, 7/12). According to USA Today, AIDSVAX, the only AIDS vaccine to complete two large-scale clin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cal trails, "proved a flop." In addition, most of the 30 vaccine candidates are "relatively untested" and "so si}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ilar that if one fails, they all might fail," USA Today reports. Further, conducting human clinical trials of va}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cine candidates could prove "challenging" because the countries with the largest numbers of HIV-positive people lack the resources to study thousands of patients, according to USA Today reports (USA Today, 7/13).\par New York Times Examines 'Growing Interference From Conservatives' in Sexual Health Research\par [Jul 13, 2004]\par The New York Times on Sunday examined what some sexual health experts believe is a "growing interfe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ence from conservatives in and out of government with their work in research, education and disease pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 vention." According to the Times, such interference has consisted of reduced financing for sexual health pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 grams and an "overall chilling effect" on research in the field. "Programs almost have to hide what they do," Richard Parker, a professor at the Mailman School of Public Health at <a ="http://www.mailman.hs.columbia.edu/index.html">Columbia University</a> and co-chair of the International Working Group on Sexuality and Social Policy, said. IWGSSP in June released a report that cited what it called "sex policing" by the Bush administration as well as inquiries by members of Congress regarding NIH research grants, the Times reports (Navarro, New York Times, 7/11). Earlier this year, conservative House members questioned at least 10 NIH research grants, including grants for studies on emergency contrace}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion, Asian sex workers in San Francisco and women's response to pornography. NIH staff were required to review the grants to determine whether the projects "were relevant to the public health needs of our country," used methodology that was "scientifically and ethically appropriate," had been "properly reviewed and funded by NIH" and received funding that was proportional "relative to the burden of sexually related diseases as compared to other diseases" (<a ="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=1&DR_ID=21951">Kaiser Daily HIV/AIDS Report, 1/30). Andrea Lafferty, executive director of the Traditional Values Coalition, said that her group is challenging research grants that "don't pass the ... test," adding, "There's an arrogance in the scientific co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 munity that they know better than the average American" (New York Times, 7/11).\par Public Health & Education\par HIV Prevention Programs Emphasizing 'Ethnic Pride, Communication Skills' Increase Condom Usage, Study Says\par [Jul 13, 2004]\par Sexually active African-American teenage girls, who are at high risk for contracting HIV, were less likely to engage in sex without a condom after taking part in an HIV prevention program that "emphasiz[ed] ethnic pride and communication skills," according to a study published in the July 14 issue of the <a ="http://jama.ama-assn.org/cgi/content/abstract/292/2/171">Journal of the American Medical Association, which focuses on HIV/AIDS, and presented Sunday at the XV International AIDS Conference in Bangkok, Thailand, <a ="http://www.newsday.com/news/health/ny-hsteen113888258jul11,0,1711920.story">Long I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 land Newsday reports (Rabin, Long Island Newsday, 7/11). Ralph DiClemente of Emory University's <a ="http://www.sph.emory.edu/">Rollins School of Public Health</a> and colleagues from December 1996 to April 1999 studied 522 sexually active black girls between the ages of 14 and 18. About half of the partic}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 pants were separated into an intervention group, which offered information on ethnic and gender pride, communication skills, HIV/AIDS, condom use and healthy relationships. The other half of the participants were offered information on exercise and nutrition. Researchers evaluated the intervention program on the basis of different behavior change factors, including condom use and number of sexual partners, according to the <a ="http://www.washingtontimes.com/national/20040710-113547-2629r.htm">Washington Times. Researchers did not evaluate the program based on an increase in sexual abstinence because "they thought the goal was unrealistic," the Times reports (Howard Price, Washington Times, 7/11). After 12 months, 73% of the 251 girls in the intervention program reported using condoms regularly in the previous 30 days, co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 pared with 56% of the participants in the control group. The girls in the intervention group also were more likely to turn down unsafe sexual advances; slightly less likely to start sexual relationships with new partners; slightly less likely to report pregnancies; and had more favorable attitudes toward condoms, according to the study, Newsday reports (Long Island Newsday, 7/11). Researchers concluded that it is "compellingly urgent" to develop new HIV prevention programs that target high-risk groups (Washington Times, 7/11).\par Kaiser Daily HIV/AIDS Report Summarizes Features on HIV/AIDS Among Blacks in United States\par [Jul 13, 2004]\par Several newspapers this week published features on HIV/AIDS among blacks in the United States to coi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cide with the opening of the <a ="http://www.aids2004.org/">XV International AIDS Conference</a> taking place this week in Bangkok, Thailand. Summaries of the features appear below:\par "AIDS: Darkening in America," <a ="http://www.usnews.com/usnews/issue/040712/health/12wilson.htm">U.S. News & World Report: U.S. News & World Report on Monday profiled <a ="http://www.blackaids.org/">Black AIDS Institute</a> Founder Phill Wilson. Although the development of effective antiretroviral therapy in 1996 caused a shift in the pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ception of HIV/AIDS from an epidemic of young, white, gay men, to an epidemic centered on Africa, the Ca}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ibbean and Eastern Europe, the "constant epidemic in people of color" -- which is "having a devastating e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 fect in black communities" in the United States -- has been "ignored," Wilson said. Over the last five years, Wilson has worked to obtain support from civil rights leaders, the black media, seven black fraternities and sororities and historically black colleges and universities to make HIV/AIDS education a priority. According to Wilson, individuals and local organizations must "bridge the gap" between the "overwhelmingly white" med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cal community and the "increasingly black" HIV community, adding, "We are faced with the worst health di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 aster that our community has seen in the last century. What I do is ordinary. It's only extraordinary because we're not all doing it" (Brink, U.S. News & World Report, 7/12).\par "Black Church Has Vital Role in Fighting AIDS," <a ="http://www.chicagotribune.com/news/printedition/chi-0407120205jul12,1,2064933.column">Chicago Tribune: HIV/AIDS is a "reality about which everybody needs to be concerned," and African-American churches are starting HIV/AIDS prevention programs "not a moment too soon," the Tribune reports. Although black churches historically have avoided addressing HIV/AIDS or issues of sexuality, HIV/AIDS education and outreach is "particularly important" in light of recent studies showing an increase in HIV incidence among black male college students. Trinity United Church of Christ's HIV/AIDS ministry, which started in 1992, includes workshops on prevention, treatment options and living with HIV/AIDS, as well as a youth sexuality project that includes HIV/AIDS education (Turner Trice, Chicago Tribune, 7/12).\par "Danger on the Down Low," Houston Chronicle: African-American women who remain faithful to their sexual partners and have no history of injection drug use but who contract HIV from their husbands or boyfriends are "part of a troubling trend" in new HIV infections, the Chronicle reports. Some observers say that the i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 crease in the number of HIV cases linked to heterosexual sex among black women stems from men "on the down low" -- black men who have sex with men but do not mention their male relationships to their female sex partners, friends or family members -- but researchers do not know whether the phenomenon is to blame. CDC spokesperson Karlie Stanton said that although researchers know the phenomenon is a factor, "we don't know how big a factor it is" (Kever, Houston Chronicle, 7/10).\par "HIV Alarm for Mid-Age Blacks," New York Post: An increasing number of black men between the ages of 40 and 54 are testing HIV-positive, according to a study by New York City health officials presented Monday at the conference. City officials, who began collecting and reporting data on HIV in 2000, found that out of the more than 75,000 HIV-positive people in the city, one in 15 is a black middle-aged man and one in 10 is fo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 eign-born, primarily in the Caribbean, Africa or South America. Of the city's 11,039 black, middle-aged, HIV-positive men, 1,523 men had developed AIDS at the time of diagnosis, which city scientists said indicates that many were "long infected but not tested until symptomatic" (Edozien, New York Post, 7/12).\par "Inequities in Health, Race? Among African Americans, Disease Rates Are Higher and Care Is Inferior," <a ="http://www.philly.com/mld/inquirer/9121368.htm?1c">Philadelphia Inquirer: The "tragic phenomenon" that blacks suffer higher rates of diseases -- including HIV/AIDS -- and the issue of minority health disparities in rates of illness and quality of care "finally seems to have hit the mainstream," the Inquirer reports. According to the Inquirer, "pressure is mounting" on researchers, health care providers, lawmakers, insurance comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nies and other businesses to address "what is arguably one of the nation's worst public health crises." The "uncomfortable but unavoidable" conclusion that health care workers "like everyone else, bring their biases to work" have led some researchers to believe that a potential long-term solution to minority health disparities is to increase the number of minorities in medicine, academia and other areas that influence research, fun}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing and policy, the Inquirer reports (Smith, Philadelphia Inquirer, 7/10).\par The Black AIDS Institute has <a ="http://www.blackaids.org/bangkok/">additional conference coverage</a> relating to blacks and AIDS.\par Media & Society\par Kaiser Daily HIV/AIDS Report Summarizes Media Coverage of International HIV/AIDS Issues\par [Jul 13, 2004]\par Several U.S. and international broadcast programs have included features on HIV/AIDS in response to the XV International AIDS Conference in Bangkok, Thailand, from July 11-16. Summaries of the coverage a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 pear below.\par Australian Broadcasting Corporation's "<a ="http://www.abc.net.au/ra/asiapac/default.htm">Asia Pacific</a>": The segment reports on the world's AIDS orphans and includes comments from Carol Bellamy, executive director of UNICEF (Thompson, "Asia Pacific," ABC, 7/13). The complete segment is available <a ="http://www.abc.net.au/ra/asiapac/programs/m914590.asx">online</a> in Window Media.\par BBC's "<a ="http://news.bbc.co.uk/2/hi/talking_point/talking_point_programme/default.stm">Talking Point": The segment includes comments from Dr. Jim Kim, director of WHO's HIV/AIDS program and Jack Summe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 side, head of health promotion at the Terrence Higgins Trust. Complete video of the program in RealPlayer is available <a ="http://www.bbc.co.uk/newsa/n5ctrl/progs/talkingpoint/04/11jul.ram">online</a>. A complete audio version of the program is available <a ="http://www.bbc.co.uk/newsa/n5ctrl/progs/talkingpoint/04/11jul_audio.ram">online</a> in RealPlayer. In addition, an interactive discussion board about abstinence is available <a ="http://news.bbc.co.uk/2/hi/talking_point/3870335.stm">online</a>.\par NPR's "Day to Day": The segment will examine how gender inequality in South Africa is contributing to the spread of HIV/AIDS ("Day to Day," NPR, 7/13). The complete segment will be available online in RealPlayer and Windows Media after the broadcast. Expanded NPR coverage is available <a ="http://www.npr.org/healthscience/aids2004/">online</a>.\par NPR's "Morning Edition" on Tuesday profiled the Indian drug company <a ="http://www.}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 cipla.}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 com/">}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 </a> and the debate over drug makers that produce generic versions of brand-name antiretroviral drugs to treat people with HIV/AIDS in developing countries (Wilson, "Morning Ed}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion," NPR, 7/13). The complete segment is available <a ="http://www.npr.org/dmg/dmg.php?prgCode=ME&showDate=13-Jul-2004&segNum=13&mediaPref=RM">online</a> in RealPlayer. Expanded NPR coverage is available <a ="http://www.npr.org/healthscience/aids2004/">online</a>.\par PBS' "NewsHour with Jim Lehrer": The segment profiles Botswana's HIV testing and antiretroviral drug pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 grams. The segment includes comments from Dr. Ernes Darkoh, director of Botswana's antiretroviral pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gram; Richard Holbrooke, former U.N. ambassador and president of the <a ="http://www.businessfightsaids.org/">Global Business Coalition on HIV/AIDS; Dr. Banu Kahn, head of the Botswanan HIV/AIDS program; Botswanan President Festus Mogae; and Thai Sen. Mechai Viravaidya (de Sam Lazaro, "NewsHour with Jim Lehrer," PBS, 7/12). The complete transcript is available <a ="http://www.pbs.org/newshour/bb/health/july-dec04/botswana_7-12.html">online</a>. The complete se}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment is available <a ="http://audio.pbs.org:8080/ramgen/newshour/expansion/2004/07/12/fl28.rm?altplay=fl28.rm">online</a> in RealPlayer. Expanded PBS coverage of the conference is available <a ="http://www.pbs.org/newshour/health/aids/aids2004/">online</a>.\par WAMU's "The Diane Rehm Show": The NPR-syndicated show in the first hour of the broadcast will include a panel discussion of research findings and policy debates from the conference. Guests on the program will include Dr. Kathleen Cravero, deputy executive director of <a ="http://www.unaids.org/en/default.asp">UNAIDS</a>; Dr. Anthony Fauci, director of the NIH <a ="http://www.niaid.nih.gov/">National Institute of Allergy and Infectious Diseases; David Gartner, policy dire}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tor for the <a ="http://www.globalaidsalliance.org/">Global AIDS Alliance</a>; and Dr. Joseph O'Neill, deputy coordinator and chief medical officer in the <a ="http://www.state.gov/">State Department</a>'s <a ="http://www.state.gov/s/gac/">Office of the Global AIDS Coordinator</a> (Page, "The Diane Rehm Show," WAMU, 7/13). The complete segment will be available online in RealPlayer after the broadcast.\par Opinion\par Kaiser Daily HIV/AIDS Report Summarizes Editorials, Opinion Pieces on Global HIV/AIDS Epidemic\par [Jul 13, 2004]\par Several newspapers have published editorials and opinion pieces focusing on HIV/AIDS-related issues to mark the XV International AIDS Conference, which began on Sunday in Bangkok, Thailand, and runs through July 16. Summaries of some of the editorials and opinion pieces appear below:\par <a ="http://www.azcentral.com/arizonarepublic/opinions/articles/0712mon1-12.html">Arizona Republic: While the "threat" of the global AIDS epidemic "has never been higher," the world's "ability to control it has never been greater," a Republic editorial says. Education, prevention, outreach and treatment strategies, along with increased funding commitments to global initiatives, are the most effective ways of controlling the spread of HIV/AIDS, the editorial concludes (Arizona Republic, 7/12).\par <a ="http://www.chicagotribune.com/news/opinion/chi-0407120187jul12,1,1440465.story?coll=chi-newsopinion-hed">Chicago Tribune: Because the HIV/AIDS epidemic "keeps outpacing efforts to contain it," more needs to be done to distribute antiretroviral drugs -- including reconsidering FDA's policy to retest g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 neric drugs that have already been vetted by the <a ="http://www.who.int/en">World Health Organiz}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion</a>, a Tribune editorial says. The double-processing is "unwarranted and only delays delivery of esse}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tial medicines," the Tribune concludes (Chicago Tribune, 7/12).\par <a ="http://www.latimes.com/news/opinion/editorials/la-ed-aids12jul12,1,1201813.story?coll=la-news-comment-editorials">Los Angeles Times: Without better training on how to teach health care workers HIV prevention methods, children are "more likely to repeat the mistakes of their parents and continue to spread the disease," a Times editorial says, concluding, "[T]he war on AIDS can be won only with a fight on many fronts, not just by giving poor countries more cash to buy drugs" (Los Angeles Times, 7/12).\par <a ="http://www.miami.com/mld/miamiherald/news/opinion/9133199.htm?ERIGHTS=-5144001735320941980miami::kennedyb@advisory.com&KRD_RM=8ooxsrrtwrqouwtqwwqooooooobN">Miami Herald: The "fundamental barrier" to stemming the HIV/AIDS epidemic is not ability but will, a Herald ed}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 torial says. While counseling, outreach and public-awareness campaigns provide knowledge and expertise, financial commitments on the part of wealthy nations -- including the United States -- ultimately make preve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion and treatment measures effective, the editorial says, concluding, "The United States should -- and easily can do its share" (Miami Herald, 7/12).\par <a ="http://www.startribune.com/stories/561/4872618.html">Minneapolis Star Tribune: Because the global HIV/AIDS epidemic has worsened since the 2002 International AIDS Conference in Barcelona, Spain, HIV/AIDS advocates must continue to "hammer away at the trilogy of what works": education and awareness programs, prevention and treatment while wealthy nations must financially "fully support" global initiatives, a Star Tribune editorial says (Minneapolis Star Tribune, 7/13).\par <a ="http://www.nj.com/opinion/ledger/editorials/index.ssf?/base/news-2/1089445905139970.xml">Newark Star-Ledger: Both the successes and failures of the continuing fight against the HIV/AIDS epidemic provide "a lesson to learn" -- HIV/AIDS can be contained with resources and leadership that require an adequate and sustained financial commitment from the United States and other wealthy nations, a Star-Ledger editorial says (Newark Star-Ledger, 7/10).\par Salt Lake City Deseret Morning News: AIDS is "more than a global health crisis" because it creates the p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tential for the development and proliferation of terrorism worldwide, a Morning News editorial says. Global HIV/AIDS initiatives therefore would save lives and "stem the spread of terrorist activities," the editorial co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cludes (Deseret Morning News, 7/11).\par Opinion Pieces\par Enriqueta Bond, <a ="http://www.washingtonpost.com/wp-dyn/articles/A43460-2004Jul11.html">Washington Post: The global HIV/AIDS epidemic has recently overshadowed the "accelerating" malaria epidemic that has affected more people in the past two decades than HIV/AIDS, Bond, president of the <a ="http://www.bwfund.org/">Burroughs Wellcome Fund</a>, writes in a Post opinion piece (Washington Post, 7/12).\par Jane Eisner, <a ="http://www.philly.com/mld/inquirer/news/editorial/">Philadelphia Inquirer: It is a "shame" that the United States has to choose between funding prevention initiatives and treating people living with HIV/AIDS, Inquirer columnist Eisner writes in an opinion piece. Because both approaches are necessary, the United States should be "compassionate enough to do more than one," Eisner concludes (Philadelphia I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 quirer, 7/11).\par Desmond Tutu, <a ="http://www.guardian.co.uk/business/story/0,3604,1259032,00.html">Guardian</a>: Even the "greatest speeches do not save lives ... [a]id does," Tutu, former archbishop of Cape Town, South Africa, says in a London Guardian opinion piece. To combat global HIV/AIDS and poverty, wealthy nations should "tak[e] action" on international trade regulations and debt owed by developing countries and "[d]ramatically" increase aid to "heal not only the physical suffering of the poor south, but also the moral su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 fering of the rich north," Tutu concludes (Guardian, 7/12).\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV (94%); ANTIVIRALS (92%); PHARMACEUTICAL PREPARATION MFG (90%); AIDS & HIV TREATMENT (90%); PHARMACEUTICALS INDUSTRY (90%); RESEARCH & DEVELOPMENT (89%); PATENTS (87%); GENERIC DRUGS (78%); PRESCRIPTION DRUGS (78%); DEVELOPING COUNTRIES (78%); HEALTH CARE ACCESS (77%); FOUNDATIONS (76%); HEALTH DEPARTMENTS (73%); PUBLIC HEALTH ADMINISTRATION (72%); RESEARCH (70%); GENERIC PRODUCTS (67%); MONOPOLIZATION (61%); UNITED NATIONS INSTITUTIONS (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PFZ (LSE) (58%); PFEB (BRU) (58%); PFE (NYSE) (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (58%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTURING (58%); SIC2834 PHARMACEUTICAL PREPARATIONS (58%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 KAISER DAILY HIV (96%); JON COHEN (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD HEALTH ORGANIZATION  (57%); WORLD HEALTH ORGANIZATION (57%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 THAILAND (92%); PHILIPPINES (78%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 BANGKOK, THAILAND (92%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD HEALTH ORGANIZATION (63%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 July 13, 2004\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2004 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS;Daily HIV/Aids Report Africa News July 7, 2004 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_53}{\*\bkmkstart DOC_ID_53_0}{\*\bkmkstart doc_id_10}{\*\bkmkend DOC_ID_53}{\*\bkmkend DOC_ID_53_0}{\*\bkmkend doc_id_10}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_10"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310030000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 10 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 July}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  7, 2004 Wednesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 AIDS;\par Daily HIV/Aids Report}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Kaisernetwork.org\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 4531 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Global Challenges\par Number of New HIV Cases Increases Worldwide, Many Concentrated in Asia, UNAIDS Report Says\par [Jul 07, 2004]\par The 2004 UNAIDS Report of the Global AIDS Epidemic released by UNAIDS on Tuesday in advance of the XV International AIDS Conference illustrates "daunting trends" and an increasing "need for assistance" in the world's fight against the pandemic, the Boston Globe reports (Donnelly, Boston Globe, 7/7). According to the report, which for the first time includes revised HIV prevalence for previous years based on improved met}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 odology and more comprehensive country surveillance data, five million new HIV cases were reported worldwide last year -- the most cases reported in any single year since the beginning of the epidemic. The report shows that the number of people living with HIV increased from 35 million in 2001 to 38 million in 2003. The report also shows that nearly three million people died from AIDS-related causes in 2003. In add}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion, almost 50% of new HIV cases worldwide were among people ages 15 to 24, and women comprised almost 50% of people living with HIV, the report says (Kaiser Daily HIV/AIDS Report, 7/6). \par Asian Crisis\par Although sub-Saharan Africa remains the most affected region in the world with about 25 million HIV-positive people, the report shows that Asia could "face an AIDS catastrophe" if the region does not make bigger strides in combating the disease, the Financial Times reports (Dyer/Marcelo, Financial Times, 7/6). Asia, which accounts for 60% of the world's population, has 7.4 million HIV-positive people and has experienced some of the "sharpest" increases in numbers of HIV cases, the report says. In Asia, the epidemic is still "largely concentrated" among injection drug users, men who have sex with men, commercial sex workers and clients of sex workers and their sexual partners, according to the report (Kaiser Daily HIV/AIDS Report, 7/6). However, the Asian epidemic is "fast moving into the general population," Kathleen Cravero, deputy executive director of UNAIDS, said. The report shows that of the five million new HIV cases reported in 2003, nearly 1.2 million occurred in Asia, the New York Times reports. In addition, China, Indonesia and Vietnam account for 50% of the Asian population and are seeing "rapidly ... expanding" epidemics, the report says. HIV epidemics are "much harder to stop" after HIV prevalence begins to exceed 1% -- the prevalence level that most epidemiologists use to define a generalized HIV epidemic -- than before prevalence reaches 1%, according to Cravero, the Times reports. Because "many countries [in Asia] have prevalence rates less than 1%, and some are hovering around 1%," there is a "small window of opportunity" to curb the spread of HIV in Asia, Cravero said. "If we miss it, it will slam shut forever," and "we will see an epidemic the likes of which we never imagined," Cravero said, adding, "You either drive [the Asian HIV/AIDS epidemic] down now through maximum scaling up of prevention or you spend exponentially more money and energy trying to drive it down" (Altman, New York Times, 7/7).\par India\par India has 5.1 million people living with HIV, up from about four million in 2002, according to the Globe (Bo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ton Globe, 7/7). The epidemic in India, which now ranks second behind South Africa for the most HIV/AIDS cases in the world, stems from "widespread ignorance" about HIV, according to the Chicago Tribune. In add}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion, the "down low" phenomenon -- in which men have sex with men but do not mention their male relatio}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ships to their female sex partners, friends or family members -- is an "emerging concern," the Tribune r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ports. NIH National Institute of Allergy and Infectious Diseases Director Anthony Fauci said that although only a small percentage of the India's population of one billion is HIV-positive, "you're talking tens of millions of additional infections" if the number of cases doubles or triples, the Tribune reports. He added that he is concerned that "several Asian countries [have] a gross underestimate, not only of what is actually going on but what the potential is" for the HIV/AIDS epidemic, adding, "You have the potential for an explosion that, given the numbers of people who live in Asia, could potentially dwarf what we're seeing in Africa" (Graham, Chicago Tribune, 7/7). However, the Indian government has said that the rate of increase in the number of HIV cases in 2003 "had slowed" compared with statistics for 2002, according to the Financial Times. India's National AIDS Control Organization Director Meenakshi Datta Ghosh said, "There is no galloping AIDS ep}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 demic in India" (Financial Times, 7/6).\par Prevention, Treatment Among Women\par To help curb the spread of HIV in Asia and elsewhere, countries must "vastly increase" prevention and treatment efforts, Cravero said, according to the Times. However, prevention and treatment programs in Asia "largely miss" women and girls, who often do not have the option of abstaining from sex and have "little co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 trol" over whether their partners use condoms or remain faithful, according to Cravero, the Times reports (New York Times, 7/7). However, the epidemic's "feminization" is most apparent in sub-Saharan Africa, where 57% of HIV-positive adults are women and 75% of young people living with HIV are female, the report says, according to AFP/Yahoo! News. In the region's "male-dominated culture," women are the caregivers and therefore "bear the largest AIDS burden," the report says, according to AFP/Yahoo! News (AFP/Yahoo! News, 7/6). UNAIDS Executive Director Peter Piot said that the "ABC" model of prevention -- Abstinence, Be faithful, use Condoms -- is "pretty irrelevant" for women in Africa. Many women in the region face "violent, nonconsensual sex," according to the Mail & Guardian (Mail & Guardian, 7/7). He added that teenage girls in the region often have their first sexual experience with a man who is five to 15 years older, which "introduces extremely high-risk situations to girls, who are already more vulnerable" (Maugh, Los Angeles Times, 7/7). Cravero said, "Most of the women and girls, as much in Asia as in Africa, don't have the option to abstain [from sex] when they want to," adding, "Women who are the victims of violence are in no position to negot}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ate anything, nevermind faithfulness and condom use" (Nakashima, Washington Post, 7/7). Piot said that "[t]o ensure women become less infected, we have to target men," adding, "We are getting into a need for quite fundamental and long-ranging behavior change. We have to change norms in society" (Mail & Guard}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 an, 7/7).\par NBC's "Nightly News" on Tuesday reported on the study. The segment includes comments from Dr. Wafaa El-Sadr, a professor of epidemiology at Columbia University's Mailman School of Public Health and Piot (B}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 zell, "Nightly News," NBC, 7/6). The complete segment is available online in Windows Media.\par Thailand to Launch Revitalized HIV/AIDS Awareness Campaign Aimed at Nation's Youth\par [Jul 07, 2004]\par Thailand at the close of the XV International AIDS Conference next week will launch a revitalized HIV/AIDS awareness campaign to promote condom use among the nation's youth, Thai Public Health Minister Sudarat Keyuraphan said Tuesday, the Bangkok Post reports. The campaign will target young people between the ages of 14 and 25, an age group whose "ignorance" about condom use has become a "prime concern" for Thai health officials, Sudarat said, according to the Bangkok Post. Approximately one-third of sexually active young people are not using condoms, primarily because of confidence in their partners, according to Health Ministry surveys. Health officials fear that such high-risk behavior could make young people increasingly at risk for HIV. "They worry about getting pregnant more than AIDS," Sudarat said (Bangkok Post, 7/7). Tee}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 agers and young adults worldwide are at the greatest risk of HIV infection, especially female teenagers, a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cording to a UNAIDS report released Tuesday, Xinhua News Agency reports (Xinhua News Agency, 7/7). As part of the new campaign, the government will install more condom vending machines throughout the cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 try, especially near secondary schools, Charal Trinvuthipong, director general of the Disease Control D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 partment, said. Seven thousand machines already have been installed nationwide, including 5,000 in Ban}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 kok, which offer condoms for about 12 cents each -- one-tenth the price of condoms sold at drug and co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 venience stores. Local singers also will be asked to take part in the campaign to promote condom use and inform teenagers about the risks of HIV/AIDS (Bangkok Post, 7/7).\par Increased Risk\par Teenagers are increasingly at risk because they are too young to have learned from the public education campaigns the government launched a decade ago, Hakan Bjorkman, U.N. deputy resident for HIV/AIDS programs in Thailand, said (VOA News, 7/6). Thailand was one of the first "hard hit" countries to recognize and address HIV/AIDS in the early 1990s. The country initiated programs to encourage condom use, esp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cially among commercial sex workers, and implemented antiretroviral drug programs to prevent mother-to-child HIV transmission (Kaiser Daily HIV/AIDS Report, 7/6). HIV/AIDS cases in the country decreased from 140,000 in 1991 to 21,000 in 2003, according to UNAIDS (Bangkok Post, 7/7). "Young people, the really young people, they come on the scene, so to speak, become sexually active -- they weren't around in the early '90s when this big campaign was going on," Bjorkman said, adding, "So they come out, they don't use condoms, they experiment with drugs ... they're very vulnerable" (VOA News, 7/6). Thai Sen. Mechai V}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ravaidya, who is known as the "condom king" for spearheading the national condom promotion initiative 10 years ago, said that Thailand has become complacent about HIV education in recent years, Reuters reports. "In the last two or three years, we have fallen into a state of hibernation in terms of public education," Mechai said, adding, "A new generation hasn't heard much about HIV. They think it's gone" (Schuettler, Reuters, 7/6).\par A kaisernetwork.org video feature -- prepared by Fred de Sam Lazaro, who also is a correspondent for the "NewsHour with Jim Lehrer" -- includes interviews with people who are on front lines of efforts to fight HIV/AIDS in Thailand. The video is the fourth in a series of spotlights from kaisernetwork.org on local efforts around the world to combat the HIV/AIDS epidemic. The other features -- which examine HIV/AIDS in Haiti, Brazil and India -- also are available online.\par South Asia Lacks Leadership, Strategy for Fighting HIV/AIDS, World Bank Officials Say\par [Jul 07, 2004]\par South Asia lacks the leadership and strategy necessary for confronting the region's HIV/AIDS epidemic, World Bank officials last week said at a news conference ahead of the XV International AIDS Conference, the Taipei Times reports (Taipei Times, 7/5). Asia accounts for 60% of the world's population and has exp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 rienced some of the sharpest increases in numbers of HIV cases, according to the 2004 UNAIDS Report of the Global AIDS Epidemic. Asia has 7.4 million HIV-positive people, the report said (Kaiser Daily HIV/AIDS Report, 7/6). Although the World Bank has set aside $380 million annually to address AIDS in the region, much of the money has not been spent because of a lack of programs, World Bank Vice President for South Asia Praful Patel said. The officials said that political leaders have "wasted time arguing" about the number of people with the disease instead of implementing programs to address it, according to the Times (Taipei Times, 7/5). "We are facing exactly the same situation in South Asia now where this disease has gained a foothold and absolutely there is no serious strategy to address it," Patel said. There are approximately 4.6 million HIV-positive people living in India, almost two-thirds of South Asia's total number of infected individ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 als, and the epidemic has progressed from being concentrated in high-risk groups to a generalized epidemic in six of the country's 28 states (Agence France-Presse, 6/30).\par Women, Other Groups\par The epidemic is also increasingly affecting women, previously considered a low-risk group, according to I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 dia's National AIDS Control Agency's Project Director Meenakshi Datta Ghosh, VOA News reports. "We used to believe that for every eight men getting the infection maybe one woman will get it," Ghosh said, ad}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing, "But now we believe that is not so. For every eight men getting (HIV) maybe three women will be getting it" (VOA News, 7/6). Other countries in the region, such as Pakistan, Bangladesh and Nepal, have low HIV prevalence among the general population but high prevalence among injection drug users and commercial sex workers. However, the size of these subpopulations is "frightening," and could lead to an increase in HIV prevalence in the region, Patel said. For example, although HIV prevalence among the general population of Nepal is 0.5%, the prevalence among injection drug users is as high as 68% (Agence France-Presse, 6/30). The lack of leadership in fighting the disease could be a setback in the economic development of the region, Jean-Louis Sarbib, World Bank vice president for development, said. The epidemic could reduce economic growth by as much as 1% and could lead to a 1% to 3% increase in health expenditures, according to World Bank estimates (Taipei Times, 7/5).\par HIV-Positive Employees Still Face Discrimination in Thai Business Sector, Nation Reports\par [Jul 07, 2004]\par Thailand's business leaders have not fulfilled a promise to reduce discrimination against HIV-positive e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ployees in the country's business sector, Thailand's Nation reports. Thai business leaders attending an inte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 national summit in 2001 agreed to take steps to reduce discrimination in the work force. However, recent complaints received by the country's Centre for AIDS Rights show that Thai employers have asked job appl}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cants to submit blood for HIV tests, have screened employees during annual medical exams and fired HIV-positive employees. A recent survey conducted by the Thailand Business Coalition on AIDS of 510 bus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nesses found that the percentage of companies conducting compulsory pre-employment HIV testing fell from 27% in 2001 to 12% in 2004, TBCA Executive Director Anthony Pramualratana said, according to the Nation. The survey also found that the percentage of companies that said they would not terminate HIV-positive e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ployees has decreased from 64% in 2001 to 41% currently, the Nation reports.\par Reaction\par CAR program officer Sathien Tanprom said that although companies claim they do not discriminate on the basis of HIV status, many companies do so in practice, the Nation reports. CAR and the Thai AIDS Access Foundation say that discrimination against HIV-positive employees amounts to a violation of human rights that "fl[ies] in the face" of the country's commitment to ensuring that at least 50% of companies establish HIV/AIDS-friendly policies by 2003, according to the Nation. Sathien said, "Although many employers verba}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ly promised to stop preventing the hiring of workers with HIV, none dared make it a formal company policy." Only a "handful" of companies in Thailand have adopted all of the HIV-friendly workplace policies, Anthony said, according to the Nation. These policies include anti-discrimination training, prevention programs and workplace support networks. Ignorance among upper management is largely responsible for the lack of HIV-friendly programs, according to Anthony, the Nation reports (Nation, 7/5). However, the Thai government after the XV International AIDS Conference plans to launch a campaign focused on employers and creating better job opportunities for HIV-positive employees, the Bangkok Post reports. The campaign aims to e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 courage factories to employ more HIV/AIDS patients and includes an educational campaign about how HIV is transmitted (Bangkok Post, 7/7).\par Social Welfare\par Advocates also are criticizing the Thai government for denying people living with HIV/AIDS equal access to antiretroviral drugs, the Bangkok Post reports. The government's requirement that HIV/AIDS patients who receive public health services through the country's Social Welfare Fund pay extra for antiretrovirals that cost more than $120 per month is "unacceptable" because they already contribute part of their income to the fund, AAF Director Nimit Tien-udom said, according to the Nation. All workers must contribute 5% of their monthly salaries to the fund, and employers contribute an equal amount per employee. Unlike the National Health Care Program -- which allows HIV/AIDS patients access to generic antiretrovirals for 75 cents per month -- workers covered by the Social Health program pay the difference in cost for any drug treatment re}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 imen that exceeds the fund's budget (Bangkok Post, 7/7).\par U.S., Thai HIV/AIDS Advocates To Protest Opening of XV International AIDS Conference\par [Jul 07, 2004]\par More than 1,000 HIV/AIDS advocates and HIV-positive people in Bangkok, Thailand, on Sunday are pla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ning to protest at the opening of the XV International AIDS Conference, to call for improved access to a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tiretroviral treatment for people living with HIV, among other issues, Thailand's Nation reports. Nimit Tien-udom, director of Thailand's AIDS Access Foundation -- which is organizing the protest with U.S.-based Health GAP and the Thai Network of People Living With HIV/AIDS -- said that he wants the conference to "live up to its theme" of "Access for All," according to the Nation (Nantiya, Nation, 7/7). Demonstrators plan to protest "failures of government worldwide" to take sufficient steps to combat the HIV/AIDS pandemic, Agence France-Presse reports. The advocates said that "government inactivity, ... political obstruction and free trade pacts" could worsen the HIV/AIDS pandemic, according to Agence France-Presse. Health GAP Director Asia Russell said that the United States and other countries seem to be "backtracking" on funding pledges while the amount of money needed to effectively combat the disease is increasing, Agence France-Presse reports. She added that President Bush is requesting a reduction in AIDS funding from fiscal year 2004 to FY 2005, according to Agence France-Presse (Agence France-Presse, 7/6). The House Foreign Operations Appropriations Subcommittee in June by voice vote approved a $19.4 billion draft foreign aid spending bill for FY 2005, including $2.2 billion for global AIDS, tuberculosis and malaria programs. Although the approved funding -- most of which will go to AIDS programs -- meets Bush's request for FY 2005, the subcommittee allocated a larger portion of the money to the Global Fund to Fight AIDS, Tuberculosis and Malaria than Bush had requested. Bush's proposed FY 2005 budget, which is $1.9 billion more than the total amount the subcommittee approved, includes $2.8 billion for international HIV/AIDS, TB and malaria pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 grams, including $1.45 billion for the State Department Office of the Global AIDS Coordinator, which will a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 minister the President's Emergency Plan for AIDS Relief, and $200 million for the Global Fund (Kaiser Daily HIV/AIDS Report, 6/24).\par Access for All?\par Russell also said that the advocates were concerned about the high cost of registration for the conference, according to the Nation (Nation, 7/7). The early registration fee for the conference was $800 and standard registration was $900; however, after May 1 the fee rose to $1,000, which comes to $1,250 including Thai tax. Although the conference fees include access to all conference sessions and copies of related doc}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ments and reports, meals and accommodations are not included in the price (Kaiser Daily HIV/AIDS Report, 6/29). Russell said, "To tackle HIV/AIDS is partly about an exchange of information between scientists and infected people. But such a high price damages opportunities for an open exchange." Nimit said that the price of registration could provide a person living with HIV in Thailand with antiretroviral treatment for about three years, according to the Nation (Nation, 7/7). Kamol Upakaew of the Thai Network of People Living With HIV/AIDS said that although the conference theme of Access for All is an "admirable goal," it is not likely to happen, according to the Associated Press (Associated Press, 7/6). Russell said that in the two years since the 2002 International AIDS Conference in Barcelona, Spain, six million people have died from AIDS-related causes and another 10 million have tested HIV-positive, adding, "The lessons that the international comm}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nity has been unwilling to learn in countries in Africa we appear to be poised to relive" elsewhere (Agence France-Presse, 7/6).\par Webcasts and other coverage of the XV International AIDS Conference will be available online at kaiserne}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 work.org/aids2004. Kaisernetwork.org will serve as the conference's official webcaster.\par San Francisco Chronicle Continues Five-Part Series Examining AIDS in India\par [Jul 07, 2004]\par In advance of the XV International AIDS Conference in Bangkok, Thailand, next week, when "[w]orld atte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion will focus on the threat AIDS poses to Asia," the San Francisco Chronicle on Sunday began a five-part series on AIDS in India. Experts believe that the "key" to HIV/AIDS trends in Asia lie with India, the most populous nation in the world, according to the Chronicle. Other articles in the series focused on women and AIDS; AIDS among the country's commercial sex workers; and prevention campaigns at truck stops (Kaiser Daily HIV/AIDS Report, 7/6). A summary of the fourth article in the series appears below:\par "Drugs for a Few: Disease Strikes Five Million--Only the Lucky Get Medicine, Government's Slack Taken up by Tireless Informal Network:" Although there are more people living with HIV in India than in any other cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 try besides South Africa, HIV/AIDS prevention is "underfunded, treatment is spotty" and access to brand-name drugs is a "luxury saved for the wealthy or the lucky," the Chronicle reports. However, India's "best weapon" against AIDS may be its "vast network" of "mom-and-pop" nongovernmental organizations that a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 dress the disease, according to the Chronicle.\par Chronicle medical writer Sabin Russell traveled to India for five weeks earlier this year as part of a fellowship from the Kaiser Family Foundation (Russell, San Francisco Chronicle, 7/7).\par Drug Access\par World Trade Organization Generic Drug Deal Not Being Implemented, Leaving Developing Countries Wit}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 out Antiretrovirals, UNAIDS Says\par [Jul 07, 2004]\par Some countries have not taken steps to implement a World Trade Organization agreement that allows d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 veloping countries to waive patent laws to import generic drugs, including antiretroviral drugs, UNAIDS E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ecutive Director Peter Piot said, Reuters reports (Reuters, 7/6). }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  negotiators in August 2003 reached an agreement to allow developing countries to issue a compulsory license in order to import generic drugs if the country confirms that it cannot domestically manufacture them (Kaiser Daily HIV/AIDS Report, 5/24). Only Mozambique, Malaysia and Canada have adopted legislation to implement the agreement, Piot said on Tuesday (Reuters, 7/6). The Canadian Parliament in May adopted a bill (C-9) that would would amend the country's patent laws to permit the government to order the override of patents to allow certain pharmaceut}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cal manufacturers to produce and export generic drugs -- including antiretrovirals -- for use in developing countries (Kaiser Daily HIV/AIDS Report, 5/13). Although the price of antiretrovirals in developing countries has decreased by more than 90%, only 440,000 of the six million people in the developing world that need treatment have access to the drugs, Reuters reports. Piot also said that it is important to ensure that the quality of generic antiretroviral drugs matches that of brand-name drugs. "We don't only want and need cheap drugs, we need top quality medicines," Piot said, adding, "There is no compromise possible on quality ... that would be immoral" (Reuters, 7/6).\par The San Francisco Chronicle on Wednesday profiled Indian pharmaceutical company }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  which produces the generic fixed-dose combination antiretroviral Triomune and other antiretrovirals (Russell, San Francisco Chronicle, 7/7). Triomune combines three different medicines into one pill that is taken twice a day and costs as little as $140 per person per year (Kaiser Daily HIV/AIDS Report, 4/29). The full article is available online.\par Lack of Political Will, Drug Shortages Impede South African AIDS Drug Program, Study Says\par [Jul 07, 2004]\par A lack of political will and a shortage of antiretroviral drugs have impeded the rollout of South Africa's natio}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 al antiretroviral drug program, according to a report released on Saturday by the South African treatment a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 vocacy group Treatment Action Campaign and the AIDS Law Project of Johannesburg, South Africa's Witw}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tersrand University, AFP/Independent Online reports. TAC and ALP compiled the report -- the "First Monito}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing Report of the Antiretroviral Rollout," which is the first to measure progress since the plan was announced in November 2003 -- using information from provincial health departments and from the South African D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 partment of Health (AFP/Independent Online, 7/3). Officials expect 50,000 HIV-positive people to be on a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tiretroviral drugs by the end of the year and 1.4 million people to be on the drugs by 2009, at a total cost of $700 million (Kaiser Daily HIV/AIDS Report, 4/27). However, the report says that during the seven months after the plan was announced, less than 10,000 people have started treatment (AFP/Independent Online, 7/3). Sibani Mngadi, a spokesperson for South African Health Minister Manto Tshabalala-Msimang, said that the number of people currently receiving antiretroviral treatment is less than 5,000, AFP/Yahoo! News r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ports. Mngadi also said that there are slightly more than 30 health facilities that provide antiretrovirals throughout South Africa, according to AFP/Yahoo! News (AFP/Yahoo! News, 7/6). Although the district and provincial governments have put a "great deal of effort" into implementing the program, the national gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment has not "matched" the effort, the report said. In addition, the report said that communication about the plan was "extremely weak," adding that the health department "violate[d] the right to access health care se}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 vices by operating secretly and refusing to make important information available" (Health-e News, 7/5). For example, although lists of approved treatment sites are available on the internet and to the media, the list of treatment sites has not been published for "ordinary South Africans who have some access to radio, telev}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sion and/or newspapers," the report said, adding that television advertisements about the program have "disappeared" ("First Monitoring Report of the Antiretroviral Rollout," 7/3).\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV (96%); EPIDEMICS (90%); AIDS & HIV REPORTING (90%); DISEASE REPOR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ING (89%); EPIDEMIOLOGY (89%); DISEASES & DISORDERS (89%); POPULATION SIZE (79%); TRENDS (78%); POPULATION & DEMOGRAPHICS (76%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS511110 NEWSPAPER PUBLISHERS  (82%); SIC2711 NEWSPAPERS: PUBLISHING, OR PUBLISHING & PRINTING (82%); NAICS511110 NEWSPAPER PUBLISHERS (82%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 KAISER DAILY HIV (97%); KATHLEEN CRAVERO (76%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (94%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ASIA (96%); CHINA (79%); AFRICA (79%); INDONESIA (79%); SUB SAHARAN AFRICA (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 FINANCIAL TIMES LTD (65%);  CHICAGO TRIBUNE (61%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 July 7, 2004\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2004 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Business Times Singapore June 7, 2004 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_54}{\*\bkmkstart DOC_ID_54_0}{\*\bkmkstart doc_id_11}{\*\bkmkend DOC_ID_54}{\*\bkmkend DOC_ID_54_0}{\*\bkmkend doc_id_11}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_11"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310031000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 11 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Indian drug firms stand to gain much from }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928  talks;\par Potential to carve out slice of US$15b US generics market}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 June}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  7, 2004 Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par Yogi Aggarwal in Bombay\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 A HUGE opportunity awaits Indian pharmaceutical companies - if India plays its cards right during the u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 coming World Trade Organisation (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ) negotiations.\par A research report by investment bankers JM Morgan Stanley says Indian companies have opportunities in the US$15 billion generics market in the US, and can also expect to capture a part of the US$33 billion ma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ket in challenging patents for drugs that have been unduly extended by US and European companies.\par Other segments where Indian companies could score is in novel drug delivery systems and subcontracting much of the research to develop new drugs.\par In a document called Vision 21, global consulting firm McKinsey & Co estimated the total market for Indian companies to be around US$25 billion by the end of the decade, up from around US$7 billion now. \par T R Gopalakrishnan, assistant secretary general of the Indian Drug Manufacturers Association, the leading industry body, said: 'Everything boils down to the patent regime that is coming.\par 'If there are balanced patent laws that allow Indian companies to export freely as per the Doha Declaration (of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ) under conditions agreed upon under Trips (trade-related intellectual property rights), the going will be good. But non-trade barriers should not be allowed to distort trade.'\par Under the 1970 Indian Patent Act, pharmaceutical companies in India used 'reverse engineering' to man}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 facture drugs to bypass US patent laws. This has enabled them to manufacture drugs for the Indian market at less than one-tenth the cost in the West.\par But multinational companies have vigorously opposed Indian companies' attempts to develop cheaper drugs, including anti-Aids drugs. Indian companies like }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  could sell an anti-Aids drug in Africa for as little as US$250 for a year's treatment, compared to a cost to the patient of US$15,000 a year using Western form}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lations.\par William Haddard, a US expert on generic drugs, commented: 'The poor nations of the world now look to India to provide them with safe, effective and affordable medicines. But it is ironic that India, with enormous pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lems of its own, should be the hope of the Third World.'\par US and European pharmaceutical companies, meanwhile, have been furious at the enormous loss in profits, and the matter has not yet been fully settled despite the acrimony. With the rules of the game changing in 2005 - when patent laws are to be more strictly enforced - the fine print of the new rules will become more important.\par Some points of contention are compulsory licensing to manufacture drugs in developing countries in times of emergency, and whether the cut-off date for allowing the manufacture of patented drugs by third countries is 1995 or 2005.\par If India handles its case at the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  well, there could be tremendous opportunities after 2005. Drugs with an annual sale of some US$55 billion to US$65 billion are going off patent in the next five years. But the patent holders can be counted on to try all manner of stratagems to extend the patent periods.\par Despite a price erosion to around one-forth the original price, the market is still worth around US$15 billion, and Indian companies should be able to capture at least part of this potential.\par Indian companies could also be a subcontractor for the testing of a new drug. It costs some US $600 million to US$900 million to develop a new molecule, much of this cost in testing. A McKinsey & Co. report says I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 dian companies could get a chunk of this by conducting clinical trials.\par Bioinformatics is also a very promising area with a market potential of US$2 billion. While India has been lax in exploiting the potential of its indigenous herbal systems of medicine, this could change in the next decade.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par  PHARMACEUTICALS INDUSTRY (94%); PHARMACEUTICAL PREPARATION MFG (93%); PATENTS (91%); TRADE DEVELOPMENT (91%); PHARMACEUTICALS ASSOCIATIONS (90%); PATENT LAW (90%); INTELLECTUAL PROPERTY LAW (90%); INTERNATIONAL TRADE (90%); PHARMACEUTICALS PATENTS (89%); GENERIC PRODUCTS (89%); INTERNATIONAL ECONOMIC ORGANIZATIONS (89%); AIDS & HIV TREATMENT (78%); DRUG DELIVERY SYSTEMS (78%); DRUG DESIGN & DISCOVERY (78%); EXPORT TRADE (78%); ENGINEERING (78%); MULTINATIONAL CORPORATIONS (78%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TELLECTUAL PROPERTY (78%); GENERIC DRUGS (78%); DEVELOPING COUNTRIES (78%); INVES}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MENT BANKING (77%); CONSULTING SERVICES (74%); REVERSE ENGINEERING (71%); \par \par  CIPLA LTD (90%); MCKINSEY & CO INC (83%); MORGAN STANLEY (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 THE NEWS; South Asia\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 632 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 June 6, 2004\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2004 Singapore Press Holdings Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Business Times Singapore September 2, 2003 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_55}{\*\bkmkstart DOC_ID_55_0}{\*\bkmkstart doc_id_12}{\*\bkmkend DOC_ID_55}{\*\bkmkend DOC_ID_55_0}{\*\bkmkend doc_id_12}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_12"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310032000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 12 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928  drug deal to spark competition}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 September}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  2, 2003 Tuesday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par By RAVI KANTH IN GENEVA\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 THE landmark agreement to override patent provisions for addressing HIV/Aids, tuberculosis, and malaria in poor countries reached among 146 members of the World Trade Organization on Saturday is expected to result in intense competition among leading generic drug producers, analysts said.\par The historic deal will help poor countries avoid being drowned in complying with complex patent rules that provide monopoly-marketing rights to pharmaceutical giants such as Pfizer, Merck, and GlaxoSmithKline Wellcome.\par It would provide political and legal clarity to the use of what is called the compulsory-licensing instrument in the trade-related intellectual property rights , said Faisal Ismail, the South African trade envoy to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 . \par Under the agreement - in which Singapore's Ambassador to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 , Vanu Gopala Menon, played a major role - poor developing countries lacking manufacturing facilities to produce latest patented drugs could issue a compulsory licence to a third government that would enable its generic producers to supply the much-needed drug at affordable prices.\par Leading global generic drug producers in Canada, India, Brazil, Israel, the United States and Switzerland are expected to jump into fray once poor countries in Africa declare their intention to issue compulsory licences to manufacture the latest drugs for HIV/Aids, said a Geneva-based trade analyst. The compulsory licence allows }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  members to revoke the rights of a patent holder to address serious public health problems, but the existing law says that production under compulsory licensing must be predominantly for domestic co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sumption.\par To overcome this provision for poor countries with insufficient facilities to manufacture pharmaceutical pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ucts, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  members had to struggle hard for almost two years to arrive at Saturday's agreement.\par Asked whether Canadian generic companies would export medicines under this route, the Canadian amba}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sador to }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 , Sergio Marchi, said he would imagine all generic producers would be able to compete for any compulsory licence issued under Paragraph 6 mechanism of the Doha Trips (trade-related intellectual pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 erty rights) and Public Health agreement.\par Intense competition between generic producers could lead to downward pressure on prices of most of the important life-saving drugs needed to combat HIV/Aids, an Indian pharmaceutical industry analyst said.\par Significantly, shares of leading India generic drug companies like }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Ranbaxy and Reddy Labs have ri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 en steadily over the last few days in anticipation of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  agreement.\par Rich countries such as the US, Japan, Canada, and the EU members cannot use this agreement as impor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ers, while nations like South Korea, Hong Kong, and Singapore among others voluntarily said they would not use it except in grave public health emergencies.\par However, Oxfam and MSF (Medicines sans Frontiers) criticised the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  agreement saying it watered down the goals set out in the Doha declaration and would make the implementation ineffectual.\par With tightened safeguards, the agreement would not help achieve the objective of letting poor countries gain easy access to cheap copies of patented medicines, said a representative of the Penang-based Third World Network.\par 'We do not agree with this, and we are confident that we could use the compulsory licensing provisions wit}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 out much hindrance,' said Mr Ismail of South Africa.\par Until now, many countries found it difficult to use compulsory licence when faced with serious public health crisis because of arm-twisting by the US administration and its pharmaceutical companies, said a Geneva-based patent law analyst.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par  PHARMACEUTICALS INDUSTRY (91%); PHARMACEUTICAL PREPARATION MFG (91%); PATENTS (90%); LICENSING AGREEMENTS (90%); PATENT LAW (90%); AIDS & HIV (90%); INTELLECTUAL PROPERTY LAW (90%); GENERIC DRUGS (90%); DEVELOPING COUNTRIES (90%); INTERNATIONAL TRADE (90%); MALARIA (90%); INTERNATIONAL ECONOMIC ORGANIZATIONS (90%); AIDS & HIV TREATMENT (89%); PHARMACEUTICALS PATENTS (89%); TRADE TREATIES & AGREEMENTS (89%); PUBLIC HEALTH ADMINISTRATION (89%); INDUSTRY ANALYSTS (89%); INTELLECTUAL PROPERTY (89%); EMBASSIES & CONSULATES (89%); BUSINESS FORECASTS (89%); INTERNATIONAL TRADE LAW (89%); TUBERCULOSIS (78%); EXPORT TRADE (78%); TREATIES & AGREEMENTS (78%); PHARMACEUTICALS TRADE (78%); IMPORT TRADE (78%); CONTROLLED SUBSTANCES CRIME (77%); GENERIC PRODUCTS (77%); PHARMACEUTICALS & BIOTECHNOLOGY REGULATORY CO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 M}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PLIANCE (76%); RELIEF ORGANIZATIONS (73%); EUROPEAN UNION (73%); MANUFACTURING FACI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ITIES (68%); CONSUMPTION (64%); \par \par  PFIZER INC (90%); GLAXOSMITHKLINE PLC (90%); CIPLA LTD (57%); RANBAXY LABORATORIES LTD (52%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 THE NEWS; World\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 610 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 September 1, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2003 Singapore Press Holdings Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Cheap drug plan founders The Globe and Mail (Canada) August 30, 2003 Saturday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_56}{\*\bkmkstart DOC_ID_56_0}{\*\bkmkstart doc_id_13}{\*\bkmkend DOC_ID_56}{\*\bkmkend DOC_ID_56_0}{\*\bkmkend doc_id_13}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_13"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310033000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 13 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Globe and Mail (Canada)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 August}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  30, 2003 Saturday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Cheap drug plan founders}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WARREN GILES, Bloomberg News\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 REPORT ON BUSINESS: INTERNATIONAL; Pg. B6\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 544 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GENEVA \par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  A U.S.-backed compromise meant to boost poor countries' access to inexpensive medicines threatened to unravel yesterday after the Philippines and as many as two dozen other nations put up last-minute obstacles.  \par  Philippine and other negotiators demanded "modifications" to a World Trade Organization agreement that would increase sales of generic drugs from countries such as India to the poorest nations in Africa and Latin America so that they could fight diseases such as AIDS and malaria. \par  "I'm very, very disappointed," }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  secretary-general Supachai Panitchpakdi said after negotiations broke off. Officials from the 146-nation }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  met late yesterday afternoon to try to resolve their differences, on the last day before they were scheduled to return to their individual capitals. \par  The impasse casts a shadow over broader }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  talks to give the global economy an $800-billion-a-year (U.S.) boost by lowering trade barriers on financial services and products from cars to chocolate. A deadlock over drugs may jeopardize progress on issues such as reducing rich nations' farm subsidies when trade mi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 isters meet next month in Cancun, Mexico. \par  The compromise was meant to limit the ability of companies in larger poor nations, including India's }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Ltd., to profit on sales to the poorest nations, such as Zambia or Bolivia, of drugs patented by companies such as Pfizer Inc. The Philippines said it objected to this restriction. \par  Carlos Perez del Castillo, Uruguay's ambassador to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  and the chairman of the governing council, said he's still aiming for an accord before the Cancun gathering. \par  "My bet is that there will be [an agreement] either before or at Cancun," European Union Trade Commi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sioner Pascal Lamy told French radio Station Europe 1. \par  Observers said that the compromise that the United States worked out with India, Kenya, South Africa and Brazil this week represented a reversal for the Bush administration from December, when the United States was the sole holdout to an agreement. \par  "We're back to the December text," said James Love, director of the Washington-based Consumer Project on Technology, which has lobbied for lower drug prices. "A lot of developing countries think this is the best deal they're going to get." \par  Negotiators are scheduled to return to their capitals this weekend, before travelling to the Mexico meeting, which begins Sept. 10, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  spokesman Keith Rockwell told reporters. \par  An agreement would clear the way for the poorest nations, such as Bolivia and Zambia, to buy cheap copies of medicine to fight health epidemics. Sub-Saharan Africa is home to almost 30 million of the 42 million pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ple worldwide with AIDS or HIV. \par  Even as it held out in December, the Bush administration had pledged not to oppose at the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  any use by poor nations of patent infringement to treat medical emergencies and says it wants a deal that both helps the poor and protects the investments of the pharmaceutical companies. \par  American drug makers including Pfizer and Merck & Co. Inc. had feared that any loosening of patent rules could be interpreted to allow nations such as Brazil to override patents on medicines for non- infectious di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 eases such as asthma or cancer, and flood European and U.S. markets with cheap generics. \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 INTERNATIONAL ECONOMIC ORGANIZATIONS (92%); TRADE DEVELOPMENT (90%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TERNATIONAL TRADE (90%); AGRICULTURAL TRADE (90%); DEVELOPING COUNTRIES (90%); DI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 EASES & DISORDERS (89%); COMMERCE DEPARTMENTS (89%); AIDS & HIV (89%); PHARMACEUT}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 CALS PATENTS (78%); PHARMACEUTICALS INDUSTRY (78%); GENERIC DRUGS (78%); INTERN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TIONAL TRADE LAW (77%); MALARIA (76%); EPIDEMICS (76%); GENERIC PRODUCTS (76%); GLO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 B}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ALIZATION (75%); TRADE DISPUTES (75%); DRUG PRICES (73%); BANKING & FINANCE (72%); TRE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TIES & AGREEMENTS (72%); EUROPEAN UNION (71%); INTELLECTUAL PROPERTY LAW (70%); P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TENTS (70%); LOBBYING (68%); PATENT INFRINGEMENT (65%); GOVERNMENT GRANTS & SUBS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 DIES (57%); AGRICULTURAL SUBSIDIES (52%) trade; policy; drugs\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PFIZER INC (84%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  LTD (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION (94%) World Trade Organization\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PFZ (LSE) (84%); PFEB (BRU) (84%); PFE (NYSE) (84%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325414 BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING (84%); NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (84%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTURING (84%); SIC2836 BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES (84%); SIC2834 PHARMACEUTICAL PREPARATIONS (84%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PASCAL LAMY (56%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 UNITED STATES (95%); INDIA (94%); MEXICO (94%); PHILIPPINES (93%); AFRICA (93%); LATIN AMERICA (92%); ZAMBIA (92%); URUGUAY (79%); KENYA (79%); BRAZIL (79%); SUB SAHARAN AFRICA (79%); EUROPEAN UNION MEMBER STATES (77%) United States; Third World\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 September 16, 2006\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Illustration\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2003 The Globe and Mail, a division of CTVglobemedia Publishing Inc.\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Business Times Singapore August 29, 2003 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_57}{\*\bkmkstart DOC_ID_57_0}{\*\bkmkstart doc_id_14}{\*\bkmkend DOC_ID_57}{\*\bkmkend DOC_ID_57_0}{\*\bkmkend doc_id_14}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_14"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310034000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 14 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Proposed }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928  deal set to bring hope to poorer nations;\par It calls for relaxing patent provisions, issuing of licences to producers in poorer nations}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 August}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  29, 2003 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par Ravi Kanth\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PREPARATIONS are set for a final and long delayed humanitarian deal at the World Trade Organization to allow poor countries to relax patent provisions on latest medicines and issue licences to generic producers in India and Brazil to supply them at affordable prices.\par 'We are hoping to have a deal by the end of the day,' said the architect of the proposed deal, Singapore A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 bassador to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Vanu Gopala Menon.\par Ensuring poorer states unable to manufacture medicines can import cheap generic drugs when they need to is seen as vital to beating major killers such as Aids and malaria. But it also means setting aside patent laws protecting multinational firms. \par Agreement is crucial for the success of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  current Doha Round of free trade talks, which is due to be discussed at a major summit in the Mexican city of Cancun next month.\par Over the last five months, Mr Menon, who now heads the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Intellectual Property Council, quietly worked behind the scenes to resolve the differences between the key players such as the US, the European Union, India, Brazil, and South Africa for implementing the Doha Agreement on trade-related intellectual property rights (TRIPS) and Public Health.\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  members are expected to endorse the statement that Mr Menon had prepared to bring the US on the board.\par The leading US pharmaceutical companies, particularly Pfizer, were unhappy with the proposed agreement and forced their government to block the deal last year on the ground that it would be abused by generic producers like }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  and Ranbaxy in India to produce cheap copies of Viagra and other profit-making drugs.\par Except for the US, the entire }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  membership had approved a draft deal last year to implement the co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 plex 'paragraph six' mechanism requiring countries lacking manufacturing facilities to transfer their compuls}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ry licences to generic producers in India and Brazil for supply of affordable medicines.\par Faced with severe public criticism and the outbreak of Sars (severe acute respiratory syndrome) and A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 thrax, the Bush administration was forced to give up its strident opposition to this agreement.\par The final three-page chairman's statement that Mr Menon issued late on Wednesday evening to members lists the 'the good faith' intentions for members to follow during the implementation of the 'paragraph six' mechanism. It would ensure that the proposed Doha agreement on TRIPS and Public Health is not pursued for 'industrial or commercial policy objectives'.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par  INTERNATIONAL ECONOMIC ORGANIZATIONS (91%); PHARMACEUTICALS INDUSTRY (90%); P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TENTS (90%); TRADE DEVELOPMENT (90%); PHARMACEUTICAL PREPARATION MFG (90%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 LECTUAL PROPERTY LAW (90%); INTELLECTUAL PROPERTY (90%); INTERNATIONAL TRADE (90%); RESPIRATORY DISEASE (78%); TRADE TREATIES & AGREEMENTS (78%); TALKS & MEETINGS (78%); INTERGOVERNMENTAL TALKS (78%); PATENT LAW (78%); FREE TRADE TREATIES & AGREEMENTS (78%); PUBLIC POLICY (78%); GENERIC DRUGS (78%); LICENSES & PERMITS (77%); MALARIA (77%); MANUFACTURING FACILITIES (76%); MULTINATIONAL CORPORATIONS (73%); G}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NERIC PRODUCTS (72%); APPROVALS (71%); EUROPEAN UNION (68%); SARS (61%); \par \par  PFIZER INC (58%); CIPLA LTD (58%); RANBAXY LABORATORIES LTD (54%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 THE NEWS; World\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 416 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 August 28, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2003 Singapore Press Holdings Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Last-minute deal on cheap drugs: Late deal on cheap drugs The Guardian (London) August 28, 2003 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_58}{\*\bkmkstart DOC_ID_58_0}{\*\bkmkstart doc_id_15}{\*\bkmkend DOC_ID_58}{\*\bkmkend DOC_ID_58_0}{\*\bkmkend doc_id_15}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_15"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310035000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 15 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Guardian (London)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 August}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  28, 2003\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Last-minute deal on cheap drugs: Late deal on cheap drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Charlotte Denny and Sarah Boseley\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Guardian Home Pages, Pg. 1\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 757 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  An eleventh-hour deal to provide cut-price drugs for the world's poorest people was being finalised in Gen}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 va last night in an effort to save next month's trade summit in Cancun, Mexico, from collapse.\par  After being delayed for nine months by intense lobbying from US pharmaceutical companies, the agreement between key developing countries and Washington is meant to open the door for poor countries to import copies of life-saving drugs without running foul of global patent laws.\par  But fears expressed by US pharmaceutical companies, led by Pfizer, that relaxing the rules will open wes}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ern markets to a flood of copycat drugs, have forced poor countries to accept strict safeguards against smuggling.\par  The deal represents a climbdown for Washington, which has single-handedly blocked agreement at the World Trade Organisation's Geneva headquarters since December, demanding that the patent override be restricted to the poorest countries and for a limited list of diseases. \par  Agreement was secured after the US agreed instead to accept assurances from developing countries that they would not bend the rules for "commercial objectives".\par  Diplomats said a deal on drugs was the bare minimum needed to prevent the trade ministers' Cancun mee}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing turning into a rerun of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  disastrous Seattle meeting, which ended in chaos after African cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tries walked out. Even now, heated disagreements over agriculture and whether the liberalisation of trade should be extended into new areas are clouding last-minute preparations for next month's meeting.\par  Washington was under intense pressure to deliver a package on drugs for poor countries after concessions were promised at the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  meeting in Doha, Qatar, in November 2001, as a way of getting the sceptical d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 veloping world on board.\par  The details were supposed to have been hammered out in Geneva by the end of last year, but the White House vetoed the proposed deal after heavy lobbying from US drug companies.\par  Aid agencies said America's intransigence had forced the developing world to accept a flawed agreement with significant hurdles for countries hoping to import cheap drugs from abroad.\par  Oxfam said last night that the draft agreement had left the world's poorest states dependent upon other countries standing up to the intense pressure from the US pharmaceutical industry. "This deal has been w}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tered down so much that it isn't really anything to cheer about," said Oxfam's Michael Bailey.\par  Under current trade rules any country can override patents in its home market and authorise production of the generic equivalent - as the US threatened to do during the anthrax scare in 2001 to force down the price of treatment. But global trade rules prevent generic manufacturers from exporting to countries that do not have a domestic drug industry.\par  Under the deal, exporting countries would have to issue a compulsory licence overriding foreign patents, something the agencies fear they may be reluctant to do.\par  Ellen t'Hoen, of the volunteer doctors' organisation Medecins sans Frontieres, said the deal was disastrous. She said: "It poses so many hurdles and hoops to jump through that we are really worried it may not work at all.\par  "By continually demanding more restrictions, the US seems to be pushing for a watertight system so that no generic drugs ever get through to the patients in developing countries who desperately need them.\par  "(This) will, over time, lead to the complete drying up of availability of generic sources and will inevitably lead to increased drug prices."\par  The undertaking that the Doha get-out clause, allowing the overriding of patents, should not be used for commercial advantage meant that generics companies such as }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  in India, which undercut the multin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tionals to offer Aids drugs for less than Dollars 300 (pounds 190) a year and forced the big companies to bring down their prices, would have no incentive to produce cheap copies.\par  "The drugs that we have access to now that are affordable are produced by commercial entities," Ms t'Hoen said. "We need more industrial activity and greater competition in the market. That is the mechanism which is being killed."\par  She blamed pressure from the US for "a text that is blatantly ridiculous", but also the EU for failing to join the closed discussions. "After all the rhetoric of (Pascal) Lamy (its chief trade negotiator), he is completely a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sent from these talks," she said.\par  Notebook, page 22\par  Gordon Brown, page 25\par  guardian.co.uk/aids\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PFIZER INC (90%);   WORLD TRADE ORGANIZATION  (83%); WORLD TRADE ORGANIZ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TION (83%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION  (83%); WORLD TRADE ORGANIZATION (83%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PFZ (LSE) (90%); PFE (NYSE) (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325414 BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING (90%); NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (90%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTURING (90%); SIC2836 BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES (90%); SIC2834 PHARMACEUTICAL PREPARATIONS (90%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 UNITED STATES (95%); MEXICO (93%); QATAR (92%); SWITZERLAND (91%); AFRICA (79%);   WASHINGTON, USA (79%);   SEATTLE, WA, USA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 UNITED STATES (95%); MEXICO (93%); QATAR (92%); SWITZERLAND (91%); AFRICA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TRADE DEVELOPMENT (91%); PHARMACEUTICALS INDUSTRY (90%); DEVELOPING COUNTRIES (90%); INTERNATIONAL TRADE (90%); PATENTS (89%); EMERGING MARKETS (89%); EXPORT TRADE (89%); PHARMACEUTICAL PREPARATION MFG (89%); AGRICULTURAL TRADE (89%); GENERIC DRUGS (89%); INTERNATIONAL TRADE LAW (89%); IMPORT TRADE (89%); LOBB}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 Y}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ING (89%); RELIEF ORGANIZATIONS (88%); GENERIC PRODUCTS (78%); POVERTY & HOMELES}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NESS (78%); TALKS & MEETINGS (77%); GLOBALIZATION (76%); INTERNATIONAL ECONOMIC O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GANIZATIONS (76%); VETO (75%); SMUGGLING (73%); COMMERCE DEPARTMENTS (72%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 LECTUAL PROPERTY LAW (71%); PATENT LAW (70%); ANTHRAX (67%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 August 28, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2003 Guardian Newspapers Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Americans seeking pledges on drug rules The Toronto Star August 26, 2003 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_59}{\*\bkmkstart DOC_ID_59_0}{\*\bkmkstart doc_id_16}{\*\bkmkend DOC_ID_59}{\*\bkmkend DOC_ID_59_0}{\*\bkmkend doc_id_16}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_16"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310036000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 16 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Toronto Star\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 August}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  26, 2003 Tuesday Ontario Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Americans seeking pledges on drug rules}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Warren Giles, Bloomberg News\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 BUSINESS; Pg. D02\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 238 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The United States is pressing poor countries to accept a new condition before agreeing to let them bypass drug patents to import copies of medical treatments for AIDS, malaria and other diseases, according to aid agencies including Oxfam.\par In December, the United States was the only member of the World Trade Organization to block an accord to ease the supply of essential medicines to poor countries. \par Washington says a pact may enable generic drug makers, such as India's }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Ltd., to sidestep patents held by U.S. companies including Pfizer Inc. and Merck & Co. on other drugs, such as those used to treat obesity or hair loss.\par The administration of U.S. President George W. Bush is trying to secure guarantees from countries including Brazil, Kenya, South Africa and India that they won't apply the new agreement except for "humanitarian use" to fight AIDS, tuberculosis and malaria, according to Oxfam, Doctors Without Borders and the Third World Network. Treatments for illnesses such as cancer may be excluded.\par "The U.S. seems to be pushing for a watertight system so that no generic drugs ever get through to the p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tients in developing countries who desperately need them," Ellen 't Hoen, a spokesperson for Paris-based Doctors Without Borders, said in an e-mail. "We are really worried it may not work at all."\par Dave Hamill, a spokesperson for the U.S. mission to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  in Geneva, declined comment.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PHARMACEUTICALS INDUSTRY (91%); RELIEF ORGANIZATIONS (91%); AIDS & HIV TREATMENT (90%); PHARMACEUTICALS PATENTS (90%); DISEASES & DISORDERS (90%); PHA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MACEUTICAL PREPARATION MFG (90%); AIDS & HIV (90%); MEDICAL CHARITIES (90%); GENERIC DRUGS (90%); DEVELOPING COUNTRIES (90%); MALARIA (90%); CANCER (78%); INTERNATIONAL ASSISTANCE (77%); PHYSICIANS & SURGEONS (75%); TUBERCULOSIS (73%); US PRESIDENTS (73%); BARIATRICS (73%); INTERNATIONAL ECONOMIC ORGANIZATIONS (73%); OBESITY (72%); HAIR LOSS (55%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MRK (PAR) (91%); MRK (NYSE) (91%); PFZ (LSE) (91%); PFE (NYSE) (91%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (83%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (91%); SIC2834 PHARMACEUTICAL PREPARATIONS (91%); NAICS325414 BIOLOGICAL PRODUCT (EXCEPT DIA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 G}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NOSTIC) MANUFACTURING (91%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTURING (91%); SIC2836 BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES (91%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (91%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GEORGE W BUSH (54%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION  (84%); WORLD TRADE ORGANIZATION (84%); DOCTORS WITHOUT BORDERS  (83%); DOCTORS WITHOUT BORDERS (83%); THIRD WORLD NE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORK  (56%); THIRD WORLD NETWORK (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 UNITED STATES (98%); INDIA (92%); KENYA (79%); BRAZIL (79%); SWITZERLAND (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 STATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GENEVA, SWITZERLAND (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GENEVA, SWITZERLAND (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MERCK & CO INC (91%); PFIZER INC (91%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  LTD (83%);   WORLD TRADE ORGAN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ZATION  (84%); WORLD TRADE ORGANIZATION (84%); DOCTORS WITHOUT BORDERS  (83%); DO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 C}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TORS WITHOUT BORDERS (83%); THIRD WORLD NETWORK  (56%); THIRD WORLD NETWORK (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 August 26, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2003 Toronto Star Newspapers, Ltd.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Uganda;3 Firms to Supply Cheap Aids Drugs Africa News May 8, 2003 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_60}{\*\bkmkstart DOC_ID_60_0}{\*\bkmkstart doc_id_17}{\*\bkmkend DOC_ID_60}{\*\bkmkend DOC_ID_60_0}{\*\bkmkend doc_id_17}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_17"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310037000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 17 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 May}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  8, 2003 Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Uganda;\par 3 Firms to Supply Cheap Aids Drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Monitor\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 363 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The National Drug Authority has licensed three Indian companies to supply cheap Aids drugs, lawmakers heard yesterday.\par The head of drug registration at the National Drug Authority Francis Otim told a seminar organised for me}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 bers of the committee on Legal and Parliamentary Affairs that Ranbaxy Laboratories Ltd, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Ltd and Hefero Drugs Ltd have been licensed, while five others are being appraised.\par Unfortunately, he said, a proposed patent law could bar Uganda from importing the cheap generic drugs from the Indian companies. \par "That is what we are fighting," Mr Otim said. "If government passes this law the way it is, it will exclude Uganda from using these cheap drugs."\par The seminar, held at the International Conference Centre in Kampala, was organised by Uganda Access to Essential Medicines Coalition to discuss the proposed patent law now before the Law Reform Commission.\par The United States Agency for International Development (USAID) is funding the exercise.\par The revelation followed fears from some of the MPs that if the law is not enacted, cheap but ineffective drugs could find their way here.\par "NDA does not in any way allow poor quality drugs to come into the market," Mr Otim said. "The companies we allow into the country do research. They are approved by the Medicine Control Authority of the UK and even the World Trade Organisation. So their quality is not any different from that of the companies in deve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 oped countries."\par Ms Winnie Masiko (Rukungiri) said that government should instead provide incentives such as tax exem}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tions on packaging materials for local pharmaceuticals to manufacture drugs.\par "Many of these drugs, I hear are made from simple raw materials like plants," she said.\par The MPs also wondered why government is in such a hurry to enact the law yet }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  allows poor countries up to 2016 to enact it.\par "I get worried; most of our people use generic drugs," Ms Jane Alisemera (Bundibugyo) said. "If we are going to pass a law allowing the manufacturer to charge expensively, I look at a situation where our people can not even get an Aspirin. When we pass the law, it may make some of these drugs inaccessible."\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV TREATMENT (90%); GENERIC DRUGS (90%); LEGISLATORS (90%); INTELLE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 C}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TUAL PROPERTY LAW (78%); PHARMACEUTICALS INDUSTRY (78%); PATENTS (78%); CONFE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENCES & CONVENTIONS (78%); INTERNATIONAL ECONOMIC ORGANIZATIONS (77%); LEGISLATION (76%); PATENT LAW (76%); TRADE DEVELOPMENT (76%); INTERNATIONAL ASSISTANCE (74%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TERNATIONAL TRADE (74%); APPROVALS (73%); LICENSES & PERMITS (73%); GENERIC PRO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 UCTS (73%); TAX LAW (73%); PHARMACEUTICALS PRODUCT DEVELOPMENT (73%); INTERNATIO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AL ECONOMIC DEVELOPMENT (68%); PACKAGING MATERIALS (64%); TAX INCENTIVES (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (84%); RANBAXY (NSE) (72%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (84%); SIC2834 PHARMACEUTICAL PREPARATIONS (84%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ING (72%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (72%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 FRANCIS OTIM (87%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 US AGENCY FOR INTERNATIONAL DEVELOPMENT (83%); WORLD TRADE ORGA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 IZATION  (54%); WORLD TRADE ORGANIZATION (54%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 UGANDA (95%); UNITED KINGDOM (79%); UNITED STATES (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 KAMPALA, UGANDA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HEFERO DRUGS LTD (73%); INDIAN COS (73%); INTERNATIONAL DEVELOPMENT CO (68%); RANBAXY LABORATORIES LTD (68%);  NATIONAL DRUG AUTHORITY (90%); WORLD TRADE ORGANISATION (68%); AGENCY FOR INTERNATIONAL DEVELOPMENT (53%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 May 8, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2003 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PanAfrica;Aids: Even With Discounts from Drug Firms, Generics Remain Far Cheaper Africa News May 5, 2003 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_61}{\*\bkmkstart DOC_ID_61_0}{\*\bkmkstart doc_id_18}{\*\bkmkend DOC_ID_61}{\*\bkmkend DOC_ID_61_0}{\*\bkmkend doc_id_18}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_18"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310038000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 18 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 May}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  5, 2003 Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 PanAfrica;\par Aids: Even With Discounts from Drug Firms, Generics Remain Far Cheaper}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The East African\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1233 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 SEAN FLYNN, senior attorney at the Consumer Project on Technology (CPTech), a non-profit organisation in Washington DC that focuses on the impact of intellectual property protection on consumer interests, spoke to GICHINGA NDIRANGU on compulsory licensing in relation to the HIV/Aids pandemic\par What is the problem you are addressing?\par It is the lack of access to medicines needed to treat Aids. About 95 per cent of people who have HIV/Aids live in the developing world. Africa accounts for over 70 per cent of the world's Aids deaths and Aids is the leading cause of deaths in Africa. \par Since 1996, there have been antiretroviral (ARV) medicines that can cut Aids deaths by up to 70 per cent and allow people with Aids to live relatively normal lives. There are about 30 million people with Aids in Africa and between four and five million Africans need immediate access to ARV treatment or they will soon die. Yet, only 30,000-50,000 people in Africa have access to this treatment, including only about 7,000 in Kenya and 10,000 people in Uganda. We want to help increase the accessibility of treatment.\par How do you plan to do that?\par For there to be treatment, affordable medication must be available as well as effective health systems, sele}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion of medicines through registration procedures and funding. CPTech's work focuses on expanding access to affordable medicines by attacking patent barriers that prevent low-cost/high-quality drugs from reaching African markets. We are helping citizen groups and government officials understand the flexibilities they have under national and international law to force patent holders to allow competition in the supply of life-saving products, thereby bringing the prices of the products down. Of course, to get the drugs to people who need them, the other barriers - health systems, drug registration and funding - need to be addressed.\par How can a government force a patent holder to allow competition?\par We are educating African decision makers on compulsory licensing. Patents are sets of rights granted by the government to an inventor to use and profit from an invention. Since the first international agreement regar}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing patents in the late 1800s, governments have always retained the right to allow others to use the patent without permission from the patent holder if the holder fails to serve the needs of the market on reasonable terms.\par The act of allowing another to use a patent without permission of the patent holder is called "non-voluntary use" or a "compulsory licence."\par The latest international agreement, the World Trade Organisation Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS), authorises governments to use compulsory licences for government use, to meet public emergencies or circumstances of extreme urgency (including health crises), as a remedy to anticompetitive practices or for any other public purpose, as long as certain procedures are followed.\par The Ministerial Conference of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  in Doha (2001) instructed states to interpret the TRIPS agreement "in a manner supportive of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  members' right to protect public health and, in particular, to promote access to medicines for all." Specifically, the Conference agreed that "each member has the right to grant compulsory licences and the freedom to determine the grounds upon which such licences are granted."\par Has competition affected the price of Aids drugs?\par In the past few years, several countries have allowed the manufacture of generic ARVs with the result that prices dropped. In 1998, multinational companies were charging about $12,000 per year for the cheapest ARV treatment - a combination of d4T+3TC+nevirapine. In 2000, Brazil began offering this triple drug ther}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 py for $2,767 annually after allowing local suppliers to make or import the medicines. By March 2001, Indian drug manufacturer }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  was offering a generic treatment for $350 and the brand name version had dropped to $727. Today, suppliers offer the treatment for as low as $200 per year.\par Are there other benefits of competition for the supply of medicines?\par Competition has multiple benefits. One of the most dramatic in the supply of ARV medicines has been the ability to compete to provide the most innovative product for developing countries.\par For example, none of the brand name companies provides a d4T+3TC+nevirapine treatment in a single pill because the drugs are patented by different companies and they do not work together. But several generic firms now provide these treatments in a single pill, allowing increased ease of administration.\par Having one company provide each drug has also caused shortages of supplies because when the supplier runs out of a product there are no alternatives, as has happened several times recently in Kenya.\par Another benefit may be the possibility that local production could begin to capture a share of the market, providing positive feedback effects in terms of employment and technology transfer.\par There is an argument that patents cannot be a problem in Africa because most ARVs are not patented in most countries in Africa?\par It is true that not all ARV drugs are patented Africa. The multinational pharmaceutical companies use this information to argue that patents are not a problem. But when one looks at which drugs are patented in Afr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ca, one finds that the drugs that are the cheapest to produce and the most effective to administer are widely patented.\par For example, a drug called Indinivir is only patented in two African countries. But it is very expensive to pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 duce and is not appropriate for many patients in Africa because you must consume at least two litres of w}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ter each day (more in hot areas) to prevent kidney stones. The least expensive, easy to administer and most effective treatments are (AZT or d4T)+3TC+nevirapine. One or more of these drugs or combinations are p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tented in 37 African countries.\par When should countries grant compulsory licences?\par To maximise the ability of competition in the supply of medicines to drive down prices and foster innovation, compulsory licences of right (a licence for any supplier to compete that can meet regulatory approval r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 quirements) should be granted whenever the number of people who need access to the medicines signif}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cantly exceeds those with access; or the patent holder has not implemented an automatic licensing pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gramme for all qualified suppliers on reasonable terms (international standard of two per cent to five 5 per cent royalties on annual sales) or if the major barrier to access is price. These drugs have been available in the West since 1996. The time to act is now.\par Are discounts and donations by the brand companies not solving the problem?\par No. Even with the most recent discounts by GlaxoSmithKline last week, the generic price for ARVs remains far cheaper than those of the brand name companies. The drug company discounts do not reach the private sector where perhaps a majority of people receive treatment now, and where more could receive treatment if prices were low enough. In addition, the prices will not fall further unless competition is allowed.\par Finally, the other benefits of competition - incentives to innovate, an increase in the number of suppliers to avert shortages and an allowance of local production - will not occur through discounts and donations.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GENERIC PRODUCTS (90%); HEALTH CARE ACCESS (90%); AIDS & HIV TREATMENT (90%); PHARMACEUTICALS INDUSTRY (90%); AIDS & HIV (90%); PHARMACEUTICAL PREPARATION MFG (89%); INTELLECTUAL PROPERTY LAW (89%); PATENTS (89%); NONPROFIT ORGANIZATIONS (89%); LICENSING AGREEMENTS (89%); PATENT LAW (78%); ANTIVIRALS (76%); DEATHS & DEATH RATES (76%); INTERNATIONAL ECONOMIC ORGANIZATIONS (74%); EPIDEMICS (72%); RESTRAINT OF TRADE (72%); INFECTIOUS DISEASE (72%); TRADE TREATIES & AGREEMENTS (71%); INTERN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TIONAL TRADE LAW (68%); TREATIES & AGREEMENTS (65%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANISATION (66%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AFRICA (94%); UNITED STATES (92%); KENYA (79%); UGANDA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 STATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 DISTRICT OF COLUMBIA, USA (92%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANISATION (66%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 May 13, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2003 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Saving grace: Yusuf Hamied Generic drugs boss: He says he could save millions from death if the western giants would waive their patent rights and more governments would buy his drugs The Guardian (London) February 18, 2003 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_62}{\*\bkmkstart DOC_ID_62_0}{\*\bkmkstart doc_id_19}{\*\bkmkend DOC_ID_62}{\*\bkmkend DOC_ID_62_0}{\*\bkmkend doc_id_19}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_19"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00310039000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 19 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Guardian (London)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 February}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  18, 2003\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Saving grace: Yusuf Hamied Generic drugs boss: He says he could save millions from death if the western giants would waive their patent rights and more governments would buy his drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Guardian Special Supplement, Pg. 8\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1353 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  The drug barons consider him a pirate and a thief. Yusuf Hamied, a Cambridge-educated multi-millionaire who lives for the summer months in what used to be Lady Shirley Porter's London apartment, believes he is doing Ghandi's bidding. He manufactures perfect copies of many of the world's best and most important medicines and sells them at a snip. Dr Hamied and his family are certainly very rich but many poor people owe him their health, without which they would be destitute indeed.\par  The question of Dr Hamied's motivation is absorbing but at the end of the day irrelevant. What matters is that he exists. He single-handedly broke the cartel of the big drug companies by offering to supply Aids drugs at less than a tenth of their prices. That audacious offer at a big European Commission meeting on Aids in September 2000 ("you could hear the breath being sucked out of the room" said Bill Haddad, former New York Post investigative journalist turned US generics boss) made everything possible. The assumption that Aids drugs were not for the poor - that they could not afford them and therefore that there was no point even thinking about ways to get people treated - was blown out of the water. \par  Now, in the post-Hamied era, the genie will not go back in the bottle. The big drug companies have been forced to drop their prices for these new and powerful drugs and offer them to a market they had no interest in developing - the impoverished African states where a whole generation of parents, teachers and workers are dying.\par  Dr Hamied's prices are still lower - his Bombay-based company, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 , offers a three-drug cocktail for around Dollars 304 per year which used to sell for around Dollars 12,000 and would now cost Dollars 727 from the brand-name companies. And yet his sales are few in countries where the need is desperate. Fewer than 50,000 people are being treated out of nearly 30 million infected with the lethal HIV virus in Africa, and - although Malawi is buying them - most of those are not getting }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  drugs.\par  Part of the reason is money - Dollars 304 is still impossible in countries with a per capita income of under Dollars 200 a year. But another part of it is a fight-back by the US and Europe-based big-name pharmaceut}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cal industry, which has long wanted to wipe the buccaneering generics companies off the face of the planet. Their long-term strategy to do that, through a World Trade Organisation agreement called Trips (trade rela}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ed intellectual property rights) - which will sign up every nation to protect patents on new drugs for 20 years - is now in jeopardy because of the Aids crisis and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  affordable medicines.\par  The drug giants have dropped their prices and argue that there is no need for generic piracy. But many of those who are concerned about the damage being wreaked on the economies of poor nations by a single virus have come to believe that it is not safe for the world to rely on voluntary price reductions by generous drug barons for desperately needed medicines to keep poor people alive and nations stable.\par  Campaigners in the US and Europe, as well as governments in developing countries, now see generics - or the threat of them - as the only way to get affordable medicines for all sorts of diseases that afflict the pop}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lation of poor countries and damage their economies. Just over a year ago, they secured an exemption clause to Trips, called the Doha Declaration, which allows developing countries to ignore patents and buy generics in a health crisis. Now the fight is on to decide in which countries and for which diseases poor pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ple should be allowed cheap medicines - the US government, which champions the industry, wants to rule out such illnesses as asthma, diabetes and cancer and restrict the concession to the very poorest nations.\par  The crucial issue is whether the generics companies of India, Brazil and Thailand will be allowed to export to countries that cannot make their own cheap copies after the Trips patent rules bite in 2005. Unless they can, new drugs invented for Aids or other diseases will be untouchable and unaffordable in Africa for 20 years.\par  }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  was set up as an Indian solution to India's health problems by Dr Hamied's father in 1935 when war stopped medicines arriving from Europe. Its website features a picture of Ghandi expressing his delight at visiting "this Indian enterprise". In 1972, India passed a law which permitted medicines to be copied even if they were under international patent, as long as the process was not the same. There are now hundreds of generic companies in India - many of them tiny. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  is one of the biggest, with a market capitalisation, said Dr Hamied, of about Dollars 1.4bn. "I don't want to make money on Aids drugs," he says. "I make enough money on other things. On this particular issue, can't we all pool our resources? I make 800 drugs. If I don't make money on six, why should I worry?"\par  Dr Hamied runs a free cancer hospital in India. There are reasons to believe in his altruism. "I'm not going to take it with me, so I have to leave it here," he says. But there's no doubt he stands to win all ways round. His public stand has given }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  excellent publicity. The World Health Organisation has endorsed the quality of his generic Aids drugs and approved his factories. And the fight over the Trips agreement could bring him a lot more business not only from the poorest countries but - and this is why the research-based companies are fighting so hard - also the massive developing markets of China and South America.\par  Dr Hamied, though, is frustrated. He is disappointed with the governments of Aids-hit nations, who are not placing orders for his drugs. "It is a joke," he says. "I should have the demand. Demand creates the incentive to produce, but with only 50,000 in the whole of Africa, where is the demand?"\par  If demand grew as fast as the spread of the virus, he could not keep pace. He would like to see countries set up their own generics factories, and he has offered to show them how to produce Aids drugs for free. The Global Fund should put up the money, he says. None of that is happening. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  sells a three-drug cocktail in one pill, called Triomune, to be taken twice a day, which makes treatment much easier in poor countries. Malawi buys it for the couple of thousand patients who can afford to pay Dollars 28 a month, but its Dollars 196m from the Global Fund will only buy treatment for 50,000 more.\par  Dr Hamied will shortly launch the world's first once-a-day, three-drug treatment, called Odivir. It's clearly well suited to poor countries and it will be affordable, he says, but there's no reason to suppose it will be taken up where his other drugs have not been. "India has four million cases and I'm breaking my head to make my government take a more active role," he says. "I offered totally free nevirapine (to prevent babies being i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 fected by their mothers at birth) and nobody takes it. It is up to the various governments to avail (themselves) of the opportunities offered. What has really saddened me is, firstly, the governments and, sec ondly, I have been totally disillusioned by the UN who talk, talk, talk and do nothing at all."\par  What, apart from lack of money in the poorest, is stopping the governments biting }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  hand off? The research-based pharmaceutical industry would say the political will is not there. But patents have been an issue. In Ghana, for instance, says Dr Hamied, it was GlaxoSmithKline that challenged the decision to import generic versions of drugs which were under patent there.\par  But there are countries where Aids drugs are not patented. According to Bill Haddad, who has voluntarily taken up }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  cause in the US, "the governments are too scared of the US government to buy generics". The US trade representative bats for the giant pharmaceutical companies. Whatever the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  trade rules say about allowing countries to buy generics in a health crisis, he suggests, there are those who would rather not risk the wrath and possible sanctions of the US.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  LTD (82%);   EUROPEAN COMMISSION  (56%); EUROPEAN COMMISSION (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 EUROPEAN COMMISSION  (56%); EUROPEAN COMMISSION (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (82%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (82%); SIC2834 PHARMACEUTICAL PREPARATIONS (82%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 EUROPE (92%); AFRICA (92%); UNITED STATES (79%); MALAWI (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 EUROPE (92%); AFRICA (92%); UNITED STATES (79%); MALAWI (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PHARMACEUTICALS INDUSTRY (90%); WEALTHY PEOPLE (90%); INTELLECTUAL PRO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ERTY LAW (90%); GENERIC DRUGS (90%); AIDS & HIV TREATMENT (89%); PHARMACEUTICALS P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TENTS (89%); PATENTS (83%); PHARMACEUTICALS ASSOCIATIONS (78%); CONTROLLED SU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 B}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 STANCES CRIME (78%); AIDS & HIV (78%); INTELLECTUAL PROPERTY (78%); TRADE DEVELO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MENT (73%); TALKS & MEETINGS (73%); GENERIC PRODUCTS (73%); INVESTIGATIONS (72%); CA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TELS (69%); TREATIES & AGREEMENTS (50%); VIRUSES (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 February 18, 2003\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2003 Guardian Newspapers Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Nigeria;Problems Dog Abuja's ARV Programme Africa News April 5, 2002 Friday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_63}{\*\bkmkstart DOC_ID_63_0}{\*\bkmkstart doc_id_20}{\*\bkmkend DOC_ID_63}{\*\bkmkend DOC_ID_63_0}{\*\bkmkend doc_id_20}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_20"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320030000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 20 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 April}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  5, 2002 Friday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Nigeria;\par Problems Dog Abuja's ARV Programme}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Access Alert\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1856 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 After a series of false starts, 'Africa's largest antiretroviral treatment programme' finally kicks off.\par IN April 2001 in Abuja, at the Summit of African Leaders on HIV/AIDS, Tuberculosis and Other Related Infe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tious Diseases, President Olusegun Obasanjo formally announced his government's determination to co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 mence what would soon be touted 'Africa's largest antiretroviral (ARV) treatment programme'.\par Huge cheers greeted the Nigerian president's announcement of the plan, which would provide life-prolonging treatment to 10,000 adults and 5000 children living with HIV/AIDS. Although this was a drop in the bucket considering that three million Nigerians are living with HIV/AIDS, many activists hailed the plan as a signal that Africa's political leaders were waking up to the responsibility of providing care and support for people living with HIV/AIDS. It would also put to shame critics who thought that large-scale ARV treatment in Africa was impracticable. \par Outside Nigeria, only Botswana has started a similar programme to provide access to people living with HIV/AIDS. Many African governments cite obstacles such as costs, poor healthcare infrastructure, negative side effects associated with using ARV drugs and fears of non-compliance by patients. Many of these go}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ernments have however failed to take advantage of various strategies available to them to reduce the costs involved and the many opportunities offered by agencies such as the Joint United Nations Programme on HIV/AIDS (UNAIDS) to address the challenges posed by ARV treatment. South African President, Thabo Mbeki, for example has consistently refused offers by drug companies to supply free or low-cost treatment to reduce the risk of mother-to-child transmission and to alleviate AIDS-related illnesses.\par Little wonder then that the commitment demonstrated by the Obasanjo-led government in providing trea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment for PLWHA was greeted with much applause.\par It was evident that, at last, one African leader was making the right move.\par Last September, Nigeria's Health Minister, Alphonsus Nwosu, announced that the country was ready to begin the clinical trials. "We have completed the training for the health workers. We have the drugs. We have designated the centres and we have set up the monitoring mechanisms. We are ready", he said.\par Nwosu said that government doctors at more than 60 federal and state health centres had already been trained to administer the trial treatment to 15,000 people living with HIV/AIDS.\par Under the Nigerian programme, generic drugs would be purchased from two Indian pharmaceutical firms, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  and Ranbaxy, at annual cost of 500 million naira. Although the first consignment of generic ARVs were purchased at the cost of $350 per person from }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  government officials hoped that prices would dip lower, through stimulation of competition among various interested pharmaceutical companies.\par "Our ultimate target is to ensure that the drugs are purchased at a cost of $200, so that Nigerians can pu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 chase it at the affordable cost of about N20, 000 per annum", Nwosu told Access Alert last December. "Through mass purchase and mass acceptance, the prices would be lowered, to such an extent that market forces would bring down the cost of ARVs to an affordable price.\par The health system should be such that ARVs would be easily available on prescription, as that is the only way the treatment programme can be sustained".\par A series of false starts nearly put paid to hopes that the project would turn out to be a success. An initial plan to start distribution of the drugs September 2000 was postponed for 'logistics reasons', and a December 1 (World AIDS Day) fixed. That, too, failed. Amidst the controversy over the delays, Dr. Nasir Sani-Gwarzo, head of the AIDS/STD programme at the health ministry, announced that the pilot sites for the treatment programme had been expanded from 18 to 100 hospitals across the nation in order to accommodate more people living with HIV/AIDS.\par Last January, officials quietly began administering the drugs on a limited basis at 25 sites across the country. Some of the centres are yet to fill their initial quota of 25 patients each. They are expected to meet the quota before the end of March 2002, by which time a preliminary report will be submitted to the National Agency for Food and Drugs Administration and Control (NAFDAC).\par Three drugs - Lamivudine (also known as 3TC), Nevirapine and Stavudine (AZT) - are being provided under the programme. These three drugs make up one AIDS cocktail.\par Because the Indian-supplied drugs are not yet registered in Nigeria, they are being administered on a trial basis, and NAFDAC may give three-month extensions to the programme, until the agency's officials are co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 vinced that the drugs are wholesome and suitable for use in the country.\par The government, which is subsidising 80 per cent of the cost of the drugs, seeks eventually to treat about 10,000 adults and 5,000 children, but it has only bought enough drugs to treat 8,000 patients this year. Pa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ticipants are required to pay for the treatment, which will cost them about $1 a day.\par Ebenezer Durojaye, an HIV/AIDS counsellor at the Center for the Right to Health told Reuters that it was "unbelievable" that the centres had not yet filled their initial 25-person quota "in a country with many people living with AIDS as Nigeria." One in 17, or 5.8 per cent, of Nigerians between the ages of 15 and 49 are e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 timated to be HIV-positive.\par The mis-steps that have dogged the progress of the project has heightened fears that the ARV treatment plan could lead end up a stillbirth. Questions are being raised about the highly sensitive and temperature specific nature of these drugs and the quality of storage facilities provided by the government.\par For instance, government has purchased and received drugs that could conveniently treat 8000 patients for the next one year, but only 625 patients are currently enrolled in the programme. At the current low rate of enrollment into the programme, the 500 million naira worth of drugs would have to be thrown away if not used up by March 2003, the expiration date of the drugs. The prospects bring back sad memories of the scandalous purchase, in 1997/98, of over $10 million worth of expired HIV test kits by the defunct Petroleum Trust Fund (PTF).\par Last January 27, the programme nearly suffered a calamitous abortion when several bombs from the Ikeja military cantonment munitions dump explosions landed on the roof of the Central Medical Stores, Oshodi, Lagos, where majority of the ARV drugs were stored. A member of the national ARV committee told Access Alert that it was a 'miracle' that the entire stocks of the ARV drugs were not consumed by the bombs.\par Dr. Pat Matemilola, coordinator of the Network of People Living with HIV/AIDS, also raised the issue of fake drugs and drug resistance, which is a growing problem in the country. According to a recent study published in The Lancet, over 40 per cent of drugs circulating in Nigeria are fake or substandard. Matemilola noted that because some of these imported generics are already in the open market, they might be 'cloned' or abused by those who can afford to purchase them.\par "As a result of drug misuse, resistant strains of HIV are likely to emerge.\par This would portend a great problem for the country as these strains could easily be transmitted across bo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ders. How does resistance develop? Why have only three types of drugs being imported? What is the basis of the reactions of the drugs used in the combination therapy? Should resistance develop, what should we do? These are the questions that the review committee monitoring the trials has to be able to answer if the programme is to go full scale", Matemilola said.\par He also noted that the cost of the series of preliminary screening tests, which PLWA have to undergo before being included in the trials, is a big barrier, which must also be addressed if access to these drugs is to be opened up, and distribution networks improved.\par Due to the non-existence of a proper national drug policy, the drugs are being imported from different pha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 maceutical firms without setting an international tender which could bring down the prices. Yet, quality gene}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ic combination treatment is increasingly available in the world. Thailand and Brazil are among such nations already producing generic ARVs in large quantities for their local populations. Indeed, Thailand has a pro-active programme to transfer technology to African nations for local manufacture of generics.\par In the case of Brazil, not only did the national legislation and improved infrastructure facilitate the drug trea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment programme (which now offers free or subsidised treatment to over 50,000 Brazilians living with HIV/AIDS) the country, which started off treatment on a small scale, is today producing its own generic drugs.\par Aside from the option of local manufacture of these generics, the Obasanjo government can make antiretr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 virals available at lower costs by using legal mechanisms and such as compulsory licensing and parallel i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 portation included in the Agreement on Trade-Related Aspects of Intellectual Property (TRIPS).\par Compulsory licensing is one of the elements in the Agreement on Trade-Related Aspects of Intellectual Property (TRIPs) that is designed to mitigate the negative consequences of patent monopoly. According to this article, member-states of the World Trade Organisation (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO)}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  may allow the use of compulsory licen}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing to a third party without the patent holder's consent, in specific cases of national emergency or public, as well as non-commercial use.\par Parallel importation, on the other hand, when written into national law, allows cross-border trade in a patent product without the permission of the patent's owner. Parallel imports allow countries to import brand name products from countries where they are sold at lower prices. For instance, Nigeria should be able to import drugs from Spain, the cheapest source of drugs in Europe, instead of from the United Kingdom.\par Nigeria's ARV programme need not stop with the importation of generics and the creation of a price war. L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cal manufacturers too should be encouraged to produce generic drugs. It is the responsibility of the Nigerian government to make use of these safeguards. There is an ethical imperative to provide treatment to the po}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ulation. Nigeria has endless opportunities. There are no proprietary laws in existence at the moment. The environment is conducive to implement the necessary technology transfer to get a cost-effective combin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion.\par Culled from Access Alert, the bi-monthly newsletter on access to HIV/AIDS care and treatment in Nigeria, March/April 2002. Access Alert is a publication of Journalists Against AIDS (JAAIDS) Nigeria, published with the support of The Ford Foundation as part of a 2-year advocacy campaign on access to HIV/AIDS care and treatment in Nigeria. For further information about the project or to be included on our mailing list, please contact the undersigned.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV (95%); ANTIVIRALS (91%); AIDS & HIV TREATMENT (90%); INFECTIOUS DI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 EASE (90%); PHARMACEUTICALS INDUSTRY (89%); GENERIC DRUGS (89%); DISEASES & DISO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 DERS (89%); UNITED NATIONS INSTITUTIONS (78%); TUBERCULOSIS (78%); HEALTH DEPAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MENTS (77%); PUBLIC HEALTH ADMINISTRATION (77%); PRESCRIPTION DRUGS (71%); PHARM}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 CEUTICALS & BIOTECHNOLOGY REGULATORY COMPLIANCE (70%); PHARMACEUTICALS PRODUCT DEVELOPMENT (69%); DRUG INTERACTIONS & SIDE EFFECTS (68%); HEALTH CARE (66%); PHA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MACEUTICAL PREPARATION MFG (65%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (51%); RANBAXY (NSE) (51%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (51%); SIC2834 PHARMACEUTICAL PREPARATIONS (51%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ING (51%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (51%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 THABO MBEKI (54%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (82%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NIGERIA (99%); AFRICA (94%); BOTSWANA (79%); SOUTH AFRICA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ABUJA, NIGERIA (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 UNITED NATIONS (50%);  UNITED NATIONS (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 April 5, 2002\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2002 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PanAfrica;U.S. Post-Doha Conditions Can Kill Africa News March 4, 2002 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_64}{\*\bkmkstart DOC_ID_64_0}{\*\bkmkstart doc_id_21}{\*\bkmkend DOC_ID_64}{\*\bkmkend DOC_ID_64_0}{\*\bkmkend doc_id_21}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_21"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320031000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 21 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 March}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  4, 2002 Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 PanAfrica;\par U.S. Post-Doha Conditions Can Kill}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Health Gap\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 3501 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Although the U.S. has not yet committed itself in writing with respect to its proposals for addressing the pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 duction-for-export issue left open in paragraph 6 of the Doha Declaration on the TRIPS Agreement and Pu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lic Health, it has informally shopped several ideas, most of which would dramatically limit the scope and e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 fectiveness of a post-Doha solution, sacrificing lives while securing future profits for the patent pharmaceut}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cal industry in the U.S. These conditions, which have the potential to kill millions of people living with HIV/AIDS, include the following:\par (1) limits on the types of public health products to be covered by the agreement;\par (2) limits on the sectors which might be supplied by the agreement, specifically excluding the private sector (and perhaps the NGO and mission sectors);\par (3) limits on the importing countries that might benefit from the agreement:\par (a) no application to small market countries that theoretically have technical capacity to produce medicines but insufficient market size to achieve economies of scale,\par (b) strict application of the "insufficient manufacturing capacity" standard to exclude countries where produ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion is nontheless infeasible or impractical,\par (c) income limits that would exclude many developing countries, especially middle-tier countries;\par (4) a preference for Article 31(f) compulsory licensing solutions in the exporting state that create multiple ba}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 riers to implementation including:\par (a) prior negotiation on commercially reasonable terms with the patent holder who might itself impose one}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ous conditionalities,\par (b) costly, burdensome, and protracted individual determinations in administrative or judicial proceedings to grant each license on a case-by-case basis,\par (c) dependence on the willingness of a third country to go through such burdensome procedures because of a public health need in a third countries,\par (d) proof in these proceedings both of a triggering public health need in the affected country and of technical incapacity to produce a particular medicine,\par (e) determination of the level of license compensation in the producing country rather than in the importing country and imposition of a licensing fee even with respect to imports into a no-patent country and possibly of double-license fees for CL importing countries;\par (5) a probable limitation that export licenses be limited to addressing "serious" or "urgent" public health needs, such as HIV/AIDS, TB, and malaria;\par (6) supply limitations or limitations on re-export, especially to developed countries, but perhaps even regio}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ally between or to developing countries with comparable public health needs. \par Each of these conditions (except the first part of #6) go against the letter and spirit of the Doha Declaration, each of them reflects erroneous assumptions and poor public policy, each of them has the potential to kill.\par PHARMACEUTICALS ONLY VS. PUBLIC HEALTH PRODUCTS\par Admittedly, paragraph 6 makes reference to the "pharmaceutical sector" and paragraph 4 makes reference to the imperative "to promote access to medicines for all." Likewise, there is little doubt that one of the most pressing needs with respect to infectious and pandemic diseases in developing countries is affordable med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cines, especially those like anti-retrovirals which have been priced so exorbitantly in the recent past and which are still three times cheaper when supplied by generic producers.\par But, treatment activists and public health specialists have clearly foreseen the need to achieve economies in other public health products, like blood tests and testing equipment. Given that paragraphs 1 and 4 make explicit reference to a broad public health exception (not just pharmaceuticals) and given that the TRIPS Agreement contains a principal of non-discrimination against a field of technology, it makes sense to broaden the category of products and processes covered beyond pharmaceutical alone to "health need products" as previously recommended by treatment NGOs in their letter to the TRIPS Council dated January 28, 2002.\par SECTOR LIMITS, ESP. PRIVATE SECTOR EXCLUSIONS\par The U.S. is shameless in trying to preserve the "right" of U.S. patent holders to make profits off of a narrow spectrum of rich elites in developing countries. In the era of highest pricing, only 10,000-15,000 Africans could afford medicines, even when treatment was partially subsidized by private medical aid schemes. (U.S. companies made $9000-$14,000 profit per patient per year for a total of $90,000,000-$210,000,000 a year.)\par However, as important as it is to achieve universal coverage through the public sector (such as Brazil has done so successfully), at present it is important to extend access to affordable medicines in the private sector as well as the public sector for several reasons. First, there is considerable capacity in the private business sector to deliver treatment and care through workplace clinics already provided by some of the larger e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ployers. Some of these employers, for example AngloGold, are refusing to supply anti-retroviral therapy to their non-central-office employees because of the price of ARV medicines which have not been heavily di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 counted in the private sector by pharmaceutical patent-holders, e.g., GlaxoSmithKline.\par Secondly, most medical aid schemes extended to private and public sector employees have benefit limits that make it impossible to pay for anti-retroviral medicines and associated testing unless they are heavily discounted. Third, the private sector technically includes NGOs and mission hospital systems which are also well poised to deliver high quality treatment and care but only if medicines are made available at a more a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 fordable price. What is particularly cynical about the U.S. position is that it coincides with U.S.\par backed imperatives in the World Bank requiring borrowers to privatize health systems and as it presses fu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ther for health care privatization in the General Agreement on Trade in Services. There is no reason in the world to exclude untreated private and public sector employees and their families from the benefit of more affordable medicines and medical products.\par IMPORTING COUNTRY LIMITS\par The U.S. is trying to dramatically limit that countries that might benefit from the production-for-export exce}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion in three ways. First, the U.S.\par refuses to consider application of the new rule to countries with a small market for a particular medical pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 uct through fear of benefiting customers in small but rich markets.\par Many African countries are "small market" both in terms of absolute population and number of citizens suffe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing a particular disease and in terms of consumers who can afford medicines. Even though these countries might theoretically have, or in the future develop, some limited technological capacity, production for dome}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tic use only will remain impractical because it will be impossible to achieve meaningful economies of scale by domestic production. Certainly it is important in the long run to promote technological transfer and to develop pharmaceutical capacity in Africa and in other developing nations.\par But in terms of AIDS and many other diseases of poverty, it is important to achieve both economies of scale and some degree of competition so that high quality medicines can be made available on a low-cost basis as soon as possible. Thus, any post-Doha agreement must address the importing needs of small-market cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tries as well as limited capacity countries.\par Parenthetically, there are many instances where U.S. and E.U. consumers can and should benefit from this same principle. There are many so-called orphan diseases which have a small incidence, but where orphan drugs are available but only at truly exorbitant prices. Likewise, in times of threats of bio-terrorism (remember anthrax and Cipro?) or epidemic outbreaks of certain infectious diseases, developed countries should have the flexibility in their national legislation to address public health needs as well through import of critically i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 portant medicines. Although the NGO letter clearly addresses this public health need, the U.S. position staunchly ignores health market needs in both developed and developing countries in order to preserve pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 its.\par Second, the U.S. is trying to narrowly interpret the meaning of "no and insufficient manufacturing capacity countries" to impose an onerous pharmaceutical capacity test which will exclude several countries with the}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 retical or marginal capacity or even capacity in some sectors but not in others. Many developing countries have some residual capacity to finish medicines (press them into pills) from raw ingredients manufactured abroad.\par However, few of these countries have current capacity to make ingredients from scratch (nor would it be economically sensible to do so). Even fewer of them have the current productive capacity to manufacture the newest generation of sophisticated drugs, especially anti-retrovirals where production and quality control standards are extraordinarily important because of the risk of drug resistance and/or toxicity where the bio-availability of medicine is not maintained in a very narrow range.\par The NGO letter has opted to drop any "capacity" requirement whatsoever in favor of addressing a public health mandate that might affect all countries, even those with theoretical capacity. Even if countries event}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ally negotiate something narrower with respect to capacity, the definition should err on the side of over- r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ther than under-inclusion and it should be easy to administer to avoid complex determinations in the country of production.\par Third, the U.S. is trying to preserve pharmaceutical monopolies in low-middle and middle-income countries by refusing to automatically include all "developing countries" in its coverage provisions. As previously sta}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ed, the NGO letter has urged a broader inclusion of all }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  members who face a public health need - the interests of consumers in developing countries could be addressed in this new agreement and there is no sound reason not to do so. Moreover, if the U.S. or the E.U. or Japan decided that their consumers somehow did not need the benefit of public health imports in times of dire need, they could simply keep their current generic/import exclusion rules in place.\par In other words, the developed countries can always protect their own domestic markets from generic comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tition but means of their national legislation. However, the U.S. is also trying to figure out how to exclude some of the bigger developing and middle income markets because that is an area of future growth for the patent pharmaceutical industry. Once again, pharmaceutical profits and intellectual properties rights are b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing put ahead of the health rights of people in South Africa, Brazil, and other middle income countries.\par PREFERENCE FOR COSTLY, INEFFICIENT, AND NULLIFYING COMPULSORY LICENSE SOLUTIONS\par Both the E.U. and the U.S. have stated a preference for an Article 31(f) solution liberalizing the "predom}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nantly for the supply of the domestic market" rule so as to permit production for export. Although an Article 31(f) solution without onerous conditions would certainly be better than no solution, it is inferior to an Article 30 solution because of the numerous procedural and practical hoops that will inevitably delay implementation of production for export.\par First, a production for export license (except one granted under 31(k)) would ordinarily required protracted negotiations with the license holder seeking commercially reasonable terms for a commercially reasonable period of time. During these negotiations, there is little doubt that patent holders would attempt to impose the same limitations and conditions on voluntary licenses that the U.S. seeks to impose in its post-Doha pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 posals, e.g., product limits, country limits, sector limits, etc.\par Moreover, at a minimum, these negotiations are likely to drag out for months if not years and might result in time-limited rather than life-of-patent agreements. Second, compulsory license procedures are costly, bu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 densome and protracted, imposing substantial procedural and substantive barriers that many countries seek to avoid. Compulsory licenses, even under administratively streamlined procedures, take lawyers, burea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cratic decision-makers, and other official resources, are subject to pharmaceutical company opposition and subversion, and can give rise to covert bilateral trade pressure from the U.S. which wants CLs to remain "e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ceptional" rather than "ordinary."\par Paradoxically, however, the U.S. is attempting to impose a system that requires dozens of separate applic}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tions - one for each and every required medicine and perhaps one for each and every importing country. Third, these kinds of burdens may well make many countries loath to permit compulsory licenses on human}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tarian grounds merely to serve public health needs in distant countries. As previously stated, many countries have been reluctant to even consider imposing licenses for their own needy populations. (Remember, no developing country has yet issued a compulsory license for AIDS medicines, though Brazil has threatened to do so and although a current }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  application is pending in South Africa.)\par What makes the U.S. think that countries will readily go through this grief even to benefit a fledgling generics industry? Fourth, the license-granting, export-producing country will have to undertake a determination both of the public health need and the level of technical capacity in distant countries, at least under the U.S. pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 posal. Once again, this is an unreasonable and impractical burden. Finally, under this scenario, it is the pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ducing/exporting country that will determine and impose a license royalty fee to be paid to the patent holder and tacked onto the product price. It makes a lot more sense for the licensing fee to be determined in the importing country where local realities and markets are affected. (It makes no sense that an importing cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 try that has issued its own compulsory license might have to pay double compensation!)\par Moreover, there is no justification for any fee whatsoever to be imposed on products destined for no-patent countries. If the pharmaceutical company has not bothered to secure a patent in a particular country, why should it get a royalty on sales there? The extension of the transitional time periods in the Doha Declaration expressly permits least developed countries to remain non-patent or to revert to non-patent status. Why should these poorest countries pay a premium just because they can't manufacture medical products on their own?\par LIMITATION TO SERIOUS OR URGENT PUBLIC HEALTH NEEDS\par At Doha, the U.S. famously negotiated for an AIDS, TB, and malaria platform only. The E.U. has partially resurrected the U.S. position in its proposal that talks about "serious" public health needs rather than any legitimate public health need whatsoever. The Doha Declaration makes not such distinction except in the paragraph 1 preamble and with respect to paragraph 5(c) dealing with the emergency rules of Article 31. I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 deed, the Doha Declaration is significant for having adopted a much broader public health perspective, pa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ticularly in paragraph 4: "We agree that the TRIPS Agreement does not and should not prevent Members from taking measures to protect public health.\par Accordingly, while reiterating our commitment to the TRIPS Agreement, we affirm that the Agreement can and should be interpreted and implemented in a manner supportive of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Members' right to protect public health and, in particular, to promote access to medicines for all." Although the U.S. and E.U. language would undoubtedly permit production and export of medicines for AIDS, TB, and malaria, it would not give member countries the option of accessing most or all of their pharmaceutical and other medical products at more a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 fordable price should public policy so mandate. Thus, scarce resources, otherwise available for public and private health care and poverty alleviation, would be "wasted" on high cost antibiotics, or diabetes medicines, or the like. Since the TRIPS Agreement places no limits on the public health issues that Member Countries might address, there is no sound reason for limiting the scope of paragraph 6 solutions to "serious" or "u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gent" needs only.\par SUPPLY LIMITS AND RESTRICTIONS ON RE-EXPORT\par The U.S. and E.U. are understandably concerned about preventing the leakage of TRIPS sanctioned med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cines back into developed countries markets where pharmaceutical companies make the vast majority of their profits. As previously discussed, however, the U.S. and E.U. are in the driver's seat with respect to this alleged problem because they will certainly maintain or expand their existing legislation to prohibit import}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion of "production-for-export" medicines into their national markets. However, even with these legislative barriers and with their capable customs systems, the E.U. and U.S. still want some protections against grey market or black market re-export.\par As a practical matter, this grey market danger has never materialized, but if the U.S. and E.U. can fashion some reasonable language on this issue, it might not be so bad. Unfortunately, in an effort to protect their own markets from generic competition, the U.S. and E.U. are attempting to impose barriers that impede r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gional procurement and distribution of medical products among developing countries, whether mediated by international agencies or not. This is unconscionable.\par MORATORIUMS AVOID SOLUTIONS\par The U.S. has floated the idea of a moratorium, which in the view of treatment activists delays a solution r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ther than implements one.\par Unfortunately, the problem of public health needs and access to medical products in the developing world is not going to go away quickly, especially for the pandemic diseases of AIDS, TB, and malaria. When a mor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 torium ends, the same conundrum about how to structure a workable solution will still exist. Even worse, a moratorium, especially a short moratorium, does not give producing countries and generic manufacturers the legal security they need to pass enabling legislation or to invest in production for export.\par In particular, it is clear that generic manufactures seek to avoid all risk of litigation with patent holders, whose army of lawyers terrifies both companies and nations. (Note, it took South Africa three years and 400,000 lives to beat off the litigation by the pharmaceutical industry over its legislation permitting generic substitution of off-patent medicines and parallel importation.) Accordingly, clear rules are preferable to vanishing morat}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 riums.\par ARTICLE 30\par The E.U. has at least considered the possibility of an Article 30 limited exception to supply a compulsory l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cense issued in the importing country (ignoring the right of no-patent countries to access medicines.) The NGO paper has stated many of the advantages of an Article 30 limited-exception solution and has proposed implementing language broader than the E.U.\par proposal. Similarly, the Africa Group and other countries proposed Article 30 language that would "authorize the production and export of medicines by persons other than holders of patents on those medicines to a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 dress public health needs in importing Members."\par These solutions are streamlined, easily negotiated, and even easier to implement once authorizing legisl}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion is enacted in producing and importing countries. The U.S. has argued that negotiating an Article 30 li}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ited exception is more time consuming than negotiating an amendment to Article 31(f) or a highly conditional moratorium on its enforcement. This is sophistry. Surely, amending the text of TRIPS is more time consu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing and procedurally burdensome than a binding interpretation of the TRIPS Council on an Article 30 limited exception.\par LIVES HANG IN THE BALANCE\par Once again, the U.S. seems to have forgotten that lives - millions of lives, 13,000 lives everyday with respect to AIDS, TB, and malaria - hang in the balance. The U.S., the E.U., and the rest of the world made a promise at Doha, that the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  would find an expeditious solution to the production-for-export issue left open on N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 vember 14, 2001. Now the U.S.\par and the E.U., but particularly the U.S., are threatening to renege on that promise - to break their word - and to conditionalize the Doha Declaration to death.\par Although the U.S. might decide to callously ignore the current and future public health needs of its own cit}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 zens in times of bio-terrorism or with respect to orphan medicines, it should not be permitted to kill countless others in its drive to preserve pharmaceutical profits. Developing countries and treatment activists worldwide must protest the U.S.'s narrow, Doha-strangling conditions at the upcoming TRIPS Council negotiations.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 EXPORT TRADE (90%); PHARMACEUTICALS INDUSTRY (89%); PATENTS (89%); IMPORT TRADE (89%); AIDS & HIV (89%); NONTARIFF BARRIERS (78%); EXPORT CONTROLS (78%); MAN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 U}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 FACTURING SECTOR PERFORMANCE (78%); MALARIA (77%); MANUFACTURING OUTPUT (73%); PUBLIC POLICY (73%); DEVELOPING COUNTRIES (73%); LICENSES & PERMITS (72%); TUBERCUL}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 SIS (70%); PLANT CAPACITY (67%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TRIPS COUNCIL (64%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 UNITED STATES (94%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 DOHA, QATAR (94%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TRIPS COUNCIL (64%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 March 4, 2002\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2002 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 South Africa;US Gives Licence to Ignore Patents Africa News November 5, 2001 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_65}{\*\bkmkstart DOC_ID_65_0}{\*\bkmkstart doc_id_22}{\*\bkmkend DOC_ID_65}{\*\bkmkend DOC_ID_65_0}{\*\bkmkend doc_id_22}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_22"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320032000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 22 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 November}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  5, 2001 Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 South Africa;\par US Gives Licence to Ignore Patents}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Business Day\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 539 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 No retaliation over five years even if SA violates pharmaceuticals' rights\par THE BUSH administration says it will take no action, either in the World Trade Organisation (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ) or bila}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 erally, if SA violates the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  agreement on intellectual property (Trips) to obtain affordable drugs for HIV/AIDS and "other pandemics".\par This moratorium would last five years and would appear to lift one of the remaining obstacles to the provision of cheap antiretroviral treatment for HIV-positive South Africans.\par A senior US trade official confirmed on Friday that during the period there would be no US retaliation even if SA broke a US company's pharmaceutical patents without due process of law or compensation. \par Options the US would forego include denial of African Growth and Opportunity Act trade preferences and the use of blacklisting and sanctions procedures under section 301 of the Trade Act.\par The safe harbour would apply only to the violation of patents related to the treatment of HIV/AIDS, tubercul}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sis and malaria, the official said. He was speaking on behalf of US Trade Representative Robert Zoellick.\par Despite the limitations on time and product, the offer goes beyond the current policy inherited from the Cli}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ton administration, which is not to object if trading partners like SA use Trips-tolerated compulsory licensing and parallel imports to meet their needs for affordable medicine.\par Before 1999 the US reserved, and exercised, the right to penalise such practices unilaterally.\par The senior trade official also made it clear the US wanted the world's poorest countries, most of which are in Africa, to be excused from having to honour any pharmaceutical patents until 2016 pushing back by a de}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ade the current 2006 deadline for Trips compliance by all developing nations.\par This 10-year extension would be available for countries officially classified by the World Bank as least deve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 oped, and therefore not for India or other richer but still developing economies that have exercised their right to defer full implementation of Trips.\par In theory, the US offer would enable a company like India's }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  which copies patented drugs without the patent owners' permission, to start manufacturing unauthorised generics in, for example, Mozambique or Tanzania for sale locally and in other least-developed countries.\par These proposals are part of an effort led by the US, Switzerland, Japan and Australia to block what they see as an attempt to have pharmaceutical patent protections gutted at the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  ministerial meeting in Doha this week.\par Brazil is spearheading a drive, nominally on behalf of poor countries, to have ministers officially declare that "nothing in the Trips agreement shall prevent members (of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ) taking measures to protect public health".\par Supporters of the Brazil plan say the US offer is an attempt to conquer developing nations by dividing them.\par Patrick Wadula reports that trade and industry ministry spokesman Edwin Smith said last night: "Our problem with Trips has nothing to do with patents and trademarks but access to medicines affordably." He said it would be difficult to comment on the matter until the SA government had received an official statement from the US.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV TREATMENT (91%); PHARMACEUTICALS INDUSTRY (91%); ANTIVIRALS (90%); TRADE DEVELOPMENT (90%); PATENTS (90%); AIDS & HIV (90%); PHARMACEUTICALS PATENTS (89%); INTELLECTUAL PROPERTY LAW (89%); INTERNATIONAL ECONOMIC ORGANIZATIONS (89%); DEVELOPING COUNTRIES (89%); EMERGING MARKETS (88%); TRADE TREATIES & AGREEMENTS (78%); DUE PROCESS (78%); EMBARGOES & SANCTIONS (78%); PATENT INFRINGEMENT (78%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TERNATIONAL TRADE LAW (78%); COMMERCE DEPARTMENTS (78%); EPIDEMICS (77%); TALKS & MEETINGS (77%); MALARIA (77%); GENERIC PRODUCTS (76%); PATENT LAW (74%); IMPORT TRADE (73%); TREATIES & AGREEMENTS (72%); TUBERCULOSIS (72%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (56%); SIC2834 PHARMACEUTICAL PREPARATIONS (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ROBERT ZOELLICK  (55%); ROBERT ZOELLICK (55%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION  (94%); WORLD TRADE ORGANIZATION (94%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 UNITED STATES (96%); INDIA (92%); MOZAMBIQUE (79%); QATAR (79%); AFRICA (79%); TANZANIA, UNITED REPUBLIC OF (79%); JAPAN (79%); SWITZERLAND (51%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANISATION (88%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 November 5, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 AllAfrica, Inc.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Co-operation, not coercion, to improve drug access National Post (Canada) July 09, 2001 Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_66}{\*\bkmkstart DOC_ID_66_0}{\*\bkmkstart doc_id_23}{\*\bkmkend DOC_ID_66}{\*\bkmkend DOC_ID_66_0}{\*\bkmkend doc_id_23}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_23"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320033000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 23 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 National Post (Canada)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 July}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  09, 2001 Monday NATIONAL EDITIONS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Co-operation, not coercion, to improve drug access}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Owen Lippert;Owen Lippert is a senior fellow of The Fraser Institute and lives in Santiago, Chile.\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 FINANCIAL POST: EDITORIAL; Pg. C15\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 886 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 No doubt Linda McQuaig sincerely believes 'Big Pharma' has failed in sub-Saharan Africa's HIV/AIDS crisis and that more government is the answer (Big Pharma Fails the Poor and Sick, July 3). Industry hasn't failed, though it could do more. That any drugs at all are available stems from substantial private investment in r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 search and development. A problem of affordability exists, but her recommendations -- to remove patent pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tection from pharmaceuticals in the developing world -- will not solve matters.\par Ms. McQuaig rehashes the activist proposal to reinterpret or amend the 1994 Trade Related Aspects of Inte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lectual Property Rights (TRIPS) agreement which protects patents internationally. The goal is to revise TRIPS so as to prevent developed countries from launching trade complaints against developing countries if the latter grant compulsory licences or engage in parallel trade. Compulsory licensing is when a country r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 vokes patent protection, and grants domestic producers the licence to manufacture a drug. Parallel importing is when copied drugs are imported from other countries. \par She claims the European Union supports changing TRIPS. I attended the press conference in Geneva when the EU representative to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  made his announcement. Ambassador Carlos Trojan couched his words to appear sympathetic, or at least anti-American, but the document he presented stated clearly that 'the TRIPS agreement cannot be held responsible for the health crisis in developing countries.' The Canadian government responded appropriately to a non-proposal.\par Despite the claims, compulsory licensing and parallel importing will not make a substantial difference to the lives of most HIV/AIDS sufferers in the developing world.\par First, the current HIV/AIDS drug regime is a transitional one. The 'cocktail' of up to 25 pills a day is the pha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 maceutical equivalent of shots in the dark. Fire enough bullets and you will hit something. The danger is that the 'cocktail' incorrectly manufactured and administered may create new drug-resistant strains.\par Revoking patent protection for pharmaceuticals will lower prices. Yet, the problem of affordability remains. The Indian generic drug manufacturer }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offered the South African government a 'cocktail' drug regime for US$350 per person. According to Health Action International, sub-Saharan governments spend US$2 per person on drugs. USAID, the United States Agency for International Development, calculates that for every US$100 spent on drugs, only US$12 reaches patients due to waste, corruption and poor handling. Even a full US$12-billion UN AIDS fund cannot make up that difference.\par Total public health-care spending per person in the region averages between US$3 and US$10 dollars per person, or about 1.9% of GDP, according to the International Monetary Fund. Private expenditures bring health spending up to about US$24 per person. In comparison, the U.S. State Department calculates that sub-Saharan African governments spend US$26 per person on military spending, or 2.9% of GDP.\par The government of South Africa ultimately rejected the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offer. An unstated reason was a desire to cr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ate its own domestic drug industry. It is unlikely that a protected African generic industry will produce drugs any cheaper than the Indian industry. A legitimate concern of the pharmaceutical industry is the unregulated export of generic drugs of unknown quality.\par Ms. McQuaig cites the success of Brazil in manufacturing generic AIDS drugs. Note that Brazil has not r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sorted to compulsory licensing to do so. The United States dropped its }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  challenge on the understanding that Brazil would negotiate any future grant of a compulsory licence.\par As a side shot, Ms. McQuaig chides the pharmaceutical industry for failing to produce drugs for other tropical diseases. The WHO has a list of around 300 essential medicines. Only about 20 of them are under patent. As for her example of the 'sleeping sickness' drug, Aventis announced two months ago that it would donate a global supply for the next five years.\par Co-operation and charity will make a difference in sub-Saharan Africa. The GlaxoSmithKline, Pfizer, and Merck corporations as well as the Bill & Melinda Gates Foundation are providing genuine assistance. Their contributions much exceed the current pledges to the UN AIDS fund. The US$700-million pledged by the governments of developed countries equals about one day's worth of the farm subsidies they pay out annua}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ly.\par Africans are dying now from AIDS in horrific numbers. The worst is yet to come. The real responsibility of the pharmaceutical companies is to find a vaccine, if it exists, or, if it does not, a simpler, less expensive drug maintenance regime. Undermining global patent law to hothouse production of first-generation drugs makes little sense. It will not make drugs substantially more affordable to the poor. It will drive the research-based industry and their medical expertise out of developing countries. It could ultimately weaken the incentive to invest in still much-needed research.\par Africa does not need more government. It needs the resources to improve its health care through the dyna}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ic of a market economy in physician care, medical technology and pharmaceutical drugs.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 EUROPEAN UNION (81%); UNITED STATES AGENCY FOR INTERNATIONAL D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 VELOPMENT (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NORTH AMERICA (50%); CANADA (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 EUROPEAN UNION LEISURE LTD (66%);   EUROPEAN UNION (81%); UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Pharmaceutical industry; Health care; Medical drugs; Developing countries; Patents; Foreign aid; Government spending; Laws and regulations; World; Africa  INTERNATIONAL ECONOMIC ORGANIZ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TIONS (92%); ECONOMIC NEWS (92%); PHARMACEUTICALS INDUSTRY (91%); EDITORIALS & OPI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 IONS (90%); AIDS & HIV (90%); DISEASES & DISORDERS (90%); IMMUNE SYSTEM DISORDERS (90%); DEVELOPING COUNTRIES (90%); PATENT LAW (90%); PATENTS (90%); INTELLECTUAL PROPERTY (90%); ECONOMIC DEVELOPMENT (89%); INTERNATIONAL ECONOMIC DEVELOPMENT (89%); EMERGING MARKETS (89%); IMPORT TRADE (88%); INTERNATIONAL TRADE (88%); INTERNATIO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AL RELATIONS (85%); AIDS TREATMENT (78%); RESEARCH & DEVELOPMENT (77%); GENERIC DRUGS (77%); IMPORT CONTROLS (73%); DRUG RESISTANCE (72%); GROSS DOMESTIC PRODUCT (72%); PHARMACEUTICAL PREPARATION MFG (72%); CHEMICAL INDUSTRY (72%); PHARMACEUT}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 CAL & MEDICINE MFG (72%); INFECTIOUS DISEASE (71%); ANTIVIRALS (71%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 LINDA MCQUAIG (81%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 July 09, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Business; Opinion\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 Financial Post DataGroup,\par A division of The National Post Company\par All rights reserved.\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Kenya;Country to Feature in WTO Talks  Africa News June 19, 2001 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_67}{\*\bkmkstart DOC_ID_67_0}{\*\bkmkstart doc_id_24}{\*\bkmkend DOC_ID_67}{\*\bkmkend DOC_ID_67_0}{\*\bkmkend doc_id_24}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_24"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320034000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 24 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 June}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  19, 2001\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Kenya;\par Country to Feature in }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928  Talks}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Nation\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NEWS, DOCUMENTS & COMMENTARY\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 881 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Last week's decision of the Kenyan parliament to pass a law enabling the government to buy or make cheap drugs is likely to prove a critical aspect of Wednesday's important World Trade Organisation Trips (Trade Related Intellectual Property Rights) talks in Geneva.\par The talks were requested by a number of African governments following the decision of the world's major pharmaceutical companies to pull out of their hugely controversial court case over the use of generic anti-Aids drugs by the South African government.\par After Pretoria's court victory, other African governments now want to be able to have access to cheap gene}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ic drugs to help the many millions of people across the continent who have Aids.\par With the multinationals on the defensive over the price they charge for anti-retroviral drugs, African gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ments want to be given the green light to either buy cheap generic drugs or manufacture them. \par The only other alternative, they are likely to say at tomorrow's talks, is for the multinationals to produce the anti-retrovial drugs at prices most ordinary Africans can afford.\par Following an extremely active international campaign on the issue both in Africa and the West there are signs that the multi-national pharmaceuticals are now moving in this direction, slashing prices on a number of Aids-related drugs to Africa.\par However, the position of the US government in tomorrow's talks will be critical.\par President George Bush is a known friend of big business and the US government is still operating the notor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ous List 301, which names countries that may incur trade sanctions if it is thought they are infringing drug and other patents.\par At a press conference in Geneva tomorrow, Dr Chris Ouma of the Kenyan Coalition for Access to Medicines is likely to outline what NGOs and development agencies want from Wednesday's talks.\par Oxfam say the fact that the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  has even agreed to hold the talks at the request of the African governments is unprecedented. Part of the reason may well be the special UN conference on Aids which has been called by Secretary- General Kofi Annan at the end of this month.\par African governments are said to want a loosening of trade regulations that have been used to prevent the poorest countries from buying cheap medicines.\par If agreed, this will mean a loosening of the TRIPS regulations enshrining in law the ability of poor countries to import vitally needed life-saving drugs at affordable prices.\par Western observers are still unsure what exactly Nairobi wants from the talks.\par Some believe the government is not in reality keen to import generic drugs but wants instead the big produ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ers to drop their prices further.\par Health Minister Sam Ongeri said recently that the government's aim was to " push the drugs companies into creating competition."\par The price of Aids drugs in Africa has fallen by up to 80 per cent since the South African court ruling but the cheapest anti-retroviral cocktail still costs around *650 (about Sh70,000) a year in Kenya, against the *250 (about Sh27,000) offer by }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  the Indian generic drugs company.\par The aim is to eventually get the price of aids-related drugs down to below $1 per day which together with new funding from the new UN Aids Fund for Africa should make the drugs available to hundreds of tho}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sands of ordinary Kenyans. At present only 1,000 are able to afford taking the anti-retroviral drugs.\par Campaigners such as Oxfam have noted that the language of the pharmaceuticals has changed as the d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 bate on the issue has warmed up.\par The companies are no longer pleading that they need the high prices to cover research and development costs - after it was proved that many anti- retrovirals were in fact largely produced through western gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment funding - but are instead raising the spectre of drugs flooding into Africa unregulated.\par The result could be that the major drugs companies will indeed sell their drugs at cost price or even below - given the billions in profits they have made in recent years - providing they can get guarantees from NGOs and governments that the drugs will be properly administered to ensure there is no build-up in drug r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sistance.\par Speaking about the Kenyan parliament's decision to pass the new law last week, a Glaxo spokesman told the Guardian newspaper that the company was "not concerned about the bill itself but with how it will be i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 plemented."\par "People are going to bring in all kinds of counterfeit products," William Kiarie said. "We want to be sure there will be a regulatory system in place."\par With growing public pressure and parliaments such as Kenya's emboldened by the South African case dec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sion, the drugs firms know that their days of making big money out of anti-retrovirals in Africa at least, are over.\par The Kenyan parliament was originally due to pass legislation last week making it compliant with TRIPS but it was changed to emphasise the government's right to get-out clauses and buy drugs at the cheapest global price.\par Now it will be interesting to see if Wednesday's talks also address the issue of not only limiting the extent of patent protection in Africa, but whether or not African governments are any longer going to be forced to give new drugs 20 years of patent protection.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TRADE DEVELOPMENT (91%); MULTINATIONAL CORPORATIONS (90%); INTERNATIONAL TRADE (90%); AIDS & HIV TREATMENT (90%); PHARMACEUTICALS INDUSTRY (90%); GENERIC DRUGS (90%); AIDS & HIV (90%); DRUG PRICES (89%); TALKS & MEETINGS (89%); INTERNATIONAL ECONOMIC ORGANIZATIONS (89%); LEGISLATION (89%); GENERIC PRODUCTS (78%); INTERN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TIONAL TRADE LAW (78%); HEALTH DEPARTMENTS (78%); PATENT LAW (78%); NONGOVERNME}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TAL ORGANIZATIONS (77%); INTELLECTUAL PROPERTY LAW (77%); PATENTS (77%); RELIEF O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GANIZATIONS (77%); PHARMACEUTICAL PREPARATION MFG (76%); HEALTH CARE ACCESS (74%); ANTIVIRALS (73%); PRICE CHANGES (73%); EMBARGOES & SANCTIONS (72%); PATENT INFRING}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MENT (71%); APPROVALS (68%); PRICE CUTTING (68%); US PRESIDENTS (64%); PUBLIC HEALTH ADMINISTRATION (64%); PRESS CONFERENCES (63%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GEORGE W BUSH (54%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION  (91%); WORLD TRADE ORGANIZATION (91%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AFRICA (96%); KENYA (95%); SWITZERLAND (93%); UNITED STATES (93%); SOUTH A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 F}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 RICA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 STATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GENEVA, SWITZERLAND (93%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GENEVA, SWITZERLAND (93%); NAIROBI, KENYA (78%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION  (91%); WORLD TRADE ORGANIZATION (91%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 June 18, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 English\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 AllAfrica, Inc\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Dying for drugs: Battle over cheap drugs goes to WTO: Since the Guardian's award-winning series began, prices have been slashed, but the fight goes on The Guardian (London) June 16, 2001 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_68}{\*\bkmkstart DOC_ID_68_0}{\*\bkmkstart doc_id_25}{\*\bkmkend DOC_ID_68}{\*\bkmkend DOC_ID_68_0}{\*\bkmkend doc_id_25}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_25"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320035000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 25 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Guardian (London)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 June}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  16, 2001\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Dying for drugs: Battle over cheap drugs goes to }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 : Since the Guardian's award-winning series began, prices have been slashed, but the fight goes on}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Sarah Boseley and James Astill\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Guardian Foreign Pages, Pg. 14\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1064 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  The United States and Europe will come under unprecedented pressure from developing countries next week to loosen the trade regulations that have been used to prevent the poorest countries buying cheap medicines.\par  International outrage at the court case brought by 39 pharmaceutical companies to prevent South Africa i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 porting drugs from abroad if they were cheaper there has prompted the World Trade Organisation to agree to hold a one-day meeting on Wednesday to look again at the controversial issue of drugs patents.\par  It is a significant moment in a time of great change for the drug giants, which stand accused of improving the health of the west for decades while turning their backs on the developing world.\par  South Africa's court victory seven weeks ago has raised the hopes of the millions infected with HIV who once expected only death. Drug prices have been cut and cut again by companies facing public pressure, competition from copycat generic manufacturers and bold moves from governments: only last week Kenya passed laws enabling it to buy or make cheap drugs. \par  The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  meeting will go to the heart of the issue - the trade protection legislation that ensures drug co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 panies make high profits from their new medicines. The Trips (trade related intellectual property rights) agreement requires even the poorest countries to give new drugs 20 years of patent protection.\par  Poor countries are theoretically given special dispensation under Trips to buy or make cheap copies of high-cost patented drugs in situations of dire emergency, such as the Aids epidemic.\par  But in the past they have been bullied out of the idea by lawyers for the pharmaceutical companies or the US government's threats of trade sanctions.\par  Now campaigners believe there is a real chance of movement on patent rules. They hope it may be agreed that in cases of a dispute - as now in Brazil, against whom the US government has filed an official complaint to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  about plans to import cheap drugs - the interests of public health will prevail.\par  Ruth Mayne of Oxfam, which has been campaigning for cuts in the cost of medicines to poor countries, said it was unprecedented for the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  to hold a special one-day session.\par  The biggest question is over the attitude of the Bush government. The US is still operating the notorious List 301, which names countries that may incur trade sanctions if it is thought they are infringing drug and other patents. Brazil is on it.\par  But Oxfam hopes the US will soften its line. "In the past they have blocked things, but maybe this time they might concede some ground because of the sheer weight of public opinion," Ms Mayne said.\par  The pharmaceutical industry has had to alter its stance. Prices of anti-retroviral drugs for HIV/Aids have tumbled since the South African court case. Copies of three-drug combinations which cost around pounds 10,000 a year for a patient in the west were offered for pounds 250 by the Indian generics company }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 .\par  This week GlaxoSmithKline went further and offered a comprehensive package of discounts on the med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cines most needed by poor countries.\par  Its report, Facing the Challenge, offered long-term discounts on Aids drugs and malaria medicines, and the prospect of future price cuts for drugs to treat other diseases of the developing world - as long as it can be shown that money will not be diverted from the crucial vaccination, malaria, tuberculosis and Aids pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 grammes as a consequence.\par  Sophia Tickell of Oxfam said: "It's as far as we can expect an individual company to reasonably go within the existing structure and rules, but those need to be changed."\par  She added that she thought GSK acted because investors had been critical of the company for being caught unawares by the consequences of the court action in South Africa. She doubted whether other companies would follow GSK's lead.\par  Although the Kenyan government says it is ready to buy generic drugs, observers think its real aim is to pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 suade the big producers to drop their drug prices further.\par  "We are pushing the drug companies into creating competition," the Kenyan public health minister, Sam Ongeri, said. "They must know that we will use these powers - we could bring generic drugs in tomorrow."\par  The price of Aids drugs in Africa has fallen by up to 80% since the South African court ruling but the chea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 est anti-retroviral cocktail still costs around pounds 650 a year in Kenya, against }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offer of pounds 250. With more than half the population earning less than a dollar a day, only 1,000 Kenyans are currently taking anti-retrovirals. About the same number are dying of the virus each day.\par  "Since we started with this bill we have seen drug prices drop from Dollars 6 to Dollars 2 a day. When the generics start coming in, they will drop below Dollars 1," Mr Ongeri said.\par  Competition\par  At that price, with funding from the new UN Aids fund for Africa, it should at least be possible to preserve Kenya's teachers and technocrats.\par  The act Kenya passed on Tuesday was originally intended to make it compliant with Trips, but it was changed to emphasise the government's right to use get-out clauses, bypass patents and buy drugs at the cheapest global price or make them locally.\par  As prices have plummeted, the drug companies' argument for patent protection has shifted away from their need to cover research and developments costs.\par  They now raise the spectre of drugs flooding into Africa unregulated, their regimens being abused, and anti-retroviral drug resistance resulting.\par  "We are not concerned about the bill itself but we are concerned with how it will be implemented," said Glaxo's commercial director, William Kearie. "People are going to bring in all kinds of counterfeit products. We want to be sure there will be a regulatory system put in place."\par  One World Media Award\par  The Guardian's Dying for Drugs series has won the One World Media Award for the national press.\par  The award, now in its 15th year, is given for press coverage that "most advances understanding of global and development issues".\par  Mike Aaronson, director of Save the Children which sponsored the award, praised the Guardian's team of writers for making a "significant contribution to public aware- ness of the pharmaceutical companies and the lack of availability of cheap drugs".\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION  (91%); WORLD TRADE ORGANIZATION (91%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION  (91%); WORLD TRADE ORGANIZATION (91%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 UNITED STATES (95%); SOUTH AFRICA (94%); BRAZIL (92%); EUROPE (92%); KENYA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 UNITED STATES (95%); SOUTH AFRICA (94%); BRAZIL (92%); EUROPE (92%); KENYA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PHARMACEUTICALS INDUSTRY (92%); PATENTS (90%); PHARMACEUTICALS PATENTS (90%); PATENT LAW (90%); INTELLECTUAL PROPERTY LAW (90%); DEVELOPING COUNTRIES (90%); INTERNATIONAL TRADE LAW (90%); AIDS & HIV TREATMENT (89%); US FEDERAL GOVERNMENT (89%); PHARMACEUTICAL PREPARATION MFG (89%); AIDS & HIV (89%); DRUG PRICES (89%); TRADE DISPUTES (89%); PROTECTIONISM (78%); TALKS & MEETINGS (78%); INTELLECTUAL PRO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ERTY (78%); EMBARGOES & SANCTIONS (78%); GENERIC DRUGS (78%); IMPORT TRADE (78%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TERNATIONAL ECONOMIC ORGANIZATIONS (78%); EMERGING MARKETS (77%); DISEASES & DI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ORDERS (77%); PATENT INFRINGEMENT (77%); INTERNATIONAL TRADE (77%); RELIEF ORGANIZ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TIONS (76%); LAWYERS (74%); PRICE CUTTING (73%); EPIDEMICS (73%); ANTIVIRALS (72%); LEGI}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 S}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 LATION (72%); GENERIC PRODUCTS (72%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 June 16, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 Guardian Newspapers Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Kenya;New Move to Bring Down Prices of HIV/AIDS Drugs  Africa News May 28, 2001 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_69}{\*\bkmkstart DOC_ID_69_0}{\*\bkmkstart doc_id_26}{\*\bkmkend DOC_ID_69}{\*\bkmkend DOC_ID_69_0}{\*\bkmkend doc_id_26}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_26"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320036000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 26 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 May}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  28, 2001\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Kenya;\par New Move to Bring Down Prices of HIV/AIDS Drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 African Church Information Service\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NEWS, DOCUMENTS & COMMENTARY\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 729 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Kenya Coalition for Access to Essential Medicines has called on the country's Members of Parliament to ensure that public health takes precedence over private financial interests and that essential HIV/AIDS med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cines are affordable.\par The call comes at a time when parliamentary sessional committees are preparing to review the Industrial Property Bill 2001(IP Bill) during May recess that will allow for parallel importing and compulsory licensing of HIV/AIDS antiretroviral medicines.\par The coalition warns that millions of Kenyans are at risk of disease and death unless the government is a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lowed to make full use of World Trade Organisation }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 /TRIPS-related safeguards like parallel importing and compulsory licensing.\par Once passed, the IP Bill 2001 will make Kenya TRIPS/}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  compliant. "Every Kenyan has a friend or family member suffering from HIV- related infections, " Dr Christopher Ouma of Action Aid, said here. \par "The Industrial Property Bill is a unique opportunity to ensure that Kenyan patients and doctors can legally access cheaper medicines to prolong and save lives," Ouma added.\par "Kenya must be able to shop around the world for the cheapest drugs. The MPs must not miss this oppo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tunity to include life-saving }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 /TRIPS safeguards such as parallel importing and compulsory licensing in the bill," he said.\par The Kenya Coalition was concerned that the multinationals could put pressure on the Kenyan government to drop or amend these vital, legal and internationally recognised safeguards, which could ensure the right of access to affordable medicines for millions of people suffering from AIDS and other diseases.\par Despite high profile publicity around multinational discount offers, these offers are no substitution or a legal system, which will ensure long-term sustainable access to affordable medicines. The companies' offers are only for AIDS drugs and have only been offered under heavy public pressure.\par These do not cover medicines for other life-threatening diseases like TB, and malaria. Kenya cannot afford to rely on the charity of profit making companies for its future, says Kenya Coalition for Access to Essential Medicines.\par The published Bill protects intellectual property rights (increasing patent protection to 20 years), but also gives the governments the means to access cheaper medicines though internationally recognised "saf}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 guard" mechanisms.\par These include parallel importing (the right to shop around the world for the cheapest offer of patented drugs); and compulsory licenses (issuing licenses for the production or importation of cheaper generic medicines). It is essential that these safeguards remain in the Bill as published.\par One of the key-guards, recommended by }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  and World Health Organisation WHO, which is not currently in the Bill is the "Bolar provision", which allows local generic manufacturers to do the appropriate trials, regi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tration process to be ready to roll off the production line as soon as the patent expires.\par In Kenya, it is estimated that around 2.5 million adults are living with HIV, and that around 500 die per day of HIV-related infections. What has become a chronic disease in Europe and America, where patients are treated, reducing mortality by 75 percent, remains a deadly plague in Africa.\par One of the key factors why people continue to die of AIDS is that antiretrovirals (ARVs) and other essential medicines are too expensive. Although generic companies such as India's }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  have been selling triple combination of ARVs governments (to Cameroon and Nigeria), at US $ 350 per patient per year.\par Presently, in Kenya, the cheapest price negotiated by certain hospitals came to US $ 1,330 - 1,620 per p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tient per year, according to Ministry of Health statistics. Not more than 2,000 people are estimated to be u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 dergoing treatment.\par A document prepared by Kenya's Ministry of Health says that, there is now sufficient evidence that triple combination antiretroviral therapy reduce viral load plasma level to undetectable levels.\par HIV-related symptoms may disappear, the incidence of opportunistic infections is reduced and quality of life improves.\par Kenya is the second country in sub-Sahara Africa after South Africa to pursue the issue of parallel importing and generic drugs. Currently between 1,000 - 2,000 victims in Kenya have access to HIV/AIDS drugs.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV (94%); AIDS & HIV TREATMENT (92%); HEALTH CARE ACCESS (90%); ANTIV}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 RALS (90%); LEGISLATIVE BODIES (90%); IMPORT TRADE (90%); DISEASES & DISORDERS (89%); PHARMACEUTICALS PATENTS (89%); INTELLECTUAL PROPERTY LAW (89%); GENERIC DRUGS (89%); PATENTS (89%); PUBLIC HEALTH ADMINISTRATION (89%); MULTINATIONAL CORPORATIONS (75%); INTERNATIONAL ECONOMIC ORGANIZATIONS (75%); MALARIA (73%); HEALTH DEPAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 T}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MENTS (73%); GENERIC PRODUCTS (72%); TUBERCULOSIS (72%); PHYSICIANS & SURGEONS (69%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION  (90%); WORLD TRADE ORGANIZATION (90%); A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 C}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TIONAID INTERNATIONAL  (56%); ACTIONAID INTERNATIONAL (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 KENYA (97%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION  (90%); WORLD TRADE ORGANIZATION (90%); ACTIO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AID INTERNATIONAL  (56%); ACTIONAID INTERNATIONAL (56%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 May 29, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 English\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 AllAfrica, Inc\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Paying for AIDS Newsweek March 19, 2001, \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_70}{\*\bkmkstart DOC_ID_70_0}{\*\bkmkstart doc_id_27}{\*\bkmkend DOC_ID_70}{\*\bkmkend DOC_ID_70_0}{\*\bkmkend doc_id_27}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_27"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320037000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 27 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Newsweek\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 March}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  19, 2001, Atlantic Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Paying for AIDS}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 By Carla Power; }{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid15420928 With}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Tom Masland, Esther Pan }{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid15420928 and}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Lara Santoro }{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid15420928 in Africa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 , Ron Moreau }{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid15420928 in Tha}{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid15420928 land}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  }{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid15420928 and }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Mac Margolis }{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid15420928 in Rio}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 EUROPE; Pg. 16\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1738 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 HIGHLIGHT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Facing outraged victims in poor countries, Big Pharma cuts the prices of lifesaving drugs.\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 On Jan. 11, just after London-based GlaxoSmithKline became the world's largest drug company, its new CEO, Jean-Pierre Garnier, spoke to the company's 100,000 employees via satellite. There was the predict}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ble pat on the back for surviving a tough merger between Glaxo Wellcome and SmithKline Beecham, i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 pressive statistics--every minute 1,100 people receive a prescription for a GSK product--and plenty of inside jokes. But tucked in just before Garnier's conclusion was a call to arms. "The pharmaceutical industry today sells 80 percent of its products to 20 percent of the world's population," said Garnier. "I don't want to be the CEO of a company that only caters to the rich... I want those medicines in the hands of many more people who need them." \par Maybe Garnier, head of the world's largest maker of AIDS drugs, was feeling the heat from the street. A growing army of activists, charities and governments are attacking European and American pharmaceutical giants--Big Pharma--over the high cost of AIDS drugs in the developing world. Last week activists from Pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 toria to Philadelphia protested the opening of a trial in South Africa, where 41 major drug companies are s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing former president Nelson Mandela and other government officials over a law they say threatens their p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tents. Last month members of ACT UP stormed GSK's investor-relations offices in New York, hurling "blood money" and empty pill bottles, chanting, "GlaxoSmithKline! Global serial killer!" And radicals aren't the only ones upset. In Britain, money manager Friends Ivory & Sime, with about 1 billion invested in GSK, and other institutional investors recently met to see whether the company do more to combat the AIDS crisis in Africa. "Dare to Lead," Oxfam's new report on GSK, warns that drug companies face "a major reputation risk" over the issue. Even John Le Carre is firing shots. His latest novel, "The Constant Gardener," puts drug exec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tives in the villain roles once reserved for Soviet apparatchiks.\par Big Pharma has a big problem. In the early 1990s companies created exotic and effective combinations of drugs to stall HIV, the virus that causes AIDS. But the better the "cocktail," the more expensive. As a result the developing world--home to more than 34 million HIV-infected people, 95 percent of the global total--was shut out. Big Pharma always said poor countries didn't have the doctors to administer the complicated drug regimes and, besides, profits from selling patented drugs provide the seed money to develop new ones. But as AIDS ravaged the planet, outrage focused on Big Pharma as never before. The companies had to do something.\par Last week they did. Besieged by increasing condemnation--as well as competition from the makers of gene}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ic AIDS drugs--U.S.-based Merck & Co. announced it was slashing prices on two protease inhibitors, potent cocktail components, to one tenth of their U.S. prices. The offer was soon undercut by Hetero International, an Indian generics producer, which said it would sell generic versions of the same drugs for $347 a year. Similarly, when five major companies joined a U.N. initiative to increase access last May, Garnier slashed the price of Combivir, GSK's combination AIDS drug, to $2 a day for the developing world. Then }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 other Indian generic firm, offered a cocktail for $600 a year. "For now, GSK's price is sustainable," says company spokesman Philip Thomson. "But it might not stick."\par It is not a position Big Pharma is used to. The massive multinationals, especially the five largest firms (GSK, Merck, Pfizer, Novartis and Bristol-Myers Squibb), basically control the world's drug supply. The industry g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ant, GSK, has revenues of $26.3 billion a year and the largest arsenal of AIDS drugs. The challenge, as Garnier noted in his address, is to find a business model that will allow companies to increase access, make a profit and invest millions in R&D.\par Technically, GSK and others can afford to write off their sales to the Third World. Africa constitutes a tiny sliver, about 1 percent, of global drug sales. But the company fears "parallel trade," drugs sold cheaply to the developing world that make their way back to higher-priced markets through back channels. It also worries that Westerners will want lower prices, too. "The developed world must be willing to pay reasonable prices for medicines in order to cover costs for developing countries," Garnier wrote Romano Prodi, president of the European Commission, last fall. "Essentially we must be allowed to generate revenue for R&D in Europe, the United States and Japan, while transferring the benefit of this research, basically for free, to the developing world."\par Last week's price cuts show Big Pharma is moving--to a point. The South African lawsuit suggests that GSK and its allies are keen to protect their patents, even at the risk of looking like Scrooge. At issue: South Afr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ca's 1997 Medicines Act. Designed to increase access to cheap drugs, the law would allow parallel impor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing--global comparison-shopping for drugs--and compulsory licensing, which lets companies make a drug without the patentholder's consent. South Africa's Pharmaceutical Manufacturer's Association (PMA), on b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 half of the drug companies, says the law violates the World Trade Organization's Trade-Related Aspects of Intellectual Property Rights Agreement (TRIPS) by unfairly singling out patented drugs. Under Section 15C of the law, "the minister can wake up one day and decide that seven out of Glaxo's 10 products are nece}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sary [to protect] national security, and abrogate patent rights on them," says Mirryena Deeb, PMA's chief e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ecutive. GSK executives in Britain insist the case is not about health. "It's essentially about a vague law on patents," says Vikki Ehrich, head of GSK's external relations for HIV/AIDS. "Patents do not block access to medicines."\par What blocks access, argue the drug companies, is a lack of political will and health-care infrastructure in AIDS-devastated countries. Under TRIPS, countries are allowed to issue compulsory licenses if they declare a national emergency. South Africa, despite its 4.5 million AIDS cases, has not. Some AIDS activists say the government, keen to attract foreign investment, is afraid that invoking TRIPS on AIDS drugs would send a hostile signal to would-be investors.\par But the Pretoria High Court clearly believes the case is as much about public health as patents. Last week the presiding judge ruled that AIDS activists could join the government's side, and postponed the case until April to allow PMA to respond to points raised by the Treatment Action Campaign, an AIDS activist group. Toby Kasper, coordinator of the Access to Essential Medicines Campaign for Medicins Sans Frontieres in South Africa, thinks the suit smacks of hypocrisy. "[Drug companies] make a lot of noise about wanting to improve access to medicines," he says. "Now here's a chance for them to do something about it, and they're suing to block it."\par For Big Pharma's challengers in the developing world, the battle is only beginning. A Kenya-based Jesuit, Father Angelo D'Agostino, grew so tired of burying children at his Nairobi orphanage that last month he a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cepted an offer by }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  the generics firm, to provide GSK's patented antiretrovirals at one fifth the price charged by the company. In Thailand, Lufthansa air crews have hand-carried nearly expired AIDS drugs d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nated by Frankfurt pharmacists to Bangkok hospitals. Last month, when officials from the U.S. trade repr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sentative's office called on the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  to press a complaint over a Brazilian law that Washington says discrim}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nates against foreign-made goods (read: pharmaceuticals), Brazilians and their supporters jammed the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  switchboard in Geneva, demanding that the plaintiffs lay off. Now Health Minister Jose Serra warns that Brazil plans to override patents on two key AIDS drugs made by Merck and the Swiss firm Roche.\par The drug companies' de facto surrender to tiered pricing may ease the war against them. But will it alleviate the AIDS crisis? Back in 1997, when tiered pricing was still considered blasphemy, Peter Young, the mana}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 er in charge of HIV at Glaxo Wellcome, came up with a strategy to do it. Ethically, Young argued, it was wrong to have a drug that was too expensive for the market that needed it most. Commercially, he said, high prices kept GW out of a promising market. The company gave the go-ahead for local managers to cut prices for the combination therapy Combivir, with the idea that increased volume would compensate for lower pri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 es. It didn't work. Glaxo managers, responsible for regional profits, worried about losing money, since go}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 v}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ernments were too poor to commit to minimum volumes.\par Now GSK is working on a plan--to be completed by June--that would give its managers a proper incentive to cut prices. But changing from a company that sells a few pills at high prices in the developing world to one that sells high volumes to the masses will require a revolution in the corporate culture. "It means talking to governments without money, people without money, working with health-care providers," notes David Ear}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 shaw, until last month a GSK manager in Brussels. "These are people most of the managers have never talked to. Garnier is a man of vision. The problem is the corporate clones around him."\par Garnier's new strategy will face another challenge: the poor don't have enough money to afford even cheap drugs. Since May, GSK has twice approached Kenya's Ministry of Health to offer a 20 to 52 percent redu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion on AZT, 3TC and Combivir. Julius Meme, permanent secretary at the ministry, calculates that even with 85 percent discounts, Kenya would have to spend $12 billion yearly to treat its 2.2 million AIDS patients. "The whole health budget is $9 billion," he says. "There's nothing to negotiate because we cannot afford it."\par Accordingly, Big Pharma says the protests cloud the core issue: a lack of aid from the North to buy drugs. "Somebody has to write the check," says Joseph Saba of Axios International, a Dublin firm working to build public- and private-sector cooperation on drug access. If Jean-Pierre Garnier wants to solve his PR problem and make a difference in the poor countries, his work has just begun.\par With Tom Masland, Esther Pan and Lara Santoro in Africa, Ron Moreau in Thailand and Mac Margolis in Rio\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GSK (NYSE) (84%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PRODUCT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PENNSYLVANIA, USA (87%); NEW YORK, USA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 JEAN-PIERRE GARNIER (90%); NELSON ROLIHLAHLA MANDELA (51%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 SOUTH AFRICA (92%); UNITED KINGDOM (92%); EUROPE (92%); AFRICA (92%); UNITED STATES (91%); NORTH AMERICA (79%); ENGLAND (73%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 EUROPE (73%); NORTH AMERICA (50%); SOUTH AFRICA (50%); AFRICA (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 LONDON, ENGLAND, UK (73%); PHILADELPHIA, PA, USA (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 LONDON, ENGLAND (90%); PHILADELPHIA, PA, USA (87%);   SOUTH AFRICA (92%); UNITED KINGDOM (92%); EUROPE (92%); AFRICA (92%); UNITED STATES (91%); NORTH AMERICA (79%); ENGLAND (73%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PHARMACEUTICALS INDUSTRY (92%); AIDS & HIV (90%); DISEASES & DISORDERS (90%); IMMUNE SYSTEM DISORDERS (90%); DEVELOPING COUNTRIES (90%); AIDS TREATMENT (90%); PHARMACEUTICAL PREPARATION MFG (90%); CHEMICAL INDUSTRY (90%); PHARMACEUTICAL & MEDICINE MFG (90%); ANTIVIRALS (89%); EMERGING MARKETS (87%); PRESCRIPTION DRUGS (78%); RELIEF ORGANIZATIONS (65%); PATENTS (64%); SUITS & CLAIMS (52%); LITIGATION (52%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 March 16, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PHOTO: Anger has been building for years over the high cost of medicine. Finally corporations are reacting - in a big way.; GRAPHIC: (Chart) In the End, 'Somebody Has to Write the Check' (Graphic omi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ted)\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 Newsweek\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  What price a life? The Times (London) March 19, 2001, Monday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_71}{\*\bkmkstart DOC_ID_71_0}{\*\bkmkstart doc_id_28}{\*\bkmkend DOC_ID_71}{\*\bkmkend DOC_ID_71_0}{\*\bkmkend doc_id_28}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_28"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320038000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 28 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li480\ri480\widctlpar\wrapdefault\faauto\rin480\lin480\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Times (London)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li480\ri480\widctlpar\wrapdefault\faauto\rin480\lin480\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 March}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  19, 2001, Monday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928  What price a life?}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Anjana Ahuja\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Features\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1408 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Yusuf Hamied's offer to supply cheap Aids drugs is an embarrassment to the major pharmaceutical comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nies. Anjana Ahuja reports\par  There has never been a worse time to be a titan of the pharmaceutical industry. Emboldened by massive publicity for campaigns against Huntingdon Life Sciences, animal rights protesters are turning to bigger fish, such as GlaxoSmithKline (GSK). Oxfam recently launched an astonishingly outspoken campaign condem}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing drug companies -and the Western governments that support them -for not supplying cheap medicines to the world's poorest nations.\par  Their public image is now getting another pummelling. In a gripping legal test case, 40 companies are taking the South African Government to the High Court in Pretoria for introducing legislation that would allow the import of cheap copycat drugs to combat Aids. The companies, which include GSK, claim that the legislation rides roughshod over their patent rights. \par  The action has provoked outrage. Oxfam has denounced it as "corporate bullying". Medecins sans Fro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tieres (MSF), the medical charity, has called it an "act of corporate inhumanity". It is not difficult to view the legal case as morally difficult -the companies are, effectively, fighting to protect their right to charge premium prices for their lifesaving elixirs, even in the world's most disease-ridden corners.\par  The apparent greed of the drugs industry is also thrown into sharp relief by the gesture of an Indian bus}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nessman. Last month Dr Yusuf Hamied, the head of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 , a major Indian pharmaceutical company, offered to supply Aids drugs at bargain prices to MSF, and to the governments of India and African nations.\par  Nevirapine, one such therapy, helps to prevent the transmission of HIV from a pregnant mother to her u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 born child. Its maker, Boehringer Ingelheim, charges about $ 8 per pill; Hamied is offering it free.\par  Hamied, who saw a close friend die of Aids, is offering MSF a proven triple-cocktail therapy at $ 350 per p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tient per year; it would normally cost about $ 10,000 in America and a similar sum in Britain. His gesture, which has provoked both anger and admiration, and the shenanigans in Pretoria, have put the drugs industry in the public eye. The big companies and their fat profit margins, legally protected by 20-year monopolies on patented formulations, have begun to raise eyebrows.\par  The ten largest drug companies in America enjoyed collective sales of about $ 179 billion last year, crea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing off $ 121 billion of that as gross profit. Those margins are unmatched by virtually any other industry and are simply too high to get away with, according to Professor Uwe Reinhardt, a medical economist at Princ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ton University in New Jersey. "They (the drug companies) have had almost too good a ride," Reinhardt o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 serves. "They have had the run of the market for too long and they are in for something of a shock."\par  The fundamental problem for drug companies is that they make money by charging a price to tackle human misery. That is not too controversial for big companies operating in the West, where insurers and gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ments tend to foot the health bill. When a company develops a medicine, it is granted a 20-year patent -a monopoly on producing it. It is like devising a recipe and being the only company allowed to bake the cake. Those patents are protected under laws policed by the World Trade Organisation -except that countries r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 serve the right to override the laws in cases of national emergency. That will be the basis of South Africa's defence against the collective might of the drug industry. The case is expected to return to the Pretoria High Court next month.\par  As a result of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  laws, companies can charge what they like. Phil Thomson, a spokesman for GSK, defends the large profits by saying that research and development swallows much of it and, without that money, no new medicines would be developed. The profits are extraordinary -in 1999, before it merged with SmithKlineBeecham to become GSK, GlaxoWellcome turned over Pounds 8.4 billion. Of that, Pounds 1.3 billion went into research, while Pounds 2.8 billion represented operating profit.\par  After the 20-year patent has expired, any drug company -subject to safety controls and approval from reg}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 latory authorities -can use the same recipe. These drugs are called generics and, because anyone can use the recipe, they tend to be cheaper.\par  The problem with Aids is that the medicines, developed over the past two decades, are still under patent. The prices of the drugs are too high for African nations, so human misery has lingered in a way that would have been unthinkable in Western Europe. The UN estimates that the march of Aids across sub-Saharan Africa has already claimed 17 million lives and threatens 25 million more. It is not hard to see how this situ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion can be elevated to a scandal -a continent is dying while waiting for patents to expire.\par  Belatedly, United Nations agencies have urged companies to slash their prices for poor nations. As a result, Glaxo-Wellcome (now GSK), Merck, Boehringer Ingelheim, F. Hoffmann-La Roche and Bristol-Myers Squibb agreed to provide Aids drugs to Senegal, Rwanda and Uganda for about $ 1,000-$ 2,000 per patient per year.\par  Kenya rejected the offer as "cynical" because the discounted prices are still unaffordable. Thomson says GSK's offer to about 30 governments is now $ 700 and that the company has been offering a 90 per cent discount since 1997. Last week, the Government of Ivory Coast took up the offer.\par  Thomson cannot say, however, how many people in developing nations have been treated at that price, nor how many doses GSK will make available. He admits that, even at these discounts, the therapies are beyond the reach of many countries. "There is a recognition within the industry that more needs to be done," he co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cedes.\par  So the Indian company }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  has stepped in. It can afford to sell cheap knock-offs because it has never spent a rupee on developing Aids drugs, holds no patents on them, and doesn't pay a licensing fee to the companies that did develop them.\par  India revoked its patent laws in the early Seventies and allows the copying of blockbuster drugs protected by international law in other countries. Hamied is offering MSF the chance to distribute the triple cocktail in pilot projects across Africa for just $ 350 per patient per year. The charity has accepted. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  also plans to sell it to poor governments, including India's, for about $ 600. Thomson questions whether }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offer is "su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tainable", but refuses to comment further on its pricing policy.\par  }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  is the second largest supplier of medicines to pharmacies in India; Forbes magazine estimates Hamied to be worth $ 550 million. Hamied says that he was moved to make his offer because of the Gujarat earthquake -this was an unforeseen tragedy, he says, while the rising death toll due to Aids is a foreseeable, preventable one. Hamied explains: "Until 1997, if someone in India was diagnosed HIV-positive, it was a death sentence. Today it is not a death sentence. It can be treated like any other chronic disease, and pe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ple can have a good quality of life. We (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ) want to do a service to society in our own little way."\par  But surely he can understand why other companies might get upset at him swanning on to the international stage, copying their products, which have cost millions to develop, then positioning himself as an anti-Aids crusader? "There's room for the multinationals at their price, and there's room for us at our price," says Hamied. "There's room for 100 }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Ciplas}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  and ten Glaxos. Why are we fighting each other?"\par  Reinhardt believes there could be a middle ground between }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  and its aggrieved rivals, such as GSK. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  should sell the Aids drugs at cost -he says it would not be right for }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  to profit from a drug that it has spent no money on developing. Western drug companies, meanwhile, should offer their drugs much more cheaply to developing nations than to those in the West. Laws should be in place prohibiting foreign gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ments from selling the cheap drugs on, so that those discounted medicines don't find their way back into pri}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ier markets.\par  "I think it's perfectly ethical to charge more in wealthier countries," says Reinhardt. "The fact is that Western companies have made their money from Western Aids patients. They don't need any more profits."\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GLAXOSMITHKLINE PLC (90%); GLAXOSMITHKLINE (57%);   DOCTORS WITHOUT BO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 DERS (81%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 DOCTORS WITHOUT BORDERS (81%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GSK (NYSE) (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 SOUTH AFRICA (55%); AFRICA (55%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 SOUTH AFRICA (55%); AFRICA (55%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Science  PHARMACEUTICALS INDUSTRY (96%); PROFITS (90%); AIDS & HIV (90%); AIDS TREATMENT (90%); DISEASES & DISORDERS (90%); IMMUNE SYSTEM DISORDERS (90%); CHEM}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 CAL INDUSTRY (90%); PHARMACEUTICAL & MEDICINE MFG (90%); PHARMACEUTICAL PREPAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TION MFG (90%); FINANCIAL RESULTS (78%); COMPANY EARNINGS (78%); INTELLECTUAL PRO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ERTY (77%); RELIEF ORGANIZATIONS (76%); PATENT LAW (74%); PATENTS (74%); LEGISLATION (74%); ANIMAL RIGHTS (72%); LEGISLATORS (71%); PREGNANCY & CHILDBIRTH (63%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 March 19, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li480\ri480\widctlpar\wrapdefault\faauto\rin480\lin480\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 Times Newspapers Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Global groups seek AIDS drugs for poor patients;Drug firms back off from patents The Washington Times March 19, 2001, Monday, Final Edition \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_72}{\*\bkmkstart DOC_ID_72_0}{\*\bkmkstart doc_id_29}{\*\bkmkend DOC_ID_72}{\*\bkmkend DOC_ID_72_0}{\*\bkmkend doc_id_29}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_29"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00320039000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 29 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Washington Times\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 March}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  19, 2001, Monday, Final Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Global groups seek AIDS drugs for poor patients; \par Drug firms back off from patents}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Ben Barber; THE WASHINGTON TIMES\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PART A; WORLD; AFRICA; Pg. A13\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 795 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The World Health Organization and the World Trade Organization today announce an effort to bring ine}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 pensive AIDS drugs to poor Africans and others now that major pharmaceutical companies are backing away from the fight over patent rights and profits.\par The WHO and }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  are to hold their first meeting April 8-11 in Hosbjor, Norway, aimed at bringing lifesaving AIDS medication to the world's poor.\par "The world is ready to move on from squabbling about patent issues," said Dr.  Nils Daulaire, head of the Global Health Council that is organizing the meeting on "Differential Pricing and Financing of Essential Drugs."\par Since anti-AIDS medications appeared on Western pharmacy shelves a few years ago at roughly $10,000 a year to keep a patient alive, millions of poor in Africa and Asia have died for want of those drugs. \par In recent weeks, two major companies that invested hundreds of millions of dollars to create those drugs have bowed to international pressure and agreed to sell the drugs at or below cost or to give up the right to sell them in the Third World.\par "This is not aimed at undercutting pharmaceutical patents," said Dr. Daulaire.  Rather the Norway meeting will try to create a system of licensing the right to produce generic versions at a few cents per pill for those unable to afford the current cost in America and Europe.\par Major pharmaceutical companies such as Pfizer, Bristol-Meyers Squibb and Merck will attend.  So will sp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cialists from AIDS advocacy and consumer groups.  The meeting comes after 39 pharmaceutical companies went to court to block South Africa, where millions are dying of AIDS, from obtaining generic drugs produced without permission from the patent holders.\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  an Indian drug manufacturer, recently offered to sell South Africa inexpensive copycat versions of eight anti-AIDS drugs, including Zerit and Videx.  Then Merck said it would offer at its manufacturing cost the protease inhibitor Crixivan and another anti-retroviral, Sustiva.\par Last week, Bristol-Myers said it would sell Zerit and Videx for a combined cost of $1 per day.\par While this is far below the U.S.  daily cost of $18 for the two drugs, most Africans will still be unable to afford them without an international plan of assistance and delivery, said Mr.  Daulaire.\par "I recall working in Nepal and we had cut the cost of an anti-pneumonia drug for children to 7 cents and still many could not pay it," said Mr. Daulaire, formerly the senior international health official at the U.S. Agency for International Development.\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  the Indian firm, was the first to offer cheap AIDS drugs.  When India joined the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  as a developing country, it claimed an exemption from respecting drug patents for several years, said a }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  official who spoke on the condition of anonymity by telephone from Geneva on Friday.\par The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  treaty requires its 140 member nations, including the United States, to change their domestic laws on patents and trade to accord with the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO.}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par South Africa, however, which joined the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  in 1994 as it shifted from white to black-dominated gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment, did not claim the status of a developing country that could have given it an exemption from patent i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 fringement.\par According to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  official, South Africa could still declare a national emergency, which allows it under }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  agreements to buy or produce the cheap drugs regardless of patent prohibitions.\par However, last week South Africa's government, despite acknowledging that 20 percent of its people carry the HIV virus that causes AIDS, said it would not declare such an emergency existed.\par The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  official noted that pharmaceutical companies may actually increase their profits if the Norway meeting can come up with a way to offer cheap drugs in Asia and Africa while still keeping them at current high prices in the West.\par A study of the issue by Doctors without Borders, a humanitarian nongovernmental organization, has shown that millions of new customers will come on line if the drug price falls in the Third World, offering a promise of profits there, said the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  official.\par The Norway meeting will discuss how to prevent the cheap, generic drugs "from leaking back from poor countries to rich ones," said a joint statement by the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  WHO, GHC and Norwegian Foreign Ministry that was prepared Friday but embargoed for release until today.\par If cheap drugs undercut those currently on sale in America and Europe, drug companies say it will dissuade them from making costly investments in research needed to find new drugs.\par The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  official said the meeting may also explore other ways to fund research, such as through gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ments and universities, so that lifesaving drugs, once developed, will not be available only to wealthy soci}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ties.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV (97%); PHARMACEUTICALS INDUSTRY (96%); AIDS & HIV TREATMENT (93%); PATENTS (92%); PHARMACEUTICAL PREPARATION MFG (92%); PHARMACEUTICALS PATENTS (90%); ANTIVIRALS (90%); INTELLECTUAL PROPERTY LAW (90%); GENERIC DRUGS (90%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NATIONAL TRADE (90%); UNITED NATIONS INSTITUTIONS (90%); TRADE DEVELOPMENT (89%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 FECTIOUS DISEASE (89%); HEALTH DEPARTMENTS (89%); PATENT LAW (89%); PRESCRIPTION DRUGS (89%); PUBLIC HEALTH ADMINISTRATION (89%); INTERNATIONAL ECONOMIC ORGANIZ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TIONS (89%); PHARMACEUTICAL DRUG & DEVICES LITIGATION (78%); INTERNATIONAL ECONOMIC DEVELOPMENT (78%); AIDS & HIV POLICY (78%); POOR POPULATION (78%); TALKS & MEETINGS (77%); ENZYME INHIBITORS (73%); PROTEIN BASED DRUGS (73%); RESPIRATORY DISEASE (73%); PNEUMONIA (73%); DEVELOPING COUNTRIES (73%); PRODUCT PRICING (70%); TREATIES & AGREEMENTS (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 BMY (NYSE) (91%); PFZ (LSE) (90%); PFE (NYSE) (90%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (91%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTURING (91%); SIC2834 PHARMACEUTICAL PREPARATIONS (91%); NAICS325414 BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING (90%); SIC2836 BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES (90%); SIC2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NILS DAULAIRE (68%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD HEALTH ORGANIZATION  (92%); WORLD HEALTH ORGANIZATION (92%); WORLD TRADE ORGANIZATION  (90%); WORLD TRADE ORGANIZATION (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AFRICA (94%); UNITED STATES (93%); NORWAY (92%); NEPAL (79%); EUROPE (79%); ASIA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 BRISTOL-MYERS SQUIBB CO (91%); PFIZER INC (90%); }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  LTD (58%);   WORLD HEALTH ORGANIZATION  (92%); WORLD HEALTH ORGANIZATION (92%); WORLD TRADE ORGAN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ZATION  (90%); WORLD TRADE ORGANIZATION (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 March 19, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 The Washington Times LLC\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Business Times Singapore March 15, 2001, Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_73}{\*\bkmkstart DOC_ID_73_0}{\*\bkmkstart doc_id_30}{\*\bkmkend DOC_ID_73}{\*\bkmkend DOC_ID_73_0}{\*\bkmkend doc_id_30}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_30"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330030000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 30 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Business Times Singapore\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Profits versus patients in South Africa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 March}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  15, 2001, Thursday\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par G Panicker\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PHARMACEUTICAL companies are giving globalisation a bad name. And if they have their way, they may even unwittingly help hang it.\par In the Pretoria High Court, Judge Bernard Ngoepe last week began hearing a case on a law not yet put into practice. In the dock is the South African government. Its accusers are 39 drug companies, including Glaxo Wellcome, Merck and Roche. They say a law passed in 1997 -- and blocked by a court ruling since 1998 -- violates international laws on trade and intellectual property rights. The disputed legislation empowers the health minister to procure or produce generic versions of life-saving drugs including antiretrovirals, allow pa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 allel imports of patented drugs, and sets up a committee to monitor drug prices. \par The implications of the case transcend the Aids-ravaged country's borders. It raises questions about the right of a country to take desperate remedies in desperate times. A government defeat here would probably set back the efforts of developing countries capable of making generic medicines; a victory would erode comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nies' hold on the pricing of medications and thus their profits, which they contend will harm the search for new drugs.\par The suit comes at a time when a human rights campaign for access to cheaper medicines is growing globa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ly. So this trial has been dubbed the "profits vs patients case". Non-governmental organisations such as Oxfam, Medicins sans Frontieres and the International Red Cross have backed the South African gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment. There have been demonstrations around the world in support of the South African law. The country's Treatment Action Campaign (TAC) and trade unions have led the protests in Pretoria where the catch cry is: the pharmaceutical companies are "deadlier than the virus". What has focussed people's minds is the cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 try's 4.3 million HIV patients -- a whopping 10 per cent of the population. The government has pressured companies to cut prices of drugs that are routinely used in the West and cost US$10,000 to US$15,000 (S$17,600 to S $26,400) per patient annually. The companies have offered reductions but the prices are still beyond the reach of mostly poor African patients.\par Meanwhile, India's }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  has offered a combination of three Aids drugs for just US$600 per patient to the government and at US$350 directly to Medicins sans Frontieres. This is possible because India will reco}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nise the Western concept of patents only from 2005. The Western pharmaceutical companies, of course, didn't want the bad publicity associated with this litigation. And they suffered a setback when the EU, the US and the World Trade Organization (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ) all backed the law. In fact, in Europe and Canada, there are price controls on patented medicines and in the US, generic medicines are available. Besides, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  rules permit poor countries to license drugs without patent holders' consent for public use or when they face an emerge}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cy. In South Africa, where 200 Aids patients die every day, the government is under pressure to assume emergency powers to provide the medication to patients. Brazil has used similar powers to treat its own Aids patients.\par The South African court was to have held hearings throughout the past week. But Judge Ngoepe allowed the TAC Aids advocacy group to make a submission and gave the companies five weeks to reply. Worse, the judge ordered them to reveal their business practices, including pricing policies. "For the first time, the pha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 maceutical industry will have to justify to South Africa and to the world why their drug prices are so high and why their patents should be so aggressively protected when millions of people are dying and cheaper drugs exist," the agencies backing the South African government said after the ruling.\par Aids kills more people than wars, famine and floods, and it poses a huge threat to the country's economic development. In this situation, even if the pharmaceutical companies win the battle in South Africa, they risk losing the war. South Africa is a functioning democracy. Affordable drugs will reach all those who are suffe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing because people will demand it. The niceties of patent rights will be overridden, one way or another. Pharmaceutical giant Merck has just offered to sell the two Aids drugs it makes at cost in developing cou}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tries. It is a telling concession.\par The writer is a journalist with BT's Foreign Desk\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par  PHARMACEUTICALS INDUSTRY (93%); EDITORIALS & OPINIONS (92%); PHARMACEUTICAL PREP}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 RATION MFG (91%); LAW COURTS & TRIBUNALS (90%); ENTERPRISE GLOBALIZATION (90%); G}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NERIC DRUGS (90%); PATENTS (89%); PHARMACEUTICALS PATENTS (89%); DRUG PRICES (89%); INTELLECTUAL PROPERTY LAW (89%); INTERNATIONAL ECONOMIC ORGANIZATIONS (89%); R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 LIEF ORGANIZATIONS (86%); AIDS & HIV TREATMENT (79%); INTELLECTUAL PROPERTY (79%); D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 CISIONS & RULINGS (78%); SETTLEMENTS & DECISIONS (78%); TRADE DEVELOPMENT (78%); LIT}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GATION (78%); PATENT LAW (78%); JUDGES (78%); INTERNATIONAL TRADE (78%); INTERNATIONAL LAW (78%); IMPORT TRADE (78%); GLOBALIZATION (78%); LEGISLATION (77%); EXPORT & IMPORT LAW (77%); AIDS & HIV (77%); INTERNATIONAL TRADE LAW (77%); ANTIVIRALS (76%); PROTESTS & DEMONSTRATIONS (76%); NONGOVERNMENTAL ORGANIZATIONS (75%); EUROPEAN UNION (75%); PRICE CUTTING (74%); PRICE MANAGEMENT (74%); PRICE CHANGES (74%); HUMAN RIGHTS (70%); HEALTH DEPARTMENTS (70%); INTERNATIONAL ASSISTANCE (70%); DEVELOPING COUNTRIES (68%); HEALTH CARE ACCESS (67%); LABOR UNIONS (50%); \par \par  CIPLA LTD (59%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Editorial & Opinion, Pg. 10, The Bottom Line\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 738 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 March 16, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 Singapore Press Holdings Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 South Africa Resists Call For AIDS 'Emergency' The Washington Post March 15, 2001 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_74}{\*\bkmkstart DOC_ID_74_0}{\*\bkmkstart doc_id_31}{\*\bkmkend DOC_ID_74}{\*\bkmkend DOC_ID_74_0}{\*\bkmkend doc_id_31}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_31"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330031000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 31 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\shppict{\pict{\*\picprop\shplid1025{\sp{\sn shapeType}{\sv 75}}{\sp{\sn fFlipH}{\sv 0}}{\sp{\sn fFlipV}{\sv 0}}{\sp{\sn fLine}{\sv 0}}{\sp{\sn fLayoutInCell}{\sv 1}}}\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw7620\pich2540\picwgoal4320\pichgoal1440\pngblip\bliptag657880520 89504e470d0a1a0a0000000d49484452000000d8000000480803000000a398cb9c00000300504c5445ffffff000000404040bfbfbf7f7f7fccccccefefef9900331010103030309f9f9f606060cfcfcfdfdfdf2020208f8f8f505050707070afafafd47d96c04064eabfcbde9baefaeff2b0103df4dfe5e5afbecb607ebb3057c55071b6204aefcfd8000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000335c3c3e00000c254944415478daed1b8972dbb6720192004f9152e2a449dad7ffffacccbc695ed234b12d89120f106f770152b41cc94ae31ef1043316491c8b5dec89050cf0a33cf1a256df079ef22bfb87f1fe49b22b11e99394432944004f5014950588bf335ea4615516ee35470a965fec54082c288b2af40aa7ce2ec30148faa000e797ac6b78f779a2aceeea0e958c485b49fc94274551c4f4c8e82b13893aa78f13903c7e4835b3f02205c76953ff3c594a798430972443a471e409c202ea83040951297e9ca66c06a488b1e7592f9189f012ba683ec94f7972ded44fcbbf811dabf7b5857d74d2a21bc6827e6f82654dfd4fda92ec00a41148dce61c5df505821844349f81889ef69404a4bbb13b7f75a9296dd4bba6061117f6cbe31045888cc29e3dc4921f274a7b0062642cc5ee0cce08440e0f1166878c61862d4ddfda934befa665c2cc629db6619dc79d28fa86b0175689d07819580c664e586b244d31ec67c8e451dc4e3ebc68208d3b06e28626a12486e5ccc57498702ad29046e5d837192457171e5011091c9946dd813043efdab4c6da117bb59838b48a0713c81c173bb632f2085728e429a40b7452d2691c49b2d79f60210ee68d75cce964307da1c2a24d0980fb176c87166a02a2c876641889a905a9464a76b5f0b88818df5905517d585cb06ae5142ae1bea5ef3b5a02320da4e9ac4239ce157a0bcc30726704e3c2732c8a6aa1827d8beb402b81c8c6720fbda2d50b871635c9ce38e61fd8d37fa9e216b96e338122921a56c4be9f80e8c034d0454604a8492adb62a34cf6b4dabb064c2f454be25c74ba05150f58b50f9301d5bccf0cf2ae91d24bbbd2c4cb0e2c48cfb1b26b90917261863c22fd8120dd6a037a88b6a328b690ec07eeee09eb15f2bd4fd7ca0e258ed60ef8b2812f101684db25a949278c2a36c6561d54f50148dc936c0dade52f1162cf6267d0716d169ae0c57b8b7d0de290234225926ca3c44a03ad6251174eac0abb6f79e691305c4eb3b4d8a88c685a94f024687716870c4337e371c10c3e882249177ea29404c45e6678ee5cc29128e6fc5e7183831190101f801490d0bb725f289024476e54e6c0f909f8b1724356ec21aa51d65173dde4c1248a214fced078a08af311f7d1782824bbf1ebe039266ccf9f64640cc921fd1db47ece3163c7eee0604469d864ed01c81e06078abf7ab62a7e94b523383244fcd8091e4256aff550dde2ab226ae71c6363d332341e882c95d6e1ce0b317aa7d3c56475e03dc17e78d8dfe4fd1aa086c72e2afe742eaed5d9cdd1fe6ab4bceb036647588581d7dfa431e2610c6eff9a60b63ebf56f75ac3794ce1e83a8a6e3259fbc6f5652808d5fc03517c1cadef6d5bd291c082deeaa3e0a7be6e2f868e56021643fb771325842e77f5fdfdd85ae35fb6d08b5b243ab4473bae0571711e73fa302d56b30f5f3643256efe7e6e0d99aabfb8d124a75fef424429b7461c730c370a72be5dda658a3eeb00294bb733bfadd055f72776141a238872fe41f1ca9d76450b358c2b386b536abefbb322d3f77671dbb03d06e5220f7282a64b068d91974cc8bfa56c8f537c357d26ec68114232a55d04e83fd1fff641431134ce96917d89f27013ec658615417c006221eea1af5ad5e2a0a423cf9df51471efd36ef21e5d35b05b513810a3d48222092dc91d2432e37830e98c73321d0e8d3590a797180f17611bda16fd97f51ea84fa4191cc7d6ce90ee2de219384b11393a7292cb5a4c8cee39a20bb621d5ef138a22142b26ce040dc63bb5311ba5bd19f5cbb82460379227199817b5b6c4b39d3ac8f68dd00902ddf773252535d88b4fced5ccb5c16c1285809a9d2df79bdc5863861007a2c4d10879d873ac62bfd30c79af865b54174460704781e8dc4dc5ecda69bb974edb447cc5fa2a8fab6cc19bd03b400a17f952178a49305e4dd54a615491a4dcbe1a27a1ba8513afc205e1e9340b6e9b29040a160b8a9cc7d09b86a924596253420383bc1477f7d7aa94386de642e974c9718b330fe551fe23afdc3a2f0f76a34c5d7d482bb1f4ebb09a0349b9b2c8d42c0322134581fd629c912165a392a96c36906c55ee0239a9b249e173d6fd55c900c68141f54076475cb05d7f30457406484ebc41c65f98f62a7c842abf1125158be5238441a781a8380890c1abaf58beaf22ec44ce2208e3ee9be3bd734054d060081c674d7ef934e4548a5339814bd75a3d46dc7a06482512cee57d4dc61c076489847f75099605edec931cbe8ab0eca164e9bfe58ce3ebe4422ee169961c7e14dac8ff58831fe547f9171529e4f782e99365c10fc2eefbcbb07c9a3a36db433f2d8e456366e4246cf90884a7f2cfa1f80dc1f22092ddd90e161e2175fa8dfbafbfc4dc3f4672814e8bbe5d14d5d33106248a01241bbf5d9ff2055853a09c65c3baa8a955852d587f3691a280c55857d460809a030153e3ea1660f14919846106d09606531d427290d386b2b6c9da8d27b8d3d879479e1e7be5b6c641c128d3af29f319bca3d797344cff46afaf7af8fd054e29dec3d580ccfadde511a4859c81a5bb25e726f32da4dbe5b5a7d1880149e6f3fe2df68d813397490da1412d0a8d48386bc1c9ee5c32a058dda228b883d621372ed599767c6e573ac471261cbfacf9604670867ad53b92f8306ec52d49edee124847faebf0bd73347f003c8b3e331c89a43ddbc0f38f446b177ea0caf203277370ac4bb326ade667d4814e6f28c31df45619ca51ef40146d977602fabea0e4725fb43c27fe743a6fb5e9025c9fbe066cd54de38e1e09e76cdb739de914a227a069633a85b7d2e0d0bde126a0a674dd424cf72c2ce5c86da3076d82c425c1dd21e58bcf5bb84a917bba8637d77b28aab4deef9e6d4986eae522adb7f11f58b985e6c5c65b04ce6a52da9612a68510552a4442ef41cc67ba319df1ca50713e05c0dd5360b50eddb5a39ceb173ea19b8d47d47432ecef37605dc5c7ccd4a3a403e6501cba670421e673e38a86212e39e48bd5dc785c69fdd315f1e597e7f042ebe7aff0fdd79fb5be82675affe725c02f5aeb5fb9df0baf346e024267e9ec5090f80c2ecd20099f6a4a1471fd02511909cb5dd649d2817838f96e4f5838dd70ac68d97ce257f9a6f00035f380dc3a07d3e5ab0361bf30dacc3af849ffec5e5ffda49f13612f1ce56fa8ee3ff420ab58172436a8cb05ecf8d29c40954a9cbe1a4ed49670333a5bc1f51b38b8b08dfbb1d04c46f660a1d3f13a039d99eec01f9db6776d32ae5a5843ba19073761a0e1737637c7f1f2033c7feb5e3fbcfe0cfe34fc5d07eb97e0f2a3088d55a99e30e961bdc259f5004d0a61c3b88c07472ce4750c76b7484fa6315dd979aae769d8f5e450d63167639ad9a0b1fb27c6683cf6c2c9db566aa8b7778ee5067775810b02f9edb036442319caf7f38979da5ac335ae6db229c9ce4171ef1a41bb438d5bef2e4e7f355fae3c7fee7ee728b48e2a0d767b3751dd3d38b13d72d068a5966bfc95b00fe9991c725dfe59df26487d716182ecb032fa70174ac1f16e600c080a3ec1cc0fb56888d69f87e04ec890ce84035b5e1d04263d1d7948629958c3a7827d2e6cf448bbe27554051fd93e707d0399ea57f87082128fa77be899ef31b249471986ae98567ba085c109db3e85d969dfdb9713d8d7c1414d0778f9f634617c4fabf2b24fef09acc3719de836eaf6a2a81897da1d6ad5331d6b52aecb075ab1e311ccce1ce9d8a09ebb03bb00bd5d5b6d4acf706f39d0ce6fe1fd1b67f78777056c9c497fb386edb9e89e42288a3a76bae10b615bdd984adee89019b63550add12beafdd91078bdbc5eeb7203f18c0093d53705425f5cc3173068e8509b9a42c018a34e445336384db889e136b4a21e8dc12b7bfbfce31f3ffffef1b9b491c020235a7ebe79633b317c84abff9e236c9db99b2f6d86a1053d73686e4846748c0f19ed6f485e1e8aec3f6735051df5fc82ea36ab2952bac660e6d37d8bda701324d814a63728781827215d3068bea7a7fd8cfd2ddd9ee98ab50bba96ff7bf7ebcbf71f9dfc77e7a37be9df8487b5192a1493a21a5a74dead090aba7e5863c8e044849e8a5ca7f215fc01db44b0e47a6bcece7c2b4b4d90a24f53158de7e740e7e9ba94b4a8ed7542a0e260407fb6a1b4834ea3b5032cafc8b4bcffc837e8afe804fd6d535214f2a2fc4846be7016aae01b38608bf91e2e806317f4d5a508262097fc47c59fdd695d5682630ff00d1bd661baf797f427af4bcf84e52fdd1b3f66fa6d31b9943d68f384f28ae8fd06f6b2a985efe57f7b2ecc28d1bf50846132deeef82775ec7161a7830b2ee26073016106ec77c3335556526697fdb7e39fcd18fe284fb3fc1f6304efb39e95003b0000000049454e44ae426082}}{\nonshppict{\pict\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw216\pich72\picwgoal4320\pichgoal1440\macpict\bliptag657880520 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000004800d8001102ff0c00fffe0000004800000048000000000000004800d800000000001e0001000a00000000004800d882000000f39a0000000100000000000000000000000000000001000000000000000000000000000040000000000000000000000000000000000000000000004800d8000003000000000000000056726177200000000000000000000000006170706c000004000000040000d8004800480000004800000000f300000100000000000000000000000000000000000000000000000000000000000000000020ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff202020ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff7f7f7fff505050ff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfffffffffffffffffffefefefff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff000000ff000000ff000000ff606060ffdfdfdfffffffffffffffffffffffffffafafafff404040ffffffffffefefefff303030ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff101010ffffffffffffffffff404040ff000000ff606060ffffffffffffffffffffffffffffffffff606060ff000000ff303030ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff606060ffffffffffffffffff9f9f9fffffffffffefefefff303030ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff303030ff606060ff404040ff000000ff606060ffefefefff303030ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ffffffffff606060ff000000ff000000ff000000ff505050ffefefefffffffffff606060ff000000ff000000ff000000ff303030ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff000000ff303030ffefefefff404040ffefefefff303030ff000000ff000000ff000000ff404040ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffbfbfbfff606060ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff606060ff101010ff000000ff000000ff000000ff000000ff303030ff707070ff000000ff000000ff000000ff000000ff000000ff303030ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff707070ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff202020ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff202020ff000000ff000000ff000000ff000000ffbfbfbfff404040ff606060ff202020ff000000ff000000ff000000ff000000ff505050ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff606060ffbfbfbfff707070ff101010ff303030ff000000ff000000ff000000ff000000ff000000ff000000ff606060ffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff606060ffefefefff303030ff000000ff000000ff000000ff000000ff303030ffdfdfdfff303030ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff606060ff101010ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffefefefff202020ff000000ff000000ff000000ffbfbfbfff000000ff9f9f9fffefefefff303030ff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff8f8f8fffffffffff606060ff101010ffcfcfcfffffffffffcfcfcfff202020ff404040ff404040ff202020ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffefefefff7f7f7fffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff707070ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffefefefff202020ff000000ff000000ff000000ffbfbfbfffffffffffefefefff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff606060ffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff8f8f8fffffffffffffffffff9f9f9fffdfdfdfff404040ff000000ff000000ff404040ffffffffffefefefff707070ffefefefffffffffffffffffffffffffffffffffffcfcfcfff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffcfcfcfff707070ffffffffffffffffffffffffffffffffff9f9f9fffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff505050ffcfcfcfffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff000000ff606060ffbfbfbfffbfbfbfffffffffffffffffffffffffffffffffffffffffffdfdfdfff606060ffdfdfdfffffffffffffffffffffffffffffffffffffffffffdfdfdfff606060ffefefefffffffffffffffffffffffffff9f9f9fff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff303030ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffefefefff707070ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff707070ffefefefffffffffffbfbfbfffbfbfbfffdfdfdfff303030ff000000ff000000ff303030ffbfbfbfffbfbfbfffefefefffffffffffffffffffffffffffffffffffffffffffffffffff505050ffffffffff606060ff000000ff9f9f9fffffffffff9f9f9fff202020ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffefefefff303030ff000000ff303030ffefefefffffffffffffffffffffffffffffffffffffffffffbfbfbfff202020ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffff8f8f8fff000000ff000000ff101010ffbfbfbfffffffffffefefefffffffffffffffffffffffffffffffffffdfdfdfff303030ff000000ff000000ff000000ff000000ff202020ffefefefff404040ff000000ff000000ff404040ffefefefff303030ff000000ff303030ffefefefffefefefffffffffffcfcfcfff101010ff000000ff606060ffefefefffafafafffffffffffefefefff202020ff000000ff404040ffefefefffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffffdfdfdfffffffffffffffffffffffffffffffffffffffffffafafafff101010ff000000ff101010ff9f9f9fffffffffffdfdfdfffdfdfdfff101010ff000000ff000000ff000000ff000000ff000000ff303030ffffffffffffffffffffffffffffffffff9f9f9fff101010ff000000ff101010ffafafafffffffffffffffffffffffffffefefefff303030ff000000ff303030ffefefefffffffffff9f9f9fff000000ff000000ff8f8f8fffffffffffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff8f8f8fff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffcfcfcfff303030ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffefefefff707070ff000000ff000000ff000000ff000000ff000000ffcfcfcfff303030ff000000ff000000ff000000ff000000ff000000ff101010ffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff606060ff000000ff404040ffcfcfcfff303030ff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff303030ff303030ff000000ff000000ff000000ff303030ff303030ffcfcfcfffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffffefefefff505050ff000000ff000000ff000000ff000000ff000000ff606060ff303030ffffffffffffffffffffffffff9f9f9fff101010ff101010ff000000ff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff303030ff303030ff000000ff000000ff000000ff303030ff202020ff9f9f9fff101010ff000000ff000000ff000000ff101010ff9f9f9fffefefefff303030ff000000ff000000ff000000ff303030ff8f8f8fff000000ff000000ff000000ff000000ff404040ff505050ffffffffffffffffffffffffffefefefff707070ff101010ff000000ff000000ff000000ff000000ff404040ff101010ff7f7f7fff404040ff000000ff000000ff000000ff202020ff404040ffcfcfcfffffffffffffffffffefefefff606060ff101010ff000000ff000000ff000000ff000000ff7f7f7fff606060ffbfbfbfff303030ff000000ff000000ff000000ff202020ff7f7f7fff000000ff000000ff000000ff000000ff404040ff303030ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff9f9f9fff202020ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffff8f8f8fff101010ff000000ff000000ff000000ff000000ff404040ff8f8f8fff7f7f7fffffffffffcfcfcfff202020ff101010ff000000ff000000ff000000ff000000ff7f7f7fffafafafff404040ff101010ff000000ff000000ff101010ff404040ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff9f9f9fffbfbfbfff7f7f7fff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff000000ff606060ff000000ff000000ff000000ff000000ff8f8f8fffffffffffefefefff404040ff000000ff505050ff000000ff000000ff000000ff303030ffffffffffffffffffffffffffffffffffffffffffffffffff707070ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffbfbfbfff101010ff000000ffafafafff303030ff000000ff000000ff000000ff000000ffefefefffffffffffefefefff505050ff000000ff000000ffbfbfbfffafafafff7f7f7fff404040ff707070ffffffffffffffffff404040ff000000ff000000ff000000ff606060ff000000ff000000ff000000ff000000ff8f8f8fff101010ff404040ff000000ff000000ff000000ff404040ffffffffff404040ff606060ff000000ff000000ff000000ff000000ff303030ff303030ff000000ff000000ff000000ff202020ffefefefffffffffffffffffffcfcfcfff303030ff000000ffafafafff505050ff000000ff000000ff000000ff000000ffcfcfcfffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffcfcfcfff202020ff000000ff7f7f7fff707070ff000000ff000000ff000000ff000000ff606060ff505050ff606060ff101010ff000000ff000000ff000000ff101010ff404040ff000000ff000000ff000000ff000000ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffefefefff505050ff000000ff000000ffafafafff101010ff000000ff000000ff000000ff202020ffefefefff7f7f7fff000000ff000000ff7f7f7fffcfcfcfff7f7f7fff606060ff303030ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffdfdfdfffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffff8f8f8fff000000ff000000ff000000ffbfbfbfffffffffff101010ff000000ff000000ffbfbfbfff303030ff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffcfcfcfff000000ff000000ff000000ffbfbfbfffffffffff505050ff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffbfbfbfff303030ffefefefffffffffffffffffff404040ff000000ff000000ff404040ffffffffff8f8f8fff000000ff000000ff000000ffbfbfbfffdfdfdfffffffffff303030ff000000ff000000ff404040ffffffffffefefefffffffffff8f8f8fff000000ff000000ff000000ffbfbfbfffefefefff202020ff000000ff000000ff404040ffffffffffffffffffcfcfcfff000000ff000000ff000000ffbfbfbfffffffffff606060ff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffafafafff000000ff000000ff000000ffbfbfbfffdfdfdfffffffffffafafafff000000ff000000ff000000ffafafafffffffffff505050ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffcfcfcfff202020ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff7f7f7fffffffffffefefefff101010ffcfcfcfffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffefefefff202020ff8f8f8fffbfbfbfffcfcfcfffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff101010ff707070ff202020ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff7f7f7fffffffffff505050ff606060ffbfbfbfffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffbfbfbfffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff7f7f7fff606060ffbfbfbfff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ff8f8f8fff606060ff000000ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fffafafafffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff606060ff8f8f8fff000000ff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffdfdfdfffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffcfcfcfff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffbfbfbfff7f7f7fff202020ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfffefefefffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ff9f9f9fffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffcfcfcfff505050ff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ff202020ff505050ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ff404040ff101010ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff000000ff303030ff202020ff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff000000ff202020ffffffffffbfbfbfff000000ff000000ff202020ffdfdfdfffffffffff404040ffffffffff404040ff7f7f7fff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffcfcfcfff404040ff404040ff000000ff8f8f8fffffffffff404040ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff404040ff404040ff101010ff505050ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ff000000ff000000ff000000ff606060ff707070ff101010ff8f8f8fffffffffffffffffffffffffff404040ff7f7f7fff000000ffcfcfcfff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffafafafffffffffffffffffffffffffffcfcfcfffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffff404040ff000000ff000000ff000000ff606060ffefefefffffffffff000000ff000000ff000000ff606060ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffafafafff404040ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffdfdfdfff202020ffefefefffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff707070ff000000ff000000ff000000ff000000ff101010ffcfcfcfffffffffffffffffffffffffffcfcfcfff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ff101010ff9f9f9fffffffffffefefefff202020ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ff606060ffefefefff202020ff000000ff000000ff000000ff000000ff303030ffefefefff000000ff000000ff606060ffffffffffffffffffbfbfbfff000000ff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff000000ffefefefffffffffffefefefffdfdfdfff202020ffdfdfdfffffffffffffffffff404040ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff303030ffffffffffdfdfdfffffffffffafafafff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff303030ffffffffffdfdfdfffbfbfbfff000000ff000000ff000000ffafafafffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff606060ffffffffffefefefffefefefff000000ff000000ff000000ff404040ffefefefffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffafafafff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff101010ff000000ff000000ff000000ffbfbfbfff000000ff000000ff606060ff9f9f9fff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffcfcfcfffffffffff404040ff000000ff000000ff404040ffffffffffffffffff404040ffafafafffffffffffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff303030ffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ff000000ff000000ff303030ff404040ff101010ff000000ff000000ff000000ffbfbfbfff9f9f9fff000000ff000000ff000000ff000000ff9f9f9fffbfbfbfff000000ff000000ff000000ffbfbfbfff606060ff000000ff000000ff000000ff000000ff000000ff606060ff303030ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ff000000ff101010ff606060ff101010ff000000ff000000ff000000ff000000ff303030ff000000ff7f7f7fffffffffffffffffffffffffff606060ff000000ff000000ff000000ff000000ff606060ff303030ff000000ff000000ff000000ff101010ff505050ff8f8f8fff404040ff606060ff7f7f7fff7f7f7fffdfdfdfff404040ff000000ff000000ff7f7f7fff9f9f9fff000000ff000000ff000000ff000000ff9f9f9fffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff303030ff000000ff000000ff000000ff505050ff101010ff9f9f9fff101010ff000000ff000000ff000000ff606060ffffffffff404040ff000000ff000000ff000000ff606060ff101010ff9f9f9fff000000ff000000ff000000ff000000ff9f9f9fff404040ff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff000000ff505050ff303030ff7f7f7fff000000ff000000ff000000ff000000ff303030ffcfcfcfff000000ff000000ff404040ffefefefffffffffffdfdfdfff101010ff000000ff000000ff000000ff303030ffefefefff7f7f7fff000000ff000000ff000000ff303030ff303030ffafafafffffffffffffffffffffffffffffffffffffffffff303030ff000000ff000000ff000000ff000000ff000000ffbfbfbfff000000ff000000ff000000ff000000ff000000ff000000ff303030ffcfcfcfffefefefff303030ff000000ff000000ff000000ff101010ff9f9f9fff404040ff000000ff202020ffcfcfcfffffffffff7f7f7fff404040ff7f7f7fff7f7f7fffbfbfbfff7f7f7fff000000ff000000ff404040ffffffffffffffffff404040ff000000ff000000ff000000ff303030ff303030ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fffffffffff9f9f9fff000000ff000000ff000000ff000000ff8f8f8fffbfbfbfff000000ff000000ff000000ffbfbfbfff8f8f8fffdfdfdfff303030ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff606060ffffffffffcfcfcfff303030ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffdfdfdfff707070ff606060ff000000ff000000ff000000ff000000ff707070ff101010ff000000ff000000ff000000ff606060ff8f8f8fff000000ff000000ff000000ff000000ff000000ff101010ff101010ffbfbfbfffffffffff9f9f9fff000000ff000000ff000000ff000000ff7f7f7fffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff707070ff202020ff000000ff000000ff000000ff000000ff9f9f9fffcfcfcfff101010ff000000ff000000ff000000ff303030ffffffffff707070ff000000ff000000ff000000ff000000ff8f8f8fff303030ff202020ff000000ff000000ff000000ff000000ff101010ff000000ff000000ff000000ffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff000000ff9f9f9fff606060ff9f9f9fff303030ff000000ff000000ff000000ff101010ff000000ff8f8f8fffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ff303030ffefefefffafafafff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff000000ff000000ffbfbfbfff000000ff000000ff000000ff000000ff000000ff606060ffefefefffffffffff8f8f8fff8f8f8fff505050ff000000ff000000ff000000ff000000ff000000ff505050ffefefefffffffffffcfcfcfff000000ff000000ff000000ff000000ff000000ff101010ff000000ff8f8f8fffffffffffffffffffcfcfcfff000000ff000000ff000000ff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff101010ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff9f9f9fff000000ff000000ff606060ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffffefefefff606060ff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff404040ffffffffffffffffffffffffffefefefff303030ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ff9f9f9fffffffffffcfcfcfff101010ff000000ff505050ffcfcfcfff101010ff505050ff606060ff202020ff000000ff000000ff505050ffefefefffffffffffffffffffffffffff9f9f9fff000000ff000000ff606060ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffdfdfdfffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffffffffffffcfcfcfff101010ff000000ff303030ffefefefffffffffffffffffff707070ff000000ff000000ff9f9f9fffefefefffafafafffefefefff505050ff000000ff000000ff303030ff9f9f9fff000000ff000000ff000000ffbfbfbfffffffffffafafafffefefefff606060ff000000ff000000ff8f8f8fffffffffffffffffffffffffffefefefff505050ff000000ff000000ff202020ffcfcfcfffffffffffffffffffffffffffffffffffffffffffdfdfdfff303030ff000000ff303030ffefefefffffffffffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff606060ff303030ff000000ff000000ff000000ffbfbfbfff202020ff202020ff000000ff101010ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff000000ff000000ff000000ff8f8f8fffffffffffffffffffefefefff303030ff303030ff707070ff303030ff000000ff000000ff303030ffcfcfcfffffffffffffffffffffffffffbfbfbfffcfcfcfff8f8f8fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff8f8f8fff404040ff101010ff000000ff303030ff606060ffdfdfdfffffffffffffffffffffffffffffffffffffffffff9f9f9fff707070ffffffffffffffffffbfbfbfff000000ff000000ff101010ffefefefffffffffffffffffffffffffffffffffff8f8f8fff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff505050ffefefefffffffffffffffffffffffffffffffffffffffffff707070ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff9f9f9fffffffffffffffffffffffffffcfcfcfff505050ffefefefff7f7f7fffbfbfbfffffffffffffffffffefefefff707070ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffafafafff707070ffffffffffffffffffbfbfbfff000000ff000000ff101010ffefefefffffffffffffffffffffffffffffffffff9f9f9fff8f8f8fffffffffffffffffffffffffffffffffffdfdfdfff606060ffefefefffffffffffffffffffffffffffffffffff9f9f9fff9f9f9fffffffffffffffffffffffffffffffffffffffffff404040ff303030ffefefefffdfdfdfff101010ff000000ff000000ff202020ffffffffffffffffffffffffffffffffff9f9f9fff707070ffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff606060ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff606060ffefefefffffffffffffffffffffffffffffffffff9f9f9fff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ffcfcfcfffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffefefefff606060ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff404040ffcfcfcfffffffffffffffffffffffffffafafafff8f8f8fffffffffffffffffffffffffff9f9f9fff707070ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff505050ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff202020ffcfcfcfffffffffffffffffffefefefff303030ff000000ff101010ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ffbfbfbfffbfbfbfffbfbfbfffffffffffffffffffafafafff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff101010ff505050ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff101010ff505050ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff000000ff000000ff101010ff8f8f8fff303030ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff8f8f8fff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff505050ff000000ff303030ff404040ff000000ff000000ff000000ff101010ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff606060ff303030ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff707070ffdfdfdfffffffffffffffffffcfcfcfff303030ff303030ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff606060ffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff7f7f7fff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff202020ff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff404040ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff404040ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff404040ff606060ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffbfbfbfffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffbfbfbfffcfcfcfffffffffffffffffffdfdfdfff7f7f7fff7f7f7fff7f7f7fff8f8f8fffdfdfdfffffffffffdfdfdfffbfbfbfffcfcfcfffffffffffffffffffffffffffefefefff9f9f9fff7f7f7fff7f7f7fffbfbfbfffffffffffffffffffffffffff404040ff000000ff404040ffffffffff9f9f9fff7f7f7fff7f7f7fff7f7f7fffcfcfcfffffffffffffffffffffffffffdfdfdfffbfbfbfffbfbfbfffffffffffffffffffdfdfdfffbfbfbfffcfcfcfffffffffffbfbfbfff7f7f7fff7f7f7fff7f7f7fffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff7f7f7fff7f7f7fff7f7f7fffafafafffffffffffefefefffbfbfbfffbfbfbfffefefefffefefefffbfbfbfff000000ff000000ff606060ffbfbfbfffcfcfcfffffffffffffffffffffffffffafafafff7f7f7fff7f7f7fff7f7f7fff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffffffffffbfbfbfffbfbfbfffdfdfdfffefefefff9f9f9fff7f7f7fff7f7f7fff7f7f7fffdfdfdfffffffffffffffffffffffffffdfdfdfffbfbfbfffbfbfbfffffffffffefefefff9f9f9fff7f7f7fff7f7f7fff7f7f7fffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff7f7f7fff7f7f7fff7f7f7fff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff7f7f7fff7f7f7fff7f7f7fffdfdfdfffffffffffffffffffcfcfcfff606060ff000000ff000000ffbfbfbfffbfbfbfffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffe5afbeffd47d96ffd47d96ffd47d96ffde9baefff4dfe5fffffffffffffffffffffffffffffffffffffffffffaeff2ffde9baeffd47d96ffd47d96ffd47d96ffe5afbefffffffffffffffffffffffffffffffffffffffffff4dfe5ffeabfcbffeabfcbffffffffffde9baeffd47d96ffd47d96ffde9baefffaeff2ffffffffffffffffffeabfcbffd47d96ffd47d96ffd47d96ffeabfcbffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffdfdfdfffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ffafafafffffffffffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff606060ffffffffff707070ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fff7f7f7fff000000ff404040ffffffffffffffffffefefefff303030ff000000ff000000ff000000ff000000ff606060ffffffffffffffffff404040ff000000ff303030ff303030ff000000ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ff606060ff000000ff000000ff000000ff000000ff000000ff606060ffffffffffffffffffffffffffffffffffcfcfcfff202020ff000000ff000000ff000000ff000000ff000000ff303030ff8f8f8fff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ff000000ff000000ff000000ff404040ffffffffffcfcfcfff303030ff000000ff000000ff000000ff000000ff000000ff000000ff606060ffefefefffffffffffffffffffffffffff000000ff000000ff505050ff202020ff000000ff000000ff000000ff000000ff000000ffafafafffffffffffffffffff7f7f7fff000000ff000000ffafafafff101010ff000000ff000000ff000000ff000000ff000000ff404040ffefefefffffffffffffffffffffffffffffffffffafafafff202020ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffafafafff101010ff000000ff000000ff000000ff000000ff9f9f9fffffffffff404040ff000000ff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffe5afbeffb6204aff990033ff990033ff990033ff990033ff990033ff990033ffd47d96ffffffffffffffffffffffffffd47d96ffb0103dff990033ff990033ff990033ff990033ff990033ffb0103dffe5afbeffffffffffffffffffffffffffd47d96ff990033ff990033ffcb607eff990033ff990033ff990033ff990033ffb6204afff4dfe5ffc55071ff990033ff990033ff990033ff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff707070ffffffffffffffffffffffffffffffffffffffffff202020ff000000ff505050ffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ffdfdfdfff505050ff000000ff000000ff000000ff404040ff606060ff303030ff000000ff000000ff101010ff000000ff404040ffffffffffffffffff606060ff000000ff000000ff404040ff202020ff000000ff000000ff9f9f9fffffffffff404040ff000000ff000000ff000000ff202020ff606060ff404040ff000000ff000000ff000000ffdfdfdfffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ff000000ff101010ff505050ff404040ff101010ff000000ff000000ffbfbfbfffffffffffffffffffcfcfcfff101010ff000000ff000000ff202020ff606060ff404040ff101010ff000000ff000000ff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ff000000ff000000ff000000ff404040ffcfcfcfff000000ff000000ff000000ff202020ff606060ff404040ff101010ff000000ff000000ff303030ffefefefffffffffffffffffff000000ff000000ff000000ff000000ff303030ff505050ff303030ff000000ff000000ff101010ffefefefffffffffff7f7f7fff000000ff000000ff000000ff000000ff202020ff606060ff404040ff101010ff000000ff000000ff303030ffefefefffffffffffffffffff9f9f9fff000000ff000000ff000000ff303030ff505050ff404040ff000000ff000000ff000000ff606060ffffffffffffffffffffffffff101010ff000000ff101010ff404040ff101010ff000000ff101010ffdfdfdfff404040ff000000ff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffde9baeff990033ff990033ff990033ffbb3057ffcb607effc04064ff990033ff990033ffc04064ffffffffffffffffffcb607eff990033ff990033ff990033ffc04064ffc55071ffbb3057ff990033ff990033ff990033ffde9baeffffffffffffffffffd47d96ff990033ff990033ff990033ffb0103dffc55071ffbb3057ff990033ff990033ffb0103dff990033ff990033ffc04064ffc55071ff990033ff990033ff990033fff4dfe5ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff101010ffefefefffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffdfdfdfffffffffffffffffffffffffffdfdfdfff000000ff000000ff505050ff9f9f9fff000000ff000000ff303030ffdfdfdfffffffffffffffffffffffffffbfbfbfff101010ff000000ff000000ff404040ffffffffffffffffff101010ff000000ff7f7f7fffffffffffefefefff404040ff7f7f7fffefefefffffffffff404040ff000000ff000000ff606060ffffffffffffffffffffffffff9f9f9fff000000ff000000ff8f8f8fffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ff303030ffefefefffffffffffffffffffcfcfcfff000000ff000000ff606060ffffffffffffffffff202020ff000000ff000000ff8f8f8fffffffffffffffffffffffffffefefefff606060ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffefefefff101010ff000000ff101010ffafafafffffffffffffffffffffffffffefefefff606060ff000000ff000000ff505050ffffffffffffffffff000000ff000000ff000000ff8f8f8fffffffffffffffffffffffffff8f8f8fff000000ff000000ffafafafffffffffff7f7f7fff000000ff000000ff000000ff8f8f8fffffffffffffffffffffffffffefefefff606060ff000000ff000000ff606060ffffffffffcfcfcfff000000ff000000ff101010ffbfbfbfffffffffffffffffffffffffffefefefff505050ff000000ff000000ff7f7f7fffffffffffbfbfbfff000000ff000000ffcfcfcfffffffffffcfcfcfff202020ffafafafffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffb0103dffeabfcbfffffffffffffffffffffffffffaeff2ffc55071ffc04064ffffffffffde9baeff990033ff990033ffc04064fff4dfe5ffffffffffffffffffffffffffefcfd8ffbb3057ff990033ff990033ffeabfcbffffffffffd47d96ff990033ff990033ffb6204afffaeff2ffffffffffffffffffc55071ff990033ff990033ff990033ffefcfd8ffffffffffffffffffeabfcbff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff8f8f8fffffffffffffffffffffffffff606060ff000000ff000000ff000000ff707070ffffffffffffffffffffffffff7f7f7fff000000ff000000ffbfbfbfff303030ff000000ff101010ffefefefffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff404040ffffffffffffffffff000000ff000000ff505050ffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffefefefffffffffffffffffffffffffffffffffff202020ff000000ff606060ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ffcfcfcfffffffffffffffffffffffffffffffffff505050ff000000ff404040ffffffffffafafafff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffff505050ff000000ff000000ffdfdfdfffffffffff000000ff000000ff202020ffffffffffffffffffffffffffffffffffefefefff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffefefefff606060ff000000ff000000ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff101010ffefefefffbfbfbfff000000ff000000ffafafafffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffc55071ff990033ff990033ffefcfd8ffffffffffffffffffffffffffffffffffffffffffffffffffde9baeffffffffffb0103dff990033ffbb3057fffffffffffffffffffffffffffffffffffffffffffffffffff4dfe5ffb0103dff990033ffc04064ffffffffffd47d96ff990033ff990033ffde9baeffffffffffffffffffffffffffeabfcbff990033ff990033ffcb607effffffffffffffffffffffffffffffffffb6204aff990033ffcb607effffffffffffffffffffffffffffffffffffffffffffffffff202020ff000000ff202020ffffffffffffffffffdfdfdfff000000ff000000ff202020ff000000ff101010ffffffffffffffffffefefefff101010ff000000ff404040ffefefefff000000ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff404040ffffffffffffffffff505050ff000000ff000000ff404040ff9f9f9fffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff606060ff000000ff000000ffefefefffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff202020ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff7f7f7fffffffffff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffafafafff000000ff000000ff9f9f9fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff9f9f9fffefefefff101010ff000000ff000000ff606060ffcfcfcfffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000fffffffffffffffffffffffffffffffffffffffffffffffffffaeff2ff990033ff990033ffcb607effffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffe5afbeff990033ff990033ffe5afbeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffd47d96ff990033ff990033fffaeff2ffd47d96ff990033ff990033fff4dfe5fffffffffffffffffffffffffffaeff2ff990033ff990033ffd47d96ffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ffafafafffffffffff7f7f7fff000000ff101010ffcfcfcfff000000ff000000ff9f9f9fffffffffff9f9f9fff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffefefefff303030ff000000ff000000ff000000ff202020ff9f9f9fffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff505050ffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff404040ff000000ff000000ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffff9f9f9fff101010ff000000ff000000ff000000ff404040ffcfcfcfffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffe5afbeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffeabfcbffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ff000000ff404040ffffffffff202020ff000000ff707070ffffffffff505050ff000000ff303030ffffffffff202020ff000000ff202020ffffffffffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffff9f9f9fff202020ff000000ff000000ff000000ff707070ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff404040ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffdfdfdfff707070ff101010ff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffeabfcbffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff707070ff000000ff000000ffdfdfdfffffffffffafafafff000000ff000000ff7f7f7fff000000ff000000ff9f9f9fffffffffffcfcfcfff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff505050ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff101010ff000000ff000000ffdfdfdfff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff404040ff000000ff202020ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff101010ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ff000000ff707070ffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff101010ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff707070ff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffefefefff7f7f7fff000000ff000000ff303030ffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffefcfd8ff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffde9baeff990033ff990033fff4dfe5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffde9baeff990033ff990033ffefcfd8ffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff000000ff000000ff404040ffffffffffffffffffffffffff202020ff000000ff000000ff000000ff202020ffffffffffffffffffffffffff101010ff000000ff202020ffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff404040ffffffffffffffffffefefefffdfdfdfffffffffffffffffffffffffffafafafff000000ff000000ffbfbfbfff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff8f8f8fff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff505050ff000000ff101010ffefefefffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffcfcfcfff202020ff000000ff202020ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffcfcfcfffffffffffdfdfdfffffffffffffffffffffffffffffffffff606060ff000000ff000000ffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb6204aff990033ffb6204affffffffffffffffffffffffffffffffffffffffffffffffffffffffffe5afbefff4dfe5ff990033ff990033ffd47d96ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffc04064ff990033ffb6204affffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ffafafafffffffffffffffffffffffffff8f8f8fff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffff707070ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff505050ff000000ff000000ff404040ffffffffff8f8f8fff101010ff404040ffffffffffffffffffffffffffafafafff000000ff000000ffbfbfbfff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffdfdfdfff000000ff000000ff202020ffefefefffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffbfbfbfff000000ff000000ff505050ffefefefffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff202020ffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff101010ffdfdfdfffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff202020ffffffffff9f9f9fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff404040ffefefefff505050ff000000ff8f8f8fffffffffffffffffffffffffff606060ff000000ff101010ffffffffff7f7f7fff000000ff000000fffffffffffffffffffffffffffaeff2ffeabfcbffffffffffffffffffd47d96ff990033ff990033ffcb607effffffffffffffffffffffffffffffffffffffffffeabfcbffb0103dffffffffffc04064ff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffffcb607eff990033ff990033ffd47d96ffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff202020ffffffffffffffffffffffffffffffffffefefefff101010ff000000ff101010ffefefefffffffffffffffffffffffffffefefefff101010ff000000ff000000ff505050ffafafafffbfbfbfff9f9f9fff202020ff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff505050ffbfbfbfff9f9f9fff101010ff000000ff101010ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffff707070ff000000ff000000ff101010ff8f8f8fffbfbfbfffbfbfbfff606060ff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffff606060ff000000ff000000ff202020ff8f8f8fffbfbfbfffbfbfbfff707070ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff000000ff101010ff7f7f7fffbfbfbfffbfbfbfff707070ff000000ff000000ff000000ffafafafffffffffffffffffff404040ff000000ff000000ff303030ff9f9f9fffbfbfbfffafafafff606060ff000000ff000000ff101010ffcfcfcfffffffffff202020ff000000ff000000ff7f7f7fffbfbfbfff7f7f7fff000000ff000000ff606060ffffffffff7f7f7fff000000ff000000fffffffffffffffffff4dfe5ffb0103dff990033ffc04064ffffffffffffffffffbb3057ff990033ff990033ffc04064ffde9baeffeabfcbffe5afbeffcb607eff990033ff990033fffffffffff4dfe5ffb0103dff990033ff990033ffcb607effe5afbeffeabfcbffde9baeffc04064ff990033ff990033ffbb3057ffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff000000ff000000ff000000ff000000ff000000ff101010ff505050ff000000ff404040ffffffffffefefefff303030ff000000ff000000ff000000ff000000ff000000ff000000ff9f9f9fffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffff606060ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff404040ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffff606060ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff101010ffafafafffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff404040ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffefefefff505050ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff101010ffcfcfcfffffffffffffffffffcfcfcfff101010ff000000ff000000ff000000ff000000ff000000ff101010ffdfdfdfffffffffff7f7f7fff000000ff000000ffffffffffffffffffeabfcbff990033ff990033ff990033fffffffffffffffffffaeff2ffc04064ff990033ff990033ff990033ff990033ff990033ff990033ff990033ffb0103dffffffffffffffffffefcfd8ffb6204aff990033ff990033ff990033ff990033ff990033ff990033ff990033ffc04064fffaeff2ffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ffefefefffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffefefefff707070ff202020ff000000ff000000ff202020ff707070ffefefefff9f9f9fff404040ff707070ffffffffffffffffffefefefff7f7f7fff202020ff000000ff000000ff303030ffbfbfbfffffffffffffffffff707070ff404040ff707070ffffffffffffffffffffffffffffffffffffffffff707070ff404040ff707070ffffffffff9f9f9fff404040ff404040ffffffffffffffffff9f9f9fff404040ff707070ffffffffffffffffffffffffffffffffffffffffff9f9f9fff404040ff404040ffffffffffffffffffffffffffffffffff9f9f9fff404040ff000000ff000000ff000000ff505050ffbfbfbfffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffff404040ff404040ff9f9f9fffffffffffffffffffffffffffffffffffbfbfbfff505050ff101010ff000000ff000000ff202020ff707070ffdfdfdfffffffffffffffffffffffffffffffffff404040ff404040ff9f9f9fffffffffffffffffffffffffffffffffffffffffff707070ff404040ff9f9f9fffffffffff7f7f7fff000000ff000000ffffffffff9f9f9fff303030ff000000ff000000ff101010ff505050ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff505050ff000000ff000000ff000000ff303030ff7f7f7fffefefefffffffffffffffffffffffffffffffffffcfcfcfff505050ff000000ff000000ff101010ff606060ffdfdfdfffffffffffffffffff9f9f9fff404040ff404040fffffffffffffffffffaeff2ffbb3057ff990033ffd47d96ffffffffffffffffffffffffffffffffffde9baeffc04064ff990033ff990033ff990033ffbb3057ffd47d96fffaeff2fffffffffffffffffffffffffffaeff2ffde9baeffbb3057ff990033ff990033ff990033ffc55071ffde9baeffffffffffffffffffffffffffffffffffde9baeffc04064ffc04064ffffffffffffffffffffffffffffffffffffffffffc04064ffc04064ffefcfd8ffffffffffffffffffffffffffffffffffd47d96ffc04064ffd47d96ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfffbfbfbfffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff101010ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff101010ffcfcfcfffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff505050ff7f7f7fff7f7f7fff303030ff000000ff000000ff101010ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff101010ff000000ff000000ff000000ff000000ff000000ff000000ff303030ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff8f8f8fff505050ff404040ff404040ff606060ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff404040ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000700ae00700007000100010003000300040000000d000c001000d800d800d800d800280018003610517569636b54696d65aa20616e6420610000280024003f0d206465636f6d70726573736f7200280030000f1f617265206e656564656420746f20736565207468697320706963747572652e000000a100e007ac00000000000007a86170706c022000006d6e74725247422058595a2007d900020019000b001a000b616373704150504c000000006170706c000000000000000000000000000000000000f6d6000100000000d32d6170706c00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000b64657363000001080000006f6473636d000001780000056c63707274000006e400000038777470740000071c000000147258595a00000730000000146758595a00000744000000146258595a0000075800000014725452430000076c0000000e636861640000077c0000002c625452430000076c0000000e675452430000076c0000000e64657363000000000000001447656e65726963205247422050726f66696c6500000000000000000000001447656e65726963205247422050726f66696c6500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000006d6c7563000000000000001e0000000c736b534b00000028000001786872485200000028000001a06361455300000024000001c87074425200000026000001ec756b55410000002a0000021266724655000000280000023c7a685457000000160000026469744954000000280000027a6e624e4f00000026000002a26b6f4b5200000016000002c86373435a00000022000002de6865494c0000001e00000300646544450000002c0000031e68754855000000280000034a7376534500000026000002a27a68434e00000016000003726a614a500000001a00000388726f524f00000024000003a2656c475200000022000003c67074504f00000026000003e86e6c4e4c000000280000040e6573455300000026000003e874685448000000240000043674725452000000220000045a66694649000000280000047c706c504c0000002c000004a47275525500000022000004d06172454700000026000004f2656e555300000026000005186461444b0000002e0000053e005601610065006f006200650063006e00fd0020005200470042002000700072006f00660069006c00470065006e006500720069010d006b00690020005200470042002000700072006f00660069006c00500065007200660069006c0020005200470042002000670065006e00e800720069006300500065007200660069006c0020005200470042002000470065006e00e9007200690063006f0417043004330430043b044c043d043804390020043f0440043e044404300439043b002000520047004200500072006f00660069006c0020006700e9006e00e9007200690071007500650020005200560042901a75280020005200470042002082725f6963cf8ff000500072006f00660069006c006f0020005200470042002000670065006e0065007200690063006f00470065006e0065007200690073006b0020005200470042002d00700072006f00660069006cc77cbc1800200052004700420020d504b85cd30cc77c004f006200650063006e00fd0020005200470042002000700072006f00660069006c05e405e805d505e405d905dc0020005200470042002005db05dc05dc05d90041006c006c00670065006d00650069006e006500730020005200470042002d00500072006f00660069006c00c1006c00740061006c00e1006e006f00730020005200470042002000700072006f00660069006c666e901a0020005200470042002063cf8ff065874ef64e00822c0020005200470042002030d730ed30d530a130a430eb00500072006f00660069006c0020005200470042002000670065006e0065007200690063039303b503bd03b903ba03cc002003c003c103bf03c603af03bb002000520047004200500065007200660069006c0020005200470042002000670065006e00e9007200690063006f0041006c00670065006d00650065006e0020005200470042002d00700072006f006600690065006c0e420e1b0e230e440e1f0e250e4c002000520047004200200e170e310e480e270e440e1b00470065006e0065006c0020005200470042002000500072006f00660069006c00690059006c00650069006e0065006e0020005200470042002d00700072006f006600690069006c00690055006e006900770065007200730061006c006e0079002000700072006f00660069006c0020005200470042041e04310449043804390020043f0440043e04440438043b044c00200052004700420645064406410020062a06390631064a0641002000520047004200200627064406390627064500470065006e00650072006900630020005200470042002000500072006f00660069006c006500470065006e006500720065006c0020005200470042002d006200650073006b0072006900760065006c007300657465787400000000436f707972696768742032303037204170706c6520496e632e2c20616c6c207269676874732072657365727665642e0058595a20000000000000f35200010000000116cf58595a20000000000000744d00003dee000003d058595a200000000000005a750000ac730000173458595a20000000000000281a0000159f0000b83663757276000000000000000101cd0000736633320000000000010c42000005defffff326000007920000fd91fffffba2fffffda3000003dc0000c06c00a100e000040000000200ff}}}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par The Washington Post\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 March}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  15, 2001 Thursday  \par Final Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 South Africa Resists Call For AIDS 'Emergency'}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Jon Jeter, Washington Post Foreign Service\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 A SECTION; Pg. A01\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1063 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 CAPE TOWN, South Africa March 14\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  President Thabo Mbeki today rejected appeals to declare South Africa's AIDS epidemic a national emerge}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cy, a step that would enable the government to override patents owned by foreign pharmaceutical firms and buy or manufacture cheap, generic versions of life-prolonging medicines. \par  Addressing Parliament here, Mbeki said he did not believe it would be necessary to invoke a World Trade Organization provision that allows member countries to suspend patents in cases of extreme national urge}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cy, without the patent-holders' consent. \par  An estimated 4.2 million of South Africa's 45 million people are infected with the virus that causes AIDS, more than in any other country. \par  With only a fraction of the population able to afford the potent antiretroviral drugs and other therapies pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 duced by multinational pharmaceutical companies, Mbeki's government has been under intense pressure to take steps that would make AIDS drugs available and affordable. At the same time, however, the gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment is wary of taking any drastic steps that would scare off needed foreign investment or raise questions about its commitment to free markets.  \par  The government passed a law four years ago that permitted its health minister to bypass drug-makers' p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tents to provide cheaper generic versions of the treatments. But that law, which is narrower in scope than the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  provision, is being challenged in court by a coalition of nearly 40 pharmaceutical firms. Labor unions, human rights activists and opposition politicians have urged Mbeki's governing party, the African National Congress, to declare a state of emergency that would make cheaper drugs available under the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  prov}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sion, rather than place all its hopes on the 1997 law and face a protracted legal ordeal. \par  While he did not explicitly say so today, Mbeki and other government officials apparently fear that while i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 voking the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  measure could alleviate the AIDS crisis, it could also worsen South Africa's broader social and economic woes by scaring away foreign investors just as the country is trying to catch up with a fast-moving global economy.  \par  If the trade pact's national emergency clause were activated, all property rights in South Africa would be temporarily suspended, and many in the country's business community have raised concern over the kind of signal that would send abroad. Foreign investment here declined by 50 percent last year, and surveys show that foreign business executives often fail to distinguish South Africa from neighboring Zimbabwe, where the government all but encourages black peasants to illegally occupy land owned by white farmers.  \par  "There are other consequences," Mbeki said today, "which are not desirable." \par  Mbeki explained his refusal to declare an emergency by saying that South Africa's own law was adequate in providing wider access to AIDS medicines. Furthermore, government officials express fear that an emerge}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cy declaration would dry up investment altogether just as they are trying to right the economy following years of sanctions and mismanagement by the white-minority apartheid government, ousted in the country's first all-races election seven years ago. \par  "It really is a very difficult balance," said Greg Mills, executive director of the South African Institute of Inte}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 national Affairs. "On the one hand, we face a massive AIDS crisis. But on the other hand, if we declare a state of emergency, we run the risk of looking like another unstable player in an unstable region." \par  Additionally, because South Africa's is the most robust market economy of any country that is led by a mos}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ly black government, Mbeki and other officials are sensitive to criticism -- real or imagined -- that they are not up to the job. \par  "No other country has declared a state of emergency on these grounds," Mbeki said in his address. "We see no reason why we should not rely on the more comprehensive legislation approved by this Parliament." \par  Mbeki said that under }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  guidelines, a state of emergency could only be declared to restore peace and order and that no such threats to the country's security existed. \par  The question of how to provide affordable AIDS medicines to impoverished people is plaguing governments throughout sub-Saharan Africa, where 25.3 million of the 36.1 million people with HIV live, according to U.N. estimates. In neighboring Botswana, where 36 percent of adults are infected with the human immunodef}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ciency virus, which causes AIDS, the government announced today it hoped to provide antiretroviral medic}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion by year's end to all who need it. Botswana has the highest rate of HIV infection in the world, but the country's entire population of 1.6 million is less than the number of HIV victims here. \par  Botswana's President Festus Mogae said that failure to arrest the spread of AIDS in his country "means blank extinction -- it's a reality," news services reported. \par  But such programs and rhetoric have been slower to come in South Africa. \par  Known for his restless intellect, Mbeki last year puzzled his allies and foes here and abroad by questioning the efficacy of conventional AIDS medicines and supporting scientists who have discounted the connection between HIV and AIDS. \par  And while the median household income in South Africa is less than the $ 10,000 annual cost for the triple-drug therapy, or "cocktail," commonly used in the West to treat the disease, Mbeki's governing party refused until last month to administer even affordable medicines that have been shown to reduce transmission of HIV from mothers to their unborn children. \par  Now that the government has begun to shift its stance, and Mbeki has withdrawn from public debate on HIV, international scrutiny has been refocused from South Africa's policies to pharmaceutical companies' pricing policies. \par  One of the world's biggest drug companies, New Jersey-based Merck & Co., agreed this month to sell two of the roughly 14 medicines used to treat HIV at drastically reduced costs. And an Indian-based drug manufa}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 turer, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Ltd., last week asked South African officials to grant it a license to sell cheap, generic AIDS drugs to the government. And today New York-based Bristol-Myers Squibb Co. announced that it will sell the two AIDS medicines it manufactures to sub-Saharan countries "below cost" and will not prevent South Africa from ignoring the patent rights it holds on one of the drugs. \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV (92%); PHARMACEUTICALS INDUSTRY (91%); PHARMACEUTICAL PREPAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TION MFG (91%); EPIDEMICS (90%); AIDS & HIV TREATMENT (90%); DISEASES & DISORDERS (90%); ANTIVIRALS (90%); GENERIC DRUGS (90%); PATENTS (90%); INTERNATIONAL ECONOMIC ORGAN}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ZATIONS (89%); FOREIGN INVESTMENT (89%); POLITICS (79%); HEALTH DEPARTMENTS (78%); V}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 RUSES (78%); LEGISLATION (78%); TRADE TREATIES & AGREEMENTS (77%); GENERIC PRODUCTS (77%); MULTINATIONAL CORPORATIONS (77%); HEALTH CARE ACCESS (77%); EMBARGOES & SANCTIONS (76%); INTERNATIONAL TRADE (76%); TRADE DEVELOPMENT (76%); AGRICULTURAL TRADE (76%); EXECUTIVES (74%); PUBLIC HEALTH ADMINISTRATION (73%); POLLS & SURVEYS (72%); ECONOMIC CONDITIONS (67%); HUMAN RIGHTS (64%); LABOR UNIONS (50%); TREATIES & AGREEMENTS (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION (83%); AFRICAN NATIONAL CONGRESS (ANC) (54%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 THABO MBEKI (90%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 CAPE TOWN, SOUTH AFRICA (78%) SOUTH AFRICA (98%); ZIMBABWE (79%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 March 15, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 The Washington Post\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 South Africa;Cipla Request Will Test Patent Act Ability To Allow Cheap Aids Drugs In  Africa News March 9, 2001 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_75}{\*\bkmkstart DOC_ID_75_0}{\*\bkmkstart doc_id_32}{\*\bkmkend DOC_ID_75}{\*\bkmkend DOC_ID_75_0}{\*\bkmkend doc_id_32}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_32"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330032000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 32 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 March}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  9, 2001\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 South Africa;\par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928  Request Will Test Patent Act Ability To Allow Cheap Aids Drugs In}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WOZA Internet\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NEWS, DOCUMENTS & COMMENTARY\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 597 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  communication to the Registrar of Patents about compulsory licensing for various anti-retroviral drugs this week will test the notion that the Pharmaceutical Manufacturers' Association and the companies it represents would be prepared to see compulsory licensing effected through the Patents Act, the health d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 partment said in a statement on Friday.\par The Registrar of Patents is expected to be informing the company on how to processed with the application soon.\par "It's a little difficult at this stage to predict whether the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  initiative will translate into affordable AIDS trea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment for large numbers of South African on a sustainable basis. We would need more information about the possibilities this creates for local manufacturing and the likely pricing of the drugs," says health department senior spokesperson Jo-Anne Collinge. \par The eight drugs for which }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  is seeking non-exclusive compulsory licences are all anti-retroviral drugs used for the management of AIDS.\par The government maintains that the disputed Section C and the court case around it - instigated by the Pha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 maceutical Manufacturers' Association and potponed until April 18 - is justified.\par "The department considers it important to wage the struggle for affordable medicines across the widest po}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sible front. The cost of treating other conditions - such as multidrug resistant TB and AIDS-related opportu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 istic infections - is also a huge burden to our public health sector," says Collinge.\par The department has also been asked to comment on media reports that US-based multinational Merck i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tends to offer greatly discounted prices to South Africa for certain certain AIDS drugs.\par "There has been no communication on this matter from Merck to my office," says Health Minister Manto Tshabalala-Msimang.\par "While I welcome any signs of a willingness to negotiate affordable medicine prices, I cannot conduct such negotiations through the media and on the basis of a press release.\par "I would also like to point out that, even if a satisfactory agreement could be concluded with Merck or any other company, this would not negate the need for this country to have effective legislation to ensure access to affordable medicines.\par "We cannot rely forever on the begging bowl, aid programmes and charitable gestures. We need mech}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nisms that are sustainable in the long run if we want to fulfil our constitutional obligations to the people of this country," says the Health Minister.\par The question as to why the drug companies are "so worried" about the prospect of cheap generic drugs in developing nations remains. This is answered by recent Pharmaceutical Research and Manufacturers of America statements, reported in US papers.\par PhRMA Vice President Judy Bello was reported as saying, "While there is an agenda that many are propo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing that there should be lower prices in the neediest countries, nonetheless we think it's very important for you all to see the picture that there will be enormous demand to bring those same low prices into the US market."\par Since the formation of the World Trade Organisation in 1995, most countries agree to abide by a single set of international trade rules, so if one }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  member is allowed to disregard drug patents, "pretty soon the trend will spread to other countries and other products", according to Bello.\par Government has so far been unable to provide satisfactory answers to media questions as to why it has not made more use of tiered pricing, drug offers - with a few exceptions - and existing legislation such as the P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tent Act.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV TREATMENT (93%); PATENTS (93%); AIDS & HIV (93%); ANTIVIRALS (91%); PHARMACEUTICAL PREPARATION MFG (90%); PHARMACEUTICALS ASSOCIATIONS (90%); HEALTH DEPARTMENTS (90%); PUBLIC HEALTH ADMINISTRATION (90%); PATENT LAW (90%); DRUG PRICES (89%); PHARMACEUTICALS INDUSTRY (89%); BUSINESS & PROFESSIONAL ASSOCIATIONS (89%); GENERIC DRUGS (78%); CHEMICALS RESEARCH (78%); PHARMACEUTICALS TRADE (78%); HEALTH CARE ACCESS (75%); AIDS POLICY (75%); DRUG RESISTANCE (73%); GENERIC PRODUCTS (69%); HEALTH CARE (67%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (92%); MRK (PAR) (85%); MRK (NYSE) (85%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (92%); SIC2834 PHARMACEUTICAL PREPARATIONS (92%); NAICS325414 BIOLOGICAL PRODUCT (EXCEPT DIA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 G}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NOSTIC) MANUFACTURING (85%); SIC2834 PHARMACEUTICAL PREPARATIONS  (85%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 SOUTH AFRICA (94%); UNITED STATES (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  LTD (92%); MERCK & CO INC  (85%); MERCK & CO INC (85%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 March 9, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 English\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 AllAfrica, Inc\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 South Africa;Indian Generic AIDS Drug Offer Puts EU in Dilemma  Africa News March 9, 2001 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_76}{\*\bkmkstart DOC_ID_76_0}{\*\bkmkstart doc_id_33}{\*\bkmkend DOC_ID_76}{\*\bkmkend DOC_ID_76_0}{\*\bkmkend doc_id_33}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_33"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330033000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 33 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 March}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  9, 2001\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 South Africa;\par Indian Generic AIDS Drug Offer Puts EU in Dilemma}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 SouthScan\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NEWS, DOCUMENTS & COMMENTARY\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 374 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The offer by one of the largest Indian pharmaceutical producers, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Ltd, to deliver a generic version of the most common triple therapy drugs package for AIDS treatment to African governments at a break-even price of US$600 per patient per year, has triggered a flurry of defensive actions by the big four patent holders and multinationals of the pharmaceutical business.\par The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offer, made public by its chairman Yusuf Hamied on February 6 in Geneva at the headquarters of the Medicines Access Campaign, just across from the UN World Health Organisation headquarters, has also placed both the UNAIDS Programme(UNAIDS) and, even more significantly, the EU Commission, in a pai}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ful dilemma.\par UNAIDS had only shortly before published a long overdue public tender for the provision of UNAIDS-funded treatment programmes in Africa; the EU Commission was still brooding over a "co-ordinated action pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gramme" which it had announced at the end of September last year at a round table conference with U}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS, the WHO, the World Bank and the pharmaceutical industry. \par The core question is funding from these programmes for purchases of generic drugs, which cost for the 3T-treatment in the range of $10-15,000 per year per patient in Europe and North America. As public entities, UNAIDS and the EU have to accept the lowest priced offer, other things being equal.\par However, the EU Commission is the most ardent promoter of the World Trade Organisation's industrial p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tent protection regulation for Trade Related Intellectual Properties (TRIPS), and there seems little chance that they could buy from }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 , which is producing the medicines because Indian will only become subject to }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  rules in 2005. The EU would face massive opposition from the pharmaceuticals industry.\par After Glaxo had announced "major price rebates" for some of its patented AIDS drugs last week - without releasing price details - Merck followed on Wednesday with a public announcement for their 3T package tagged to precisely the Indian price level.\par For the full-length version of this article go to SouthScan's website: "http:/www.gn.apc.org/southscan/allafricastories01/intaidsdrug1605.html"> Indian generic AIDS drug offer places EU in a dilemma\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GENERIC DRUGS (92%); AIDS & HIV (91%); AIDS & HIV TREATMENT (90%); EUROPEAN UNION INSTITUTIONS (90%); INTERNATIONAL ECONOMIC ORGANIZATIONS (90%); PHARMACEUT}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 CALS INDUSTRY (90%); PHARMACEUTICALS PATENTS (89%); PHARMACEUTICAL PREPARATION MFG (89%); INTELLECTUAL PROPERTY LAW (89%); PATENTS (89%); ANTIVIRALS (89%); HEALTH DEPARTMENTS (78%); CONFERENCES & CONVENTIONS (75%); TRADE DEVELOPMENT (74%); D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 VELOPMENT BANKS (72%); MULTINATIONAL CORPORATIONS (71%); PUBLIC HEALTH ADMINISTR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TION (71%); INTERNATIONAL TRADE LAW (69%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (95%); GSK (NYSE) (58%); GSK (LSE) (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (95%); SIC2834 PHARMACEUTICAL PREPARATIONS (95%); SIC2834 PHARMACEUTICAL PREPARATIONS  (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 JOSEPH C PAPA (53%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (94%); WORLD HEALTH O}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GANIZATION  (83%); WORLD HEALTH ORGANIZATION (83%); UNITED NATIONS  (57%); UNITED N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TIONS (57%); WORLD TRADE ORGANIZATION  (54%); WORLD TRADE ORGANIZATION (54%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 EUROPEAN UNION MEMBER STATES (94%); AFRICA (93%); NORTH AMERICA (79%); E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 U}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ROPE (76%); SWITZERLAND (73%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 STATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GENEVA, SWITZERLAND (55%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  LTD (95%); GLAXOSMITHKLINE PLC  (58%); GLAXOSMITHKLINE PLC (58%);   JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (94%); WORLD HEALTH ORGANIZATION  (83%); WORLD HEALTH ORGANIZATION (83%); UNITED NATIONS  (57%); UNITED NATIONS (57%); WORLD TRADE ORGANIZATION  (54%); WORLD TRADE ORGANIZATION (54%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 March 14, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 English\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 AllAfrica, Inc\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Poverty, Prejudice Hinder India's AIDS Fight; Drug Maker Fears 'Another Africa' The Washington Post March 7, 2001 Wednesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_77}{\*\bkmkstart DOC_ID_77_0}{\*\bkmkstart doc_id_34}{\*\bkmkend DOC_ID_77}{\*\bkmkend DOC_ID_77_0}{\*\bkmkend doc_id_34}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_34"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330034000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 34 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\shppict{\pict{\*\picprop\shplid1026{\sp{\sn shapeType}{\sv 75}}{\sp{\sn fFlipH}{\sv 0}}{\sp{\sn fFlipV}{\sv 0}}{\sp{\sn fLine}{\sv 0}}{\sp{\sn fLayoutInCell}{\sv 1}}}\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw7620\pich2540\picwgoal4320\pichgoal1440\pngblip\bliptag657880520 89504e470d0a1a0a0000000d49484452000000d8000000480803000000a398cb9c00000300504c5445ffffff000000404040bfbfbf7f7f7fccccccefefef9900331010103030309f9f9f606060cfcfcfdfdfdf2020208f8f8f505050707070afafafd47d96c04064eabfcbde9baefaeff2b0103df4dfe5e5afbecb607ebb3057c55071b6204aefcfd8000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000335c3c3e00000c254944415478daed1b8972dbb6720192004f9152e2a449dad7ffffacccbc695ed234b12d89120f106f770152b41cc94ae31ef1043316491c8b5dec89050cf0a33cf1a256df079ef22bfb87f1fe49b22b11e99394432944004f5014950588bf335ea4615516ee35470a965fec54082c288b2af40aa7ce2ec30148faa000e797ac6b78f779a2aceeea0e958c485b49fc94274551c4f4c8e82b13893aa78f13903c7e4835b3f02205c76953ff3c594a798430972443a471e409c202ea83040951297e9ca66c06a488b1e7592f9189f012ba683ec94f7972ded44fcbbf811dabf7b5857d74d2a21bc6827e6f82654dfd4fda92ec00a41148dce61c5df505821844349f81889ef69404a4bbb13b7f75a9296dd4bba6061117f6cbe31045888cc29e3dc4921f274a7b0062642cc5ee0cce08440e0f1166878c61862d4ddfda934befa665c2cc629db6619dc79d28fa86b0175689d07819580c664e586b244d31ec67c8e451dc4e3ebc68208d3b06e28626a12486e5ccc57498702ad29046e5d837192457171e5011091c9946dd813043efdab4c6da117bb59838b48a0713c81c173bb632f2085728e429a40b7452d2691c49b2d79f60210ee68d75cce964307da1c2a24d0980fb176c87166a02a2c876641889a905a9464a76b5f0b88818df5905517d585cb06ae5142ae1bea5ef3b5a02320da4e9ac4239ce157a0bcc30726704e3c2732c8a6aa1827d8beb402b81c8c6720fbda2d50b871635c9ce38e61fd8d37fa9e216b96e338122921a56c4be9f80e8c034d0454604a8492adb62a34cf6b4dabb064c2f454be25c74ba05150f58b50f9301d5bccf0cf2ae91d24bbbd2c4cb0e2c48cfb1b26b90917261863c22fd8120dd6a037a88b6a328b690ec07eeee09eb15f2bd4fd7ca0e258ed60ef8b2812f101684db25a949278c2a36c6561d54f50148dc936c0dade52f1162cf6267d0716d169ae0c57b8b7d0de290234225926ca3c44a03ad6251174eac0abb6f79e691305c4eb3b4d8a88c685a94f024687716870c4337e371c10c3e882249177ea29404c45e6678ee5cc29128e6fc5e7183831190101f801490d0bb725f289024476e54e6c0f909f8b1724356ec21aa51d65173dde4c1248a214fced078a08af311f7d1782824bbf1ebe039266ccf9f64640cc921fd1db47ece3163c7eee0604469d864ed01c81e06078abf7ab62a7e94b523383244fcd8091e4256aff550dde2ab226ae71c6363d332341e882c95d6e1ce0b317aa7d3c56475e03dc17e78d8dfe4fd1aa086c72e2afe742eaed5d9cdd1fe6ab4bceb036647588581d7dfa431e2610c6eff9a60b63ebf56f75ac3794ce1e83a8a6e3259fbc6f5652808d5fc03517c1cadef6d5bd291c082deeaa3e0a7be6e2f868e56021643fb771325842e77f5fdfdd85ae35fb6d08b5b243ab4473bae0571711e73fa302d56b30f5f3643256efe7e6e0d99aabfb8d124a75fef424429b7461c730c370a72be5dda658a3eeb00294bb733bfadd055f72776141a238872fe41f1ca9d76450b358c2b386b536abefbb322d3f77671dbb03d06e5220f7282a64b068d91974cc8bfa56c8f537c357d26ec68114232a55d04e83fd1fff641431134ce96917d89f27013ec658615417c006221eea1af5ad5e2a0a423cf9df51471efd36ef21e5d35b05b513810a3d48222092dc91d2432e37830e98c73321d0e8d3590a797180f17611bda16fd97f51ea84fa4191cc7d6ce90ee2de219384b11393a7292cb5a4c8cee39a20bb621d5ef138a22142b26ce040dc63bb5311ba5bd19f5cbb82460379227199817b5b6c4b39d3ac8f68dd00902ddf773252535d88b4fced5ccb5c16c1285809a9d2df79bdc5863861007a2c4d10879d873ac62bfd30c79af865b54174460704781e8dc4dc5ecda69bb974edb447cc5fa2a8fab6cc19bd03b400a17f952178a49305e4dd54a615491a4dcbe1a27a1ba8513afc205e1e9340b6e9b29040a160b8a9cc7d09b86a924596253420383bc1477f7d7aa94386de642e974c9718b330fe551fe23afdc3a2f0f76a34c5d7d482bb1f4ebb09a0349b9b2c8d42c0322134581fd629c912165a392a96c36906c55ee0239a9b249e173d6fd55c900c68141f54076475cb05d7f30457406484ebc41c65f98f62a7c842abf1125158be5238441a781a8380890c1abaf58beaf22ec44ce2208e3ee9be3bd734054d060081c674d7ef934e4548a5339814bd75a3d46dc7a06482512cee57d4dc61c076489847f75099605edec931cbe8ab0eca164e9bfe58ce3ebe4422ee169961c7e14dac8ff58831fe547f9171529e4f782e99365c10fc2eefbcbb07c9a3a36db433f2d8e456366e4246cf90884a7f2cfa1f80dc1f22092ddd90e161e2175fa8dfbafbfc4dc3f4672814e8bbe5d14d5d33106248a01241bbf5d9ff2055853a09c65c3baa8a955852d587f3691a280c55857d460809a030153e3ea1660f14919846106d09606531d427290d386b2b6c9da8d27b8d3d879479e1e7be5b6c641c128d3af29f319bca3d797344cff46afaf7af8fd054e29dec3d580ccfadde511a4859c81a5bb25e726f32da4dbe5b5a7d1880149e6f3fe2df68d813397490da1412d0a8d48386bc1c9ee5c32a058dda228b883d621372ed599767c6e573ac471261cbfacf9604670867ad53b92f8306ec52d49edee124847faebf0bd73347f003c8b3e331c89a43ddbc0f38f446b177ea0caf203277370ac4bb326ade667d4814e6f28c31df45619ca51ef40146d977602fabea0e4725fb43c27fe743a6fb5e9025c9fbe066cd54de38e1e09e76cdb739de914a227a069633a85b7d2e0d0bde126a0a674dd424cf72c2ce5c86da3076d82c425c1dd21e58bcf5bb84a917bba8637d77b28aab4deef9e6d4986eae522adb7f11f58b985e6c5c65b04ce6a52da9612a68510552a4442ef41cc67ba319df1ca50713e05c0dd5360b50eddb5a39ceb173ea19b8d47d47432ecef37605dc5c7ccd4a3a403e6501cba670421e673e38a86212e39e48bd5dc785c69fdd315f1e597e7f042ebe7aff0fdd79fb5be82675affe725c02f5aeb5fb9df0baf346e024267e9ec5090f80c2ecd20099f6a4a1471fd02511909cb5dd649d2817838f96e4f5838dd70ac68d97ce257f9a6f00035f380dc3a07d3e5ab0361bf30dacc3af849ffec5e5ffda49f13612f1ce56fa8ee3ff420ab58172436a8cb05ecf8d29c40954a9cbe1a4ed49670333a5bc1f51b38b8b08dfbb1d04c46f660a1d3f13a039d99eec01f9db6776d32ae5a5843ba19073761a0e1737637c7f1f2033c7feb5e3fbcfe0cfe34fc5d07eb97e0f2a3088d55a99e30e961bdc259f5004d0a61c3b88c07472ce4750c76b7484fa6315dd979aae769d8f5e450d63167639ad9a0b1fb27c6683cf6c2c9db566aa8b7778ee5067775810b02f9edb036442319caf7f38979da5ac335ae6db229c9ce4171ef1a41bb438d5bef2e4e7f355fae3c7fee7ee728b48e2a0d767b3751dd3d38b13d72d068a5966bfc95b00fe9991c725dfe59df26487d716182ecb032fa70174ac1f16e600c080a3ec1cc0fb56888d69f87e04ec890ce84035b5e1d04263d1d7948629958c3a7827d2e6cf448bbe27554051fd93e707d0399ea57f87082128fa77be899ef31b249471986ae98567ba085c109db3e85d969dfdb9713d8d7c1414d0778f9f634617c4fabf2b24fef09acc3719de836eaf6a2a81897da1d6ad5331d6b52aecb075ab1e311ccce1ce9d8a09ebb03bb00bd5d5b6d4acf706f39d0ce6fe1fd1b67f78777056c9c497fb386edb9e89e42288a3a76bae10b615bdd984adee89019b63550add12beafdd91078bdbc5eeb7203f18c0093d53705425f5cc3173068e8509b9a42c018a34e445336384db889e136b4a21e8dc12b7bfbfce31f3ffffef1b9b491c020235a7ebe79633b317c84abff9e236c9db99b2f6d86a1053d73686e4846748c0f19ed6f485e1e8aec3f6735051df5fc82ea36ab2952bac660e6d37d8bda701324d814a63728781827215d3068bea7a7fd8cfd2ddd9ee98ab50bba96ff7bf7ebcbf71f9dfc77e7a37be9df8487b5192a1493a21a5a74dead090aba7e5863c8e044849e8a5ca7f215fc01db44b0e47a6bcece7c2b4b4d90a24f53158de7e740e7e9ba94b4a8ed7542a0e260407fb6a1b4834ea3b5032cafc8b4bcffc837e8afe804fd6d535214f2a2fc4846be7016aae01b38608bf91e2e806317f4d5a508262097fc47c59fdd695d5682630ff00d1bd661baf797f427af4bcf84e52fdd1b3f66fa6d31b9943d68f384f28ae8fd06f6b2a985efe57f7b2ecc28d1bf50846132deeef82775ec7161a7830b2ee26073016106ec77c3335556526697fdb7e39fcd18fe284fb3fc1f6304efb39e95003b0000000049454e44ae426082}}{\nonshppict{\pict\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw216\pich72\picwgoal4320\pichgoal1440\macpict\bliptag657880520 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000004800d8001102ff0c00fffe0000004800000048000000000000004800d800000000001e0001000a00000000004800d882000000f39a0000000100000000000000000000000000000001000000000000000000000000000040000000000000000000000000000000000000000000004800d8000003000000000000000056726177200000000000000000000000006170706c000004000000040000d8004800480000004800000000f300000100000000000000000000000000000000000000000000000000000000000000000020ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff202020ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff7f7f7fff505050ff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfffffffffffffffffffefefefff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff000000ff000000ff000000ff606060ffdfdfdfffffffffffffffffffffffffffafafafff404040ffffffffffefefefff303030ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff101010ffffffffffffffffff404040ff000000ff606060ffffffffffffffffffffffffffffffffff606060ff000000ff303030ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff606060ffffffffffffffffff9f9f9fffffffffffefefefff303030ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff303030ff606060ff404040ff000000ff606060ffefefefff303030ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ffffffffff606060ff000000ff000000ff000000ff505050ffefefefffffffffff606060ff000000ff000000ff000000ff303030ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff000000ff303030ffefefefff404040ffefefefff303030ff000000ff000000ff000000ff404040ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffbfbfbfff606060ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff606060ff101010ff000000ff000000ff000000ff000000ff303030ff707070ff000000ff000000ff000000ff000000ff000000ff303030ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff707070ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff202020ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff202020ff000000ff000000ff000000ff000000ffbfbfbfff404040ff606060ff202020ff000000ff000000ff000000ff000000ff505050ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff606060ffbfbfbfff707070ff101010ff303030ff000000ff000000ff000000ff000000ff000000ff000000ff606060ffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff606060ffefefefff303030ff000000ff000000ff000000ff000000ff303030ffdfdfdfff303030ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff606060ff101010ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffefefefff202020ff000000ff000000ff000000ffbfbfbfff000000ff9f9f9fffefefefff303030ff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff8f8f8fffffffffff606060ff101010ffcfcfcfffffffffffcfcfcfff202020ff404040ff404040ff202020ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffefefefff7f7f7fffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff707070ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffefefefff202020ff000000ff000000ff000000ffbfbfbfffffffffffefefefff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff606060ffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff8f8f8fffffffffffffffffff9f9f9fffdfdfdfff404040ff000000ff000000ff404040ffffffffffefefefff707070ffefefefffffffffffffffffffffffffffffffffffcfcfcfff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffcfcfcfff707070ffffffffffffffffffffffffffffffffff9f9f9fffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff505050ffcfcfcfffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff000000ff606060ffbfbfbfffbfbfbfffffffffffffffffffffffffffffffffffffffffffdfdfdfff606060ffdfdfdfffffffffffffffffffffffffffffffffffffffffffdfdfdfff606060ffefefefffffffffffffffffffffffffff9f9f9fff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff303030ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffefefefff707070ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff707070ffefefefffffffffffbfbfbfffbfbfbfffdfdfdfff303030ff000000ff000000ff303030ffbfbfbfffbfbfbfffefefefffffffffffffffffffffffffffffffffffffffffffffffffff505050ffffffffff606060ff000000ff9f9f9fffffffffff9f9f9fff202020ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffefefefff303030ff000000ff303030ffefefefffffffffffffffffffffffffffffffffffffffffffbfbfbfff202020ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffff8f8f8fff000000ff000000ff101010ffbfbfbfffffffffffefefefffffffffffffffffffffffffffffffffffdfdfdfff303030ff000000ff000000ff000000ff000000ff202020ffefefefff404040ff000000ff000000ff404040ffefefefff303030ff000000ff303030ffefefefffefefefffffffffffcfcfcfff101010ff000000ff606060ffefefefffafafafffffffffffefefefff202020ff000000ff404040ffefefefffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffffdfdfdfffffffffffffffffffffffffffffffffffffffffffafafafff101010ff000000ff101010ff9f9f9fffffffffffdfdfdfffdfdfdfff101010ff000000ff000000ff000000ff000000ff000000ff303030ffffffffffffffffffffffffffffffffff9f9f9fff101010ff000000ff101010ffafafafffffffffffffffffffffffffffefefefff303030ff000000ff303030ffefefefffffffffff9f9f9fff000000ff000000ff8f8f8fffffffffffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff8f8f8fff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffcfcfcfff303030ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffefefefff707070ff000000ff000000ff000000ff000000ff000000ffcfcfcfff303030ff000000ff000000ff000000ff000000ff000000ff101010ffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff606060ff000000ff404040ffcfcfcfff303030ff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff303030ff303030ff000000ff000000ff000000ff303030ff303030ffcfcfcfffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffffefefefff505050ff000000ff000000ff000000ff000000ff000000ff606060ff303030ffffffffffffffffffffffffff9f9f9fff101010ff101010ff000000ff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff303030ff303030ff000000ff000000ff000000ff303030ff202020ff9f9f9fff101010ff000000ff000000ff000000ff101010ff9f9f9fffefefefff303030ff000000ff000000ff000000ff303030ff8f8f8fff000000ff000000ff000000ff000000ff404040ff505050ffffffffffffffffffffffffffefefefff707070ff101010ff000000ff000000ff000000ff000000ff404040ff101010ff7f7f7fff404040ff000000ff000000ff000000ff202020ff404040ffcfcfcfffffffffffffffffffefefefff606060ff101010ff000000ff000000ff000000ff000000ff7f7f7fff606060ffbfbfbfff303030ff000000ff000000ff000000ff202020ff7f7f7fff000000ff000000ff000000ff000000ff404040ff303030ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff9f9f9fff202020ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffff8f8f8fff101010ff000000ff000000ff000000ff000000ff404040ff8f8f8fff7f7f7fffffffffffcfcfcfff202020ff101010ff000000ff000000ff000000ff000000ff7f7f7fffafafafff404040ff101010ff000000ff000000ff101010ff404040ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff9f9f9fffbfbfbfff7f7f7fff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff000000ff606060ff000000ff000000ff000000ff000000ff8f8f8fffffffffffefefefff404040ff000000ff505050ff000000ff000000ff000000ff303030ffffffffffffffffffffffffffffffffffffffffffffffffff707070ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffbfbfbfff101010ff000000ffafafafff303030ff000000ff000000ff000000ff000000ffefefefffffffffffefefefff505050ff000000ff000000ffbfbfbfffafafafff7f7f7fff404040ff707070ffffffffffffffffff404040ff000000ff000000ff000000ff606060ff000000ff000000ff000000ff000000ff8f8f8fff101010ff404040ff000000ff000000ff000000ff404040ffffffffff404040ff606060ff000000ff000000ff000000ff000000ff303030ff303030ff000000ff000000ff000000ff202020ffefefefffffffffffffffffffcfcfcfff303030ff000000ffafafafff505050ff000000ff000000ff000000ff000000ffcfcfcfffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffcfcfcfff202020ff000000ff7f7f7fff707070ff000000ff000000ff000000ff000000ff606060ff505050ff606060ff101010ff000000ff000000ff000000ff101010ff404040ff000000ff000000ff000000ff000000ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffefefefff505050ff000000ff000000ffafafafff101010ff000000ff000000ff000000ff202020ffefefefff7f7f7fff000000ff000000ff7f7f7fffcfcfcfff7f7f7fff606060ff303030ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffdfdfdfffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffff8f8f8fff000000ff000000ff000000ffbfbfbfffffffffff101010ff000000ff000000ffbfbfbfff303030ff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffcfcfcfff000000ff000000ff000000ffbfbfbfffffffffff505050ff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffbfbfbfff303030ffefefefffffffffffffffffff404040ff000000ff000000ff404040ffffffffff8f8f8fff000000ff000000ff000000ffbfbfbfffdfdfdfffffffffff303030ff000000ff000000ff404040ffffffffffefefefffffffffff8f8f8fff000000ff000000ff000000ffbfbfbfffefefefff202020ff000000ff000000ff404040ffffffffffffffffffcfcfcfff000000ff000000ff000000ffbfbfbfffffffffff606060ff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffafafafff000000ff000000ff000000ffbfbfbfffdfdfdfffffffffffafafafff000000ff000000ff000000ffafafafffffffffff505050ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffcfcfcfff202020ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff7f7f7fffffffffffefefefff101010ffcfcfcfffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffefefefff202020ff8f8f8fffbfbfbfffcfcfcfffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff101010ff707070ff202020ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff7f7f7fffffffffff505050ff606060ffbfbfbfffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffbfbfbfffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff7f7f7fff606060ffbfbfbfff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ff8f8f8fff606060ff000000ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fffafafafffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff606060ff8f8f8fff000000ff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffdfdfdfffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffcfcfcfff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffbfbfbfff7f7f7fff202020ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfffefefefffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ff9f9f9fffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffcfcfcfff505050ff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ff202020ff505050ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ff404040ff101010ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff000000ff303030ff202020ff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff000000ff202020ffffffffffbfbfbfff000000ff000000ff202020ffdfdfdfffffffffff404040ffffffffff404040ff7f7f7fff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffcfcfcfff404040ff404040ff000000ff8f8f8fffffffffff404040ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff404040ff404040ff101010ff505050ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ff000000ff000000ff000000ff606060ff707070ff101010ff8f8f8fffffffffffffffffffffffffff404040ff7f7f7fff000000ffcfcfcfff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffafafafffffffffffffffffffffffffffcfcfcfffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffff404040ff000000ff000000ff000000ff606060ffefefefffffffffff000000ff000000ff000000ff606060ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffafafafff404040ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffdfdfdfff202020ffefefefffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff707070ff000000ff000000ff000000ff000000ff101010ffcfcfcfffffffffffffffffffffffffffcfcfcfff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ff101010ff9f9f9fffffffffffefefefff202020ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ff606060ffefefefff202020ff000000ff000000ff000000ff000000ff303030ffefefefff000000ff000000ff606060ffffffffffffffffffbfbfbfff000000ff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff000000ffefefefffffffffffefefefffdfdfdfff202020ffdfdfdfffffffffffffffffff404040ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff303030ffffffffffdfdfdfffffffffffafafafff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff303030ffffffffffdfdfdfffbfbfbfff000000ff000000ff000000ffafafafffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff606060ffffffffffefefefffefefefff000000ff000000ff000000ff404040ffefefefffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffafafafff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff101010ff000000ff000000ff000000ffbfbfbfff000000ff000000ff606060ff9f9f9fff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffcfcfcfffffffffff404040ff000000ff000000ff404040ffffffffffffffffff404040ffafafafffffffffffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff303030ffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ff000000ff000000ff303030ff404040ff101010ff000000ff000000ff000000ffbfbfbfff9f9f9fff000000ff000000ff000000ff000000ff9f9f9fffbfbfbfff000000ff000000ff000000ffbfbfbfff606060ff000000ff000000ff000000ff000000ff000000ff606060ff303030ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ff000000ff101010ff606060ff101010ff000000ff000000ff000000ff000000ff303030ff000000ff7f7f7fffffffffffffffffffffffffff606060ff000000ff000000ff000000ff000000ff606060ff303030ff000000ff000000ff000000ff101010ff505050ff8f8f8fff404040ff606060ff7f7f7fff7f7f7fffdfdfdfff404040ff000000ff000000ff7f7f7fff9f9f9fff000000ff000000ff000000ff000000ff9f9f9fffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff303030ff000000ff000000ff000000ff505050ff101010ff9f9f9fff101010ff000000ff000000ff000000ff606060ffffffffff404040ff000000ff000000ff000000ff606060ff101010ff9f9f9fff000000ff000000ff000000ff000000ff9f9f9fff404040ff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff000000ff505050ff303030ff7f7f7fff000000ff000000ff000000ff000000ff303030ffcfcfcfff000000ff000000ff404040ffefefefffffffffffdfdfdfff101010ff000000ff000000ff000000ff303030ffefefefff7f7f7fff000000ff000000ff000000ff303030ff303030ffafafafffffffffffffffffffffffffffffffffffffffffff303030ff000000ff000000ff000000ff000000ff000000ffbfbfbfff000000ff000000ff000000ff000000ff000000ff000000ff303030ffcfcfcfffefefefff303030ff000000ff000000ff000000ff101010ff9f9f9fff404040ff000000ff202020ffcfcfcfffffffffff7f7f7fff404040ff7f7f7fff7f7f7fffbfbfbfff7f7f7fff000000ff000000ff404040ffffffffffffffffff404040ff000000ff000000ff000000ff303030ff303030ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fffffffffff9f9f9fff000000ff000000ff000000ff000000ff8f8f8fffbfbfbfff000000ff000000ff000000ffbfbfbfff8f8f8fffdfdfdfff303030ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff606060ffffffffffcfcfcfff303030ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffdfdfdfff707070ff606060ff000000ff000000ff000000ff000000ff707070ff101010ff000000ff000000ff000000ff606060ff8f8f8fff000000ff000000ff000000ff000000ff000000ff101010ff101010ffbfbfbfffffffffff9f9f9fff000000ff000000ff000000ff000000ff7f7f7fffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff707070ff202020ff000000ff000000ff000000ff000000ff9f9f9fffcfcfcfff101010ff000000ff000000ff000000ff303030ffffffffff707070ff000000ff000000ff000000ff000000ff8f8f8fff303030ff202020ff000000ff000000ff000000ff000000ff101010ff000000ff000000ff000000ffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff000000ff9f9f9fff606060ff9f9f9fff303030ff000000ff000000ff000000ff101010ff000000ff8f8f8fffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ff303030ffefefefffafafafff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff000000ff000000ffbfbfbfff000000ff000000ff000000ff000000ff000000ff606060ffefefefffffffffff8f8f8fff8f8f8fff505050ff000000ff000000ff000000ff000000ff000000ff505050ffefefefffffffffffcfcfcfff000000ff000000ff000000ff000000ff000000ff101010ff000000ff8f8f8fffffffffffffffffffcfcfcfff000000ff000000ff000000ff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff101010ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff9f9f9fff000000ff000000ff606060ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffffefefefff606060ff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff404040ffffffffffffffffffffffffffefefefff303030ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ff9f9f9fffffffffffcfcfcfff101010ff000000ff505050ffcfcfcfff101010ff505050ff606060ff202020ff000000ff000000ff505050ffefefefffffffffffffffffffffffffff9f9f9fff000000ff000000ff606060ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffdfdfdfffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffffffffffffcfcfcfff101010ff000000ff303030ffefefefffffffffffffffffff707070ff000000ff000000ff9f9f9fffefefefffafafafffefefefff505050ff000000ff000000ff303030ff9f9f9fff000000ff000000ff000000ffbfbfbfffffffffffafafafffefefefff606060ff000000ff000000ff8f8f8fffffffffffffffffffffffffffefefefff505050ff000000ff000000ff202020ffcfcfcfffffffffffffffffffffffffffffffffffffffffffdfdfdfff303030ff000000ff303030ffefefefffffffffffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff606060ff303030ff000000ff000000ff000000ffbfbfbfff202020ff202020ff000000ff101010ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff000000ff000000ff000000ff8f8f8fffffffffffffffffffefefefff303030ff303030ff707070ff303030ff000000ff000000ff303030ffcfcfcfffffffffffffffffffffffffffbfbfbfffcfcfcfff8f8f8fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff8f8f8fff404040ff101010ff000000ff303030ff606060ffdfdfdfffffffffffffffffffffffffffffffffffffffffff9f9f9fff707070ffffffffffffffffffbfbfbfff000000ff000000ff101010ffefefefffffffffffffffffffffffffffffffffff8f8f8fff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff505050ffefefefffffffffffffffffffffffffffffffffffffffffff707070ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff9f9f9fffffffffffffffffffffffffffcfcfcfff505050ffefefefff7f7f7fffbfbfbfffffffffffffffffffefefefff707070ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffafafafff707070ffffffffffffffffffbfbfbfff000000ff000000ff101010ffefefefffffffffffffffffffffffffffffffffff9f9f9fff8f8f8fffffffffffffffffffffffffffffffffffdfdfdfff606060ffefefefffffffffffffffffffffffffffffffffff9f9f9fff9f9f9fffffffffffffffffffffffffffffffffffffffffff404040ff303030ffefefefffdfdfdfff101010ff000000ff000000ff202020ffffffffffffffffffffffffffffffffff9f9f9fff707070ffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff606060ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff606060ffefefefffffffffffffffffffffffffffffffffff9f9f9fff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ffcfcfcfffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffefefefff606060ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff404040ffcfcfcfffffffffffffffffffffffffffafafafff8f8f8fffffffffffffffffffffffffff9f9f9fff707070ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff505050ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff202020ffcfcfcfffffffffffffffffffefefefff303030ff000000ff101010ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ffbfbfbfffbfbfbfffbfbfbfffffffffffffffffffafafafff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff101010ff505050ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff101010ff505050ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff000000ff000000ff101010ff8f8f8fff303030ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff8f8f8fff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff505050ff000000ff303030ff404040ff000000ff000000ff000000ff101010ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff606060ff303030ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff707070ffdfdfdfffffffffffffffffffcfcfcfff303030ff303030ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff606060ffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff7f7f7fff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff202020ff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff404040ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff404040ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff404040ff606060ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffbfbfbfffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffbfbfbfffcfcfcfffffffffffffffffffdfdfdfff7f7f7fff7f7f7fff7f7f7fff8f8f8fffdfdfdfffffffffffdfdfdfffbfbfbfffcfcfcfffffffffffffffffffffffffffefefefff9f9f9fff7f7f7fff7f7f7fffbfbfbfffffffffffffffffffffffffff404040ff000000ff404040ffffffffff9f9f9fff7f7f7fff7f7f7fff7f7f7fffcfcfcfffffffffffffffffffffffffffdfdfdfffbfbfbfffbfbfbfffffffffffffffffffdfdfdfffbfbfbfffcfcfcfffffffffffbfbfbfff7f7f7fff7f7f7fff7f7f7fffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff7f7f7fff7f7f7fff7f7f7fffafafafffffffffffefefefffbfbfbfffbfbfbfffefefefffefefefffbfbfbfff000000ff000000ff606060ffbfbfbfffcfcfcfffffffffffffffffffffffffffafafafff7f7f7fff7f7f7fff7f7f7fff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffffffffffbfbfbfffbfbfbfffdfdfdfffefefefff9f9f9fff7f7f7fff7f7f7fff7f7f7fffdfdfdfffffffffffffffffffffffffffdfdfdfffbfbfbfffbfbfbfffffffffffefefefff9f9f9fff7f7f7fff7f7f7fff7f7f7fffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff7f7f7fff7f7f7fff7f7f7fff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff7f7f7fff7f7f7fff7f7f7fffdfdfdfffffffffffffffffffcfcfcfff606060ff000000ff000000ffbfbfbfffbfbfbfffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffe5afbeffd47d96ffd47d96ffd47d96ffde9baefff4dfe5fffffffffffffffffffffffffffffffffffffffffffaeff2ffde9baeffd47d96ffd47d96ffd47d96ffe5afbefffffffffffffffffffffffffffffffffffffffffff4dfe5ffeabfcbffeabfcbffffffffffde9baeffd47d96ffd47d96ffde9baefffaeff2ffffffffffffffffffeabfcbffd47d96ffd47d96ffd47d96ffeabfcbffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffdfdfdfffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ffafafafffffffffffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff606060ffffffffff707070ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fff7f7f7fff000000ff404040ffffffffffffffffffefefefff303030ff000000ff000000ff000000ff000000ff606060ffffffffffffffffff404040ff000000ff303030ff303030ff000000ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ff606060ff000000ff000000ff000000ff000000ff000000ff606060ffffffffffffffffffffffffffffffffffcfcfcfff202020ff000000ff000000ff000000ff000000ff000000ff303030ff8f8f8fff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ff000000ff000000ff000000ff404040ffffffffffcfcfcfff303030ff000000ff000000ff000000ff000000ff000000ff000000ff606060ffefefefffffffffffffffffffffffffff000000ff000000ff505050ff202020ff000000ff000000ff000000ff000000ff000000ffafafafffffffffffffffffff7f7f7fff000000ff000000ffafafafff101010ff000000ff000000ff000000ff000000ff000000ff404040ffefefefffffffffffffffffffffffffffffffffffafafafff202020ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffafafafff101010ff000000ff000000ff000000ff000000ff9f9f9fffffffffff404040ff000000ff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffe5afbeffb6204aff990033ff990033ff990033ff990033ff990033ff990033ffd47d96ffffffffffffffffffffffffffd47d96ffb0103dff990033ff990033ff990033ff990033ff990033ffb0103dffe5afbeffffffffffffffffffffffffffd47d96ff990033ff990033ffcb607eff990033ff990033ff990033ff990033ffb6204afff4dfe5ffc55071ff990033ff990033ff990033ff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff707070ffffffffffffffffffffffffffffffffffffffffff202020ff000000ff505050ffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ffdfdfdfff505050ff000000ff000000ff000000ff404040ff606060ff303030ff000000ff000000ff101010ff000000ff404040ffffffffffffffffff606060ff000000ff000000ff404040ff202020ff000000ff000000ff9f9f9fffffffffff404040ff000000ff000000ff000000ff202020ff606060ff404040ff000000ff000000ff000000ffdfdfdfffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ff000000ff101010ff505050ff404040ff101010ff000000ff000000ffbfbfbfffffffffffffffffffcfcfcfff101010ff000000ff000000ff202020ff606060ff404040ff101010ff000000ff000000ff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ff000000ff000000ff000000ff404040ffcfcfcfff000000ff000000ff000000ff202020ff606060ff404040ff101010ff000000ff000000ff303030ffefefefffffffffffffffffff000000ff000000ff000000ff000000ff303030ff505050ff303030ff000000ff000000ff101010ffefefefffffffffff7f7f7fff000000ff000000ff000000ff000000ff202020ff606060ff404040ff101010ff000000ff000000ff303030ffefefefffffffffffffffffff9f9f9fff000000ff000000ff000000ff303030ff505050ff404040ff000000ff000000ff000000ff606060ffffffffffffffffffffffffff101010ff000000ff101010ff404040ff101010ff000000ff101010ffdfdfdfff404040ff000000ff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffde9baeff990033ff990033ff990033ffbb3057ffcb607effc04064ff990033ff990033ffc04064ffffffffffffffffffcb607eff990033ff990033ff990033ffc04064ffc55071ffbb3057ff990033ff990033ff990033ffde9baeffffffffffffffffffd47d96ff990033ff990033ff990033ffb0103dffc55071ffbb3057ff990033ff990033ffb0103dff990033ff990033ffc04064ffc55071ff990033ff990033ff990033fff4dfe5ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff101010ffefefefffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffdfdfdfffffffffffffffffffffffffffdfdfdfff000000ff000000ff505050ff9f9f9fff000000ff000000ff303030ffdfdfdfffffffffffffffffffffffffffbfbfbfff101010ff000000ff000000ff404040ffffffffffffffffff101010ff000000ff7f7f7fffffffffffefefefff404040ff7f7f7fffefefefffffffffff404040ff000000ff000000ff606060ffffffffffffffffffffffffff9f9f9fff000000ff000000ff8f8f8fffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ff303030ffefefefffffffffffffffffffcfcfcfff000000ff000000ff606060ffffffffffffffffff202020ff000000ff000000ff8f8f8fffffffffffffffffffffffffffefefefff606060ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffefefefff101010ff000000ff101010ffafafafffffffffffffffffffffffffffefefefff606060ff000000ff000000ff505050ffffffffffffffffff000000ff000000ff000000ff8f8f8fffffffffffffffffffffffffff8f8f8fff000000ff000000ffafafafffffffffff7f7f7fff000000ff000000ff000000ff8f8f8fffffffffffffffffffffffffffefefefff606060ff000000ff000000ff606060ffffffffffcfcfcfff000000ff000000ff101010ffbfbfbfffffffffffffffffffffffffffefefefff505050ff000000ff000000ff7f7f7fffffffffffbfbfbfff000000ff000000ffcfcfcfffffffffffcfcfcfff202020ffafafafffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffb0103dffeabfcbfffffffffffffffffffffffffffaeff2ffc55071ffc04064ffffffffffde9baeff990033ff990033ffc04064fff4dfe5ffffffffffffffffffffffffffefcfd8ffbb3057ff990033ff990033ffeabfcbffffffffffd47d96ff990033ff990033ffb6204afffaeff2ffffffffffffffffffc55071ff990033ff990033ff990033ffefcfd8ffffffffffffffffffeabfcbff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff8f8f8fffffffffffffffffffffffffff606060ff000000ff000000ff000000ff707070ffffffffffffffffffffffffff7f7f7fff000000ff000000ffbfbfbfff303030ff000000ff101010ffefefefffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff404040ffffffffffffffffff000000ff000000ff505050ffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffefefefffffffffffffffffffffffffffffffffff202020ff000000ff606060ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ffcfcfcfffffffffffffffffffffffffffffffffff505050ff000000ff404040ffffffffffafafafff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffff505050ff000000ff000000ffdfdfdfffffffffff000000ff000000ff202020ffffffffffffffffffffffffffffffffffefefefff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffefefefff606060ff000000ff000000ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff101010ffefefefffbfbfbfff000000ff000000ffafafafffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffc55071ff990033ff990033ffefcfd8ffffffffffffffffffffffffffffffffffffffffffffffffffde9baeffffffffffb0103dff990033ffbb3057fffffffffffffffffffffffffffffffffffffffffffffffffff4dfe5ffb0103dff990033ffc04064ffffffffffd47d96ff990033ff990033ffde9baeffffffffffffffffffffffffffeabfcbff990033ff990033ffcb607effffffffffffffffffffffffffffffffffb6204aff990033ffcb607effffffffffffffffffffffffffffffffffffffffffffffffff202020ff000000ff202020ffffffffffffffffffdfdfdfff000000ff000000ff202020ff000000ff101010ffffffffffffffffffefefefff101010ff000000ff404040ffefefefff000000ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff404040ffffffffffffffffff505050ff000000ff000000ff404040ff9f9f9fffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff606060ff000000ff000000ffefefefffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff202020ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff7f7f7fffffffffff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffafafafff000000ff000000ff9f9f9fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff9f9f9fffefefefff101010ff000000ff000000ff606060ffcfcfcfffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000fffffffffffffffffffffffffffffffffffffffffffffffffffaeff2ff990033ff990033ffcb607effffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffe5afbeff990033ff990033ffe5afbeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffd47d96ff990033ff990033fffaeff2ffd47d96ff990033ff990033fff4dfe5fffffffffffffffffffffffffffaeff2ff990033ff990033ffd47d96ffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ffafafafffffffffff7f7f7fff000000ff101010ffcfcfcfff000000ff000000ff9f9f9fffffffffff9f9f9fff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffefefefff303030ff000000ff000000ff000000ff202020ff9f9f9fffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff505050ffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff404040ff000000ff000000ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffff9f9f9fff101010ff000000ff000000ff000000ff404040ffcfcfcfffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffe5afbeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffeabfcbffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ff000000ff404040ffffffffff202020ff000000ff707070ffffffffff505050ff000000ff303030ffffffffff202020ff000000ff202020ffffffffffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffff9f9f9fff202020ff000000ff000000ff000000ff707070ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff404040ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffdfdfdfff707070ff101010ff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffeabfcbffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff707070ff000000ff000000ffdfdfdfffffffffffafafafff000000ff000000ff7f7f7fff000000ff000000ff9f9f9fffffffffffcfcfcfff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff505050ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff101010ff000000ff000000ffdfdfdfff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff404040ff000000ff202020ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff101010ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ff000000ff707070ffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff101010ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff707070ff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffefefefff7f7f7fff000000ff000000ff303030ffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffefcfd8ff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffde9baeff990033ff990033fff4dfe5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffde9baeff990033ff990033ffefcfd8ffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff000000ff000000ff404040ffffffffffffffffffffffffff202020ff000000ff000000ff000000ff202020ffffffffffffffffffffffffff101010ff000000ff202020ffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff404040ffffffffffffffffffefefefffdfdfdfffffffffffffffffffffffffffafafafff000000ff000000ffbfbfbfff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff8f8f8fff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff505050ff000000ff101010ffefefefffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffcfcfcfff202020ff000000ff202020ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffcfcfcfffffffffffdfdfdfffffffffffffffffffffffffffffffffff606060ff000000ff000000ffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb6204aff990033ffb6204affffffffffffffffffffffffffffffffffffffffffffffffffffffffffe5afbefff4dfe5ff990033ff990033ffd47d96ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffc04064ff990033ffb6204affffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ffafafafffffffffffffffffffffffffff8f8f8fff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffff707070ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff505050ff000000ff000000ff404040ffffffffff8f8f8fff101010ff404040ffffffffffffffffffffffffffafafafff000000ff000000ffbfbfbfff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffdfdfdfff000000ff000000ff202020ffefefefffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffbfbfbfff000000ff000000ff505050ffefefefffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff202020ffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff101010ffdfdfdfffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff202020ffffffffff9f9f9fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff404040ffefefefff505050ff000000ff8f8f8fffffffffffffffffffffffffff606060ff000000ff101010ffffffffff7f7f7fff000000ff000000fffffffffffffffffffffffffffaeff2ffeabfcbffffffffffffffffffd47d96ff990033ff990033ffcb607effffffffffffffffffffffffffffffffffffffffffeabfcbffb0103dffffffffffc04064ff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffffcb607eff990033ff990033ffd47d96ffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff202020ffffffffffffffffffffffffffffffffffefefefff101010ff000000ff101010ffefefefffffffffffffffffffffffffffefefefff101010ff000000ff000000ff505050ffafafafffbfbfbfff9f9f9fff202020ff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff505050ffbfbfbfff9f9f9fff101010ff000000ff101010ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffff707070ff000000ff000000ff101010ff8f8f8fffbfbfbfffbfbfbfff606060ff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffff606060ff000000ff000000ff202020ff8f8f8fffbfbfbfffbfbfbfff707070ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff000000ff101010ff7f7f7fffbfbfbfffbfbfbfff707070ff000000ff000000ff000000ffafafafffffffffffffffffff404040ff000000ff000000ff303030ff9f9f9fffbfbfbfffafafafff606060ff000000ff000000ff101010ffcfcfcfffffffffff202020ff000000ff000000ff7f7f7fffbfbfbfff7f7f7fff000000ff000000ff606060ffffffffff7f7f7fff000000ff000000fffffffffffffffffff4dfe5ffb0103dff990033ffc04064ffffffffffffffffffbb3057ff990033ff990033ffc04064ffde9baeffeabfcbffe5afbeffcb607eff990033ff990033fffffffffff4dfe5ffb0103dff990033ff990033ffcb607effe5afbeffeabfcbffde9baeffc04064ff990033ff990033ffbb3057ffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff000000ff000000ff000000ff000000ff000000ff101010ff505050ff000000ff404040ffffffffffefefefff303030ff000000ff000000ff000000ff000000ff000000ff000000ff9f9f9fffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffff606060ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff404040ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffff606060ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff101010ffafafafffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff404040ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffefefefff505050ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff101010ffcfcfcfffffffffffffffffffcfcfcfff101010ff000000ff000000ff000000ff000000ff000000ff101010ffdfdfdfffffffffff7f7f7fff000000ff000000ffffffffffffffffffeabfcbff990033ff990033ff990033fffffffffffffffffffaeff2ffc04064ff990033ff990033ff990033ff990033ff990033ff990033ff990033ffb0103dffffffffffffffffffefcfd8ffb6204aff990033ff990033ff990033ff990033ff990033ff990033ff990033ffc04064fffaeff2ffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ffefefefffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffefefefff707070ff202020ff000000ff000000ff202020ff707070ffefefefff9f9f9fff404040ff707070ffffffffffffffffffefefefff7f7f7fff202020ff000000ff000000ff303030ffbfbfbfffffffffffffffffff707070ff404040ff707070ffffffffffffffffffffffffffffffffffffffffff707070ff404040ff707070ffffffffff9f9f9fff404040ff404040ffffffffffffffffff9f9f9fff404040ff707070ffffffffffffffffffffffffffffffffffffffffff9f9f9fff404040ff404040ffffffffffffffffffffffffffffffffff9f9f9fff404040ff000000ff000000ff000000ff505050ffbfbfbfffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffff404040ff404040ff9f9f9fffffffffffffffffffffffffffffffffffbfbfbfff505050ff101010ff000000ff000000ff202020ff707070ffdfdfdfffffffffffffffffffffffffffffffffff404040ff404040ff9f9f9fffffffffffffffffffffffffffffffffffffffffff707070ff404040ff9f9f9fffffffffff7f7f7fff000000ff000000ffffffffff9f9f9fff303030ff000000ff000000ff101010ff505050ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff505050ff000000ff000000ff000000ff303030ff7f7f7fffefefefffffffffffffffffffffffffffffffffffcfcfcfff505050ff000000ff000000ff101010ff606060ffdfdfdfffffffffffffffffff9f9f9fff404040ff404040fffffffffffffffffffaeff2ffbb3057ff990033ffd47d96ffffffffffffffffffffffffffffffffffde9baeffc04064ff990033ff990033ff990033ffbb3057ffd47d96fffaeff2fffffffffffffffffffffffffffaeff2ffde9baeffbb3057ff990033ff990033ff990033ffc55071ffde9baeffffffffffffffffffffffffffffffffffde9baeffc04064ffc04064ffffffffffffffffffffffffffffffffffffffffffc04064ffc04064ffefcfd8ffffffffffffffffffffffffffffffffffd47d96ffc04064ffd47d96ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfffbfbfbfffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff101010ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff101010ffcfcfcfffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff505050ff7f7f7fff7f7f7fff303030ff000000ff000000ff101010ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff101010ff000000ff000000ff000000ff000000ff000000ff000000ff303030ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff8f8f8fff505050ff404040ff404040ff606060ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff404040ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000700ae00700007000100010003000300040000000d000c001000d800d800d800d800280018003610517569636b54696d65aa20616e6420610000280024003f0d206465636f6d70726573736f7200280030000f1f617265206e656564656420746f20736565207468697320706963747572652e000000a100e007ac00000000000007a86170706c022000006d6e74725247422058595a2007d900020019000b001a000b616373704150504c000000006170706c000000000000000000000000000000000000f6d6000100000000d32d6170706c00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000b64657363000001080000006f6473636d000001780000056c63707274000006e400000038777470740000071c000000147258595a00000730000000146758595a00000744000000146258595a0000075800000014725452430000076c0000000e636861640000077c0000002c625452430000076c0000000e675452430000076c0000000e64657363000000000000001447656e65726963205247422050726f66696c6500000000000000000000001447656e65726963205247422050726f66696c6500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000006d6c7563000000000000001e0000000c736b534b00000028000001786872485200000028000001a06361455300000024000001c87074425200000026000001ec756b55410000002a0000021266724655000000280000023c7a685457000000160000026469744954000000280000027a6e624e4f00000026000002a26b6f4b5200000016000002c86373435a00000022000002de6865494c0000001e00000300646544450000002c0000031e68754855000000280000034a7376534500000026000002a27a68434e00000016000003726a614a500000001a00000388726f524f00000024000003a2656c475200000022000003c67074504f00000026000003e86e6c4e4c000000280000040e6573455300000026000003e874685448000000240000043674725452000000220000045a66694649000000280000047c706c504c0000002c000004a47275525500000022000004d06172454700000026000004f2656e555300000026000005186461444b0000002e0000053e005601610065006f006200650063006e00fd0020005200470042002000700072006f00660069006c00470065006e006500720069010d006b00690020005200470042002000700072006f00660069006c00500065007200660069006c0020005200470042002000670065006e00e800720069006300500065007200660069006c0020005200470042002000470065006e00e9007200690063006f0417043004330430043b044c043d043804390020043f0440043e044404300439043b002000520047004200500072006f00660069006c0020006700e9006e00e9007200690071007500650020005200560042901a75280020005200470042002082725f6963cf8ff000500072006f00660069006c006f0020005200470042002000670065006e0065007200690063006f00470065006e0065007200690073006b0020005200470042002d00700072006f00660069006cc77cbc1800200052004700420020d504b85cd30cc77c004f006200650063006e00fd0020005200470042002000700072006f00660069006c05e405e805d505e405d905dc0020005200470042002005db05dc05dc05d90041006c006c00670065006d00650069006e006500730020005200470042002d00500072006f00660069006c00c1006c00740061006c00e1006e006f00730020005200470042002000700072006f00660069006c666e901a0020005200470042002063cf8ff065874ef64e00822c0020005200470042002030d730ed30d530a130a430eb00500072006f00660069006c0020005200470042002000670065006e0065007200690063039303b503bd03b903ba03cc002003c003c103bf03c603af03bb002000520047004200500065007200660069006c0020005200470042002000670065006e00e9007200690063006f0041006c00670065006d00650065006e0020005200470042002d00700072006f006600690065006c0e420e1b0e230e440e1f0e250e4c002000520047004200200e170e310e480e270e440e1b00470065006e0065006c0020005200470042002000500072006f00660069006c00690059006c00650069006e0065006e0020005200470042002d00700072006f006600690069006c00690055006e006900770065007200730061006c006e0079002000700072006f00660069006c0020005200470042041e04310449043804390020043f0440043e04440438043b044c00200052004700420645064406410020062a06390631064a0641002000520047004200200627064406390627064500470065006e00650072006900630020005200470042002000500072006f00660069006c006500470065006e006500720065006c0020005200470042002d006200650073006b0072006900760065006c007300657465787400000000436f707972696768742032303037204170706c6520496e632e2c20616c6c207269676874732072657365727665642e0058595a20000000000000f35200010000000116cf58595a20000000000000744d00003dee000003d058595a200000000000005a750000ac730000173458595a20000000000000281a0000159f0000b83663757276000000000000000101cd0000736633320000000000010c42000005defffff326000007920000fd91fffffba2fffffda3000003dc0000c06c00a100e000040000000200ff}}}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par The Washington Post\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 March}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  7, 2001 Wednesday  \par Final Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Poverty, Prejudice Hinder India's AIDS Fight; \par Drug Maker Fears 'Another Africa'}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Pamela Constable, Washington Post Foreign Service\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 A SECTION; Pg. A01\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1839 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 BOMBAY \par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  In a garbage-strewn alley in the city's red-light district, a 24-year-old prostitute slumps on a string bed, weak from tuberculosis and diarrhea. She knows she has AIDS, but she has never heard of the multidrug "cocktail" that curbs the progress of the disease. Even if she had, she could never afford to buy it. \par  "Nobody wants the girls once they get sick," explains Manju, a health counselor who visits the alley each week. She says prostitutes with AIDS are shunned by many hospital doctors, brothel operators and their own families. "We feel so helpless; all we can do is comfort them and find them a place where they can go to die." \par  In a corporate office a few blocks away, Yusuf Hamied, a 65-year-old drug company owner, is embroiled in an international battle to bring down the prices of anti-AIDS drugs. In December, he infuriated Western pharmaceutical firms by offering copies of their patented drugs to Third World governments at sharply r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 duced prices; in February he offered the drugs that make up the AIDS cocktail for a mere $ 350 per patient per year -- compared with $ 10,000 to $ 15,000 in the West -- to a doctors' charity that works with AIDS p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tients in Africa.  \par  "We are called pirates, but who is being pirated? Patients in countries where there is a monopoly on these drugs," asserts Hamied, chairman of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Ltd. In India, he says, "AIDS is a foreseen tragedy. In five years we will probably have 35 million HIV-positive people. If we do nothing about it, India will become another A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 rica, and then it will be too late." \par  Fifteen years after the first case of AIDS was reported in India, the country now has the second-largest number of HIV-infected people in the world, ranking just below South Africa. The government estimates there are 3.5 million HIV-positive Indians; the World Health Organization puts the figure at 4 million.  \par  According to various estimates, between 100,000 and 300,000 people are dying each year in India of AIDS-related illnesses. Although the nationwide rate of HIV infection remains less than 1 percent, doctors and health experts here say that, in a country of 1 billion people, the sheer volume of cases makes India's AIDS problem costly and potentially devastating. \par  The Indian government and international agencies have made intensive efforts -- especially in major cities, where most cases have been reported -- to promote awareness of AIDS and control the spread of the human immunodeficiency virus (HIV), which causes AIDS. Yet the disease remains widely misunderstood in India, because of a combination of cultural taboos and lack of education. \par  Most people in rural areas, where an estimated 73 percent of Indians live, still know little about the disease, and most urban residents with AIDS are afraid to be identified because the disease is associated with sexual behavior, contagion and death. There is no national lobby of AIDS patients, and only one well-known Indian, a 35-year-old Madras musician named Ashok Pillai, has publicly declared he is HIV-positive. \par  Moreover, while antibiotics and other medicines that control the infections that result from AIDS are ine}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 pensive and widely available in India, far less attention has been paid to helping people with HIV avoid d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 veloping the disease. Government health policies stress prevention over treatment, and only a tiny portion of patients receive the antiretroviral medicines that can prevent HIV from multiplying in the blood and causing AIDS.  \par  Thus, although }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  decision to offer low-cost antiretrovirals has unleashed an international debate on the patent rights of drug manufacturers vs. the need to combat AIDS in underdeveloped countries, it is u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 likely to be of much immediate help to Manju's patients and most other HIV-infected Indians. \par  Bombay, which has a large population of migrant workers, truck drivers and prostitutes and a hidden but active gay community, has become known as the epicenter of India's AIDS problem. More than 7 percent of tested individuals in the Bombay region have been found to be HIV-positive; the rates among tested prost}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tutes and gays are much higher. \par  A number of public and private agencies in Bombay have worked hard, with relative success, to combat the spread of HIV among these vulnerable populations. One group provides free condoms and medical chec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ups from a van at a central truck stop; another sends counselors regularly to the red-light district; a third o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 fers gays private HIV testing and information.  \par  "Our customers are as afraid of AIDS as we are. We insist on condoms now, and our business has fallen to less than half," said Shanti, 35, a prostitute who has spent the last 16 years in a second-floor Bombay brot}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 el. "This is my life now, and I know it is my fate to die in it, but at least this fear is preventing younger girls from coming into the life." \par  But doctors and activists here said this new awareness has largely failed to translate into effective medical treatment. While affluent AIDS patients can obtain antiretroviral drugs privately, the vast majority of people with AIDS cannot afford them. And even before the easier availability of such medicines can make much di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ference here, those involved contend, both poverty and prejudice must be tackled. \par  "Better access to information and care is just as important as lower drug prices," said I.S. Gilada, a phys}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cian who operates several clinics for HIV testing and AIDS treatment. "Ninety percent of patients still don't know they have it, and there is no patient lobby in India because of the social stigma. Even if you provide these drugs at one-tenth the cost, you will never reach everyone who needs them." \par  Akshay Kolukor, president of the regional branch of the Network for Positive People, an advocacy and self-help organization, said virtually none of the local group's 3,000 HIV-positive members have publicly revealed their condition. Taboos in India against discussing sex are extremely strong, he said, and the AIDS scare has only deepened bias against people with the disease. \par  "People are afraid of losing their jobs, or of being labeled a bad person," he said. "Doctors are still reluctant to treat patients or admit them to hospitals, for fear they will infect others. Most of our members have spent all their own money on their illness by the time they come to us for help, and less than 1 percent of them could afford antiretroviral drugs in any case." \par  A handful of doctors and lawyers here have been pressing for cheaper AIDS drugs. In interviews last week, they praised Hamied for bringing down his prices and criticized Western drug companies for attempting to maintain tight control of their patents and keeping prices of antiretrovirals exorbitantly expensive. \par  At the same time, they warned that antiretrovirals, which have harmful side effects, must be monitored with extra care before they are widely introduced to a transient patient population that knows little about them and is often afraid to seek treatment. \par  In the West, a triple-drug cocktail to retard the progress of AIDS can cost $ 10,000 to $ 15,000 a year. Until recently, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  charged $ 1,800 for a year's supply of one such cocktail's three components -- stavudine, lamivudine and nevirapine -- which it markets under different names. Hamied has now offered them at $ 800 per year to the Indian government, $ 600 to underdeveloped countries and $ 350 to Doctors Without Bo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ders, which works in AIDS-ravaged countries in Africa, where the disease is rampant.  \par  Hamied's actions have angered major drug companies that pioneered the development of antiretrovirals, including Britain's GlaxoSmithKline and Bristol-Myers Squibb in the United States. They have accused }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  of stealing their inventions through loopholes in India's patent laws and of undercutting the prices they say they must charge to finance research.  \par  }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  motives, its foreign rivals say, are based less on altruism than on a desire to capture the growing market for anti-AIDS drugs in India and other impoverished countries. Hamied, in turn, asserts that the mult}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 national manufacturers are using research costs as a ploy to protect their already substantial profits. \par  "The name of the game is monopoly," Hamied said. "If these companies spend 'x' on research, they spent '9x' on protecting their monopoly. I have broken no laws, and I am not a threat to anyone. There is room for a hundred }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Ciplas}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 . I am not against patents and I am willing to pay royalties, but a country like India, with a bi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lion people, simply cannot afford a monopoly on these drugs." \par  However, most needy governments cannot take advantage of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offer because they have signed agreements with the World Trade Organization that protect drug patents and manufacturing processes. One exception is Brazil, where laws allow patent-breaking in health emergencies; the government there has pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 vided free AIDS drugs for five years and has already cut the AIDS death rate in half. \par  India, which protects only drug-making processes and allows domestic companies to copy foreign med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cines, will become subject to the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  rules in 2005. But even today, with }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  providing AIDS cocktails at a far lower price than imports, critics say the Indian government has been slow to recognize the need to make them available. \par  "The government thinks these drugs are too costly, and there is no huge public demand. It is very shor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 sighted," said Bitra George, a physician who treats venereal diseases and AIDS in New Delhi. "There is a three-tiered war going on here: an international war over pharmaceutical prices, a national war over drug and health policies, and a grass-roots war over information and attitudes about AIDS." \par  At the Dahaiser Check Post, a vast truck stop on the outskirts of Bombay, the grass-roots war is in full swing. One morning last week, health workers fanned out among dozens of cargo trucks, offering drivers bags of condoms and brochures on AIDS. A mobile van broadcast Hindi pop tunes mingled with cautionary soap-opera stories about AIDS.  \par  But many drivers were too embarrassed to take the proffered packets, mumbling excuses or shaking their heads. Most said they knew about AIDS but did not think they needed to worry about it, although sexual co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tact between drivers and prostitutes is a major channel for the spread of HIV between Bombay and rural ar}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 as. \par  One man politely refused the packet, but then soberly described how a woman in his village had gotten AIDS from her husband and was now very sick. Instead of getting medical help, he said, she had been shunned by her frightened family and neighbors and was being kept in an isolated hut, awaiting death.  \par  "People listen to all these warnings and they get scared, but tomorrow when they are on the road again, alone in the night and maybe drinking, the devils will rise up again and they will look for a woman," said a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 other veteran driver who identified himself as Nana. "You might carry an umbrella, but when that sudden shower comes, you don't think about death." \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV (95%); PHARMACEUTICALS INDUSTRY (91%); AIDS & HIV TREATMENT (90%); DISEASES & DISORDERS (89%); INFECTIOUS DISEASE (89%); PUBLIC HEALTH ADMINISTRATION (78%); PROSTITUTION (78%); DISEASE REPORTING (77%); TUBERCULOSIS (77%); HEALTH D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PARTMENTS (76%); ANTIVIRALS (73%); PRICE CHANGES (73%); POVERTY & HOMELESSNESS (72%); INTELLECTUAL PROPERTY LAW (72%); PHARMACEUTICAL PREPARATION MFG (72%); V}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 RUSES (71%); HOSPITALS (70%); UNITED NATIONS INSTITUTIONS (50%); RURAL COMMUNITIES (50%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  LTD (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (84%); SIC2834 PHARMACEUTICAL PREPARATIONS (84%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MUMBAI, INDIA (54%) INDIA (95%); AFRICA (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 April 2, 2002\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 The Washington Post\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Kenya;Why Not Take Up Offer Of Cheaper Aids Drugs?  Africa News February 24, 2001 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_78}{\*\bkmkstart DOC_ID_78_0}{\*\bkmkstart doc_id_35}{\*\bkmkend DOC_ID_78}{\*\bkmkend DOC_ID_78_0}{\*\bkmkend doc_id_35}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_35"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330035000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 35 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 February}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  24, 2001\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Kenya;\par Why Not Take Up Offer Of Cheaper Aids Drugs?}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Daily Nation\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NEWS, DOCUMENTS & COMMENTARY\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 983 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The offer last week by an Indian company, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 , to supply cheap Aids drugs to developing countries, inclu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing Kenya, at near rock-bottom prices, has suddenly thrust the issue of access to such drugs into sharp f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cus.\par Just last Wednesday, members of the Kenya Coalition of NGOs on Access to Medicines held an internatio}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 al Press conference, in which it reaffirmed its commitment to lobby Government to allow the importation of cheap generic alternatives.\par The excitement generated by the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offer is understandable in a country where at least 14 per cent of the population, or more than 2.2 million people, are infected with HIV.\par Aids drugs like Zidovudine (AZT), Zerit (d4T) and Indinavir have been way out of reach for the majority of people with HIV, with the effective three-drug combination costing anything between Sh800,000 to Sh1.6 million a year. In Western countries, this cost has been met by the State, easing access for the sufferers. \par But in poor developing countries like Kenya, only the rich have had access. Today, only an estimated 1,000 Kenyans, for example, use the drugs on a regular basis. The rest can't afford them.\par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offer changes the equation of cost and access dramatically, and opens the possibility of thousands more being able to afford the life- saving medications.\par The company says it is willing to supply generic versions of the drugs, which are scientifically known as anti-retrovirals, to governments at just Sh48,000 for a year's course. The company is also willing to supply the drugs to the international humanitarian agency, Medicins sans Frontieres, at just Sh28,000, provided the agency uses them to treat the poor for free.\par What is most significant about }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offer is that it is far more attractive to poor countries than that made by UNAids and five Western multinationals last May, in which they offered to reduce the prices of anti-retrovirals by 85 per cent.\par Critics of the offer by the five companies - Boehringer Ingelheim, Bristol Meyers-Squibb, Glaxo Wellcome (now known as GlaxoSmithkline), Merck and F. Hoffman-La Roche - have dismissed it as a public relations gimmick, pointing out that eight months after the offer, the companies have not moved to effect the redu}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tions.\par The possibility of the offer having been a public relations gimmick by the drug companies is not far-fetched. According to the current issue of The EastAfrican, a senior executive of one of the five multinationals last May conceded to the British Secretary of State for International Development, Ms Clare Short, "that little of practical value would emerge from the UN- industry announcement".\par In Kenya, the offer by the five has been mostly met with scepticism from doctors and humanitarian agencies. Though the companies are reported to have started negotiations with the Government last month, little is known of just how far these talks have gone, or what has been achieved so far.\par Further, only two - Glaxo Wellcome and Boehringer-Ingelheim - have actually moved to reduce drug prices. Glaxo has reduced the prices of AZT, 3TC and Combivir by between 20 and 50 per cent, while Boehringer has reduced the price of nevirapine by 80 per cent.\par In their own defence, pharmaceutical multinationals say that though they are, in principle, not opposed to price reductions, they are worried by the spectre of a situation where patent rights as envisaged by the World Trade Organisation (}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ) are not recognised, making it difficult for companies which have invested millions of dollars in research and development to recoup their investments.\par The companies are also concerned about the possibility of a domino effect in pricing, in which reductions in drug prices in one region, such as Africa where more than 70 per cent of the globe's HIV cases are found, could lead to agitation for reduction in other regions. The possibility of "reverse leakage", in which lower priced drugs meant for Africa leak back to the West, thus destabilising the market, is real, they say.\par Lastly, the companies say, providing anti-retrovirals to countries like Kenya without strengthening delivery and regulatory mechanisms would lead to the emergence of drug resistance.\par Amidst the acrimony and rising death toll from Aids, what no side disputes is that something needs to be done to stem the tide of devastation.\par Two mechanisms allowed for in the World Trade Organisation's Treaty on Intellectual Property Rights (Trips) offer a window of opportunity to reconcile the positions of Western pharmaceuticals with the need to address the humanitarian crisis now unfolding in developing countries due to Aids.\par The first, known as compulsory licensing, enables a government to circumvent patent rights during a medical emergency, enabling licences to be granted to local manufacturers to produce patented medicines for local use. The patent-holder must also be, nominally, compensated.\par The second, called parallel licensing, empowers a government facing a medical crisis to shop around for the cheapest drugs, thus ensuring that as much medicine as possible is obtained at the cheapest price possible. This mechanism would, for instance, enable Kenya to take up the offer made by }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  without any fear of litigation.\par Unfortunately, as the Minister for Public Health, Prof Sam Ongeri, conceded last Wednesday, Kenya's legi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lation does not allow the country to take full advantage of these mechanisms.\par Luckily, Kenya is currently re-drafting its intellectual property laws to become compliant with }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  requir}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ments. As this is done, a good starting point in making Aids drugs available at affordable prices to Kenyans infected with HIV would be to enact legislation which allows for the full utilisation of both the parallel licensing and compulsory licensing mechanisms.\par Dagi Kimani is the health correspondent for The EastAfrican.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV TREATMENT (92%); ANTIVIRALS (90%); AIDS & HIV (90%); DEVELOPING COUNTRIES (90%); PHARMACEUTICALS INDUSTRY (89%); GENERIC PRODUCTS (78%); NONGO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 V}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ERNMENTAL ORGANIZATIONS (78%); GENERIC DRUGS (78%); IMPORT TRADE (78%); TALKS & MEETINGS (78%); RELIEF ORGANIZATIONS (77%); MULTINATIONAL CORPORATIONS (76%); INTE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NATIONAL ECONOMIC DEVELOPMENT (73%); PRESS CONFERENCES (71%); LOBBYING (71%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (91%); GSK (NYSE) (74%); GSK (LSE) (74%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (91%); SIC2834 PHARMACEUTICAL PREPARATIONS (91%); SIC2834 PHARMACEUTICAL PREPARATIONS  (74%); SIC5122 DRUGS, DRUG PROPRIETARIES, & DRUGGISTS' SUNDRIES (52%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 KENYA (95%); UNITED KINGDOM (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  LTD (91%); GLAXOSMITHKLINE PLC  (74%); GLAXOSMITHKLINE PLC (74%); BOEHRINGER INGELHEIM GMBH  (52%); HOFFMANN-LA ROCHE INC (52%); BOEHRINGER INGE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HEIM GMBH (52%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 February 23, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 English\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 AllAfrica, Inc\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Kenya;Aids: Drug Firms Making A Killing  Africa News February 23, 2001 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_79}{\*\bkmkstart DOC_ID_79_0}{\*\bkmkstart doc_id_36}{\*\bkmkend DOC_ID_79}{\*\bkmkend DOC_ID_79_0}{\*\bkmkend doc_id_36}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_36"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330036000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 36 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 February}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  23, 2001\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Kenya;\par Aids: Drug Firms Making A Killing}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Daily Nation\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NEWS, DOCUMENTS & COMMENTARY\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 402 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The outrage by NGOs over the Government's reluctance to push for cheap anti-HIV/Aids drugs is unde}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 standable. It brings to the fore the subtle but dangerous commercial games being played on Third World countries by multinational pharmaceutical firms.\par It also questions the ethical standards that guide the firms. For, although they have to do business, they rea}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ly cannot be allowed to endanger the lives of millions of people, especially in the geopolitical South, by vet}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing cheaper options from Asia to sell their own very expensive anti-Aids drugs. \par The facts are clear. Local NGOs are pushing the Government to step up campaigns at the international level, particularly through the World Trade Organisation, to allow countries to buy affordable generic drugs so long as such drugs can halt or reverse HIV infection.\par It is morally indefensible for Third World countries, which lack resources for basic necessities, to be co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 pelled to buy expensive Aids-control drugs because international protocols so demand.\par The Kenyan Government, for instance, has never come out clearly on the issue of free access to, and use of, the cheaper generic drugs that reverse infections and ensure a longer life for many people living with Aids.\par Apparently, the Government is observing to the letter the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  proviso that gives some multinational pha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 maceuticals the monopoly of selling exorbitantly expensive drugs, like Fluconazole, which treats opportuni}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tic diseases like meningitis that kill many Aids sufferers.\par While the drug retails at $10.56 (Sh792) a pill, a generic version developed by }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  an Indian firm, sells at $0.64 (less than Sh10) a pill.\par In South Africa, the situation is different. The Government there has defied international cartels and allowed the importation of the cheaper drugs to make treatment easier. Indeed, the international pharmaceutical heavyweights have taken the matter to court seeking redress. The ruling is set for next month.\par Whatever it takes, our Government has to put up a spirited fight for the welfare of Kenyans. It has to make a strong case at international forums, the way South Africa has done, about making it cheaper and easier for Kenyans to access Aids-control drugs.\par The multinationals, which represent the interests of their home countries, must not be allowed to play cold-blooded games with the lives of millions of poverty-stricken people.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV TREATMENT (91%); PHARMACEUTICALS INDUSTRY (91%); NONGOVER}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MENTAL ORGANIZATIONS (90%); GENERIC DRUGS (90%); ANTIVIRALS (90%); AIDS & HIV (90%); GENERIC PRODUCTS (89%); PRESCRIPTION DRUGS (89%); MULTINATIONAL CORPORATIONS (89%); DISEASES & DISORDERS (78%); PHARMACEUTICAL PREPARATION MFG (77%); POOR POP}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 U}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 LATION (76%); INTERNATIONAL TRADE (74%); POVERTY & HOMELESSNESS (72%); ETHICS (72%); MENINGITIS (68%); INTERNATIONAL ECONOMIC ORGANIZATIONS (68%); CARTELS (65%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (58%); SIC2834 PHARMACEUTICAL PREPARATIONS (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD TRADE ORGANIZATION  (83%); WORLD TRADE ORGANIZATION (83%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 KENYA (94%); SOUTH AFRICA (92%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  LTD (58%);   WORLD TRADE ORGANIZATION  (83%); WORLD TRADE ORGANIZ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TION (83%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 February 23, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 English\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 AllAfrica, Inc\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Kenyan Orphanage Takes Initiative on AIDS Drugs The Washington Post February 22, 2001 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_80}{\*\bkmkstart DOC_ID_80_0}{\*\bkmkstart doc_id_37}{\*\bkmkend DOC_ID_80}{\*\bkmkend DOC_ID_80_0}{\*\bkmkend doc_id_37}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_37"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330037000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 37 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\shppict{\pict{\*\picprop\shplid1027{\sp{\sn shapeType}{\sv 75}}{\sp{\sn fFlipH}{\sv 0}}{\sp{\sn fFlipV}{\sv 0}}{\sp{\sn fLine}{\sv 0}}{\sp{\sn fLayoutInCell}{\sv 1}}}\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw7620\pich2540\picwgoal4320\pichgoal1440\pngblip\bliptag657880520 89504e470d0a1a0a0000000d49484452000000d8000000480803000000a398cb9c00000300504c5445ffffff000000404040bfbfbf7f7f7fccccccefefef9900331010103030309f9f9f606060cfcfcfdfdfdf2020208f8f8f505050707070afafafd47d96c04064eabfcbde9baefaeff2b0103df4dfe5e5afbecb607ebb3057c55071b6204aefcfd8000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000335c3c3e00000c254944415478daed1b8972dbb6720192004f9152e2a449dad7ffffacccbc695ed234b12d89120f106f770152b41cc94ae31ef1043316491c8b5dec89050cf0a33cf1a256df079ef22bfb87f1fe49b22b11e99394432944004f5014950588bf335ea4615516ee35470a965fec54082c288b2af40aa7ce2ec30148faa000e797ac6b78f779a2aceeea0e958c485b49fc94274551c4f4c8e82b13893aa78f13903c7e4835b3f02205c76953ff3c594a798430972443a471e409c202ea83040951297e9ca66c06a488b1e7592f9189f012ba683ec94f7972ded44fcbbf811dabf7b5857d74d2a21bc6827e6f82654dfd4fda92ec00a41148dce61c5df505821844349f81889ef69404a4bbb13b7f75a9296dd4bba6061117f6cbe31045888cc29e3dc4921f274a7b0062642cc5ee0cce08440e0f1166878c61862d4ddfda934befa665c2cc629db6619dc79d28fa86b0175689d07819580c664e586b244d31ec67c8e451dc4e3ebc68208d3b06e28626a12486e5ccc57498702ad29046e5d837192457171e5011091c9946dd813043efdab4c6da117bb59838b48a0713c81c173bb632f2085728e429a40b7452d2691c49b2d79f60210ee68d75cce964307da1c2a24d0980fb176c87166a02a2c876641889a905a9464a76b5f0b88818df5905517d585cb06ae5142ae1bea5ef3b5a02320da4e9ac4239ce157a0bcc30726704e3c2732c8a6aa1827d8beb402b81c8c6720fbda2d50b871635c9ce38e61fd8d37fa9e216b96e338122921a56c4be9f80e8c034d0454604a8492adb62a34cf6b4dabb064c2f454be25c74ba05150f58b50f9301d5bccf0cf2ae91d24bbbd2c4cb0e2c48cfb1b26b90917261863c22fd8120dd6a037a88b6a328b690ec07eeee09eb15f2bd4fd7ca0e258ed60ef8b2812f101684db25a949278c2a36c6561d54f50148dc936c0dade52f1162cf6267d0716d169ae0c57b8b7d0de290234225926ca3c44a03ad6251174eac0abb6f79e691305c4eb3b4d8a88c685a94f024687716870c4337e371c10c3e882249177ea29404c45e6678ee5cc29128e6fc5e7183831190101f801490d0bb725f289024476e54e6c0f909f8b1724356ec21aa51d65173dde4c1248a214fced078a08af311f7d1782824bbf1ebe039266ccf9f64640cc921fd1db47ece3163c7eee0604469d864ed01c81e06078abf7ab62a7e94b523383244fcd8091e4256aff550dde2ab226ae71c6363d332341e882c95d6e1ce0b317aa7d3c56475e03dc17e78d8dfe4fd1aa086c72e2afe742eaed5d9cdd1fe6ab4bceb036647588581d7dfa431e2610c6eff9a60b63ebf56f75ac3794ce1e83a8a6e3259fbc6f5652808d5fc03517c1cadef6d5bd291c082deeaa3e0a7be6e2f868e56021643fb771325842e77f5fdfdd85ae35fb6d08b5b243ab4473bae0571711e73fa302d56b30f5f3643256efe7e6e0d99aabfb8d124a75fef424429b7461c730c370a72be5dda658a3eeb00294bb733bfadd055f72776141a238872fe41f1ca9d76450b358c2b386b536abefbb322d3f77671dbb03d06e5220f7282a64b068d91974cc8bfa56c8f537c357d26ec68114232a55d04e83fd1fff641431134ce96917d89f27013ec658615417c006221eea1af5ad5e2a0a423cf9df51471efd36ef21e5d35b05b513810a3d48222092dc91d2432e37830e98c73321d0e8d3590a797180f17611bda16fd97f51ea84fa4191cc7d6ce90ee2de219384b11393a7292cb5a4c8cee39a20bb621d5ef138a22142b26ce040dc63bb5311ba5bd19f5cbb82460379227199817b5b6c4b39d3ac8f68dd00902ddf773252535d88b4fced5ccb5c16c1285809a9d2df79bdc5863861007a2c4d10879d873ac62bfd30c79af865b54174460704781e8dc4dc5ecda69bb974edb447cc5fa2a8fab6cc19bd03b400a17f952178a49305e4dd54a615491a4dcbe1a27a1ba8513afc205e1e9340b6e9b29040a160b8a9cc7d09b86a924596253420383bc1477f7d7aa94386de642e974c9718b330fe551fe23afdc3a2f0f76a34c5d7d482bb1f4ebb09a0349b9b2c8d42c0322134581fd629c912165a392a96c36906c55ee0239a9b249e173d6fd55c900c68141f54076475cb05d7f30457406484ebc41c65f98f62a7c842abf1125158be5238441a781a8380890c1abaf58beaf22ec44ce2208e3ee9be3bd734054d060081c674d7ef934e4548a5339814bd75a3d46dc7a06482512cee57d4dc61c076489847f75099605edec931cbe8ab0eca164e9bfe58ce3ebe4422ee169961c7e14dac8ff58831fe547f9171529e4f782e99365c10fc2eefbcbb07c9a3a36db433f2d8e456366e4246cf90884a7f2cfa1f80dc1f22092ddd90e161e2175fa8dfbafbfc4dc3f4672814e8bbe5d14d5d33106248a01241bbf5d9ff2055853a09c65c3baa8a955852d587f3691a280c55857d460809a030153e3ea1660f14919846106d09606531d427290d386b2b6c9da8d27b8d3d879479e1e7be5b6c641c128d3af29f319bca3d797344cff46afaf7af8fd054e29dec3d580ccfadde511a4859c81a5bb25e726f32da4dbe5b5a7d1880149e6f3fe2df68d813397490da1412d0a8d48386bc1c9ee5c32a058dda228b883d621372ed599767c6e573ac471261cbfacf9604670867ad53b92f8306ec52d49edee124847faebf0bd73347f003c8b3e331c89a43ddbc0f38f446b177ea0caf203277370ac4bb326ade667d4814e6f28c31df45619ca51ef40146d977602fabea0e4725fb43c27fe743a6fb5e9025c9fbe066cd54de38e1e09e76cdb739de914a227a069633a85b7d2e0d0bde126a0a674dd424cf72c2ce5c86da3076d82c425c1dd21e58bcf5bb84a917bba8637d77b28aab4deef9e6d4986eae522adb7f11f58b985e6c5c65b04ce6a52da9612a68510552a4442ef41cc67ba319df1ca50713e05c0dd5360b50eddb5a39ceb173ea19b8d47d47432ecef37605dc5c7ccd4a3a403e6501cba670421e673e38a86212e39e48bd5dc785c69fdd315f1e597e7f042ebe7aff0fdd79fb5be82675affe725c02f5aeb5fb9df0baf346e024267e9ec5090f80c2ecd20099f6a4a1471fd02511909cb5dd649d2817838f96e4f5838dd70ac68d97ce257f9a6f00035f380dc3a07d3e5ab0361bf30dacc3af849ffec5e5ffda49f13612f1ce56fa8ee3ff420ab58172436a8cb05ecf8d29c40954a9cbe1a4ed49670333a5bc1f51b38b8b08dfbb1d04c46f660a1d3f13a039d99eec01f9db6776d32ae5a5843ba19073761a0e1737637c7f1f2033c7feb5e3fbcfe0cfe34fc5d07eb97e0f2a3088d55a99e30e961bdc259f5004d0a61c3b88c07472ce4750c76b7484fa6315dd979aae769d8f5e450d63167639ad9a0b1fb27c6683cf6c2c9db566aa8b7778ee5067775810b02f9edb036442319caf7f38979da5ac335ae6db229c9ce4171ef1a41bb438d5bef2e4e7f355fae3c7fee7ee728b48e2a0d767b3751dd3d38b13d72d068a5966bfc95b00fe9991c725dfe59df26487d716182ecb032fa70174ac1f16e600c080a3ec1cc0fb56888d69f87e04ec890ce84035b5e1d04263d1d7948629958c3a7827d2e6cf448bbe27554051fd93e707d0399ea57f87082128fa77be899ef31b249471986ae98567ba085c109db3e85d969dfdb9713d8d7c1414d0778f9f634617c4fabf2b24fef09acc3719de836eaf6a2a81897da1d6ad5331d6b52aecb075ab1e311ccce1ce9d8a09ebb03bb00bd5d5b6d4acf706f39d0ce6fe1fd1b67f78777056c9c497fb386edb9e89e42288a3a76bae10b615bdd984adee89019b63550add12beafdd91078bdbc5eeb7203f18c0093d53705425f5cc3173068e8509b9a42c018a34e445336384db889e136b4a21e8dc12b7bfbfce31f3ffffef1b9b491c020235a7ebe79633b317c84abff9e236c9db99b2f6d86a1053d73686e4846748c0f19ed6f485e1e8aec3f6735051df5fc82ea36ab2952bac660e6d37d8bda701324d814a63728781827215d3068bea7a7fd8cfd2ddd9ee98ab50bba96ff7bf7ebcbf71f9dfc77e7a37be9df8487b5192a1493a21a5a74dead090aba7e5863c8e044849e8a5ca7f215fc01db44b0e47a6bcece7c2b4b4d90a24f53158de7e740e7e9ba94b4a8ed7542a0e260407fb6a1b4834ea3b5032cafc8b4bcffc837e8afe804fd6d535214f2a2fc4846be7016aae01b38608bf91e2e806317f4d5a508262097fc47c59fdd695d5682630ff00d1bd661baf797f427af4bcf84e52fdd1b3f66fa6d31b9943d68f384f28ae8fd06f6b2a985efe57f7b2ecc28d1bf50846132deeef82775ec7161a7830b2ee26073016106ec77c3335556526697fdb7e39fcd18fe284fb3fc1f6304efb39e95003b0000000049454e44ae426082}}{\nonshppict{\pict\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw216\pich72\picwgoal4320\pichgoal1440\macpict\bliptag657880520 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000004800d8001102ff0c00fffe0000004800000048000000000000004800d800000000001e0001000a00000000004800d882000000f39a0000000100000000000000000000000000000001000000000000000000000000000040000000000000000000000000000000000000000000004800d8000003000000000000000056726177200000000000000000000000006170706c000004000000040000d8004800480000004800000000f300000100000000000000000000000000000000000000000000000000000000000000000020ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff202020ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff7f7f7fff505050ff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfffffffffffffffffffefefefff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff000000ff000000ff000000ff606060ffdfdfdfffffffffffffffffffffffffffafafafff404040ffffffffffefefefff303030ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff101010ffffffffffffffffff404040ff000000ff606060ffffffffffffffffffffffffffffffffff606060ff000000ff303030ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff606060ffffffffffffffffff9f9f9fffffffffffefefefff303030ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff303030ff606060ff404040ff000000ff606060ffefefefff303030ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ffffffffff606060ff000000ff000000ff000000ff505050ffefefefffffffffff606060ff000000ff000000ff000000ff303030ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff000000ff303030ffefefefff404040ffefefefff303030ff000000ff000000ff000000ff404040ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffbfbfbfff606060ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff606060ff101010ff000000ff000000ff000000ff000000ff303030ff707070ff000000ff000000ff000000ff000000ff000000ff303030ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff707070ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff202020ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff202020ff000000ff000000ff000000ff000000ffbfbfbfff404040ff606060ff202020ff000000ff000000ff000000ff000000ff505050ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff606060ffbfbfbfff707070ff101010ff303030ff000000ff000000ff000000ff000000ff000000ff000000ff606060ffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff606060ffefefefff303030ff000000ff000000ff000000ff000000ff303030ffdfdfdfff303030ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff606060ff101010ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffefefefff202020ff000000ff000000ff000000ffbfbfbfff000000ff9f9f9fffefefefff303030ff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff8f8f8fffffffffff606060ff101010ffcfcfcfffffffffffcfcfcfff202020ff404040ff404040ff202020ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffefefefff7f7f7fffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff707070ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffefefefff202020ff000000ff000000ff000000ffbfbfbfffffffffffefefefff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff606060ffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff8f8f8fffffffffffffffffff9f9f9fffdfdfdfff404040ff000000ff000000ff404040ffffffffffefefefff707070ffefefefffffffffffffffffffffffffffffffffffcfcfcfff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffcfcfcfff707070ffffffffffffffffffffffffffffffffff9f9f9fffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff505050ffcfcfcfffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff000000ff606060ffbfbfbfffbfbfbfffffffffffffffffffffffffffffffffffffffffffdfdfdfff606060ffdfdfdfffffffffffffffffffffffffffffffffffffffffffdfdfdfff606060ffefefefffffffffffffffffffffffffff9f9f9fff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff303030ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffefefefff707070ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff707070ffefefefffffffffffbfbfbfffbfbfbfffdfdfdfff303030ff000000ff000000ff303030ffbfbfbfffbfbfbfffefefefffffffffffffffffffffffffffffffffffffffffffffffffff505050ffffffffff606060ff000000ff9f9f9fffffffffff9f9f9fff202020ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffefefefff303030ff000000ff303030ffefefefffffffffffffffffffffffffffffffffffffffffffbfbfbfff202020ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffff8f8f8fff000000ff000000ff101010ffbfbfbfffffffffffefefefffffffffffffffffffffffffffffffffffdfdfdfff303030ff000000ff000000ff000000ff000000ff202020ffefefefff404040ff000000ff000000ff404040ffefefefff303030ff000000ff303030ffefefefffefefefffffffffffcfcfcfff101010ff000000ff606060ffefefefffafafafffffffffffefefefff202020ff000000ff404040ffefefefffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffffdfdfdfffffffffffffffffffffffffffffffffffffffffffafafafff101010ff000000ff101010ff9f9f9fffffffffffdfdfdfffdfdfdfff101010ff000000ff000000ff000000ff000000ff000000ff303030ffffffffffffffffffffffffffffffffff9f9f9fff101010ff000000ff101010ffafafafffffffffffffffffffffffffffefefefff303030ff000000ff303030ffefefefffffffffff9f9f9fff000000ff000000ff8f8f8fffffffffffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff8f8f8fff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffcfcfcfff303030ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffefefefff707070ff000000ff000000ff000000ff000000ff000000ffcfcfcfff303030ff000000ff000000ff000000ff000000ff000000ff101010ffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff606060ff000000ff404040ffcfcfcfff303030ff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff303030ff303030ff000000ff000000ff000000ff303030ff303030ffcfcfcfffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffffefefefff505050ff000000ff000000ff000000ff000000ff000000ff606060ff303030ffffffffffffffffffffffffff9f9f9fff101010ff101010ff000000ff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff303030ff303030ff000000ff000000ff000000ff303030ff202020ff9f9f9fff101010ff000000ff000000ff000000ff101010ff9f9f9fffefefefff303030ff000000ff000000ff000000ff303030ff8f8f8fff000000ff000000ff000000ff000000ff404040ff505050ffffffffffffffffffffffffffefefefff707070ff101010ff000000ff000000ff000000ff000000ff404040ff101010ff7f7f7fff404040ff000000ff000000ff000000ff202020ff404040ffcfcfcfffffffffffffffffffefefefff606060ff101010ff000000ff000000ff000000ff000000ff7f7f7fff606060ffbfbfbfff303030ff000000ff000000ff000000ff202020ff7f7f7fff000000ff000000ff000000ff000000ff404040ff303030ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff9f9f9fff202020ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffff8f8f8fff101010ff000000ff000000ff000000ff000000ff404040ff8f8f8fff7f7f7fffffffffffcfcfcfff202020ff101010ff000000ff000000ff000000ff000000ff7f7f7fffafafafff404040ff101010ff000000ff000000ff101010ff404040ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff9f9f9fffbfbfbfff7f7f7fff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff000000ff606060ff000000ff000000ff000000ff000000ff8f8f8fffffffffffefefefff404040ff000000ff505050ff000000ff000000ff000000ff303030ffffffffffffffffffffffffffffffffffffffffffffffffff707070ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffbfbfbfff101010ff000000ffafafafff303030ff000000ff000000ff000000ff000000ffefefefffffffffffefefefff505050ff000000ff000000ffbfbfbfffafafafff7f7f7fff404040ff707070ffffffffffffffffff404040ff000000ff000000ff000000ff606060ff000000ff000000ff000000ff000000ff8f8f8fff101010ff404040ff000000ff000000ff000000ff404040ffffffffff404040ff606060ff000000ff000000ff000000ff000000ff303030ff303030ff000000ff000000ff000000ff202020ffefefefffffffffffffffffffcfcfcfff303030ff000000ffafafafff505050ff000000ff000000ff000000ff000000ffcfcfcfffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffcfcfcfff202020ff000000ff7f7f7fff707070ff000000ff000000ff000000ff000000ff606060ff505050ff606060ff101010ff000000ff000000ff000000ff101010ff404040ff000000ff000000ff000000ff000000ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffefefefff505050ff000000ff000000ffafafafff101010ff000000ff000000ff000000ff202020ffefefefff7f7f7fff000000ff000000ff7f7f7fffcfcfcfff7f7f7fff606060ff303030ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffdfdfdfffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffff8f8f8fff000000ff000000ff000000ffbfbfbfffffffffff101010ff000000ff000000ffbfbfbfff303030ff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffcfcfcfff000000ff000000ff000000ffbfbfbfffffffffff505050ff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffbfbfbfff303030ffefefefffffffffffffffffff404040ff000000ff000000ff404040ffffffffff8f8f8fff000000ff000000ff000000ffbfbfbfffdfdfdfffffffffff303030ff000000ff000000ff404040ffffffffffefefefffffffffff8f8f8fff000000ff000000ff000000ffbfbfbfffefefefff202020ff000000ff000000ff404040ffffffffffffffffffcfcfcfff000000ff000000ff000000ffbfbfbfffffffffff606060ff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffafafafff000000ff000000ff000000ffbfbfbfffdfdfdfffffffffffafafafff000000ff000000ff000000ffafafafffffffffff505050ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffcfcfcfff202020ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff7f7f7fffffffffffefefefff101010ffcfcfcfffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffefefefff202020ff8f8f8fffbfbfbfffcfcfcfffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff101010ff707070ff202020ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff7f7f7fffffffffff505050ff606060ffbfbfbfffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffbfbfbfffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff7f7f7fff606060ffbfbfbfff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ff8f8f8fff606060ff000000ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fffafafafffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff606060ff8f8f8fff000000ff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffdfdfdfffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffcfcfcfff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffbfbfbfff7f7f7fff202020ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfffefefefffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ff9f9f9fffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffcfcfcfff505050ff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ff202020ff505050ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ff404040ff101010ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff000000ff303030ff202020ff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff000000ff202020ffffffffffbfbfbfff000000ff000000ff202020ffdfdfdfffffffffff404040ffffffffff404040ff7f7f7fff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffcfcfcfff404040ff404040ff000000ff8f8f8fffffffffff404040ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff404040ff404040ff101010ff505050ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ff000000ff000000ff000000ff606060ff707070ff101010ff8f8f8fffffffffffffffffffffffffff404040ff7f7f7fff000000ffcfcfcfff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffafafafffffffffffffffffffffffffffcfcfcfffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffff404040ff000000ff000000ff000000ff606060ffefefefffffffffff000000ff000000ff000000ff606060ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffafafafff404040ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffdfdfdfff202020ffefefefffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff707070ff000000ff000000ff000000ff000000ff101010ffcfcfcfffffffffffffffffffffffffffcfcfcfff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ff101010ff9f9f9fffffffffffefefefff202020ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ff606060ffefefefff202020ff000000ff000000ff000000ff000000ff303030ffefefefff000000ff000000ff606060ffffffffffffffffffbfbfbfff000000ff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff000000ffefefefffffffffffefefefffdfdfdfff202020ffdfdfdfffffffffffffffffff404040ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff303030ffffffffffdfdfdfffffffffffafafafff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff303030ffffffffffdfdfdfffbfbfbfff000000ff000000ff000000ffafafafffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff606060ffffffffffefefefffefefefff000000ff000000ff000000ff404040ffefefefffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffafafafff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff101010ff000000ff000000ff000000ffbfbfbfff000000ff000000ff606060ff9f9f9fff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffcfcfcfffffffffff404040ff000000ff000000ff404040ffffffffffffffffff404040ffafafafffffffffffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff303030ffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ff000000ff000000ff303030ff404040ff101010ff000000ff000000ff000000ffbfbfbfff9f9f9fff000000ff000000ff000000ff000000ff9f9f9fffbfbfbfff000000ff000000ff000000ffbfbfbfff606060ff000000ff000000ff000000ff000000ff000000ff606060ff303030ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ff000000ff101010ff606060ff101010ff000000ff000000ff000000ff000000ff303030ff000000ff7f7f7fffffffffffffffffffffffffff606060ff000000ff000000ff000000ff000000ff606060ff303030ff000000ff000000ff000000ff101010ff505050ff8f8f8fff404040ff606060ff7f7f7fff7f7f7fffdfdfdfff404040ff000000ff000000ff7f7f7fff9f9f9fff000000ff000000ff000000ff000000ff9f9f9fffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff303030ff000000ff000000ff000000ff505050ff101010ff9f9f9fff101010ff000000ff000000ff000000ff606060ffffffffff404040ff000000ff000000ff000000ff606060ff101010ff9f9f9fff000000ff000000ff000000ff000000ff9f9f9fff404040ff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff000000ff505050ff303030ff7f7f7fff000000ff000000ff000000ff000000ff303030ffcfcfcfff000000ff000000ff404040ffefefefffffffffffdfdfdfff101010ff000000ff000000ff000000ff303030ffefefefff7f7f7fff000000ff000000ff000000ff303030ff303030ffafafafffffffffffffffffffffffffffffffffffffffffff303030ff000000ff000000ff000000ff000000ff000000ffbfbfbfff000000ff000000ff000000ff000000ff000000ff000000ff303030ffcfcfcfffefefefff303030ff000000ff000000ff000000ff101010ff9f9f9fff404040ff000000ff202020ffcfcfcfffffffffff7f7f7fff404040ff7f7f7fff7f7f7fffbfbfbfff7f7f7fff000000ff000000ff404040ffffffffffffffffff404040ff000000ff000000ff000000ff303030ff303030ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fffffffffff9f9f9fff000000ff000000ff000000ff000000ff8f8f8fffbfbfbfff000000ff000000ff000000ffbfbfbfff8f8f8fffdfdfdfff303030ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff606060ffffffffffcfcfcfff303030ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffdfdfdfff707070ff606060ff000000ff000000ff000000ff000000ff707070ff101010ff000000ff000000ff000000ff606060ff8f8f8fff000000ff000000ff000000ff000000ff000000ff101010ff101010ffbfbfbfffffffffff9f9f9fff000000ff000000ff000000ff000000ff7f7f7fffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff707070ff202020ff000000ff000000ff000000ff000000ff9f9f9fffcfcfcfff101010ff000000ff000000ff000000ff303030ffffffffff707070ff000000ff000000ff000000ff000000ff8f8f8fff303030ff202020ff000000ff000000ff000000ff000000ff101010ff000000ff000000ff000000ffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff000000ff9f9f9fff606060ff9f9f9fff303030ff000000ff000000ff000000ff101010ff000000ff8f8f8fffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ff303030ffefefefffafafafff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff000000ff000000ffbfbfbfff000000ff000000ff000000ff000000ff000000ff606060ffefefefffffffffff8f8f8fff8f8f8fff505050ff000000ff000000ff000000ff000000ff000000ff505050ffefefefffffffffffcfcfcfff000000ff000000ff000000ff000000ff000000ff101010ff000000ff8f8f8fffffffffffffffffffcfcfcfff000000ff000000ff000000ff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff101010ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff9f9f9fff000000ff000000ff606060ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffffefefefff606060ff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff404040ffffffffffffffffffffffffffefefefff303030ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ff9f9f9fffffffffffcfcfcfff101010ff000000ff505050ffcfcfcfff101010ff505050ff606060ff202020ff000000ff000000ff505050ffefefefffffffffffffffffffffffffff9f9f9fff000000ff000000ff606060ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffdfdfdfffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffffffffffffcfcfcfff101010ff000000ff303030ffefefefffffffffffffffffff707070ff000000ff000000ff9f9f9fffefefefffafafafffefefefff505050ff000000ff000000ff303030ff9f9f9fff000000ff000000ff000000ffbfbfbfffffffffffafafafffefefefff606060ff000000ff000000ff8f8f8fffffffffffffffffffffffffffefefefff505050ff000000ff000000ff202020ffcfcfcfffffffffffffffffffffffffffffffffffffffffffdfdfdfff303030ff000000ff303030ffefefefffffffffffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff606060ff303030ff000000ff000000ff000000ffbfbfbfff202020ff202020ff000000ff101010ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff000000ff000000ff000000ff8f8f8fffffffffffffffffffefefefff303030ff303030ff707070ff303030ff000000ff000000ff303030ffcfcfcfffffffffffffffffffffffffffbfbfbfffcfcfcfff8f8f8fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff8f8f8fff404040ff101010ff000000ff303030ff606060ffdfdfdfffffffffffffffffffffffffffffffffffffffffff9f9f9fff707070ffffffffffffffffffbfbfbfff000000ff000000ff101010ffefefefffffffffffffffffffffffffffffffffff8f8f8fff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff505050ffefefefffffffffffffffffffffffffffffffffffffffffff707070ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff9f9f9fffffffffffffffffffffffffffcfcfcfff505050ffefefefff7f7f7fffbfbfbfffffffffffffffffffefefefff707070ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffafafafff707070ffffffffffffffffffbfbfbfff000000ff000000ff101010ffefefefffffffffffffffffffffffffffffffffff9f9f9fff8f8f8fffffffffffffffffffffffffffffffffffdfdfdfff606060ffefefefffffffffffffffffffffffffffffffffff9f9f9fff9f9f9fffffffffffffffffffffffffffffffffffffffffff404040ff303030ffefefefffdfdfdfff101010ff000000ff000000ff202020ffffffffffffffffffffffffffffffffff9f9f9fff707070ffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff606060ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff606060ffefefefffffffffffffffffffffffffffffffffff9f9f9fff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ffcfcfcfffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffefefefff606060ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff404040ffcfcfcfffffffffffffffffffffffffffafafafff8f8f8fffffffffffffffffffffffffff9f9f9fff707070ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff505050ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff202020ffcfcfcfffffffffffffffffffefefefff303030ff000000ff101010ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ffbfbfbfffbfbfbfffbfbfbfffffffffffffffffffafafafff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff101010ff505050ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff101010ff505050ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff000000ff000000ff101010ff8f8f8fff303030ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff8f8f8fff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff505050ff000000ff303030ff404040ff000000ff000000ff000000ff101010ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff606060ff303030ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff707070ffdfdfdfffffffffffffffffffcfcfcfff303030ff303030ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff606060ffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff7f7f7fff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff202020ff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff404040ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff404040ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff404040ff606060ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffbfbfbfffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffbfbfbfffcfcfcfffffffffffffffffffdfdfdfff7f7f7fff7f7f7fff7f7f7fff8f8f8fffdfdfdfffffffffffdfdfdfffbfbfbfffcfcfcfffffffffffffffffffffffffffefefefff9f9f9fff7f7f7fff7f7f7fffbfbfbfffffffffffffffffffffffffff404040ff000000ff404040ffffffffff9f9f9fff7f7f7fff7f7f7fff7f7f7fffcfcfcfffffffffffffffffffffffffffdfdfdfffbfbfbfffbfbfbfffffffffffffffffffdfdfdfffbfbfbfffcfcfcfffffffffffbfbfbfff7f7f7fff7f7f7fff7f7f7fffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff7f7f7fff7f7f7fff7f7f7fffafafafffffffffffefefefffbfbfbfffbfbfbfffefefefffefefefffbfbfbfff000000ff000000ff606060ffbfbfbfffcfcfcfffffffffffffffffffffffffffafafafff7f7f7fff7f7f7fff7f7f7fff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffffffffffbfbfbfffbfbfbfffdfdfdfffefefefff9f9f9fff7f7f7fff7f7f7fff7f7f7fffdfdfdfffffffffffffffffffffffffffdfdfdfffbfbfbfffbfbfbfffffffffffefefefff9f9f9fff7f7f7fff7f7f7fff7f7f7fffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff7f7f7fff7f7f7fff7f7f7fff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff7f7f7fff7f7f7fff7f7f7fffdfdfdfffffffffffffffffffcfcfcfff606060ff000000ff000000ffbfbfbfffbfbfbfffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffe5afbeffd47d96ffd47d96ffd47d96ffde9baefff4dfe5fffffffffffffffffffffffffffffffffffffffffffaeff2ffde9baeffd47d96ffd47d96ffd47d96ffe5afbefffffffffffffffffffffffffffffffffffffffffff4dfe5ffeabfcbffeabfcbffffffffffde9baeffd47d96ffd47d96ffde9baefffaeff2ffffffffffffffffffeabfcbffd47d96ffd47d96ffd47d96ffeabfcbffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffdfdfdfffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ffafafafffffffffffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff606060ffffffffff707070ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fff7f7f7fff000000ff404040ffffffffffffffffffefefefff303030ff000000ff000000ff000000ff000000ff606060ffffffffffffffffff404040ff000000ff303030ff303030ff000000ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ff606060ff000000ff000000ff000000ff000000ff000000ff606060ffffffffffffffffffffffffffffffffffcfcfcfff202020ff000000ff000000ff000000ff000000ff000000ff303030ff8f8f8fff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ff000000ff000000ff000000ff404040ffffffffffcfcfcfff303030ff000000ff000000ff000000ff000000ff000000ff000000ff606060ffefefefffffffffffffffffffffffffff000000ff000000ff505050ff202020ff000000ff000000ff000000ff000000ff000000ffafafafffffffffffffffffff7f7f7fff000000ff000000ffafafafff101010ff000000ff000000ff000000ff000000ff000000ff404040ffefefefffffffffffffffffffffffffffffffffffafafafff202020ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffafafafff101010ff000000ff000000ff000000ff000000ff9f9f9fffffffffff404040ff000000ff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffe5afbeffb6204aff990033ff990033ff990033ff990033ff990033ff990033ffd47d96ffffffffffffffffffffffffffd47d96ffb0103dff990033ff990033ff990033ff990033ff990033ffb0103dffe5afbeffffffffffffffffffffffffffd47d96ff990033ff990033ffcb607eff990033ff990033ff990033ff990033ffb6204afff4dfe5ffc55071ff990033ff990033ff990033ff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff707070ffffffffffffffffffffffffffffffffffffffffff202020ff000000ff505050ffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ffdfdfdfff505050ff000000ff000000ff000000ff404040ff606060ff303030ff000000ff000000ff101010ff000000ff404040ffffffffffffffffff606060ff000000ff000000ff404040ff202020ff000000ff000000ff9f9f9fffffffffff404040ff000000ff000000ff000000ff202020ff606060ff404040ff000000ff000000ff000000ffdfdfdfffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ff000000ff101010ff505050ff404040ff101010ff000000ff000000ffbfbfbfffffffffffffffffffcfcfcfff101010ff000000ff000000ff202020ff606060ff404040ff101010ff000000ff000000ff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ff000000ff000000ff000000ff404040ffcfcfcfff000000ff000000ff000000ff202020ff606060ff404040ff101010ff000000ff000000ff303030ffefefefffffffffffffffffff000000ff000000ff000000ff000000ff303030ff505050ff303030ff000000ff000000ff101010ffefefefffffffffff7f7f7fff000000ff000000ff000000ff000000ff202020ff606060ff404040ff101010ff000000ff000000ff303030ffefefefffffffffffffffffff9f9f9fff000000ff000000ff000000ff303030ff505050ff404040ff000000ff000000ff000000ff606060ffffffffffffffffffffffffff101010ff000000ff101010ff404040ff101010ff000000ff101010ffdfdfdfff404040ff000000ff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffde9baeff990033ff990033ff990033ffbb3057ffcb607effc04064ff990033ff990033ffc04064ffffffffffffffffffcb607eff990033ff990033ff990033ffc04064ffc55071ffbb3057ff990033ff990033ff990033ffde9baeffffffffffffffffffd47d96ff990033ff990033ff990033ffb0103dffc55071ffbb3057ff990033ff990033ffb0103dff990033ff990033ffc04064ffc55071ff990033ff990033ff990033fff4dfe5ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff101010ffefefefffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffdfdfdfffffffffffffffffffffffffffdfdfdfff000000ff000000ff505050ff9f9f9fff000000ff000000ff303030ffdfdfdfffffffffffffffffffffffffffbfbfbfff101010ff000000ff000000ff404040ffffffffffffffffff101010ff000000ff7f7f7fffffffffffefefefff404040ff7f7f7fffefefefffffffffff404040ff000000ff000000ff606060ffffffffffffffffffffffffff9f9f9fff000000ff000000ff8f8f8fffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ff303030ffefefefffffffffffffffffffcfcfcfff000000ff000000ff606060ffffffffffffffffff202020ff000000ff000000ff8f8f8fffffffffffffffffffffffffffefefefff606060ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffefefefff101010ff000000ff101010ffafafafffffffffffffffffffffffffffefefefff606060ff000000ff000000ff505050ffffffffffffffffff000000ff000000ff000000ff8f8f8fffffffffffffffffffffffffff8f8f8fff000000ff000000ffafafafffffffffff7f7f7fff000000ff000000ff000000ff8f8f8fffffffffffffffffffffffffffefefefff606060ff000000ff000000ff606060ffffffffffcfcfcfff000000ff000000ff101010ffbfbfbfffffffffffffffffffffffffffefefefff505050ff000000ff000000ff7f7f7fffffffffffbfbfbfff000000ff000000ffcfcfcfffffffffffcfcfcfff202020ffafafafffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffb0103dffeabfcbfffffffffffffffffffffffffffaeff2ffc55071ffc04064ffffffffffde9baeff990033ff990033ffc04064fff4dfe5ffffffffffffffffffffffffffefcfd8ffbb3057ff990033ff990033ffeabfcbffffffffffd47d96ff990033ff990033ffb6204afffaeff2ffffffffffffffffffc55071ff990033ff990033ff990033ffefcfd8ffffffffffffffffffeabfcbff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff8f8f8fffffffffffffffffffffffffff606060ff000000ff000000ff000000ff707070ffffffffffffffffffffffffff7f7f7fff000000ff000000ffbfbfbfff303030ff000000ff101010ffefefefffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff404040ffffffffffffffffff000000ff000000ff505050ffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffefefefffffffffffffffffffffffffffffffffff202020ff000000ff606060ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ffcfcfcfffffffffffffffffffffffffffffffffff505050ff000000ff404040ffffffffffafafafff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffff505050ff000000ff000000ffdfdfdfffffffffff000000ff000000ff202020ffffffffffffffffffffffffffffffffffefefefff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffefefefff606060ff000000ff000000ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff101010ffefefefffbfbfbfff000000ff000000ffafafafffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffc55071ff990033ff990033ffefcfd8ffffffffffffffffffffffffffffffffffffffffffffffffffde9baeffffffffffb0103dff990033ffbb3057fffffffffffffffffffffffffffffffffffffffffffffffffff4dfe5ffb0103dff990033ffc04064ffffffffffd47d96ff990033ff990033ffde9baeffffffffffffffffffffffffffeabfcbff990033ff990033ffcb607effffffffffffffffffffffffffffffffffb6204aff990033ffcb607effffffffffffffffffffffffffffffffffffffffffffffffff202020ff000000ff202020ffffffffffffffffffdfdfdfff000000ff000000ff202020ff000000ff101010ffffffffffffffffffefefefff101010ff000000ff404040ffefefefff000000ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff404040ffffffffffffffffff505050ff000000ff000000ff404040ff9f9f9fffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff606060ff000000ff000000ffefefefffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff202020ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff7f7f7fffffffffff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffafafafff000000ff000000ff9f9f9fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff9f9f9fffefefefff101010ff000000ff000000ff606060ffcfcfcfffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000fffffffffffffffffffffffffffffffffffffffffffffffffffaeff2ff990033ff990033ffcb607effffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffe5afbeff990033ff990033ffe5afbeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffd47d96ff990033ff990033fffaeff2ffd47d96ff990033ff990033fff4dfe5fffffffffffffffffffffffffffaeff2ff990033ff990033ffd47d96ffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ffafafafffffffffff7f7f7fff000000ff101010ffcfcfcfff000000ff000000ff9f9f9fffffffffff9f9f9fff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffefefefff303030ff000000ff000000ff000000ff202020ff9f9f9fffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff505050ffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff404040ff000000ff000000ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffff9f9f9fff101010ff000000ff000000ff000000ff404040ffcfcfcfffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffe5afbeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffeabfcbffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ff000000ff404040ffffffffff202020ff000000ff707070ffffffffff505050ff000000ff303030ffffffffff202020ff000000ff202020ffffffffffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffff9f9f9fff202020ff000000ff000000ff000000ff707070ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff404040ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffdfdfdfff707070ff101010ff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffeabfcbffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff707070ff000000ff000000ffdfdfdfffffffffffafafafff000000ff000000ff7f7f7fff000000ff000000ff9f9f9fffffffffffcfcfcfff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff505050ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff101010ff000000ff000000ffdfdfdfff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff404040ff000000ff202020ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff101010ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ff000000ff707070ffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff101010ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff707070ff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffefefefff7f7f7fff000000ff000000ff303030ffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffefcfd8ff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffde9baeff990033ff990033fff4dfe5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffde9baeff990033ff990033ffefcfd8ffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff000000ff000000ff404040ffffffffffffffffffffffffff202020ff000000ff000000ff000000ff202020ffffffffffffffffffffffffff101010ff000000ff202020ffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff404040ffffffffffffffffffefefefffdfdfdfffffffffffffffffffffffffffafafafff000000ff000000ffbfbfbfff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff8f8f8fff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff505050ff000000ff101010ffefefefffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffcfcfcfff202020ff000000ff202020ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffcfcfcfffffffffffdfdfdfffffffffffffffffffffffffffffffffff606060ff000000ff000000ffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb6204aff990033ffb6204affffffffffffffffffffffffffffffffffffffffffffffffffffffffffe5afbefff4dfe5ff990033ff990033ffd47d96ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffc04064ff990033ffb6204affffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ffafafafffffffffffffffffffffffffff8f8f8fff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffff707070ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff505050ff000000ff000000ff404040ffffffffff8f8f8fff101010ff404040ffffffffffffffffffffffffffafafafff000000ff000000ffbfbfbfff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffdfdfdfff000000ff000000ff202020ffefefefffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffbfbfbfff000000ff000000ff505050ffefefefffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff202020ffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff101010ffdfdfdfffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff202020ffffffffff9f9f9fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff404040ffefefefff505050ff000000ff8f8f8fffffffffffffffffffffffffff606060ff000000ff101010ffffffffff7f7f7fff000000ff000000fffffffffffffffffffffffffffaeff2ffeabfcbffffffffffffffffffd47d96ff990033ff990033ffcb607effffffffffffffffffffffffffffffffffffffffffeabfcbffb0103dffffffffffc04064ff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffffcb607eff990033ff990033ffd47d96ffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff202020ffffffffffffffffffffffffffffffffffefefefff101010ff000000ff101010ffefefefffffffffffffffffffffffffffefefefff101010ff000000ff000000ff505050ffafafafffbfbfbfff9f9f9fff202020ff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff505050ffbfbfbfff9f9f9fff101010ff000000ff101010ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffff707070ff000000ff000000ff101010ff8f8f8fffbfbfbfffbfbfbfff606060ff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffff606060ff000000ff000000ff202020ff8f8f8fffbfbfbfffbfbfbfff707070ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff000000ff101010ff7f7f7fffbfbfbfffbfbfbfff707070ff000000ff000000ff000000ffafafafffffffffffffffffff404040ff000000ff000000ff303030ff9f9f9fffbfbfbfffafafafff606060ff000000ff000000ff101010ffcfcfcfffffffffff202020ff000000ff000000ff7f7f7fffbfbfbfff7f7f7fff000000ff000000ff606060ffffffffff7f7f7fff000000ff000000fffffffffffffffffff4dfe5ffb0103dff990033ffc04064ffffffffffffffffffbb3057ff990033ff990033ffc04064ffde9baeffeabfcbffe5afbeffcb607eff990033ff990033fffffffffff4dfe5ffb0103dff990033ff990033ffcb607effe5afbeffeabfcbffde9baeffc04064ff990033ff990033ffbb3057ffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff000000ff000000ff000000ff000000ff000000ff101010ff505050ff000000ff404040ffffffffffefefefff303030ff000000ff000000ff000000ff000000ff000000ff000000ff9f9f9fffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffff606060ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff404040ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffff606060ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff101010ffafafafffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff404040ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffefefefff505050ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff101010ffcfcfcfffffffffffffffffffcfcfcfff101010ff000000ff000000ff000000ff000000ff000000ff101010ffdfdfdfffffffffff7f7f7fff000000ff000000ffffffffffffffffffeabfcbff990033ff990033ff990033fffffffffffffffffffaeff2ffc04064ff990033ff990033ff990033ff990033ff990033ff990033ff990033ffb0103dffffffffffffffffffefcfd8ffb6204aff990033ff990033ff990033ff990033ff990033ff990033ff990033ffc04064fffaeff2ffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ffefefefffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffefefefff707070ff202020ff000000ff000000ff202020ff707070ffefefefff9f9f9fff404040ff707070ffffffffffffffffffefefefff7f7f7fff202020ff000000ff000000ff303030ffbfbfbfffffffffffffffffff707070ff404040ff707070ffffffffffffffffffffffffffffffffffffffffff707070ff404040ff707070ffffffffff9f9f9fff404040ff404040ffffffffffffffffff9f9f9fff404040ff707070ffffffffffffffffffffffffffffffffffffffffff9f9f9fff404040ff404040ffffffffffffffffffffffffffffffffff9f9f9fff404040ff000000ff000000ff000000ff505050ffbfbfbfffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffff404040ff404040ff9f9f9fffffffffffffffffffffffffffffffffffbfbfbfff505050ff101010ff000000ff000000ff202020ff707070ffdfdfdfffffffffffffffffffffffffffffffffff404040ff404040ff9f9f9fffffffffffffffffffffffffffffffffffffffffff707070ff404040ff9f9f9fffffffffff7f7f7fff000000ff000000ffffffffff9f9f9fff303030ff000000ff000000ff101010ff505050ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff505050ff000000ff000000ff000000ff303030ff7f7f7fffefefefffffffffffffffffffffffffffffffffffcfcfcfff505050ff000000ff000000ff101010ff606060ffdfdfdfffffffffffffffffff9f9f9fff404040ff404040fffffffffffffffffffaeff2ffbb3057ff990033ffd47d96ffffffffffffffffffffffffffffffffffde9baeffc04064ff990033ff990033ff990033ffbb3057ffd47d96fffaeff2fffffffffffffffffffffffffffaeff2ffde9baeffbb3057ff990033ff990033ff990033ffc55071ffde9baeffffffffffffffffffffffffffffffffffde9baeffc04064ffc04064ffffffffffffffffffffffffffffffffffffffffffc04064ffc04064ffefcfd8ffffffffffffffffffffffffffffffffffd47d96ffc04064ffd47d96ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfffbfbfbfffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff101010ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff101010ffcfcfcfffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff505050ff7f7f7fff7f7f7fff303030ff000000ff000000ff101010ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff101010ff000000ff000000ff000000ff000000ff000000ff000000ff303030ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff8f8f8fff505050ff404040ff404040ff606060ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff404040ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000700ae00700007000100010003000300040000000d000c001000d800d800d800d800280018003610517569636b54696d65aa20616e6420610000280024003f0d206465636f6d70726573736f7200280030000f1f617265206e656564656420746f20736565207468697320706963747572652e000000a100e007ac00000000000007a86170706c022000006d6e74725247422058595a2007d900020019000b001a000b616373704150504c000000006170706c000000000000000000000000000000000000f6d6000100000000d32d6170706c00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000b64657363000001080000006f6473636d000001780000056c63707274000006e400000038777470740000071c000000147258595a00000730000000146758595a00000744000000146258595a0000075800000014725452430000076c0000000e636861640000077c0000002c625452430000076c0000000e675452430000076c0000000e64657363000000000000001447656e65726963205247422050726f66696c6500000000000000000000001447656e65726963205247422050726f66696c6500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000006d6c7563000000000000001e0000000c736b534b00000028000001786872485200000028000001a06361455300000024000001c87074425200000026000001ec756b55410000002a0000021266724655000000280000023c7a685457000000160000026469744954000000280000027a6e624e4f00000026000002a26b6f4b5200000016000002c86373435a00000022000002de6865494c0000001e00000300646544450000002c0000031e68754855000000280000034a7376534500000026000002a27a68434e00000016000003726a614a500000001a00000388726f524f00000024000003a2656c475200000022000003c67074504f00000026000003e86e6c4e4c000000280000040e6573455300000026000003e874685448000000240000043674725452000000220000045a66694649000000280000047c706c504c0000002c000004a47275525500000022000004d06172454700000026000004f2656e555300000026000005186461444b0000002e0000053e005601610065006f006200650063006e00fd0020005200470042002000700072006f00660069006c00470065006e006500720069010d006b00690020005200470042002000700072006f00660069006c00500065007200660069006c0020005200470042002000670065006e00e800720069006300500065007200660069006c0020005200470042002000470065006e00e9007200690063006f0417043004330430043b044c043d043804390020043f0440043e044404300439043b002000520047004200500072006f00660069006c0020006700e9006e00e9007200690071007500650020005200560042901a75280020005200470042002082725f6963cf8ff000500072006f00660069006c006f0020005200470042002000670065006e0065007200690063006f00470065006e0065007200690073006b0020005200470042002d00700072006f00660069006cc77cbc1800200052004700420020d504b85cd30cc77c004f006200650063006e00fd0020005200470042002000700072006f00660069006c05e405e805d505e405d905dc0020005200470042002005db05dc05dc05d90041006c006c00670065006d00650069006e006500730020005200470042002d00500072006f00660069006c00c1006c00740061006c00e1006e006f00730020005200470042002000700072006f00660069006c666e901a0020005200470042002063cf8ff065874ef64e00822c0020005200470042002030d730ed30d530a130a430eb00500072006f00660069006c0020005200470042002000670065006e0065007200690063039303b503bd03b903ba03cc002003c003c103bf03c603af03bb002000520047004200500065007200660069006c0020005200470042002000670065006e00e9007200690063006f0041006c00670065006d00650065006e0020005200470042002d00700072006f006600690065006c0e420e1b0e230e440e1f0e250e4c002000520047004200200e170e310e480e270e440e1b00470065006e0065006c0020005200470042002000500072006f00660069006c00690059006c00650069006e0065006e0020005200470042002d00700072006f006600690069006c00690055006e006900770065007200730061006c006e0079002000700072006f00660069006c0020005200470042041e04310449043804390020043f0440043e04440438043b044c00200052004700420645064406410020062a06390631064a0641002000520047004200200627064406390627064500470065006e00650072006900630020005200470042002000500072006f00660069006c006500470065006e006500720065006c0020005200470042002d006200650073006b0072006900760065006c007300657465787400000000436f707972696768742032303037204170706c6520496e632e2c20616c6c207269676874732072657365727665642e0058595a20000000000000f35200010000000116cf58595a20000000000000744d00003dee000003d058595a200000000000005a750000ac730000173458595a20000000000000281a0000159f0000b83663757276000000000000000101cd0000736633320000000000010c42000005defffff326000007920000fd91fffffba2fffffda3000003dc0000c06c00a100e000040000000200ff}}}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par The Washington Post\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 February}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  22, 2001 Thursday  \par Final Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Kenyan Orphanage Takes Initiative on AIDS Drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Karl Vick, Washington Post Foreign Service\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 A SECTION; Pg. A12\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1295 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAIROBI Feb. 21\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  -- A small orphanage run by a Jesuit priest from the United States will be the first place in Africa to seek to import deeply discounted AIDS drugs under an Indian pharmaceutical company's new program to make such drugs more affordable on the continent where most of the world's AIDS patients live and die. \par  The Rev. Angelo D'Agostino, a former Georgetown University Hospital medical professor who runs the Nyumbani home for orphans with AIDS or HIV in suburban Nairobi, said today that he will import antiretrov}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ral medicines from }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Ltd. of Bombay. \par  "I am sick and tired of doing funerals," D'Agostino said. Although he estimated that the discounted drugs might be sufficient to treat only 20 of the 70 children at his orphanage, his efforts reflect increasing willin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ness of nongovernmental organizations and AIDS activists to defy national regulations and international p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tent rules to buy cheaper, generic AIDS drugs.  \par  }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  chairman, Yusuf Hamied, made headlines two weeks ago when he announced that, by taking a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 vantage of World Trade Organization rules that permit countries to suspend patents in the event of national emergency, he would sell a combination of three generic antiretroviral medicines for as little as $ 350 for a year's supply for one person; similar treatment in the United States costs $ 10,000. \par  }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offer amounted to an open challenge to major pharmaceutical companies that hold the patents on many such AIDS drugs and have worked hard to control prices. In countries such as India and Brazil where Western pharmaceutical giants' patents do not apply, generic AIDS drugs such as antiretrovirals are man}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 factured and can be provided to HIV patients at comparatively low cost. \par  Antiretroviral drugs are the components of the "triple-drug cocktail" that has been found to delay or prevent the onset of AIDS in patients infected with HIV, the human immunodeficiency virus. \par  }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offer to provide triple-drug therapy for $ 350 per person was originally made only to the French me}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ical aid group Doctors Without Borders, which would then provide the drugs at no cost to patients at its treatment centers throughout Africa. But D'Agostino said today that he was seeking to buy the antiretrovirals directly from }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  and would accept donated AZT, another AIDS drug, from a Brazilian firm. \par  When -- or whether -- the drugs will reach D'Agostino's orphanage remains to be seen. Sam Ongeri, Ke}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ya's minister of public health, said today that despite D'Agostino's announcement, Kenyan law barring co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 mercial import of generic drugs will remain in force. But he also noted that Kenya's parliament may amend the law next month to allow imports of generics. "And it's a desired event," Ongeri said. "But before we get to that point, the pharmaceutical industry should drop their prices." \par  In addition, officials with Doctors Without Borders said loopholes in existing law may allow D'Agostino to i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 port the drugs before new legislation is passed. \par  "I'm hoping the government will transcend the restrictions and allow [the drugs] in," said D'Agostino. "The companies might put up some static, but I don't think the government, in the interest of the people, will give us any problem." \par  D'Agostino's announcement, on the heels of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  discount offer, underscored how the question of a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cess to expensive AIDS drugs appears to be moving beyond the control of the Western drug giants. \par  Brazil, whose national AIDS program is hailed as a model for developing nations, treats 90,000 citizens with drugs it manufactures under the same }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  provision. It has offered to export both the drugs and the tec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nology to African nations. \par  "In a way, Brazil right now is kind of driving the market," said James Love of the Consumer Project on Tec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nology, a Washington-based advocacy group that has championed wider access to essential medicines. "Now if you were to add any reasonable market in Africa, it's reasonable to expect prices to go down even further." \par  The drug giants are fighting back on several fronts. With the encouragement of American drug firms, the U.S. Trade Representative is challenging Brazil's interpretation of a key }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  rule. And in South Africa, which three years ago passed legislation allowing the manufacture of AIDS drugs there, 42 drug companies have filed suit to block the law. \par  That case, scheduled for trial March 5 in South Africa, has cast an intimidating shadow over other African governments.  \par  The industry giants also have tried to satisfy growing calls to provide drugs for poor countries while assuring the drugs were brand names. Last year, five large Western firms offered to negotiate with African gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ments to reduce prices on AIDS medicines by up to 80 percent. \par  Nine months later, however, agreements have been reached with only three countries. And the deals, with Senegal, Uganda and Rwanda, will provide medicine for fewer than 3,000 of the 1.3 million infected with HIV in those countries. Throughout the continent, an estimated 22 million people are infected; 11 million have already died of AIDS-related causes. \par  One company, Glaxo Wellcome, announced today it would offer aid agencies working in Africa "greatly di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 counted" prices on its AIDS drugs, but provided no specifics. The company holds the patent on lamivudine (3TC), one of the drugs offered by }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 . \par  "Should it be found we cannot assist an organization such as the Nyumbani orphanage, we will be symp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 thetic to the need for action and will judge each situation on its merits," said Glaxo spokeswoman Vicki Ehrich. \par  In South Africa, Pfizer Inc. will begin distributing the drug Diflucan free to HIV and AIDS patients at gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment hospitals and clinics within the next few weeks, the health department and Pfizer said today. The drug, generically known as fluconazole, is used to treat some infections that occur in AIDS patients. \par  And in Kenya, where 2.1 million are infected with HIV and another million have died, another firm, Boehringer Ingelheim, recently reduced by 80 percent -- to just 74 cents -- its price for nevirapine, which r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 duces the chance of transmission of HIV from mother to child. But prices of many drugs remain prohibitive. Fluconazole, a meningitis treatment that Pfizer sells in Nairobi for $ 6 a pill, is available as a generic in Tha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 land for 30 cents. \par  "It's really the darker side of capitalism, the greed that is being manifest by these drug companies holding sub-Saharan Africa hostage," said D'Agostino. "People are dying because they can't afford their prices." \par  "We wonder what sacrifices are going to be made at the altar of profit," said Chris Ouma, a Nairobi physician with Action Aid Kenya. "Which is more deadly to Africa? Is it HIV, or is it the businessmen who have brie}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cases of patent applications?" \par  Such rhetoric -- far bolder than was heard in this part of Africa just months ago -- reflects the momentum that has gathered behind the AIDS drug campaign led by Doctors Without Borders. The movement scored a major victory in December 1999 when President Bill Clinton issued an executive order barring the U.S. trade office from challenging African nations that wanted to import or manufacture generics, while paying a royalty to the patent holder. \par  But the effect of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  price cut this month was tectonic. Hamied, the company chairman, said the $ 350 annual rate for a triple-drug cocktail was "a humanitarian price," subsidized by his firm and available only to Doctors Without Borders, which operates pilot programs involving only a few thousand patients. Gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ments would have to pay $ 600 for a year's supply of the same three-drug combination of stavudine, lamiv}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 dine and nevirapine.  \par  "It's time the international community looked at it from a more human point of view," Hamied said. \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV (97%); AIDS & HIV TREATMENT (96%); ANTIVIRALS (93%); PHARMACEUT}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 CALS INDUSTRY (91%); PHARMACEUTICAL PREPARATION MFG (90%); GENERIC DRUGS (90%); P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TENTS (88%); CATHOLICS & CATHOLICISM (78%); INTERNATIONAL TRADE LAW (78%); ORPHANS (78%); INTERNATIONAL TRADE (78%); GENERIC PRODUCTS (78%); DRUG PRICES (77%); HEALTH DEPARTMENTS (77%); AIDS POLICY (77%); VIRUSES (75%); NONGOVERNMENTAL ORGANIZATIONS (74%); RELIEF ORGANIZATIONS (73%); PATENT LAW (73%); INTERNATIONAL ASSISTANCE (73%); PHYSICIANS & SURGEONS (72%); COLLEGE & UNIVERSITY PROFESSORS (71%); MEDICAL CHAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TIES (71%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  LTD (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GEORGETOWN UNIVERSITY (57%); WORLD TRADE ORGANIZATION (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (94%); SIC2834 PHARMACEUTICAL PREPARATIONS (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAIROBI, KENYA (88%); MUMBAI, INDIA (73%) KENYA (96%); UNITED STATES (93%); AFRICA (93%); BRAZIL (92%); INDIA (79%); FRANCE (67%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 April 2, 2002\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 The Washington Post\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Kenyan Orphanage Takes Initiative on AIDS Drugs The Washington Post February 22, 2001 Thursday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_81}{\*\bkmkstart DOC_ID_81_0}{\*\bkmkstart doc_id_38}{\*\bkmkend DOC_ID_81}{\*\bkmkend DOC_ID_81_0}{\*\bkmkend doc_id_38}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_38"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330038000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 38 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\shppict{\pict{\*\picprop\shplid1028{\sp{\sn shapeType}{\sv 75}}{\sp{\sn fFlipH}{\sv 0}}{\sp{\sn fFlipV}{\sv 0}}{\sp{\sn fLine}{\sv 0}}{\sp{\sn fLayoutInCell}{\sv 1}}}\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw7620\pich2540\picwgoal4320\pichgoal1440\pngblip\bliptag657880520 89504e470d0a1a0a0000000d49484452000000d8000000480803000000a398cb9c00000300504c5445ffffff000000404040bfbfbf7f7f7fccccccefefef9900331010103030309f9f9f606060cfcfcfdfdfdf2020208f8f8f505050707070afafafd47d96c04064eabfcbde9baefaeff2b0103df4dfe5e5afbecb607ebb3057c55071b6204aefcfd8000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000335c3c3e00000c254944415478daed1b8972dbb6720192004f9152e2a449dad7ffffacccbc695ed234b12d89120f106f770152b41cc94ae31ef1043316491c8b5dec89050cf0a33cf1a256df079ef22bfb87f1fe49b22b11e99394432944004f5014950588bf335ea4615516ee35470a965fec54082c288b2af40aa7ce2ec30148faa000e797ac6b78f779a2aceeea0e958c485b49fc94274551c4f4c8e82b13893aa78f13903c7e4835b3f02205c76953ff3c594a798430972443a471e409c202ea83040951297e9ca66c06a488b1e7592f9189f012ba683ec94f7972ded44fcbbf811dabf7b5857d74d2a21bc6827e6f82654dfd4fda92ec00a41148dce61c5df505821844349f81889ef69404a4bbb13b7f75a9296dd4bba6061117f6cbe31045888cc29e3dc4921f274a7b0062642cc5ee0cce08440e0f1166878c61862d4ddfda934befa665c2cc629db6619dc79d28fa86b0175689d07819580c664e586b244d31ec67c8e451dc4e3ebc68208d3b06e28626a12486e5ccc57498702ad29046e5d837192457171e5011091c9946dd813043efdab4c6da117bb59838b48a0713c81c173bb632f2085728e429a40b7452d2691c49b2d79f60210ee68d75cce964307da1c2a24d0980fb176c87166a02a2c876641889a905a9464a76b5f0b88818df5905517d585cb06ae5142ae1bea5ef3b5a02320da4e9ac4239ce157a0bcc30726704e3c2732c8a6aa1827d8beb402b81c8c6720fbda2d50b871635c9ce38e61fd8d37fa9e216b96e338122921a56c4be9f80e8c034d0454604a8492adb62a34cf6b4dabb064c2f454be25c74ba05150f58b50f9301d5bccf0cf2ae91d24bbbd2c4cb0e2c48cfb1b26b90917261863c22fd8120dd6a037a88b6a328b690ec07eeee09eb15f2bd4fd7ca0e258ed60ef8b2812f101684db25a949278c2a36c6561d54f50148dc936c0dade52f1162cf6267d0716d169ae0c57b8b7d0de290234225926ca3c44a03ad6251174eac0abb6f79e691305c4eb3b4d8a88c685a94f024687716870c4337e371c10c3e882249177ea29404c45e6678ee5cc29128e6fc5e7183831190101f801490d0bb725f289024476e54e6c0f909f8b1724356ec21aa51d65173dde4c1248a214fced078a08af311f7d1782824bbf1ebe039266ccf9f64640cc921fd1db47ece3163c7eee0604469d864ed01c81e06078abf7ab62a7e94b523383244fcd8091e4256aff550dde2ab226ae71c6363d332341e882c95d6e1ce0b317aa7d3c56475e03dc17e78d8dfe4fd1aa086c72e2afe742eaed5d9cdd1fe6ab4bceb036647588581d7dfa431e2610c6eff9a60b63ebf56f75ac3794ce1e83a8a6e3259fbc6f5652808d5fc03517c1cadef6d5bd291c082deeaa3e0a7be6e2f868e56021643fb771325842e77f5fdfdd85ae35fb6d08b5b243ab4473bae0571711e73fa302d56b30f5f3643256efe7e6e0d99aabfb8d124a75fef424429b7461c730c370a72be5dda658a3eeb00294bb733bfadd055f72776141a238872fe41f1ca9d76450b358c2b386b536abefbb322d3f77671dbb03d06e5220f7282a64b068d91974cc8bfa56c8f537c357d26ec68114232a55d04e83fd1fff641431134ce96917d89f27013ec658615417c006221eea1af5ad5e2a0a423cf9df51471efd36ef21e5d35b05b513810a3d48222092dc91d2432e37830e98c73321d0e8d3590a797180f17611bda16fd97f51ea84fa4191cc7d6ce90ee2de219384b11393a7292cb5a4c8cee39a20bb621d5ef138a22142b26ce040dc63bb5311ba5bd19f5cbb82460379227199817b5b6c4b39d3ac8f68dd00902ddf773252535d88b4fced5ccb5c16c1285809a9d2df79bdc5863861007a2c4d10879d873ac62bfd30c79af865b54174460704781e8dc4dc5ecda69bb974edb447cc5fa2a8fab6cc19bd03b400a17f952178a49305e4dd54a615491a4dcbe1a27a1ba8513afc205e1e9340b6e9b29040a160b8a9cc7d09b86a924596253420383bc1477f7d7aa94386de642e974c9718b330fe551fe23afdc3a2f0f76a34c5d7d482bb1f4ebb09a0349b9b2c8d42c0322134581fd629c912165a392a96c36906c55ee0239a9b249e173d6fd55c900c68141f54076475cb05d7f30457406484ebc41c65f98f62a7c842abf1125158be5238441a781a8380890c1abaf58beaf22ec44ce2208e3ee9be3bd734054d060081c674d7ef934e4548a5339814bd75a3d46dc7a06482512cee57d4dc61c076489847f75099605edec931cbe8ab0eca164e9bfe58ce3ebe4422ee169961c7e14dac8ff58831fe547f9171529e4f782e99365c10fc2eefbcbb07c9a3a36db433f2d8e456366e4246cf90884a7f2cfa1f80dc1f22092ddd90e161e2175fa8dfbafbfc4dc3f4672814e8bbe5d14d5d33106248a01241bbf5d9ff2055853a09c65c3baa8a955852d587f3691a280c55857d460809a030153e3ea1660f14919846106d09606531d427290d386b2b6c9da8d27b8d3d879479e1e7be5b6c641c128d3af29f319bca3d797344cff46afaf7af8fd054e29dec3d580ccfadde511a4859c81a5bb25e726f32da4dbe5b5a7d1880149e6f3fe2df68d813397490da1412d0a8d48386bc1c9ee5c32a058dda228b883d621372ed599767c6e573ac471261cbfacf9604670867ad53b92f8306ec52d49edee124847faebf0bd73347f003c8b3e331c89a43ddbc0f38f446b177ea0caf203277370ac4bb326ade667d4814e6f28c31df45619ca51ef40146d977602fabea0e4725fb43c27fe743a6fb5e9025c9fbe066cd54de38e1e09e76cdb739de914a227a069633a85b7d2e0d0bde126a0a674dd424cf72c2ce5c86da3076d82c425c1dd21e58bcf5bb84a917bba8637d77b28aab4deef9e6d4986eae522adb7f11f58b985e6c5c65b04ce6a52da9612a68510552a4442ef41cc67ba319df1ca50713e05c0dd5360b50eddb5a39ceb173ea19b8d47d47432ecef37605dc5c7ccd4a3a403e6501cba670421e673e38a86212e39e48bd5dc785c69fdd315f1e597e7f042ebe7aff0fdd79fb5be82675affe725c02f5aeb5fb9df0baf346e024267e9ec5090f80c2ecd20099f6a4a1471fd02511909cb5dd649d2817838f96e4f5838dd70ac68d97ce257f9a6f00035f380dc3a07d3e5ab0361bf30dacc3af849ffec5e5ffda49f13612f1ce56fa8ee3ff420ab58172436a8cb05ecf8d29c40954a9cbe1a4ed49670333a5bc1f51b38b8b08dfbb1d04c46f660a1d3f13a039d99eec01f9db6776d32ae5a5843ba19073761a0e1737637c7f1f2033c7feb5e3fbcfe0cfe34fc5d07eb97e0f2a3088d55a99e30e961bdc259f5004d0a61c3b88c07472ce4750c76b7484fa6315dd979aae769d8f5e450d63167639ad9a0b1fb27c6683cf6c2c9db566aa8b7778ee5067775810b02f9edb036442319caf7f38979da5ac335ae6db229c9ce4171ef1a41bb438d5bef2e4e7f355fae3c7fee7ee728b48e2a0d767b3751dd3d38b13d72d068a5966bfc95b00fe9991c725dfe59df26487d716182ecb032fa70174ac1f16e600c080a3ec1cc0fb56888d69f87e04ec890ce84035b5e1d04263d1d7948629958c3a7827d2e6cf448bbe27554051fd93e707d0399ea57f87082128fa77be899ef31b249471986ae98567ba085c109db3e85d969dfdb9713d8d7c1414d0778f9f634617c4fabf2b24fef09acc3719de836eaf6a2a81897da1d6ad5331d6b52aecb075ab1e311ccce1ce9d8a09ebb03bb00bd5d5b6d4acf706f39d0ce6fe1fd1b67f78777056c9c497fb386edb9e89e42288a3a76bae10b615bdd984adee89019b63550add12beafdd91078bdbc5eeb7203f18c0093d53705425f5cc3173068e8509b9a42c018a34e445336384db889e136b4a21e8dc12b7bfbfce31f3ffffef1b9b491c020235a7ebe79633b317c84abff9e236c9db99b2f6d86a1053d73686e4846748c0f19ed6f485e1e8aec3f6735051df5fc82ea36ab2952bac660e6d37d8bda701324d814a63728781827215d3068bea7a7fd8cfd2ddd9ee98ab50bba96ff7bf7ebcbf71f9dfc77e7a37be9df8487b5192a1493a21a5a74dead090aba7e5863c8e044849e8a5ca7f215fc01db44b0e47a6bcece7c2b4b4d90a24f53158de7e740e7e9ba94b4a8ed7542a0e260407fb6a1b4834ea3b5032cafc8b4bcffc837e8afe804fd6d535214f2a2fc4846be7016aae01b38608bf91e2e806317f4d5a508262097fc47c59fdd695d5682630ff00d1bd661baf797f427af4bcf84e52fdd1b3f66fa6d31b9943d68f384f28ae8fd06f6b2a985efe57f7b2ecc28d1bf50846132deeef82775ec7161a7830b2ee26073016106ec77c3335556526697fdb7e39fcd18fe284fb3fc1f6304efb39e95003b0000000049454e44ae426082}}{\nonshppict{\pict\picscalex100\picscaley100\piccropl0\piccropr0\piccropt0\piccropb0\picw216\pich72\picwgoal4320\pichgoal1440\macpict\bliptag657880520 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000004800d8001102ff0c00fffe0000004800000048000000000000004800d800000000001e0001000a00000000004800d882000000f39a0000000100000000000000000000000000000001000000000000000000000000000040000000000000000000000000000000000000000000004800d8000003000000000000000056726177200000000000000000000000006170706c000004000000040000d8004800480000004800000000f300000100000000000000000000000000000000000000000000000000000000000000000020ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff202020ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff7f7f7fff505050ff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfffffffffffffffffffefefefff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff000000ff000000ff000000ff606060ffdfdfdfffffffffffffffffffffffffffafafafff404040ffffffffffefefefff303030ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff101010ffffffffffffffffff404040ff000000ff606060ffffffffffffffffffffffffffffffffff606060ff000000ff303030ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff606060ffffffffffffffffff9f9f9fffffffffffefefefff303030ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff303030ff606060ff404040ff000000ff606060ffefefefff303030ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ffffffffff606060ff000000ff000000ff000000ff505050ffefefefffffffffff606060ff000000ff000000ff000000ff303030ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff000000ff303030ffefefefff404040ffefefefff303030ff000000ff000000ff000000ff404040ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffbfbfbfff606060ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff606060ff101010ff000000ff000000ff000000ff000000ff303030ff707070ff000000ff000000ff000000ff000000ff000000ff303030ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff707070ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff202020ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff202020ff000000ff000000ff000000ff000000ffbfbfbfff404040ff606060ff202020ff000000ff000000ff000000ff000000ff505050ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff606060ffbfbfbfff707070ff101010ff303030ff000000ff000000ff000000ff000000ff000000ff000000ff606060ffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff606060ffefefefff303030ff000000ff000000ff000000ff000000ff303030ffdfdfdfff303030ff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff606060ff101010ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffefefefff202020ff000000ff000000ff000000ffbfbfbfff000000ff9f9f9fffefefefff303030ff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff8f8f8fffffffffff606060ff101010ffcfcfcfffffffffffcfcfcfff202020ff404040ff404040ff202020ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffefefefff7f7f7fffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff707070ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffefefefff202020ff000000ff000000ff000000ffbfbfbfffffffffffefefefff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff606060ffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff8f8f8fffffffffffffffffff9f9f9fffdfdfdfff404040ff000000ff000000ff404040ffffffffffefefefff707070ffefefefffffffffffffffffffffffffffffffffffcfcfcfff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffcfcfcfff707070ffffffffffffffffffffffffffffffffff9f9f9fffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff505050ffcfcfcfffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff000000ff606060ffbfbfbfffbfbfbfffffffffffffffffffffffffffffffffffffffffffdfdfdfff606060ffdfdfdfffffffffffffffffffffffffffffffffffffffffffdfdfdfff606060ffefefefffffffffffffffffffffffffff9f9f9fff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff303030ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffefefefff707070ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff707070ffefefefffffffffffbfbfbfffbfbfbfffdfdfdfff303030ff000000ff000000ff303030ffbfbfbfffbfbfbfffefefefffffffffffffffffffffffffffffffffffffffffffffffffff505050ffffffffff606060ff000000ff9f9f9fffffffffff9f9f9fff202020ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffefefefff303030ff000000ff303030ffefefefffffffffffffffffffffffffffffffffffffffffffbfbfbfff202020ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffff8f8f8fff000000ff000000ff101010ffbfbfbfffffffffffefefefffffffffffffffffffffffffffffffffffdfdfdfff303030ff000000ff000000ff000000ff000000ff202020ffefefefff404040ff000000ff000000ff404040ffefefefff303030ff000000ff303030ffefefefffefefefffffffffffcfcfcfff101010ff000000ff606060ffefefefffafafafffffffffffefefefff202020ff000000ff404040ffefefefffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffffdfdfdfffffffffffffffffffffffffffffffffffffffffffafafafff101010ff000000ff101010ff9f9f9fffffffffffdfdfdfffdfdfdfff101010ff000000ff000000ff000000ff000000ff000000ff303030ffffffffffffffffffffffffffffffffff9f9f9fff101010ff000000ff101010ffafafafffffffffffffffffffffffffffefefefff303030ff000000ff303030ffefefefffffffffff9f9f9fff000000ff000000ff8f8f8fffffffffffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff8f8f8fff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffcfcfcfff303030ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffefefefff707070ff000000ff000000ff000000ff000000ff000000ffcfcfcfff303030ff000000ff000000ff000000ff000000ff000000ff101010ffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff606060ff000000ff404040ffcfcfcfff303030ff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff303030ff303030ff000000ff000000ff000000ff303030ff303030ffcfcfcfffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffffefefefff505050ff000000ff000000ff000000ff000000ff000000ff606060ff303030ffffffffffffffffffffffffff9f9f9fff101010ff101010ff000000ff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff303030ff303030ff000000ff000000ff000000ff303030ff202020ff9f9f9fff101010ff000000ff000000ff000000ff101010ff9f9f9fffefefefff303030ff000000ff000000ff000000ff303030ff8f8f8fff000000ff000000ff000000ff000000ff404040ff505050ffffffffffffffffffffffffffefefefff707070ff101010ff000000ff000000ff000000ff000000ff404040ff101010ff7f7f7fff404040ff000000ff000000ff000000ff202020ff404040ffcfcfcfffffffffffffffffffefefefff606060ff101010ff000000ff000000ff000000ff000000ff7f7f7fff606060ffbfbfbfff303030ff000000ff000000ff000000ff202020ff7f7f7fff000000ff000000ff000000ff000000ff404040ff303030ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff9f9f9fff202020ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffff8f8f8fff101010ff000000ff000000ff000000ff000000ff404040ff8f8f8fff7f7f7fffffffffffcfcfcfff202020ff101010ff000000ff000000ff000000ff000000ff7f7f7fffafafafff404040ff101010ff000000ff000000ff101010ff404040ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff9f9f9fffbfbfbfff7f7f7fff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff000000ff606060ff000000ff000000ff000000ff000000ff8f8f8fffffffffffefefefff404040ff000000ff505050ff000000ff000000ff000000ff303030ffffffffffffffffffffffffffffffffffffffffffffffffff707070ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffbfbfbfff101010ff000000ffafafafff303030ff000000ff000000ff000000ff000000ffefefefffffffffffefefefff505050ff000000ff000000ffbfbfbfffafafafff7f7f7fff404040ff707070ffffffffffffffffff404040ff000000ff000000ff000000ff606060ff000000ff000000ff000000ff000000ff8f8f8fff101010ff404040ff000000ff000000ff000000ff404040ffffffffff404040ff606060ff000000ff000000ff000000ff000000ff303030ff303030ff000000ff000000ff000000ff202020ffefefefffffffffffffffffffcfcfcfff303030ff000000ffafafafff505050ff000000ff000000ff000000ff000000ffcfcfcfffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffcfcfcfff202020ff000000ff7f7f7fff707070ff000000ff000000ff000000ff000000ff606060ff505050ff606060ff101010ff000000ff000000ff000000ff101010ff404040ff000000ff000000ff000000ff000000ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffffefefefff505050ff000000ff000000ffafafafff101010ff000000ff000000ff000000ff202020ffefefefff7f7f7fff000000ff000000ff7f7f7fffcfcfcfff7f7f7fff606060ff303030ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffdfdfdfffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffff8f8f8fff000000ff000000ff000000ffbfbfbfffffffffff101010ff000000ff000000ffbfbfbfff303030ff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffcfcfcfff000000ff000000ff000000ffbfbfbfffffffffff505050ff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffbfbfbfff303030ffefefefffffffffffffffffff404040ff000000ff000000ff404040ffffffffff8f8f8fff000000ff000000ff000000ffbfbfbfffdfdfdfffffffffff303030ff000000ff000000ff404040ffffffffffefefefffffffffff8f8f8fff000000ff000000ff000000ffbfbfbfffefefefff202020ff000000ff000000ff404040ffffffffffffffffffcfcfcfff000000ff000000ff000000ffbfbfbfffffffffff606060ff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffafafafff000000ff000000ff000000ffbfbfbfffdfdfdfffffffffffafafafff000000ff000000ff000000ffafafafffffffffff505050ff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffcfcfcfff202020ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff7f7f7fffffffffffefefefff101010ffcfcfcfffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ff000000ff404040ffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffefefefff202020ff8f8f8fffbfbfbfffcfcfcfffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff101010ff707070ff202020ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff7f7f7fffffffffff505050ff606060ffbfbfbfffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffbfbfbfffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff7f7f7fff606060ffbfbfbfff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ff8f8f8fff606060ff000000ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fffafafafffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff606060ff8f8f8fff000000ff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffdfdfdfffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffffffffffcfcfcfff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffbfbfbfff7f7f7fff202020ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfffefefefffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ff9f9f9fffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ffffffffffcfcfcfff505050ff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ff202020ff505050ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffbfbfbfff000000ff000000ff000000ff000000ff404040ff101010ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff000000ff000000ff000000ff000000ff303030ff202020ff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff000000ff202020ffffffffffbfbfbfff000000ff000000ff202020ffdfdfdfffffffffff404040ffffffffff404040ff7f7f7fff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff000000ff000000ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffcfcfcfff404040ff404040ff000000ff8f8f8fffffffffff404040ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff404040ff404040ff101010ff505050ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ff000000ff000000ff000000ff606060ff707070ff101010ff8f8f8fffffffffffffffffffffffffff404040ff7f7f7fff000000ffcfcfcfff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ffafafafffffffffffffffffffffffffffcfcfcfffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffff404040ff000000ff000000ff000000ff606060ffefefefffffffffff000000ff000000ff000000ff606060ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffafafafff404040ffffffffffffffffff404040ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff000000ff000000ff000000ff7f7f7fffffffffffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffbfbfbfff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffdfdfdfff202020ffefefefffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff707070ff000000ff000000ff000000ff000000ff101010ffcfcfcfffffffffffffffffffffffffffcfcfcfff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff000000ff000000ff000000ff101010ff9f9f9fffffffffffefefefff202020ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff000000ff000000ff000000ff606060ffefefefff202020ff000000ff000000ff000000ff000000ff303030ffefefefff000000ff000000ff606060ffffffffffffffffffbfbfbfff000000ff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff000000ffefefefffffffffffefefefffdfdfdfff202020ffdfdfdfffffffffffffffffff404040ff000000ff000000ff404040ffffffffff404040ff000000ff000000ff404040ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff404040ff000000ff000000ff303030ffffffffffdfdfdfffffffffffafafafff000000ff000000ff000000ffbfbfbfffffffffff404040ff000000ff000000ff303030ffffffffffdfdfdfffbfbfbfff000000ff000000ff000000ffafafafffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff606060ffffffffffefefefffefefefff000000ff000000ff000000ff404040ffefefefffffffffff000000ff000000ff000000ffbfbfbfffffffffffffffffffafafafff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ff000000ffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff101010ff000000ff000000ff000000ffbfbfbfff000000ff000000ff606060ff9f9f9fff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff000000ffcfcfcfffffffffff404040ff000000ff000000ff404040ffffffffffffffffff404040ffafafafffffffffffffffffff7f7f7fff000000ff000000ff000000ffffffffffffffffff404040ff000000ff000000ff303030ffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ff000000ff000000ff303030ff404040ff101010ff000000ff000000ff000000ffbfbfbfff9f9f9fff000000ff000000ff000000ff000000ff9f9f9fffbfbfbfff000000ff000000ff000000ffbfbfbfff606060ff000000ff000000ff000000ff000000ff000000ff606060ff303030ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ff000000ff000000ff101010ff606060ff101010ff000000ff000000ff000000ff000000ff303030ff000000ff7f7f7fffffffffffffffffffffffffff606060ff000000ff000000ff000000ff000000ff606060ff303030ff000000ff000000ff000000ff101010ff505050ff8f8f8fff404040ff606060ff7f7f7fff7f7f7fffdfdfdfff404040ff000000ff000000ff7f7f7fff9f9f9fff000000ff000000ff000000ff000000ff9f9f9fffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffff303030ff000000ff000000ff000000ff505050ff101010ff9f9f9fff101010ff000000ff000000ff000000ff606060ffffffffff404040ff000000ff000000ff000000ff606060ff101010ff9f9f9fff000000ff000000ff000000ff000000ff9f9f9fff404040ff000000ff000000ff000000ffffffffffffffffffffffffff000000ff000000ff000000ff000000ff505050ff303030ff7f7f7fff000000ff000000ff000000ff000000ff303030ffcfcfcfff000000ff000000ff404040ffefefefffffffffffdfdfdfff101010ff000000ff000000ff000000ff303030ffefefefff7f7f7fff000000ff000000ff000000ff303030ff303030ffafafafffffffffffffffffffffffffffffffffffffffffff303030ff000000ff000000ff000000ff000000ff000000ffbfbfbfff000000ff000000ff000000ff000000ff000000ff000000ff303030ffcfcfcfffefefefff303030ff000000ff000000ff000000ff101010ff9f9f9fff404040ff000000ff202020ffcfcfcfffffffffff7f7f7fff404040ff7f7f7fff7f7f7fffbfbfbfff7f7f7fff000000ff000000ff404040ffffffffffffffffff404040ff000000ff000000ff000000ff303030ff303030ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fffffffffff9f9f9fff000000ff000000ff000000ff000000ff8f8f8fffbfbfbfff000000ff000000ff000000ffbfbfbfff8f8f8fffdfdfdfff303030ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff606060ffffffffffcfcfcfff303030ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffdfdfdfff707070ff606060ff000000ff000000ff000000ff000000ff707070ff101010ff000000ff000000ff000000ff606060ff8f8f8fff000000ff000000ff000000ff000000ff000000ff101010ff101010ffbfbfbfffffffffff9f9f9fff000000ff000000ff000000ff000000ff7f7f7fffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffff707070ff202020ff000000ff000000ff000000ff000000ff9f9f9fffcfcfcfff101010ff000000ff000000ff000000ff303030ffffffffff707070ff000000ff000000ff000000ff000000ff8f8f8fff303030ff202020ff000000ff000000ff000000ff000000ff101010ff000000ff000000ff000000ffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff000000ff9f9f9fff606060ff9f9f9fff303030ff000000ff000000ff000000ff101010ff000000ff8f8f8fffffffffffffffffffffffffffdfdfdfff101010ff000000ff000000ff000000ff303030ffefefefffafafafff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff000000ff000000ff000000ffbfbfbfff000000ff000000ff000000ff000000ff000000ff606060ffefefefffffffffff8f8f8fff8f8f8fff505050ff000000ff000000ff000000ff000000ff000000ff505050ffefefefffffffffffcfcfcfff000000ff000000ff000000ff000000ff000000ff101010ff000000ff8f8f8fffffffffffffffffffcfcfcfff000000ff000000ff000000ff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff101010ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffff9f9f9fff000000ff000000ff606060ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffffffffffefefefff606060ff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff404040ffffffffffffffffffffffffffefefefff303030ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ff9f9f9fffffffffffcfcfcfff101010ff000000ff505050ffcfcfcfff101010ff505050ff606060ff202020ff000000ff000000ff505050ffefefefffffffffffffffffffffffffff9f9f9fff000000ff000000ff606060ffffffffffbfbfbfff000000ff000000ff000000ffbfbfbfffffffffffdfdfdfffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffffffffffffcfcfcfff101010ff000000ff303030ffefefefffffffffffffffffff707070ff000000ff000000ff9f9f9fffefefefffafafafffefefefff505050ff000000ff000000ff303030ff9f9f9fff000000ff000000ff000000ffbfbfbfffffffffffafafafffefefefff606060ff000000ff000000ff8f8f8fffffffffffffffffffffffffffefefefff505050ff000000ff000000ff202020ffcfcfcfffffffffffffffffffffffffffffffffffffffffffdfdfdfff303030ff000000ff303030ffefefefffffffffffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff606060ff303030ff000000ff000000ff000000ffbfbfbfff202020ff202020ff000000ff101010ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff000000ff000000ff000000ff8f8f8fffffffffffffffffffefefefff303030ff303030ff707070ff303030ff000000ff000000ff303030ffcfcfcfffffffffffffffffffffffffffbfbfbfffcfcfcfff8f8f8fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff8f8f8fff404040ff101010ff000000ff303030ff606060ffdfdfdfffffffffffffffffffffffffffffffffffffffffff9f9f9fff707070ffffffffffffffffffbfbfbfff000000ff000000ff101010ffefefefffffffffffffffffffffffffffffffffff8f8f8fff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff505050ffefefefffffffffffffffffffffffffffffffffffffffffff707070ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff9f9f9fffffffffffffffffffffffffffcfcfcfff505050ffefefefff7f7f7fffbfbfbfffffffffffffffffffefefefff707070ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffafafafff707070ffffffffffffffffffbfbfbfff000000ff000000ff101010ffefefefffffffffffffffffffffffffffffffffff9f9f9fff8f8f8fffffffffffffffffffffffffffffffffffdfdfdfff606060ffefefefffffffffffffffffffffffffffffffffff9f9f9fff9f9f9fffffffffffffffffffffffffffffffffffffffffff404040ff303030ffefefefffdfdfdfff101010ff000000ff000000ff202020ffffffffffffffffffffffffffffffffff9f9f9fff707070ffffffffffffffffffffffffffffffffffffffffffffffffff8f8f8fff606060ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff606060ffefefefffffffffffffffffffffffffffffffffff9f9f9fff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ffcfcfcfffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffefefefff606060ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff404040ffcfcfcfffffffffffffffffffffffffffafafafff8f8f8fffffffffffffffffffffffffff9f9f9fff707070ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff505050ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff202020ffcfcfcfffffffffffffffffffefefefff303030ff000000ff101010ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ffbfbfbfffbfbfbfffbfbfbfffffffffffffffffffafafafff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ffbfbfbfff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff101010ff505050ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff101010ff505050ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ff000000ff000000ff000000ff000000ff101010ff8f8f8fff303030ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff000000ff8f8f8fff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff505050ff000000ff303030ff404040ff000000ff000000ff000000ff101010ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ff606060ff303030ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff707070ffdfdfdfffffffffffffffffffcfcfcfff303030ff303030ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff606060ffffffffffefefefff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffccccccffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff7f7f7fff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff202020ff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff404040ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff404040ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffcfcfcfff404040ff606060ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffbfbfbfffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffefefefff303030ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffbfbfbfffcfcfcfffffffffffffffffffdfdfdfff7f7f7fff7f7f7fff7f7f7fff8f8f8fffdfdfdfffffffffffdfdfdfffbfbfbfffcfcfcfffffffffffffffffffffffffffefefefff9f9f9fff7f7f7fff7f7f7fffbfbfbfffffffffffffffffffffffffff404040ff000000ff404040ffffffffff9f9f9fff7f7f7fff7f7f7fff7f7f7fffcfcfcfffffffffffffffffffffffffffdfdfdfffbfbfbfffbfbfbfffffffffffffffffffdfdfdfffbfbfbfffcfcfcfffffffffffbfbfbfff7f7f7fff7f7f7fff7f7f7fffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff7f7f7fff7f7f7fff7f7f7fffafafafffffffffffefefefffbfbfbfffbfbfbfffefefefffefefefffbfbfbfff000000ff000000ff606060ffbfbfbfffcfcfcfffffffffffffffffffffffffffafafafff7f7f7fff7f7f7fff7f7f7fff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffffffffffbfbfbfffbfbfbfffdfdfdfffefefefff9f9f9fff7f7f7fff7f7f7fff7f7f7fffdfdfdfffffffffffffffffffffffffffdfdfdfffbfbfbfffbfbfbfffffffffffefefefff9f9f9fff7f7f7fff7f7f7fff7f7f7fffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff7f7f7fff7f7f7fff7f7f7fff8f8f8fffdfdfdfffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff7f7f7fff7f7f7fff7f7f7fffdfdfdfffffffffffffffffffcfcfcfff606060ff000000ff000000ffbfbfbfffbfbfbfffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffe5afbeffd47d96ffd47d96ffd47d96ffde9baefff4dfe5fffffffffffffffffffffffffffffffffffffffffffaeff2ffde9baeffd47d96ffd47d96ffd47d96ffe5afbefffffffffffffffffffffffffffffffffffffffffff4dfe5ffeabfcbffeabfcbffffffffffde9baeffd47d96ffd47d96ffde9baefffaeff2ffffffffffffffffffeabfcbffd47d96ffd47d96ffd47d96ffeabfcbffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffdfdfdfffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ffafafafffffffffffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff606060ffffffffff707070ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fff7f7f7fff000000ff404040ffffffffffffffffffefefefff303030ff000000ff000000ff000000ff000000ff606060ffffffffffffffffff404040ff000000ff303030ff303030ff000000ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ff606060ff000000ff000000ff000000ff000000ff000000ff606060ffffffffffffffffffffffffffffffffffcfcfcfff202020ff000000ff000000ff000000ff000000ff000000ff303030ff8f8f8fff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ff000000ff000000ff000000ff404040ffffffffffcfcfcfff303030ff000000ff000000ff000000ff000000ff000000ff000000ff606060ffefefefffffffffffffffffffffffffff000000ff000000ff505050ff202020ff000000ff000000ff000000ff000000ff000000ffafafafffffffffffffffffff7f7f7fff000000ff000000ffafafafff101010ff000000ff000000ff000000ff000000ff000000ff404040ffefefefffffffffffffffffffffffffffffffffffafafafff202020ff000000ff000000ff000000ff000000ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffafafafff101010ff000000ff000000ff000000ff000000ff9f9f9fffffffffff404040ff000000ff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffe5afbeffb6204aff990033ff990033ff990033ff990033ff990033ff990033ffd47d96ffffffffffffffffffffffffffd47d96ffb0103dff990033ff990033ff990033ff990033ff990033ffb0103dffe5afbeffffffffffffffffffffffffffd47d96ff990033ff990033ffcb607eff990033ff990033ff990033ff990033ffb6204afff4dfe5ffc55071ff990033ff990033ff990033ff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff707070ffffffffffffffffffffffffffffffffffffffffff202020ff000000ff505050ffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ffdfdfdfff505050ff000000ff000000ff000000ff404040ff606060ff303030ff000000ff000000ff101010ff000000ff404040ffffffffffffffffff606060ff000000ff000000ff404040ff202020ff000000ff000000ff9f9f9fffffffffff404040ff000000ff000000ff000000ff202020ff606060ff404040ff000000ff000000ff000000ffdfdfdfffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ff000000ff101010ff505050ff404040ff101010ff000000ff000000ffbfbfbfffffffffffffffffffcfcfcfff101010ff000000ff000000ff202020ff606060ff404040ff101010ff000000ff000000ff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ff000000ff000000ff000000ff404040ffcfcfcfff000000ff000000ff000000ff202020ff606060ff404040ff101010ff000000ff000000ff303030ffefefefffffffffffffffffff000000ff000000ff000000ff000000ff303030ff505050ff303030ff000000ff000000ff101010ffefefefffffffffff7f7f7fff000000ff000000ff000000ff000000ff202020ff606060ff404040ff101010ff000000ff000000ff303030ffefefefffffffffffffffffff9f9f9fff000000ff000000ff000000ff303030ff505050ff404040ff000000ff000000ff000000ff606060ffffffffffffffffffffffffff101010ff000000ff101010ff404040ff101010ff000000ff101010ffdfdfdfff404040ff000000ff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffde9baeff990033ff990033ff990033ffbb3057ffcb607effc04064ff990033ff990033ffc04064ffffffffffffffffffcb607eff990033ff990033ff990033ffc04064ffc55071ffbb3057ff990033ff990033ff990033ffde9baeffffffffffffffffffd47d96ff990033ff990033ff990033ffb0103dffc55071ffbb3057ff990033ff990033ffb0103dff990033ff990033ffc04064ffc55071ff990033ff990033ff990033fff4dfe5ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff101010ffefefefffffffffffffffffffffffffffbfbfbfff000000ff000000ff000000ffdfdfdfffffffffffffffffffffffffffdfdfdfff000000ff000000ff505050ff9f9f9fff000000ff000000ff303030ffdfdfdfffffffffffffffffffffffffffbfbfbfff101010ff000000ff000000ff404040ffffffffffffffffff101010ff000000ff7f7f7fffffffffffefefefff404040ff7f7f7fffefefefffffffffff404040ff000000ff000000ff606060ffffffffffffffffffffffffff9f9f9fff000000ff000000ff8f8f8fffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ff303030ffefefefffffffffffffffffffcfcfcfff000000ff000000ff606060ffffffffffffffffff202020ff000000ff000000ff8f8f8fffffffffffffffffffffffffffefefefff606060ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffefefefff101010ff000000ff101010ffafafafffffffffffffffffffffffffffefefefff606060ff000000ff000000ff505050ffffffffffffffffff000000ff000000ff000000ff8f8f8fffffffffffffffffffffffffff8f8f8fff000000ff000000ffafafafffffffffff7f7f7fff000000ff000000ff000000ff8f8f8fffffffffffffffffffffffffffefefefff606060ff000000ff000000ff606060ffffffffffcfcfcfff000000ff000000ff101010ffbfbfbfffffffffffffffffffffffffffefefefff505050ff000000ff000000ff7f7f7fffffffffffbfbfbfff000000ff000000ffcfcfcfffffffffffcfcfcfff202020ffafafafffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffb0103dffeabfcbfffffffffffffffffffffffffffaeff2ffc55071ffc04064ffffffffffde9baeff990033ff990033ffc04064fff4dfe5ffffffffffffffffffffffffffefcfd8ffbb3057ff990033ff990033ffeabfcbffffffffffd47d96ff990033ff990033ffb6204afffaeff2ffffffffffffffffffc55071ff990033ff990033ff990033ffefcfd8ffffffffffffffffffeabfcbff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff8f8f8fffffffffffffffffffffffffff606060ff000000ff000000ff000000ff707070ffffffffffffffffffffffffff7f7f7fff000000ff000000ffbfbfbfff303030ff000000ff101010ffefefefffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff404040ffffffffffffffffff000000ff000000ff505050ffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffefefefffffffffffffffffffffffffffffffffff202020ff000000ff606060ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ffcfcfcfffffffffffffffffffffffffffffffffff505050ff000000ff404040ffffffffffafafafff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffff505050ff000000ff000000ffdfdfdfffffffffff000000ff000000ff202020ffffffffffffffffffffffffffffffffffefefefff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff000000ffefefefff606060ff000000ff000000ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff101010ffefefefffbfbfbfff000000ff000000ffafafafffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffc55071ff990033ff990033ffefcfd8ffffffffffffffffffffffffffffffffffffffffffffffffffde9baeffffffffffb0103dff990033ffbb3057fffffffffffffffffffffffffffffffffffffffffffffffffff4dfe5ffb0103dff990033ffc04064ffffffffffd47d96ff990033ff990033ffde9baeffffffffffffffffffffffffffeabfcbff990033ff990033ffcb607effffffffffffffffffffffffffffffffffb6204aff990033ffcb607effffffffffffffffffffffffffffffffffffffffffffffffff202020ff000000ff202020ffffffffffffffffffdfdfdfff000000ff000000ff202020ff000000ff101010ffffffffffffffffffefefefff101010ff000000ff404040ffefefefff000000ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff404040ffffffffffffffffff505050ff000000ff000000ff404040ff9f9f9fffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff606060ff000000ff000000ffefefefffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff202020ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff7f7f7fffffffffff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffafafafff000000ff000000ff9f9f9fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff9f9f9fffefefefff101010ff000000ff000000ff606060ffcfcfcfffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000fffffffffffffffffffffffffffffffffffffffffffffffffffaeff2ff990033ff990033ffcb607effffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffe5afbeff990033ff990033ffe5afbeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffd47d96ff990033ff990033fffaeff2ffd47d96ff990033ff990033fff4dfe5fffffffffffffffffffffffffffaeff2ff990033ff990033ffd47d96ffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ffafafafffffffffff7f7f7fff000000ff101010ffcfcfcfff000000ff000000ff9f9f9fffffffffff9f9f9fff000000ff000000ffbfbfbfffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffefefefff303030ff000000ff000000ff000000ff202020ff9f9f9fffffffffffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff303030ff000000ff505050ffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff404040ff000000ff000000ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffff9f9f9fff101010ff000000ff000000ff000000ff404040ffcfcfcfffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffe5afbeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffeabfcbffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ff000000ff404040ffffffffff202020ff000000ff707070ffffffffff505050ff000000ff303030ffffffffff202020ff000000ff202020ffffffffffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffff9f9f9fff202020ff000000ff000000ff000000ff707070ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff404040ff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffdfdfdfff707070ff101010ff000000ff000000ff000000ffbfbfbfffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffeabfcbff990033ff990033ffeabfcbffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff707070ff000000ff000000ffdfdfdfffffffffffafafafff000000ff000000ff7f7f7fff000000ff000000ff9f9f9fffffffffffcfcfcfff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffff505050ff000000ff404040ffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff101010ff000000ff000000ffdfdfdfff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff404040ff000000ff202020ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff101010ff000000ff707070ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff101010ff000000ff707070ffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff101010ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff707070ff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff8f8f8fffffffffffffffffffffffffffffffffffefefefff7f7f7fff000000ff000000ff303030ffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffefcfd8ff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffde9baeff990033ff990033fff4dfe5ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffde9baeff990033ff990033ffefcfd8ffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff000000ff000000ff404040ffffffffffffffffffffffffff202020ff000000ff000000ff000000ff202020ffffffffffffffffffffffffff101010ff000000ff202020ffffffffffffffffffffffffffffffffffffffffffffffffffefefefff000000ff000000ff404040ffffffffffffffffffefefefffdfdfdfffffffffffffffffffffffffffafafafff000000ff000000ffbfbfbfff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffff8f8f8fff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffff505050ff000000ff101010ffefefefffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff9f9f9fffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffcfcfcfff202020ff000000ff202020ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffcfcfcfffffffffffdfdfdfffffffffffffffffffffffffffffffffff606060ff000000ff000000ffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffb6204aff990033ffb6204affffffffffffffffffffffffffffffffffffffffffffffffffffffffffe5afbefff4dfe5ff990033ff990033ffd47d96ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffc04064ff990033ffb6204affffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ff000000ffafafafffffffffffffffffffffffffff8f8f8fff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffff707070ff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff505050ff000000ff000000ff404040ffffffffff8f8f8fff101010ff404040ffffffffffffffffffffffffffafafafff000000ff000000ffbfbfbfff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffdfdfdfff000000ff000000ff202020ffefefefffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffbfbfbfff000000ff000000ff505050ffefefefffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff202020ffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff101010ffdfdfdfffffffffffffffffffffffffffffffffffcfcfcfff000000ff000000ff202020ffffffffff9f9f9fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ff404040ffefefefff505050ff000000ff8f8f8fffffffffffffffffffffffffff606060ff000000ff101010ffffffffff7f7f7fff000000ff000000fffffffffffffffffffffffffffaeff2ffeabfcbffffffffffffffffffd47d96ff990033ff990033ffcb607effffffffffffffffffffffffffffffffffffffffffeabfcbffb0103dffffffffffc04064ff990033ff990033ffde9baeffffffffffffffffffffffffffffffffffffffffffcb607eff990033ff990033ffd47d96ffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ff000000ff202020ffffffffffffffffffffffffffffffffffefefefff101010ff000000ff101010ffefefefffffffffffffffffffffffffffefefefff101010ff000000ff000000ff505050ffafafafffbfbfbfff9f9f9fff202020ff000000ff000000ff000000ff404040ffffffffff7f7f7fff000000ff000000ff505050ffbfbfbfff9f9f9fff101010ff000000ff101010ffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffff707070ff000000ff000000ff101010ff8f8f8fffbfbfbfffbfbfbfff606060ff000000ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffff606060ff000000ff000000ff202020ff8f8f8fffbfbfbfffbfbfbfff707070ff000000ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff000000ff101010ff7f7f7fffbfbfbfffbfbfbfff707070ff000000ff000000ff000000ffafafafffffffffffffffffff404040ff000000ff000000ff303030ff9f9f9fffbfbfbfffafafafff606060ff000000ff000000ff101010ffcfcfcfffffffffff202020ff000000ff000000ff7f7f7fffbfbfbfff7f7f7fff000000ff000000ff606060ffffffffff7f7f7fff000000ff000000fffffffffffffffffff4dfe5ffb0103dff990033ffc04064ffffffffffffffffffbb3057ff990033ff990033ffc04064ffde9baeffeabfcbffe5afbeffcb607eff990033ff990033fffffffffff4dfe5ffb0103dff990033ff990033ffcb607effe5afbeffeabfcbffde9baeffc04064ff990033ff990033ffbb3057ffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff606060ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ff000000ff000000ff000000ff000000ff000000ff000000ff101010ff505050ff000000ff404040ffffffffffefefefff303030ff000000ff000000ff000000ff000000ff000000ff000000ff9f9f9fffffffffff404040ff000000ff404040ffffffffffffffffffffffffffffffffffffffffff404040ff000000ff404040ffffffffff7f7f7fff000000ff000000ffffffffffffffffff7f7f7fff000000ff404040ffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffff606060ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff404040ff000000ff000000ffbfbfbfffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffff606060ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff101010ffafafafffffffffffffffffffffffffff000000ff000000ff7f7f7fffffffffffffffffffffffffffffffffffffffffff404040ff000000ff7f7f7fffffffffff7f7f7fff000000ff000000ff404040ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff9f9f9fffffffffffffffffffffffffffefefefff505050ff000000ff000000ff000000ff000000ff000000ff000000ff000000ff101010ffcfcfcfffffffffffffffffffcfcfcfff101010ff000000ff000000ff000000ff000000ff000000ff101010ffdfdfdfffffffffff7f7f7fff000000ff000000ffffffffffffffffffeabfcbff990033ff990033ff990033fffffffffffffffffffaeff2ffc04064ff990033ff990033ff990033ff990033ff990033ff990033ff990033ffb0103dffffffffffffffffffefcfd8ffb6204aff990033ff990033ff990033ff990033ff990033ff990033ff990033ffc04064fffaeff2ffffffffffffffffffd47d96ff990033ff990033ffffffffffffffffffffffffffffffffffffffffff990033ff990033ffeabfcbffffffffffffffffffffffffffffffffffc04064ff990033ffc04064ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfff000000ffefefefffffffffffffffffffffffffffffffffffffffffffcfcfcfff101010ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffefefefff707070ff202020ff000000ff000000ff202020ff707070ffefefefff9f9f9fff404040ff707070ffffffffffffffffffefefefff7f7f7fff202020ff000000ff000000ff303030ffbfbfbfffffffffffffffffff707070ff404040ff707070ffffffffffffffffffffffffffffffffffffffffff707070ff404040ff707070ffffffffff9f9f9fff404040ff404040ffffffffffffffffff9f9f9fff404040ff707070ffffffffffffffffffffffffffffffffffffffffff9f9f9fff404040ff404040ffffffffffffffffffffffffffffffffff9f9f9fff404040ff000000ff000000ff000000ff505050ffbfbfbfffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffff404040ff404040ff9f9f9fffffffffffffffffffffffffffffffffffbfbfbfff505050ff101010ff000000ff000000ff202020ff707070ffdfdfdfffffffffffffffffffffffffffffffffff404040ff404040ff9f9f9fffffffffffffffffffffffffffffffffffffffffff707070ff404040ff9f9f9fffffffffff7f7f7fff000000ff000000ffffffffff9f9f9fff303030ff000000ff000000ff101010ff505050ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff505050ff000000ff000000ff000000ff303030ff7f7f7fffefefefffffffffffffffffffffffffffffffffffcfcfcfff505050ff000000ff000000ff101010ff606060ffdfdfdfffffffffffffffffff9f9f9fff404040ff404040fffffffffffffffffffaeff2ffbb3057ff990033ffd47d96ffffffffffffffffffffffffffffffffffde9baeffc04064ff990033ff990033ff990033ffbb3057ffd47d96fffaeff2fffffffffffffffffffffffffffaeff2ffde9baeffbb3057ff990033ff990033ff990033ffc55071ffde9baeffffffffffffffffffffffffffffffffffde9baeffc04064ffc04064ffffffffffffffffffffffffffffffffffffffffffc04064ffc04064ffefcfd8ffffffffffffffffffffffffffffffffffd47d96ffc04064ffd47d96ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfdfdfffbfbfbfffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffbfbfbfff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ffbfbfbfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffafafafff000000ff000000ff9f9f9fffffffffffffffffffffffffffffffffffffffffffffffffff404040ff000000ff101010ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff101010ff000000ff101010ffcfcfcfffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff606060ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff000000ff000000ff000000ff505050ff7f7f7fff7f7f7fff303030ff000000ff000000ff101010ffefefefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff101010ff000000ff000000ff000000ff000000ff000000ff000000ff303030ffcfcfcfffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff7f7f7fff000000ff000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffefefefff8f8f8fff505050ff404040ff404040ff606060ffafafafffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff9f9f9fff404040ff404040ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff000700ae00700007000100010003000300040000000d000c001000d800d800d800d800280018003610517569636b54696d65aa20616e6420610000280024003f0d206465636f6d70726573736f7200280030000f1f617265206e656564656420746f20736565207468697320706963747572652e000000a100e007ac00000000000007a86170706c022000006d6e74725247422058595a2007d900020019000b001a000b616373704150504c000000006170706c000000000000000000000000000000000000f6d6000100000000d32d6170706c00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000b64657363000001080000006f6473636d000001780000056c63707274000006e400000038777470740000071c000000147258595a00000730000000146758595a00000744000000146258595a0000075800000014725452430000076c0000000e636861640000077c0000002c625452430000076c0000000e675452430000076c0000000e64657363000000000000001447656e65726963205247422050726f66696c6500000000000000000000001447656e65726963205247422050726f66696c6500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000006d6c7563000000000000001e0000000c736b534b00000028000001786872485200000028000001a06361455300000024000001c87074425200000026000001ec756b55410000002a0000021266724655000000280000023c7a685457000000160000026469744954000000280000027a6e624e4f00000026000002a26b6f4b5200000016000002c86373435a00000022000002de6865494c0000001e00000300646544450000002c0000031e68754855000000280000034a7376534500000026000002a27a68434e00000016000003726a614a500000001a00000388726f524f00000024000003a2656c475200000022000003c67074504f00000026000003e86e6c4e4c000000280000040e6573455300000026000003e874685448000000240000043674725452000000220000045a66694649000000280000047c706c504c0000002c000004a47275525500000022000004d06172454700000026000004f2656e555300000026000005186461444b0000002e0000053e005601610065006f006200650063006e00fd0020005200470042002000700072006f00660069006c00470065006e006500720069010d006b00690020005200470042002000700072006f00660069006c00500065007200660069006c0020005200470042002000670065006e00e800720069006300500065007200660069006c0020005200470042002000470065006e00e9007200690063006f0417043004330430043b044c043d043804390020043f0440043e044404300439043b002000520047004200500072006f00660069006c0020006700e9006e00e9007200690071007500650020005200560042901a75280020005200470042002082725f6963cf8ff000500072006f00660069006c006f0020005200470042002000670065006e0065007200690063006f00470065006e0065007200690073006b0020005200470042002d00700072006f00660069006cc77cbc1800200052004700420020d504b85cd30cc77c004f006200650063006e00fd0020005200470042002000700072006f00660069006c05e405e805d505e405d905dc0020005200470042002005db05dc05dc05d90041006c006c00670065006d00650069006e006500730020005200470042002d00500072006f00660069006c00c1006c00740061006c00e1006e006f00730020005200470042002000700072006f00660069006c666e901a0020005200470042002063cf8ff065874ef64e00822c0020005200470042002030d730ed30d530a130a430eb00500072006f00660069006c0020005200470042002000670065006e0065007200690063039303b503bd03b903ba03cc002003c003c103bf03c603af03bb002000520047004200500065007200660069006c0020005200470042002000670065006e00e9007200690063006f0041006c00670065006d00650065006e0020005200470042002d00700072006f006600690065006c0e420e1b0e230e440e1f0e250e4c002000520047004200200e170e310e480e270e440e1b00470065006e0065006c0020005200470042002000500072006f00660069006c00690059006c00650069006e0065006e0020005200470042002d00700072006f006600690069006c00690055006e006900770065007200730061006c006e0079002000700072006f00660069006c0020005200470042041e04310449043804390020043f0440043e04440438043b044c00200052004700420645064406410020062a06390631064a0641002000520047004200200627064406390627064500470065006e00650072006900630020005200470042002000500072006f00660069006c006500470065006e006500720065006c0020005200470042002d006200650073006b0072006900760065006c007300657465787400000000436f707972696768742032303037204170706c6520496e632e2c20616c6c207269676874732072657365727665642e0058595a20000000000000f35200010000000116cf58595a20000000000000744d00003dee000003d058595a200000000000005a750000ac730000173458595a20000000000000281a0000159f0000b83663757276000000000000000101cd0000736633320000000000010c42000005defffff326000007920000fd91fffffba2fffffda3000003dc0000c06c00a100e000040000000200ff}}}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par The Washington Post\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 February}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  22, 2001 Thursday  \par Final Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Kenyan Orphanage Takes Initiative on AIDS Drugs}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Karl Vick, Washington Post Foreign Service\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 A SECTION; Pg. A12\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1295 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 DATELINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAIROBI Feb. 21\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  -- A small orphanage run by a Jesuit priest from the United States will be the first place in Africa to seek to import deeply discounted AIDS drugs under an Indian pharmaceutical company's new program to make such drugs more affordable on the continent where most of the world's AIDS patients live and die. \par  The Rev. Angelo D'Agostino, a former Georgetown University Hospital medical professor who runs the Nyumbani home for orphans with AIDS or HIV in suburban Nairobi, said today that he will import antiretrov}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ral medicines from }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Ltd. of Bombay. \par  "I am sick and tired of doing funerals," D'Agostino said. Although he estimated that the discounted drugs might be sufficient to treat only 20 of the 70 children at his orphanage, his efforts reflect increasing willin}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 g}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ness of nongovernmental organizations and AIDS activists to defy national regulations and international p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tent rules to buy cheaper, generic AIDS drugs.  \par  }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  chairman, Yusuf Hamied, made headlines two weeks ago when he announced that, by taking a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 vantage of World Trade Organization rules that permit countries to suspend patents in the event of national emergencies, he would sell a combination of three generic antiretroviral medicines for as little as $ 350 for a year's supply for one person; similar treatment in the United States costs $ 10,000. \par  }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offer amounted to an open challenge to major pharmaceutical companies that hold the patents on many such AIDS drugs and have worked hard to control prices. In countries such as India and Brazil where Western pharmaceutical giants' patents do not apply, generic AIDS drugs such as antiretrovirals are man}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 factured and can be provided to HIV patients at comparatively low cost. \par  Antiretroviral drugs are the components of the "triple-drug cocktail" that has been found to delay or prevent the onset of AIDS in patients infected with HIV, the human immunodeficiency virus. \par  }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offer to provide triple-drug therapy for $ 350 per person was originally made only to the French me}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ical aid group Doctors Without Borders, which would then provide the drugs at no cost to patients at its treatment centers throughout Africa. But D'Agostino said today that he was seeking to buy the antiretrovirals directly from }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  and would accept donated AZT, another AIDS drug, from a Brazilian firm. \par  When -- or whether -- the drugs will reach D'Agostino's orphanage remains to be seen. Sam Ongeri, Ke}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ya's minister of public health, said today that despite D'Agostino's announcement, Kenyan law barring co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 mercial import of generic drugs would remain in force. But he also noted that Kenya's parliament may amend the law next month to allow such imports. "And it's a desired event," Ongeri said. "But before we get to that point, the pharmaceutical industry should drop their prices." \par  In addition, Doctors Without Borders officials said loopholes in existing law may allow D'Agostino to import the drugs before new legislation is passed. \par  "I'm hoping the government will transcend the restrictions and allow [the drugs] in," said D'Agostino. "The companies might put up some static, but I don't think the government, in the interest of the people, will give us any problem." \par  D'Agostino's announcement, on the heels of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  discount offer, underscored how the question of a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 c}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cess to expensive AIDS drugs appears to be moving beyond the control of the Western drug giants. \par  Brazil, whose national AIDS program is hailed as a model for developing countries, treats 90,000 citizens with drugs it manufactures under the same }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  provision. It has offered to export both the drugs and the technology to African countries. \par  "In a way, Brazil right now is kind of driving the market," said James Love of the Consumer Project on Tec}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 h}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nology, a Washington-based advocacy group that has championed wider access to essential medicines. "Now if you were to add any reasonable market in Africa, it's reasonable to expect prices to go down even further." \par  The drug giants are fighting back on several fronts. With the encouragement of American drug firms, the U.S. Trade Representative is challenging Brazil's interpretation of a key }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  rule. And in South Africa, which three years ago passed legislation allowing the manufacture of AIDS drugs there, 42 drug companies have filed suit to block the law. \par  That case, scheduled for trial March 5 in South Africa, has cast an intimidating shadow over other African governments.  \par  The industry giants also have tried to satisfy growing calls to provide drugs for poor countries while assuring the drugs were brand names. Last year, five large Western firms offered to negotiate with African gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ments to reduce prices on AIDS medicines by up to 80 percent. \par  Nine months later, however, agreements have been reached with only three countries. And the deals, with Senegal, Uganda and Rwanda, will provide medicine for fewer than 3,000 of the 1.3 million infected with HIV in those countries. Throughout the continent, an estimated 22 million people are infected; 11 million have already died of AIDS-related causes. \par  One company, Glaxo Wellcome, announced today it would offer aid agencies working in Africa "greatly di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 counted" prices on its AIDS drugs, but provided no specifics. The company holds the patent on lamivudine (3TC), one of the drugs offered by }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 . \par  "Should it be found we cannot assist an organization such as the Nyumbani orphanage, we will be symp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 thetic to the need for action and will judge each situation on its merits," said Glaxo spokeswoman Vicki Ehrich. \par  In South Africa, Pfizer Inc. will begin distributing the drug Diflucan free to HIV and AIDS patients at gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment hospitals and clinics within the next few weeks, the health department and Pfizer said today. The drug, generically known as fluconazole, is used to treat some infections that occur in AIDS patients. \par  And in Kenya, where 2.1 million are infected with HIV and another million have died, another firm, Boehringer Ingelheim, recently reduced by 80 percent -- to just 74 cents -- its price for nevirapine, which r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 duces the chance of transmission of HIV from mother to child. But prices of many drugs remain prohibitive. Fluconazole, a meningitis treatment that Pfizer sells in Nairobi for $ 6 a pill, is available as a generic in Tha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 land for 30 cents. \par  "It's really the darker side of capitalism, the greed that is being manifest by these drug companies holding sub-Saharan Africa hostage," said D'Agostino. "People are dying because they can't afford their prices." \par  "We wonder what sacrifices are going to be made at the altar of profit," said Chris Ouma, a Nairobi physician with Action Aid Kenya. "Which is more deadly to Africa? Is it HIV, or is it the businessmen who have brie}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cases of patent applications?" \par  Such rhetoric -- far bolder than was heard in this part of Africa just months ago -- reflects the momentum that has gathered behind the AIDS drug campaign led by Doctors Without Borders. The movement scored a major victory in December 1999 when President Bill Clinton issued an executive order barring the U.S. trade office from challenging African nations that wanted to import or manufacture generics, while paying a royalty to the patent holder. \par  But the effect of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  price cut this month was tectonic. Hamied, the company chairman, said the $ 350 annual rate for a triple-drug cocktail was "a humanitarian price," subsidized by his firm and available only to Doctors Without Borders, which operates pilot programs involving only a few thousand patients. Gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ments would have to pay $ 600 for a year's supply of the same three-drug combination of stavudine, lamiv}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 u}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 dine and nevirapine.  \par  "It's time the international community looked at it from a more human point of view," Hamied said. \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV (97%); AIDS & HIV TREATMENT (96%); ANTIVIRALS (93%); PHARMACEUT}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 CALS INDUSTRY (91%); PHARMACEUTICAL PREPARATION MFG (90%); GENERIC DRUGS (90%); P}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TENTS (88%); CATHOLICS & CATHOLICISM (78%); INTERNATIONAL TRADE LAW (78%); ORPHANS (78%); INTERNATIONAL TRADE (78%); DRUG PRICES (77%); HEALTH DEPARTMENTS (77%); AIDS POLICY (77%); VIRUSES (75%); NONGOVERNMENTAL ORGANIZATIONS (74%); RELIEF ORGANIZ}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TIONS (73%); PATENT LAW (73%); INTERNATIONAL ASSISTANCE (73%); GENERIC PRODUCTS (73%); PHYSICIANS & SURGEONS (72%); COLLEGE & UNIVERSITY PROFESSORS (71%); MEDICAL CHAR}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TIES (71%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  LTD (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GEORGETOWN UNIVERSITY (57%); WORLD TRADE ORGANIZATION (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (94%); SIC2834 PHARMACEUTICAL PREPARATIONS (94%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAIROBI, KENYA (88%); MUMBAI, INDIA (73%) KENYA (96%); UNITED STATES (93%); AFRICA (93%); BRAZIL (92%); INDIA (79%); FRANCE (67%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 April 2, 2002\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 The Washington Post\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Prognosis: grim; FEATURES Australian Financial Review February 20, 2001 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_82}{\*\bkmkstart DOC_ID_82_0}{\*\bkmkstart doc_id_39}{\*\bkmkend DOC_ID_82}{\*\bkmkend DOC_ID_82_0}{\*\bkmkend doc_id_39}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_39"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00330039000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 39 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Australian Financial Review\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 February}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  20, 2001 Tuesday  \par Late Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 Prognosis: grim; \par FEATURES}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Julie Macken\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NEWS; Pg. 47\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 1689 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 While the developing world cannot afford drugs that would solve some of the health problems ravishing its population, pharmaceutical companies are focusing their research and marketing programs on countries where the profits are biggest. Julie Macken reports.\par The human genome project is creating a centrifugal force that has the potential to absorb the entire research and development budgets of the world's largest pharmaceutical companies, giving citizens of the rich world undreamt of access to health care\par and longevity.\par However, for the 75 per cent of the world's population that lives in developing countries, the existence of the genome will worsen an already dire situation. \par Simon Foote, assistant director of the Australian Genome Research Facility, believes the problem is a very simple one. "Diseases of the third world are of no interest to drug companies unless these diseases also a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 fect the first world. Because, if a drug company can't make a profit in the developed world, they won't make the drug," he says.\par The good news for global pharmaceutical companies is that, according to the World Health Organisation, the global burden of disease is shifting from diseases primarily affecting the developing world malaria, pneum}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nia, diarrhoeal and nutritional disease to diseases of the developed world. These include ischaemic heart disease, unipolar major depression and cerebrovascular disease. Happily, these are also the diseases that are receiving the lion's share of R&D dollars in the burgeoning area of genetic medicines.\par Unfortunately, even when a disease such as HIV/AIDS does infiltrate the developed world, gaining access to drug therapies remains an impossibility for many developing nations. Nor is access the only issue. The story of the drug eflornithine offers a very recent example of the economics and politics of global disease and drug distribution.\par Discovered during the 1970s, eflornithine was originally thought to offer a treatment for cancer. It was through a series of serendipitous meetings that Cyrus J. Bacchi, a biochemist working for Haskins Laborat}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ries at New York's Pace University, discovered the drug was also lethal against trypanosomiasis, or sleeping sickness.\par According to WHO, up to 500,000 Africans have trypanosomiasis and 60 million of the 400 million people in sub-Saharan countries are at risk.\par The name, sleeping sickness, suggests a gentle slide into unconsciousness before dying. Nothing could be further from the truth. Spread by infected tsetse flies, the first stage of the parasitic infection is characterised by fever and general weakness hard to diagnose but easy to treat. The second stage begins when the par}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 site has breached the brain wall and is multiplying in the brain itself. The result is madness, convulsions and sleep disorders, coma and death. Without treatment, it is fatal in all cases.\par Eflornithine earned the nickname "resurrection drug" because it can drag comatose patients back from the brink of death to full recovery within a couple of weeks. Unfortunately, it was not a success in fighting cancer. So, in 1990, the US Food and Drug Administration approved it as an orphan drug one that lacks a profitable market.\par The patent for the drug travelled through a number of mergers before eventually becoming the property of Bristol-Myers Squibb. Because there was no lucrative market for the drug in the developed world, production ceased. In a gesture of goodwill, the company donated the patent to WHO and the last of its stocks to Medecins Sans Frontieres.\par WHO was not up to the task of locating a company to produce the drug or to interest the United Nations. Supply was due to run out later this month. But then, in partnership with Gillette, Bristol-Myers Squibb di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 covered that eflornithine also removed facial hair.\par Production of this new product, Vaniqua, began last year. According to the company, with 20 million Amer}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 can women removing facial hair once a week and a two-month supply costing $US50 ($95), eflornithine's potential market is $US6 billion a year.\par In another gesture of goodwill and given that production of the drug is now in full swing Bristol-Myers Squibb announced last week that it would be donating a three-year supply of the drug to MSF. As one doctor said recently: "Thank God for unsightly facial hair."\par However, these small gestures of goodwill are overshadowed by the aggressive stance taken by global pharmaceutical companies over the issue of compulsory licensing and the production of generic drugs.\par On March 5 this year, 42 national and international pharmaceutical companies are taking the South African Government to the High Court of South Africa. The companies' complaints centre on the legality of the 1997 South African Medicines Act, Section 15(c), introduced by President Nelson Mandela.\par The act was an attempt by the Government to lower the prices of vitally needed pharmaceuticals particularly antiretrovirals to combat the spread and effect of HIV/AIDS. It focused on issues such as generic drug subst}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tution, restrictions of inappropriate marketing efforts, parallel imports and compulsory licensing.\par While the pharmaceutical companies maintain they are committed to supplying cheaper drugs to South Afr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ca to fight the HIV/AIDS pandemic, they believe Section 15(c) gives the country's health minister unlimited power to dismiss patents without following due process. Nevertheless, the Government is committed to fighting the court action, saying: "The Government would defend the action, seeing it as important to ensure the Government has the right to obtain cheap drugs to fight the AIDS epidemic sweeping the country."\par Most commentators believe the drug companies have little chance of success. And, were the matter referred to the World Trade Organisation as a breach of the Trade-Related Aspects on Intellectual Property and Se}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 vices (TRIPS) agreement, it would have even less chance. As a member of the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  South Africa has a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ways maintained the TRIPS agreement must be maintained in its entirety. Unfortunately for the drug comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nies, TRIPS allows for both compulsory licensing and parallel imports in the circumstances of a "health e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ception". It would be difficult to argue that the 25 million people living with HIV in sub-Saharan Africa do not constitute a "health exception".\par Nevertheless, having lost the support of the previous US administration after President Bill Clinton issued his executive order entitled "Access to HIV/AIDS Pharmaceutical and Medical Technologies", the drug comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nies are desperate to prevent the cheap generic drugs of the developing world flushing back onto the lucr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tive markets of the developed world.\par Last May, five multinational drug companies, with the sponsorship of WHO and other UN agencies, offered to sell their HIV/AIDS drugs to poor nations at reduced prices. However, with the companies doing their n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gotiations on a country-by-country basis, the process is a slow one. Only Uganda, Senegal and Rwanda have agreements. And, according to MSF, the cost of a typical set of combination therapies in Senegal is $US1,000 a year per person.\par While that is better than similar drug combinations that cost between $US10,000 and $US15,000 per patient each year in the US and Europe, it is still a lot more than $US350 a year. That is how much Indian pharm}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ceutical giant }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  is willing to charge MSF for generic antiretrovirals. On February 7, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  announced it would sell its triple-combination therapy for AIDS to MSF for $US350 a year per patient and to governments for $US600 a year.\par This is a discount of 96.6 per cent off the price of the same combination in the US, which would cost about $US10,400.\par While the global pharmaceutical companies investigate the legality of the offer, several of them have voiced concerns about the long-term sustainability of offering drug therapies at cost and have questioned whether South Africa has the infrastructure to administer and monitor the drug therapies without creating a drug-resistant strain of HIV.\par The spectre of drug resistance has often been used by pharmaceutical companies to argue that providing low-cost drugs to developing countries is not the whole answer. The experience of Brazil's attempt to rein in the virus over the past three years now gives a lie to that argument.\par In 1997, Brazil took responsibility for its growing HIV/AIDS problem by assuming a compulsory licence for the local manufacture of antiretrovirals. It committed itself to providing free HIV/AIDS therapies to everyone with the virus whether they lived in the cities, the streets or in rural outposts.\par This commitment reduced the death toll from the virus by 50 per cent between 1997 and 1999. It has had a major impact in preventing mother-to-child transmission and has saved the Government an estimated $US422 million over the same period. Nor has there been an increase in drug-resistance in the virus in Brazil despite the complexity of the drug combinations.\par However, while this is great news for those living with the virus, it is of major concern to pharmaceutical companies. So much so that they have pressed the new US Administration to bring a complaint before the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  dispute settlement body opposing Brazil's system for granting compulsory licences and the Gover}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ment's right to override patents in certain circumstances.\par The outcome is pending.\par While it is easy to see the question of access to medicines as a story of corporate greed versus the powe}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 less citizens of the developing world, the narrative is more complex than that. The pharmaceutical comp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 nies argue that they are not in the business of delivering global health; nor are they equipped to do so.\par At some point, the role of WHO and even the UN must be brought into question. Both organisations have the knowledge, the infrastructure and, given some leadership, the global goodwill to take a leading role in the distribution of drug therapies throughout the developing world.\par Unfortunately for the 15 million people who will die this year from infectious diseases, time is not on their side and all the advances made as a result of the genome project will not change a thing.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PHARMACEUTICALS INDUSTRY (93%); DEVELOPING COUNTRIES (90%); EMERGING MARKETS (90%); PHARMACEUTICAL PREPARATION MFG (90%); RESEARCH & DEVELOPMENT (90%); INFECTIOUS DISEASE (90%); GENOMICS (90%); DISEASES & DISORDERS (90%); TROPICAL DISEASES (89%); CANCER (78%); POPULATION SIZE (78%); MALARIA (78%); GENE BASED DRUGS (78%); PUBLIC HEALTH ADMINISTRATION (78%); BIOTECHNOLOGY & GENETIC SCIENCE (78%); R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 SEARCH INSTITUTES (78%); BRAIN (78%); LIFE EXPECTANCY (78%); POPULATION & D}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MOGRAPHICS (78%); HEALTH CARE ACCESS (78%); SLEEP (78%); GENETIC BIOCHEMISTRY (78%); HEALTH CARE (77%); GOVERNMENT BUDGETS (76%); BUDGETS (76%); ONCOLOGY (73%); SC}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENCE NEWS (73%); AIDS & HIV (73%); HEALTH DEPARTMENTS (73%); RESPIRATORY DISEASE (73%); SCIENCE & TECHNOLOGY (73%); DEPRESSION (69%); HEART DISEASE (69%); PNEUMONIA (67%); MULTINATIONAL CORPORATIONS (67%); BIOCHEMISTRY (64%); SLEEP DISORDERS (62%) Industry/Pharmaceutical; Health/Diseases; Statistics\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WORLD HEALTH ORGANIZATION (55%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NEW YORK, USA (79%) UNITED STATES (79%); AFRICA (79%) Third World; International\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 April 11, 2012\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Illus: Many developing nations are finding it impossible to gain access to drug therapies for HIV/AIDS. Photo: REUTERS\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 Fairfax Media Publications Pty. Limited\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 An AIDS Drug-Price War Newsweek February 19, 2001, \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_83}{\*\bkmkstart DOC_ID_83_0}{\*\bkmkstart doc_id_40}{\*\bkmkend DOC_ID_83}{\*\bkmkend DOC_ID_83_0}{\*\bkmkend doc_id_40}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_40"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00340030000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 40 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Newsweek\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 February}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  19, 2001, Atlantic Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 An AIDS Drug-Price War}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 By Fred Guterl; }{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid15420928 With }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Mac Margolis }{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid15420928 in Rio,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Sudip Mazumdar}{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid15420928  in New Delhi,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Tom Masland }{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid15420928 in Cape Town and }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Shehnaz Suterwalla }{\rtlch\fcs1 \ai\af1 \ltrch\fcs0 \i\f1\insrsid15420928 in London}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 SCIENCE TECHNOLOGY; Public Health; Pg. 53\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 627 words\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 HIGHLIGHT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 An Indian firm takes on the big suppliers\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 People infected with the HIV virus can stay alive indefinitely, but only if they can afford drug treatments that cost $10,000 to $15,000 a year in the United States. The big pharmaceutical companies that make the drugs say these steep prices are necessary; otherwise they would have no incentive to pony up hundreds of mi}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lions of dollars for research and development. What happens, though, when whole continents full of people are too poor even to contemplate paying the price?\par Government officials, humanitarians and business executives have batted this question around for years, but last week Yusuf Hamied came up with an unequivocal answer. The chairman of Bombay pharmaceutical firm }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  announced that the company would provide AIDS cocktails to be distributed through Medecins sans Frontieres, the nonprofit health organization, for a mere $350 a year for each patient. }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  stipulates only that MSF administer the drugs free of charge. "We want to provide these drugs at an economical and affor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 d}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 able price to the very needy," says Hamied. "I am confident that }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  will be able to supply any amount of drugs that [MSF] may need." \par Hamied's surprise announcement may provide a fillip to an ad hoc and rather haphazard campaign to get drugs more cheaply to AIDS patients in defiance of the leading drug companies. Brazil got things going in 1997 when it passed legislation protecting patent holders but reserving the right to break patents in a health emergency. In January, U.S. trade officials complained to the World Trade Organization. The law, they wo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ry, may set a precedent that erodes patent protections in other countries as well. "This is an unfair trade practice," says a U.S. official. The }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  convened a special panel to consider the issue. Brazil's health mini}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ter, Jose Serra, replied last week by threatening to usurp patents of two important AIDS drugs unless the prices come down fast. He named no names, but the two costliest cocktail ingredients imported into Brazil are Nelfinavir, made by Roche, and Merck's Efavirenz.\par It's easy to see why the Brazilians are up in arms. Steeper drug prices might threaten the health service's ability to maintain its care and treatment of 100,000 AIDS patients free of charge. The program was started in 1994; in the last five years, AIDS deaths have halved, and Brazil has become a model for other countries around the world. But the program is expensive, with imported drugs taking a big bite. Of the $305 million it costs to administer 12 different drugs, more than half goes toward four costly imports. And that's accounting for price reductions that Brazil has already won from drug companies, which have driven AIDS treatment costs to $4,500 a year per patient.\par Elsewhere, however, progress has been markedly slower. Five big pharmaceutical companies began wor}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing with United Nations agencies last May to get drugs cheaply to poor countries. Merck, for instance, su}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 plies Senegal with AIDS drugs at a cost of $1,000 to $1,800 a year for each patient. A lack of money and distribution problems have limited the program to only 120 patients since October. "We may have 1,000 p}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tients in a couple of years," says a Merck spokesman. With about 80,000 Senegalese carrying HIV, that would amount to a drop in the bucket.\par Back in July, Brazilian health officials met privately with ministers from Nigeria, South Africa, India and China about exporting generics and even the know-how to make the drugs. Nothing concrete appears to have come of the talks, at least not yet, but this is just the kind of defiance the big drug companies fear.\par With Mac Margolis in Rio, Sudip Mazumdar in New Delhi, Tom Masland in Cape Town and Shehnaz Sute}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 walla in London\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PERSON: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 YUSUF HAMIED (68%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 BRAZIL (96%); UNITED STATES (93%); AFRICA (79%); SOUTH AMERICA (79%); NORTH AMERICA (79%); ASIA (79%); INDIA (71%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NORTH AMERICA (77%); UNITED STATES (77%); SOUTH AFRICA (59%); AFRICA (59%); ASIA (54%); BRAZIL (50%); SOUTH AMERICA (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 CITY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 BOMBAY, INDIA (54%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 MUMBAI, INDIA (71%);   BRAZIL (96%); UNITED STATES (93%); AFRICA (79%); SOUTH AMERICA (79%); NORTH AMERICA (79%); ASIA (79%); INDIA (71%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV (91%); DISEASES & DISORDERS (91%); IMMUNE SYSTEM DISORDERS (91%); INTERNATIONAL ECONOMIC ORGANIZATIONS (90%); ECONOMIC NEWS (90%); PHARMACEUTICALS INDUSTRY (90%); PHARMACEUTICAL PREPARATION MFG (90%); CHEMICAL INDUSTRY (90%); PHARMACEUTICAL & MEDICINE MFG (90%); ANTIVIRALS (89%); PRICE CHANGES (89%); PRICE CUTTING (89%); AIDS TREATMENT (89%); PATENTS (86%); NONPROFIT ORGANIZATIONS (71%); R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 E}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 LIEF ORGANIZATIONS (70%); PATENT LAW (70%); LEGISLATION (70%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 February 15, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PHOTO: Breaking ranks: Yusuf Hamied, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  chairman, is offering low-cost AIDS drugs; PHOTO: Awaiting medicine: an AIDS patient in South Africa\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 Newsweek\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Cipla launches AIDS drugs price battle Australian Financial Review February 13, 2001 Tuesday \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_84}{\*\bkmkstart DOC_ID_84_0}{\*\bkmkstart doc_id_41}{\*\bkmkend DOC_ID_84}{\*\bkmkend DOC_ID_84_0}{\*\bkmkend doc_id_41}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_41"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00340031000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 41 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Australian Financial Review\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 February}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  13, 2001 Tuesday  \par Late Edition\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928  launches AIDS drugs price battle}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Julie Macken\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NEWS; International News; Pg. 10\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 388 words\par \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Firing the first shot in a global price war over HIV/AIDS drugs, Indian pharmaceutical giant }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  has offered to sell Medecins Sans Frontieres its triple-combination therapy for AIDS for $US350 ($652.50) per year per patient, and to governments for $US600 per year. \par According to MSF, "the $US350 price is a discount of 96.6 per cent off the price of the same combination in the United States, which would cost about $US10,400".\par Dr Yusuf Hamied, }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  chairman, has promised to supply "10,000 doses or 20,000 or 30,000, however many they want ... This is the way to break the stranglehold of the multinationals".\par While the large pharmaceutical companies wait for more detail of the offer before they comment, a German-based company, Boehringer-Ingelheim, said it was concerned about the legality of the offer.\par The company said the offer might be in breach of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  rules and the Trade-Related aspects on Intellectual Property and Services (TRIPS) agreement.\par But according to MSF Australia, as India has not yet signed the TRIPS agreement, Indian companies are entitled to produce and export generic drugs.\par The South African Government will face a court action on March 5 by 40 national and international pharm}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ceutical companies, including Boehringer-Ingelheim, Glaxo Wellcome, Bristol-Myers Squibb and Eli Lilly.\par It is doubtful whether South Africa will be able to take up }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offer until the case is resolved. That could take up to a year.\par That court action centres on the Medicines and Related Substances Control Amendment of 1997, introduced into the South African Parliament by the then prime minister, Mr Nelson Mandela.\par The amendment would have allowed the Government to bypass the monopoly granted to companies holding the patents in South Africa. The Government argued the measure was necessary to ensure access to HIV/AIDS drug treatments, which were priced much higher than what most South Africans could afford.\par According to Mr Toby Casper, MSF's co-ordinator of the Access to Medicines Campaign for Africa, the big pharmaceutical companies have already won a major victory whatever the outcome of the court case.\par "They have been able to keep cheaper, generic drugs out of Africa for three years, while they sell their drugs and make a huge profit at the expense of millions of AIDS sufferers across the continent," he said.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 AIDS & HIV (94%); PHARMACEUTICALS INDUSTRY (93%); AIDS & HIV TREATMENT (93%); PHARMACEUTICAL PREPARATION MFG (91%); ANTIVIRALS (90%); DRUG PRICES (90%); PRICE CUTTING (90%); PRESCRIPTION DRUGS (89%); PRICE CHANGES (89%); GENERIC DRUGS (89%); HEALTH CARE ACCESS (89%); MEDICAL CHARITIES (78%); INTERNATIONAL ASSISTANCE (78%); MULTINATIONAL CORPORATIONS (78%); DISEASES & DISORDERS (78%); HEADS OF STATE & GOVERNMENT (77%); GENERIC PRODUCTS (73%); EXPORT & IMPORT LAW (72%); INTERNATIONAL TRADE LAW (72%); EXPORT TRADE (72%); INTELLECTUAL PROPERTY LAW (67%); PATENTS (67%); PRIME MINISTERS (66%); RELIEF ORGANIZATIONS (58%) Industry/Pharmaceutical; Health/Diseases/Aids; Law/Cases\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  LTD (92%); ELI LILLY & CO (90%); BRISTOL-MYERS SQUIBB CO (90%); BOEHRINGER INGELHEIM GMBH (56%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (92%); LLY (SWX) (90%); LLY (NYSE) (90%); LEL (LSE) (90%); BMY (NYSE) (90%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (90%); SIC2834 PHARMACEUTICAL PREPARATIONS (90%); NAICS325411 MEDICINAL & BOTANICAL MANUFACTU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 R}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ING (90%); SIC5122 DRUGS, DRUG PROPRIETARIES, & DRUGGISTS' SUNDRIES (56%)\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 SOUTH AFRICA (95%); UNITED STATES (92%); AFRICA (92%); INDIA (79%) India; South Africa\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 April 11, 2012\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 PUBLICATION-TYPE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Newspaper\par \par \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 Fairfax Media Publications Pty. Limited\par All Rights Reserved\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 At the mercy of drug giants: Millions struggle with disease as pharmaceutical firms go to court to protect profits The Guardian (London) February 12, 2001 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_85}{\*\bkmkstart DOC_ID_85_0}{\*\bkmkstart doc_id_42}{\*\bkmkend DOC_ID_85}{\*\bkmkend DOC_ID_85_0}{\*\bkmkend doc_id_42}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_42"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00340032000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 42 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 The Guardian (London)\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 February}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  12, 2001\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 At the mercy of drug giants: Millions struggle with disease as pharm}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 ceutical firms go to court to protect profits}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Sarah Boseley in Johannesburg\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Guardian Home Pages, Pg. 1\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 2245 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Refilwe is a spectral figure, so thin that the light from the huge hospital window at her back seems to pass through her. She sits as straight as a knife, all bone, white robe, and huge eyes gazing at nothing, breathing shallowly through an open mouth. She is 30 and has a son of seven. She has tuberculosis and her mouth is covered with the telltale white spots of a common infection she cannot fight off, because HIV is destroying her body's resistance.\par  Ask her how she is and she slowly turns her entire body towards you. "I'm feeling better," she whispers. It is a fiction maintained by the plump and jolly nurses at the Natalspruit hospital outside Johannesburg who have dozens more like her on drips in wards 13 and 16, where anybody with any strength resists going because if you have HIV, you have no future.\par  Refilwe, impossibly, gets to her feet and makes her way with pitiful steps and the arm of a nurse to the door, a walking wraith. She is going to the TB clinic. They will sort out the TB but then they will send her home to die. She is fatally weakened and there are no antiretroviral drugs to take on HIV here. \par  Nokuthula, 23, is also under a death sentence, for all that she appears robust with health. So is her 18-month-old son Sipho, whose name means a gift. The young mother has put herself and her child in the care of the traditional healer in the township outside Natalspruit hospital who gives them herb and bark infusions to make them strong. But traditional medicine could not save Nokuthula's husband, who died of Aids last September.\par  At an age when women in the west are embarking on families and careers, Refilwe and Nokuthula have b}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 gun the business of dying. They live in the East Rand suburbs of Johannesburg, South Africa, where one in five is estimated to be harbouring the virus that will kill them.\par  Across Africa and the developing world millions more will die of diseases that are treatable in the west, such as diarrhoea, meningitis, malaria, TB and Aids. The hospitals do what they can, but their best efforts are a sticking plaster on a haemorrhage. The western drugs they need are unaffordable. Life is priced too high.\par  Thirty-five miles away in Pretoria, a legal battle critical to the fate of many more women like Refilwe and Nokuthula, their men and their children, is about to begin. Case number 4183/98 in the South African high court is an action brought by 42 pharmaceutical companies, including the British giant GlaxoSmithKline, against the South African government.\par  The case is an attempt to block South Africa from importing cheap medicines. The drug companies have spent three years and millions of pounds preparing the case.\par  They have retained virtually every patent lawyer in South Africa. On March 5 their barristers will try to stop the South African government from buying the medicines its people so badly need from countries where the prices are lowest, on the grounds that it is infringing world trade agreements.\par  The rest of Africa will be closely watching the outcome of the trial. So will developing countries on other co}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tinents. With the death toll from infectious diseases inexorably rising, especially in Africa, a tide of outrage is swelling among local activists and international aid organisations who see medicines denied to the sick in the name of commerce.\par  More than 2.5m people die every year from Aids-related illnesses. More than 13m children have lost one or both parents to the condition. There are more than 32m men, women and children infected by HIV in deve}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 oping countries. AZT and 3TC, the basic antiretroviral drugs in the west, would keep them alive and well, but the price tag is Dollars 10,000 (pounds 7,000) to Dollars 15,000 per patient a year. The majority of employed people in South Africa, with whole families to support, earn less than Dollars 3,000 a year, and by compar}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 son with most of the rest of the continent, they are rich.\par  But there are now alternatives - cheap copies of life-saving medicines called generics, made mainly in Br}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 zil, India and Thailand whose national laws allow them to ignore drug patents in cases of dire human need. Thailand believes it could reduce the cost to Dollars 200 a year per patient. It is a price the South African government might be able to pay for the life of Refilwe and Nokuthula, but the drug companies, in Case 4183/98, afraid of the potential worldwide consequences if their prices start to be undercut, say no.\par  Today in Cape Town at least 5,000 supporters of the successful grassroots Treatment Action Campaign will march on parliament to demand the medicines. At the same time in London, Oxfam is launching an intern}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tional campaign demanding help for developing countries who want to use legitimate measures to buy or make their own cheap drugs, but who are bullied into submission by the lawyers working for drug companies and by the western governments who support them.\par  The pharmaceutical companies argue that they need 20 years of patent protection to recoup the vast sum it costs to research and develop drugs. They say it takes Dollars 1bn and at least 12 years to get a new med}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 cine to market.\par  But, their accusers say, 90% of those new medicines are designed for 10% of the world's population in rich countries who can pay for them. The companies argue they already sell to developing countries at prices lower than in the west and that, with the approval of UNAids, the joint UN programme on HIV/Aids, five major companies have offered 85% discounts on drugs that are badly needed.\par  That could bring antiretrovirals down to Dollars 1,500 a patient, low enough for poor countries to hand them out to a chosen few but, say critics, millions would still have to die.\par  The Pharmaceutical Manufacturers Association of South Africa, which is bringing the case with the intern}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tional companies, says it supports any country's right to buy supplies of drugs that are cheaper abroad "in exceptional circumstances". But it argues that section 15c of the Medicines Act, passed by the South African government in 1997 to allow it to import cheap copies of western medicines, would give the health minister "unfettered discretion to override patent rights for medicines in this country". And it was appalled when the South African delegation told a World Health Organisation meeting in January 1999 that the new legislation was a model which the rest of Africa should follow.\par  It is not just Africa that worries the big pharmaceuticals. On behalf of the industry the US government is ta}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 k}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ing the offensive to Brazil, which has had dramatic success in manufacturing its own cheap copies of paten}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 t}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ed drugs and now exports generics. Its price for an AZT equivalent is down from Dollars 15,000 a year to Dollars 4,000. There are now 60,000 people with HIV in Brazil who get free treatment.\par  At the heart of the growing legal battles directed against South Africa, Brazil and several other developing countries lies a little known international agreement called Trips - trade related intellectual property rights. It was agreed within the World Trade Organisation in order to ensure patent rights were respected around the world. The poorest countries have until 2006 to comply with Trips by passing their own patent laws. Under Trips, signatory states can pass clauses, as South Africa has tried to do, to bypass patents and make or buy cheaper drugs in cases of "dire emergency", and few could argue Aids is less than that.\par  But the west's sharp legal minds, backed by vast drug company wealth, are willing and able to mount e}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 x}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 pensive challenges in the courts to uphold their patent rights - and thus the price of their drugs - as is about to happen in Pretoria.\par  For the first time, there is also about to be a challenge in the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  itself. Last month the new US administr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tion, which accepted substantial election funding from the pharmaceutical industry, asked for a }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  di}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 s}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 putes hearing where it will claim Brazil is in breach of Trips. Oxfam and others fear the offensive against Br}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 a}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 zil and South Africa marks a new determination by the drugs companies to resist the flouting of their patents by poor countries.\par  GlaxoSmithKline has recently threatened legal action against the Indian generics company }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla,}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  blocking its plans to bring a cheap version of Combivir - AZT and 3TC in one pill - into Uganda and Ghana. "The i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 m}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 plementation of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  patent rules is taking place against the backdrop of a sustained campaign led by the pharmaceutical industry which may well erode the public health protection provided by safeguard provisions," says an Oxfam report published today.\par  In Khayelitsha, a shanty town that sprawls over a vast plain near Cape Town's airport, the Nobel prize-winning volunteer doctors are raising the stakes. They pioneered the use of nevirapine, a drug that stops pregnant women transmitting HIV to their babies. Now the government is rolling out the programme to the entire country.\par  After the period of apostasy, when President Thabo Mbeki upset the medical world by doubting that HIV caused Aids, the government seems willing to seek out and use cheap drugs if it is allowed to.\par  Last year it opened an infectious diseases clinic - code for HIV - where people are offered counselling and treatment for the "opportunistic infections" that can kill. They use flucona zole, a strong antibiotic most hosp}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tals lack because of its price, to treat cryptococcal meningitis and thrush.\par  In May, they will take the most radical step of all and start 150 adults and 30 children who are at death's door on antiretrovirals - the very medication that keeps people in the west with HIV alive. Dr Eric Goemaere, head of the South African mission of Medecins sans Frontieres, sees it as a marker for the future. "We are here on the frontline to show that it is possible and it will change attitudes totally," he says.\par  South Africa could by now be in the relatively advantageous position of Brazil, he believes, making its own cheap drugs and importing others. Perhaps Nokuthula's husband need not have died and Refilwe might be strong. There was a political willingness to use generics in 1997, but Case 4183/98 put a stop to all that. "I have no hesitation in saying that I'm totally convinced that's exactly where it is," Dr Goemaere said. "The pharmaceutical companies blocked South Africa becoming like Brazil."\par  South Africa's director general of health, Ayunda Ntsaluba, says something similar. "Three years down the road, access to medicines would have been completely different. We would be providing certainly for oppo}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 r}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 tunistic infections, although it would be disingenuous to say we would have been providing triple therapy," he said.\par  It is hard to be a doctor in Africa. Herman Reuter, a young South African of German extraction who works for MSF in Khayelitsha, has more medicines at his disposal than most, but he is clearly under strain. Doctors go into the profession to cure the sick, not temporarily staunch their wounds before they die.\par  "We have our worse days and our better days," he says. "I saw one woman last Friday with a CD4 count of two (very low resistance to infection). I said we hope to give antiretrovirals by May. She said, 'yes, but doctor, what happens until May?' I see many people die."\par  A very sick woman of about 41 had been brought to his clinic that morning by her 18-year-old daughter. She had cryptococcal meningitis. A week earlier, she had been to a government hospital and was turned away. There was nothing they could do for her, they said. They did not have the right medicine. But they mentioned the MSF clinic.\par  Dr Reuter was able to give her fluconazole, which costs around Dollars 4 for a 200mg capsule that will, for the moment, save her life. His last resort is to send the very sick to Somerset hospital in Cape Town, where pharmaceutical companies are running trials of drug combinations for HIV.\par  There is a bitter irony in it. The trials cannot be run in Britain or the US where the drugs will eventually be sold because everyone who needs antiretrovirals is on them. Refilwe and Nokuthula have no hope of a trial. Their best chance is to eat well, if they can afford to, to build up their strength and hang on.\par  Refilwe, like the rest of the patients in wards 13 and 16, refuses to accept she has HIV. What is the point when there is no treatment? "I don't know why I'm sick," she says, barely audibly.\par  Nokuthula places all her hope in the traditional healer, David Ngalana, even though he acknowledges he can give her only limited help. A large poster on the wall declares: "Traditional medicine can cure almost all sicknesses but currently we cannot cure HIV/Aids."\par  Nokuthula knows nothing about Aids drugs. There are no antiretrovirals for the people of her township, so they may as well not exist. She will drink her treebark infusions and convince herself they failed to save her husband only because he did not take them properly. In that way, maybe, hope can triumph for a while over despair.\par  Tomorrow: Dying for Drugs - how the drug giants flex their global muscle. Plus: Luke Harding in India on the company battling against the new patent threat\par  Links:\par  www.oxfam.org.uk/cutthecost Oxfam's campaign for cheap drugs for the developing world www.cptech.org Consumer Project on Technology: independent watchdog with archive on access to medicines\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GLAXOSMITHKLINE PLC (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 GSK (NYSE) (58%); GSK (LSE) (58%); BIOC (EGX) (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (58%); SIC2834 PHARMACEUTICAL PREPARATIONS (58%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 GEOGRAPHIC: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 SOUTH AFRICA (95%); AFRICA (79%);   JOHANNESBURG, SOUTH AFRICA (90%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 SOUTH AFRICA (95%); AFRICA (79%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TUBERCULOSIS (90%); DISEASES & DISORDERS (90%); AIDS & HIV (90%); PHARMACE}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 U}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TICALS INDUSTRY (89%); ALTERNATIVE MEDICINE (89%); INFECTIOUS DISEASE (89%); PHARM}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 A}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 CEUTICAL PREPARATION MFG (88%); HOSPITALS (78%); MENINGITIS (78%); NURSES & NURSING (78%); RESPIRATORY DISEASE (77%); AIDS & HIV TREATMENT (76%); MALARIA (76%); ANTIVIRALS (75%); CHILDREN (71%); NEUROLOGICAL DISORDERS & INJURIES (71%); CAPITAL PUNISHMENT (70%); FAMILY (70%); LAW COURTS & TRIBUNALS (60%); PATENTS (50%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 February 12, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 ENGLISH\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 Guardian Newspapers Limited\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \page \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\qr \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Page \chpgn \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 South Africa;MSF Challenges Pharmaceutical Industry To Match Generic AIDS Drug Cuts  Africa News February 9, 2001 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 {\*\bkmkstart DOC_ID_86}{\*\bkmkstart DOC_ID_86_0}{\*\bkmkstart doc_id_43}{\*\bkmkend DOC_ID_86}{\*\bkmkend DOC_ID_86_0}{\*\bkmkend doc_id_43}\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\field{\*\fldinst {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 HYPERLINK \\l"cite_id_43"}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid4002276 {\*\datafield 08d0c9ea79f9bace118c8200aa004ba90b02000000080000000b00000063006900740065005f00690064005f00340033000000}}}{\fldrslt {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\ul\cf2\insrsid15420928 Return to List}}}\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li0\ri0\widctlpar\wrapdefault\hyphpar0\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 43 of 43 DOCUMENTS\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  Africa News\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 February}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  9, 2001\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1\afs28 \ltrch\fcs0 \b\f1\fs28\insrsid15420928 South Africa;\par MSF Challenges Pharmaceutical Industry To Match Generic AIDS Drug Cuts}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 BYLINE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 WOZA Internet\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SECTION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NEWS, DOCUMENTS & COMMENTARY\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LENGTH: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 654 words\par \par  \par }\pard \ltrpar\ql \li0\ri0\sb120\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Medecins Sans Frontieres (MSF) hopes the pharmaceutical industry in South Africa will take up the cha}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 l}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 lenge posed by generic drug manufacturer }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 , that it will sell its triple-combination therapy for AIDS to MSF at less than R8 a day.\par Speaking on SABC radio on Friday, MSF spokesperson Toby Casper said there was no reason why there should be any delay in the access to the drug for SA patients. "There should be no barriers in SA in terms of multinational company's patent rights - if government wants the drug, it can issue a compulsory licence, a mechanism allowed under international trade law in cases of emergency such as that posed by the AIDS pandemic," says Casper. \par He anticipates that drug companies in SA will exert pressure, but hopes they will respond to the challenge by slashing their own prices. "}{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  move shows how cheaply these drugs can be made available once the will is there," he says, adding that company's R&D costs have been paid many times over - all multinational drug company's sales these days are pure profits. "We have no problem with these companies making pro}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 f}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 its in rich northern countries, but the AIDS crisis in Africa demands a different approach," says Casper. In a statement this week, MSF says the details of }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla's}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offer request that government purchases have the "backing of MSF," which the international doctors' organisation says is not practical or necessary. "Therefore MSF requests that }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  offer this price directly to governments and UN agencies," says MSF.\par This offer demonstrates that the target price of R1 600/year, set out in an MSF report at the international AIDS conference in Durban last July, is almost within reach. The price is a discount of 96.6% off the price of the same combination in the US. For the short term, MSF calls on the five pharmaceutical companies i}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 n}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 volved in the UNAIDS Accelerating Access Initiative to match the current offer, make their prices public, and streamline the implementation process, so that drugs can be delivered as quickly as possible to patients. "The offer by Indian generic manufacturer }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 Cipla}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  demonstrates that proprietary companies can immediately reduce their prices further," says MSF. On World AIDS Day, MSF called on the five companies to lower their US prices by 95%. The organisation says that no company has responded positively. Under the UNAIDS initiative, Senegal is currently paying almost three times the generic price, while companies have refused to disclose prices for Uganda and Rwanda, according to MSF. "Political commitment to combating AIDS and improving access to treatment is a cornerstone of defeating this epidemic.\par For example, the political commitment of the government of Brazil has successfully cut AIDS deaths in half, largely thanks to its ability to produce generic AIDS medicines. "Large-scale quality producers, including the government of Brazil, can both supply life-saving medicines to other developing countries and support their efforts to begin domestic production. "Developing countries should take full advantage of their rights to pr}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 o}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 duce or import generic AIDS drugs under the }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 WTO}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  TRIPS agreement," urges MSF. The organisation says tat the immediate challenge is to convert this generic price into action. "The international community must now provide political, practical, and financial support. Political support is needed for developing countries to overcome barriers posed by patents."\par It says that the UN system can provide practical support through procurement and distribution assistance. And donors can provide financial support by allocating funds for purchase of drugs and implementation of antiretroviral treatment programmes. MSF calls for an international meeting to be immediately convened with representatives from developing countries, UN agencies, drug manufacturers, and funders to determine the best strategy for implementation.\par }\pard \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 SUBJECT: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 PHARMACEUTICALS INDUSTRY (95%); AIDS & HIV TREATMENT (91%); GENERIC DRUGS (91%); AIDS & HIV (91%); INTERNATIONAL ASSISTANCE (90%); PHARMACEUTICAL PREPARATION MFG (89%); MEDICAL CHARITIES (79%); RELIEF ORGANIZATIONS (79%); GENERIC PRODUCTS (78%); EPIDEMICS (77%); DELAYS & POSTPONEMENTS (77%); HEALTH CARE ACCESS (76%); MU}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 L}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TINATIONAL CORPORATIONS (75%); RESEARCH & DEVELOPMENT (73%); INFECTIOUS DISEASE (73%); PRICE CUTTING (73%); COMPANY PROFITS (71%); INTERNATIONAL TRADE LAW (70%); I}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928\hres1\chhres0 N}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 TELLECTUAL PROPERTY LAW (70%); PATENTS (70%); INTERNATIONAL TRADE (69%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 TICKER: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  (NSE) (92%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 INDUSTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 NAICS325412 PHARMACEUTICAL PREPARATION MANUFACTURING (92%); SIC2834 PHARMACEUTICAL PREPARATIONS (92%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 ORGANIZATION: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 DOCTORS WITHOUT BORDERS (95%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COUNTRY: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 SOUTH AFRICA (94%); UGANDA (79%); BRAZIL (79%); RWANDA (79%); AFRICA (79%); UNITED STATES (79%); SENEGAL (78%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 COMPANY: }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\cf18\insrsid15420928 CIPLA}{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928  LTD (92%);   DOCTORS WITHOUT BORDERS (95%); \par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LOAD-DATE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 February 9, 2001\par \par }{\rtlch\fcs1 \ab\af1 \ltrch\fcs0 \b\f1\insrsid15420928 LANGUAGE: }{\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 English\par \par }\pard \ltrpar\qc \li1200\ri1200\widctlpar\wrapdefault\faauto\rin1200\lin1200\itap0 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 Copyright 2001 AllAfrica, Inc\par \sect }\sectd \ltrsect\sbknone\linex0\sectdefaultcl\sftnbj {\headerr \ltrpar \pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af0\afs24 \ltrch\fcs0 \fs24\insrsid15420928 \par }}\pard\plain \ltrpar\ql \li0\ri0\widctlpar\wrapdefault\faauto\rin0\lin0\itap0 \rtlch\fcs1 \af0\afs20\alang1033 \ltrch\fcs0 \f6\fs20\lang1033\langfe1033\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af1 \ltrch\fcs0 \f1\insrsid15420928 \par }{\*\themedata 504b0304140006000800000021009be8704ffc0000001c020000130000005b436f6e74656e745f54797065735d2e786d6cac91cb6ac3301045f785fe83d0b6d872ba28a5d8cea28f5d1f8bf40306796c8bd823214d42f2f71d3b2e941202856e04d2ccbdf7cca85c1fc641ed3126e7a9d2abbcd00ac9fac65157e9cfcd4b76af5562a006064f58e92326bdaeafafcacd316052a2a654e99e393c18936c8f23a4dc0724a9b43e8ec0728d9d0960b7d0a1b92d8a3b633d3112673c79e8ba7cc2167603abe7833c9f4844aed5e3a96f8aaa348430380b2ca066aa9ab3ba8843ba20dc53f38b2e5bc87251cee6a97721dd2c09efb29ae81a541f10f90d46e1302c43e2cff31548468bf965e633d1be6d9dc5c6dbdd28ebc867e3c5ec4f00abff89fece34f3dfd65f000000ffff0300504b030414000600080000002100a5d6a7e7c0000000360100000b0000005f72656c732f2e72656c73848fcf6ac3300c87ef85bd83d17d51d2c31825762fa590432fa37d00e1287f68221bdb1bebdb4fc7060abb0884a4eff7a93dfeae8bf9e194e720169aaa06c3e2433fcb68e1763dbf7f82c985a4a725085b787086a37bdbb55fbc50d1a33ccd311ba548b63095120f88d94fbc52ae4264d1c910d24a45db3462247fa791715fd71f989e19e0364cd3f51652d73760ae8fa8c9ffb3c330cc9e4fc17faf2ce545046e37944c69e462a1a82fe353bd90a865aad41ed0b5b8f9d6fd010000ffff0300504b0304140006000800000021006b799616830000008a0000001c0000007468656d652f7468656d652f7468656d654d616e616765722e786d6c0ccc4d0ac3201040e17da17790d93763bb284562b2cbaebbf600439c1a41c7a0d29fdbd7e5e38337cedf14d59b4b0d592c9c070d8a65cd2e88b7f07c2ca71ba8da481cc52c6ce1c715e6e97818c9b48d13df49c873517d23d59085adb5dd20d6b52bd521ef2cdd5eb9246a3d8b4757e8d3f729e245eb2b260a0238fd010000ffff0300504b030414000600080000002100215aa28421070000db1d0000160000007468656d652f7468656d652f7468656d65312e786d6cec594f6f1b4514bf23f11d467b2fb113274da23a55ecd80db469a3d82dea71bc3bf64e33bbb39a1927f10db547242444411ca8c48d03022ab51297f269024550a47e05deccecae77e271939400153487d63bfb7b6fdefbbd3ff367af5c3d4a183a2042529e3683fa7bb5009134e4114d47cde076bf7b69354052e134c28ca7a4194c880cae6ebcfbce15bcae62921004f2a95cc7cd20562a5b5f5890210c63f91ecf480aef865c2458c1a3182d44021f82de842d2cd66a2b0b09a66980529c80da5bc3210d09ea6b95c146a1bcc3e03155520f844cf4b46ae248186cb45fd70839916d26d00166cd00e689f8619f1ca900312c15bc680635f3172c6c5c59c0ebb9105373642b725df397cbe502d1fea299538c06e5a4f56e63edf256a9df00989ac5753a9d76a75eea33001c86e0a9b5a5aab3d15dadb70a9d1590fd39abbb5d5bae355c7c45ffd28ccd6bad566b792db7c52a3520fbb331835fadad3436171dbc0159fcf20cbed1da6cb7571cbc0159fcca0cbe7b796da5e1e20d286634dd9f41eb8076bbb9f61232e46cdb0b5f05f86a2d874f51900d6576e929863c55f3722dc1f7b8e8024003195634456a9291210e218bdb98d181a07a02bc4e70e58d1d0ae5cc909e0bc950d04c35830f320c1531d5f7f2d9772f9f3d41c7f79f1edffff1f8c183e3fb3f58458ed4364e4755a917df7cfac7a38fd0ef4fbe7ef1f0733f5e56f1bf7cfff1cf3f7de60742f94ccd79fec5e35f9f3e7efee527bf7dfbd003df14785085f7694224ba490ed11e4fc031c38a6b391988f349f4634cab129be948e214eb593cfa3b2a76d0372798610fae455c06ef08681f3ee0b5f13dc7e05e2cc62a8fb7e3d9f53871803b9cb316175e16aeebb92a34f7c7e9c83fb91857717b181ff8e66ee3d4896f679c41dfa43e95ed983866ee329c2a3c22295148bfe3fb8478f8ba4ba9c3eb0e0d05977ca8d05d8a5a987a29e9d381934d53a16d9a405c263e0321de0e373b77508b339fd75be4c045425560e631be4f9843e3353c5638f1a9ece3845509bf8155ec33b237116115d7910a223d228ca34e44a4f4c9dc12e06f25e8d7a175f8c3bec326898b148aeefb74dec09c57915b7cbf1de324f3617b348dabd8f7e53ea42846bb5cf9e03bdcad10fd0c71c0e9dc70dfa1c409f7e9dde0361d39264d1344bf190b4f2caf11eee46f6fc286989856034ddde9d5094d5fd5b813e8dbb9e317d7b8a1553effea91c7ee37b5656f0209be9ad93ed1a8e7e14eb6e73617117df3bbf3161ea7bb040a6276897adb9cdf36e7e03fdf9ce7d5f3c5b7e469178606adb74c76a36db6ddc9dc5df79032d65313466e48b3f196b0f6445d18d472e6c449ca535816c34f5dc93081831b096c6490e0ea43aae25e8c33d8b4d703ad642473d52389322ee1b06886bdba351e36feca1e3597f521c4760e89d50e8fecf0921e2ece1aa51a63d5c81c688b8996b482b34eb67439570abebdce64756dd49967ab1bd34c5374662b5dd6149b4339505eba0683259bb0a941b015029657e0ccafa786c30e6624d2bcdb1815613151f87b42947b6d1d8971446c889ce10a9b7513bb228566fcd3eed91c391f9b256b40dae94698b4989f3f6724b950302519044f56134babb5c55274d80cd69617970314e2ac190ce1980b3f930c8226f53610b311dc15854ad8ac3db5164d914e3d5ef367551d6e2ee6148c53c699906a0bcbd8c6d0bcca43c5523d93b57f71b9a193ed621cf03493b359b1b40a29f2af5901a176434b864312aa6ab02b239a3bfb9877423e5644f4e2e8100dd858ec61083f70aafd89a884db0a53d0fa01aed634dbe695db5bf34e53bdd032383b8e5916e3bc5beaab99a2e22cdcf493d206f354310f7cf3da6e9c3bbf2bbae22fca956a1affcf5cd1cb015c1e2c453a0221dcec0a8c74a534032e54cca10b65310dbb02d67dd33b205be07a165e03f970bf6cfe17e440ff6f6bceea30650d6740b547474850584e542c08d985b664b2ef1465f57ce9b12a59aec86454c55c9959b307e480b0beee812bba070728865437dd246f03067732ffdce7bc820623bd47a9d69bd3c9caa5d3d6c03fbd71b1c50c4e9dd84be8fc2df82f4d2c57f7e9ea67e58d78b146561dd12fa6bba4465115cee2b7b6964ff59a269c6501aeacb5b663cd78bcb85c1807519cf51806cbfd4c06574048ff03eb1f1521b31f2bf482dae77bd05b117c7bb0fc21c8ea4bbaab4106e906697f0d60df63076d32695596da7ce7a3592b16eb0bdea896f39e205b5b7696789f93ec7213e54ee7d4e245929d33ec706dc7e6520d913d59a230342cce212630e62b57f543141fdc83406fc195ff98d94f533283275307d9ae30d935e0d124ffc9a45d706dd6e9338c46b2748f0c118d8e8af347c9842d21fb79a4d8221bb416d389560a2ef90e0dae608ed7a276b52c85174f172e25ccccd0b24b617397e653001fc7f2c6ad8f7680b74dd67aad8bab608aa57f85b23318efa7cc7bf2392b65f6a0f8ca40bd0665eae8d594e54c0179b389079f370586a357cff45f58746ca69b94ddf8130000ffff0300504b0304140006000800000021000dd1909fb60000001b010000270000007468656d652f7468656d652f5f72656c732f7468656d654d616e616765722e786d6c2e72656c73848f4d0ac2301484f78277086f6fd3ba109126dd88d0add40384e4350d363f2451eced0dae2c082e8761be9969bb979dc9136332de3168aa1a083ae995719ac16db8ec8e4052164e89d93b64b060828e6f37ed1567914b284d262452282e3198720e274a939cd08a54f980ae38a38f56e422a3a641c8bbd048f7757da0f19b017cc524bd62107bd5001996509affb3fd381a89672f1f165dfe514173d9850528a2c6cce0239baa4c04ca5bbabac4df000000ffff0300504b01022d00140006000800000021009be8704ffc0000001c0200001300000000000000000000000000000000005b436f6e74656e745f54797065735d2e786d6c504b01022d0014000600080000002100a5d6a7e7c0000000360100000b000000000000000000000000002d0100005f72656c732f2e72656c73504b01022d00140006000800000021006b799616830000008a0000001c00000000000000000000000000160200007468656d652f7468656d652f7468656d654d616e616765722e786d6c504b01022d0014000600080000002100215aa28421070000db1d00001600000000000000000000000000d30200007468656d652f7468656d652f7468656d65312e786d6c504b01022d00140006000800000021000dd1909fb60000001b0100002700000000000000000000000000280a00007468656d652f7468656d652f5f72656c732f7468656d654d616e616765722e786d6c2e72656c73504b050600000000050005005d010000230b00000000}{\*\colorschememapping 3c3f786d6c2076657273696f6e3d22312e302220656e636f64696e673d225554462d3822207374616e64616c6f6e653d22796573223f3e0d0a3c613a636c724d617020786d6c6e733a613d22687474703a2f2f736368656d61732e6f70656e786d6c666f726d6174732e6f72672f64726177696e676d6c2f323030362f6d61696e22206267313d226c743122207478313d22646b3122206267323d226c743222207478323d22646b322220616363656e74313d22616363656e74312220616363656e74323d22616363656e74322220616363656e74333d22616363656e74332220616363656e74343d22616363656e74342220616363656e74353d22616363656e74352220616363656e74363d22616363656e74362220686c696e6b3d22686c696e6b2220666f6c486c696e6b3d22666f6c486c696e6b222f3e}{\*\latentstyles\lsdstimax276\lsdlockeddef0\lsdsemihiddendef1\lsdunhideuseddef1\lsdqformatdef0\lsdprioritydef99{\lsdlockedexcept \lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority0 \lsdlocked0 Normal;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority9 \lsdlocked0 heading 1;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 2;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 3;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 4;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 5;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 6;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 7;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 8;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 9;\lsdpriority39 \lsdlocked0 toc 1;\lsdpriority39 \lsdlocked0 toc 2;\lsdpriority39 \lsdlocked0 toc 3;\lsdpriority39 \lsdlocked0 toc 4;\lsdpriority39 \lsdlocked0 toc 5;\lsdpriority39 \lsdlocked0 toc 6;\lsdpriority39 \lsdlocked0 toc 7;\lsdpriority39 \lsdlocked0 toc 8;\lsdpriority39 \lsdlocked0 toc 9;\lsdqformat1 \lsdpriority35 \lsdlocked0 caption;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority10 \lsdlocked0 Title;\lsdpriority1 \lsdlocked0 Default Paragraph Font;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority11 \lsdlocked0 Subtitle;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority22 \lsdlocked0 Strong;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority20 \lsdlocked0 Emphasis;\lsdsemihidden0 \lsdunhideused0 \lsdpriority59 \lsdlocked0 Table Grid;\lsdunhideused0 \lsdlocked0 Placeholder Text;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority1 \lsdlocked0 No Spacing;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 1;\lsdunhideused0 \lsdlocked0 Revision;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority34 \lsdlocked0 List Paragraph;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority29 \lsdlocked0 Quote;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority30 \lsdlocked0 Intense Quote;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority19 \lsdlocked0 Subtle Emphasis;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority21 \lsdlocked0 Intense Emphasis;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority31 \lsdlocked0 Subtle Reference;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority32 \lsdlocked0 Intense Reference;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority33 \lsdlocked0 Book Title;\lsdpriority37 \lsdlocked0 Bibliography;\lsdqformat1 \lsdpriority39 \lsdlocked0 TOC Heading;}}{\*\datastore 010001000200000008000000556e6b6e6f776e00000000000000000000060000d0cf11e0a1b11ae1000000000000000000000000000000003e000300feff090006000000000000000000000001000000010000000000000000100000feffffff00000000feffffff0000000000000000fffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffdfffffffeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff5200000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000002000500ffffffffffffffffffffffff0c6ad98892f1d411a65f0040963251e500000000000000000000000068e3e54f96eace01feffffff00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000ffffffffffffffffffffffff0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000ffffffffffffffffffffffff0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000ffffffffffffffffffffffff0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000100010000000000}}